ID,Target_Status
1076,Discontinued in Phase 2/3
190816,Phase 2b
180551,Phase 2a
51630,Phase 1b/2a
50566,Phase 2
148985,Discontinued in Phase 1
71409,Patented
18091,Phase 1
39903,Phase 2/3
178779,Phase 1/2a
2407,Phase 1
77234,Discontinued in Phase 1/2
111828,Phase 1/2
82352,Phase 0
91923,Investigative
100272,Phase 0
150202,Phase 1/2a
69018,Phase 2/3
52918,Phase 1b
139576,Phase 1b
183241,Discontinued in Preregistration
19238,Discontinued in Phase 2b
79175,Phase 3
86970,Phase 1b
167681,Phase 1/2a
41364,Phase 2
164543,Phase 1/2
128103,Phase 1/2
108193,Phase 1b
174744,Phase 1/2
76428,Discontinued in Phase 1/2
172171,Discontinued in Phase 3
172407,Discontinued in Phase 2/3
75293,Patented
146326,Phase 2
109927,Discontinued in Phase 4
53344,Phase 1/2
175089,Discontinued in Preregistration
152739,Discontinued in Phase 3
117103,Discontinued in Phase 1
39865,Phase 1/2a
163171,Patented
28134,Phase 1
35973,Phase 0
134865,Phase 0
179451,Phase 2a
184077,Discontinued in Phase 4
97569,Phase 0
166430,Investigative
29450,IND submitted
44419,Phase 1/2a
23068,Phase 2/3
122443,IND submitted
161708,Phase 1b
55646,IND submitted
36052,Phase 1/2a
75218,Phase 2
65730,Approved
3414,Phase 2a
42637,Phase 1
84072,Phase 0
54295,Phase 1/2a
61724,Discontinued in Phase 4
81456,Phase 1b
159919,Phase 1b/2a
170561,Phase 0
97956,Discontinued in Phase 2
47124,Discontinued in Phase 1/2
101661,Investigative
72399,Phase 2
11624,Investigative
36380,Patented
142752,Phase 1b/2a
68178,Phase 1
155070,Phase 1b/2a
87634,BLA submitted
20173,Patented
121712,Phase 0
22702,Phase 1/2a
28424,Investigative
58479,Phase 1
160461,Phase 0
135469,Phase 0
98016,Phase 0
25987,Phase 2
126791,Phase 1/2a
198,Discontinued in Phase 1/2
83445,Phase 1b/2a
2427,Discontinued in Preregistration
90338,Phase 1b
29321,IND submitted
169121,Discontinued in Phase 1/2
71635,Discontinued in Preregistration
64195,Phase 2
1280,Investigative
45899,Phase 1/2a
187156,Discontinued in Preregistration
615,Discontinued in Phase 1
1504,Discontinued in Phase 2/3
62231,Phase 2/3
185606,Clinical trial
133311,Approved
1429,Discontinued in Phase 2/3
154212,Patented
115650,Phase 2/3
155951,Phase 1b/2a
166073,Phase 1b/2a
36424,Phase 1
92574,Phase 1b/2a
51518,Phase 2
173546,Phase 1/2
145905,Phase 1b
58782,Investigative
154622,Phase 1b/2a
49121,Discontinued in Phase 2/3
56599,Discontinued in Phase 2b
28100,Phase 1
112175,Discontinued in Phase 3
10130,Phase 0
142344,Discontinued in Phase 2/3
185022,Phase 1
58218,Phase 1/2
54311,Phase 1
48970,Phase 1b/2a
179558,Discontinued in Phase 1/2
88828,Phase 1/2a
53623,Investigative
32817,Phase 1/2a
20604,Phase 1/2
173983,Discontinued in Preregistration
181428,Phase 1/2a
67230,Phase 2/3
132349,Discontinued in Preregistration
181260,Phase 2
158509,Phase 1
131828,Phase 0
125926,Investigative
104817,Discontinued in Preregistration
23151,IND submitted
179403,Phase 1/2a
83397,IND submitted
166894,Phase 2b
235,Phase 1
94684,Patented
145681,Phase 0
55749,Phase 0
99332,Phase 1/2
59161,Phase 1/2a
35023,Phase 2a
130224,Phase 1/2
72003,Patented
179542,Phase 1
143972,Patented
6,Discontinued in Phase 3
27865,Phase 2
98585,Phase 1b
80387,Discontinued in Phase 2
67043,Phase 0
92348,Discontinued in Phase 4
129344,Phase 0
91571,IND submitted
109280,Phase 1/2a
42700,Phase 2/3
87885,Phase 1
187373,Phase 4
90239,Discontinued in Phase 2
115872,Phase 1b
143157,Phase 2
126584,Phase 0
12835,Phase 0
160456,Phase 1
126388,Discontinued in Phase 3
175277,Phase 1/2
24912,Phase 1b
70214,Phase 1b/2a
85364,Discontinued in Phase 2b
44607,Phase 2/3
92924,Phase 2
41867,Phase 1/2a
122081,IND submitted
165594,Phase 1
124112,Phase 0
182729,Phase 1/2
22832,Phase 1
15536,Phase 0
20771,Phase 1/2
134695,Phase 0
88453,Phase 1
70839,Phase 2/3
146661,Investigative
154091,Discontinued in Phase 2b
119331,Phase 2a
191472,Discontinued in Phase 1
125304,Phase 1/2
78198,Clinical trial
165065,Phase 1/2
141550,Investigative
168044,Patented
37748,Phase 1/2a
32955,Phase 2
143091,Phase 2a
58875,Phase 2/3
56982,Phase 1
94506,Phase 1/2
148425,Investigative
122086,Phase 1b
142356,Investigative
86078,Clinical trial
67717,Approved (orphan drug)
192048,Discontinued in Phase 2
166316,Discontinued in Phase 1/2
3627,Discontinued in Phase 3
86412,Phase 2
31010,Investigative
47339,Phase 0
160766,Phase 1/2a
178070,Phase 1
100799,Phase 2/3
135055,Phase 0
32732,Discontinued in Phase 1
117831,Discontinued in Phase 1
142387,Discontinued in Phase 2b
41715,Phase 1/2a
74155,Phase 1/2
14509,Phase 1/2a
19539,IND submitted
126939,Discontinued in Phase 1
174782,Discontinued in Phase 3
87329,Phase 1/2
157699,IND submitted
96574,Discontinued in Phase 2b
14909,Phase 1/2
103270,Approved
127377,IND submitted
57788,Phase 1
168734,Phase 2
41595,Phase 1b
17247,Phase 1
144165,Phase 2
52088,Phase 1/2a
179928,Phase 1/2
140825,Registered
34785,Discontinued in Preregistration
120829,Discontinued in Phase 2
187992,Discontinued in Phase 4
130353,Discontinued in Preregistration
111425,Phase 1
111893,Discontinued in Phase 3
166029,Phase 1b
186429,Phase 0
151440,Phase 2
185252,Discontinued in Phase 1
5670,Investigative
146635,Phase 1
45969,Phase 2/3
120366,Approved (orphan drug)
148225,Phase 1/2
179000,Phase 0
162859,Phase 1/2
61893,Investigative
78874,Phase 1b
135424,Phase 0
179554,Discontinued in Phase 1
149092,Phase 1
77411,Phase 1b
144191,Clinical trial
133228,Discontinued in Phase 1
35331,Phase 0
126969,Phase 0
144984,Investigative
89914,Discontinued in Preregistration
131549,IND submitted
172101,Discontinued in Phase 2b
148041,Phase 1b/2a
46997,Phase 1/2
98808,Phase 1b/2a
43146,Phase 0
66137,Phase 2/3
112697,Discontinued in Phase 3
180294,Discontinued in Phase 2b
12550,Phase 1
155571,Phase 2
27026,Phase 1b/2a
29244,Discontinued in Phase 2/3
19710,Phase 1
82907,Phase 1/2a
7942,Patented
110171,Discontinued in Phase 2/3
14749,Phase 1b/2a
4742,Discontinued in Phase 2
132032,Phase 1/2
89564,Phase 1
183141,Discontinued in Preregistration
120058,Phase 0
168856,Patented
131012,Discontinued in Preregistration
94312,Phase 1/2a
87653,Phase 0
147612,Phase 1b/2a
49271,Investigative
49080,Phase 1/2
7941,Patented
176036,Phase 1/2a
59785,Phase 1b/2a
47618,Investigative
49689,Discontinued in Preregistration
131551,Discontinued in Phase 2/3
18125,Phase 2a
191833,Patented
12914,Phase 1
51358,Phase 1b/2a
64216,Phase 2a
96865,Investigative
135397,Phase 0
149886,Phase 1b
57277,Phase 0
48570,Phase 1b/2a
1948,Investigative
97593,Investigative
149207,Phase 2b
52128,Phase 2/3
33604,Phase 1b/2a
119724,Discontinued in Phase 4
122618,Phase 0
119377,Discontinued in Preregistration
36652,Phase 0
93710,Discontinued in Phase 1
22884,Phase 2/3
191345,Phase 2a
113016,Phase 1
145070,Phase 2/3
2126,Phase 2b
38114,Discontinued in Phase 2
162981,Phase 1/2a
148886,Phase 1b/2a
23811,Patented
178031,Patented
26151,Phase 1/2
165273,Phase 0
83182,Phase 1
22787,Phase 1/2
171228,Phase 2/3
188172,Phase 1b
29183,Phase 1/2a
120309,Discontinued in Phase 4
73026,Phase 2
50819,Discontinued in Phase 2/3
112924,Phase 1
82829,Discontinued in Phase 4
383,Phase 2
131070,Phase 1b
19985,Phase 2a
38976,Discontinued in Preregistration
2797,Discontinued in Phase 3
32628,Phase 1/2a
102702,Investigative
73562,Approved (orphan drug)
91494,Phase 1b/2a
119670,Discontinued in Preregistration
59470,Investigative
58003,Phase 1
142506,Phase 0
30931,Investigative
100618,Phase 3
122117,Phase 1b
45286,Phase 1/2a
113838,Discontinued in Preregistration
98906,Phase 1
171090,Phase 1
144669,Discontinued in Phase 4
105387,Phase 1b
23005,Phase 1/2
179129,Phase 0
108396,Phase 1b
112355,Discontinued in Phase 3
191364,Discontinued in Phase 1
81588,Approved
81457,Discontinued in Phase 1
143442,Phase 1b/2a
190751,Preclinical
122961,Phase 0
119846,Approved (orphan drug)
6991,Phase 4
61351,Phase 1
191164,Phase 2a
152756,Approved
95542,Phase 1b
177791,Phase 2
14671,Phase 1
43091,IND submitted
169098,Discontinued in Phase 2
16170,Phase 1
95577,Phase 2
35038,Phase 1/2a
299,Phase 2
36279,Patented
125901,IND submitted
73172,Investigative
178061,Patented
24333,Discontinued in Phase 4
30860,Investigative
126177,BLA submitted
73532,Investigative
167960,Investigative
131769,Patented
85355,Discontinued in Phase 2b
124331,Approved
190735,Clinical trial
158939,BLA submitted
43407,Phase 2/3
50535,Phase 1b/2a
28390,Phase 1b
119632,Discontinued in Phase 2b
179611,Phase 1/2a
70536,Phase 1b/2a
153937,Phase 1b/2a
98459,Phase 1/2
58581,Phase 1b/2a
126580,Phase 1b/2a
161681,IND submitted
48635,Phase 1/2a
70555,Discontinued in Phase 4
154676,Phase 2/3
412,Discontinued in Phase 2/3
65899,Discontinued in Phase 2
55854,Discontinued in Phase 2b
51174,IND submitted
28394,Phase 1/2a
166322,Phase 1b/2a
2939,Phase 0
164180,Phase 2/3
43829,Phase 1/2a
53822,Discontinued in Phase 3
119744,Phase 1/2a
44335,Phase 2/3
168539,Clinical trial
26934,IND submitted
84104,Phase 1
192123,Phase 1/2
167416,Discontinued in Phase 1/2
20486,Phase 1/2
113698,Phase 2
188648,Approved (orphan drug)
183896,Discontinued in Phase 4
34687,Phase 0
191493,Discontinued in Phase 4
144223,Discontinued in Phase 4
24935,Investigative
174786,Phase 1
14822,Phase 0
19305,Phase 1/2a
150585,Phase 1b/2a
52868,Phase 1/2
189159,Phase 2/3
30232,Phase 0
129047,Discontinued in Preregistration
17807,Phase 0
169210,Discontinued in Phase 2
93287,Phase 2
141523,Patented
93403,Phase 1b
24093,Investigative
47117,BLA submitted
23547,Discontinued in Preregistration
40724,Phase 2
124365,Investigative
26710,Phase 1b
56175,Phase 1b/2a
172815,Discontinued in Phase 2b
165623,Phase 1b/2a
170486,Phase 1b/2a
68391,Clinical trial
2595,Phase 1b/2a
35208,Investigative
72817,Investigative
60496,Phase 0
167795,Approved (orphan drug)
95363,Discontinued in Phase 4
8733,Investigative
137748,Investigative
65337,Discontinued in Phase 2/3
55944,Discontinued in Preregistration
89820,Investigative
62522,Patented
124397,Approved
35546,Discontinued in Phase 2b
3565,Discontinued in Preregistration
46167,Phase 2/3
139969,Clinical trial
159957,Discontinued in Phase 1/2
84088,Discontinued in Phase 1/2
102577,Phase 1
99672,Phase 1/2
176382,Discontinued in Phase 2
60847,Phase 2/3
28002,IND submitted
86849,Phase 1/2
153454,IND submitted
31294,Discontinued in Preregistration
188808,Discontinued in Phase 3
126467,Phase 1
103365,Phase 1/2a
17201,Phase 1
54229,Discontinued in Phase 4
11896,Discontinued in Phase 2/3
151285,Phase 0
4720,Phase 2a
21531,Discontinued in Phase 3
60692,Phase 0
1460,Phase 0
125351,Phase 1b
12690,Phase 1
77029,Phase 1/2
42381,Phase 1
91345,Phase 0
185436,Discontinued in Preregistration
157663,Phase 1b
68133,Phase 2b
168462,Discontinued in Phase 4
161325,Phase 2a
189595,Phase 2b
152253,Phase 1
57467,Phase 1
55992,Discontinued in Phase 2b
148054,Clinical trial
95545,Phase 2/3
185450,Discontinued in Phase 2
189045,Clinical trial
103962,BLA submitted
93802,Phase 1/2a
144948,Phase 1b/2a
171550,Phase 2a
114593,Investigative
108171,Investigative
110089,Phase 1
15156,Phase 0
128044,Discontinued in Phase 2b
158631,Phase 1
110045,Phase 1
156123,Phase 1/2a
83194,IND submitted
23877,Discontinued in Phase 2/3
177372,Phase 1b
80852,Discontinued in Phase 3
178002,Phase 1
168729,Clinical trial
8600,Phase 1/2
73242,Approved
22993,Phase 1b
97129,Phase 1b
158740,Phase 1b/2a
158963,BLA submitted
123927,Phase 1
166120,Discontinued in Phase 4
87051,Phase 1b
66340,Discontinued in Phase 1/2
88131,Phase 0
119067,Approved
96328,Phase 1b/2a
47476,Discontinued in Phase 2/3
68675,Phase 2b
163405,Phase 0
85294,Discontinued in Phase 3
127057,Discontinued in Phase 4
87393,Approved
79449,Phase 2a
168053,Phase 1b
56066,Discontinued in Phase 3
50307,Phase 0
117793,Phase 1
167437,Discontinued in Phase 1
122381,Phase 1b
25876,Phase 2
69614,Phase 1b/2a
36922,Phase 0
116679,Discontinued in Phase 3
150104,Phase 2b
14571,Phase 1b/2a
15090,Phase 1
104376,Phase 1/2
122841,Phase 1/2
105626,Phase 1b/2a
122136,Phase 0
52455,Discontinued in Phase 2b
58552,Phase 1/2a
6662,Phase 2a
84848,Phase 1/2
145268,Phase 2b
56925,Phase 2
172879,Patented
106944,Phase 0
32235,Phase 2a
142668,Phase 2a
141670,Investigative
157832,Phase 1b/2a
170536,Phase 1b
53229,Phase 1
96918,Phase 0
184395,BLA submitted
155307,Phase 2
76164,Phase 1b/2a
92963,Phase 2b
170832,Patented
116047,Phase 1b/2a
118950,BLA submitted
40599,Phase 2
181981,Phase 1
91412,Patented
87994,Phase 0
112799,Discontinued in Phase 3
173734,Phase 1
15138,Phase 0
105363,Phase 1
114974,Discontinued in Preregistration
167732,Phase 0
149243,Phase 2/3
131898,Discontinued in Phase 4
180848,Discontinued in Phase 4
77804,Phase 0
125108,Phase 1/2
39652,Discontinued in Phase 4
41476,Phase 1
93547,Phase 2
127503,Investigative
28974,Phase 1/2a
56513,Phase 4
167736,Phase 1/2a
250,Phase 1/2a
127821,Phase 1/2
60045,Phase 1b/2a
167553,Phase 4
168560,Clinical trial
151912,Phase 2a
42450,Phase 2
137994,Phase 1/2a
104180,Phase 2
2031,Approved
66813,Phase 2a
73286,Investigative
149369,Phase 2b
114008,Discontinued in Phase 3
130406,Discontinued in Phase 1
106868,Discontinued in Phase 4
35281,Discontinued in Phase 3
149513,Discontinued in Phase 2
100474,Investigative
131737,Discontinued in Phase 2b
107062,IND submitted
158163,Discontinued in Preregistration
121982,Phase 2b
134792,Phase 0
56705,Phase 1b/2a
42549,Phase 1
84324,Phase 0
71289,Phase 1b/2a
33508,Phase 1b/2a
127412,Phase 0
149756,Phase 1
12910,Phase 0
41530,Investigative
89455,Discontinued in Preregistration
185090,BLA submitted
175816,Phase 1/2
64998,Phase 1/2
89957,Phase 0
187774,Patented
167162,Discontinued in Phase 2
81317,Clinical trial
29886,Phase 2
160924,Phase 0
157474,Registered
175750,Phase 2b
52667,Discontinued in Phase 2b
86429,Phase 2
61108,Phase 1b
46568,Clinical trial
123230,Phase 0
152007,Phase 0
103160,Phase 0
63490,Phase 1/2a
50542,Phase 1b/2a
41301,Phase 1
190607,Patented
59810,Phase 2/3
31722,Phase 1
57571,Phase 2/3
83402,Discontinued in Preregistration
24132,Phase 2
6604,Phase 4
23488,Phase 1/2
77479,Patented
158659,Phase 2
137618,Phase 1/2a
69170,Discontinued in Phase 2/3
2392,Phase 0
63845,Phase 1b/2a
41667,Phase 2
81545,Approved
59448,Phase 1/2a
156443,Phase 1/2a
72570,Phase 2
52122,Discontinued in Phase 3
142217,Phase 2/3
162225,Phase 2a
52253,Phase 0
153647,Phase 3
148703,Phase 1
152469,Patented
144679,Patented
28766,Investigative
15447,Phase 0
91087,Approved (orphan drug)
95086,Phase 1/2a
43807,Phase 2/3
168622,Discontinued in Phase 1/2
43213,Investigative
134434,Phase 1/2
14738,Phase 1
162222,Investigative
70723,Phase 2
149133,Phase 1b/2a
35119,Phase 2a
190285,Approved (orphan drug)
182019,Phase 1b/2a
69829,Phase 1
22821,Phase 1/2
22724,Investigative
29014,Phase 1/2a
117907,Investigative
40739,Phase 0
171978,Phase 1b
162695,Phase 2
12878,Phase 1
126776,Discontinued in Phase 3
60921,Discontinued in Phase 3
148490,Patented
96208,BLA submitted
37572,Phase 2a
61861,Discontinued in Phase 2b
155014,Discontinued in Preregistration
46290,Patented
155478,Phase 2/3
105708,Phase 1/2a
6267,Phase 1b/2a
75701,Phase 0
59722,Investigative
79046,Phase 0
190549,Phase 1b/2a
135918,Phase 1b/2a
132544,Discontinued in Phase 4
186082,Phase 1b
178140,Phase 2
3237,Investigative
15662,Phase 1
82831,Phase 2/3
105874,Phase 2/3
82349,Phase 0
21756,Discontinued in Phase 2b
189296,Phase 1/2a
49042,Phase 1b
36095,Phase 2
67244,Clinical trial
84176,Phase 0
22678,Investigative
151763,Phase 0
130815,Phase 2
50214,Phase 1b
14794,Phase 1/2
124913,Phase 0
20340,Phase 1b/2a
173132,Discontinued in Phase 2
48648,Discontinued in Phase 2b
33389,Phase 2a
84060,Phase 0
4012,Phase 0
56301,Phase 0
20332,Phase 1
139578,Phase 1/2
72212,Phase 1/2
32680,Phase 1/2
56698,Phase 0
179133,Discontinued in Phase 3
19119,Phase 1
9301,Phase 1/2
150469,Investigative
177314,Phase 2a
113882,Patented
115284,Phase 1b/2a
128915,Phase 1/2a
71275,Phase 0
4150,IND submitted
105079,Phase 0
58063,Phase 2/3
150220,IND submitted
24361,Discontinued in Preregistration
11705,Phase 1/2a
66041,Phase 4
109883,Discontinued in Preregistration
58582,Phase 1/2
152399,Phase 2/3
134128,Phase 1/2a
93120,Phase 2b
142772,Phase 2/3
24595,Discontinued in Phase 4
81826,IND submitted
185337,Discontinued in Phase 4
122881,Discontinued in Preregistration
109721,Approved
16340,Phase 1/2a
186588,Phase 0
105077,Phase 0
41427,IND submitted
186040,Phase 0
151301,Discontinued in Phase 2/3
19413,Discontinued in Preregistration
119272,Discontinued in Phase 3
52516,Discontinued in Phase 3
147980,Discontinued in Phase 2/3
135610,Phase 0
166690,Phase 1/2a
22089,Phase 2/3
140130,Phase 1/2a
38603,Phase 2/3
185347,Discontinued in Phase 3
171999,Discontinued in Phase 2
189663,Phase 1/2
115014,Discontinued in Phase 2
72863,Phase 1/2
57730,Discontinued in Phase 3
133368,Discontinued in Phase 1
71091,Discontinued in Phase 3
176930,Phase 0
92800,Discontinued in Phase 1
26608,Phase 1b
127555,Patented
84745,Phase 0
168900,Clinical trial
104200,Phase 2
60872,Approved (orphan drug)
115947,Phase 2
93196,Phase 1
121169,Phase 1b
36121,Phase 0
80140,Clinical trial
30665,Phase 1
114500,Investigative
107595,IND submitted
141586,Discontinued in Preregistration
82285,Phase 1b/2a
18689,Phase 1b
48894,Discontinued in Preregistration
15124,Phase 1
115705,Phase 1/2
177214,Phase 1b
45034,Phase 2/3
73495,Phase 1b
65476,Approved (orphan drug)
10462,Phase 0
82614,IND submitted
44828,Phase 1/2a
8058,Phase 2
171351,Discontinued in Phase 2
128927,Discontinued in Preregistration
10576,Discontinued in Phase 3
104627,Patented
131157,Investigative
182499,Phase 1b/2a
26838,Phase 0
113858,Patented
95058,Phase 1
67224,Clinical trial
81174,Phase 1b
132305,IND submitted
150207,Discontinued in Preregistration
180930,Phase 1/2
143074,Discontinued in Phase 4
58835,Phase 1b/2a
34458,Phase 1/2
19744,Phase 2
163616,Discontinued in Phase 2
77075,Phase 1/2
21148,Phase 2
175300,Phase 1
36729,Phase 2
84237,Phase 0
81133,Discontinued in Phase 1
152957,Phase 1b/2a
38050,Phase 1
138369,Phase 1/2a
26907,Phase 1b
147203,Patented
93951,Phase 2b
99502,Phase 1/2
162209,Investigative
19132,Discontinued in Preregistration
94184,Phase 1
109129,Patented
145308,Phase 0
102462,Approved (orphan drug)
170270,IND submitted
184745,Phase 0
162529,IND submitted
114363,Patented
9049,Phase 2/3
67153,Phase 1b/2a
25137,Discontinued in Phase 4
65838,Discontinued in Phase 2b
46767,Discontinued in Phase 1/2
20126,Clinical trial
40358,Phase 1
166175,Phase 1
110720,Phase 1/2
67467,Discontinued in Phase 1
126808,Phase 0
4376,Phase 2a
136805,Phase 1/2
62646,Phase 1
34365,Phase 1/2a
66204,Discontinued in Phase 3
52742,Phase 2
61052,Phase 1b
190698,Phase 4
114680,Investigative
1817,Phase 1
127317,Phase 1/2
101959,Patented
8456,Discontinued in Phase 2/3
108957,Phase 1/2a
156223,IND submitted
142978,Discontinued in Preregistration
158878,BLA submitted
69023,Phase 1b
101291,Phase 1/2
53874,Phase 1b/2a
190660,Phase 2b
55057,Investigative
156590,Preregistration
51113,Investigative
47070,Approved
109759,Preregistration
133565,IND submitted
146500,Phase 0
17855,Phase 2b
103469,Discontinued in Phase 2/3
143871,Phase 1/2
165002,BLA submitted
85870,Discontinued in Phase 3
46127,Phase 2/3
177443,Approved
188826,Phase 4
69971,Phase 1
133062,Phase 1/2
70647,Discontinued in Preregistration
158942,Phase 1b
51706,Discontinued in Phase 2b
81903,Discontinued in Phase 1
181904,Phase 2a
80101,Phase 2a
14029,Phase 1/2a
24686,Phase 2
181924,Phase 2a
171593,Phase 2a
12809,Phase 1
74931,Discontinued in Phase 2/3
43974,Phase 1/2a
39925,Phase 1/2a
172546,Discontinued in Phase 2b
111343,Phase 1/2
401,Discontinued in Phase 2/3
171017,Discontinued in Preregistration
28906,Investigative
10140,Preclinical
107694,Phase 2/3
78789,Discontinued in Phase 4
133613,Phase 1b
62452,Phase 1b
57197,Discontinued in Phase 3
102712,Phase 0
175987,Discontinued in Phase 1/2
75575,Phase 0
35974,Discontinued in Phase 1
121555,Approved
29194,Investigative
30343,Phase 1
77283,Phase 1/2a
137931,Investigative
62306,Investigative
63963,Clinical trial
23692,Discontinued in Phase 2/3
23470,Discontinued in Phase 2/3
147817,Investigative
12196,Phase 1/2
69101,Phase 1
42197,Phase 0
81025,Phase 2a
101946,Phase 1
130108,Phase 2/3
189681,Phase 1/2
14508,Phase 1/2a
10544,Discontinued in Phase 2/3
74461,IND submitted
107796,Discontinued in Phase 2/3
164505,Discontinued in Preregistration
47294,Discontinued in Phase 4
21822,Patented
12725,Phase 1/2
96133,Phase 0
62023,Discontinued in Phase 2b
12487,Phase 0
58132,Phase 1/2a
107956,Discontinued in Phase 4
503,Phase 1/2a
9021,Approved
183777,Discontinued in Phase 2
102503,Application submitted
105933,Discontinued in Phase 4
125181,IND submitted
158108,Phase 1/2
175884,Phase 3
182501,Phase 2a
7222,Phase 2a
18454,Phase 1/2
83791,Phase 1
29273,Phase 2
9909,Patented
148749,Phase 2b
21799,Phase 1b/2a
111274,Discontinued in Phase 3
68839,Discontinued in Preregistration
1055,Phase 1
5785,Phase 4
7756,Phase 1
53520,Phase 3
130326,Investigative
24457,Phase 1b/2a
138457,Phase 1/2a
153447,Phase 1b
36056,Phase 2/3
150397,Phase 1/2a
171039,Phase 2/3
165190,Discontinued in Preregistration
165011,Phase 1/2
111702,Phase 0
83250,Patented
52546,Investigative
124472,Phase 1
72477,Phase 2
51207,Discontinued in Preregistration
31690,Phase 0
45218,Phase 2/3
186885,Phase 2b
178888,Phase 1/2
562,Phase 2b
66786,IND submitted
144582,Discontinued in Phase 2
104683,Phase 1/2
161160,Discontinued in Phase 4
73922,Discontinued in Preregistration
103971,Phase 1b
177450,Phase 2
100828,Phase 3
42265,Phase 1/2a
96539,Phase 0
176965,Phase 2b
12636,Phase 1b/2a
1374,Discontinued in Preregistration
3447,Investigative
22849,Patented
73396,Phase 2
65362,Phase 1/2a
105560,Phase 1b/2a
128891,Discontinued in Preregistration
120834,Discontinued in Phase 3
135462,Phase 0
159529,Phase 0
157672,Clinical trial
93749,Phase 1/2
52809,Phase 2
130251,Phase 1b/2a
14981,Phase 1
10066,Phase 1
66514,Phase 0
113336,Phase 2a
180987,Phase 2/3
66313,Phase 2
134261,Phase 1/2
9271,Discontinued in Phase 2
176142,Discontinued in Preregistration
79647,Phase 1
92726,Phase 1/2a
111515,Phase 1/2
106044,Phase 1b
174402,Discontinued in Phase 4
7256,Phase 2/3
185354,Approved
63095,Phase 1b
95386,Phase 1
9581,Patented
145830,Phase 1b
87483,Phase 2/3
179806,Discontinued in Phase 4
116459,Discontinued in Phase 3
47857,Phase 1
40055,Phase 1
104819,Patented
171759,Phase 2
106037,Phase 1b
52445,Phase 2
76643,Phase 1/2a
107230,IND submitted
25599,Phase 1/2
32246,Phase 1/2
39053,Phase 2/3
111752,Phase 1/2
45871,Phase 2/3
16708,Phase 3
139880,Clinical trial
79715,Discontinued in Phase 2
134236,Phase 1
99126,Discontinued in Phase 2/3
135851,Phase 1/2
96827,Phase 1/2a
9234,Discontinued in Phase 2/3
165713,Phase 1b/2a
87856,Phase 0
48861,IND submitted
34314,Phase 1/2a
48767,Phase 1b/2a
189580,Phase 4
57999,Phase 1
126251,Phase 1b
58480,Phase 0
100458,Phase 1/2
35269,Phase 1b
69845,Phase 1
17626,Phase 1
126355,Phase 1b/2a
92142,Phase 1/2
76204,Investigative
81792,Phase 2
150804,Phase 0
191570,Investigative
166796,Phase 1/2
128991,Discontinued in Phase 1
60308,Phase 1
143154,Phase 1b/2a
184305,Discontinued in Phase 4
69151,Discontinued in Phase 3
159832,Phase 1b
156430,Phase 1/2a
72456,IND submitted
148167,Phase 1b
132204,Phase 2
82714,Phase 2
42402,Approved
36993,Discontinued in Phase 2b
110979,Phase 1/2
15083,Phase 1/2a
72860,Phase 1b/2a
173640,Phase 1/2
52657,Discontinued in Phase 2/3
120546,Discontinued in Phase 3
188374,Phase 2b
111927,Phase 1
116400,Discontinued in Phase 3
77091,Phase 0
111616,Patented
118580,Discontinued in Preregistration
90527,Discontinued in Phase 2b
54424,Discontinued in Phase 2b
56337,Discontinued in Phase 3
124819,IND submitted
121475,Phase 1b/2a
120108,Discontinued in Phase 1/2
14284,Phase 1b/2a
61054,Discontinued in Phase 3
6343,Phase 4
33725,Phase 2a
126120,Discontinued in Preregistration
166416,Discontinued in Phase 1/2
97116,Discontinued in Phase 2
21787,Patented
45856,Phase 2/3
38791,Phase 1b/2a
96966,Phase 1/2a
44794,Phase 2/3
11986,Discontinued in Phase 2/3
103133,Discontinued in Preregistration
144459,Discontinued in Phase 2
19769,Phase 2a
4982,Phase 1/2
151706,Phase 1b/2a
59549,Discontinued in Phase 3
31118,Discontinued in Phase 2b
114325,Phase 1
151014,Phase 1
63530,Discontinued in Phase 2/3
125176,BLA submitted
176492,Phase 1b
191283,Phase 1
177195,Phase 1b/2a
110379,Phase 1b/2a
191195,BLA submitted
170826,Discontinued in Phase 1
44492,Phase 1/2a
87571,Phase 1/2a
94374,Phase 1/2a
44187,Phase 1/2a
185624,Phase 2b
139190,Investigative
118609,Discontinued in Preregistration
47644,Phase 0
7237,IND submitted
131878,Discontinued in Phase 1/2
48714,Discontinued in Phase 2b
100602,Phase 1/2
31488,Discontinued in Phase 2b
90422,Discontinued in Preregistration
28836,Investigative
80027,Phase 1/2a
75187,Phase 1/2
54150,IND submitted
42283,Phase 1b
4180,Phase 2/3
17065,Discontinued in Phase 1
172718,Phase 1/2
161280,Patented
71314,Phase 0
279,Phase 1
165520,Discontinued in Phase 1
55975,Phase 2
145424,Phase 2b
83206,Discontinued in Phase 4
100447,Phase 1b
131332,Phase 1/2
7162,Phase 4
58568,Phase 0
104804,Phase 1b/2a
136862,Phase 1/2a
113081,Phase 2a
74927,Discontinued in Phase 4
82060,Discontinued in Phase 2/3
124840,Phase 1
170006,IND submitted
146906,Phase 2b
4451,Phase 1/2
73470,Approved
130252,Investigative
19948,Phase 2a
106207,Phase 2/3
108348,Phase 1b
180106,Phase 1b
135519,Phase 0
168320,Approved
120677,Discontinued in Phase 4
102676,Patented
106076,Phase 1/2a
96231,Phase 1b
35669,Discontinued in Phase 1/2
124022,Phase 0
12031,Phase 2/3
2835,Discontinued in Phase 2
29770,Phase 0
146314,Phase 1/2
32859,Phase 1/2a
28620,Investigative
139530,BLA submitted
172179,Phase 2
2575,Discontinued in Phase 1/2
163131,Discontinued in Phase 2
153666,Investigative
43274,Phase 1/2a
152310,Phase 2a
125011,Phase 1b
47991,Phase 1/2a
144442,Phase 1/2a
141696,Discontinued in Phase 2b
47307,Discontinued in Phase 4
189587,Phase 1b/2a
137405,Discontinued in Phase 2
3894,Phase 1
124009,Patented
52320,Discontinued in Phase 2b
59888,Phase 1
152846,Phase 2/3
146535,Phase 1/2a
143374,Phase 2b
145169,Phase 1b
164156,Phase 1/2a
58880,Phase 1
7981,Discontinued in Phase 3
110104,Phase 1/2a
54080,Discontinued in Phase 3
153548,Phase 1b
186759,Phase 0
79462,Phase 1b/2a
10025,Phase 1b/2a
121653,Patented
104160,Phase 2
102216,Phase 1/2a
61255,Phase 1
112420,Phase 1
40318,Investigative
26226,Phase 1/2
112823,Discontinued in Phase 3
189402,Approved (orphan drug)
167877,Phase 1/2a
175533,Phase 3
46557,Discontinued in Phase 2b
6118,Phase 4
6224,Phase 1/2
116215,Phase 1b/2a
131654,Discontinued in Phase 1/2
104310,Phase 1/2a
87401,Phase 1b/2a
79166,Phase 0
28761,Investigative
37973,Phase 0
129460,Phase 1b/2a
103466,Phase 1/2
120949,Phase 1b
14640,Phase 0
93777,Phase 1
499,Phase 1
161533,Investigative
98436,Patented
60192,Phase 0
58083,Phase 1
29135,Phase 1b/2a
36118,Discontinued in Phase 1
65909,Discontinued in Phase 2/3
35168,Phase 1b/2a
74266,Discontinued in Phase 4
172313,Discontinued in Phase 2b
165951,Phase 2
15160,Phase 0
2819,Phase 1/2
112477,Phase 1/2
127911,Discontinued in Phase 1
151427,Phase 1b/2a
21747,Investigative
3462,IND submitted
166925,Investigative
165315,IND submitted
99215,Phase 1/2a
56494,Phase 0
160022,Phase 1b/2a
109224,Investigative
139488,Phase 1b
138165,Clinical trial
72240,Phase 0
161356,Phase 0
188319,Patented
112740,Discontinued in Phase 3
4031,Discontinued in Phase 2
45151,Phase 2/3
53907,Phase 1/2a
16101,Phase 1
49130,Discontinued in Phase 3
52848,Phase 1b
76210,Phase 1b
29479,Phase 1
4207,Phase 2/3
189656,Phase 1/2a
59862,Investigative
154090,Phase 1/2a
113633,Phase 1
88857,Phase 1/2a
73428,Phase 2/3
125582,Phase 1b
6316,Phase 4
47260,Patented
173042,Phase 1/2
29579,Clinical trial
129120,Discontinued in Phase 2b
185381,Discontinued in Phase 4
88281,Phase 2a
33594,Phase 2/3
27727,Phase 1
59037,Phase 1b/2a
147948,Investigative
144101,Phase 2
45993,Phase 2/3
50415,Discontinued in Phase 2b
72406,IND submitted
54693,Discontinued in Preregistration
151015,Phase 1
72450,Phase 2
51480,Phase 3
162174,Investigative
52293,Discontinued in Phase 2b
146637,Phase 1b/2a
108825,Discontinued in Preregistration
163668,Discontinued in Phase 2/3
116485,Clinical trial
1344,Discontinued in Phase 2
117385,Clinical trial
78858,Phase 0
161668,Phase 1b
72221,Phase 0
124125,Phase 1
5933,Phase 2a
108424,Phase 1b
73815,Clinical trial
18865,Phase 1b
124533,Phase 1b
5928,Investigative
26224,Phase 1/2
125661,IND submitted
177320,Phase 1b
184187,Discontinued in Phase 4
36147,Phase 0
91103,BLA submitted
38294,Phase 2b
108270,Phase 0
156578,Approved (orphan drug)
140731,Phase 2a
165490,Discontinued in Phase 2/3
72082,Discontinued in Phase 1
36298,Investigative
124270,Phase 2
113110,Phase 1b/2a
102672,Application submitted
136935,Phase 1/2a
58674,Discontinued in Phase 3
93322,Phase 1b/2a
38925,Phase 1/2a
101089,Discontinued in Preregistration
65813,BLA submitted
134648,Phase 0
147587,Phase 1b
38078,Phase 0
16898,Phase 3
107218,Phase 0
163702,Patented
165807,Patented
160420,Phase 1
186311,Patented
163099,Investigative
116183,Phase 1/2
66030,Phase 1
61170,Phase 1
93712,Phase 1b/2a
76755,Phase 1/2a
88323,Phase 1
89147,Discontinued in Preregistration
122319,Investigative
147280,Phase 0
74702,Phase 1/2a
4132,IND submitted
130047,Phase 2a
52640,Phase 2/3
160471,Phase 1/2a
48841,Phase 2
112201,Phase 1/2
3160,Phase 1/2a
121522,Phase 0
93713,Phase 1b
9827,Discontinued in Phase 2b
37737,Discontinued in Phase 3
128679,Phase 1/2
120551,Investigative
165749,Phase 1b
147435,Phase 2/3
72351,Phase 1b
65431,Discontinued in Phase 2
31091,Investigative
71036,Phase 1b
138185,BLA submitted
67214,Clinical trial
165492,Phase 0
7424,Discontinued in Phase 2
1024,Clinical trial
82913,Discontinued in Phase 4
83370,Phase 1/2
130790,Clinical trial
117711,Phase 1b
40770,Discontinued in Phase 2/3
43681,Phase 2/3
60904,Phase 1/2a
176669,Discontinued in Phase 4
102072,Phase 1/2
184806,Phase 0
62474,Discontinued in Phase 2b
118500,Phase 1b/2a
91698,BLA submitted
47386,Discontinued in Preregistration
134989,Phase 0
50970,IND submitted
165401,Discontinued in Preregistration
62041,Discontinued in Phase 2b
76908,Patented
121815,Approved (orphan drug)
118436,Discontinued in Preregistration
70909,Discontinued in Phase 3
94869,Phase 1b
121519,Phase 2
17116,Investigative
71910,Discontinued in Preregistration
182422,Phase 2a
22806,Discontinued in Phase 4
150293,Discontinued in Phase 2
5022,Investigative
4195,IND submitted
56596,Discontinued in Phase 3
43939,Phase 1/2a
187781,Phase 0
171281,Phase 1
107086,Phase 1/2a
95000,Discontinued in Phase 1
27380,Phase 0
91059,Discontinued in Phase 2b
109356,Phase 2
191002,Phase 2b
102535,IND submitted
35573,Discontinued in Preregistration
100395,Phase 1
81326,Phase 1b/2a
88631,Phase 1/2
177635,Phase 1b/2a
71382,Discontinued in Preregistration
36574,Discontinued in Preregistration
85487,Discontinued in Phase 2b
42422,Discontinued in Phase 1
192030,Discontinued in Phase 2
51862,Patented
115140,Discontinued in Phase 2
64987,Phase 0
9327,Phase 2
107197,Phase 1b
15988,Phase 1
146646,Phase 1b
86562,Discontinued in Phase 4
18018,Phase 2
22181,BLA submitted
32447,Phase 2/3
19499,Investigative
178961,Phase 1/2a
78663,Phase 2a
19526,Discontinued in Phase 2b
109442,Phase 3
123328,Phase 1b
138527,Discontinued in Phase 2
112769,Discontinued in Phase 3
158144,Discontinued in Phase 2/3
188243,Phase 2b
123979,Phase 1/2
155934,Discontinued in Phase 2b
70067,Phase 0
13312,Phase 1
50327,Phase 1b/2a
95249,Patented
90655,Approved
15948,Phase 1/2a
173365,Phase 1b
132436,Discontinued in Phase 2b
173326,Discontinued in Phase 2
27035,Phase 1b
75004,Phase 1b/2a
127370,Phase 1/2
38838,Phase 0
143279,Phase 1b/2a
163208,Phase 2
9144,IND submitted
11642,Patented
57785,Discontinued in Phase 3
67766,Phase 2a
170288,Phase 0
181155,Phase 2a
12284,IND submitted
128693,Discontinued in Phase 2b
180572,Phase 2a
52592,Discontinued in Phase 2b
146649,Phase 1b
127105,IND submitted
98248,Phase 1b/2a
62606,Phase 1
23067,Phase 1b
26144,Phase 1/2a
34245,Phase 0
48745,Phase 0
4574,Phase 2a
154715,Phase 1b/2a
139013,Approved (orphan drug)
90341,Discontinued in Phase 1
11366,Phase 1b/2a
43105,Discontinued in Phase 1
173699,Phase 1b/2a
157160,Clinical trial
145183,Phase 1/2
117257,Phase 2
81447,Approved
101752,Phase 1
103579,Discontinued in Phase 1/2
189168,Approved (orphan drug)
86599,Phase 1/2a
118701,Registered
32597,Phase 1b/2a
68923,Discontinued in Phase 4
78611,Phase 0
111589,Phase 1/2a
11205,Phase 1/2
22353,Investigative
83013,Phase 0
145437,Phase 1b
13288,Phase 1
157510,Phase 1/2
66848,Investigative
83136,IND submitted
115810,Phase 1/2
179106,Phase 0
135436,Phase 0
128742,Discontinued in Phase 2b
134877,Phase 0
92428,Phase 0
18475,Phase 0
58318,Discontinued in Phase 3
126308,Discontinued in Phase 3
151385,Phase 1b/2a
185558,Phase 1/2a
171731,Discontinued in Phase 2
13459,Phase 1
168761,Patented
84652,Phase 1/2a
19616,Phase 0
23210,Phase 1b
19509,Patented
115461,Phase 2/3
180077,Discontinued in Phase 1
37603,Phase 1b/2a
96503,Phase 1
33129,IND submitted
80692,Phase 2a
25662,Phase 1/2a
136457,Phase 1/2a
174785,Discontinued in Phase 4
112199,Discontinued in Phase 3
116228,Phase 1b
131424,Discontinued in Preregistration
3790,Investigative
150420,Phase 1b/2a
43488,Phase 2/3
7630,Phase 2
16482,Phase 0
191992,Clinical trial
90086,Approved (orphan drug)
158481,Phase 1/2
133755,Patented
40239,Phase 0
62276,Phase 1b
131452,Discontinued in Preregistration
129952,Discontinued in Phase 3
63702,Phase 1
187006,Discontinued in Preregistration
124672,Phase 1/2
47451,Discontinued in Preregistration
91516,Phase 1b
104117,Discontinued in Phase 4
32218,Phase 1/2
176902,Phase 1/2a
15640,Phase 0
99810,Phase 1/2a
186324,Phase 4
83721,Discontinued in Preregistration
185316,Discontinued in Phase 1
123047,Phase 0
83568,Investigative
12199,Phase 0
2190,Discontinued in Phase 2
41039,Discontinued in Phase 1/2
27974,Phase 1/2
109418,Preregistration
48336,Phase 0
180130,Phase 1/2
17699,Phase 1
38336,Discontinued in Phase 3
119428,Phase 1/2
26039,Phase 1/2
37710,Phase 1b
14059,Phase 1
41662,Discontinued in Phase 1
98626,Phase 1
96568,Discontinued in Phase 3
147073,Phase 2b
73521,Patented
161104,Discontinued in Phase 4
24220,Phase 1/2a
107078,Phase 0
44070,Phase 1/2a
116409,Discontinued in Phase 1
50880,Phase 1b
153332,Phase 1/2
1421,BLA submitted
112252,Phase 1
25826,Phase 1b/2a
83796,Phase 1
191024,Phase 1/2a
178726,Discontinued in Phase 1/2
74344,Phase 1/2a
163433,Discontinued in Phase 2/3
90361,Clinical trial
108295,Discontinued in Phase 1/2
22254,Phase 1/2
54725,Phase 0
92501,Phase 1
110960,Phase 1/2
115695,Phase 2
77956,Discontinued in Phase 3
129489,Phase 0
104699,Phase 2
35909,Phase 1b
65044,Phase 2
96776,Phase 2
93051,IND submitted
110833,Discontinued in Phase 4
141424,Phase 2/3
52505,Phase 1b/2a
148827,Phase 2b
37264,Discontinued in Preregistration
31404,Discontinued in Phase 3
24280,Phase 2
24381,Discontinued in Phase 2/3
136141,Phase 1b
43208,Discontinued in Preregistration
69497,Phase 1
27258,Patented
78604,Phase 1b
72469,IND submitted
122362,Phase 1/2
142422,Phase 3
81104,Phase 1b/2a
142931,Discontinued in Preregistration
39089,Phase 0
89051,IND submitted
62598,Discontinued in Phase 3
88773,Patented
179081,Discontinued in Phase 3
59188,Phase 1
31117,Phase 1b
36988,Phase 1b/2a
150539,Phase 2a
31745,Phase 1
73082,Patented
94187,Phase 2b
35260,Phase 2/3
178404,Phase 0
169369,Discontinued in Phase 4
158773,Phase 1b/2a
113432,Patented
117139,Discontinued in Phase 3
84537,Phase 1/2a
40807,Phase 1/2a
156098,Discontinued in Preregistration
93417,Phase 2
86730,Phase 1b
20075,Phase 2a
108590,Phase 1b/2a
153863,IND submitted
119213,Phase 1/2a
112681,Phase 1/2
190755,Phase 1/2
52291,Phase 1
9880,Preclinical
156206,Phase 1
149277,Phase 1b/2a
35774,Discontinued in Phase 4
37353,Discontinued in Phase 2b
161676,Phase 0
27738,Phase 1/2a
110272,Phase 1b/2a
112452,Discontinued in Phase 3
80310,Phase 2
141834,Phase 0
58141,Phase 1b/2a
168993,Approved
51914,Phase 1b
72804,Phase 2
41055,Discontinued in Phase 1
78576,Phase 2/3
17366,Phase 0
613,Phase 1/2a
67368,Approved (orphan drug)
54818,Phase 1b/2a
119444,Phase 1/2
3279,Investigative
138685,Investigative
29085,Phase 1/2a
100115,Approved
66293,Discontinued in Phase 2/3
47865,Phase 1b/2a
122125,Phase 1b/2a
114451,Phase 1
153828,Phase 0
120115,Discontinued in Phase 1/2
16778,Phase 1b/2a
131260,Discontinued in Phase 2b
185088,Phase 1/2
35738,Phase 1/2
24485,Phase 1/2
75633,Investigative
118312,BLA submitted
129614,Phase 1/2
98089,Phase 1/2a
119203,Discontinued in Preregistration
118582,IND submitted
37532,Discontinued in Phase 3
165496,Phase 1
39962,Phase 0
186664,Patented
128325,Phase 1/2
182483,Phase 1
28756,Phase 1/2a
191989,Patented
94470,Phase 1
71685,Phase 1b
124412,Phase 1/2
53659,Phase 1b/2a
151795,Phase 2
154262,Phase 1/2a
142205,Discontinued in Phase 2b
154266,Phase 1/2a
16960,Phase 1
129508,Phase 0
113394,Patented
132809,IND submitted
172404,Discontinued in Phase 2/3
175214,Discontinued in Phase 3
106368,Phase 0
122728,Phase 0
56430,Phase 0
155381,Discontinued in Preregistration
30197,Discontinued in Phase 2b
176037,Discontinued in Phase 1/2
98586,Phase 1b
131907,Patented
46198,Phase 1/2a
154157,Discontinued in Phase 2b
183411,IND submitted
49092,Phase 1
50075,Discontinued in Phase 2b
24346,Phase 1b/2a
140649,Phase 3
155708,Phase 2/3
82629,Phase 1/2
122820,Phase 1/2
9434,Discontinued in Phase 2b
172736,Discontinued in Phase 2
74828,Phase 1/2a
149422,Phase 1/2a
139133,Clinical trial
43031,Phase 1b
87309,Phase 1b/2a
153422,IND submitted
20175,Clinical trial
103389,Phase 1/2a
187886,Phase 0
80132,Phase 2a
169611,IND submitted
54595,Phase 1/2a
126342,Phase 1b
166954,Phase 4
158210,Phase 1/2
91638,Discontinued in Preregistration
37416,Phase 1
118877,Phase 1b/2a
36917,Discontinued in Phase 3
121445,BLA submitted
32620,Phase 2
76093,Phase 1/2
123252,Discontinued in Phase 4
133493,Approved
164465,Phase 1/2
74049,Phase 1/2
128460,Discontinued in Phase 3
63075,Phase 1b
130359,Patented
8269,Patented
52844,Phase 2
145023,Investigative
185172,Investigative
156570,Discontinued in Phase 2
105645,Investigative
15721,Discontinued in Phase 1
123874,Phase 2
38137,Phase 0
80220,Approved (orphan drug)
190923,Phase 1
159553,Phase 1b/2a
116956,Discontinued in Preregistration
32220,Phase 2
47582,Patented
132317,Discontinued in Phase 4
3285,Phase 1b
41957,Phase 2a
176736,Phase 1b/2a
79269,Phase 2/3
125516,BLA submitted
137934,Approved (orphan drug)
49482,Phase 0
32413,Phase 0
159119,Phase 1b/2a
134416,Discontinued in Phase 4
141886,Investigative
177604,Phase 2
104476,Phase 1/2
16538,Investigative
108512,BLA submitted
188532,Clinical trial
61317,Patented
79200,Phase 0
170173,Phase 1/2
100181,Discontinued in Phase 1/2
184679,Discontinued in Phase 4
69688,IND submitted
25014,Patented
42078,Phase 1
131280,Phase 2
103159,Phase 1/2
138097,Clinical trial
127110,Investigative
137463,Discontinued in Phase 4
60889,Phase 0
37607,Discontinued in Phase 3
31717,Phase 1b
68127,Phase 0
151082,Phase 0
93097,Phase 2b
101540,Phase 1/2
176237,Investigative
47675,Phase 1b/2a
129529,Patented
90388,Clinical trial
128081,Discontinued in Phase 3
51756,Phase 2/3
3800,Approved
164717,Phase 0
166044,Phase 1b/2a
2600,Phase 1b/2a
57427,Discontinued in Phase 4
93767,Phase 1b
184167,BLA submitted
114616,Discontinued in Phase 1
72710,Phase 1
65127,Phase 1b
43248,Phase 1/2
96009,Phase 1/2
34513,Phase 1b/2a
22792,Phase 1b/2a
83646,Phase 1
107826,Discontinued in Preregistration
191671,Phase 1
67988,Phase 2b
166447,IND submitted
57425,Phase 1/2a
50127,Phase 1b/2a
97513,Phase 0
64033,Approved (orphan drug)
169836,Phase 1/2a
65843,Phase 2a
22570,Phase 1b/2a
114710,Investigative
89525,Patented
191051,BLA submitted
176262,Discontinued in Phase 4
144300,Discontinued in Phase 2/3
130916,Investigative
128,Phase 1/2a
101349,Phase 1b/2a
108341,Phase 0
80413,Clinical trial
104939,Phase 0
33444,Phase 1b
6024,Phase 1b/2a
117499,Discontinued in Phase 4
52451,Discontinued in Phase 2/3
159418,Phase 1
181427,Phase 1/2a
25482,Discontinued in Preregistration
42837,Phase 2/3
191007,Discontinued in Phase 4
189556,Phase 1/2a
164817,Phase 1/2
150952,Phase 2
149284,IND submitted
21618,Discontinued in Phase 4
135518,Phase 0
32271,Phase 1/2a
51853,Discontinued in Preregistration
134271,Phase 1b
26913,Phase 1b/2a
569,Phase 1/2a
150457,Phase 1
170726,Phase 2/3
89290,Discontinued in Phase 3
190559,Phase 1/2
177944,Phase 2/3
130593,Phase 1
117404,Discontinued in Phase 1
8074,Phase 1b
96952,Patented
123654,Phase 0
121562,Phase 2
121467,Phase 2
43334,Phase 1/2a
181640,Phase 1/2a
96272,Discontinued in Phase 3
27369,Discontinued in Preregistration
112963,Discontinued in Phase 2
7270,Phase 4
156626,Phase 1/2
181679,Phase 1/2
52424,Phase 1
40540,Phase 1/2
99711,Phase 1
5759,Discontinued in Phase 2
103829,Phase 1/2a
83532,Phase 1b/2a
78086,Approved (orphan drug)
52135,Phase 1/2
158538,Phase 2/3
175264,Phase 2b
152934,Investigative
184295,Discontinued in Phase 4
150370,Phase 1/2
148454,Phase 1/2
166732,Phase 1/2a
145328,Discontinued in Phase 2/3
113603,Phase 1/2
106707,Phase 1b
107070,Phase 0
19051,IND submitted
31874,IND submitted
16468,Phase 1
127499,Discontinued in Preregistration
116554,Discontinued in Phase 3
32213,Phase 1b/2a
111750,Phase 0
145511,Phase 1b/2a
161193,Phase 1
18686,Phase 2
40274,Phase 2
76291,Phase 0
2861,Phase 1/2
39059,Phase 1
5479,Preregistration
42552,Phase 1/2
123638,Approved
145903,Phase 2b
109530,Phase 3
176282,Phase 1b/2a
131353,IND submitted
24635,Phase 1/2
24051,Phase 2
107692,Phase 3
36812,Discontinued in Phase 3
150179,Phase 2/3
6070,Phase 2/3
186133,Phase 2/3
107301,Phase 1b
108224,Phase 1/2a
96758,Phase 2
65517,Phase 1b
23721,Phase 1b/2a
85756,Discontinued in Phase 2b
125049,Phase 1
40539,Phase 0
92365,Discontinued in Phase 4
88887,Phase 1
165961,Discontinued in Phase 4
113632,Phase 1/2
21803,Approved (orphan drug)
149169,Phase 0
40215,Phase 1/2
69862,Phase 1b
146972,Phase 1/2
13122,Phase 0
113168,Phase 1
18515,Phase 2a
143819,Discontinued in Phase 4
16578,Phase 0
47041,BLA submitted
129634,Phase 0
88870,Phase 1/2a
6003,Investigative
17757,IND submitted
48991,Phase 1/2a
74302,Phase 1/2a
175735,Phase 1/2
171023,Phase 0
25478,Phase 1/2a
65396,Discontinued in Phase 2b
74977,Phase 1/2
8832,IND submitted
17805,Phase 0
144316,Discontinued in Phase 1/2
110962,Discontinued in Phase 3
147852,Phase 2b
183853,Phase 4
43005,IND submitted
138218,Discontinued in Phase 2
103080,Phase 1/2
7619,Discontinued in Phase 3
126672,Discontinued in Phase 2b
162944,Patented
170167,Patented
20419,Discontinued in Phase 2
79435,Discontinued in Phase 2
156977,Phase 1
5163,Investigative
117267,Discontinued in Phase 2/3
137295,Discontinued in Phase 4
72726,Investigative
12093,Discontinued in Phase 2/3
58665,Phase 1b/2a
18450,Discontinued in Phase 2/3
95486,Phase 1b/2a
74476,Investigative
90630,Clinical trial
178750,Phase 2a
30172,Phase 0
67707,Phase 2
44054,Phase 1/2a
92997,Phase 0
38216,Phase 2a
168687,Investigative
23656,Phase 2
23607,Phase 2
24441,Phase 1/2a
80669,Discontinued in Phase 2
28401,Patented
180675,Phase 2b
87594,Phase 1/2a
185927,Phase 1b/2a
18219,Discontinued in Phase 2b
3744,Approved
30331,Investigative
37249,Discontinued in Phase 4
160549,Phase 3
92167,Approved (orphan drug)
155040,Clinical trial
46919,Phase 4
169419,Discontinued in Preregistration
150254,Discontinued in Phase 2/3
74103,Investigative
5151,Phase 1b/2a
16161,Phase 1/2
39492,Discontinued in Phase 2
143591,Phase 1b/2a
3700,Discontinued in Phase 4
180660,Phase 2
164459,Phase 1
149712,Investigative
72977,Phase 1b/2a
137972,Phase 1/2a
14993,Phase 1
162843,Phase 1/2
73822,Phase 2a
8920,Discontinued in Phase 2
77527,Patented
151891,Phase 1
49958,Phase 0
111785,Phase 1
184476,Phase 1/2
19160,Discontinued in Phase 2/3
33283,Clinical trial
31405,Clinical trial
36034,Phase 1/2a
179972,Discontinued in Phase 2/3
131617,Discontinued in Phase 4
115021,Phase 1/2a
84568,Phase 1/2
134673,Phase 0
115125,Phase 2/3
52530,Discontinued in Phase 3
12535,Phase 1/2
93567,Phase 1/2
143755,Investigative
174547,Phase 1/2
141711,Discontinued in Phase 4
133241,Approved
9045,Discontinued in Phase 1
173927,Phase 2
191698,IND submitted
178687,Phase 0
39124,Phase 2
139188,Approved (orphan drug)
53262,Phase 1b/2a
113693,Patented
159222,Phase 1/2
27841,Discontinued in Phase 1
75712,Patented
82784,Phase 0
188771,Phase 1/2
104380,Phase 2
164893,Investigative
116257,Phase 1b/2a
17260,Phase 1b/2a
186584,Phase 2b
182431,Phase 1
174201,Discontinued in Phase 1/2
56375,Discontinued in Preregistration
57130,Investigative
116767,Discontinued in Phase 2/3
50949,Phase 2
143787,Phase 2a
36965,Discontinued in Preregistration
31241,Investigative
87435,Approved
75367,Phase 1/2a
15196,Investigative
129162,Investigative
82813,Phase 0
24378,Phase 1/2
160478,Phase 1/2a
166452,Patented
90219,Phase 1b
77611,Phase 1
168877,Investigative
76420,Phase 1/2
48246,Discontinued in Phase 3
75970,Investigative
176710,Phase 1/2a
87325,Discontinued in Phase 3
84688,Phase 1/2
114330,Phase 1
173236,Discontinued in Phase 2b
6945,Investigative
165374,Discontinued in Phase 2/3
59370,Investigative
73799,Phase 2a
148130,Phase 2a
152134,Phase 1
170790,Patented
138344,Phase 1b
37864,Phase 1b
7688,Patented
18545,Phase 1/2a
12948,Phase 0
12271,Phase 1
148635,Phase 1b
156405,IND submitted
180531,Phase 1
141166,Investigative
20554,Discontinued in Phase 3
172437,Discontinued in Phase 2b
190120,Phase 2/3
98284,Discontinued in Phase 2b
68202,Phase 2b
170255,Phase 1b/2a
79970,Phase 1b/2a
160717,Phase 1
31519,Phase 1/2
66097,Discontinued in Phase 2/3
120712,Approved
130975,Phase 0
171930,Phase 0
124643,Phase 1/2
77617,Discontinued in Phase 1/2
88218,Discontinued in Phase 2
3656,Discontinued in Preregistration
143558,Investigative
168886,Phase 2
90217,Phase 2a
81698,Approved
65630,Discontinued in Phase 2b
154830,Phase 1b/2a
32887,Phase 2a
66419,Phase 0
31814,IND submitted
5495,Phase 1/2
32047,Phase 2a
161498,Phase 1b
33356,Phase 1/2a
30150,Discontinued in Phase 4
172672,Discontinued in Phase 2b
126696,Discontinued in Phase 3
55684,Phase 1/2a
166028,Phase 1b
57420,Phase 0
102718,IND submitted
41851,Approved
73367,Phase 2a
162321,Investigative
87010,Discontinued in Phase 2
42080,Discontinued in Phase 1
133380,Phase 1/2
66948,Patented
155958,Phase 1/2
17373,IND submitted
138434,Phase 1/2a
124155,Investigative
2128,Phase 1b
125745,Phase 1b/2a
101478,Phase 0
117416,Discontinued in Preregistration
67296,Patented
164246,Phase 1/2a
18322,Discontinued in Preregistration
10535,IND submitted
39535,IND submitted
74572,IND submitted
9736,Phase 1b/2a
107581,Phase 1b
87740,Phase 0
78180,Clinical trial
108840,Phase 1
191015,BLA submitted
28897,Phase 1/2a
140389,Phase 2
82525,Patented
144111,Investigative
182997,Discontinued in Phase 4
80839,Phase 1/2a
113731,Phase 1
3355,Phase 1/2a
38734,Phase 1
19045,Discontinued in Phase 2/3
166213,Phase 1b/2a
168803,Approved
144364,Discontinued in Phase 1/2
165689,Phase 1b
62728,Phase 0
176513,Discontinued in Phase 4
176089,Patented
78814,Phase 0
76464,Investigative
182396,Discontinued in Phase 2b
60503,Discontinued in Phase 2/3
174905,Phase 1
88069,Phase 1
101462,Discontinued in Phase 2b
179040,Phase 1/2a
57082,Phase 2
56479,Investigative
112897,Phase 1/2
127445,Discontinued in Phase 4
91468,Approved (orphan drug)
187264,Patented
7567,Phase 4
123465,Phase 1
186926,Clinical trial
26307,Phase 1b/2a
109495,Preregistration
88415,Phase 0
142087,Phase 1/2
37611,Phase 1
35598,Phase 1/2
148477,Phase 2b
85540,Discontinued in Phase 3
167497,Discontinued in Phase 1
148097,Discontinued in Phase 2/3
34231,Discontinued in Phase 2/3
6467,Phase 1/2
65791,Phase 2a
167849,Patented
10837,Phase 1
14989,Phase 1/2a
188105,Phase 1b/2a
183726,IND submitted
15647,Phase 2b
13828,Phase 3
178459,Discontinued in Phase 2/3
166644,Phase 0
164665,Phase 1/2a
28199,Discontinued in Phase 2b
113702,Phase 1/2a
180336,Phase 1b
89712,Phase 1b
87732,Phase 1/2a
80664,Phase 2a
174585,Phase 2
133948,Phase 1b
56928,Phase 1b/2a
163381,Investigative
114936,Phase 2/3
31430,Investigative
139002,BLA submitted
49419,Phase 1/2a
74573,IND submitted
52348,Phase 0
149501,Discontinued in Phase 2/3
77367,Phase 1/2
147344,Phase 1b/2a
29677,Phase 1b
5724,Investigative
72680,Phase 1b/2a
38386,Patented
61241,Phase 1
164922,Phase 1/2
167914,Phase 1/2
106274,Phase 2/3
119378,Phase 1b/2a
61015,Phase 2/3
14506,Phase 1/2
169114,Phase 2
117640,Discontinued in Phase 4
21646,Discontinued in Phase 1/2
65244,Phase 1b/2a
38675,Phase 1/2a
17299,Phase 1
35294,Phase 2
160014,Phase 1b/2a
5200,Preregistration
144232,Discontinued in Phase 1/2
82836,Phase 1b/2a
123511,Phase 2
18749,Discontinued in Phase 2/3
34500,Phase 0
132745,Discontinued in Phase 3
181630,Phase 1/2
117347,Discontinued in Phase 2/3
153589,Phase 1/2a
89141,Discontinued in Phase 4
140933,Discontinued in Phase 2b
75541,Phase 1/2
154486,Discontinued in Preregistration
135081,Phase 0
174939,Phase 3
105860,Phase 1/2a
142801,Phase 1b/2a
62132,Discontinued in Phase 4
178900,Discontinued in Phase 3
3782,Discontinued in Preregistration
84701,Phase 0
55694,Discontinued in Preregistration
98564,Discontinued in Phase 2b
68470,Discontinued in Preregistration
88712,Phase 1
156702,Discontinued in Phase 4
141386,Discontinued in Phase 2b
29795,Phase 1
141580,Discontinued in Phase 2b
186370,Phase 0
28056,Phase 2
166731,Discontinued in Preregistration
100031,Phase 2/3
130259,Investigative
108366,Phase 0
187760,Phase 2a
85020,Phase 0
164775,Discontinued in Preregistration
94908,Phase 1/2a
2818,Discontinued in Phase 2b
91590,Discontinued in Phase 2b
113367,Phase 1
178036,Patented
21511,Phase 1b/2a
170805,Discontinued in Phase 1
177732,Phase 2a
98418,Phase 1b
173786,Phase 2a
177525,Phase 1b/2a
114037,Phase 1
4253,Phase 1/2
58651,Phase 2/3
191768,Phase 1
27199,Phase 1b/2a
184462,Discontinued in Phase 4
51288,Phase 1b
112753,Phase 1/2
36202,Phase 1/2
122815,Discontinued in Preregistration
97141,Phase 2/3
22007,BLA submitted
90297,Phase 1b
133307,Discontinued in Preregistration
115719,Clinical trial
149273,Phase 1/2
17935,Patented
24513,Phase 1
164866,Discontinued in Preregistration
116307,Clinical trial
142749,Phase 1b/2a
150242,Discontinued in Phase 2/3
46930,Discontinued in Phase 1
80706,BLA submitted
2408,Investigative
170528,Phase 1b/2a
88481,Phase 1
134525,Patented
83175,Discontinued in Phase 2/3
167004,Discontinued in Phase 1/2
170517,Patented
68590,IND submitted
17722,Phase 1
104170,Phase 1/2a
62495,Phase 1/2
44167,Phase 2/3
92170,Phase 1b
131302,Phase 1b/2a
108708,Patented
4139,Discontinued in Phase 2
139110,Clinical trial
137965,Clinical trial
106546,Phase 2/3
182680,Phase 1/2
84305,Discontinued in Phase 3
106106,Phase 2/3
100510,Phase 1/2
34870,Phase 1b
121761,Phase 1b/2a
66306,Phase 0
153696,IND submitted
167048,Phase 1/2a
28438,Phase 0
49914,Discontinued in Preregistration
143859,Phase 2a
149119,Phase 1/2a
169889,Phase 2b
84331,Phase 0
48031,Discontinued in Phase 2/3
38290,Phase 1b
87168,Patented
137408,Phase 2
125386,Investigative
74565,Phase 1/2a
30248,Discontinued in Phase 2b
169082,Phase 0
152947,Discontinued in Phase 3
64365,Discontinued in Phase 2/3
151422,Discontinued in Phase 2/3
21650,Approved (orphan drug)
128527,Patented
147681,Discontinued in Phase 2
189352,Phase 1/2
174908,Discontinued in Phase 2
89583,Phase 1b
85580,Discontinued in Phase 2b
187869,Patented
7318,IND submitted
147649,Phase 1
38240,Phase 1b
113462,Phase 0
147613,Phase 2
177133,Phase 2b
22145,Discontinued in Phase 2
73048,Phase 0
75418,Phase 1/2
645,Phase 1/2a
5387,Phase 1/2
138196,Discontinued in Phase 2
97681,Phase 0
159971,Investigative
76474,Phase 0
115773,Approved (orphan drug)
49002,Phase 2
32360,Phase 1b/2a
35079,Patented
130402,Discontinued in Phase 1
45148,Phase 1/2a
89482,Phase 1/2a
166385,Phase 1b/2a
97908,Phase 2
2710,Discontinued in Phase 1/2
8810,Discontinued in Preregistration
164256,Phase 1/2
39503,Phase 2/3
82734,Phase 1
48819,Investigative
22326,IND submitted
74432,Discontinued in Phase 4
37227,Phase 2a
15267,Phase 3
110613,Discontinued in Phase 2b
84542,Phase 1/2a
149488,Phase 1b/2a
86813,Discontinued in Phase 1/2
127121,Discontinued in Phase 4
61437,Patented
36227,Phase 1
81814,Approved
113348,Phase 1
44867,Phase 1/2a
187047,Clinical trial
99163,Phase 1
103096,Patented
164850,Phase 1
109579,Discontinued in Phase 2/3
113060,Phase 1/2
136553,Phase 1/2
18677,IND submitted
158333,Phase 2b
149561,Phase 1
11727,IND submitted
51127,Phase 1/2a
61612,Phase 1b
189386,Phase 2b
143227,Investigative
177286,Phase 1b
128497,Discontinued in Phase 4
17919,Phase 2/3
42675,Phase 2
48410,Discontinued in Phase 2
112666,Phase 0
61065,Phase 1/2a
174851,Phase 1/2
121323,Phase 1/2a
180535,Phase 1b
107309,Phase 1b
36361,Discontinued in Phase 3
109138,Phase 1b
1605,Discontinued in Phase 2/3
117091,Phase 1b
7316,Discontinued in Phase 2
85907,Discontinued in Phase 2b
32351,Phase 1/2
69665,Phase 2b
43838,Phase 1/2a
104563,Patented
176104,Discontinued in Phase 3
13468,Investigative
164653,Investigative
62935,Phase 1/2a
87910,BLA submitted
12070,IND submitted
91619,Approved (orphan drug)
125110,Phase 1b
51503,Discontinued in Phase 2b
101190,Discontinued in Phase 1/2
107381,Phase 1/2a
74435,Discontinued in Phase 2b
63208,Phase 0
39328,Phase 2/3
12419,Phase 1
49353,Phase 1
124613,Phase 1/2
165987,Patented
173889,BLA submitted
182156,Phase 2a
143377,Phase 1b/2a
13509,Phase 1
88328,Patented
14889,Phase 1/2
143274,Phase 1b/2a
15349,Phase 0
15205,Phase 1
141088,Phase 2/3
174576,Discontinued in Preregistration
58032,Phase 0
51653,Phase 2
68676,Discontinued in Preregistration
40607,Patented
153852,Phase 1b/2a
56426,Patented
167285,Investigative
131251,Phase 1b/2a
143499,Phase 2a
181641,Phase 1
175924,Phase 1/2
137239,Discontinued in Phase 4
119247,IND submitted
58814,Discontinued in Phase 3
56269,Discontinued in Phase 3
29568,Phase 1b/2a
114905,Phase 1b
98067,Phase 1/2
28574,Phase 1b
15628,Phase 1b/2a
64322,Phase 1b/2a
183303,Phase 1/2
1339,Approved
68261,Discontinued in Phase 2/3
170292,Phase 1
178721,Discontinued in Phase 1
153875,Phase 1/2a
186261,Preclinical
8579,Patented
39730,Phase 1
87920,Phase 2/3
51611,Phase 1
103827,IND submitted
21785,Discontinued in Phase 2b
115812,Discontinued in Phase 2
111482,Discontinued in Phase 4
145803,Investigative
121180,Phase 1b
140310,Approved (orphan drug)
24386,Phase 1
22708,Discontinued in Phase 4
102472,Investigative
75647,Discontinued in Phase 1/2
37910,Phase 1b
179810,Phase 1/2a
121131,Phase 0
17703,Phase 0
441,Phase 2b
108997,Phase 1/2a
3172,Phase 1b
72075,Patented
87881,Phase 1/2
77740,Phase 2/3
52896,Phase 1/2a
83750,Discontinued in Preregistration
152354,Investigative
12777,Phase 1/2
44012,Phase 1/2a
97978,Phase 1/2a
189295,Preclinical
136661,Phase 2
47442,Patented
69201,Phase 1b
94765,Phase 1
37296,Phase 1
109670,Phase 1
42851,Phase 1
154913,Phase 3
163705,Discontinued in Phase 1/2
54437,IND submitted
58212,Approved (orphan drug)
171236,IND submitted
28132,Discontinued in Phase 2/3
49649,Phase 1b/2a
92712,IND submitted
187251,Phase 4
177011,Phase 1b
125179,Phase 1b
111723,Phase 1
163420,Discontinued in Phase 2b
59698,Phase 2/3
91715,Preregistration
135965,IND submitted
46032,Phase 2/3
123159,Phase 0
150250,Phase 1/2a
77932,Discontinued in Phase 3
163217,Phase 2
190295,Patented
147001,Clinical trial
32173,Phase 2a
20306,IND submitted
165160,Discontinued in Preregistration
109340,Phase 1
60082,Discontinued in Phase 3
109868,Phase 1
27183,Phase 1b/2a
53821,Discontinued in Phase 3
172550,Phase 1/2
77524,Patented
61887,Discontinued in Phase 2b
31532,Discontinued in Preregistration
6156,Investigative
4041,Investigative
86407,IND submitted
84110,Phase 1
52807,Investigative
32951,Phase 2/3
91387,Clinical trial
52481,Phase 1
163201,Patented
173286,Discontinued in Phase 2/3
49803,Discontinued in Phase 2b
28170,Phase 1
28319,Phase 2a
34909,Phase 1b
75405,Discontinued in Phase 2
97714,Phase 1b/2a
67472,Discontinued in Preregistration
50252,Phase 1/2a
121822,Approved
2871,Patented
13249,Phase 2b
78585,Phase 2a
89597,Phase 1b/2a
159537,IND submitted
97622,Phase 1b
127069,IND submitted
82735,Discontinued in Preregistration
74780,IND submitted
12476,IND submitted
91877,Phase 0
21118,Phase 2
89276,Discontinued in Phase 4
25307,Discontinued in Phase 2/3
68277,Phase 3
48663,Phase 0
108738,Discontinued in Phase 1
85887,Discontinued in Preregistration
118160,Phase 1b/2a
30139,Phase 1/2
37014,Phase 2
147056,Discontinued in Phase 2
24223,Phase 1
2431,Discontinued in Phase 1/2
99244,Phase 1b/2a
146470,Phase 1/2
6385,Phase 2/3
74391,Investigative
39862,Phase 0
21137,Phase 2
188675,Phase 1/2
121503,Phase 0
80883,Investigative
81216,Phase 1b
52459,Phase 1/2a
139318,Discontinued in Phase 2
112101,Phase 0
83990,Phase 1b/2a
39077,Discontinued in Phase 4
23050,Discontinued in Phase 2/3
80424,Phase 2
161364,Patented
110889,Discontinued in Phase 3
159974,Phase 1b/2a
75325,Discontinued in Phase 2/3
141463,Phase 1/2
129484,Discontinued in Phase 2b
99292,Phase 1
156859,Patented
45826,Phase 2/3
1310,Discontinued in Phase 2
80980,Clinical trial
122694,Phase 0
1646,Phase 0
2258,Phase 1b/2a
97378,Phase 1b/2a
17471,Phase 2b
132090,Phase 1
187756,Discontinued in Preregistration
1330,Discontinued in Phase 2
136385,Phase 1/2
171886,Phase 2a
85512,Discontinued in Preregistration
137039,Phase 1/2
63325,Discontinued in Preregistration
138052,Clinical trial
53145,IND submitted
108401,Phase 1b
150933,Phase 1
189027,Phase 1/2
180210,Phase 2/3
103000,Phase 1/2
83870,Discontinued in Phase 4
92906,Phase 1b/2a
41625,IND submitted
29526,IND submitted
21831,Discontinued in Phase 2
42325,Phase 1
186800,Phase 2a
51627,Phase 1/2a
125800,Discontinued in Preregistration
147043,Phase 1/2a
53405,Discontinued in Phase 2/3
48326,Patented
42716,Phase 2/3
117400,Discontinued in Phase 4
88873,Phase 1
121382,Patented
157587,Patented
123721,Phase 1/2
84284,Phase 1/2
54297,Discontinued in Phase 4
97669,Phase 1/2a
159102,Phase 2
70265,Phase 1
59987,Phase 1
52369,Phase 1b/2a
126185,Phase 1b/2a
166916,Phase 1/2a
190236,Phase 1/2
22413,Investigative
112281,Phase 0
27704,Phase 2/3
185610,Phase 1b
49020,Phase 1/2a
13156,Phase 3
154920,Phase 3
44263,Phase 2/3
148,Discontinued in Phase 2/3
40391,Phase 1b/2a
25337,Phase 1/2
61492,Phase 1/2
4525,Preregistration
31459,Phase 1/2
31341,Patented
52401,Phase 2
86923,Phase 1b/2a
135310,Phase 0
83355,Phase 1/2
54844,Discontinued in Phase 4
108922,Discontinued in Preregistration
4504,Phase 2a
185513,Phase 4
25572,Phase 0
76550,Phase 1/2a
149049,Investigative
120865,Phase 4
161000,Discontinued in Phase 3
22752,Investigative
13681,Phase 0
65395,Discontinued in Phase 2
173454,Discontinued in Phase 2/3
145306,IND submitted
164783,Phase 1/2
95266,Phase 1/2a
123756,Phase 1/2
159315,Phase 0
86998,Phase 1b/2a
36895,Discontinued in Phase 1
101988,Phase 1/2
144303,Discontinued in Phase 2
50565,Phase 2
101774,Phase 1/2a
32664,Phase 0
175018,Phase 2
19262,Discontinued in Phase 3
45630,Phase 1/2a
173998,Patented
10729,Phase 1
21138,Phase 2
47082,Discontinued in Phase 1/2
172804,Phase 0
44648,Phase 2/3
56832,Phase 1/2
141094,Investigative
18034,Phase 1/2a
2320,Phase 0
176023,Discontinued in Phase 3
164451,Phase 1/2
170938,Phase 0
118271,Phase 2b
31606,Patented
8247,Patented
35310,Phase 2a
184586,BLA submitted
189723,Phase 0
47392,Discontinued in Phase 2b
75465,Discontinued in Phase 1/2
63082,Patented
189430,Phase 1/2
65795,Discontinued in Phase 2
148466,Phase 2b
67514,Phase 0
107996,Discontinued in Phase 3
74603,Phase 1/2
157579,Registered
74270,Phase 1/2a
112557,Phase 0
79706,Discontinued in Phase 3
108074,Phase 1b/2a
149790,Investigative
10374,Preclinical
80077,Clinical trial
47457,Discontinued in Phase 2b
45992,Phase 2/3
59884,Phase 0
138696,Phase 1b
163931,Phase 1/2
31131,Patented
40978,Discontinued in Phase 2
105502,Phase 1b/2a
31365,Phase 1
153392,Clinical trial
149679,Phase 1b/2a
29495,Phase 1b/2a
45973,Phase 1/2a
144574,Phase 1/2
113362,Phase 1b/2a
145307,Phase 2b
191851,Patented
119567,Discontinued in Phase 2b
150334,Discontinued in Phase 2
109204,IND submitted
181314,Phase 3
185036,Discontinued in Phase 3
152628,Approved
92310,Registered
162438,Patented
18756,Phase 0
8604,IND submitted
129623,Discontinued in Preregistration
11984,Patented
179775,Phase 1
112673,Discontinued in Phase 3
189229,Phase 0
151136,Phase 1
186743,Phase 4
31408,Phase 0
176465,Discontinued in Phase 4
168680,Discontinued in Phase 2
190246,Phase 2b
16330,Phase 1/2
29357,Discontinued in Phase 2/3
111474,Phase 1
62959,Discontinued in Phase 4
109847,Preregistration
188620,Phase 1/2a
35063,Phase 1/2a
32,Discontinued in Phase 1
118200,Phase 2a
160053,Discontinued in Phase 1/2
16214,Phase 0
180951,Phase 2a
81021,Discontinued in Phase 1
146758,Phase 1b/2a
160676,Phase 1/2a
96510,Phase 1b/2a
86854,Phase 1/2a
146840,Discontinued in Phase 1
44426,Phase 2/3
86964,Discontinued in Phase 1
134221,Discontinued in Phase 4
63744,Phase 1/2
161172,Phase 0
87869,Patented
34510,Patented
103340,Investigative
132095,Discontinued in Phase 4
187545,Phase 2b
78125,Phase 1/2
27931,Phase 2
72747,Phase 2
20396,Phase 1b/2a
156731,Phase 1
47816,Phase 1b
170949,Phase 1/2
65494,Preclinical
45782,Phase 1/2a
171891,Discontinued in Phase 2b
103357,Phase 1/2a
62523,Phase 1b
150851,Phase 1
169411,Phase 0
102044,Phase 1/2
84105,Discontinued in Phase 3
32054,Patented
106772,Phase 1b
25678,Phase 1b/2a
168146,Discontinued in Phase 2/3
50963,Phase 1/2a
75965,Phase 0
35482,Phase 0
184264,Phase 0
5453,Discontinued in Phase 2
91522,BLA submitted
18304,Discontinued in Phase 3
41295,Phase 1
59620,Clinical trial
29185,Phase 1/2a
78910,Discontinued in Phase 4
10107,IND submitted
26968,Phase 1b/2a
46616,Phase 1/2a
23257,Phase 1/2a
137588,Phase 1/2
123893,Discontinued in Phase 4
42187,Phase 1b/2a
151998,Phase 2a
122932,Phase 1b
88141,Discontinued in Phase 1
74352,Discontinued in Phase 4
101078,Phase 1/2a
23513,Phase 2/3
8486,IND submitted
140067,Discontinued in Phase 1/2
3070,Discontinued in Phase 2b
126353,Phase 1/2
158270,Discontinued in Phase 1
181372,Phase 2a
7043,Phase 1/2
27987,Discontinued in Phase 1/2
53312,Phase 1/2a
24940,Phase 0
46713,Approved
183660,IND submitted
89855,Patented
117527,Discontinued in Phase 2/3
151501,Discontinued in Phase 2/3
93472,Discontinued in Phase 3
146559,Phase 1b/2a
76742,IND submitted
70251,Phase 1
119364,IND submitted
61862,Discontinued in Phase 4
171452,Discontinued in Phase 2
152405,Patented
101140,Phase 1/2
122876,Phase 1b
158173,Patented
57751,Phase 1
131643,Phase 1b/2a
187062,Phase 0
45244,Phase 1/2a
147207,Investigative
12328,Phase 1
97675,Phase 1/2
103219,Phase 1/2a
78309,Discontinued in Phase 3
121800,Discontinued in Phase 1
53031,Phase 1/2a
99583,Phase 2
88074,Phase 2a
27574,Phase 1b/2a
29322,Investigative
74159,Discontinued in Phase 2
24915,Discontinued in Phase 4
166597,Phase 1/2
119437,Phase 2
114276,Phase 1b
68074,Discontinued in Phase 4
188272,Clinical trial
83839,Investigative
85318,Discontinued in Phase 3
101321,Phase 1/2
117787,Discontinued in Phase 2/3
73076,Phase 1/2a
102259,IND submitted
177687,Phase 1b
153232,Discontinued in Preregistration
44883,Phase 1/2a
167107,Discontinued in Phase 2
182088,Phase 2/3
72027,Phase 1b
76184,Phase 1/2a
182572,Phase 2a
15097,Investigative
137152,Investigative
140350,Phase 1/2
187647,Clinical trial
49834,Phase 0
60726,Discontinued in Phase 3
117005,Clinical trial
92386,Phase 2/3
179024,Phase 1/2a
137569,Patented
178792,Phase 0
67101,IND submitted
185103,BLA submitted
75737,Investigative
123221,Phase 0
130540,Phase 0
81678,Approved
7071,Investigative
122609,Discontinued in Preregistration
16948,Phase 1
149103,Phase 1b
70478,Phase 1b/2a
102618,Investigative
103015,IND submitted
38449,Phase 2
12323,Phase 1
121318,Patented
182695,Discontinued in Phase 2b
102892,Investigative
104447,IND submitted
147405,Phase 1b/2a
128733,Phase 0
126674,IND submitted
153106,Discontinued in Phase 3
47686,Phase 1b/2a
79550,Phase 1b/2a
963,Approved
124787,Discontinued in Preregistration
5639,Phase 1/2
140494,Phase 1/2
109745,Discontinued in Phase 1/2
134288,Phase 1/2
152312,Patented
22712,Phase 1/2a
165831,Phase 2
154771,Phase 1b/2a
110018,Phase 1
86748,Patented
188180,Discontinued in Phase 1
173704,Phase 0
95847,Phase 1
185111,Discontinued in Phase 4
62755,Phase 1/2a
10006,Discontinued in Phase 2b
54734,Discontinued in Phase 2
158669,Phase 0
86377,Discontinued in Preregistration
18921,Phase 0
41219,IND submitted
188759,Clinical trial
153242,Investigative
47278,Patented
184613,Phase 0
179565,Phase 1b
146616,Phase 2/3
118687,Phase 1/2a
44746,Phase 2/3
122314,Phase 0
1342,Discontinued in Phase 2
97151,Phase 1b
97491,Investigative
185693,Phase 4
38753,Phase 2/3
28014,Phase 1/2a
57760,Phase 1
4928,Phase 1/2
128177,Patented
67676,Phase 1b
98720,Phase 1b/2a
60424,Approved (orphan drug)
38497,Phase 2
133710,Phase 1b
158619,Phase 1b/2a
4639,Phase 2/3
42390,Discontinued in Phase 1
178865,Phase 1
78838,Phase 2a
169497,Phase 1
86792,Patented
52829,Phase 1b/2a
180542,Phase 1
9699,Phase 1/2a
70256,Phase 0
17476,Phase 3
179409,Phase 1b
180648,Discontinued in Phase 4
159874,Discontinued in Preregistration
128435,Discontinued in Preregistration
7511,Phase 1/2
95997,Phase 1b
31859,Phase 1b
98528,Phase 1b/2a
54540,Phase 3
112367,Discontinued in Phase 3
63868,Discontinued in Phase 2b
8137,Phase 2
189542,Phase 2b
9800,IND submitted
41296,Phase 1
114257,Phase 1/2
173482,Phase 2a
185514,Phase 4
56519,Phase 2
185203,Discontinued in Phase 3
47926,Phase 0
68069,Approved (orphan drug)
161573,Investigative
109369,Approved
158806,Phase 1b
47157,Phase 1
173339,IND submitted
49414,Phase 0
70450,IND submitted
90371,Phase 1b
147767,Phase 1
152936,Investigative
19019,Phase 1b
17112,Investigative
63030,Phase 1/2a
34844,Phase 1
108311,Discontinued in Phase 2
12485,Phase 0
136737,Phase 1/2a
82302,Investigative
86293,Investigative
84766,Phase 0
19419,IND submitted
41905,Phase 1/2a
91798,Phase 1b/2a
64742,Discontinued in Phase 2b
66815,Phase 1/2
97349,Phase 1/2
95074,Phase 1/2a
6018,Investigative
174925,Phase 1/2
20086,Phase 2
181207,Discontinued in Phase 2
6033,Phase 1b/2a
128832,Discontinued in Phase 2b
26103,Phase 2/3
90089,Discontinued in Preregistration
49784,Phase 2/3
79668,Phase 2
182452,Phase 2a
102323,Phase 1/2a
149986,IND submitted
154866,Phase 2
71896,Phase 1b/2a
115679,Phase 1/2
15243,Phase 1b/2a
26456,Phase 1/2a
155748,Discontinued in Phase 4
106913,Discontinued in Phase 2b
74341,Phase 1/2a
20523,Phase 1/2
99976,Phase 1/2
149563,Phase 2
160581,Phase 2/3
41894,Phase 1
88187,Discontinued in Phase 1
16799,Phase 2b
56580,Phase 3
162686,Discontinued in Phase 4
38170,Patented
59901,Investigative
183126,Phase 2b
119914,Phase 0
23315,Phase 0
190191,Phase 0
177001,Phase 2b
169473,Phase 0
83873,Discontinued in Phase 4
163146,Discontinued in Phase 3
85810,Discontinued in Phase 2b
38086,Discontinued in Phase 2b
180584,Phase 1
15157,Phase 0
149280,Discontinued in Phase 2
123201,Phase 1
8577,Phase 1
5747,Phase 1/2
9718,IND submitted
67208,Phase 1/2
101784,Phase 1b
102193,Approved (orphan drug)
58007,Phase 2/3
65390,Preclinical
68353,Phase 1
31342,Phase 0
64654,Patented
190943,BLA submitted
52637,Phase 3
73512,Phase 2/3
166404,Phase 1b/2a
114796,Phase 2a
102442,Discontinued in Preregistration
15382,Phase 1/2a
143750,Investigative
66305,Patented
101192,Phase 1/2a
75006,Phase 2a
76654,Phase 1/2a
143078,Investigative
58742,Investigative
121518,Approved
71037,Phase 1b/2a
51460,Phase 1/2
22049,Discontinued in Phase 2
100616,Phase 1/2
118389,Phase 1
74366,Phase 1/2a
143742,Discontinued in Preregistration
184716,Phase 1/2
133248,Approved
155454,Investigative
175389,Discontinued in Phase 2
98371,Phase 1
16992,Phase 2b
182294,Discontinued in Phase 2b
123332,Discontinued in Phase 4
160818,Phase 3
11478,Phase 1
82756,Investigative
33051,Phase 3
90372,Phase 1b
22813,Phase 1/2a
161634,Patented
43720,Phase 2/3
158547,Phase 1b/2a
103197,Phase 0
110525,Phase 3
32069,Phase 2/3
114962,Clinical trial
117874,Phase 1/2a
44800,Phase 2/3
70249,Phase 1
169628,Phase 2
154220,Discontinued in Phase 2b
163380,Patented
85027,Phase 1/2a
103515,Phase 1b
91624,Phase 2/3
133427,Discontinued in Phase 1
18629,Discontinued in Phase 3
30375,Phase 1
137428,BLA submitted
27812,Phase 1/2a
103042,Phase 1/2a
117930,Phase 3
11939,Phase 1/2a
82666,Discontinued in Preregistration
65414,Phase 1/2a
66725,Phase 3
38985,IND submitted
168910,Phase 3
24120,Investigative
11618,Phase 2
168994,Discontinued in Phase 4
8916,Discontinued in Phase 2
50410,IND submitted
170666,Phase 0
146400,Phase 0
23848,Patented
20734,Phase 1/2a
179995,Phase 1/2a
155530,Approved
69287,Phase 2b
139513,Phase 1/2
183715,Phase 1b/2a
119255,Phase 1b/2a
70043,Discontinued in Preregistration
184379,Discontinued in Phase 4
185465,Discontinued in Phase 1/2
64227,Phase 0
67495,Phase 1b
188838,IND submitted
71666,Phase 1b/2a
159690,Phase 1b/2a
49808,Phase 1
23635,Phase 1/2
70721,Phase 0
191596,Phase 0
1354,Discontinued in Phase 2
128201,Discontinued in Phase 4
96414,Discontinued in Phase 3
120729,Phase 0
162490,IND submitted
101606,Phase 1/2a
62443,Phase 1b
41742,Phase 1
176989,Phase 2b
65169,Discontinued in Phase 3
41209,Discontinued in Phase 1/2
145613,Discontinued in Phase 2
153901,Phase 1/2a
32490,Phase 2a
131010,Patented
156736,Clinical trial
103448,Phase 1/2a
92030,Phase 0
189820,Phase 1/2
185444,Phase 1/2a
147897,Phase 1b
160347,Phase 2/3
41527,Phase 1
115062,Phase 2/3
57665,Phase 1b/2a
169861,Phase 1b
63525,Phase 2a
37177,Phase 0
146021,Discontinued in Phase 1
15553,Phase 2b
181538,Phase 2/3
48068,Phase 1/2a
24451,Phase 1/2a
167994,Phase 1/2
41023,Discontinued in Phase 1/2
17907,Discontinued in Phase 3
175234,Phase 2
162251,Phase 1b/2a
40745,Discontinued in Preregistration
22751,Investigative
51380,Phase 2/3
79930,Discontinued in Phase 4
53785,Phase 0
26847,BLA submitted
182448,Discontinued in Phase 4
10347,Discontinued in Phase 2b
11457,Investigative
186344,Phase 2b
135679,Phase 1b
125951,Phase 1b/2a
97454,Phase 1b
19174,Phase 0
125787,Phase 1/2
86050,Phase 1
120513,Phase 4
122565,Phase 0
126742,Phase 1/2
186572,Phase 0
147927,Phase 1b/2a
85092,Phase 1/2a
127301,Discontinued in Phase 4
53289,Investigative
34303,Phase 0
149000,Phase 1/2
150354,Phase 1b
75214,Phase 1b/2a
185098,Discontinued in Phase 4
160496,Phase 1/2
74297,Phase 1b/2a
39548,Phase 2
186102,Phase 0
90421,Phase 1/2
39795,Discontinued in Preregistration
107774,Discontinued in Phase 2/3
149087,Phase 2/3
37539,Phase 2
141257,Phase 2/3
143384,Phase 1b/2a
97024,Discontinued in Phase 2b
30481,Investigative
139767,BLA submitted
28058,IND submitted
120670,Clinical trial
55113,Discontinued in Phase 3
27894,Phase 0
79691,Phase 1/2a
56470,Phase 1b
142096,Phase 2/3
101916,Phase 1b
137914,Phase 1/2a
191687,IND submitted
66838,Phase 1b/2a
28751,Phase 1/2a
148614,Phase 1b/2a
93611,Phase 1b
87576,Discontinued in Phase 1/2
96041,Phase 1/2
82957,Discontinued in Phase 1/2
9926,Discontinued in Phase 3
90855,Clinical trial
59367,Phase 1b/2a
16866,Phase 0
180707,Discontinued in Phase 2
127667,Discontinued in Preregistration
173991,Discontinued in Preregistration
97709,Phase 0
122400,Phase 0
124558,Phase 0
64910,Phase 1/2a
17509,Phase 1
178241,Phase 2/3
98715,Phase 1/2a
34056,Phase 0
155400,Phase 1b
32240,Phase 1b/2a
56399,Discontinued in Phase 2b
40651,Discontinued in Preregistration
98988,Phase 2
55358,Phase 2
9547,Phase 1/2a
143314,Discontinued in Preregistration
22331,Phase 2/3
84338,Phase 1b/2a
1665,Approved
169933,Discontinued in Phase 4
179785,Phase 1
52825,Phase 0
156555,IND submitted
117800,Phase 0
16076,Phase 0
72721,IND submitted
58826,Investigative
165142,Phase 1
185720,Phase 2a
104239,Phase 1/2a
17,Phase 1/2a
8354,Patented
50213,Phase 0
39906,Investigative
101327,Phase 1/2a
87122,Patented
43832,Phase 2/3
72990,Phase 2
15956,Phase 1/2a
7331,Phase 1/2
185930,Phase 2a
70628,Phase 1/2a
51607,Investigative
66884,Patented
125020,Phase 0
179454,Discontinued in Phase 1/2
125986,Investigative
186970,Phase 0
66152,Phase 0
126226,Investigative
21396,Phase 2
39975,Phase 1/2a
84366,Discontinued in Phase 3
98975,Patented
124085,Phase 1/2
64649,Approved (orphan drug)
32777,Phase 1
19612,Phase 1
116769,Discontinued in Phase 1/2
142431,Discontinued in Phase 2b
100977,Phase 1/2a
41224,Investigative
145379,Discontinued in Phase 2/3
17914,Phase 2/3
150297,Investigative
6117,Investigative
118300,Phase 2b
172063,Phase 1b
88167,Patented
126568,Discontinued in Phase 2b
83682,Discontinued in Phase 1/2
92855,Phase 1b
50629,IND submitted
103915,BLA submitted
169851,Patented
86820,Phase 1b
179758,Phase 1/2a
178480,Phase 0
94378,Discontinued in Phase 3
87926,Discontinued in Phase 2/3
147154,Investigative
144747,Phase 1b
131048,Phase 2a
58787,Phase 1
10825,Discontinued in Phase 2b
131697,IND submitted
15134,Phase 1
61801,Phase 1b
168391,Phase 1b/2a
186467,Phase 1b/2a
128211,Phase 1/2
56816,Discontinued in Phase 4
43214,IND submitted
89817,Phase 2/3
32439,Phase 1/2a
18144,Preregistration
20351,Phase 1
118363,Phase 1b/2a
64197,Approved
57455,Discontinued in Phase 4
15201,Phase 1/2
6744,Phase 1b/2a
117034,Discontinued in Phase 3
140316,BLA submitted
83287,Phase 0
180444,Discontinued in Phase 2b
122892,Phase 1
190512,Phase 1b
30570,Discontinued in Phase 4
11197,Phase 0
100101,Phase 0
99586,Patented
89794,Phase 1b/2a
188186,Approved (orphan drug)
50315,Investigative
144503,Clinical trial
6735,Phase 1b/2a
91772,Approved (orphan drug)
189544,Phase 2b
135837,Phase 1/2
54537,Discontinued in Phase 2b
24832,Phase 0
64250,Phase 0
63014,IND submitted
155749,Phase 1/2a
76944,Phase 1b/2a
151450,Phase 1
116490,Phase 1/2
140514,BLA submitted
122633,Phase 1/2
125362,Phase 1b
10186,Discontinued in Phase 3
8566,Phase 2
107839,Discontinued in Phase 1
126907,Patented
144866,Phase 1/2
81312,Phase 1b
156438,Phase 1/2
18399,Phase 2
143024,Phase 1b/2a
31134,Discontinued in Phase 3
29272,Phase 2
158991,Approved
14637,Phase 0
76335,Investigative
61076,Clinical trial
45623,Phase 2/3
96080,Approved (orphan drug)
73090,Phase 1b/2a
81125,Clinical trial
2592,Phase 2
103581,Phase 1/2
151707,Phase 1b/2a
42639,Discontinued in Phase 1
45419,Phase 1/2a
99608,Patented
69823,Phase 1
174784,Discontinued in Phase 4
64159,Approved
62134,Phase 1/2a
159676,Phase 1b
145619,Phase 2b
44986,Phase 2/3
190921,Phase 1/2
169363,Phase 2/3
171829,Patented
17032,Phase 0
37702,Phase 1b
160536,Phase 2/3
70767,Phase 2b
63743,Approved (orphan drug)
123373,Phase 1b
135136,Phase 0
186835,Phase 0
116327,Discontinued in Phase 2/3
189521,Phase 1/2
5777,Discontinued in Phase 2
156489,Discontinued in Phase 2b
135219,Phase 0
47501,Phase 0
98428,Phase 2
118404,Discontinued in Phase 2/3
178312,Phase 2/3
113677,Phase 0
185954,Phase 2b
187272,Phase 0
38310,Phase 0
129143,Discontinued in Preregistration
172079,IND submitted
54495,Discontinued in Phase 2b
43098,Phase 0
85866,Discontinued in Preregistration
114231,Phase 2
149308,Phase 0
168184,Approved (orphan drug)
96506,Discontinued in Phase 2b
63094,IND submitted
58861,Phase 1b/2a
152782,Phase 1/2a
16511,Phase 2b
49766,Phase 0
31316,Phase 1/2
186888,Phase 0
174267,Discontinued in Phase 4
1764,Approved
84511,Phase 0
92269,Approved (orphan drug)
157363,Discontinued in Phase 1/2
108208,Phase 1/2a
10947,Phase 1
6149,Phase 2a
49629,Phase 0
15538,Phase 0
92134,Patented
65859,Preclinical
87467,Phase 1/2
157028,Phase 2a
131889,Discontinued in Phase 1/2
20067,Phase 2a
178150,Phase 2
155440,IND submitted
107405,Discontinued in Phase 2b
78819,Phase 1b
81559,Phase 2
162885,Phase 1/2a
180955,Phase 2a
139029,Phase 1/2a
109409,Phase 3
72315,Phase 1b/2a
63718,Phase 0
163707,Discontinued in Phase 2
140535,Phase 0
174826,Discontinued in Phase 1/2
71619,Phase 1b
34095,Discontinued in Phase 2/3
30449,Phase 1b/2a
23855,Discontinued in Phase 4
5351,Phase 1/2
128608,Phase 0
29984,IND submitted
62136,Investigative
148109,Discontinued in Phase 2
136431,Phase 1/2a
164867,Phase 0
145682,Patented
176755,Phase 2
96345,Discontinued in Phase 3
57341,Phase 1/2a
160668,Phase 0
95612,Phase 2a
23681,Phase 2
182489,Phase 1/2a
14033,Phase 1
170909,Phase 1/2
93009,Discontinued in Phase 1
42533,Phase 1
122596,Phase 0
127666,IND submitted
94906,Phase 1/2a
168176,Approved
89319,Phase 1/2a
131608,Discontinued in Phase 1/2
92169,Phase 2
73047,Phase 2/3
150235,Investigative
13664,Phase 1/2
114284,Phase 1
111631,Phase 1/2
182677,Phase 1/2a
118660,BLA submitted
148738,IND submitted
167519,Phase 4
134728,Phase 0
47366,Clinical trial
65578,Discontinued in Phase 2b
52712,Phase 1b
123425,Phase 1/2
110247,Phase 0
70905,Phase 0
156587,Phase 1
35107,Discontinued in Phase 2
159683,Investigative
101026,Investigative
70960,Phase 1b
185665,Phase 0
34414,Phase 1b/2a
84428,Phase 1
48219,Phase 1b/2a
30015,Phase 1
79740,Phase 2a
34889,Phase 1/2
14162,Phase 1
85913,Discontinued in Phase 2b
53665,Phase 1b
140126,Phase 1b
77218,Investigative
70717,Phase 2
50309,Phase 0
104021,Phase 1/2
142331,Discontinued in Phase 1
187013,Phase 4
120897,Investigative
57064,Phase 1/2
67291,Discontinued in Phase 1
133264,Approved
162333,Phase 0
189724,Phase 2b
44084,Phase 1/2a
60875,Phase 2/3
73032,Phase 2a
73309,Discontinued in Phase 2
151119,Phase 2
178121,Phase 1
23853,Phase 1
131591,Discontinued in Phase 4
171723,Discontinued in Phase 2b
71051,Discontinued in Phase 3
190508,Clinical trial
185309,Discontinued in Phase 4
133330,Phase 1
35557,Phase 1/2
91922,Phase 1/2a
147492,Phase 0
116066,Discontinued in Preregistration
142416,Phase 1
165521,Phase 1b
121841,Approved
84750,Phase 0
22057,Discontinued in Phase 4
71513,Patented
114620,Investigative
105022,Phase 1b/2a
135208,Phase 0
86027,Phase 1b/2a
41786,Phase 2a
11237,Investigative
20241,Phase 0
79577,Discontinued in Phase 2
56010,Patented
150688,Phase 0
147669,Phase 2/3
66900,Phase 1b
26278,Phase 2
63565,Discontinued in Phase 2b
169532,Phase 1
108835,Phase 3
165338,Phase 0
70865,IND submitted
103950,Phase 1/2a
65477,Discontinued in Phase 4
151606,Phase 0
101942,Discontinued in Phase 2/3
95273,Patented
92967,Phase 2b
113666,Patented
113121,Discontinued in Phase 4
136262,Phase 1/2a
57122,Phase 2/3
190957,Phase 1/2
51683,Discontinued in Preregistration
163824,Phase 1/2
173995,Patented
37513,Phase 1b/2a
172967,Discontinued in Phase 2b
172525,Phase 1b
145541,Phase 2b
134084,Phase 1/2a
162101,Investigative
172292,Discontinued in Phase 2
37822,Phase 1b
49069,Phase 2
141802,Discontinued in Preregistration
117492,Investigative
87090,Phase 1b
101762,Phase 1/2a
186520,Phase 0
188832,Phase 1/2
172730,Discontinued in Phase 2b
10325,Patented
151826,Phase 1b/2a
106427,Patented
123820,Phase 1/2
141926,Patented
33606,Phase 2/3
111397,Phase 1/2a
183934,Discontinued in Phase 4
177783,Phase 2
10618,Phase 0
146145,Phase 1/2a
38637,Phase 0
62587,Phase 0
174581,Phase 1/2
147630,Phase 2/3
56894,Patented
45424,Phase 2/3
90169,Phase 1b
71913,Patented
95068,Patented
42527,Discontinued in Phase 1
70015,Phase 0
155170,Phase 1/2
178411,Phase 2a
93215,Phase 1b/2a
145570,Phase 1/2a
99646,Phase 0
4989,Phase 1b/2a
60462,Investigative
117438,Discontinued in Phase 2/3
3277,Patented
87889,Phase 1/2
33928,Discontinued in Preregistration
35963,Phase 1b
61280,Phase 1
64961,Phase 1/2a
53219,Phase 0
68833,Discontinued in Preregistration
142649,Phase 1/2a
77131,Phase 0
103248,Phase 1/2
23967,Phase 1/2
96042,Phase 1/2a
21545,Patented
125473,Phase 1/2
27773,Phase 2/3
5939,Discontinued in Phase 2
8569,Phase 2
190961,BLA submitted
179978,Phase 1b
17933,Patented
102911,Phase 1/2a
148302,Phase 1b/2a
63857,Approved (orphan drug)
59234,Discontinued in Phase 3
68589,Discontinued in Phase 4
93444,Phase 2
183837,Discontinued in Phase 2
126542,Phase 1/2
22703,Phase 1/2a
39530,Phase 0
79216,Phase 0
84648,Phase 1/2
35329,Discontinued in Phase 1/2
132213,Discontinued in Phase 2b
58249,Investigative
69141,Phase 2a
164111,Phase 1/2
136867,Patented
64258,Phase 2/3
30761,Investigative
178062,Patented
17282,Phase 3
148681,Phase 1/2a
149851,Phase 1/2a
191771,IND submitted
107454,IND submitted
44964,Phase 1/2a
126233,Phase 1/2
25382,Phase 1b/2a
183862,Approved (orphan drug)
53058,Phase 1b/2a
156611,Phase 0
163500,Discontinued in Preregistration
126357,BLA submitted
171491,IND submitted
162452,Investigative
83024,Phase 1
32298,Phase 2a
71441,Patented
14494,IND submitted
20859,Phase 2b
31598,Discontinued in Phase 2b
28696,Phase 2
166036,Discontinued in Phase 1/2
100957,Phase 1b
38019,Discontinued in Phase 3
25615,Phase 1b
168301,Approved (orphan drug)
166307,Patented
191606,Phase 0
111053,Phase 0
23134,Phase 2a
169968,Patented
133274,Phase 1
44632,Phase 2/3
37442,Discontinued in Phase 3
151680,Phase 2
161431,Patented
181556,Phase 2a
154924,Phase 2/3
94393,Phase 2b
11190,Phase 1b/2a
24557,Discontinued in Preregistration
69992,Phase 1b
34691,Phase 1b
47777,Phase 2
125920,Discontinued in Preregistration
15073,Phase 2b
153393,Clinical trial
122268,Phase 0
84782,Phase 1/2a
5643,Investigative
1265,Discontinued in Phase 4
107306,Discontinued in Phase 3
179865,Phase 1
49889,Investigative
141385,Phase 0
126168,Discontinued in Phase 3
86432,Patented
89391,Phase 1/2
2932,Discontinued in Phase 2b
150077,Discontinued in Phase 1
7525,IND submitted
98567,Phase 1
55281,Phase 1
187976,Discontinued in Phase 4
91886,Phase 0
8642,Investigative
151252,Phase 1
177847,Phase 0
54944,Phase 1/2a
101338,Phase 3
5097,Phase 1b/2a
172286,Phase 1
180958,Discontinued in Phase 2
71638,Phase 0
186303,Patented
111200,Phase 1
56021,Phase 0
26051,Phase 1
39880,Phase 0
168473,Phase 3
190434,Phase 1b
5753,Phase 2a
5504,Phase 1/2
178280,Phase 2
106119,Phase 1b
4341,Phase 1b/2a
117210,Phase 1/2
143924,Phase 1b
62599,Discontinued in Phase 4
121510,Approved (orphan drug)
58214,Phase 2/3
34780,Phase 2/3
96928,Phase 2
78551,Clinical trial
176288,Phase 1/2a
45736,Phase 2/3
169600,Phase 2
46872,Discontinued in Phase 1/2
116909,Discontinued in Phase 1/2
119994,Phase 0
173623,Phase 1/2a
188381,Phase 1/2
112370,Phase 1/2
146290,Phase 1b/2a
56277,Phase 2
39997,Phase 2
170717,Phase 1b/2a
171330,Discontinued in Phase 1
27656,Investigative
24351,Phase 0
147590,Discontinued in Phase 2/3
94249,Phase 2
82638,Discontinued in Phase 1/2
164691,Phase 1/2
77059,Phase 1/2a
129753,IND submitted
162233,Investigative
161887,Discontinued in Preregistration
122568,Phase 1/2
183081,Phase 1
18872,Phase 1/2
108600,BLA submitted
36949,Discontinued in Preregistration
167180,Phase 1/2a
73753,Phase 1b/2a
127008,Phase 1
60071,Phase 1
21049,Phase 1b/2a
124883,Discontinued in Phase 4
107170,Phase 1/2a
105262,Phase 1b
57471,Phase 1
77745,Phase 0
161343,Investigative
63591,Approved (orphan drug)
4699,IND submitted
134222,Phase 1
82553,Investigative
12099,Phase 1b
148122,Phase 1b/2a
89589,Phase 1b/2a
115276,Phase 1/2a
63902,Discontinued in Preregistration
22883,Phase 2/3
157083,Phase 2
69246,Phase 1
168490,Discontinued in Phase 2
120144,Clinical trial
182916,Phase 1b/2a
92411,Phase 4
10550,Discontinued in Phase 3
9508,Phase 1/2a
5478,Investigative
133713,Patented
49246,Phase 1b
179054,Phase 0
184807,Phase 0
50438,Patented
49444,Phase 2
95282,Patented
17926,Phase 1/2a
186941,Phase 0
153549,Discontinued in Preregistration
45980,Phase 1/2a
132326,Discontinued in Phase 1/2
143003,Discontinued in Preregistration
64121,Approved
71227,Discontinued in Phase 3
183594,Phase 2a
163566,Patented
187523,Phase 4
12376,Phase 0
87496,BLA submitted
123388,Phase 1
122434,Phase 1/2
70847,Phase 1/2
176264,Patented
132632,Discontinued in Phase 2b
172685,Phase 2a
162334,Phase 1/2a
98691,Phase 1b
83835,Phase 1/2a
169015,Discontinued in Phase 1
180995,Discontinued in Phase 2b
53362,Patented
89315,Phase 1/2a
162243,Phase 1b/2a
81553,Phase 1
87275,Discontinued in Phase 2
35224,Phase 1/2
69293,Phase 1b
108763,Patented
142134,Discontinued in Preregistration
20235,Discontinued in Phase 4
149794,Phase 1
44575,Phase 2/3
71837,Discontinued in Preregistration
32374,Phase 2/3
110405,Phase 3
12455,Discontinued in Phase 1
70649,Phase 1/2
174770,Phase 1/2
83817,Phase 2
138447,BLA submitted
76150,Phase 2/3
98611,Investigative
91257,Phase 1/2
35608,Phase 1/2
37443,Discontinued in Phase 2b
166859,Clinical trial
30677,Discontinued in Phase 2b
157196,Discontinued in Phase 4
15712,Phase 1
101554,Phase 1b
43219,Investigative
36024,Investigative
165335,Discontinued in Preregistration
134079,Phase 1/2a
111140,Phase 2
143114,Phase 2b
51365,Discontinued in Phase 2/3
158212,Phase 1/2a
161419,Phase 2
59056,Phase 1/2a
112145,Discontinued in Phase 3
182508,Discontinued in Phase 2
124187,Phase 0
189256,Phase 2b
187844,Discontinued in Phase 4
101766,Phase 2b
145906,Investigative
106758,Phase 1b
11327,Discontinued in Preregistration
157399,Phase 1b/2a
90220,Phase 1b
17550,Phase 1
77518,Patented
7397,Discontinued in Phase 2
70457,Phase 1
95903,Phase 1/2
63569,Approved (orphan drug)
128294,Investigative
92352,Phase 2/3
162947,Discontinued in Phase 1/2
17621,Phase 1/2
32348,Patented
130438,Phase 1/2a
74018,Discontinued in Phase 3
46008,Phase 2/3
156371,Discontinued in Preregistration
45432,Phase 2/3
141978,Phase 0
161620,Investigative
103568,Phase 1/2a
21055,Phase 1/2
12410,Investigative
50777,Discontinued in Preregistration
57026,Phase 2
10463,IND submitted
68472,Discontinued in Phase 4
185049,Discontinued in Phase 4
63160,Patented
155908,Discontinued in Phase 3
13193,Phase 1
58535,Phase 1
164733,Patented
186887,Phase 1b/2a
59236,Phase 0
72040,Phase 1b/2a
3566,Investigative
164987,Phase 0
38924,Phase 2
146370,Phase 2b
25299,Phase 1/2
97345,Phase 0
49753,Investigative
158837,BLA submitted
169923,Phase 1/2a
29586,Phase 1b
97725,Phase 1/2a
9608,IND submitted
144034,Phase 1/2
16711,Phase 0
80931,Phase 1b
173154,Phase 1b
53777,Phase 0
179755,Phase 1/2a
104714,Phase 1/2a
37257,Phase 2a
139401,Phase 1b
165120,Phase 1
91376,BLA submitted
188065,Phase 2b
174290,Phase 0
184695,BLA submitted
169728,Phase 1/2
103176,Application submitted
156752,Discontinued in Phase 2
127649,Discontinued in Phase 2b
32467,Phase 2a
145656,Investigative
6860,Phase 2a
19774,Phase 1
14980,Phase 3
157452,Discontinued in Phase 1/2
53993,Discontinued in Phase 2/3
103556,Phase 1b
9473,Discontinued in Phase 2b
147738,Phase 1b
28130,Discontinued in Phase 3
87721,Phase 1/2
77101,Phase 1/2
150132,Investigative
192038,Phase 2a
103327,Phase 1/2
145315,Phase 1b/2a
177059,Phase 1b
87730,Patented
162952,Phase 1/2
133751,Phase 1/2a
36393,Phase 1
90719,Phase 1b
104846,Phase 1b/2a
177588,Phase 1b
7282,IND submitted
84306,Discontinued in Phase 2/3
48712,Discontinued in Phase 2/3
88917,Patented
61828,Phase 1b
122939,Discontinued in Preregistration
99137,Phase 1
118264,Discontinued in Phase 2
103826,Patented
55687,Investigative
145474,Phase 2b
152841,Phase 1b/2a
83830,Patented
25219,Phase 1/2a
66946,Patented
187864,Phase 1b
174279,Discontinued in Preregistration
74362,Discontinued in Phase 4
95734,Phase 1
90699,Phase 0
6956,Discontinued in Phase 2
133162,Discontinued in Phase 3
76451,Phase 1/2a
10772,Phase 1/2
31716,Phase 2
186796,Discontinued in Preregistration
12018,Phase 1
82478,Discontinued in Phase 4
62583,Phase 1b
10281,IND submitted
155766,Phase 1/2
122294,Phase 1
136918,Phase 1/2a
60653,Phase 1b/2a
90876,BLA submitted
90070,Discontinued in Phase 3
1114,Discontinued in Phase 2/3
126771,Phase 1/2
14048,Phase 1/2
87319,Approved
50508,Phase 1/2
164357,Phase 0
9119,Discontinued in Preregistration
71838,Discontinued in Preregistration
109968,Phase 1b
91853,Phase 1b
55640,Phase 1b/2a
158155,Patented
158800,Approved
180379,Phase 1/2
8881,Discontinued in Phase 1/2
119787,Phase 0
162198,Phase 1b
128918,Phase 1/2
117776,Discontinued in Preregistration
163122,Discontinued in Phase 2
149906,Phase 2/3
189175,Clinical trial
97061,Investigative
56708,Phase 1/2
676,Discontinued in Phase 2/3
101253,Phase 1/2
42881,Discontinued in Phase 1
69984,Phase 0
182675,Phase 2b
13512,Discontinued in Phase 1
4055,Phase 1/2
63787,Patented
41535,Discontinued in Phase 1
7269,Investigative
20210,Discontinued in Phase 2b
61207,Phase 1
52861,Discontinued in Phase 2/3
54979,Discontinued in Phase 2b
158742,BLA submitted
78939,Phase 2/3
89509,Phase 1/2a
117727,Discontinued in Phase 2/3
180906,Phase 2a
28846,Phase 2
2023,Approved
144282,Discontinued in Phase 1/2
121026,Phase 1b
185125,Phase 1/2
22996,Phase 1
184114,Discontinued in Phase 4
52127,Investigative
11768,Patented
105108,Phase 0
55497,Phase 2
56786,Phase 2
126395,Phase 1b/2a
107407,Phase 1b
42576,Phase 1/2
133282,Phase 1/2
91930,Phase 1/2a
106277,Phase 1/2
69330,Investigative
176890,Phase 1/2a
98336,Phase 1/2a
153212,Phase 0
59903,Phase 1
62789,Phase 0
33179,Discontinued in Phase 2
15548,IND submitted
125342,Phase 1b
113624,Discontinued in Phase 3
149764,Phase 2b
105162,Discontinued in Phase 3
118446,Phase 2b
147893,Discontinued in Phase 1
41045,Discontinued in Phase 1/2
123562,Patented
94865,Patented
24291,Phase 1
11268,Patented
43136,Discontinued in Phase 2/3
132399,Phase 1b/2a
101621,Phase 2a
110882,Discontinued in Phase 4
48316,Discontinued in Phase 4
83149,Phase 2
134806,Phase 0
76835,Phase 1/2
106042,Phase 2/3
113349,Discontinued in Phase 3
37401,Phase 1
25439,Patented
10844,Phase 0
68003,Phase 1
170275,Phase 0
127897,IND submitted
165545,Discontinued in Phase 1/2
12443,Phase 1b/2a
43245,Phase 1/2a
186488,Phase 1/2a
182809,Phase 2
126436,Clinical trial
4835,Phase 2a
49858,Phase 1b
131073,Phase 1/2
121703,Phase 1b/2a
184150,Discontinued in Phase 3
180907,Discontinued in Phase 2
142581,Phase 1
84213,Phase 1
167224,Discontinued in Phase 1/2
116216,Phase 2a
73707,Clinical trial
145534,Phase 1/2
140706,Phase 2a
25076,Discontinued in Phase 4
122444,IND submitted
154187,Phase 0
67331,Discontinued in Phase 1
62484,Discontinued in Phase 4
73638,Approved
136790,Phase 1b
36791,Discontinued in Phase 1/2
14720,Phase 1/2
156146,Phase 1b/2a
146233,Phase 1/2a
146449,Phase 2b
65629,Discontinued in Phase 2
176067,Phase 1/2
47246,Discontinued in Phase 2
122311,IND submitted
93152,Phase 1/2a
161272,Phase 0
101304,Phase 1b/2a
147826,Phase 0
12453,Phase 1
51577,Discontinued in Phase 3
106780,IND submitted
42373,Phase 0
149028,Phase 1b
3942,Phase 1
180524,Phase 2a
67822,Discontinued in Phase 2b
133709,Phase 1/2a
5323,Phase 2a
12309,Phase 1/2a
82133,Phase 1b/2a
448,Phase 1/2a
172596,Phase 1/2
114343,Discontinued in Preregistration
135324,Phase 0
63990,Phase 1/2
90848,Phase 1b/2a
43297,Preregistration
47201,BLA submitted
143496,Phase 1b/2a
151486,Phase 0
183130,Phase 1b/2a
111666,Phase 1
1033,Discontinued in Phase 2b
187263,Patented
172366,Investigative
92062,Discontinued in Phase 1
75638,Phase 1/2a
49470,Discontinued in Phase 4
165761,Discontinued in Phase 4
46196,Phase 1/2a
90159,Investigative
20162,Clinical trial
53037,Phase 1
16344,Investigative
142878,Discontinued in Preregistration
101368,Phase 1b/2a
168401,Discontinued in Phase 3
13078,Phase 1/2a
118770,BLA submitted
1767,Discontinued in Phase 2/3
19701,Discontinued in Preregistration
163374,Phase 1
161247,Discontinued in Phase 1/2
24264,Phase 1/2
151963,Phase 0
125002,Phase 1/2
10695,Discontinued in Phase 2b
121571,Phase 1b/2a
16793,Phase 1
113318,Patented
144195,Discontinued in Phase 2
56545,IND submitted
113926,Phase 0
5328,Investigative
155447,Phase 0
75787,Phase 1/2a
87822,Patented
71667,Phase 1b
163615,Phase 2b
3481,Phase 0
35584,Discontinued in Preregistration
37630,Discontinued in Phase 1
106917,Phase 1b
22669,Phase 1
158735,Clinical trial
112327,Discontinued in Phase 2
99097,Patented
11010,Phase 1/2
133545,IND submitted
118216,Discontinued in Preregistration
73450,Phase 2a
38898,Phase 2
107780,Discontinued in Phase 3
179169,Phase 1/2a
89356,Phase 1b/2a
122040,Discontinued in Preregistration
143010,Phase 1b/2a
17507,Phase 1
178790,Phase 1/2a
53231,Phase 0
55125,Investigative
114491,Phase 0
6960,Phase 1b/2a
183309,Phase 2a
17778,Phase 1
6230,Phase 2a
59942,Discontinued in Phase 3
42436,Phase 1/2a
186124,Patented
63629,Approved (orphan drug)
61900,Phase 1/2a
81453,Approved
106864,IND submitted
138499,Phase 1b
174040,Phase 1b/2a
158286,Discontinued in Preregistration
54720,Discontinued in Preregistration
140337,Investigative
34197,Discontinued in Phase 2/3
29109,Phase 4
117910,Phase 0
118961,Phase 0
169326,Discontinued in Preregistration
120150,Approved (orphan drug)
24349,Phase 1
43419,Phase 1/2a
166737,Phase 2
188242,Phase 2b
186599,Patented
169838,Phase 1b/2a
120621,Discontinued in Phase 2
99481,Phase 2
156748,Patented
138532,Phase 1b
34124,Phase 1b/2a
92330,Phase 1
120063,Approved
71585,Discontinued in Phase 4
162536,Phase 1b/2a
22261,IND submitted
67388,Approved (orphan drug)
139539,Discontinued in Phase 2
151595,Phase 2
97093,Phase 0
92069,Phase 1b/2a
96842,Phase 2
135622,Phase 0
36224,Phase 0
7029,Investigative
153427,Phase 1
179856,Phase 1
140183,Phase 1b
177421,Approved
117301,Investigative
3920,Phase 1
145030,Discontinued in Phase 2
94592,Discontinued in Phase 1
94469,Phase 1b
83898,Phase 0
148770,Phase 1b/2a
17182,IND submitted
118449,Discontinued in Preregistration
3347,Patented
78175,Investigative
75323,Phase 4
140958,Discontinued in Preregistration
16434,Phase 1
181345,Discontinued in Phase 2b
44645,Phase 1/2a
30922,Phase 0
33399,Phase 1
96885,Phase 1/2a
58261,Discontinued in Phase 3
22032,Approved (orphan drug)
91982,Discontinued in Phase 2
22759,Phase 1b/2a
70000,Phase 1/2a
481,Phase 1/2a
14135,Investigative
143881,Phase 1b/2a
68834,Phase 1/2a
138580,BLA submitted
168605,Phase 1/2
180498,Discontinued in Phase 4
3595,Discontinued in Phase 4
35968,Phase 2a
123680,Phase 1
16347,Investigative
130735,Phase 1b
183953,Phase 0
11644,Discontinued in Phase 2/3
96317,Discontinued in Phase 3
159362,Patented
156173,Phase 1b
131760,Discontinued in Phase 4
185273,Discontinued in Phase 4
134856,Phase 0
18288,Discontinued in Phase 2b
181267,Phase 1/2a
75558,Discontinued in Preregistration
86276,Phase 0
32148,Phase 3
187854,Phase 0
25973,Discontinued in Phase 2/3
168789,Discontinued in Phase 1/2
135373,Phase 0
173931,Phase 2
135452,Phase 0
152577,Patented
140601,Phase 2a
167517,Phase 4
81610,Phase 1
20272,Phase 1
187722,Phase 0
171238,Patented
60467,Phase 1
97587,Phase 1
93225,Phase 2b
92796,Discontinued in Phase 3
154686,Phase 1b/2a
72893,IND submitted
16124,IND submitted
111855,Patented
128104,Phase 0
158916,Phase 1/2
183899,Phase 2a
152101,Discontinued in Phase 2/3
177146,Phase 1/2
155266,Phase 2a
36696,Phase 1
50263,Phase 1b/2a
165874,Phase 1
170987,Phase 1
70385,Phase 0
114679,Phase 2
22942,Phase 0
122539,Patented
148877,Discontinued in Phase 2/3
120222,Approved (orphan drug)
132466,Discontinued in Phase 1/2
136568,Phase 2
9293,Discontinued in Phase 1
98538,Phase 1b
146506,Phase 1/2a
62955,Phase 1/2a
56670,Discontinued in Phase 2b
183138,Phase 1/2
33923,Phase 1/2
102656,Phase 0
31737,Phase 1b/2a
25330,Phase 1/2a
16016,Phase 0
18620,Phase 2
144380,Discontinued in Phase 1/2
170807,Discontinued in Preregistration
38755,Phase 1
68440,Phase 0
166588,Discontinued in Preregistration
84658,Phase 1/2
24643,Phase 2
124278,Phase 1
126713,Discontinued in Phase 2b
44622,Phase 1/2a
24161,Phase 1b/2a
102975,Discontinued in Preregistration
147421,Phase 1b/2a
148914,Phase 1/2a
88329,Patented
68893,Phase 1b
72313,Phase 0
113100,Phase 2a
134522,Phase 1b
126875,Discontinued in Preregistration
82928,Discontinued in Phase 1/2
39396,Phase 1b
81845,Approved
128727,Investigative
37809,Phase 1/2
148906,Phase 2b
82499,Phase 2
104582,Patented
140318,BLA submitted
161006,Phase 0
114769,Phase 1b/2a
38411,Patented
151866,Phase 1b/2a
63834,Discontinued in Phase 2/3
49393,Discontinued in Phase 2/3
42544,Phase 1/2
9532,Investigative
67065,Phase 2a
57410,Investigative
105415,Phase 1b
77421,Phase 0
17618,Phase 1
184290,Phase 0
163345,Investigative
31391,Investigative
88900,Investigative
23845,Phase 2/3
170187,Phase 1
90323,Clinical trial
188354,Phase 1b
60124,Clinical trial
68287,Phase 1
73452,Phase 2/3
24078,Phase 1/2
168769,Clinical trial
23023,Phase 2a
75413,Discontinued in Phase 2/3
12969,Phase 1/2
118794,Phase 2b
88567,Phase 1
119090,Discontinued in Phase 2/3
19173,Phase 1b
90259,Phase 1b
44589,Phase 1/2a
182129,Phase 1/2
142889,Phase 1/2a
175109,Discontinued in Phase 4
69003,Phase 1b
53100,Phase 1/2a
185053,Phase 1/2
27368,Investigative
122252,Approved
75229,Phase 1/2
179117,Phase 1/2a
572,Discontinued in Phase 1/2
158457,Clinical trial
103853,Phase 0
149717,Phase 1
120153,Phase 0
43227,Investigative
147017,Discontinued in Phase 2
23501,Investigative
97416,Discontinued in Phase 2b
38506,Patented
21951,Patented
85659,Discontinued in Preregistration
127637,Patented
70062,Phase 1b
66052,Phase 2a
65928,Phase 2/3
46170,Phase 2/3
13672,Phase 0
109910,Discontinued in Phase 1/2
163918,Phase 1/2
622,Phase 1
94499,Phase 2b
113373,Phase 2/3
11571,Discontinued in Phase 2/3
71442,Investigative
25675,Investigative
171726,Phase 1b
152857,Investigative
167452,Discontinued in Phase 1/2
155671,Phase 2
168657,Phase 2
183047,Discontinued in Phase 4
84947,Phase 1/2a
126831,Discontinued in Phase 1
6108,Investigative
29355,IND submitted
61111,Phase 1
95169,Phase 1b
146609,Phase 2a
68575,Phase 1/2
173276,Discontinued in Phase 2b
115089,Clinical trial
167554,Phase 4
16266,Phase 1
42217,Phase 1
67927,Phase 0
35617,Phase 1/2
49740,Phase 1
5911,Phase 4
20959,Investigative
78216,Clinical trial
101666,Phase 1/2a
109468,Approved
37525,Discontinued in Phase 1
158083,Phase 1
18389,Phase 1
78295,Approved (orphan drug)
83179,Phase 2/3
61010,Investigative
77936,Discontinued in Phase 4
162865,Phase 1/2
100863,Phase 1/2
7834,Patented
185730,Phase 1b
55702,Phase 1b/2a
116217,Phase 2/3
146146,Phase 1/2a
45260,Phase 1/2a
5485,Phase 2a
168344,Discontinued in Phase 3
25521,Phase 1/2
65648,Phase 1/2a
2831,Investigative
51040,Phase 2/3
96707,Investigative
9092,IND submitted
34719,Patented
63142,Patented
161164,Discontinued in Phase 4
141702,Discontinued in Preregistration
109276,Phase 0
3100,Discontinued in Phase 2b
159113,Phase 1b/2a
60147,Phase 2/3
43181,Discontinued in Preregistration
135825,IND submitted
50619,Discontinued in Phase 2b
99204,Phase 0
112971,Phase 1
10253,Discontinued in Phase 2b
57048,Phase 1/2
55673,Discontinued in Preregistration
168739,Phase 3
91635,BLA submitted
176040,Phase 1/2
73812,Phase 2/3
134341,Phase 1b
114746,Discontinued in Phase 1
98733,Phase 1/2a
3846,Investigative
146890,Phase 0
114101,Patented
48604,Phase 1/2
165840,Discontinued in Phase 4
168075,Phase 0
125395,Phase 1b/2a
36222,Phase 1
103517,Discontinued in Phase 2/3
10694,Phase 1/2
56220,Phase 1/2
60133,Phase 0
40939,Phase 1/2a
76109,Phase 0
4442,Phase 1/2
45020,Phase 1/2a
112747,Discontinued in Phase 2
76695,Phase 1/2a
111964,Phase 1
112866,Discontinued in Phase 3
10188,Discontinued in Phase 2b
39869,Discontinued in Phase 2/3
160004,Phase 1
104065,Patented
70055,Phase 1b
125876,BLA submitted
83018,Patented
113741,Patented
14937,Phase 1
37042,Phase 0
120652,Discontinued in Phase 1/2
29083,Phase 1/2a
17895,Phase 2/3
52753,Phase 1
121561,Phase 2
41757,Discontinued in Phase 1
68100,Clinical trial
179220,Discontinued in Phase 1/2
20998,Discontinued in Phase 1/2
122223,Phase 1b
48873,Discontinued in Preregistration
34388,Patented
29830,Phase 0
98142,Phase 1/2a
38970,Discontinued in Preregistration
20216,Discontinued in Phase 4
127135,Discontinued in Preregistration
11355,Discontinued in Phase 2/3
30828,Discontinued in Phase 2b
14619,Investigative
47341,Phase 0
96245,Patented
124214,Phase 1/2
122635,Phase 1b
56102,Discontinued in Preregistration
161880,Discontinued in Phase 4
79718,Phase 1b/2a
163311,Clinical trial
73585,Phase 1b/2a
12979,Phase 1
177545,Phase 2a
101257,Phase 1b
129518,Investigative
97395,Phase 1/2
50672,Phase 1b
155499,Phase 2/3
57501,Phase 0
147631,Phase 0
90137,Approved (orphan drug)
89126,BLA submitted
169832,Phase 1/2
186412,Phase 1b
25365,Patented
179684,Discontinued in Phase 1
118489,Discontinued in Phase 3
36632,Discontinued in Phase 3
79447,Phase 1b
36099,Phase 1
114941,Clinical trial
158866,Phase 1
156757,Phase 1
44341,Phase 1/2a
131249,IND submitted
184637,Phase 0
99414,Phase 1b/2a
158983,Phase 2
47871,Phase 1
13675,Phase 1
152178,Phase 1
19779,Phase 2a
108968,Phase 1b
155411,Phase 1
179358,Phase 1b
52893,Phase 0
156559,Phase 0
177464,Phase 2
128910,Investigative
24375,Phase 1/2
54681,Phase 1b/2a
181602,Phase 2a
150771,Phase 1
121247,Phase 1/2a
68870,Discontinued in Phase 2
169552,Discontinued in Phase 2/3
183085,Phase 1b
8324,Phase 2
135784,Phase 1/2
134944,Phase 0
53904,Discontinued in Preregistration
43652,Phase 1/2a
126463,Phase 2b
174186,Discontinued in Phase 4
46687,Approved
44417,Phase 2/3
27873,Phase 2
49449,Phase 1b
29348,IND submitted
21656,Phase 1b/2a
137415,Investigative
158778,Phase 2
53503,Phase 0
102961,Investigative
56004,Phase 2
151605,Phase 0
101904,Phase 1b
19232,Phase 1
80514,Discontinued in Phase 1/2
53564,IND submitted
77335,Phase 1/2a
4630,Phase 2/3
108027,IND submitted
179122,Phase 1/2
123374,Approved
17283,Phase 3
40523,Phase 2
83706,Phase 1b/2a
55937,Phase 2
31670,Investigative
58366,Discontinued in Phase 3
146912,Phase 2b
58363,Phase 1
166679,Discontinued in Phase 3
161793,Investigative
71212,Phase 1b
142511,Phase 1
47334,Clinical trial
27320,Discontinued in Preregistration
47258,Phase 1/2
47466,Approved (orphan drug)
7178,Phase 1/2
117518,Discontinued in Phase 2/3
96410,Phase 1
164971,BLA submitted
110505,Phase 1b/2a
38910,IND submitted
186428,Phase 1/2a
22406,Phase 0
167770,Phase 1b/2a
45990,Phase 1/2a
61945,Phase 1b
164558,Phase 1
172414,IND submitted
44232,Phase 2/3
127592,Phase 0
6127,Phase 4
144344,Discontinued in Phase 1/2
126271,Phase 1b
91166,BLA submitted
26361,Phase 2/3
136061,Phase 1/2
54736,Phase 1
35829,Discontinued in Phase 1/2
142754,Phase 2b
32469,Phase 2a
23410,IND submitted
42777,Discontinued in Phase 2/3
176263,Phase 1b
6168,Phase 1b/2a
87334,Phase 1
109329,Phase 1
62937,Discontinued in Phase 3
148284,Phase 1b
117670,Phase 1/2
164458,Phase 1/2
59225,Phase 1b/2a
143827,Investigative
141282,Phase 0
187771,Phase 1
178192,Phase 2/3
80494,Phase 2a
177681,Phase 2
135143,Phase 0
64700,Discontinued in Preregistration
59278,Phase 2/3
123620,Phase 1/2
146876,Phase 1b/2a
115731,Approved (orphan drug)
99899,Phase 1
111393,Discontinued in Phase 3
185684,Phase 2b
159764,Phase 1
58436,Approved (orphan drug)
30493,Phase 1
164324,Investigative
111755,Phase 1/2
91507,Approved (orphan drug)
106905,Phase 1/2a
181494,Discontinued in Phase 2b
158322,Phase 1
182329,Phase 1/2
164303,Phase 1/2
122630,Phase 1/2
183210,IND submitted
164463,Phase 0
76329,Phase 1
174829,Phase 2
129970,IND submitted
44310,Phase 1/2a
124250,Phase 1/2
82633,Phase 1b/2a
139952,Phase 1/2
52616,Phase 1/2
112925,Discontinued in Phase 3
2345,Investigative
158697,Phase 2
97700,Phase 2
71509,Discontinued in Preregistration
2936,Phase 1/2a
15624,Discontinued in Phase 1
20749,Patented
175166,IND submitted
45487,Phase 2/3
111574,Discontinued in Phase 2b
87257,Phase 0
182336,Phase 1b
118165,Phase 1/2a
56971,Phase 0
130985,IND submitted
185992,Phase 1b
168373,Phase 2
87408,Patented
36288,Investigative
162953,Discontinued in Phase 1/2
154366,Phase 1b/2a
109237,Discontinued in Phase 2
3977,Discontinued in Phase 1
122669,Phase 0
115398,Phase 2/3
58680,Phase 0
5192,Discontinued in Phase 2
120974,Phase 1b
117855,Phase 1b
174574,Phase 1/2
108184,Phase 1/2a
19627,Discontinued in Phase 2b
115407,Phase 1/2a
23985,Phase 2a
157076,IND submitted
104961,Phase 1b/2a
132306,Phase 1/2
101758,Phase 1b
147606,Investigative
1151,Discontinued in Phase 1
125345,Phase 1b/2a
130653,Phase 1
174280,Patented
11334,Discontinued in Phase 2/3
44541,Phase 1/2a
85609,Discontinued in Phase 3
54836,Discontinued in Phase 2b
93826,Phase 2a
152681,Patented
136490,Discontinued in Phase 2/3
85928,Discontinued in Phase 2b
115701,Phase 1/2a
3437,Discontinued in Phase 2
165648,Phase 1b
78335,Discontinued in Phase 2b
154093,Discontinued in Phase 4
152579,Discontinued in Phase 3
22509,Phase 2
166517,Phase 1/2
30876,Phase 2
61865,Discontinued in Preregistration
106915,Phase 1
6820,Phase 4
10427,Discontinued in Phase 2
96273,Phase 1b/2a
63138,Discontinued in Phase 3
130871,Phase 1b/2a
138614,Discontinued in Phase 2
37060,Discontinued in Phase 1
174811,Discontinued in Phase 4
121188,Phase 2b
84813,Phase 1/2
114749,Phase 1b/2a
97843,Phase 1/2
82934,Phase 2
82323,Phase 0
72220,Phase 1b/2a
37588,Phase 1b/2a
155059,Investigative
170498,Phase 0
41353,Phase 2
3096,IND submitted
179291,Discontinued in Phase 2/3
164204,Investigative
121289,Phase 1b/2a
42141,Phase 1
50921,Phase 0
83534,Phase 1/2a
150927,Phase 0
114210,Phase 1
31244,IND submitted
54590,Phase 0
82177,Clinical trial
60188,Phase 0
59097,Phase 0
157583,IND submitted
73089,Phase 1b/2a
79649,Discontinued in Phase 1
171337,Phase 1/2
150213,Phase 1b/2a
143219,Discontinued in Preregistration
99804,Phase 2
115468,Phase 2
5171,Phase 1/2
106532,Approved
37460,Discontinued in Preregistration
146910,Phase 1b/2a
44020,Phase 1/2a
149175,Phase 1b/2a
159625,Phase 1b/2a
68514,Discontinued in Preregistration
59430,Discontinued in Phase 3
156282,Phase 1/2
146078,Phase 1b/2a
48515,Phase 1/2a
95458,Phase 2a
20570,IND submitted
66985,Phase 1b/2a
188185,Investigative
187640,Phase 2a
152306,Approved (orphan drug)
4352,Phase 1/2
98339,Phase 1/2a
143630,Investigative
30987,Phase 1b/2a
144453,Discontinued in Phase 1/2
136830,Phase 1
110377,Phase 1b/2a
179136,Discontinued in Phase 2/3
74022,Phase 1/2
155540,Approved
93691,Phase 2b
105322,Phase 1/2
110142,IND submitted
34498,Phase 1b/2a
102145,Phase 1/2a
181643,Discontinued in Phase 2b
49250,Phase 1b/2a
165219,Discontinued in Preregistration
78064,Approved
183225,IND submitted
2266,Phase 1
150097,Phase 1/2
187364,Phase 2b
159198,Phase 1b/2a
6812,Discontinued in Phase 2
188126,Phase 1
92517,Phase 1b/2a
157006,Registered
91962,Investigative
45985,Phase 2/3
138050,BLA submitted
187184,Phase 2b
29757,Phase 1b/2a
43188,Discontinued in Phase 4
189879,Phase 0
185653,Phase 2
113011,Phase 1
161940,Discontinued in Phase 4
74829,Discontinued in Phase 4
121076,Phase 0
143481,Phase 1b/2a
191318,Investigative
64180,Phase 1/2
3028,Discontinued in Phase 2b
191190,Phase 1/2
34543,Phase 1/2
101507,Phase 1b
176359,Patented
86464,Phase 0
87419,Phase 0
130342,Phase 1/2
108524,Phase 1b/2a
117238,Discontinued in Phase 2/3
65961,Discontinued in Phase 2/3
143256,Phase 1b/2a
64718,Discontinued in Phase 2
172312,Discontinued in Phase 2b
75223,Patented
90600,Phase 1b
154367,Phase 1b/2a
137226,Phase 1/2a
100402,Approved
80659,Investigative
148069,Phase 1/2
41655,Phase 1b/2a
33054,Phase 2a
151295,Phase 1
148997,Patented
124433,Phase 0
89299,Phase 1/2
6216,Investigative
48236,Discontinued in Phase 2/3
162889,Discontinued in Preregistration
114537,Phase 1/2a
76065,Phase 0
59206,Discontinued in Phase 3
171867,Phase 1
27221,Phase 1b/2a
107522,Phase 1
131763,Discontinued in Phase 3
162917,Discontinued in Phase 1/2
107269,Phase 1/2a
155476,Approved
32277,Phase 2a
122924,Phase 0
100845,Discontinued in Phase 1/2
53714,Discontinued in Phase 2
72579,Phase 2
106476,Preregistration
145193,Phase 1
88981,Phase 0
15068,IND submitted
174656,Phase 1/2
182199,Phase 1b/2a
86166,Phase 0
43991,Phase 2/3
44731,Phase 1/2a
92430,Discontinued in Phase 3
92554,Phase 1/2a
50505,Discontinued in Preregistration
171789,Discontinued in Phase 2
127881,IND submitted
25176,Phase 1b
106671,IND submitted
38315,Phase 0
162265,Phase 3
36569,Phase 1
27576,Phase 1/2
46345,Phase 1/2
187426,Discontinued in Preregistration
39960,IND submitted
49341,Phase 2
133283,Approved
125074,Phase 1/2
26626,Phase 1b
149322,Investigative
94606,Phase 1/2a
78594,Phase 0
166166,Patented
140747,Preregistration
151528,Phase 0
42027,Phase 1
41352,Phase 1b/2a
144785,Phase 0
143165,Phase 1b/2a
50512,Phase 0
166898,Patented
118192,BLA submitted
2189,Phase 1/2
55337,Phase 0
143544,Phase 1b/2a
139575,BLA submitted
118495,IND submitted
154647,Phase 1b/2a
177331,Phase 1b
177892,Phase 1
145045,Phase 2b
146339,Phase 1b
110967,Patented
89762,Phase 1
38500,Phase 1/2a
112511,Discontinued in Phase 3
175834,Discontinued in Phase 3
42387,Phase 0
118559,Phase 1b/2a
168838,Discontinued in Phase 3
54002,Phase 1b/2a
181910,Phase 2
29792,Discontinued in Preregistration
48345,Phase 1
128698,Phase 0
128402,Investigative
59466,Discontinued in Phase 3
111097,Discontinued in Phase 4
86626,Phase 2
146676,Phase 1b/2a
99971,Phase 1
160962,Phase 1
33199,Clinical trial
5132,Phase 2a
120352,Clinical trial
163550,Discontinued in Phase 2
111966,Discontinued in Phase 3
190629,IND submitted
32460,Phase 1/2a
47264,Discontinued in Phase 4
161801,IND submitted
118151,Phase 2
178239,Phase 2a
40827,Phase 1/2
110000,Phase 1
120573,Discontinued in Phase 2
73217,Discontinued in Phase 3
142717,Patented
100068,Phase 1
76143,Phase 0
24678,Discontinued in Phase 2/3
119881,Phase 0
191218,Phase 2a
74050,Discontinued in Phase 3
124263,Phase 1b
45562,Phase 2/3
125825,Phase 1b/2a
132233,Discontinued in Phase 4
76465,Investigative
50984,Phase 1/2
173039,Investigative
104013,Phase 0
185482,Phase 1b
122306,Phase 0
18213,Preregistration
96088,Phase 1/2
44491,Phase 1/2a
156984,Discontinued in Phase 1/2
40972,Phase 1/2a
79119,Discontinued in Phase 4
116127,Discontinued in Phase 2
110947,Phase 2
96871,Phase 1b
64689,Phase 2
173726,BLA submitted
7068,Phase 1b/2a
152795,Discontinued in Phase 3
129426,Discontinued in Phase 2b
95863,Phase 2
181615,Phase 1b/2a
116496,Discontinued in Preregistration
110784,Phase 1/2
64012,Investigative
132525,Patented
177417,Phase 2
176735,Phase 1b
93855,Phase 1
132808,Phase 0
147582,Phase 1b
172867,Discontinued in Phase 2/3
95336,Discontinued in Phase 1
129813,Phase 0
6410,Phase 2a
180234,Phase 1
19536,IND submitted
88948,Phase 1/2a
8387,Phase 1
3739,Discontinued in Phase 3
71705,Phase 0
30674,IND submitted
80899,Phase 2
188754,Phase 1/2
90721,Discontinued in Phase 1
47630,Phase 0
102412,Phase 1/2a
146106,Phase 1/2a
83263,Phase 1
109719,Phase 2
120061,Discontinued in Phase 2
10176,Phase 0
155966,Phase 1b
130899,Phase 0
16256,Phase 1/2
110949,Discontinued in Phase 2b
187897,Patented
188963,Phase 1b/2a
31136,Phase 1/2a
37033,Phase 1b/2a
72100,Discontinued in Phase 1
89692,Phase 1/2
49151,Phase 0
54878,Discontinued in Preregistration
37667,Discontinued in Phase 3
141009,Phase 1b
37059,Phase 2
104598,Patented
91527,Investigative
67470,Phase 1b/2a
87870,Phase 1/2a
174296,Discontinued in Phase 3
66552,Phase 2b
32559,Phase 0
123805,Discontinued in Preregistration
156900,Clinical trial
1966,Discontinued in Phase 1
105606,Phase 1
48947,Phase 0
162032,Investigative
82810,Phase 0
103876,Phase 1/2
151447,Phase 0
142036,Discontinued in Phase 2b
27892,Phase 2
140119,BLA submitted
16911,Phase 1
102379,Phase 1/2a
143822,Investigative
108894,Discontinued in Preregistration
180254,Phase 2a
7343,Discontinued in Phase 2
145548,Phase 1b/2a
103948,Phase 1/2a
11313,Discontinued in Phase 1
134569,Phase 1/2
69981,Investigative
77326,Discontinued in Preregistration
156358,Discontinued in Preregistration
6177,Phase 1b/2a
64620,Investigative
17167,Phase 1
150315,Phase 1b
135567,Phase 0
13275,Investigative
121506,Discontinued in Phase 2b
102496,Phase 1/2a
43384,Phase 2/3
158586,Phase 1/2a
30118,Phase 0
28123,Phase 2/3
38143,Phase 1b
67400,Phase 1b/2a
171795,Phase 1/2
29580,Approved
171861,Discontinued in Phase 2/3
139520,Investigative
114154,Phase 2
102769,Discontinued in Preregistration
93936,Discontinued in Phase 3
84869,Phase 1b/2a
111234,Phase 1
91474,Phase 1b
7694,Phase 0
101102,Phase 1/2a
82322,Patented
65416,Preclinical
34029,IND submitted
127623,Discontinued in Phase 1
176626,Phase 1/2a
173308,Phase 0
125485,Phase 1b/2a
178201,Phase 2/3
72616,Phase 2/3
176752,Phase 1
132483,Phase 1b/2a
159808,Phase 1b
63352,Phase 1b/2a
14239,Phase 1/2
124559,Phase 1b
167670,Discontinued in Preregistration
122564,Phase 1/2
78844,Discontinued in Phase 4
77556,Discontinued in Preregistration
171183,Discontinued in Phase 1
106585,Phase 1/2
142631,Phase 1b/2a
119420,Phase 1/2
56279,Phase 0
165399,Discontinued in Phase 1
17562,Phase 1
55810,Patented
84982,Phase 1/2a
45816,Phase 2/3
7319,Phase 2a
7586,Discontinued in Phase 2/3
97778,Phase 1/2a
159989,Phase 2
135578,Phase 0
125614,Phase 1/2a
130400,Discontinued in Phase 1
63913,Phase 2a
28409,Phase 1/2
158663,Phase 2
19834,Phase 2
49371,Discontinued in Preregistration
83626,Investigative
118965,Phase 1b/2a
167280,Discontinued in Phase 1/2
82969,Investigative
93481,Phase 1b
48633,Phase 1b
111869,Phase 0
187926,Phase 0
53064,Discontinued in Phase 2/3
42098,Approved
107716,Discontinued in Phase 2b
71860,Phase 1b/2a
94888,Patented
182458,Discontinued in Phase 2
161603,Investigative
22561,Phase 1/2
45588,Phase 1/2a
127111,Discontinued in Preregistration
177658,Phase 1b
97526,Phase 1/2a
120560,Clinical trial
96907,Phase 1/2
25812,Discontinued in Phase 2b
133909,Patented
160174,Discontinued in Preregistration
21652,Discontinued in Phase 2
146508,Phase 1b/2a
116339,Discontinued in Phase 4
27220,IND submitted
62197,Phase 1/2
179902,Discontinued in Phase 4
19493,Phase 0
179450,Discontinued in Phase 1
78079,Approved (orphan drug)
180351,Phase 2a
158745,Phase 1b/2a
130950,IND submitted
151686,Phase 0
148527,Phase 2/3
57145,Phase 1/2a
89270,Phase 1/2a
70389,Phase 1b/2a
69872,Phase 1
30836,Phase 1/2
176733,Phase 1/2
63611,Approved
86825,Phase 1/2
161943,Investigative
45964,Phase 1/2a
157060,Phase 1
64673,Phase 2a
179322,Phase 2a
84256,Phase 1b/2a
167688,Phase 1/2a
35407,Phase 1/2
164107,Phase 1
131592,Discontinued in Phase 4
163679,Discontinued in Phase 1/2
169677,Phase 2
47586,Phase 1b
141410,Discontinued in Phase 2b
169959,Patented
165079,Phase 2
157365,Patented
49075,Phase 1/2
119941,Discontinued in Phase 4
190425,Phase 0
138079,BLA submitted
10508,Phase 1
18216,Phase 2a
24344,Discontinued in Phase 2/3
20807,Phase 1
71349,Phase 1b
154588,Phase 2/3
124706,Phase 0
40002,Discontinued in Phase 4
123695,Discontinued in Phase 4
61906,Discontinued in Phase 2b
153582,Phase 1b
109183,Phase 1
111307,Phase 2
45539,Phase 1/2a
148345,Discontinued in Phase 2
166583,Phase 1b
84956,Phase 0
161224,Discontinued in Phase 4
140107,Phase 1/2
186350,Phase 2a
39687,Phase 0
73695,Clinical trial
95186,Patented
184052,Discontinued in Phase 4
91740,Phase 1b
104179,Phase 1/2a
53003,Phase 1/2a
66339,Phase 0
23663,Patented
94354,Phase 2
16053,Phase 1/2a
44281,Phase 2/3
41290,Phase 1
49637,Phase 0
34918,Phase 1b
84419,Investigative
69460,Phase 1
107445,Discontinued in Phase 2b
141178,Discontinued in Preregistration
66057,Phase 1b/2a
150099,Discontinued in Phase 2
134130,Phase 1b
43235,Phase 1b
174567,Discontinued in Phase 3
97283,Phase 1/2
128657,Discontinued in Phase 2b
78749,Phase 0
132286,Phase 1
133735,Phase 1/2
176358,Phase 1/2a
6892,Phase 4
92562,Phase 1/2a
98858,Phase 2
182630,Phase 1/2
42274,Phase 1
158969,Phase 2
60562,Investigative
85692,Discontinued in Preregistration
98367,Phase 1/2a
135276,Phase 0
138453,BLA submitted
128384,Phase 0
49337,IND submitted
114945,Phase 1/2a
143670,Discontinued in Preregistration
150321,Phase 2/3
55964,Phase 1/2a
171823,Discontinued in Phase 2b
80940,Phase 2a
6617,Phase 2a
49611,Investigative
189415,Phase 1/2
147020,Phase 2/3
91436,Phase 1b
83078,IND submitted
150450,Discontinued in Phase 2
136959,Discontinued in Phase 4
109437,Discontinued in Phase 1/2
115362,Clinical trial
181933,Phase 1
100955,Phase 1/2a
183915,IND submitted
159630,Phase 1b/2a
189182,Clinical trial
95633,Phase 2a
81590,Phase 1
3315,Discontinued in Phase 3
116200,Phase 1/2a
140014,BLA submitted
64739,Phase 1b/2a
64389,Approved (orphan drug)
164103,Phase 0
169592,Phase 0
138307,Discontinued in Phase 2
45678,Phase 1/2a
18274,Phase 1
28009,Phase 1/2
157457,Patented
52837,Discontinued in Phase 2b
121690,Phase 2
80199,Phase 2
76952,Phase 1
24477,Patented
6391,IND submitted
29844,Discontinued in Phase 3
144189,Discontinued in Phase 1/2
79194,Phase 1
73137,Phase 1
177886,Clinical trial
35745,Discontinued in Phase 2b
170103,Investigative
191279,Phase 1/2
15312,Phase 0
164249,Phase 1
59002,Phase 1/2
32326,Phase 2
165991,Phase 2
103092,Application submitted
52989,Phase 2
109651,Phase 3
30037,Phase 1b
118354,Phase 2
60937,Investigative
98860,Phase 1b/2a
19007,IND submitted
186741,Phase 4
124866,Phase 1/2
60083,Discontinued in Phase 2/3
32444,Phase 1b/2a
3973,IND submitted
103013,Phase 1/2a
125249,Discontinued in Phase 4
40723,Phase 2
128710,IND submitted
100155,Approved
167789,Discontinued in Phase 2
33215,Discontinued in Phase 2
43356,Phase 1/2a
183615,IND submitted
2876,Discontinued in Phase 2b
75548,Phase 1
104586,Phase 0
104300,Phase 2
76762,Phase 1b/2a
87664,Approved
166585,Discontinued in Phase 2b
181544,Discontinued in Phase 2b
64983,Approved (orphan drug)
82395,Phase 2
132517,Discontinued in Preregistration
113489,Patented
50285,Discontinued in Phase 3
78001,Clinical trial
129446,Investigative
152374,Phase 1b/2a
42347,IND submitted
135561,Phase 0
141504,Discontinued in Phase 2b
20742,Phase 1/2a
38968,Investigative
31004,IND submitted
131583,Phase 1b/2a
63839,Approved
171696,Discontinued in Phase 2b
14467,Phase 0
118797,Discontinued in Preregistration
79289,Phase 1b/2a
146333,Discontinued in Phase 1
183185,Phase 1b/2a
122860,Phase 1
82110,Clinical trial
174369,Phase 2
170912,Discontinued in Preregistration
145383,Investigative
58110,Investigative
102095,Phase 1/2
93082,Discontinued in Phase 3
5904,Investigative
58054,Investigative
120322,Discontinued in Phase 3
84447,Phase 1/2a
41500,Phase 1b
181451,Phase 2a
171063,Patented
70688,Patented
146496,Phase 1/2a
173711,Approved
56841,Phase 2
133569,IND submitted
29381,Phase 0
127511,Phase 1/2a
151504,Discontinued in Phase 2/3
29840,Investigative
175337,Phase 1/2
41929,IND submitted
157961,Discontinued in Phase 1/2
74919,Phase 0
55016,Phase 3
97058,Phase 0
2752,Phase 1
58547,Discontinued in Phase 4
152445,Investigative
49307,Phase 1b/2a
57257,Phase 1/2a
121892,Approved
28155,Phase 1b/2a
90309,Preregistration
181882,Phase 1
118119,Discontinued in Phase 2
184424,Discontinued in Phase 4
37010,Discontinued in Preregistration
161398,Phase 1b
130979,Investigative
48201,Phase 0
137388,Phase 2
43029,Discontinued in Preregistration
66259,Phase 0
39998,Phase 2
51973,Discontinued in Preregistration
46168,Phase 2/3
14774,Phase 0
133992,Patented
75147,IND submitted
149405,Phase 1
100044,Phase 1
23166,Phase 1b/2a
96029,Phase 1b
39626,Discontinued in Preregistration
135496,Phase 0
48699,Phase 1b/2a
170645,Phase 0
77600,Phase 1
123719,Phase 1/2
17000,Phase 1/2
20835,Investigative
113758,Phase 0
67333,Discontinued in Phase 2/3
107800,Phase 1
108601,Phase 1b/2a
191355,Phase 1
137033,Discontinued in Phase 3
71172,Phase 1b
46724,Phase 1/2
161982,Investigative
17165,Phase 1
172264,Phase 2a
154753,Phase 3
97579,Phase 1/2a
168364,Investigative
105657,Phase 1b
96389,Phase 1/2a
111874,Discontinued in Phase 3
161284,Patented
68338,Phase 1/2
181010,Phase 2
106107,Phase 1/2a
15231,Phase 1
21413,Phase 1b/2a
122458,Patented
93970,Discontinued in Phase 1
23728,Phase 1b
102827,Phase 1/2a
37365,Phase 2
60973,Phase 0
110850,Phase 1
86608,Phase 1b/2a
166268,Phase 1b
102124,Phase 0
25657,Phase 1b
43277,Preregistration
33533,Phase 2a
103564,Phase 1b
71530,Phase 0
5268,Phase 1b/2a
137691,Phase 1/2a
26825,Phase 1b
74156,IND submitted
167000,Phase 1/2a
149539,Phase 1/2a
24586,Phase 2/3
174714,Discontinued in Phase 1/2
63967,Phase 2
56145,Investigative
61182,Phase 1b
61955,Discontinued in Preregistration
88487,Discontinued in Phase 4
92742,Phase 2
113861,Patented
53402,IND submitted
168233,Phase 1b/2a
78876,Patented
167962,Phase 1/2
39252,Discontinued in Phase 4
20974,Phase 1
13698,Phase 0
184006,Discontinued in Phase 4
90452,Phase 1b
4746,Phase 1b/2a
47912,Phase 2/3
42563,Phase 2
188263,IND submitted
131963,Patented
150427,Phase 2b
65519,Discontinued in Phase 2/3
95497,Phase 1b
17132,Phase 0
45421,Phase 1/2a
85640,Discontinued in Phase 2b
6848,Discontinued in Phase 2
138325,Phase 1/2a
50768,Phase 2/3
44008,Phase 2/3
18603,Discontinued in Phase 3
126813,Phase 1/2
186066,Phase 2a
13942,Phase 1/2a
162159,Phase 2
5712,Investigative
78417,Discontinued in Phase 4
46182,Phase 1/2a
107489,Discontinued in Phase 3
179246,Discontinued in Phase 1/2
122709,Phase 1/2
176635,Phase 2
7091,Discontinued in Phase 2
175398,Phase 3
151972,Phase 1
112860,Discontinued in Phase 3
18554,Phase 2a
99513,Phase 1
110996,Phase 2
113728,Phase 1/2
48563,Phase 1b/2a
147259,Phase 1
42408,Phase 2
25104,Phase 2/3
68142,Phase 1
7968,Phase 2
130953,Patented
24005,Phase 1/2
104813,Patented
67380,Phase 2
47654,Phase 1b
33671,Discontinued in Phase 2
121106,Phase 1b
102819,IND submitted
167893,Phase 1b
157211,Phase 1
28126,Phase 1b/2a
145877,Patented
126289,Discontinued in Phase 4
17308,Investigative
144680,Phase 0
165183,Patented
5203,IND submitted
96202,Phase 1/2a
71551,Phase 1
60103,Phase 1
76429,Phase 0
81645,Approved
20964,Discontinued in Phase 1/2
109852,Discontinued in Preregistration
108640,Discontinued in Phase 1
128968,Phase 0
179259,Phase 0
8630,Phase 2
156676,Discontinued in Phase 4
129096,Phase 1
72936,Phase 2
36090,Phase 1b
125380,Discontinued in Phase 4
117192,Investigative
100637,Phase 1/2a
152708,Approved
21334,Phase 2
12688,Phase 1
147372,Investigative
33660,Phase 1b
110356,Phase 3
20382,IND submitted
117445,Clinical trial
131680,Discontinued in Phase 2b
183703,Phase 4
111386,Discontinued in Phase 4
185525,Phase 2a
119339,Phase 2
55044,Phase 1
172474,Phase 2a
37500,Phase 2
38977,Discontinued in Phase 4
68392,Clinical trial
118184,Phase 2b
174638,Discontinued in Phase 2
69742,IND submitted
170746,Phase 1b
116761,Investigative
31551,Patented
31850,Investigative
17762,Phase 3
14203,Phase 1
99932,Phase 1
170281,Phase 1/2a
71940,Discontinued in Preregistration
123297,Patented
33177,BLA submitted
118625,BLA submitted
144525,Phase 1
168595,Discontinued in Phase 4
23933,Phase 1/2a
84486,Phase 0
131922,Phase 1
27796,Discontinued in Phase 1
48128,Phase 1/2
156580,Discontinued in Phase 1
129802,Phase 1/2
103487,Phase 1/2a
18105,Discontinued in Phase 2/3
42785,Discontinued in Phase 2/3
75662,Discontinued in Preregistration
181653,Phase 2a
8335,Phase 0
123658,Phase 1b
149643,Phase 1b/2a
60028,Phase 1
167093,Investigative
20445,Phase 1b/2a
118000,Discontinued in Phase 4
166671,Phase 1b/2a
170747,Phase 2/3
4388,Phase 1/2
70287,Phase 2/3
169956,Discontinued in Preregistration
34106,Phase 0
85590,Discontinued in Preregistration
170117,Discontinued in Phase 4
152385,IND submitted
1069,Clinical trial
71877,Patented
85237,Discontinued in Phase 3
110313,Phase 1b/2a
114613,Investigative
128752,Phase 0
111780,Phase 1/2
174480,Phase 3
56745,Discontinued in Phase 3
54172,Phase 1b/2a
62054,Discontinued in Preregistration
122463,Phase 0
23127,Phase 0
35819,Discontinued in Phase 1/2
85525,Discontinued in Phase 3
145121,Phase 1b/2a
114117,Phase 1b/2a
104503,Investigative
88847,Patented
78153,Approved
176815,Phase 2
122641,IND submitted
31239,Discontinued in Phase 2/3
190374,Phase 2b
125403,Phase 1b
118813,Discontinued in Preregistration
105703,Phase 2/3
5761,IND submitted
40623,Phase 2
20019,Phase 0
79787,Phase 1
127279,Discontinued in Preregistration
166504,Phase 0
116083,Phase 1/2
140400,Phase 1/2
122345,IND submitted
189685,Preclinical
28608,Phase 1/2a
65556,Phase 1b/2a
108262,Phase 0
184611,BLA submitted
136518,Discontinued in Phase 2/3
95228,Discontinued in Phase 1
131061,Phase 2a
20338,Phase 0
161069,Clinical trial
122553,Phase 1b
176761,Phase 2b
152426,Phase 1b/2a
184046,BLA submitted
36025,Phase 1/2a
192096,Phase 1/2
31450,Phase 0
191262,Phase 1/2
83215,Phase 1/2a
163587,Phase 1b/2a
158744,Phase 2
128342,Phase 1/2
27991,Phase 1b/2a
172311,Discontinued in Phase 2b
2613,Phase 1b/2a
152792,Approved
42212,Approved
21717,BLA submitted
185304,Discontinued in Phase 1
117850,Phase 1
65887,Phase 1
178106,Patented
29061,Phase 2
15858,Phase 1
167200,Discontinued in Phase 1/2
157790,Discontinued in Phase 1/2
89691,Phase 1b
63237,Discontinued in Phase 3
92369,Phase 2/3
191156,Investigative
29018,Phase 1b
6380,Discontinued in Phase 2
130011,Phase 2/3
186415,Phase 0
62747,Phase 0
18922,IND submitted
96017,BLA submitted
132553,Patented
91165,Approved (orphan drug)
76509,Phase 1/2
83755,Discontinued in Phase 2/3
77121,Phase 1/2
187107,Clinical trial
49468,Phase 1
127823,Discontinued in Preregistration
67755,Discontinued in Phase 2b
49435,Phase 1/2
170866,Phase 1/2
52954,Patented
93226,Phase 1/2
88811,Phase 1
101598,Phase 2b
13418,Phase 1b/2a
75529,Investigative
44834,Phase 2/3
171106,Phase 0
14320,Phase 1
135927,Preclinical
135351,Phase 0
92276,Registered
41138,Discontinued in Phase 1/2
1562,Approved (orphan drug)
50467,Phase 1b/2a
159235,BLA submitted
72345,Phase 1b
136786,Discontinued in Phase 2b
143161,Phase 1b/2a
119711,Discontinued in Preregistration
101643,Investigative
117770,Phase 1/2
188578,IND submitted
70602,Phase 2
8103,Phase 2
114306,Phase 1
126550,IND submitted
189176,IND submitted
96699,Phase 1/2a
77770,Investigative
129248,Phase 0
42575,Discontinued in Phase 1
110761,Discontinued in Phase 4
125761,IND submitted
152627,Discontinued in Phase 3
32956,Phase 2
165481,Phase 0
14862,Phase 1
179284,Phase 1/2a
155320,Phase 0
43491,Phase 1/2a
74667,Phase 1
68875,Phase 1b
83351,Discontinued in Phase 4
116226,Phase 1/2a
116086,Discontinued in Phase 2
68605,Phase 2a
76016,Phase 1
101194,IND submitted
19750,Phase 2a
66559,Phase 1b/2a
15997,Phase 1b/2a
59514,Discontinued in Phase 3
149129,Phase 2b
5102,Discontinued in Phase 2
14733,Phase 0
159272,Phase 1b/2a
15745,Phase 2b
107232,Discontinued in Phase 4
154290,Patented
174717,Phase 1/2
152750,Phase 1/2a
112928,Discontinued in Phase 2
73713,Patented
44364,Phase 1/2a
164960,Phase 2
172724,Phase 2
11229,IND submitted
184411,Phase 0
97281,Phase 2/3
70627,Phase 1/2
86900,Phase 1/2
161944,Patented
74445,IND submitted
112806,Discontinued in Phase 3
165751,Phase 2
138880,Approved (orphan drug)
172870,Investigative
136148,Phase 1/2
142178,Discontinued in Phase 2b
162150,Phase 1/2
118643,Registered
32608,Phase 1/2a
121511,Approved (orphan drug)
34840,Phase 1/2
126213,Phase 1/2
105417,Phase 2a
161263,Phase 1
30735,Phase 1
36808,Phase 1b/2a
12132,Phase 1/2
104246,Patented
2920,Phase 1b
63349,Phase 0
59007,Phase 1
28619,Investigative
168875,Patented
3626,Discontinued in Phase 2b
57289,Discontinued in Phase 1/2
144523,Phase 1
120155,Phase 0
25713,Discontinued in Phase 2/3
30173,Phase 2
41077,Discontinued in Phase 1
74346,Discontinued in Phase 4
114534,Discontinued in Phase 3
17456,Phase 0
71445,Patented
59653,Phase 1b/2a
128209,Discontinued in Phase 4
167746,Phase 1b/2a
181057,Discontinued in Phase 2
173014,Phase 0
5033,Phase 2a
52342,Patented
181678,Phase 1/2a
57511,Discontinued in Phase 4
174339,Phase 1/2
98264,Discontinued in Phase 2
38649,Phase 2
163149,Discontinued in Phase 1/2
47834,Phase 1b
161952,Investigative
163553,Discontinued in Phase 3
15975,Phase 0
172364,Discontinued in Phase 2/3
24993,Phase 2/3
36344,Phase 1
58095,Discontinued in Phase 2/3
68381,Phase 1b
153404,Phase 0
183249,Phase 2a
25485,Phase 1/2
49662,IND submitted
104852,Phase 2
31292,Discontinued in Preregistration
113736,Phase 1
85117,Phase 1/2a
15259,Phase 1
144964,Phase 1b/2a
161516,Phase 0
45162,Phase 2/3
2106,Phase 2
122794,Phase 1
17418,Phase 1
153915,Phase 1b
129420,Phase 1
110767,Phase 1
25184,Discontinued in Phase 4
133601,Investigative
175614,Phase 3
25693,Discontinued in Preregistration
162486,Investigative
50289,Discontinued in Preregistration
169440,Discontinued in Phase 2/3
116344,Discontinued in Phase 1
186399,Phase 0
92089,Discontinued in Phase 1
164737,Phase 1
122631,Phase 0
70128,Discontinued in Phase 4
149233,Phase 1/2
56326,IND submitted
85867,Discontinued in Phase 3
16321,Phase 2b
116345,Clinical trial
35026,Phase 1b
11804,Investigative
187888,Phase 1b
30463,Phase 1
136376,Investigative
35699,Discontinued in Phase 1/2
189384,IND submitted
125581,IND submitted
85516,Discontinued in Phase 2b
141298,Discontinued in Phase 4
3290,Patented
14374,Phase 1
45158,Phase 1/2a
172349,Phase 2a
156210,Investigative
164790,Phase 1
137286,Phase 1
84196,Phase 1/2
71914,Phase 1b/2a
115252,Phase 1/2a
143073,Phase 1b/2a
142272,Discontinued in Phase 2b
10480,Phase 1b
7151,Phase 1/2
39436,Patented
66633,Discontinued in Phase 2/3
102255,IND submitted
13163,Phase 1/2a
17350,Phase 1
142418,Phase 0
127993,Discontinued in Phase 4
20354,Phase 1b/2a
62285,Phase 1b
182955,Phase 2a
133349,Discontinued in Preregistration
74852,Phase 2a
157668,Phase 2
123093,Phase 0
26030,Phase 1
108500,Discontinued in Phase 2/3
87709,Phase 1/2a
86818,Phase 1b/2a
95989,Phase 1
124021,Phase 1b
172687,Phase 0
112404,Discontinued in Phase 3
116446,Discontinued in Phase 1
88283,Patented
162936,Phase 0
84027,Phase 1/2a
177355,Approved
16588,Phase 1b/2a
45835,Phase 1/2a
46776,Approved
161824,Patented
178532,Phase 0
110824,Patented
66810,Phase 0
142808,Phase 1b/2a
94289,Phase 2b
33673,Phase 1b/2a
81169,Discontinued in Phase 1
104987,Discontinued in Phase 4
77588,Discontinued in Phase 1/2
52065,Investigative
145592,Discontinued in Phase 1
7337,Phase 2a
18539,Phase 2a
23057,Investigative
171038,Discontinued in Preregistration
173173,Patented
62855,Phase 1/2a
121624,Approved (orphan drug)
156927,Phase 2
159428,Phase 2
34577,Phase 1/2
28983,Phase 2
10182,Phase 0
85926,Discontinued in Preregistration
192036,Discontinued in Phase 1/2
131678,Discontinued in Preregistration
117595,Discontinued in Phase 2b
148917,Phase 2/3
12363,Phase 1b/2a
1529,Phase 1/2a
175892,Discontinued in Phase 2/3
161245,Discontinued in Phase 1/2
132369,IND submitted
116263,Phase 1/2a
99361,Phase 1/2a
8066,Discontinued in Phase 3
14252,Phase 0
177273,Phase 1b
83913,Discontinued in Preregistration
91599,Phase 1/2
155965,Phase 1b
168708,Approved
128399,Discontinued in Preregistration
86955,Phase 1b
19978,Phase 2
21407,Phase 2
27623,Phase 2
140303,Phase 1b
127921,Discontinued in Phase 4
43893,Phase 1/2a
121288,Phase 1/2a
114525,Discontinued in Phase 1
32997,Phase 2
48271,Phase 1/2a
69103,Discontinued in Phase 3
133958,Phase 1/2a
109766,Discontinued in Phase 2/3
10836,Phase 0
105498,Phase 3
49846,Discontinued in Preregistration
6366,Phase 1b/2a
153202,Patented
115515,Phase 1b
131556,Phase 1/2
119059,Phase 1b/2a
76696,Phase 2/3
3843,Discontinued in Phase 2b
12069,Investigative
154079,Patented
134366,Phase 1/2a
42746,Investigative
152427,Phase 1b
35543,Discontinued in Preregistration
40746,Phase 1b
109044,Discontinued in Phase 3
112675,Discontinued in Phase 2
56196,Discontinued in Phase 2b
54185,Patented
102949,Approved (orphan drug)
6468,Investigative
138178,Investigative
91916,Phase 1
40105,Phase 1
131966,Discontinued in Preregistration
14824,Phase 0
168059,Patented
102573,Discontinued in Preregistration
99940,Phase 1
171535,Patented
160,Phase 1
12523,Phase 1/2
57357,Phase 1b/2a
143904,Phase 1b/2a
173708,Phase 1/2a
61974,Investigative
97612,Discontinued in Phase 2b
56160,Phase 1/2a
150233,Discontinued in Phase 1
139850,Investigative
32761,Phase 2a
159332,Phase 0
145341,Discontinued in Phase 2
121743,Discontinued in Phase 1
130238,Phase 1/2
141841,Phase 0
118340,Phase 1/2a
116762,Discontinued in Phase 2b
72615,Phase 2
129477,Phase 1/2
16792,Phase 0
108122,Phase 2
153080,Phase 1
150116,Discontinued in Phase 1
170940,Phase 0
107787,Discontinued in Phase 2/3
170468,Phase 1/2
168754,Discontinued in Phase 2
19267,Patented
142790,Investigative
161220,Discontinued in Phase 4
162896,Patented
18960,Phase 1
2301,Discontinued in Preregistration
22486,Discontinued in Phase 4
191139,Phase 1
17447,Discontinued in Phase 1
126628,Phase 0
55896,Phase 1/2a
127769,Discontinued in Phase 4
18051,Discontinued in Phase 3
150512,Phase 1b/2a
52158,Discontinued in Preregistration
65048,Phase 0
94884,Phase 1/2a
143951,Investigative
134061,Phase 1b
20687,Phase 1/2
56763,Phase 1/2a
34258,Phase 1b/2a
15780,Phase 1
75948,Discontinued in Preregistration
72949,Phase 2
70334,Phase 2/3
36594,Phase 2
94361,Discontinued in Phase 1
59499,Discontinued in Phase 4
115621,Phase 1/2
135050,Phase 0
90358,BLA submitted
128507,Discontinued in Preregistration
96003,Discontinued in Phase 4
142535,Phase 1b
103611,Phase 1/2
95716,Phase 1b
86150,IND submitted
66847,Patented
161792,Investigative
91196,Phase 1
162463,Patented
159177,Clinical trial
25275,Phase 1b/2a
155374,Patented
177407,Phase 1b
39648,Phase 2
182960,Phase 2
142182,Discontinued in Preregistration
152624,Approved
101703,Investigative
172659,Discontinued in Phase 2/3
3360,Patented
109122,Phase 1/2
183539,Phase 2a
34640,Phase 1/2a
16517,Phase 0
17401,Investigative
7990,Phase 2
138864,BLA submitted
133116,Phase 0
91981,Discontinued in Phase 1
22630,Discontinued in Phase 2b
85561,Discontinued in Phase 3
38318,Discontinued in Phase 1
101001,Patented
164269,Phase 2/3
69326,Phase 1b/2a
41806,Investigative
102964,Phase 0
152971,Phase 1b/2a
178306,Discontinued in Phase 1
98806,Phase 1b/2a
79510,Discontinued in Phase 4
64407,Phase 2a
81403,Discontinued in Phase 1
144234,Discontinued in Phase 1/2
110888,Phase 1
8500,Phase 0
159298,Phase 0
102873,Phase 1/2a
142551,IND submitted
69627,Phase 2a
167753,Discontinued in Phase 2
5948,Discontinued in Phase 2
23256,Patented
187520,Phase 2a
113516,Phase 1
53330,Phase 1b/2a
98743,Phase 1/2a
132354,Discontinued in Phase 1/2
40925,IND submitted
163350,Discontinued in Phase 4
15785,Phase 1
12831,Phase 1
57397,Phase 1/2a
86083,Preregistration
53612,Discontinued in Phase 2b
104356,Phase 1/2
15341,Phase 1
159347,Clinical trial
47862,Phase 0
37317,Phase 2a
135082,Phase 0
60014,Investigative
130112,Phase 1/2
59054,Phase 2/3
156313,Phase 1/2a
175376,Discontinued in Phase 3
179966,Discontinued in Preregistration
123134,Discontinued in Phase 4
74139,Phase 1/2
39822,Phase 2/3
129877,Patented
3599,Discontinued in Phase 3
65039,Discontinued in Phase 2/3
116977,Phase 2
185145,Discontinued in Phase 3
8187,Investigative
96691,Phase 1
172336,Discontinued in Phase 2b
31952,Phase 1/2
56516,Phase 2
182941,Phase 1
174912,Phase 3
108015,Discontinued in Phase 3
135661,Preclinical
163759,Phase 2/3
10559,Phase 0
152776,Approved
1462,Discontinued in Phase 1
4572,Investigative
163602,Discontinued in Phase 2
52517,Discontinued in Preregistration
721,Phase 1
106363,Phase 0
116252,Phase 1/2a
71559,Phase 1b
36853,Phase 1b/2a
17118,Phase 1/2
15959,Investigative
96681,Phase 1b
57893,Phase 0
133451,Approved
19915,Discontinued in Phase 2b
99219,Phase 1
177663,Approved
15085,Phase 1/2a
68759,Phase 2a
50579,Phase 0
146849,Discontinued in Phase 2/3
51432,Discontinued in Phase 2/3
133830,Phase 1
18607,Phase 2a
107236,Discontinued in Phase 1/2
47195,Approved
49168,Phase 3
119076,Discontinued in Phase 2
76071,Phase 1/2a
14478,Phase 1
55268,Phase 1/2
180565,Phase 1b/2a
48019,Phase 1b/2a
87751,Phase 1/2
102667,Discontinued in Preregistration
136315,Discontinued in Phase 4
77935,Registered
186168,Phase 0
144588,Phase 1/2a
11201,Discontinued in Phase 3
138142,Clinical trial
92346,Phase 1/2
9266,Discontinued in Phase 1
24930,Phase 1/2
53302,Phase 0
108878,Phase 4
57011,Discontinued in Phase 2b
17973,Discontinued in Phase 4
178069,Patented
180753,Phase 2a
95405,IND submitted
150572,Phase 1
26059,Phase 1b
176457,Phase 1/2
8861,Discontinued in Preregistration
165971,Phase 2
70762,Discontinued in Phase 2b
67535,Phase 1b/2a
44462,Phase 1/2a
190362,Phase 1/2a
108202,Phase 1b
188294,Phase 2b
132257,IND submitted
118838,Phase 2a
62412,Phase 1b
130335,Patented
6737,Phase 1/2
86926,Phase 2
151684,Phase 0
184250,BLA submitted
138195,Phase 1/2a
144198,Discontinued in Phase 1/2
178128,Patented
114094,Phase 0
123171,Phase 1/2
42299,Phase 2a
68618,Investigative
87923,Discontinued in Phase 3
79844,Discontinued in Phase 3
125475,Phase 1b/2a
169153,Discontinued in Phase 2
184692,Phase 1/2
46278,BLA submitted
91941,Phase 1/2a
53297,Phase 1
7494,Investigative
3326,Phase 1b
74079,Discontinued in Phase 1/2
65008,BLA submitted
25927,Discontinued in Phase 4
31479,Discontinued in Phase 2b
172762,Phase 0
91986,Phase 1/2a
9287,IND submitted
15284,Phase 1/2a
61716,Discontinued in Phase 2b
129996,IND submitted
42580,Phase 2/3
20558,Discontinued in Phase 4
125690,Phase 2
109114,Discontinued in Phase 3
86966,Discontinued in Phase 2b
93054,Phase 2
141232,Phase 2/3
12329,Phase 1
8201,Patented
149460,Phase 1/2a
126281,IND submitted
97564,Discontinued in Phase 2
169201,Phase 1b/2a
69194,Discontinued in Phase 2
73580,Investigative
72353,Phase 1/2
143770,Discontinued in Preregistration
2834,Discontinued in Phase 3
178174,Phase 1/2a
44776,Phase 2/3
171562,Discontinued in Phase 2
67094,Patented
152389,Investigative
54651,Phase 1/2
85948,Discontinued in Phase 3
61704,Investigative
143068,Discontinued in Phase 3
132196,Discontinued in Phase 1/2
115633,Phase 1/2a
97600,Phase 2
32124,Phase 1/2a
49998,Phase 1b/2a
32379,Phase 3
125513,Phase 1
148941,Phase 1b/2a
185817,Clinical trial
43815,Phase 2/3
118574,Approved
123975,Phase 1/2
37654,Discontinued in Preregistration
37943,Phase 0
105794,Phase 1/2
123270,Phase 1/2
178638,Phase 0
56727,Phase 1/2a
122652,Phase 1b
57335,Phase 2/3
5411,Phase 2a
86502,Discontinued in Phase 4
79163,Discontinued in Phase 4
110563,Phase 2
45353,Phase 2/3
174297,Discontinued in Phase 4
5932,IND submitted
144436,Discontinued in Phase 2
26580,Phase 0
11322,Phase 1
21795,Approved (orphan drug)
109694,Phase 4
63124,Discontinued in Phase 4
99168,Phase 1
185202,Approved
72026,Phase 1b/2a
149824,Phase 1/2
122950,Phase 2
109865,Discontinued in Phase 2/3
84741,Phase 0
9803,Discontinued in Phase 2/3
3747,Discontinued in Preregistration
174240,Discontinued in Phase 4
16716,Phase 1/2a
171669,Phase 1/2
191383,Discontinued in Phase 1
6522,Investigative
99431,Phase 1b/2a
7956,Phase 2
124925,Approved
68446,Patented
142018,Discontinued in Phase 4
12548,Phase 1
182015,Phase 1b/2a
124044,Discontinued in Phase 4
83166,Phase 2
11797,Phase 2/3
166665,Phase 1b/2a
108843,Phase 1/2a
180795,Discontinued in Phase 2b
78285,Investigative
90541,Approved (orphan drug)
179935,Phase 1/2
81191,Clinical trial
77088,Investigative
37746,Phase 1/2
50669,Phase 1b/2a
23658,Discontinued in Preregistration
171929,Phase 2a
31175,Phase 1
104861,Patented
13298,Phase 1
110940,Phase 1/2
155886,Discontinued in Phase 3
65329,Phase 1b/2a
103552,Phase 1/2a
184744,Phase 0
184458,Phase 0
129846,Investigative
15246,Phase 1
44598,Phase 1/2a
127648,Discontinued in Phase 2b
37690,Phase 1b
105379,Phase 1b
62986,Phase 1
88460,Phase 1
132921,IND submitted
184226,BLA submitted
76117,Phase 0
165500,Discontinued in Phase 4
49459,Discontinued in Phase 2/3
3418,IND submitted
65756,Approved
16500,Phase 0
46545,Discontinued in Preregistration
139427,Phase 1/2a
153820,Phase 2/3
134976,Phase 0
178476,Phase 1
57542,Phase 2/3
56965,IND submitted
68649,Phase 2a
70361,Phase 1
103132,Phase 0
110606,Phase 1/2a
185601,Phase 4
51447,Investigative
11231,Discontinued in Phase 4
151506,Phase 2
126462,Phase 1
103378,Phase 0
40330,Phase 1
33078,Phase 2a
157857,Discontinued in Phase 1/2
122471,Phase 0
45222,Phase 1/2a
84714,Phase 1b/2a
24071,Phase 1/2a
176538,Discontinued in Phase 2
153784,Phase 1b/2a
14276,Phase 1
82019,Clinical trial
13866,Phase 1
181127,Phase 1/2a
144997,Phase 1
13169,Phase 1
43657,Phase 2/3
125139,Phase 1/2
84853,Phase 1/2
142587,Phase 3
243,Phase 2b
137964,Clinical trial
91562,Discontinued in Preregistration
8223,Phase 2
61080,Phase 1b
52140,Phase 1/2
190679,Phase 1b/2a
85968,Discontinued in Preregistration
117862,Phase 0
186401,Patented
3776,Investigative
132842,Phase 1b/2a
12021,Discontinued in Phase 2/3
188270,Phase 2b
19870,Phase 2
109851,Phase 2
132806,Discontinued in Preregistration
144534,Clinical trial
112485,Phase 0
77666,Investigative
142244,Patented
181712,Phase 1/2a
49282,Patented
111649,Discontinued in Phase 4
59977,Discontinued in Phase 1/2
151973,Phase 1
159395,Approved
42687,Discontinued in Phase 1
183663,Phase 1/2
90821,Approved (orphan drug)
105497,Phase 1/2a
86297,Discontinued in Phase 4
1917,Phase 1/2a
24744,Phase 1/2
183588,Phase 1/2
50155,Investigative
10227,Discontinued in Phase 2b
81977,Clinical trial
65404,Discontinued in Phase 1
172716,Discontinued in Phase 3
14172,Phase 1b/2a
52047,Discontinued in Phase 2b
135064,Phase 0
128516,Phase 0
112852,Phase 1
170756,Phase 1
83427,Phase 2
137401,Patented
112244,Discontinued in Phase 2
132673,Discontinued in Phase 1/2
139753,Phase 1b
154392,Investigative
53995,Discontinued in Preregistration
29352,Phase 1/2a
134696,Phase 0
139393,BLA submitted
17387,Phase 1/2a
59297,Discontinued in Phase 3
136392,BLA submitted
14274,Phase 0
124634,Phase 1b/2a
175606,Discontinued in Phase 2
95598,Phase 2
36136,Patented
42338,Investigative
31641,Patented
133126,Phase 1
85356,Discontinued in Preregistration
166248,Phase 1b
73442,Approved (orphan drug)
167501,Investigative
675,Phase 1
124612,Phase 1/2
121949,Approved
29649,Discontinued in Phase 2b
3122,Phase 0
80358,Phase 1b/2a
184460,Discontinued in Phase 4
165990,Phase 2
59491,Phase 2/3
138975,BLA submitted
108929,Phase 1/2a
67102,Patented
65321,Discontinued in Phase 4
43529,Phase 2/3
80287,Phase 1b
49515,Phase 1b/2a
36286,Phase 1/2a
69703,Phase 1b
155015,Phase 1/2a
160521,Phase 3
102717,Phase 1
179396,Discontinued in Phase 2/3
131042,Investigative
155156,Investigative
132837,IND submitted
59240,Phase 0
172684,Phase 2a
122441,Discontinued in Phase 4
130140,Patented
124298,Approved
54175,Phase 1/2
5779,IND submitted
37474,Discontinued in Preregistration
160349,Phase 0
112905,Phase 0
78704,Phase 0
101247,Phase 1b
20138,Clinical trial
106188,Phase 2a
32160,Phase 0
9154,Discontinued in Phase 2
172572,Discontinued in Phase 2/3
84078,Phase 2
127448,Phase 0
178864,Phase 1b
92007,Investigative
165762,Phase 1b/2a
3965,Phase 1
46331,Discontinued in Phase 2
121179,Phase 1b
65923,Discontinued in Phase 4
93941,Discontinued in Phase 2b
161359,Phase 2
40014,Phase 0
77198,Phase 1/2a
179516,Phase 1
80057,Approved (orphan drug)
169863,Phase 0
110984,Phase 1
53124,Phase 1b
5116,Phase 2a
179058,Discontinued in Phase 2/3
127848,Discontinued in Phase 3
65566,Phase 2
75055,Patented
106902,Phase 0
116990,Phase 1/2
22120,Phase 1b/2a
73059,Phase 1/2a
84548,Phase 1/2
137412,Investigative
7442,Discontinued in Phase 2
141268,Discontinued in Phase 2b
59778,Investigative
130481,Phase 1/2a
30054,Discontinued in Phase 3
56913,Phase 0
56500,Phase 1/2a
17430,Phase 1/2
151272,Phase 2
131664,Discontinued in Phase 1/2
15260,IND submitted
169312,Discontinued in Preregistration
102603,Phase 1/2a
5161,Phase 2a
178810,Phase 1/2
47800,Phase 1
883,Phase 1/2a
31112,Discontinued in Preregistration
108798,Phase 1
61811,Discontinued in Preregistration
20209,Patented
181990,Phase 1/2a
93378,Phase 1
79223,Phase 2a
120535,Investigative
179970,Phase 1b
21095,Phase 1/2
25028,Phase 1b
146793,Phase 1b/2a
102636,Phase 1/2a
114360,Phase 1
129368,Discontinued in Phase 3
43709,Phase 1/2a
146036,Phase 1/2
166220,Discontinued in Phase 4
51189,Phase 1
43161,Patented
71704,Discontinued in Phase 1
36094,Phase 2
16843,Phase 1
117031,Phase 1b
8811,Discontinued in Phase 1
103747,Phase 1
130946,Patented
21195,Discontinued in Preregistration
36062,Patented
187378,Patented
102818,Phase 1/2a
78057,Discontinued in Phase 3
175320,Discontinued in Phase 4
49058,Phase 1b
186730,Phase 0
44929,Phase 2/3
110001,Phase 1
44282,Phase 2/3
73207,Approved (orphan drug)
102098,Approved (orphan drug)
130174,Phase 1/2
123846,Discontinued in Phase 4
90387,Investigative
81181,Discontinued in Phase 1
81700,Phase 1
182450,Phase 1b/2a
100574,Phase 2/3
98873,Phase 1/2a
135490,Phase 0
75458,Phase 1/2
67898,Phase 1b
71479,Phase 1
141814,Investigative
89976,Phase 0
149996,Phase 1b
45971,Phase 1/2a
44342,Phase 1/2a
6690,Phase 1b/2a
90772,Phase 1b/2a
160302,Phase 2/3
112869,Phase 0
94089,Phase 1
165446,Discontinued in Phase 1/2
156422,Phase 1/2a
159436,Phase 1b
86681,Discontinued in Phase 2b
26378,Investigative
125672,Phase 1b/2a
6808,Phase 2/3
118822,Phase 2b
46723,Discontinued in Phase 2
155492,Phase 2
80172,Phase 2
21150,Phase 1b/2a
70747,Phase 1/2a
126868,Phase 1b/2a
160705,Phase 1/2a
49123,Discontinued in Phase 2b
56966,Patented
186690,Phase 1b
65099,Phase 4
52179,Discontinued in Phase 2/3
150488,Discontinued in Phase 2/3
100134,Approved
185735,Phase 2a
71121,Phase 1b/2a
35493,Discontinued in Preregistration
127217,Discontinued in Phase 2b
87000,Phase 1b
119531,Discontinued in Preregistration
39117,Discontinued in Phase 2
118282,Phase 1/2a
115573,Phase 2
53053,Phase 1b
113966,Phase 1b
32482,Phase 1/2a
162941,Discontinued in Phase 1/2
53701,Discontinued in Preregistration
27117,Phase 1b
57198,Discontinued in Phase 3
105438,Phase 1/2
60460,Clinical trial
6838,Phase 4
167612,Phase 1/2a
177100,Phase 1
180045,Discontinued in Phase 1
163059,Discontinued in Preregistration
140777,Preregistration
35453,Discontinued in Preregistration
53121,Phase 1b
125571,Phase 1b
108682,Phase 1
155089,Phase 1/2
89707,Phase 2
110132,Phase 1b
4146,Investigative
54440,Phase 2
120617,Phase 0
171265,Phase 1/2
168545,Discontinued in Phase 2
158106,Discontinued in Phase 4
78297,Approved
186068,Phase 1/2a
190966,Phase 2a
72252,Discontinued in Phase 3
28890,Phase 4
151833,Phase 2
159878,Phase 1b/2a
15596,Phase 0
97667,Phase 1/2a
11889,Investigative
97466,Phase 1b
25071,Phase 1/2a
168268,Phase 2
159948,Phase 2b
3019,Phase 1b
144038,IND submitted
57519,Phase 1b/2a
70597,Phase 1b
185694,Phase 4
173780,Approved
178665,Discontinued in Phase 3
142451,Phase 0
25510,Phase 2/3
149857,Phase 1/2
75456,Phase 1/2a
123004,IND submitted
50243,Phase 1/2a
191856,Discontinued in Phase 2b
179338,Phase 0
7044,Investigative
28405,Phase 1
18903,Discontinued in Phase 2/3
165172,Phase 1
167655,Phase 1/2a
57645,Discontinued in Phase 3
54676,Phase 3
49535,Phase 1/2a
92429,Phase 1
20919,Patented
84549,Phase 1b/2a
181060,Phase 2
23358,Phase 1b
96427,Phase 0
6893,Discontinued in Phase 2
190098,Phase 1/2a
130072,Phase 2/3
186249,Phase 0
86609,Phase 1/2
42222,Phase 2
30567,Phase 1b/2a
85652,Discontinued in Phase 2b
59479,Phase 1b/2a
39944,Discontinued in Phase 2b
31441,Investigative
184302,Phase 0
59675,Phase 1b/2a
167721,Discontinued in Phase 2/3
146913,Phase 1b/2a
6901,Phase 4
164876,Phase 1/2a
173503,Discontinued in Phase 2b
136816,Investigative
141728,Investigative
35752,Phase 0
139417,BLA submitted
173080,Investigative
12762,Phase 1
175697,Phase 0
130606,Phase 1/2
958,Discontinued in Phase 1/2
113366,Phase 2a
49929,Phase 2
72189,Phase 1b
13012,Phase 1
69099,Discontinued in Phase 1/2
24528,Investigative
14471,Discontinued in Phase 1
48443,Discontinued in Phase 2b
71421,Phase 1b
72471,Phase 2
893,Clinical trial
94175,Discontinued in Phase 2b
119673,Approved
16907,Phase 1/2a
144400,Discontinued in Phase 1/2
191334,Phase 1/2
114509,Phase 2
32022,Phase 2b
162406,Patented
155659,Phase 2/3
1801,Phase 2a
162310,Phase 1
166863,Phase 2
80317,Phase 2a
167676,Discontinued in Phase 4
81933,Clinical trial
100482,Phase 1/2
122366,Phase 1/2
80206,Discontinued in Phase 1/2
103620,Discontinued in Phase 1/2
14568,Discontinued in Phase 1
147322,Phase 1/2
140222,Approved (orphan drug)
65398,Approved (orphan drug)
96924,Patented
155872,Phase 1
9433,Discontinued in Phase 3
150525,Phase 1b/2a
28223,Phase 1b
162106,Discontinued in Phase 1/2
169706,Discontinued in Phase 2/3
180426,Phase 2b
84246,Phase 0
128587,Discontinued in Preregistration
24012,Discontinued in Phase 2/3
184175,Discontinued in Phase 4
68408,Phase 1
24671,Phase 1/2
9643,Phase 0
55368,Phase 1b/2a
137819,Investigative
25703,Phase 1
74817,Investigative
62608,Phase 0
143800,Phase 1/2a
67125,Phase 0
89982,Phase 2/3
168554,Investigative
55259,Phase 0
78835,Phase 1b
180185,Phase 1b
81224,Phase 1b/2a
20716,Phase 1/2
36518,Phase 2
36367,Investigative
152796,Approved
165958,Investigative
130706,Clinical trial
115216,Phase 2
126207,Phase 1/2
49089,Phase 1b/2a
47984,Phase 1b/2a
150781,Discontinued in Phase 2/3
77126,Phase 1b
187554,Phase 4
97083,Phase 1
181631,Phase 1
5910,Investigative
176906,Phase 0
38725,Phase 1/2a
168236,Discontinued in Phase 2/3
157053,Patented
69859,Phase 1
32691,Phase 1/2a
82891,Phase 1/2
187119,Phase 0
94860,Phase 1/2a
40775,Discontinued in Phase 2/3
4770,Investigative
99939,Phase 1
121544,Discontinued in Phase 2b
27690,Discontinued in Phase 2b
162184,Investigative
36105,Phase 1/2
117419,Discontinued in Phase 3
171949,Discontinued in Phase 2b
51108,Phase 2/3
162144,Patented
145026,Phase 1b/2a
64895,Discontinued in Phase 2b
2164,Phase 4
563,Phase 2
165845,Phase 1b/2a
58457,Discontinued in Phase 3
36536,Discontinued in Phase 2
102833,IND submitted
169937,Phase 2b
74908,Phase 2a
190438,Phase 4
111789,Discontinued in Phase 2b
46783,Discontinued in Phase 1
83664,Phase 0
94703,Discontinued in Phase 4
26238,Phase 0
137767,Phase 1/2
32281,Phase 1/2
118606,Phase 2a
81683,Phase 1
123051,Phase 1/2
154406,Discontinued in Preregistration
23542,Phase 1b/2a
38850,Phase 1/2a
16239,Phase 1
52182,Discontinued in Phase 2b
67118,Phase 0
85496,Discontinued in Phase 2b
37512,Phase 2a
99609,Phase 1
118014,Discontinued in Preregistration
148790,Discontinued in Phase 1
184247,Discontinued in Phase 4
83972,Discontinued in Phase 2
122077,Phase 1/2
122094,Phase 1b
23603,Investigative
48641,Discontinued in Preregistration
92664,Phase 1
114634,Discontinued in Phase 3
146298,Phase 1b
162002,Investigative
1785,Discontinued in Phase 2
64790,Phase 2/3
114527,Phase 1/2a
159184,BLA submitted
120259,Discontinued in Phase 1/2
7492,Phase 2/3
38342,Phase 1b/2a
81783,Phase 1
121877,Discontinued in Phase 1
91356,BLA submitted
183820,Phase 2
114138,Phase 1
35410,Discontinued in Phase 1/2
123478,Phase 2
63546,Clinical trial
51256,Phase 1/2
47167,Clinical trial
40444,Discontinued in Phase 2/3
64469,Phase 1
115091,Phase 1/2
8479,Discontinued in Phase 2/3
65732,Phase 1b/2a
39694,Discontinued in Phase 2b
153222,Phase 1/2
101039,Phase 2a
64660,Phase 0
17433,Phase 1
187796,Clinical trial
36349,Patented
62344,Investigative
173545,Phase 0
144024,Phase 1/2
77540,Phase 1
159279,Clinical trial
171122,Discontinued in Preregistration
138780,Clinical trial
26443,Phase 1
156754,Discontinued in Phase 4
135552,Phase 0
147163,Phase 0
133839,Patented
131111,Phase 1/2a
186732,Phase 0
45570,Phase 2/3
169150,Discontinued in Phase 1/2
70280,Phase 1
182153,Phase 2a
27125,Phase 1b/2a
161745,Phase 2a
101277,Phase 1b
121192,Phase 2/3
109392,Discontinued in Phase 2/3
42869,Discontinued in Preregistration
129220,Phase 0
168974,Approved
36480,Discontinued in Phase 1/2
67227,Discontinued in Phase 1
56446,Phase 2
74149,Phase 1/2a
145731,Discontinued in Phase 2
82222,Clinical trial
86098,Investigative
39805,Phase 1
64849,Phase 1
144621,Phase 1
46571,Phase 1/2
35290,Phase 1b
42065,Phase 1
36041,Phase 2a
118345,Phase 2a
20180,Patented
43445,Phase 1/2a
166591,Phase 1/2
19315,Patented
42689,Discontinued in Phase 2/3
136566,Phase 1b
106223,Phase 1/2a
69616,IND submitted
137633,Phase 1/2a
27315,Phase 0
147212,Discontinued in Phase 2
21940,Approved (orphan drug)
69907,Phase 1
149536,Clinical trial
24669,Discontinued in Phase 4
58974,Phase 1/2
113522,Patented
119533,Phase 0
33459,Phase 1
138135,Investigative
95512,Investigative
5556,Phase 1b/2a
79016,Phase 2/3
120552,Approved
191316,Phase 1/2
108924,Phase 1
154417,Patented
160531,Phase 3
311,Approved (orphan drug)
93484,Phase 2b
74762,Discontinued in Phase 3
141195,Discontinued in Phase 2b
171131,IND submitted
15326,Phase 1
30727,Phase 1b
150981,Discontinued in Phase 2/3
127150,Phase 0
20963,Phase 1/2a
177137,Discontinued in Preregistration
81454,Discontinued in Phase 3
111659,Phase 1/2
135267,Phase 0
99858,Investigative
106932,Phase 1/2a
151551,Phase 2
185289,Discontinued in Phase 4
23778,Discontinued in Phase 4
126311,Phase 1b/2a
181043,Discontinued in Phase 2b
142465,Phase 1/2a
191174,Investigative
111297,Discontinued in Phase 3
113830,Phase 0
189758,Phase 1b
47860,Phase 0
36697,Phase 0
93438,Phase 1/2a
106691,Phase 1
186701,Patented
47390,Investigative
132223,Discontinued in Phase 2/3
78784,Phase 2a
164197,Phase 1
44779,Phase 1/2a
120810,Phase 1
177761,Phase 2
182095,Discontinued in Phase 2b
47727,Phase 1/2a
26706,Phase 0
139130,BLA submitted
130684,Phase 2b
128888,Phase 0
137413,Discontinued in Phase 2/3
168887,Discontinued in Phase 2
172998,Discontinued in Phase 2b
99518,Patented
41428,Phase 1b
141262,Investigative
138092,Phase 1b
124423,IND submitted
75438,IND submitted
122349,Phase 1b
2271,Phase 1b/2a
69964,Phase 1b
171548,Phase 2
21870,BLA submitted
186402,Phase 0
109025,Phase 1/2a
143458,Discontinued in Preregistration
137946,BLA submitted
104647,Investigative
93810,Discontinued in Phase 3
171469,Phase 0
93307,Phase 1/2
174118,Patented
175098,Phase 2
988,Clinical trial
153468,Phase 1
145793,Phase 1b
726,Discontinued in Phase 2
145533,Phase 1b/2a
121083,Phase 2
71767,Phase 1
82848,Phase 1/2
177119,Phase 1b
31449,Discontinued in Phase 2/3
100739,Phase 2/3
96975,Phase 1/2
44517,Phase 1/2a
171927,Phase 2
44770,Phase 2/3
93162,Discontinued in Phase 2b
69542,Phase 1b/2a
179208,Phase 0
16808,Phase 1/2
66239,Phase 1b/2a
84090,Investigative
22707,Discontinued in Preregistration
67346,Phase 0
137043,Discontinued in Phase 4
125569,Discontinued in Phase 4
128686,Phase 1
14580,Phase 0
119796,IND submitted
105843,Phase 1
14447,Phase 0
48248,Discontinued in Phase 4
8284,Phase 0
146064,Phase 1b
121865,Phase 2
145368,Phase 2/3
4539,Phase 1b/2a
184218,Phase 0
115250,Phase 2/3
58891,Phase 1b/2a
109207,Patented
128601,IND submitted
62519,Discontinued in Phase 4
3877,Phase 1
54079,Phase 1b
74896,Phase 2
162770,Investigative
117420,Discontinued in Phase 4
145921,Phase 1/2a
190780,Approved (orphan drug)
38457,Investigative
81524,Approved
172544,Discontinued in Phase 2
62660,Patented
138005,Phase 1b
101445,Phase 1b/2a
173906,BLA submitted
87532,Discontinued in Phase 3
48298,Phase 1b/2a
45530,Phase 2/3
140327,Phase 1/2
121261,Phase 1b/2a
164283,Phase 0
134929,Phase 0
49440,Phase 3
141764,Patented
164879,Phase 1
117734,Discontinued in Phase 3
147701,Phase 2a
11257,Patented
190920,Phase 1
36386,Phase 1/2a
104620,Patented
56223,Phase 0
119131,IND submitted
177353,Phase 1b
89013,BLA submitted
108399,Phase 0
114018,Phase 1
142778,Phase 2b
47923,Phase 1/2a
186984,Phase 4
7052,Phase 1/2
47183,Discontinued in Phase 2
133855,Phase 1/2a
157031,Phase 2
118325,Phase 2
13806,Phase 1
10909,Phase 1
17082,Phase 1
101186,Phase 1/2
24625,Patented
191236,Phase 2a
156742,Investigative
77124,Phase 0
2462,IND submitted
62109,Investigative
124972,Phase 1
108478,Discontinued in Phase 2/3
58901,Phase 0
191706,Phase 1
22665,Phase 1/2a
174832,Phase 2b
28936,Phase 1/2a
47589,Patented
90788,Phase 2/3
96635,Phase 1
1772,Phase 0
149421,Phase 1/2a
93430,Phase 1
38594,Discontinued in Phase 2b
29233,Phase 1b
76859,Phase 1/2a
162572,Phase 1b
81870,Phase 1/2
32397,Phase 1/2a
131406,Discontinued in Preregistration
18442,Discontinued in Phase 3
79263,Phase 3
114718,Phase 1/2a
78093,Discontinued in Phase 3
121754,Phase 2b
92809,Phase 2b
423,Discontinued in Phase 2/3
87701,Phase 1
14309,Phase 1
175845,Discontinued in Preregistration
108256,Phase 1/2a
943,Discontinued in Phase 2/3
12953,Phase 1
103121,Phase 1b
104552,Patented
95575,Phase 1/2a
147204,Discontinued in Preregistration
98996,Patented
74518,Phase 1/2
116557,Phase 2
32019,Phase 1/2a
154796,Phase 2/3
102080,Investigative
148020,Phase 2/3
143100,Phase 2a
9748,Discontinued in Preregistration
89035,IND submitted
16080,Phase 0
163371,Patented
9305,Phase 1/2
141788,Patented
162727,Phase 2
124101,Investigative
90551,Clinical trial
151783,Discontinued in Phase 2/3
85841,Discontinued in Phase 2b
69264,Phase 1
95905,Phase 1/2a
65847,Discontinued in Phase 2
166812,Phase 1
67566,Phase 1b
109231,Phase 0
99590,Patented
7357,Phase 2/3
61232,Phase 1
165447,IND submitted
142852,Discontinued in Phase 3
101777,Phase 2a
71800,Patented
20537,IND submitted
115177,Phase 1b/2a
18285,Phase 2a
26216,Patented
39235,IND submitted
126891,IND submitted
117851,Phase 1
169950,IND submitted
19733,Phase 2a
45925,Phase 1/2a
93698,Phase 1/2a
166085,Phase 1b/2a
165474,Patented
109905,Discontinued in Preregistration
17866,Phase 1/2a
115092,Phase 1/2a
19623,Phase 0
25701,Discontinued in Phase 2b
176869,Phase 2b
141820,Discontinued in Phase 2b
181810,Phase 2
104298,Discontinued in Phase 4
167033,Investigative
29931,Patented
83991,Phase 2
106802,Discontinued in Phase 3
71152,Phase 1b
8350,Patented
140114,Investigative
151987,Phase 2/3
175785,Phase 1
140295,BLA submitted
26684,Phase 1/2a
30039,Discontinued in Phase 2b
59480,Clinical trial
84837,Phase 1/2a
155744,Phase 1/2
101862,Phase 2b
146744,Discontinued in Phase 2
44171,Phase 1/2a
148250,Phase 1b
144780,Discontinued in Phase 2/3
131540,Discontinued in Phase 2b
140290,Investigative
182811,Phase 1/2a
146071,Phase 0
47616,Patented
148560,Phase 1b
159806,Phase 1b/2a
73109,Phase 1b/2a
118067,Phase 2/3
100361,Preclinical
53046,Phase 1b/2a
66040,Preclinical
5215,Phase 2a
18254,Phase 2a
51133,Phase 0
58476,Phase 1b
85124,Phase 1b/2a
110668,Phase 1
11047,Phase 0
175988,Discontinued in Phase 2
44989,Phase 1/2a
31589,Phase 1b
123474,Investigative
75117,Phase 1/2
52390,Phase 1b
35588,Phase 1/2
119800,Approved
1802,Phase 2
52938,Discontinued in Phase 4
51128,Phase 1/2a
130982,Patented
171894,Phase 1b
128622,Investigative
79002,Phase 0
135158,Phase 0
150149,Phase 2b
68265,Discontinued in Phase 1/2
107259,IND submitted
122066,Discontinued in Phase 2/3
33501,BLA submitted
131803,Discontinued in Phase 2/3
160077,Discontinued in Phase 1/2
60741,Investigative
143708,Phase 2/3
27760,Phase 2/3
177301,Phase 1/2a
48265,Phase 1
10570,Discontinued in Phase 2/3
53285,Phase 2
9075,Phase 2/3
24229,Phase 1/2a
142081,Phase 0
39222,Phase 2/3
64800,Clinical trial
66575,Phase 1b/2a
50313,Phase 1b/2a
191598,Phase 2a
208,Discontinued in Phase 1
23204,Phase 0
113192,Phase 2a
36364,Phase 1
178317,Investigative
110188,Phase 1/2a
147739,Investigative
150709,Phase 2
116403,Discontinued in Phase 1
175167,IND submitted
187435,Phase 0
78986,Patented
104422,BLA submitted
95981,Phase 1b
142404,Phase 1b
179652,Phase 0
97212,Phase 1b/2a
95060,Discontinued in Phase 1
129374,Investigative
188020,Phase 1b
2472,Discontinued in Preregistration
62224,Investigative
100342,Preclinical
132774,Discontinued in Phase 1/2
65716,Discontinued in Phase 1
124936,Phase 1/2
88052,Patented
4750,Preregistration
148275,Phase 1b/2a
134277,Discontinued in Phase 4
182395,Discontinued in Phase 2b
289,Approved (orphan drug)
2580,Discontinued in Preregistration
79434,Phase 1b/2a
161678,Phase 1b
108378,Phase 1/2a
8632,Phase 2
110562,Phase 1
37330,Discontinued in Phase 1
124924,Phase 1b
188418,Discontinued in Phase 3
139909,Phase 1/2
67725,Discontinued in Phase 1/2
1403,Approved
73267,Approved (orphan drug)
120329,Phase 0
58163,Phase 1b/2a
167252,Phase 1/2a
37656,Phase 1
151712,Phase 2
114598,Phase 1/2a
41704,Phase 1
183080,Phase 1/2
30072,Phase 1
3746,Discontinued in Phase 3
20400,Discontinued in Phase 2/3
75929,Phase 1b
107547,Phase 1/2a
87016,Phase 2
149187,Phase 1/2a
149560,Phase 1
133780,Phase 1b
21852,Discontinued in Phase 2b
103417,Phase 1b
38972,Phase 2/3
81883,Phase 1/2
72265,Discontinued in Preregistration
121642,Phase 1/2
67158,Patented
162596,Phase 1b
121301,Phase 1b/2a
18825,Discontinued in Phase 2/3
83980,Phase 1/2a
1150,Phase 1
152991,Phase 1
171142,Phase 1/2a
102354,IND submitted
181942,Phase 1
86859,Discontinued in Phase 1
38692,Discontinued in Phase 2
177250,Phase 1b/2a
160152,Phase 2b
1341,Approved
66408,Phase 2b
80703,Phase 2
100875,Discontinued in Phase 1/2
113578,Phase 2
99632,Phase 1
99996,Phase 1
47231,Approved
145263,Discontinued in Phase 2
163957,Phase 1
47597,IND submitted
24998,Discontinued in Phase 2b
105137,Discontinued in Phase 2b
184976,Discontinued in Phase 4
88713,Phase 1
124011,Discontinued in Phase 4
68971,Discontinued in Phase 3
186278,Phase 1/2a
92450,Discontinued in Phase 3
132092,Phase 2
77109,Phase 1/2
66113,Preregistration
24332,Discontinued in Phase 2b
20593,Phase 1b/2a
12104,Phase 1b/2a
46140,Phase 1/2a
66341,Discontinued in Phase 2/3
174641,Phase 0
176095,Discontinued in Phase 1/2
120752,Clinical trial
66787,Patented
167381,Investigative
188790,Phase 2b
164029,Phase 2/3
113385,Phase 2a
14207,Phase 2b
33910,Phase 1
186440,Phase 2a
72945,Phase 2
84403,Phase 1/2a
79682,Phase 2a
72708,IND submitted
28161,Phase 2
81999,Clinical trial
83063,Phase 2/3
19613,Phase 0
6996,Phase 1b/2a
166061,Discontinued in Phase 4
36087,Phase 1/2
152005,Phase 0
182111,Phase 1/2a
112832,Discontinued in Phase 2
146391,Phase 1b/2a
151174,Phase 1
61275,Patented
113959,Discontinued in Preregistration
137599,Phase 1/2
117828,Phase 1b
73652,Investigative
33742,Approved (orphan drug)
73907,Discontinued in Preregistration
41651,Phase 0
54216,Discontinued in Phase 3
131497,Discontinued in Phase 1/2
108063,IND submitted
172406,Discontinued in Phase 2/3
66212,Discontinued in Phase 1/2
105297,Phase 1b
160041,Discontinued in Phase 1/2
50017,IND submitted
169907,Discontinued in Preregistration
144766,Discontinued in Phase 2/3
98312,Discontinued in Phase 2b
130490,Phase 1/2a
1472,Approved (orphan drug)
60833,Phase 0
166900,Phase 2b
99757,Phase 1/2
119617,Discontinued in Phase 2b
35668,Phase 1/2
15511,Phase 1/2
98243,Phase 1b
64341,Phase 0
152216,Phase 1
15843,Phase 3
72478,IND submitted
84404,Phase 1/2a
71279,Phase 2
182400,Phase 1b/2a
138231,Clinical trial
15654,Phase 1
178208,Phase 2b
101831,Investigative
83412,Phase 1/2
123163,Phase 1b
96281,Discontinued in Phase 3
177157,Phase 2b
185008,Phase 1
69494,Discontinued in Phase 2/3
190800,Phase 1/2a
168599,Discontinued in Phase 1/2
154544,Phase 3
88098,Patented
188241,Patented
175172,Phase 1/2a
62504,Discontinued in Phase 4
119481,Phase 0
176595,Phase 1/2
157928,Phase 2
123920,Phase 1/2
147353,Phase 1b
72441,Phase 2
66477,Phase 1b
180344,Discontinued in Phase 2b
160507,Phase 1/2a
188441,Phase 1/2
17947,Phase 1/2a
165870,Phase 2
180619,Phase 1b/2a
98387,Investigative
11057,Patented
186861,Phase 4
115041,Phase 2/3
184874,BLA submitted
94970,Patented
162621,Phase 1/2a
127498,Phase 1/2
13899,Phase 1b/2a
68663,Phase 1/2
190070,Phase 1b
159738,Phase 1b/2a
61937,Discontinued in Preregistration
78168,Phase 1/2
171373,Discontinued in Phase 3
161400,Patented
161679,Phase 2
103485,Discontinued in Phase 2/3
49683,Phase 0
100922,Phase 1/2a
85530,Discontinued in Preregistration
169129,Discontinued in Phase 1
159026,Phase 0
169206,Clinical trial
153305,Investigative
132671,Discontinued in Phase 2/3
91039,IND submitted
8417,BLA submitted
99637,Patented
165168,Phase 0
7107,Investigative
19817,Phase 1
177798,Phase 2a
2115,Phase 2
19237,IND submitted
25849,Discontinued in Phase 2b
18642,Phase 2
82228,Phase 1/2a
43450,Phase 2/3
16702,IND submitted
31802,IND submitted
173198,Discontinued in Phase 2
181770,Phase 1b/2a
47738,Discontinued in Preregistration
130230,Investigative
48864,Phase 2/3
104971,Phase 1/2a
149687,Discontinued in Phase 1
17685,Phase 1/2a
90588,Phase 1b/2a
138731,Phase 1b
64581,Phase 1/2a
68047,Phase 1
50320,Phase 1/2a
61840,Discontinued in Phase 4
145326,Phase 1/2a
80837,Discontinued in Phase 2
136652,Phase 2
92958,Phase 1b/2a
67547,Patented
6924,Phase 1b/2a
14549,Phase 1/2
156793,Phase 0
8800,Approved
15250,Phase 0
112991,Phase 1b/2a
48424,Phase 2/3
50038,Phase 0
113144,Phase 1
35606,Discontinued in Phase 3
3174,Phase 1/2a
36819,Phase 2
113112,Discontinued in Phase 3
13585,Phase 0
166654,Phase 1b
127726,Phase 0
78023,Phase 1
66349,Phase 1b
13043,Phase 0
9452,IND submitted
115265,Phase 1/2a
38319,Approved (orphan drug)
116589,Discontinued in Phase 1/2
163939,Phase 2/3
47112,Approved
8401,Approved
116260,Phase 1/2a
8265,Patented
187487,Phase 1b/2a
5035,Phase 2a
137017,Phase 1/2a
11208,Phase 1
153403,IND submitted
182126,Phase 2b
64638,Phase 2/3
84485,Phase 0
108850,Phase 4
127725,Phase 0
117270,Phase 1/2
147232,Investigative
102427,IND submitted
8226,Phase 1/2
149528,Phase 1b
185356,Discontinued in Phase 1
101191,Patented
59295,Phase 2/3
106412,Patented
83584,Phase 2
96662,Phase 1/2a
72000,Discontinued in Phase 4
111895,Discontinued in Phase 2
131783,Phase 1b/2a
84541,Phase 0
103741,Phase 1b/2a
103959,Phase 1/2a
14851,Phase 0
164047,Phase 1
103073,Investigative
59699,Phase 2/3
36939,Phase 2
23821,Phase 1/2
109710,Approved
136433,Discontinued in Phase 2/3
95846,Investigative
143169,Phase 1b/2a
177793,Phase 1b
128197,Patented
45245,Phase 1/2a
84518,Phase 1/2
135337,Phase 0
10540,Phase 0
115640,Phase 1b
177019,Phase 2/3
96969,Phase 1/2a
66965,Patented
31424,IND submitted
176085,IND submitted
37949,Phase 1/2
101865,Investigative
125127,Phase 1b
108742,Discontinued in Phase 2/3
135637,Phase 1b
54093,Discontinued in Phase 4
142887,Phase 1/2
50366,Patented
146172,Phase 1b/2a
9531,Discontinued in Phase 2/3
106527,Discontinued in Phase 2b
55170,IND submitted
103054,IND submitted
147602,Discontinued in Phase 2
52563,Phase 1
183793,Phase 4
132749,Patented
38396,Phase 1b
108615,Investigative
92412,Phase 0
63496,Phase 1b/2a
8644,Investigative
91603,Investigative
65940,Phase 1b/2a
148101,Discontinued in Preregistration
187711,Phase 1
49359,Phase 1/2a
160037,Phase 2
136149,Phase 2/3
60771,Phase 1
42598,Phase 0
143716,Discontinued in Phase 3
77806,Investigative
75631,Phase 1/2a
153104,Patented
138502,Phase 1/2a
172698,Discontinued in Phase 2/3
68333,Discontinued in Phase 2
679,Phase 1/2a
102132,Phase 1b
96743,Phase 1/2a
78381,Discontinued in Phase 3
31582,Phase 0
83697,Discontinued in Phase 2/3
69488,Phase 1b/2a
46438,Phase 1b
2886,IND submitted
20484,Phase 1
75717,Phase 1/2
135513,Phase 0
151456,Phase 1
186411,Phase 4
103403,Patented
111847,Phase 1/2
108240,Phase 1/2a
120027,Phase 0
114480,Investigative
64470,Phase 0
52987,Phase 1/2a
38160,Patented
151544,Discontinued in Phase 2/3
143684,Phase 2/3
13932,Phase 1/2a
187733,Phase 4
119614,Discontinued in Phase 4
111049,Discontinued in Phase 4
159606,Phase 1b/2a
165849,Phase 1b
109977,Patented
115890,Phase 1/2a
54692,Discontinued in Phase 3
140711,Phase 2a
130974,Patented
98633,Phase 0
143655,Phase 1/2
76338,Discontinued in Preregistration
62071,Phase 1b
102977,Approved (orphan drug)
115474,Phase 1
184018,Discontinued in Phase 4
64055,Phase 1b/2a
81232,Discontinued in Phase 3
52587,Discontinued in Phase 2/3
165021,Phase 1
26848,Phase 1b
64143,Approved
97720,Phase 1/2a
80987,Phase 1b
137482,Phase 1
129742,Phase 0
88355,Phase 1/2a
95124,Phase 1/2a
71741,Phase 0
177863,Discontinued in Phase 2/3
7473,Phase 1b/2a
65119,Discontinued in Phase 2
141225,Phase 1b
108958,Discontinued in Phase 2
58807,Phase 1b/2a
96032,BLA submitted
106039,Phase 2/3
151872,Phase 2
94126,Discontinued in Phase 1
68217,Discontinued in Phase 1
10767,Patented
138791,Discontinued in Phase 2
105243,Approved (orphan drug)
162008,Phase 1b
25224,Discontinued in Phase 4
131009,Investigative
54820,Phase 1b/2a
159731,Investigative
157886,Phase 2a
95382,Phase 1/2
160257,Discontinued in Phase 1/2
154473,IND submitted
42743,Discontinued in Phase 1
62139,Discontinued in Phase 3
80645,Approved (orphan drug)
168115,Phase 2
160058,Phase 1b/2a
140636,Phase 2a
185536,Discontinued in Preregistration
177086,Phase 1
132930,Phase 1
26686,Phase 1b
5641,Preregistration
137215,Phase 1/2a
51608,Phase 1
93071,Phase 2b
31474,IND submitted
16334,Phase 1
112188,Discontinued in Phase 3
153681,Phase 3
75867,Investigative
62832,Phase 1b/2a
187738,Patented
184866,Phase 0
113488,Phase 2a
169914,IND submitted
35990,Investigative
1384,Discontinued in Phase 2/3
101417,Discontinued in Preregistration
124666,Phase 2
11794,Phase 1b
145372,Phase 1/2
86782,Investigative
92620,Phase 0
80054,Phase 1b/2a
30280,Phase 0
8101,Discontinued in Phase 4
75363,Preclinical
73773,Patented
21427,Phase 2
79281,Discontinued in Phase 1
118453,Clinical trial
136421,Patented
152324,Phase 2/3
97636,Phase 1/2a
161586,Discontinued in Phase 1/2
130545,Patented
58311,Phase 1
186398,Phase 1/2a
143722,Discontinued in Preregistration
177730,Phase 1/2a
4361,Phase 1/2
131387,Phase 1b/2a
97154,Phase 1b/2a
164843,Phase 1/2
71277,Phase 1/2
142552,Discontinued in Phase 2/3
51808,Phase 1/2a
771,Discontinued in Phase 2/3
1937,Phase 1/2a
29074,Phase 0
185907,Clinical trial
19023,Discontinued in Phase 2/3
4945,Phase 2/3
98454,Phase 1b
41893,Phase 0
8504,Investigative
160237,Phase 1b/2a
141384,Discontinued in Phase 2b
12977,Phase 1
27400,Discontinued in Preregistration
131443,Phase 1b/2a
190210,Phase 1/2
191880,Discontinued in Phase 2b
132911,IND submitted
178760,Phase 1b
136528,Phase 1/2a
99322,Phase 1
113096,Phase 1b/2a
65203,Preclinical
118997,Phase 2b
84727,Phase 1/2a
20135,Clinical trial
178337,Investigative
85137,Phase 1/2a
133386,Phase 1
81604,Approved
142643,Discontinued in Phase 4
52400,Phase 2/3
80615,Phase 1/2a
9387,IND submitted
108454,Phase 0
135330,Phase 0
110792,Phase 1/2
146428,Phase 1/2a
180358,Discontinued in Phase 2
29536,Phase 1/2a
157732,Clinical trial
31455,Phase 1
168561,Discontinued in Phase 1/2
89104,Investigative
180488,Phase 2/3
124034,Approved
190214,Approved
147934,Investigative
79635,Phase 1/2a
158723,Phase 1b/2a
38194,Phase 0
107593,Phase 1/2
143437,Patented
143554,Discontinued in Phase 4
143232,Phase 1b/2a
15920,Phase 0
151167,Phase 0
181334,Phase 1
133674,Discontinued in Phase 4
176565,Phase 1/2
6442,Phase 4
153667,Phase 2/3
115455,Discontinued in Phase 2
163965,Discontinued in Preregistration
109941,Discontinued in Phase 4
113266,Phase 1b/2a
55302,Phase 1b/2a
103560,Phase 1/2a
100851,Patented
82306,Phase 1
66423,Phase 1/2a
181588,Phase 2/3
86606,Discontinued in Phase 2b
6669,Investigative
189072,IND submitted
61997,Discontinued in Phase 4
79113,Phase 2a
178253,Phase 2a
120641,Phase 4
99594,Phase 1
26111,Discontinued in Preregistration
127482,Discontinued in Phase 2/3
151111,Phase 2
190073,Patented
187646,Clinical trial
27958,Discontinued in Phase 4
56456,Phase 1b/2a
24984,Phase 2a
21037,Phase 2
39733,Phase 1
33496,Phase 1b/2a
46210,Phase 2/3
93700,IND submitted
141568,Phase 2/3
177026,Phase 0
101866,Phase 1b
116262,Phase 2
77782,Investigative
73905,BLA submitted
172881,Discontinued in Phase 2
133513,Phase 1/2
180301,Phase 2a
130156,Investigative
84871,Phase 0
97381,Phase 1b
31203,Discontinued in Preregistration
134859,Phase 0
97306,Phase 1b
40752,Discontinued in Phase 4
96007,Phase 1b
95085,Phase 1b
37094,Phase 1
54412,Phase 1b/2a
77020,Phase 0
1490,Phase 0
186032,Phase 0
1228,Patented
153006,Investigative
169553,Phase 1
78065,Discontinued in Phase 2/3
101101,Investigative
140133,Discontinued in Phase 2
113357,Phase 1b/2a
73689,Patented
98328,Phase 2
73827,Clinical trial
70220,Investigative
102679,IND submitted
192020,Phase 2a
54398,Phase 1
138900,Discontinued in Phase 2
28173,Phase 2a
123199,Patented
183676,Discontinued in Preregistration
133165,IND submitted
50093,Investigative
58587,Phase 1
87028,Phase 1b/2a
100146,Discontinued in Phase 2
144219,Discontinued in Phase 2
91463,Clinical trial
73789,Phase 1b/2a
190584,Phase 2b
134092,Phase 1/2a
34164,Phase 1/2a
22039,Phase 0
107677,Phase 1/2
82221,Discontinued in Phase 2
50597,Phase 3
99487,Phase 1/2a
1288,Investigative
101736,Phase 1b
80691,Approved
97186,Phase 1/2a
146198,Discontinued in Phase 2
111890,Phase 1/2
143542,Phase 2a
106740,Phase 2b
9130,Discontinued in Phase 2
77185,Phase 1/2
59481,Investigative
73382,Approved (orphan drug)
175832,Phase 0
143575,Discontinued in Phase 1/2
14129,Phase 1
131441,Discontinued in Phase 1/2
81292,Discontinued in Phase 3
109821,Discontinued in Phase 2/3
28822,Phase 4
37251,Phase 1
107710,Phase 1
8872,IND submitted
187712,Phase 0
55969,Phase 3
43021,IND submitted
70783,Discontinued in Phase 2b
139592,BLA submitted
115797,Phase 2/3
153310,Investigative
101591,IND submitted
7500,Phase 1b/2a
544,Discontinued in Phase 2/3
26598,Phase 0
115148,Phase 2
95033,Patented
47139,IND submitted
110920,Patented
154451,IND submitted
184835,Discontinued in Phase 4
15330,Phase 0
121902,Phase 0
10763,Discontinued in Phase 2b
85163,Phase 1/2
1896,Investigative
90990,BLA submitted
152615,Discontinued in Phase 3
117650,Phase 1/2
29255,Phase 1/2a
124231,Phase 1b
30426,Phase 2
125654,Phase 1b
87443,Discontinued in Phase 2/3
63597,Patented
77525,Phase 1
21955,Phase 1b/2a
22178,Phase 1b/2a
158040,Phase 1b/2a
148866,Phase 2b
25277,Investigative
47485,Discontinued in Phase 2/3
95767,Phase 2/3
137075,Phase 1/2a
25230,Investigative
43249,Phase 1
128562,Discontinued in Phase 2b
38455,Phase 1
92342,Phase 2
49097,Discontinued in Phase 2b
167890,Phase 1b
123337,Phase 0
78336,Investigative
31700,Investigative
1304,Discontinued in Phase 2/3
134066,Discontinued in Phase 4
147666,Phase 1/2a
59788,Clinical trial
138528,Approved (orphan drug)
26783,Phase 1b
123450,Discontinued in Phase 4
116483,Discontinued in Phase 1
33644,Phase 1/2a
37413,Discontinued in Phase 2b
149184,Phase 1b
52193,IND submitted
54700,Discontinued in Phase 2b
51193,Phase 0
127920,Discontinued in Phase 3
51372,Phase 1
186490,Phase 0
53029,Phase 0
116653,Phase 1
121346,Patented
108889,Discontinued in Phase 2
53583,Phase 1/2a
167066,Discontinued in Phase 2
110915,Phase 1/2
84556,Phase 0
91680,BLA submitted
84737,Phase 1/2a
109811,Discontinued in Phase 1/2
20580,Phase 1/2
134275,Phase 1/2a
156506,Discontinued in Phase 3
98507,Phase 1/2a
158172,IND submitted
109815,Phase 4
190248,Clinical trial
67546,Phase 1/2a
8753,Phase 1/2a
52387,Discontinued in Phase 2b
161414,Investigative
86208,Discontinued in Phase 4
3265,Investigative
96780,Discontinued in Phase 2
75425,Investigative
107969,Clinical trial
163430,Discontinued in Phase 2b
151981,Discontinued in Phase 2/3
150903,Discontinued in Phase 2/3
160557,Phase 3
41559,Investigative
87997,Phase 1/2
157475,Registered
13177,Investigative
178953,Discontinued in Phase 2/3
79500,Phase 2
48446,Phase 1b
137130,Phase 1/2a
84013,Investigative
148306,Discontinued in Phase 2
155917,Phase 2
131978,Phase 1
111682,Discontinued in Phase 3
15056,Phase 0
103875,BLA submitted
87248,Patented
144336,Discontinued in Phase 2/3
85679,Discontinued in Phase 2b
140259,Phase 1b
161421,IND submitted
176285,Clinical trial
129450,Investigative
102148,IND submitted
66492,Discontinued in Phase 3
67534,Patented
57575,Phase 1b/2a
31086,Phase 2
122657,Phase 1
183097,Discontinued in Phase 4
134121,Phase 1/2
130172,Phase 2b
128514,Investigative
30670,Phase 0
32851,Phase 2
175318,Phase 2b
37146,Phase 1
27986,Phase 2
186637,Investigative
162119,Phase 2
188924,Phase 2/3
191758,IND submitted
102920,Investigative
66475,Patented
88050,Phase 1/2
184259,Discontinued in Phase 4
153326,Phase 1
127525,Discontinued in Phase 4
137916,Investigative
33891,Phase 2
87212,Phase 0
60529,Discontinued in Phase 3
103798,Patented
76511,Phase 0
157922,Discontinued in Phase 2
129851,Phase 1/2a
126254,Phase 1b
142099,Patented
17075,Phase 0
161774,Investigative
57662,Investigative
171022,Phase 0
115414,Discontinued in Phase 2
176924,Phase 1b
149150,Discontinued in Phase 2/3
117724,Discontinued in Phase 1
56482,Phase 2
173062,Phase 2a
140035,Clinical trial
47352,Discontinued in Phase 1
146110,Phase 0
125959,Phase 1b
169860,Investigative
141064,Phase 2/3
79441,Approved (orphan drug)
144315,Discontinued in Phase 2
184409,Phase 0
65562,Phase 1/2
129306,Investigative
48528,Phase 1b/2a
60856,Phase 1b
92836,Phase 1/2
108480,Phase 1b/2a
113729,Phase 1
141023,IND submitted
168620,Phase 2
149881,Phase 2b
154510,IND submitted
9935,Phase 0
171253,Phase 0
62257,Phase 2a
123052,Patented
126257,BLA submitted
34264,Phase 1b/2a
85545,Discontinued in Preregistration
66125,BLA submitted
159873,Discontinued in Phase 1/2
13843,Phase 1
73634,Approved (orphan drug)
11746,Discontinued in Preregistration
17938,Patented
111754,Discontinued in Phase 3
174006,Discontinued in Phase 4
112633,Phase 1/2
26560,Phase 1b
82095,Discontinued in Phase 2/3
130457,Phase 1b/2a
117133,Phase 1
63133,Phase 1b/2a
48216,Phase 3
90801,Phase 1/2
80430,Discontinued in Phase 1/2
14305,Phase 2b
17321,Phase 1
39786,Investigative
111477,Discontinued in Phase 2b
19993,Discontinued in Preregistration
175907,Discontinued in Phase 2
75401,Phase 0
32803,Phase 2a
175853,Discontinued in Phase 2
2785,Phase 1
68960,Discontinued in Phase 2
187590,Phase 1b
28187,Phase 1/2
89024,IND submitted
6488,Discontinued in Phase 2
120386,Discontinued in Phase 3
90135,Discontinued in Phase 1
181900,Phase 1b/2a
31843,Phase 1
63269,Phase 0
6211,IND submitted
53954,Phase 1b
133645,Phase 1/2
169006,Phase 0
81782,Phase 2
139883,BLA submitted
93190,Discontinued in Phase 1
158419,Phase 2/3
159146,Phase 1b
79640,Phase 2
180966,Phase 1b/2a
121049,Phase 2/3
61113,Phase 0
135560,Phase 0
8207,Patented
165600,Discontinued in Phase 4
7005,Phase 1b/2a
148232,Phase 2b
185007,BLA submitted
155114,Phase 1b/2a
163098,Discontinued in Preregistration
53951,Discontinued in Phase 2b
56187,Phase 1b
165421,Discontinued in Phase 1
165351,Phase 1
113532,Phase 1b
5583,Phase 1b/2a
156564,Preregistration
77925,Discontinued in Phase 1
58915,Phase 2/3
98477,Phase 1/2a
11554,Discontinued in Phase 2/3
170877,Phase 0
94064,IND submitted
72236,Phase 1/2
138968,Approved (orphan drug)
113602,Phase 2
172112,Discontinued in Phase 2/3
105808,Phase 2/3
38231,Phase 2b
148989,Phase 1b
137176,BLA submitted
168968,Phase 0
162733,Phase 1/2a
24181,Patented
123235,IND submitted
78028,Approved
173604,Phase 2
129601,Patented
132508,Phase 1/2
38845,Discontinued in Preregistration
87029,Phase 1/2
85972,Discontinued in Phase 2b
21725,BLA submitted
136256,IND submitted
55496,Phase 2
56473,Discontinued in Phase 3
46270,Patented
83565,Discontinued in Preregistration
140447,Phase 1
64510,Discontinued in Phase 4
115571,Clinical trial
30351,Patented
180764,Phase 3
111511,Phase 1/2
111362,Discontinued in Phase 4
29066,Phase 1b/2a
109002,Phase 1/2
152135,Phase 1
74842,Phase 1/2a
60402,Phase 1/2
2047,Approved
178138,Phase 2a
146458,Phase 1/2a
60636,Phase 0
66473,Phase 1b/2a
157912,Phase 2a
64442,Discontinued in Phase 2/3
16858,Phase 1
41845,Phase 1b/2a
29856,Phase 2
93237,Investigative
85508,Discontinued in Phase 2b
26621,Phase 1b
70191,Phase 2/3
48990,Phase 1/2a
82535,Phase 0
163962,Phase 1/2
159538,Phase 1b/2a
65045,Phase 2
128270,Phase 1/2
66455,Phase 1/2a
79533,Phase 2a
129868,Phase 0
118720,Phase 1/2a
50190,Phase 1b/2a
60161,Phase 0
170749,Phase 0
34368,Phase 1/2a
11722,Phase 1b
176605,Phase 2b
84580,Phase 0
180032,Phase 1
61156,Phase 1/2a
130115,Phase 2
10269,Discontinued in Phase 2b
83218,Discontinued in Phase 1/2
41097,Approved
168298,Discontinued in Phase 2b
35590,Discontinued in Phase 1/2
2060,Investigative
90048,BLA submitted
127157,Discontinued in Phase 4
180158,Discontinued in Phase 2
67800,Phase 1
116604,Discontinued in Phase 1
86200,IND submitted
6150,Phase 1b/2a
189359,Patented
23628,Phase 1/2a
30233,Phase 2
144365,Discontinued in Phase 1/2
77225,Phase 1/2
167272,Discontinued in Phase 1/2
97293,Phase 1/2
73125,Phase 1b/2a
167894,Phase 2
146702,Phase 1b/2a
186485,Phase 2a
171435,Discontinued in Phase 2
70412,Investigative
32724,Phase 2
128023,Patented
184516,Phase 0
33591,Phase 1
191273,Phase 2a
139942,BLA submitted
28989,Phase 2
149364,Phase 0
19830,Phase 0
170164,IND submitted
15905,Phase 0
18950,Phase 2
126626,Phase 1/2
82010,Clinical trial
112194,Discontinued in Phase 3
128734,Phase 0
6447,Phase 1b/2a
91467,Approved (orphan drug)
69802,IND submitted
113726,Phase 1b
83600,IND submitted
144224,Discontinued in Phase 1/2
162730,Investigative
33843,Patented
149220,Phase 1b
131762,Discontinued in Preregistration
145319,Discontinued in Phase 1
11110,Discontinued in Phase 3
2440,Discontinued in Phase 1/2
7670,Phase 2
17683,Phase 1
27414,Patented
47688,Discontinued in Phase 3
117654,Discontinued in Phase 3
188787,Phase 0
50,Phase 1
95752,Phase 2
180086,Discontinued in Preregistration
4051,IND submitted
148074,Investigative
121462,Phase 2
31362,Phase 1
169445,Phase 0
175154,Phase 0
100403,Approved
115484,Phase 2
184048,Phase 0
170793,Phase 0
166680,Discontinued in Phase 3
190609,Phase 2b
63748,Phase 0
135151,Phase 0
160719,Phase 3
118414,Phase 1b/2a
97502,Phase 1b
72859,Phase 2/3
158109,Phase 1
86855,Phase 1/2
136265,Discontinued in Phase 2/3
79665,Approved (orphan drug)
126664,Phase 0
144461,Discontinued in Phase 1/2
57327,Phase 1
33692,Phase 1/2a
61252,Phase 1
127479,Discontinued in Phase 1
184554,Phase 0
156721,Preclinical
176564,Phase 1b
72381,Phase 1/2a
160452,Phase 0
165922,Phase 1b/2a
175688,Phase 1/2
168191,Discontinued in Phase 2/3
21712,Phase 1b/2a
41523,Phase 1b
76546,IND submitted
69815,Phase 1
141691,Patented
113683,Phase 1
159695,Investigative
17055,Phase 1
137296,Phase 2
34709,Phase 2a
105649,Investigative
72948,Phase 2
95560,Investigative
51527,Phase 1/2a
185348,Discontinued in Phase 1
127988,Phase 0
78893,Phase 2a
173451,Discontinued in Phase 2
170734,Patented
178088,Phase 1
24402,Phase 1
117945,Phase 2/3
110631,Patented
71945,Phase 1
23935,Investigative
48929,IND submitted
41241,IND submitted
19382,Discontinued in Phase 2b
81285,Approved
37479,Phase 2
117304,Discontinued in Phase 1
63195,Phase 1b
20259,Phase 1b/2a
137796,Investigative
125214,Phase 1b
134109,Discontinued in Phase 4
111182,Phase 1/2a
138713,BLA submitted
107875,Discontinued in Phase 1
39268,Investigative
21014,Phase 2/3
35767,Phase 1/2
79045,Phase 0
33154,Approved (orphan drug)
188461,Patented
36066,Phase 0
191816,Phase 0
84965,Phase 0
185195,Discontinued in Phase 3
54636,Phase 1
38302,Phase 2a
158996,Clinical trial
81287,Clinical trial
91007,Clinical trial
125981,IND submitted
75531,Patented
57565,Phase 1/2a
47359,Phase 0
73154,Phase 1b/2a
17673,Phase 1/2
74105,Phase 2
168437,Discontinued in Phase 4
62838,Discontinued in Phase 3
36079,Phase 1/2a
60619,Discontinued in Phase 4
20674,Phase 1/2a
114651,Phase 0
14826,Phase 1
99923,Phase 1
95795,Phase 1/2a
17421,Phase 0
48476,Phase 1/2a
63060,Patented
117839,Phase 1b
61249,Phase 1
48182,IND submitted
82305,Discontinued in Phase 2b
91469,Approved (orphan drug)
132765,Discontinued in Phase 4
124449,Phase 1/2
7738,Patented
91937,Phase 1/2a
91508,BLA submitted
20922,Phase 1
42269,Approved
115155,Phase 1/2a
63173,Phase 1b/2a
30349,Phase 1/2
106853,Phase 1b
27618,Phase 2
178154,Phase 1/2a
11113,Clinical trial
179118,Phase 1/2a
67056,Patented
6974,Discontinued in Phase 2
190659,Phase 0
102009,Investigative
179121,Phase 1/2
82150,Clinical trial
135502,Phase 0
41294,BLA submitted
151697,Phase 1
66823,Phase 0
107903,IND submitted
113742,Discontinued in Preregistration
25904,Phase 1b/2a
131356,Discontinued in Phase 1/2
169719,Phase 1b
37295,Discontinued in Preregistration
102893,Approved (orphan drug)
93956,Phase 2a
89302,Phase 1/2a
41252,IND submitted
136254,Investigative
47054,BLA submitted
136600,Investigative
38678,Phase 2/3
137642,Phase 1
11953,Phase 1/2a
159640,Phase 1b
10057,Phase 1/2
175197,Discontinued in Preregistration
84188,Phase 0
128056,Phase 1b/2a
86252,IND submitted
97277,Phase 1/2a
158557,Phase 1
56853,Phase 3
6800,Phase 1/2
164758,Phase 1/2
38100,Discontinued in Phase 2
27198,IND submitted
102517,Discontinued in Preregistration
190259,Approved (orphan drug)
126199,Phase 1b
29350,Phase 2/3
11864,IND submitted
2806,Discontinued in Phase 2b
29499,Phase 3
133547,IND submitted
71911,Phase 1
143674,Discontinued in Phase 4
95066,Patented
140817,Preregistration
134362,Phase 1
145243,Investigative
143245,Patented
112003,Discontinued in Phase 2
19278,Discontinued in Phase 3
94104,Phase 1/2a
174122,Phase 1/2
5640,Investigative
52692,Phase 1/2a
1781,Phase 0
129795,Phase 1/2
158893,Phase 1b/2a
53994,Discontinued in Preregistration
138469,BLA submitted
40595,Discontinued in Preregistration
55719,Discontinued in Phase 2b
119944,Approved
127605,Phase 1/2
175899,Discontinued in Phase 4
139900,BLA submitted
161180,Discontinued in Phase 4
56685,Phase 2
6584,Phase 1/2
89627,Investigative
14111,Phase 2b
156176,Discontinued in Preregistration
99598,Phase 1
160999,Phase 0
45095,Phase 2/3
83661,Phase 1/2a
189082,Phase 1b
189726,Phase 2b
151731,Phase 1
12738,Phase 0
446,Phase 1
59762,Investigative
173393,Patented
75594,IND submitted
8799,Discontinued in Phase 1/2
125813,Phase 1/2
33432,Phase 1b
135733,IND submitted
100914,Phase 1b/2a
100300,Phase 1
3278,IND submitted
133961,Phase 1/2a
145902,Phase 2b
83257,Discontinued in Preregistration
152334,Phase 2a
185301,Discontinued in Phase 4
3078,Phase 2a
121756,Phase 1/2
27242,Phase 1/2a
62774,Discontinued in Phase 4
134887,Phase 0
176309,Phase 2/3
38572,Phase 2/3
81484,Phase 1/2a
51602,Phase 0
55219,IND submitted
172259,Phase 0
155498,Phase 2/3
163030,Discontinued in Phase 2/3
150475,Phase 1/2a
66530,Phase 0
97,Phase 2
89171,Discontinued in Phase 4
58797,Phase 1/2a
154046,Phase 1/2a
90729,Investigative
158211,Phase 0
135864,Phase 1b/2a
115531,Phase 2
50684,Discontinued in Phase 2b
103899,Phase 1/2a
182637,Phase 2/3
40447,Phase 2
184469,Phase 0
89479,Phase 1/2
3390,IND submitted
59342,Investigative
159363,Approved
98942,Phase 1b/2a
30756,Phase 2
61308,Patented
61984,Discontinued in Phase 4
14894,Phase 1
78011,Discontinued in Phase 2
164571,Phase 1/2
135769,IND submitted
35069,Phase 2a
66640,Discontinued in Phase 2
174762,IND submitted
36644,Phase 1
180172,Phase 2a
41993,Phase 0
138473,Clinical trial
144667,Phase 2b
20731,Patented
104954,Phase 1/2
30385,Discontinued in Phase 1
90264,Discontinued in Phase 2/3
96688,Discontinued in Phase 2b
109843,Discontinued in Phase 2/3
59208,Phase 0
119391,Discontinued in Phase 4
169476,Phase 1
27654,Phase 2/3
157198,Phase 1/2
52889,Phase 1
9919,Preclinical
138794,Investigative
18880,Discontinued in Phase 2/3
84666,Phase 0
26093,Phase 2
124469,Phase 1b/2a
164735,Phase 1/2
58837,Investigative
57301,Phase 1b/2a
26537,Phase 1b
20548,Phase 1b
29108,Phase 4
119870,Approved (orphan drug)
188035,Discontinued in Phase 4
174947,Discontinued in Phase 4
164112,Phase 1/2
96587,Phase 1/2
19527,IND submitted
147909,Investigative
44871,Phase 2/3
165125,Phase 1/2
80822,Discontinued in Phase 1/2
176045,Phase 0
86408,Phase 2
54313,Discontinued in Preregistration
43441,Phase 2/3
157638,Discontinued in Phase 4
75675,Phase 0
38961,Patented
95581,Phase 1
35229,Phase 1/2a
56597,Discontinued in Preregistration
101602,Phase 1b
76185,Phase 1/2
131078,Phase 1/2a
151199,Phase 2
138699,Phase 1/2a
172558,Phase 2a
170245,Phase 0
174791,Phase 1/2
5527,IND submitted
58792,Phase 0
45309,Phase 1/2a
173069,Discontinued in Phase 2b
74904,Phase 1/2
24087,Phase 1b/2a
156563,Phase 1b/2a
48184,Phase 2/3
142467,Phase 1
79957,Discontinued in Phase 1
175029,Phase 1
72929,Investigative
141243,Discontinued in Phase 2b
137118,Phase 1
177319,Phase 1b
182089,Phase 1/2a
166905,IND submitted
73234,Clinical trial
24275,Phase 1
134460,Phase 1
94806,Phase 1
14381,Phase 1
76385,Phase 1/2a
67371,Discontinued in Phase 1
76962,IND submitted
149942,Discontinued in Phase 2/3
131264,Patented
55700,Phase 2
144183,Phase 1/2
182263,Phase 3
92923,Phase 2
118229,Phase 2a
32402,Phase 1b/2a
159580,Phase 1b
140643,Phase 1b/2a
19761,Phase 2a
13034,Phase 1b/2a
118122,Phase 2
95016,Phase 1/2a
149269,Phase 0
132676,Phase 1/2
111471,Patented
81907,Clinical trial
178746,Discontinued in Phase 2/3
26370,Discontinued in Preregistration
152286,Phase 2a
9998,Discontinued in Phase 2/3
75472,Phase 1/2
53803,Phase 1/2a
121749,BLA submitted
124267,Discontinued in Preregistration
171248,Discontinued in Preregistration
93056,Discontinued in Phase 3
155178,Phase 1b/2a
11458,Discontinued in Preregistration
6475,Phase 2/3
102512,IND submitted
2759,IND submitted
82338,Phase 2/3
111008,Phase 1/2
137657,Discontinued in Phase 2
61864,Phase 1b
108152,Patented
18397,Preregistration
92966,Phase 1/2
51188,Phase 1/2
63688,Phase 2/3
71367,Phase 1b
25255,Phase 1/2a
136379,Investigative
135332,Phase 0
53055,Phase 1/2a
45926,Phase 1/2a
111484,Phase 1/2
74847,Discontinued in Phase 2/3
63135,Phase 1b
30211,Investigative
112240,Phase 1
67568,Phase 1/2a
9348,IND submitted
50690,Phase 1b
141221,Discontinued in Phase 2b
17346,Phase 1
124420,Patented
112906,Phase 0
26796,Phase 0
116447,Discontinued in Phase 2/3
142647,Phase 1/2
143478,Discontinued in Preregistration
102952,Application submitted
68853,Phase 1
16872,Discontinued in Phase 1
113583,Phase 1b/2a
160091,Investigative
83850,Phase 1b/2a
140553,Discontinued in Phase 2
167485,Discontinued in Phase 1
147080,Phase 1b
8215,Phase 1
183110,Phase 2
156603,Phase 1b/2a
129447,Investigative
192067,Phase 1/2a
15008,Phase 1/2
95810,Phase 2a
43266,Phase 1/2a
101248,Phase 3
95468,Patented
45941,Phase 1/2a
15178,Phase 1/2
159420,Phase 1b/2a
97317,Phase 0
59387,Discontinued in Phase 4
149705,Phase 1b/2a
153576,Phase 2a
87413,Discontinued in Phase 2
126723,Discontinued in Phase 1
87813,Phase 1/2
152958,Phase 2
75804,Discontinued in Phase 1/2
67496,Phase 0
73870,Phase 2a
124890,Phase 1b
95196,Phase 1/2a
119289,Discontinued in Preregistration
101310,Discontinued in Phase 1/2
179281,Phase 1
517,Discontinued in Phase 1/2
109127,Phase 1/2a
169252,Phase 2b
162276,Phase 3
187280,Phase 2a
132991,Discontinued in Phase 4
130962,Phase 0
187294,Patented
6710,Phase 1/2
79375,Approved
31001,Investigative
65988,Preclinical
103931,Phase 1b
138291,Phase 1b
38661,Patented
29595,Discontinued in Phase 2b
1112,Phase 1/2
72273,Patented
115094,Phase 1b
173980,Discontinued in Preregistration
145269,Phase 0
137442,Discontinued in Phase 2/3
29987,Discontinued in Phase 2b
22260,Investigative
109401,Discontinued in Preregistration
129656,Discontinued in Phase 3
51617,Phase 3
100878,Phase 1/2
135067,Phase 0
70404,Phase 1b/2a
20616,Phase 0
115707,Discontinued in Phase 2
167622,Discontinued in Preregistration
170299,Phase 1/2
23469,Phase 1b
103981,Phase 1/2
102115,Investigative
181979,Phase 1/2
174894,Phase 1
144675,Phase 0
122528,Phase 0
89520,Phase 1/2
91308,BLA submitted
110971,Phase 2
59294,Phase 0
56691,Phase 1/2
21532,Investigative
180833,Phase 1
95565,Discontinued in Phase 3
82229,Phase 1/2a
82188,Clinical trial
125763,Phase 1b
158703,Phase 0
96654,Phase 1b
151875,Phase 2
165269,Phase 1
147680,Discontinued in Phase 2/3
13020,Phase 1b/2a
102511,IND submitted
146450,Discontinued in Phase 1
336,Phase 1
31830,Discontinued in Preregistration
21139,Phase 1b/2a
34131,Phase 1
78211,Investigative
181854,Phase 2a
106027,Phase 1b/2a
42509,Phase 1b/2a
93383,Phase 2b
76754,Discontinued in Preregistration
140060,Phase 1b
116092,Phase 1/2a
99946,Phase 1b
153932,Phase 1b
20374,Phase 0
168489,Discontinued in Phase 1/2
15100,Investigative
158044,Clinical trial
137532,Phase 1/2
116856,Discontinued in Preregistration
104176,Phase 1/2
49967,Phase 0
100172,Approved
43389,Phase 1/2a
10286,Phase 0
125490,Phase 1b/2a
41978,Phase 1b/2a
46033,Phase 2/3
154195,Phase 1/2a
83008,Phase 1
83971,Discontinued in Preregistration
149168,Phase 2b
172893,Phase 2
132480,Phase 1/2
160320,Phase 2/3
120893,Investigative
120477,Discontinued in Phase 2
181227,Phase 1/2a
82723,Phase 0
9677,Phase 2b
87834,Discontinued in Phase 2/3
10883,Phase 1
92136,Phase 1b
121770,Phase 2
148739,Phase 2b
109040,Phase 0
123973,Phase 2
88208,Phase 1
4936,Phase 2a
24180,Phase 1
173713,Phase 1
58017,Discontinued in Phase 1/2
77571,Discontinued in Preregistration
33424,Phase 1b/2a
114806,Phase 1/2a
110060,Phase 1
106559,Phase 0
186213,Patented
13226,Phase 1b/2a
113737,Phase 1
132365,Discontinued in Phase 1/2
25263,Phase 1/2
165619,Investigative
181644,Discontinued in Phase 2b
191320,IND submitted
94914,Phase 1
39546,Phase 1b
137856,Phase 2
114187,Phase 1
175717,Discontinued in Phase 1/2
111696,Phase 1/2
139623,Phase 1/2
6987,Phase 1b/2a
139341,Discontinued in Phase 2
80461,Discontinued in Phase 1
21193,Phase 0
65885,Preclinical
172591,Discontinued in Phase 3
124889,Phase 1b
98146,Phase 1/2a
189964,Phase 2/3
60353,Phase 1b/2a
59443,Discontinued in Phase 4
92145,Phase 1/2
165076,Discontinued in Preregistration
71161,Phase 1b/2a
70596,Phase 1b/2a
107580,Phase 3
136386,Phase 1/2a
104649,Investigative
85903,Discontinued in Phase 2b
124847,Phase 0
25601,Investigative
81368,Phase 1b/2a
120633,Phase 0
8371,Phase 1
62291,Phase 1
105302,Phase 1b
35299,Discontinued in Phase 2/3
2486,Phase 1b
164612,BLA submitted
145576,Discontinued in Phase 2
70321,Phase 0
40519,Discontinued in Phase 2b
71630,Phase 1b/2a
191248,IND submitted
149603,Phase 2b
9928,Discontinued in Phase 2b
124,Approved (orphan drug)
47939,Phase 1
90714,Phase 1b
61839,Investigative
183904,Phase 1b
28517,Discontinued in Phase 4
24077,Discontinued in Phase 4
159285,Discontinued in Phase 1
98307,Phase 1/2a
184792,Phase 0
102624,IND submitted
112426,Phase 0
100523,Phase 1/2a
130870,Phase 1b
8136,Investigative
149383,Phase 1/2a
118408,IND submitted
125428,Discontinued in Phase 3
111023,Phase 1/2
66131,Discontinued in Phase 4
141363,Discontinued in Phase 2b
129716,Phase 0
163722,Phase 1/2
92613,Phase 0
57248,Phase 0
176165,IND submitted
2985,Investigative
34920,Patented
42209,Phase 1/2a
75318,Phase 1/2a
9252,IND submitted
11071,Phase 1
26037,Discontinued in Preregistration
77966,IND submitted
123212,Patented
33942,Patented
20371,Phase 1/2
39332,Patented
142578,Discontinued in Phase 2/3
8933,Discontinued in Phase 2
26106,Phase 1/2a
48977,Phase 2
42496,Phase 2b
6528,Phase 1b/2a
165236,Phase 1/2a
18954,Phase 0
74754,Discontinued in Phase 3
165822,Phase 1b/2a
100691,Phase 1/2
47314,Investigative
43501,Phase 1/2a
32466,Phase 2a
92857,Phase 1b
29283,Phase 1b/2a
120122,Phase 0
118888,BLA submitted
151118,Phase 2
128188,Discontinued in Phase 2b
160196,Phase 1
30624,Discontinued in Phase 3
111364,Phase 1/2
150755,Phase 2
48010,Discontinued in Preregistration
150093,Investigative
102476,Application submitted
166963,Discontinued in Phase 2
139943,BLA submitted
121142,Phase 0
184762,Discontinued in Phase 4
141174,Discontinued in Preregistration
149174,Phase 2b
96655,Phase 1/2a
13864,Phase 0
1612,Phase 2a
99936,Phase 1
49438,Discontinued in Preregistration
109337,Discontinued in Phase 2/3
158182,Phase 1/2a
8470,Discontinued in Phase 1/2
112731,Phase 1
55289,Phase 3
22931,Phase 1/2
10292,Discontinued in Phase 2b
599,Discontinued in Phase 2/3
103750,Phase 1/2a
101867,Investigative
59793,Phase 1b/2a
152044,Phase 0
173067,Discontinued in Phase 2b
57793,Discontinued in Phase 1/2
90119,Preclinical
78004,Investigative
137820,BLA submitted
87188,Discontinued in Phase 1/2
77837,Phase 2
122110,Patented
63831,Discontinued in Phase 2b
91098,Phase 1b
82566,Discontinued in Phase 2/3
73699,Phase 1b
51112,Phase 1b/2a
22961,Phase 1/2a
5808,Phase 1b/2a
172399,Phase 1b
74890,Phase 1/2
77578,Phase 1/2
51609,Phase 0
178972,Phase 1/2a
14454,Phase 1/2
118825,Discontinued in Preregistration
46231,Discontinued in Phase 2
110703,Patented
13789,Phase 1b/2a
132252,Discontinued in Phase 1/2
3456,Phase 2a
62126,Discontinued in Preregistration
148923,Investigative
92111,Phase 2a
60616,Phase 1
59006,Investigative
77736,Phase 1b
5836,Phase 2/3
85429,Discontinued in Phase 3
94704,Phase 1/2a
129760,Phase 0
9187,IND submitted
10008,IND submitted
27338,Phase 1b/2a
117286,Discontinued in Phase 1
161148,Discontinued in Preregistration
177531,Approved
24811,Phase 1/2a
145054,Phase 1/2a
2251,Discontinued in Phase 1/2
191815,Phase 2a
180029,Discontinued in Phase 1
96569,Discontinued in Phase 3
175445,Phase 1/2
14668,Phase 1b/2a
78130,IND submitted
88565,Phase 1
106202,Phase 1/2a
56397,Discontinued in Phase 2b
91515,Discontinued in Phase 2b
143243,Discontinued in Phase 4
32155,Phase 1/2
34031,Phase 1b
69477,Discontinued in Phase 1/2
47109,Phase 2a
147378,Phase 1b/2a
180792,Phase 1
127510,Phase 0
14581,Phase 0
103027,Investigative
165511,Discontinued in Phase 4
115922,Phase 2a
14658,Phase 0
188860,Discontinued in Phase 3
95735,Phase 0
61139,Phase 1/2
163728,Phase 1
53657,Phase 4
13278,Phase 1/2
95646,Phase 1
69545,Phase 1b
187453,Phase 2/3
82916,Discontinued in Phase 4
111173,Phase 0
15111,Phase 0
29251,Phase 4
52302,Phase 1b/2a
189024,Phase 2b
113963,Phase 1/2
100185,Discontinued in Phase 1
92730,Phase 2b
158104,Discontinued in Phase 2
146278,Discontinued in Phase 2
13700,Phase 1
118865,Phase 1/2a
144048,Phase 1/2
135575,Phase 0
183835,Phase 1b/2a
125336,BLA submitted
132176,Phase 2
82174,Clinical trial
67272,Discontinued in Preregistration
164176,Discontinued in Preregistration
23018,Phase 1b/2a
62831,IND submitted
102597,Investigative
50638,Patented
79589,Phase 2a
129980,Discontinued in Phase 3
100519,IND submitted
120390,Approved (orphan drug)
158940,Approved
92750,Phase 1b/2a
65430,Discontinued in Phase 1
20533,Discontinued in Phase 2/3
78631,Phase 2/3
106893,Phase 1/2
41823,Phase 1b
120539,Phase 0
15448,Phase 0
4756,Phase 2a
30543,Discontinued in Preregistration
28856,Phase 0
122698,Phase 1/2
170113,Phase 1b
145539,Investigative
50600,Phase 2/3
45547,Phase 1/2a
191732,Phase 1
105027,Discontinued in Phase 4
104454,Phase 1b/2a
143479,Discontinued in Phase 1/2
69793,Phase 1/2a
107466,Phase 1
121682,Approved (orphan drug)
158321,Clinical trial
103532,Phase 1b
114667,Phase 1/2a
32726,Patented
3801,Discontinued in Phase 2b
370,Phase 1/2a
159922,Discontinued in Preregistration
63390,Phase 1/2a
22916,Phase 2
46437,Discontinued in Phase 3
176137,Phase 1
175903,Discontinued in Phase 1/2
85431,Discontinued in Preregistration
106190,Phase 2/3
81170,Phase 1b/2a
67513,Phase 1/2a
83183,Phase 1b/2a
181874,Phase 2a
47530,Discontinued in Phase 2/3
11531,Phase 1
3581,Discontinued in Phase 4
139100,Approved (orphan drug)
178350,Discontinued in Preregistration
72687,Phase 2
74495,Discontinued in Phase 1/2
82154,Phase 1b/2a
55892,Phase 1
76974,Discontinued in Phase 1/2
139296,Discontinued in Phase 2
18247,Phase 1/2
59618,Phase 1/2
102945,Phase 0
21759,Discontinued in Phase 2
88320,Phase 0
62640,Patented
7480,IND submitted
140592,Preregistration
50709,Discontinued in Preregistration
13995,Phase 1b/2a
180582,Phase 1
97060,Discontinued in Phase 2
49557,Phase 1
50105,Phase 0
190984,Phase 2b
164630,Phase 2/3
189533,Phase 1/2
30690,Discontinued in Phase 4
58234,Discontinued in Phase 3
5764,Phase 2/3
114617,Phase 1/2a
149067,Phase 1b
167104,Discontinued in Phase 1/2
15270,Phase 0
128579,Discontinued in Preregistration
111403,Phase 2
149645,Phase 1b
135486,Phase 0
45770,Phase 2/3
15635,Phase 0
173057,Phase 0
80700,Clinical trial
83356,Phase 1
16212,Phase 0
55923,Discontinued in Phase 2b
43385,Phase 2/3
188188,Discontinued in Preregistration
30368,Discontinued in Phase 2b
184168,Phase 0
112623,Phase 1
69105,Phase 2a
176062,Patented
136427,Discontinued in Phase 4
116398,Discontinued in Phase 2/3
175183,Phase 2b
78578,Phase 0
189500,Phase 1/2a
85556,Discontinued in Phase 2b
4618,IND submitted
96994,Phase 1/2a
153194,Phase 1/2a
68884,Phase 1
111979,Discontinued in Phase 2
9633,Patented
38585,IND submitted
44627,Phase 1/2a
58327,Phase 2/3
146951,Phase 2b
100775,Phase 1/2a
128568,Discontinued in Phase 3
43680,Phase 2/3
134496,Patented
25886,Discontinued in Phase 2b
26886,Phase 1b/2a
3970,Discontinued in Preregistration
33320,Phase 1/2a
29833,Phase 0
97599,Phase 1b
67849,Phase 1/2
16679,Discontinued in Phase 1
56570,Discontinued in Phase 2
151540,Phase 1
64570,Phase 1
154558,Phase 1b/2a
48578,Discontinued in Phase 2b
67344,Clinical trial
38875,Phase 1/2a
122085,Phase 2/3
37850,Phase 1b
54443,Phase 0
138688,BLA submitted
106511,Phase 2b
28599,Phase 4
146465,Phase 1/2
84619,Phase 1b/2a
76649,Patented
184470,Phase 0
51983,Phase 1/2a
88990,BLA submitted
173101,Phase 1/2
101274,Phase 1b/2a
183227,IND submitted
181377,Phase 1/2a
43772,Phase 1/2a
65084,Discontinued in Phase 2b
113639,IND submitted
18441,Discontinued in Phase 3
56927,Phase 2
107655,Phase 1/2a
74411,Phase 1/2
156811,Phase 1b/2a
155462,Phase 2
59813,Phase 1b/2a
1156,Phase 2/3
42833,Phase 2
12559,Phase 1
33362,Phase 0
101219,Phase 2a
47739,Discontinued in Preregistration
154170,Investigative
142429,Phase 0
85803,Discontinued in Preregistration
157804,IND submitted
50199,Phase 1/2a
133510,Phase 1/2
21889,Discontinued in Phase 1/2
67434,Clinical trial
41398,Phase 1/2
111248,Phase 1
73119,Discontinued in Preregistration
6420,Phase 1b/2a
128628,Phase 1
143417,Phase 1/2a
149,Phase 1
152223,Discontinued in Phase 2/3
171874,Discontinued in Phase 2b
169434,Phase 1
75724,IND submitted
168873,Phase 0
175380,Phase 1
176136,Phase 1
71889,Phase 1b
123198,Investigative
95813,Discontinued in Preregistration
131218,Phase 1b/2a
148263,Phase 1b/2a
122526,Discontinued in Phase 4
153459,Phase 1/2
47099,Discontinued in Phase 2/3
165727,Patented
10184,Investigative
146069,Discontinued in Phase 2/3
112961,Discontinued in Phase 3
57685,Phase 1b/2a
127034,Investigative
122428,Phase 1/2
104272,Phase 0
52813,Investigative
15801,Phase 1
167142,Discontinued in Preregistration
15356,IND submitted
188337,Phase 1/2
125240,Discontinued in Preregistration
1910,Discontinued in Phase 1
29017,Phase 1b
74617,Phase 2
8710,Phase 1b/2a
64210,Discontinued in Phase 2b
89575,Phase 1b
107937,Discontinued in Phase 2
50616,Discontinued in Phase 2/3
97904,Patented
42032,Phase 1b
73468,Phase 2
96046,Discontinued in Phase 1/2
69198,Phase 2/3
82589,Phase 1
19431,IND submitted
52285,Phase 1b/2a
166873,Clinical trial
73663,Phase 1b
29785,Clinical trial
58484,Phase 1
90253,Approved (orphan drug)
1052,Discontinued in Phase 2b
90324,Clinical trial
56904,Phase 0
173453,Discontinued in Phase 2
191405,Phase 1/2
6059,Phase 2a
85971,Discontinued in Preregistration
56003,Investigative
129281,Discontinued in Preregistration
44809,Phase 2/3
104102,BLA submitted
87963,Approved
29444,Phase 1b/2a
84692,Phase 1/2a
105432,Phase 1b/2a
145397,Discontinued in Phase 1
33170,Phase 0
70822,Phase 0
71994,Discontinued in Preregistration
76854,Investigative
104528,Phase 0
148396,Phase 1b/2a
91333,Phase 1/2
42395,Investigative
158181,Phase 0
72963,Phase 2
98536,Discontinued in Phase 2b
19332,IND submitted
139057,Approved (orphan drug)
134514,Discontinued in Phase 4
118351,Discontinued in Phase 2
119900,Discontinued in Phase 1/2
155901,Phase 1b/2a
140286,Discontinued in Phase 1/2
151508,Phase 2
41870,Approved
76738,IND submitted
179201,Phase 1b
11460,Phase 1
178332,Phase 2/3
52213,Phase 0
11063,BLA submitted
30560,Investigative
112176,Discontinued in Phase 3
127178,Investigative
154543,Phase 1b/2a
176268,Phase 1b/2a
86579,Phase 1/2
111985,Phase 1/2
184682,BLA submitted
119687,Discontinued in Phase 2b
96079,Discontinued in Phase 1/2
10443,Phase 1
160313,Phase 0
22257,IND submitted
18075,Preregistration
179954,Phase 1/2a
75740,Discontinued in Preregistration
37870,Phase 1b
172191,Discontinued in Phase 2
126454,IND submitted
2874,Discontinued in Phase 2b
39949,Phase 2
143625,Phase 1b/2a
172395,Discontinued in Phase 2b
42517,Phase 1/2a
64799,Clinical trial
18272,Discontinued in Phase 3
30594,Discontinued in Phase 3
54381,Discontinued in Preregistration
5530,Phase 2a
137788,Phase 1/2a
83062,Phase 2
116290,Phase 1b/2a
144741,Phase 1/2
139373,BLA submitted
85769,Discontinued in Phase 2b
48984,Discontinued in Phase 2/3
76402,Discontinued in Phase 1/2
186254,Phase 2b
63417,Discontinued in Phase 3
109319,Phase 1
76810,Phase 1/2a
142832,Phase 1b/2a
108215,Discontinued in Phase 1/2
7275,Phase 1b/2a
40814,Phase 1/2
160157,Phase 2
1325,Approved
76140,IND submitted
188198,Phase 1b
39797,Phase 2
25620,Phase 1b
26695,Phase 1
113087,Phase 1
109052,Phase 1/2
139348,BLA submitted
12255,Phase 1
173399,Phase 2a
121490,Phase 1
113010,Phase 1b
37168,Phase 1b/2a
1961,Phase 1/2a
140027,IND submitted
24715,Discontinued in Phase 2/3
184467,BLA submitted
13606,Phase 1
64875,Clinical trial
155283,Phase 1b/2a
161409,Investigative
24163,Phase 0
178781,Patented
83093,Phase 1/2
184532,Discontinued in Phase 4
107878,Discontinued in Phase 2b
184794,Phase 0
99881,Phase 1
51588,Phase 1b/2a
27018,Phase 1b
136813,Patented
119604,Discontinued in Phase 4
77757,Phase 0
46585,Discontinued in Preregistration
66799,Patented
96225,Approved (orphan drug)
81622,Phase 2
39399,Phase 2
153125,Phase 1b/2a
72550,IND submitted
109918,Discontinued in Preregistration
71188,Phase 1b
127281,Phase 1/2
158682,IND submitted
48203,Phase 1/2a
74337,Phase 1/2
190619,Patented
123489,Phase 0
73173,Phase 1b/2a
86881,Phase 2
29522,Phase 1/2
54292,Discontinued in Phase 2b
31957,Phase 1b
147689,Phase 1
156037,Phase 1
93026,Discontinued in Phase 3
171505,Phase 1/2
94602,Phase 1
95051,Discontinued in Phase 4
87936,Phase 2a
83546,Phase 1
177614,Phase 1b
159575,Phase 1/2
46385,Discontinued in Phase 4
18054,Phase 2
179811,Phase 1/2a
39804,Phase 2
138398,Investigative
44899,Phase 1/2a
19827,Discontinued in Preregistration
7351,Phase 4
100529,Phase 2
11733,Discontinued in Phase 2b
18876,Phase 1b
169684,Phase 2
74153,Phase 2
23484,Discontinued in Preregistration
162261,Approved
127297,Patented
1457,Approved (orphan drug)
157012,Discontinued in Phase 2
130881,Phase 1b
115320,Clinical trial
67319,Discontinued in Phase 1
61104,Clinical trial
115749,Discontinued in Phase 2
135361,Phase 0
188921,Phase 1/2
137256,Phase 1/2a
86920,Discontinued in Phase 2
126623,Discontinued in Preregistration
3216,Phase 1/2a
1277,Phase 0
47462,Patented
184589,Phase 1
46418,Phase 1b/2a
144504,Discontinued in Phase 2/3
161454,Investigative
100880,Phase 1/2a
55459,Investigative
32041,Phase 1/2
35676,Discontinued in Phase 3
140348,Phase 1/2a
98934,Phase 1
17896,Phase 1/2a
49490,Phase 0
190976,Investigative
96092,Phase 1b
59156,Phase 0
45072,Phase 2/3
7819,Phase 1b/2a
110628,Phase 1/2
130443,Phase 0
125828,Discontinued in Phase 3
158157,Discontinued in Preregistration
136696,Phase 1/2a
47382,Phase 0
58752,Clinical trial
143699,Discontinued in Phase 4
121652,Phase 2
7944,Phase 0
25623,Phase 1
163272,Phase 1
113460,Phase 1
35058,BLA submitted
15261,IND submitted
151887,Phase 0
102495,Investigative
13692,Phase 1b/2a
177621,Phase 1b
191084,Investigative
181564,Phase 3
121637,Phase 2
160848,Phase 0
116536,Discontinued in Preregistration
31260,Discontinued in Phase 4
33806,Investigative
181309,Phase 2
111846,Phase 0
144445,Phase 3
116733,Phase 1
73710,Approved
51855,Investigative
76933,Investigative
57988,Approved (orphan drug)
140511,Phase 0
190501,Clinical trial
75570,Discontinued in Phase 1/2
112285,Phase 1/2
176855,Phase 1b
35730,Discontinued in Phase 1/2
171133,Patented
139670,Discontinued in Phase 2
52254,Phase 1b
48454,IND submitted
30308,Discontinued in Phase 2b
147324,Investigative
39615,Phase 1/2a
20827,Phase 1/2a
183208,Phase 4
184370,BLA submitted
93653,Investigative
114485,Discontinued in Phase 1
159946,Discontinued in Preregistration
187895,Discontinued in Preregistration
4542,Investigative
174821,Phase 1/2a
54757,Phase 2
110266,Phase 1b/2a
27885,Phase 0
156109,Phase 1b
29232,Phase 1b
112422,Discontinued in Phase 3
161948,Phase 1b
74760,Phase 1/2a
145103,Phase 1b/2a
18586,Phase 1/2a
11248,Discontinued in Phase 4
41689,Phase 0
117384,Discontinued in Phase 1
60869,Phase 1/2a
56062,Phase 1b
35665,Discontinued in Phase 3
82516,Phase 1b/2a
51657,Investigative
116962,Discontinued in Phase 2b
170146,Patented
153408,Clinical trial
164741,Phase 1/2
173157,Discontinued in Phase 2
140526,Clinical trial
82797,Discontinued in Phase 4
154051,Phase 2
163915,Phase 1/2a
59940,Phase 0
129589,IND submitted
52247,Discontinued in Phase 2/3
83486,Phase 1/2
109581,Discontinued in Preregistration
143123,Discontinued in Phase 4
23812,Phase 1/2a
5384,Phase 2a
111587,Phase 1/2
184963,Phase 0
171964,Phase 0
148582,IND submitted
80203,Phase 1b
154756,Phase 2/3
121079,Phase 2a
1507,Discontinued in Phase 1
180814,Phase 3
109797,Discontinued in Preregistration
166901,Patented
95371,Phase 0
106016,Phase 1b
178962,Phase 1/2a
172559,Phase 2a
121331,Phase 1/2a
105332,Phase 1b
115518,Discontinued in Phase 2
12646,Phase 1
186142,Phase 1b
74095,Discontinued in Phase 1/2
29939,Phase 1b
145538,Phase 2/3
82998,Investigative
24327,Phase 2/3
158366,Phase 2b
161483,Investigative
27815,Phase 1b
188717,Phase 2/3
69651,Phase 1b
31938,Phase 1/2a
20248,Discontinued in Phase 2/3
12492,Phase 1/2a
6932,Phase 2a
54596,Phase 1/2a
43759,Phase 2/3
39848,Phase 2
171637,Phase 0
95200,Patented
37265,Discontinued in Preregistration
15850,Phase 1/2
138744,Phase 1/2a
127099,Discontinued in Preregistration
151320,Phase 2
112442,Phase 1/2
9407,Discontinued in Phase 3
7855,Patented
42031,Phase 0
180372,Phase 2a
95464,Phase 1b/2a
48694,Phase 1b/2a
71115,Discontinued in Phase 3
179908,Discontinued in Phase 2/3
152303,Patented
73352,Investigative
28157,Phase 1/2a
20811,Discontinued in Phase 1
3520,Patented
128179,Discontinued in Preregistration
100257,Discontinued in Phase 1/2
35368,Phase 1/2
110516,Discontinued in Phase 2/3
189263,Phase 2/3
165424,Discontinued in Phase 1/2
77245,Investigative
163813,Investigative
151056,Phase 1
92240,Phase 2
120507,Phase 0
182691,Phase 1
10554,IND submitted
69927,Patented
156323,Phase 1
126186,Investigative
137337,Phase 1/2
124369,Phase 2
59024,Approved (orphan drug)
187271,Patented
159229,Approved
188437,Preclinical
25171,Phase 1b
124601,Phase 1b/2a
86216,Phase 0
87687,Approved
21804,BLA submitted
167214,Discontinued in Preregistration
5289,Investigative
111584,Phase 1/2
83764,Phase 1b/2a
7013,Phase 2a
89296,Phase 1b/2a
162696,Phase 1b
166871,Discontinued in Phase 4
8711,Clinical trial
161267,Discontinued in Phase 1/2
82475,Phase 0
167215,Discontinued in Phase 2
97111,Phase 1
40062,Phase 0
163148,Discontinued in Phase 1/2
68422,Phase 1b/2a
129137,Discontinued in Preregistration
151601,Phase 0
41611,Discontinued in Phase 1
99175,Phase 2
113185,Patented
126472,Phase 1b/2a
30593,Phase 2
185845,Phase 0
115169,Phase 2
189695,Clinical trial
161802,Investigative
9783,Discontinued in Phase 3
46126,Phase 1/2a
71733,Patented
179205,Phase 1/2a
186381,Phase 4
143072,Phase 1b/2a
169827,Patented
88177,Phase 0
110679,Patented
149088,Investigative
25998,Discontinued in Phase 4
33898,Patented
27043,BLA submitted
52020,Phase 1/2a
71653,Discontinued in Preregistration
169839,Patented
57897,Discontinued in Phase 3
63853,Phase 2
82945,Discontinued in Phase 4
134017,Phase 1/2a
97432,Phase 2
3178,Patented
102938,Approved (orphan drug)
36527,Discontinued in Phase 3
127844,Phase 0
154124,Phase 0
191384,Phase 1/2a
144903,Discontinued in Preregistration
186581,Patented
133007,Discontinued in Phase 2/3
189630,Phase 1/2a
14653,Phase 1b/2a
136146,Phase 3
24080,Phase 1/2
158863,Phase 2
19405,Discontinued in Phase 2
188290,Approved (orphan drug)
181753,Phase 2a
1726,Patented
81137,Clinical trial
66191,Phase 1b/2a
3209,Investigative
56100,Phase 1/2a
170913,Phase 2/3
91172,Discontinued in Phase 2b
107668,Phase 1b
133535,IND submitted
172424,Phase 1/2
93759,Discontinued in Phase 2b
76606,Phase 1b/2a
124059,Phase 1
63150,Phase 1/2a
52872,Discontinued in Phase 4
108926,Phase 1/2a
70357,Phase 1b/2a
143033,Phase 1/2a
22932,Phase 1/2
115303,Phase 1b/2a
11329,IND submitted
89078,IND submitted
152422,Discontinued in Phase 3
86215,Phase 0
102632,Phase 1/2
58447,Phase 1
167396,Phase 1/2a
130003,Phase 1/2
63618,Phase 1/2a
34664,Phase 1b/2a
45485,Phase 1/2a
134608,Patented
184260,Phase 1/2
33944,Discontinued in Phase 1
110746,Discontinued in Phase 3
179587,Patented
127689,Phase 0
17233,Phase 1
183738,Phase 1/2
186093,Patented
61702,Phase 1b
2012,Investigative
116545,Clinical trial
64447,Approved
88109,Phase 0
11805,Discontinued in Phase 2/3
32414,Phase 1/2
38024,Phase 1/2a
56663,Phase 1b
158761,Phase 2
42126,Phase 0
75990,Phase 1
80867,Phase 1/2a
63920,Discontinued in Phase 2
108112,Phase 2
109314,Phase 1/2
46206,Phase 1/2a
27642,Phase 2
82591,Phase 0
19488,IND submitted
98310,Phase 1/2a
107000,Phase 0
24369,Discontinued in Phase 2b
96689,Phase 1/2a
187569,Phase 0
62215,Phase 2a
159101,Phase 2
16480,Phase 1
126405,Phase 1b/2a
149071,Phase 1/2a
141398,Patented
188909,Phase 1/2
37411,Phase 1
19475,Investigative
139737,Discontinued in Phase 2
66042,Approved
116851,Phase 1b
164005,Phase 1/2a
152412,Phase 2/3
53781,Phase 1b/2a
78136,Approved
163528,Discontinued in Phase 2/3
50476,Discontinued in Phase 3
173523,Patented
47997,Phase 0
154926,Phase 1b/2a
130727,Phase 1b
82923,Phase 1b/2a
94646,Patented
28972,Phase 1/2a
111737,Phase 1
1834,Phase 1/2a
117717,Phase 2
182446,Discontinued in Phase 2b
147463,Phase 2b
88861,Patented
56631,Phase 0
6511,Phase 2/3
22276,Phase 1b/2a
88748,Phase 1
51353,Phase 1b
113104,Clinical trial
171406,IND submitted
2621,Phase 1b
104106,Patented
107227,Phase 0
166183,Phase 1b/2a
133692,Phase 1/2
117439,Discontinued in Phase 3
148848,Phase 1b/2a
21181,Phase 1
87776,Patented
115762,Phase 2
76358,Phase 2/3
94698,Phase 1
149429,Phase 1/2
186832,Phase 1b
11550,Phase 1
55485,Phase 1
190153,Preclinical
168014,Investigative
188157,Phase 1b/2a
115194,Clinical trial
56522,Phase 1b/2a
4679,Discontinued in Phase 2
149876,Phase 2b
60097,Investigative
149972,Patented
54331,Phase 1/2
61320,Patented
72760,Phase 2/3
93132,Phase 2
153945,Phase 1
184015,Phase 0
153460,Phase 1b
12855,Phase 0
23360,Phase 2
81408,Phase 1b
192023,Discontinued in Phase 2b
70772,Phase 1/2a
188630,IND submitted
136201,Phase 1/2
3089,Phase 1b
96099,Discontinued in Phase 4
96224,Approved (orphan drug)
177346,Phase 1b
90365,Approved (orphan drug)
79089,Phase 0
34296,Phase 0
36740,Discontinued in Preregistration
30964,Discontinued in Preregistration
172067,Discontinued in Phase 2
78690,Discontinued in Phase 4
145776,Phase 0
165207,Phase 1/2
12848,Phase 0
142324,Discontinued in Phase 2b
56244,Phase 2/3
72499,Phase 2/3
120706,Discontinued in Phase 3
50761,Discontinued in Phase 3
87056,Discontinued in Phase 2b
128926,IND submitted
172665,Phase 1
937,Discontinued in Phase 2
141806,Patented
16174,Phase 0
61643,Discontinued in Phase 4
65916,Discontinued in Phase 2b
156261,Phase 1/2a
61302,Patented
47177,Approved
130143,Patented
69767,Phase 1
59576,Phase 0
153544,Phase 1
86162,Discontinued in Phase 4
189324,Approved (orphan drug)
127443,Discontinued in Phase 1
64465,Approved (orphan drug)
124660,Phase 1b
90808,Approved
16470,Phase 1/2
108516,Investigative
6909,Investigative
37214,Phase 1
25750,Discontinued in Phase 2/3
141459,Discontinued in Phase 2b
44181,Phase 1/2a
134523,Phase 1b
32569,Phase 1b/2a
42807,Discontinued in Phase 1
170612,Phase 1b/2a
32416,Phase 2/3
29972,Discontinued in Preregistration
51986,Discontinued in Phase 3
69402,Investigative
187514,Phase 2b
138728,Investigative
97570,Phase 2
1616,Phase 1b/2a
49816,Phase 2/3
128334,Investigative
53960,Discontinued in Phase 4
23905,Phase 1
93782,Phase 2
571,Discontinued in Phase 1
26028,Phase 2/3
41163,Approved
146848,Phase 1/2a
182492,Phase 1
67055,Phase 0
160447,Phase 1
101313,Phase 1/2
31576,Patented
91067,Phase 1/2
144938,Discontinued in Phase 2/3
114376,Phase 1/2a
177154,Phase 1/2a
77563,Patented
86396,Phase 2
88710,Patented
10769,Investigative
144428,Discontinued in Phase 1/2
170592,Phase 1/2
155392,Discontinued in Preregistration
27556,Discontinued in Phase 3
70484,Phase 1
181433,Phase 1
131272,Discontinued in Phase 1/2
97332,Discontinued in Phase 2b
8370,Patented
44390,Phase 1/2a
45861,Phase 1/2a
178561,Discontinued in Phase 3
125044,Phase 1b
128306,Phase 1/2
81886,Phase 1/2
185374,Approved
49436,Phase 1/2a
41885,Phase 1/2a
123007,Phase 0
95485,Phase 1/2
58455,Phase 2/3
40673,Phase 2
139894,Investigative
40879,Discontinued in Phase 2
141530,Discontinued in Phase 2/3
169739,Discontinued in Phase 2b
91669,Phase 1b
140104,Phase 1b
154563,Phase 1b/2a
14830,Phase 0
63966,Approved
113774,Phase 1/2a
125038,Phase 1
136943,Phase 1/2a
38672,Phase 2
173440,Phase 2a
44298,Phase 2/3
161600,Investigative
182056,Phase 2a
37994,Phase 1/2a
188070,Phase 2b
171196,Patented
72501,IND submitted
165858,Investigative
45320,Phase 2/3
172832,Phase 1
116960,Discontinued in Phase 3
117633,Phase 1
11375,Phase 1/2a
29095,Discontinued in Phase 2/3
60588,Phase 1
128238,Discontinued in Phase 2b
119988,IND submitted
189428,Approved (orphan drug)
133018,Discontinued in Phase 4
140652,Preregistration
130800,Phase 2
157088,Discontinued in Phase 1/2
138729,Investigative
34992,Patented
47628,Phase 1b
133704,Phase 1
66240,Phase 1
51203,Phase 1
101234,Phase 2/3
104233,Phase 0
154653,Phase 2
43707,Phase 1/2a
29953,Phase 0
90742,Clinical trial
82014,Phase 1b/2a
24593,Phase 1
9742,Phase 1b/2a
119940,IND submitted
133804,Phase 1/2
45609,Phase 2/3
76036,IND submitted
22664,Patented
98076,Phase 2
53346,Discontinued in Phase 4
131891,Phase 1b/2a
68293,BLA submitted
110751,Patented
7427,Phase 2/3
7700,Phase 1/2a
118425,Clinical trial
119025,Phase 2b
3703,Discontinued in Phase 2/3
150908,Phase 1b/2a
177640,Phase 2/3
111872,Phase 1
9350,Investigative
186519,Phase 0
146519,Phase 1
143124,Phase 2b
100604,Phase 2
40207,Patented
28011,Discontinued in Phase 2/3
87824,Phase 1/2a
48753,Phase 0
71845,Phase 0
69771,Phase 2a
175955,Phase 1/2a
118726,Discontinued in Preregistration
94459,Investigative
122343,Phase 1
36901,Phase 1
190163,Clinical trial
60816,Approved (orphan drug)
188403,Phase 1/2
168903,Discontinued in Phase 1/2
108622,BLA submitted
180469,Phase 1b/2a
106610,Discontinued in Phase 4
189480,Approved (orphan drug)
14994,Phase 1
180595,Discontinued in Phase 2b
32549,Phase 1b/2a
160804,Phase 1/2
114698,Phase 1/2a
7917,Phase 1/2
73588,Phase 2
168970,Patented
159390,Phase 1b/2a
335,Discontinued in Phase 2/3
72039,Patented
32941,Phase 2/3
126685,Patented
146141,Phase 2a
183357,Discontinued in Phase 2
88368,Discontinued in Phase 4
46353,Phase 1/2
94518,Phase 1/2
185124,Phase 1/2
80059,Phase 2
36383,Phase 1
176734,Phase 1/2a
123250,Patented
179835,Phase 1/2a
115382,Clinical trial
164815,Phase 1/2a
12638,Phase 1
46115,Phase 1/2a
26101,Phase 1b
181257,Discontinued in Phase 2
127932,Discontinued in Phase 2b
157431,Patented
109177,Phase 1/2
113037,Discontinued in Phase 1/2
74430,Phase 1/2a
131514,Discontinued in Phase 1/2
68740,Phase 1/2
61242,Patented
957,Discontinued in Phase 3
90709,Approved (orphan drug)
66316,Discontinued in Phase 3
66047,BLA submitted
61214,Phase 1
104302,BLA submitted
57782,Phase 0
73204,Patented
149477,Phase 2/3
598,Phase 1
4845,Phase 1b/2a
159175,Patented
160755,Phase 3
75082,Discontinued in Phase 2b
133246,Phase 1
40756,Investigative
154401,Patented
104902,Phase 1b/2a
20093,Phase 2a
62717,Discontinued in Phase 3
135526,Phase 0
6082,Phase 4
31599,Discontinued in Phase 2b
9249,IND submitted
22682,Phase 2
65781,Preclinical
146728,Clinical trial
5065,Preregistration
223,Approved (orphan drug)
14013,IND submitted
8536,Phase 1
40365,Phase 1/2
55884,Phase 0
7293,Phase 1b/2a
49242,Phase 1b/2a
86794,Phase 1/2a
93665,Phase 2b
56262,Discontinued in Phase 2b
111452,Phase 2
7014,Phase 1b/2a
151240,Phase 2
115548,Phase 2
33093,Phase 3
131149,Phase 1b/2a
156370,Phase 1/2a
143696,Phase 1b/2a
4385,Phase 2a
52710,Phase 1b/2a
98382,Phase 2
138248,BLA submitted
45472,Phase 2/3
125306,Investigative
111582,Phase 0
14420,Phase 1/2a
65287,Preclinical
37841,Phase 1/2a
66867,Phase 0
75038,Phase 1/2a
14108,IND submitted
62108,Discontinued in Preregistration
119273,Phase 2a
91842,Phase 1
27721,Phase 1b/2a
100369,Phase 1b/2a
104442,BLA submitted
115758,Phase 2
70734,Patented
63295,Phase 1b
17613,Phase 0
28186,Discontinued in Phase 2/3
110246,Phase 2
75536,Phase 1/2
82586,Phase 2
76137,Phase 1b
107600,Discontinued in Phase 1/2
146920,Investigative
45333,Phase 1/2a
16025,Phase 1
126521,Patented
97790,Phase 1b
104750,Phase 1/2a
13397,Phase 1/2
158989,Approved
111153,Discontinued in Phase 3
151886,Phase 0
116193,Approved (orphan drug)
24958,Patented
15962,Investigative
183992,Discontinued in Phase 4
136016,Phase 1b
65971,Discontinued in Phase 3
175297,Discontinued in Phase 3
91314,Clinical trial
28049,Phase 1/2a
43472,Phase 2/3
38058,Phase 2
188858,Phase 1/2
179489,Phase 1
183363,Phase 1/2
111170,Discontinued in Phase 4
14231,Investigative
17661,IND submitted
92407,Phase 4
69652,IND submitted
174760,Phase 1
42285,Phase 1/2a
30565,Discontinued in Phase 1
106531,Discontinued in Phase 2b
82388,Phase 0
31242,Phase 1
44997,Phase 1/2a
7447,Phase 2/3
146201,Phase 2/3
50732,Phase 3
164117,Phase 0
128921,Discontinued in Preregistration
7257,Phase 1b/2a
69484,Phase 3
101355,Discontinued in Phase 3
50586,Discontinued in Phase 2
117570,Phase 1/2
135977,Phase 1/2
7470,Investigative
30820,Phase 0
133377,Discontinued in Preregistration
187793,Phase 3
9813,IND submitted
166620,Phase 1/2
164738,Phase 1
138894,Phase 1b
73011,Phase 2
29480,Phase 1b/2a
52707,Phase 1b/2a
33282,Phase 2/3
97375,Phase 1b
61774,Phase 1b
31839,Discontinued in Phase 2/3
80362,Phase 1b/2a
138512,BLA submitted
50555,Phase 1/2a
23724,Phase 2
97915,Phase 1/2a
137873,Discontinued in Phase 3
88904,Phase 0
125321,IND submitted
58894,Investigative
140001,Discontinued in Phase 2
29486,Phase 2/3
189094,Discontinued in Phase 3
149001,Investigative
1270,Investigative
29544,Discontinued in Phase 1/2
49237,Phase 3
163840,Discontinued in Preregistration
37977,Discontinued in Phase 3
65264,Phase 1b/2a
73782,Approved
111881,Discontinued in Phase 3
26142,Patented
172062,Phase 1b
161124,Discontinued in Phase 4
92162,Phase 1/2
55158,Phase 2
104151,Phase 1b
108694,Discontinued in Phase 1
57173,Phase 1/2a
190401,Phase 2b
150707,Phase 1b/2a
142084,Discontinued in Phase 2b
140162,BLA submitted
112930,Phase 0
77840,Phase 0
82157,Clinical trial
79724,Phase 2
141278,Patented
164795,Phase 1/2
42857,Phase 1
27968,Phase 1/2
28341,Patented
148045,Phase 1b/2a
14201,Phase 1
172796,Discontinued in Phase 2
176935,Phase 2
60808,Phase 0
128473,IND submitted
135023,Phase 0
131981,Discontinued in Phase 4
84623,Phase 1/2
84227,Phase 1b/2a
165814,Phase 1
109519,Phase 3
11943,IND submitted
185426,IND submitted
65098,Phase 1b/2a
179873,Phase 1
76633,Phase 1/2
32238,Phase 2a
150403,Phase 1/2
7278,Investigative
116935,Discontinued in Phase 2b
111143,Phase 1/2
103652,Phase 1/2a
23215,Phase 1b
123935,Approved
69728,Discontinued in Phase 2/3
483,Discontinued in Phase 1
111003,Phase 1/2
178159,Phase 2a
43719,Phase 2/3
176362,Phase 1/2a
24999,Discontinued in Phase 4
66683,Phase 3
166882,Phase 1
88410,Discontinued in Phase 4
97431,Phase 1b
80464,Phase 2a
144736,Investigative
55214,Phase 1
66593,Patented
185931,Phase 4
84992,Phase 1/2a
43917,Phase 1/2a
168322,Phase 2
5288,Phase 1/2
24270,Discontinued in Phase 2/3
123409,Discontinued in Preregistration
124529,Approved
173263,Discontinued in Phase 3
25019,Phase 2
880,Phase 1/2a
158858,Phase 1b/2a
176709,Phase 1/2
108133,Discontinued in Phase 2b
166943,Phase 4
3926,Discontinued in Preregistration
28239,Phase 0
179868,Discontinued in Phase 2/3
81381,Approved
63162,Patented
169584,Phase 3
173220,Discontinued in Phase 3
95379,Phase 1/2
136196,Phase 1/2
167642,Discontinued in Phase 2/3
53059,Phase 1b
87675,Phase 1/2
82850,Phase 1
163294,IND submitted
116420,Discontinued in Phase 3
130527,Patented
67119,Patented
25278,Phase 2
137750,Discontinued in Phase 2/3
65925,Discontinued in Phase 1/2
81511,Phase 1
130241,Phase 1/2a
143167,Discontinued in Phase 1/2
116537,Phase 2
85901,Discontinued in Phase 2b
63056,Investigative
131764,Discontinued in Phase 3
168521,Discontinued in Phase 1
79723,Phase 2
45068,Phase 1/2a
31179,Discontinued in Phase 2/3
113028,Clinical trial
97155,Investigative
153051,Investigative
10879,Phase 1
163307,Phase 1
102321,Discontinued in Preregistration
32755,Phase 1/2a
26099,Discontinued in Phase 4
152753,Patented
13898,Phase 1b/2a
13646,Phase 1
183252,Discontinued in Phase 2
17309,Phase 1/2
21491,Phase 1b/2a
185670,Phase 1b
46348,BLA submitted
11096,Phase 1
171664,Discontinued in Phase 2b
132431,Discontinued in Phase 4
105873,Phase 2/3
68741,Phase 2b
96810,Phase 1b
103866,Patented
122872,IND submitted
123512,Phase 1b/2a
80995,Investigative
57885,Investigative
124563,Investigative
116540,Discontinued in Phase 3
166997,Investigative
92819,Phase 2
157534,Discontinued in Phase 4
87774,Phase 1/2
52467,Investigative
108592,Discontinued in Phase 2/3
9155,Discontinued in Phase 2
120566,Approved (orphan drug)
82039,Discontinued in Phase 2/3
155044,Phase 2
168686,Discontinued in Phase 3
115305,Phase 1b
142640,Phase 1b/2a
20423,Discontinued in Preregistration
96679,Investigative
98813,Phase 1/2a
155707,Patented
48728,Phase 2/3
703,Discontinued in Phase 1
160506,Phase 0
88072,Discontinued in Phase 1
166187,Patented
13332,Phase 0
93950,Phase 1
161812,Investigative
50145,Phase 0
137232,BLA submitted
134410,Phase 1b
52512,Phase 1b
135003,Phase 0
129974,Phase 1/2
183614,Phase 2a
135903,Phase 1b
105029,Phase 1/2
82680,Phase 0
4517,Discontinued in Phase 2
174043,Phase 1b/2a
182423,Phase 2a
82901,Investigative
106739,Phase 0
58757,Phase 1b/2a
165394,IND submitted
82766,Investigative
174069,Phase 1/2
71392,Phase 1b/2a
77220,Patented
127283,Discontinued in Preregistration
47281,Phase 0
170125,Discontinued in Phase 4
38495,Discontinued in Preregistration
173313,Phase 2
13502,Phase 1
91221,Preregistration
91194,BLA submitted
98359,Investigative
128425,Discontinued in Phase 4
153530,Phase 1/2
10978,Discontinued in Phase 1
134198,Phase 1/2a
185562,Phase 0
189722,IND submitted
184913,Phase 0
121796,Approved (orphan drug)
81905,Clinical trial
115309,Discontinued in Phase 2
183759,Phase 2a
74807,Phase 0
164530,Discontinued in Preregistration
133532,IND submitted
66103,Phase 2a
99685,Phase 2
144464,Discontinued in Phase 1/2
105063,Phase 2
54857,Discontinued in Preregistration
50067,Phase 1b
89201,Discontinued in Phase 4
158432,Phase 1b/2a
63494,Phase 1b
100542,Phase 1/2a
6094,IND submitted
191939,Discontinued in Phase 3
121400,Phase 1/2a
151050,Phase 1
21918,Discontinued in Phase 1/2
88603,Phase 1/2
191668,Phase 1/2
169075,Phase 2
121621,Phase 2b
188665,Phase 2/3
110632,Patented
28510,Discontinued in Phase 4
61666,Phase 1b
28880,Discontinued in Phase 2/3
11922,Phase 1
245,Approved (orphan drug)
54942,Phase 1
178763,Phase 1/2a
82067,Discontinued in Phase 2
22741,Discontinued in Phase 2b
32996,Phase 1b
32037,Phase 1/2
49266,Discontinued in Phase 3
62425,Discontinued in Preregistration
41480,Discontinued in Preregistration
96468,Phase 2
138805,BLA submitted
112340,Discontinued in Phase 2
64174,Phase 0
189173,IND submitted
28644,Phase 0
166872,Phase 1/2a
146073,Discontinued in Preregistration
110412,Phase 1b/2a
90464,Clinical trial
3115,Discontinued in Phase 2
176472,Phase 1b/2a
95362,Phase 1/2a
2250,Discontinued in Phase 3
177903,Discontinued in Phase 2b
190335,Preclinical
33449,Phase 2a
1782,Approved
107888,Discontinued in Phase 3
69131,Phase 1b
160622,Phase 1/2
11714,Patented
88019,Phase 1/2
163795,Phase 1/2a
146436,Investigative
51006,Phase 1b/2a
158973,BLA submitted
28698,Phase 2
14945,Phase 0
172654,Discontinued in Phase 2
44427,Phase 1/2a
142249,Phase 0
84442,Phase 1/2a
188748,Phase 4
18068,Phase 1
156922,Phase 1b/2a
41602,Phase 1
43043,Investigative
57281,Discontinued in Phase 3
53498,Patented
132122,Discontinued in Phase 4
2638,Discontinued in Phase 1/2
38691,Phase 1b/2a
128843,Phase 1/2a
47216,Approved
6128,Discontinued in Phase 2
9885,Investigative
107396,IND submitted
122111,IND submitted
163789,Phase 2a
14336,Phase 1/2
11498,Investigative
156258,Phase 1
167567,Phase 4
91462,Phase 1
52011,Phase 1/2a
190537,Phase 2/3
153135,Investigative
123094,Phase 1/2
100477,Phase 1b
35304,Investigative
190531,Phase 2b
165408,Phase 1
39277,Discontinued in Phase 4
41283,Phase 1
185842,Phase 1b
62923,Phase 1b
15554,Phase 3
186755,Phase 2a
37339,Discontinued in Preregistration
134718,Phase 0
86653,Phase 1b/2a
130971,Investigative
65535,Discontinued in Phase 2
8686,Phase 2
139959,Approved (orphan drug)
132137,IND submitted
113414,Phase 1b/2a
2646,Phase 2
86776,Phase 2
108990,Phase 0
132872,Phase 1/2
158378,Phase 1b/2a
110952,Phase 1/2
36837,Phase 2a
18514,Phase 2
72900,Phase 2
159999,Phase 1b
48243,Phase 1/2a
168505,Phase 1b/2a
97462,Phase 1b/2a
46836,Phase 2
39529,Phase 2
87087,Discontinued in Phase 3
79780,Phase 2
69775,Phase 1b
30523,Phase 1
76575,Phase 1/2
56508,Phase 1/2a
130524,Phase 0
125358,IND submitted
28516,Discontinued in Phase 2b
38745,Discontinued in Preregistration
181038,Phase 2/3
161520,Investigative
174314,Discontinued in Phase 2
43362,Phase 2/3
167320,Discontinued in Phase 1/2
100283,Discontinued in Preregistration
11055,Phase 1/2
17203,Phase 1
75562,Phase 1/2a
68279,Phase 1
105871,Phase 2/3
70105,Phase 0
65399,Discontinued in Phase 4
6242,Phase 1/2
42477,Phase 1
56747,Discontinued in Phase 2b
22641,Investigative
15485,Phase 1/2
62932,Phase 1b/2a
29618,Discontinued in Phase 2b
1311,Approved
92153,Phase 1b
117903,Phase 1b
107441,Phase 1b
99164,Phase 1/2a
96968,Discontinued in Phase 2b
83439,Phase 2
60115,Discontinued in Phase 4
116714,Discontinued in Phase 3
64645,Phase 0
119181,Phase 1/2a
85710,Discontinued in Preregistration
137137,Phase 2
155641,Phase 2
53223,Phase 1/2
168813,Discontinued in Phase 2
111418,Discontinued in Phase 3
132028,Discontinued in Phase 1/2
148216,Phase 0
16655,Phase 0
56568,Phase 1/2a
11235,Discontinued in Phase 3
112320,Discontinued in Phase 3
56741,Phase 0
165472,Phase 1
60843,Discontinued in Phase 4
71695,Phase 1
149731,Clinical trial
165245,Phase 1/2
160623,Phase 0
75830,Discontinued in Phase 1/2
108340,Phase 0
7239,Phase 1b/2a
31999,Discontinued in Phase 4
27782,Phase 2/3
150111,Phase 1b/2a
27711,Discontinued in Phase 2
168616,Discontinued in Phase 1
35817,Phase 1/2
5567,Phase 1/2
146119,Phase 1/2
122760,Phase 0
27523,Phase 1/2a
174052,Discontinued in Phase 1
167511,Discontinued in Phase 1
146284,Phase 1
161436,Phase 0
136480,Investigative
161665,Phase 2a
116918,Discontinued in Phase 2/3
50465,Phase 1b/2a
42161,Phase 1b/2a
96359,Discontinued in Phase 3
162484,Discontinued in Preregistration
109272,Phase 1/2a
83366,Patented
33077,Phase 2/3
123632,Discontinued in Preregistration
144909,Phase 1b/2a
124001,Approved
19408,Discontinued in Preregistration
33939,Discontinued in Preregistration
182172,Phase 2a
22263,IND submitted
137446,Phase 1
68809,Discontinued in Phase 4
83561,Phase 1b/2a
137758,Phase 1/2a
78983,Phase 2/3
79747,Phase 1/2a
128330,Investigative
187233,Patented
191404,Approved (orphan drug)
180371,Phase 2a
47887,Phase 1/2a
22940,Phase 1b/2a
134550,Phase 1b
62732,Phase 1b/2a
86022,Phase 1
48954,Discontinued in Phase 2
92355,Patented
99541,Phase 1
79348,Phase 2a
21647,Discontinued in Phase 4
173443,Phase 0
191463,Phase 1
101601,Investigative
152945,Phase 1b/2a
586,Approved (orphan drug)
5585,Phase 1/2
87200,Phase 2a
177352,Phase 1b
191910,Discontinued in Phase 2
18516,Phase 2a
126352,Phase 1b/2a
49432,Phase 1/2
184780,Phase 1
17404,Investigative
111765,Discontinued in Phase 2b
47917,Investigative
109243,Phase 1/2
157927,Phase 1
109770,Preregistration
60764,Phase 1/2a
108463,Discontinued in Phase 1
27816,Phase 1
143512,Phase 1/2a
7788,Phase 1
141887,IND submitted
161511,Patented
137948,Phase 1b
17006,Phase 1
125182,Phase 1b
59915,Discontinued in Phase 2/3
49405,IND submitted
64363,Discontinued in Phase 2b
189775,Patented
70825,Phase 1/2a
60550,Discontinued in Phase 3
177519,Phase 2
35440,Discontinued in Phase 1/2
96152,Phase 1
30069,Discontinued in Phase 2b
44507,Phase 1/2a
170997,Phase 2/3
66955,Patented
7298,Discontinued in Phase 2
122998,Phase 1b
184219,Phase 0
4088,Phase 2a
172471,Phase 1/2
129213,IND submitted
70415,Phase 2/3
57989,Discontinued in Phase 1/2
11438,Phase 1b/2a
128701,Patented
169514,Phase 3
173500,Investigative
61529,Discontinued in Phase 1
10357,Discontinued in Phase 2b
8927,IND submitted
137553,Discontinued in Phase 2/3
64908,Discontinued in Phase 2
191874,Discontinued in Phase 2b
90998,Approved
174355,Phase 1
123088,Phase 1/2
149930,Discontinued in Phase 2/3
80753,Discontinued in Phase 2
158643,Discontinued in Preregistration
81391,Discontinued in Phase 1
34604,Phase 1b/2a
144236,Discontinued in Phase 1/2
69638,Discontinued in Phase 2/3
98433,Investigative
16141,Phase 1/2a
9067,IND submitted
120631,Investigative
184528,Phase 0
55902,Phase 2
178987,Phase 1/2a
172752,Patented
179354,Patented
81236,Phase 1b/2a
55751,Phase 1/2a
20455,IND submitted
101242,Phase 1/2a
142192,Phase 2/3
73284,Approved
130155,Phase 1b/2a
157111,Registered
136560,BLA submitted
120190,Approved (orphan drug)
118056,Discontinued in Phase 2/3
74194,Discontinued in Phase 3
62376,Investigative
75553,Phase 1/2a
92926,Discontinued in Phase 3
129797,Patented
62044,Phase 1b
65647,Phase 1b
93315,Investigative
180432,Phase 1
137648,Phase 1/2a
125543,Phase 1b
163909,Phase 2a
24986,Phase 1b
136303,Phase 1b/2a
21798,Phase 2b
81393,Approved
167776,Phase 2
145759,Phase 0
139464,BLA submitted
158477,Phase 2/3
105180,Phase 1/2
91006,Phase 1/2
187077,Clinical trial
89237,Discontinued in Preregistration
61296,Patented
187763,Phase 4
184248,Phase 1/2
146681,Phase 1b/2a
78462,Discontinued in Phase 1/2
15837,IND submitted
125724,Phase 1/2
137160,Investigative
41027,Phase 1/2a
74342,Phase 1/2a
178565,Discontinued in Phase 1
56902,Phase 0
50271,Phase 1b
83401,Phase 1
56136,Discontinued in Phase 4
33166,Approved (orphan drug)
146505,Investigative
155026,Discontinued in Preregistration
79726,BLA submitted
100658,Phase 1/2a
96050,Discontinued in Phase 4
35101,Phase 1b
84863,Phase 1/2
127905,Phase 0
39420,Discontinued in Preregistration
62890,Phase 1/2a
60126,Investigative
100177,Phase 0
160797,Phase 2/3
83973,Phase 0
11178,IND submitted
78805,Phase 2a
150769,Phase 1
191940,Discontinued in Phase 2b
181385,Phase 1b
179212,Discontinued in Phase 3
170631,Phase 0
92839,Phase 1/2
33462,Phase 2/3
689,Phase 1/2
157554,Phase 1
73684,Phase 2
19285,IND submitted
103182,Phase 1/2a
183480,IND submitted
55871,Phase 0
118955,Discontinued in Phase 2/3
71080,Phase 1b
144438,Discontinued in Phase 1/2
97468,Phase 1/2a
125307,Phase 1/2
28332,Phase 1b
131423,Discontinued in Phase 4
136947,Phase 1b/2a
178767,Phase 0
87193,Phase 0
187111,Phase 1
42840,Investigative
50767,Investigative
100950,Discontinued in Phase 1/2
27535,Phase 1/2
90356,Discontinued in Phase 2b
10579,Phase 0
139838,BLA submitted
170527,Phase 0
44467,Phase 1/2a
93233,IND submitted
16673,Phase 0
91171,Phase 1b
135405,Phase 0
180451,Phase 2a
54541,Phase 3
68166,Phase 2a
96686,Phase 1/2a
76166,IND submitted
177941,Discontinued in Phase 3
18092,Discontinued in Preregistration
12676,Phase 3
65661,Phase 2a
67220,Phase 2/3
134643,Phase 0
952,Clinical trial
8728,Phase 1b/2a
171059,Discontinued in Preregistration
23114,IND submitted
175095,Phase 1/2
151811,Phase 1
29146,Phase 0
24626,Phase 1/2a
157753,Discontinued in Phase 1/2
189738,Phase 1/2a
2399,Investigative
81219,Approved
50640,Discontinued in Preregistration
12740,Phase 1
22284,Phase 1b
185775,Phase 2b
60605,Phase 1b/2a
132124,Discontinued in Phase 4
119435,Phase 1/2
48582,Phase 1b
64568,Phase 1/2a
163503,Discontinued in Phase 3
116829,Discontinued in Phase 1/2
49118,IND submitted
62202,Phase 1
178860,Patented
77048,Phase 1b/2a
44837,Phase 1/2a
42963,Patented
22685,Phase 1b/2a
92449,Phase 1
168164,Discontinued in Phase 2/3
73075,Phase 2/3
116924,Discontinued in Phase 1
5185,IND submitted
62833,Phase 1b/2a
90285,Clinical trial
75511,Phase 0
166278,Investigative
65020,Phase 1/2a
169873,Phase 1b/2a
147265,Phase 1b/2a
24004,Phase 1/2
166956,Discontinued in Phase 1/2
56620,Phase 1b/2a
141836,Patented
41450,Phase 1b
177087,Phase 1/2
151432,Phase 2
73873,Phase 1b/2a
87022,Investigative
17277,IND submitted
2061,Phase 1b
45647,Phase 2/3
24394,Phase 1b
121087,Phase 0
89169,Phase 1/2a
70382,Phase 2/3
126926,IND submitted
75212,Phase 1/2
114497,Phase 1/2a
94715,Discontinued in Phase 4
145074,Phase 0
128853,IND submitted
76731,Phase 1/2
133409,Approved
179864,Phase 1
144494,Phase 3
57368,Phase 1
34406,Phase 0
19312,IND submitted
117197,Phase 2
6654,Phase 1b/2a
90838,BLA submitted
119245,Discontinued in Phase 2/3
54936,Phase 1/2a
97916,Phase 1/2a
43674,Phase 2/3
151812,Phase 1
51406,Patented
120793,Phase 0
119447,Phase 1/2
190962,Investigative
110463,Phase 1b/2a
110425,Phase 1b/2a
31904,Discontinued in Phase 3
120363,Phase 0
61451,Patented
14197,Phase 0
6099,Investigative
162417,Discontinued in Preregistration
125827,Phase 1/2
180991,Phase 1
168824,Clinical trial
157284,Investigative
43837,Phase 1/2a
95996,Phase 1b
104547,Patented
132688,Discontinued in Phase 3
63863,Patented
89229,Phase 1/2a
179731,Phase 1/2a
24014,Phase 2
88314,Discontinued in Phase 2b
103100,IND submitted
19702,Phase 1
155939,Phase 1b
54853,Investigative
4142,Phase 2a
65980,Phase 2/3
188179,Discontinued in Phase 1
13997,Phase 1
188866,Phase 2b
15486,Phase 1/2
184327,Phase 0
45731,Phase 1/2a
69656,Discontinued in Phase 2/3
144541,Phase 1
85489,Discontinued in Phase 3
90367,Approved (orphan drug)
21255,Phase 1
183118,Phase 1/2a
3692,Investigative
37727,Discontinued in Phase 3
95522,Phase 2a
169390,Phase 1/2
45023,Phase 2/3
172173,Phase 1/2
69882,Patented
113809,Phase 0
183356,Discontinued in Phase 4
42865,Clinical trial
144170,Phase 1/2
133757,Phase 1/2a
186806,Clinical trial
132201,IND submitted
68826,Phase 1
39631,Investigative
79203,Phase 2/3
21520,Phase 1b/2a
176168,Discontinued in Phase 1/2
150738,Phase 1
179263,Discontinued in Phase 3
158287,Clinical trial
86387,Discontinued in Preregistration
120878,Clinical trial
26339,Phase 1/2
52005,Phase 0
184228,Phase 0
131837,IND submitted
101367,Discontinued in Phase 3
187772,Patented
128336,Phase 0
126836,Phase 0
111512,Phase 1/2
77537,Phase 1
4082,Phase 1/2
154181,Discontinued in Phase 2b
40691,Phase 1b/2a
120075,Phase 0
148962,Investigative
60681,Phase 1b/2a
68916,Investigative
38255,Phase 1b
100945,Phase 1/2
33397,Phase 1b/2a
1115,Approved (orphan drug)
137387,Investigative
106104,Phase 2a
75001,Discontinued in Phase 2/3
124870,Phase 1/2
95650,Phase 1b
184867,Phase 0
37521,Phase 1
57697,Phase 0
101951,Discontinued in Phase 2/3
175537,Discontinued in Phase 3
95742,Phase 2a
40288,Phase 0
109742,Discontinued in Preregistration
50771,Phase 0
109433,Phase 2
173448,Phase 1b
114292,Phase 0
2506,Phase 1
182475,Phase 2b
8424,Phase 1/2a
129123,Investigative
155556,Approved
36036,Phase 1b
130595,Investigative
121091,Phase 1b
150422,Phase 2b
37788,Phase 1/2a
136206,Phase 1/2a
151189,Phase 2
5885,Discontinued in Phase 2
4748,Phase 1/2
101493,Phase 1b
156369,Phase 1b
118678,Phase 2b
81948,Discontinued in Phase 2
96115,Discontinued in Phase 4
127986,Discontinued in Phase 2b
41865,Phase 1b
177700,Phase 1b
171443,Investigative
89056,BLA submitted
127188,Phase 1
15786,Phase 1
127023,Phase 1/2
7804,Discontinued in Phase 2b
26130,Phase 2
125195,Phase 1b/2a
48371,Discontinued in Phase 2/3
53541,Discontinued in Phase 2/3
117703,Discontinued in Phase 1
9805,Phase 0
95120,Discontinued in Phase 1
115030,Phase 1b/2a
13871,Phase 0
78486,Discontinued in Phase 2/3
23450,Phase 1/2
144127,IND submitted
96685,Phase 1/2a
39401,Discontinued in Preregistration
37559,Phase 1
181338,Phase 2/3
41644,IND submitted
56309,Phase 3
60718,Discontinued in Phase 3
87224,Patented
125848,Discontinued in Phase 3
179119,Patented
15018,Phase 1
102315,IND submitted
21203,Discontinued in Preregistration
188598,Phase 1/2
81829,Phase 2
114677,Phase 1/2a
53955,Phase 1/2a
65387,Phase 1b
112650,Discontinued in Phase 3
97302,Phase 1/2a
170109,Patented
53205,Phase 0
43073,Discontinued in Phase 1
6379,Phase 4
172622,Phase 1
155431,IND submitted
111296,Phase 1/2
91015,Phase 2a
160243,Phase 1b/2a
52922,Phase 1b/2a
132965,Discontinued in Preregistration
42431,Phase 2
106136,Phase 1
10344,Discontinued in Phase 2b
59382,Discontinued in Phase 3
78123,Investigative
124276,Phase 1/2
31180,Phase 0
61599,Discontinued in Phase 3
20669,Phase 2
111813,Discontinued in Phase 2b
137781,Phase 2
16863,Phase 1
27212,Phase 1
20870,Phase 1/2a
165271,BLA submitted
167332,Discontinued in Phase 1/2
59934,Discontinued in Phase 3
106131,Phase 1/2
166595,Discontinued in Phase 2b
154841,Phase 3
62146,Phase 1/2
71185,Phase 1b/2a
177136,Phase 1
98138,Phase 1b
177683,Phase 1b
79296,Discontinued in Phase 1
174927,IND submitted
8831,Discontinued in Phase 2/3
150379,Phase 1
35572,Phase 0
164362,Phase 1/2
142450,Phase 1
103289,Phase 1/2a
133946,Phase 1/2a
115080,Approved (orphan drug)
13462,Phase 1/2a
89352,Discontinued in Phase 4
154665,Phase 3
44338,Phase 2/3
135817,IND submitted
177899,Phase 2
12372,Phase 0
38636,Patented
120176,Clinical trial
40329,Phase 2
67441,Discontinued in Phase 1
169752,Phase 1/2a
129925,Patented
109565,Phase 2
34874,Phase 2
102881,Discontinued in Preregistration
35982,Phase 1b
174445,Discontinued in Phase 2
145726,Phase 1/2a
67324,Clinical trial
167838,Phase 1
49433,Phase 1
152504,Phase 1b/2a
189780,Clinical trial
34899,Phase 1b/2a
120276,IND submitted
58283,Phase 1
144228,Discontinued in Phase 2/3
179768,Phase 1
94835,Discontinued in Phase 4
69226,Phase 1
5075,Discontinued in Phase 2
20590,Patented
77061,Phase 1/2a
3979,IND submitted
67901,Discontinued in Phase 2/3
5704,Phase 4
94452,Phase 1/2a
155792,Discontinued in Phase 4
138966,Discontinued in Phase 2
54236,Phase 2/3
155724,Phase 2
184278,Phase 0
112725,Phase 0
21286,Investigative
179519,Phase 0
74907,Phase 1/2
190353,Phase 1/2
177246,Phase 1/2a
163110,Discontinued in Phase 2
175927,Patented
18007,Phase 3
46716,Phase 1
136021,IND submitted
33471,Phase 1
172263,Phase 2
180787,Phase 2/3
137216,Investigative
78088,Investigative
31465,Discontinued in Phase 1
2129,Phase 2b
115699,Phase 2
178233,Phase 2a
138862,Phase 1b
67817,Approved (orphan drug)
152268,Phase 1b/2a
28218,Phase 1/2a
90973,Approved (orphan drug)
71537,Phase 0
1716,Discontinued in Phase 1/2
11974,Phase 1b
187604,Phase 2b
98833,Phase 1/2
38718,Investigative
55060,Discontinued in Preregistration
191214,Investigative
37739,Phase 1/2
128326,Phase 1/2
72491,Phase 1b/2a
1777,Phase 2/3
4346,Discontinued in Phase 2
347,Phase 1
151837,Phase 2
111455,Phase 1/2
142049,Phase 2/3
114422,Phase 1b
133872,Phase 1
100610,Phase 1/2a
22898,Phase 1/2
92947,Investigative
128450,Phase 1/2
190880,Phase 4
1524,Discontinued in Preregistration
8168,Discontinued in Phase 3
168572,Discontinued in Phase 3
160498,Phase 1/2a
189245,Approved (orphan drug)
2239,Phase 1b
125269,Discontinued in Phase 4
27567,Phase 1b/2a
69038,Phase 1b/2a
19100,Discontinued in Phase 2/3
33336,Phase 1b
137780,Phase 2
135416,Phase 0
133115,Phase 1/2
58246,Phase 1/2
22936,Investigative
15130,Phase 1
161237,Discontinued in Phase 1/2
64779,Phase 2a
147780,Phase 1b
178015,IND submitted
7458,Investigative
137019,Phase 1/2a
36720,Phase 2
175361,Phase 1/2a
177915,Approved (orphan drug)
7280,Discontinued in Phase 2
23626,Patented
179931,Phase 1/2a
20056,Phase 2a
22514,Phase 2/3
127515,Discontinued in Phase 1
131940,Phase 0
60638,Phase 0
187359,Phase 0
16997,Phase 0
148153,IND submitted
63411,IND submitted
80382,Phase 2a
79913,Discontinued in Phase 2
169235,Discontinued in Phase 1/2
97977,Phase 1/2a
167302,Phase 4
92283,Discontinued in Phase 1
38598,Phase 2
159405,Approved (orphan drug)
145802,Phase 1/2
72105,Phase 1b
3573,Investigative
71211,Discontinued in Phase 2b
130465,Phase 1/2a
146181,Phase 1b
123344,Phase 0
5832,Investigative
48585,Discontinued in Phase 3
155493,Phase 2
18225,Phase 2
156938,Phase 1/2
36662,Discontinued in Phase 3
37244,Phase 1
1167,Phase 0
34487,Phase 1/2a
10259,Phase 1b
79388,Phase 2
140756,Phase 2/3
170534,Discontinued in Preregistration
157658,Phase 1
88962,Phase 1/2a
87119,Phase 1/2
136331,Phase 1b/2a
28397,Phase 1/2a
185864,Phase 2b
128846,Phase 1/2
152537,Patented
51147,Phase 1b/2a
150237,Phase 1b
68802,Phase 1
6183,Investigative
84597,Phase 1/2a
164475,Discontinued in Preregistration
76983,Phase 1/2a
88299,Phase 1
103333,Phase 1
124987,Phase 0
108634,Phase 1b/2a
52822,Phase 0
105151,Phase 0
67067,Phase 1/2
117939,Investigative
175219,Phase 1
17208,Investigative
48192,Discontinued in Preregistration
2228,Preclinical
45913,Phase 2a
143032,Phase 1/2a
97918,Phase 1/2a
18104,Discontinued in Phase 2b
77257,Phase 1/2
129370,Phase 1
135880,Phase 3
116947,Discontinued in Phase 2/3
10855,Phase 1
80944,Phase 2a
81659,Phase 2
158250,Phase 2/3
93741,Phase 1b
117932,IND submitted
9102,Discontinued in Phase 2
38568,Investigative
98049,Phase 1/2
16986,Phase 1
45653,Phase 1/2a
13495,Phase 1/2
91395,Phase 2a
77865,Patented
47803,Phase 1
137281,Phase 1/2
173791,Phase 2a
31227,Phase 2
110073,Phase 1
5009,Phase 1/2
62651,IND submitted
134011,Discontinued in Phase 4
180581,Phase 1
87355,Phase 1b/2a
111019,Phase 2
60975,Phase 2/3
85834,Discontinued in Phase 3
52457,Phase 0
12066,Phase 0
60678,Phase 2/3
40683,Phase 1
120042,Phase 0
96835,Phase 1/2
186274,Patented
162736,Phase 1b
168477,Discontinued in Phase 3
167021,Investigative
138023,Approved (orphan drug)
64853,Phase 1b/2a
135665,Phase 1b
79211,Phase 0
10149,Discontinued in Phase 2b
23266,Phase 1/2
84482,Phase 1/2a
138186,Clinical trial
127433,Discontinued in Phase 2b
27441,Phase 1b/2a
59340,Clinical trial
155665,Approved (orphan drug)
68708,Phase 2b
92747,Phase 1b/2a
97861,Phase 1/2a
12567,Phase 0
74431,Discontinued in Phase 1/2
116059,Phase 1b/2a
93312,Discontinued in Phase 3
56333,Phase 0
1814,Phase 1b/2a
83211,Phase 1
190814,Investigative
8673,Phase 1b/2a
112191,Phase 1
62551,IND submitted
106289,Patented
78169,Approved
96076,Phase 1b
158134,Phase 2a
82556,IND submitted
51103,Discontinued in Phase 2b
154087,Phase 1/2a
153731,Phase 1/2a
116657,Phase 2
116652,Investigative
91637,Phase 1/2
71573,Phase 1
98205,Phase 2/3
144088,Phase 1/2
66733,Phase 1b/2a
58856,Approved (orphan drug)
56836,Phase 0
149919,Phase 2b
93949,Phase 1b
84183,Phase 1/2a
113740,Phase 0
124211,Phase 0
67231,Discontinued in Phase 1
129706,Phase 0
14979,Phase 3
102274,Discontinued in Preregistration
72196,Patented
145157,Phase 2b
134506,Phase 1/2a
86409,Phase 2
182045,Discontinued in Phase 2b
86725,Discontinued in Phase 2
63510,Discontinued in Phase 2b
33300,Phase 1b
149620,Phase 0
109681,Phase 1
154936,Phase 3
168475,Discontinued in Phase 1/2
43340,Phase 1/2a
124023,Investigative
174922,Phase 1
191359,IND submitted
2651,IND submitted
191995,Patented
30755,Phase 1
191412,Investigative
80493,Phase 2a
107585,Discontinued in Phase 2b
18828,Phase 1/2
67269,Discontinued in Phase 1
19379,Patented
56997,Phase 1b
49165,Discontinued in Phase 2b
39142,Discontinued in Phase 2
605,Discontinued in Phase 1/2
162278,Discontinued in Phase 2b
27358,Phase 1/2a
147764,Phase 2b
58500,Clinical trial
125337,BLA submitted
135317,Phase 0
191974,Clinical trial
8749,Clinical trial
164442,Phase 1/2
128272,Phase 1b/2a
39654,Phase 2
111150,Phase 0
177709,Phase 1b
83280,Phase 0
56275,Investigative
108428,Phase 1b
134702,Phase 0
40675,Phase 1/2a
149415,Phase 1b
65720,Phase 2/3
160737,Phase 3
55554,Phase 1
173888,Phase 2a
50498,Phase 2
102389,Approved (orphan drug)
32087,Phase 1b/2a
13978,Phase 1
175778,Phase 0
160768,Phase 1/2a
70201,Phase 1
1189,IND submitted
162950,Patented
138628,BLA submitted
170605,IND submitted
77232,IND submitted
37491,Phase 1
8677,Clinical trial
120626,Discontinued in Phase 3
133759,Discontinued in Phase 4
124917,Phase 1
39007,Patented
156054,IND submitted
158020,Registered
58373,Discontinued in Phase 3
45651,Phase 1/2a
83962,Phase 2
13465,Investigative
18083,Discontinued in Preregistration
154533,Phase 2
175078,Discontinued in Phase 3
150524,Phase 1b/2a
145260,Phase 1b/2a
2677,Phase 1
112350,Discontinued in Phase 3
105398,Phase 1
114259,Phase 1
44995,Phase 1/2a
81075,Phase 1b/2a
182655,Phase 2a
98073,Phase 0
8423,Phase 1
177126,Discontinued in Phase 3
36577,Phase 0
25468,Discontinued in Phase 2/3
142663,Discontinued in Phase 1/2
78770,Phase 0
97322,Phase 1b/2a
54307,Phase 0
109854,Discontinued in Phase 2/3
10863,Phase 1
153824,Phase 1/2a
113075,Discontinued in Phase 1/2
87070,Discontinued in Phase 2
96289,Discontinued in Phase 1/2
10717,IND submitted
134637,Phase 0
36723,Discontinued in Phase 2b
9406,Discontinued in Phase 1
37078,Phase 1b/2a
164239,Phase 2/3
190067,Phase 1/2
835,Discontinued in Phase 1
134298,Phase 1b
50088,Phase 2/3
2702,Phase 1b
114636,Discontinued in Phase 1
150295,Discontinued in Phase 2
70949,Phase 1b/2a
84934,Phase 1b/2a
25146,Discontinued in Phase 2b
48058,Patented
125655,Phase 1b/2a
54755,Phase 1/2a
78563,Phase 2a
96722,Phase 0
49928,Phase 1b
63223,Phase 1b
99350,Phase 0
37028,Phase 1b/2a
19365,Phase 1/2
123628,Patented
161787,Discontinued in Preregistration
6378,Investigative
153321,Phase 0
112535,Discontinued in Phase 3
33593,Phase 2a
162171,Investigative
27109,BLA submitted
182542,Phase 1
124431,Investigative
105007,Discontinued in Phase 4
118457,BLA submitted
155989,IND submitted
181350,Phase 1b/2a
44113,Phase 2/3
36474,Discontinued in Phase 2
130702,Phase 2b
45751,Phase 2/3
130752,Phase 2
90115,Clinical trial
40888,Approved
105644,Phase 2
187566,Phase 2a
187442,Patented
92251,Phase 2b
72405,Phase 2
158595,Phase 1b
141224,Investigative
10235,Phase 1
40126,Discontinued in Preregistration
94002,Phase 1
7840,Discontinued in Preregistration
24442,Phase 1/2a
94713,Phase 1b
88655,Discontinued in Phase 4
84819,Phase 1b/2a
29167,Discontinued in Phase 2/3
92012,Phase 0
24855,Phase 1/2
162443,Phase 1/2a
60485,Phase 1b/2a
46634,BLA submitted
147471,Phase 1/2a
135160,Phase 0
63152,Phase 1b/2a
127161,IND submitted
74774,Phase 1/2a
27187,IND submitted
167847,Phase 0
108915,Phase 1/2a
136653,Phase 1/2a
136027,IND submitted
89502,IND submitted
23520,Phase 1
139406,Discontinued in Phase 2
172205,IND submitted
116930,Phase 1/2
185073,Discontinued in Phase 4
97583,Phase 1/2a
174416,Phase 1/2a
76864,Phase 0
79502,BLA submitted
149867,Phase 2/3
69381,Phase 1b
145824,Phase 2b
81571,Phase 1
97968,Phase 1b/2a
185822,Patented
27277,Investigative
169855,Phase 0
137663,Phase 1/2a
149380,Clinical trial
96683,Phase 1/2
104461,Phase 1/2
63971,Approved (orphan drug)
42861,Discontinued in Phase 1
155583,Phase 2
167277,Phase 4
28762,Investigative
71107,Discontinued in Phase 3
28070,Phase 2a
151639,Phase 2
100864,IND submitted
94242,Phase 2a
59697,Discontinued in Phase 1/2
162744,Phase 1b
149567,Phase 1b
53328,Phase 1b
158712,Phase 1/2
131765,Discontinued in Phase 3
54433,Discontinued in Phase 3
82992,Phase 2
191153,Phase 1/2
180103,Phase 1/2a
25731,Phase 1b
31623,Discontinued in Preregistration
10515,IND submitted
121655,Phase 0
20945,Phase 1/2a
114938,Phase 2
112241,Discontinued in Phase 3
164903,Phase 1/2
88563,Patented
112696,Phase 1
136917,Phase 1/2
131103,Phase 1b
45417,Phase 2/3
117659,Discontinued in Phase 3
43442,Phase 2/3
137885,Phase 1/2a
32785,Phase 1/2
164936,Phase 1/2a
174076,Phase 2b
74625,Phase 1/2
54726,Patented
168652,Discontinued in Phase 4
74524,IND submitted
142332,Investigative
34808,Phase 1b/2a
166958,Discontinued in Phase 2
116023,Discontinued in Phase 2
2443,Phase 1
121004,Phase 1b
150899,Phase 1
92009,Discontinued in Phase 2
5233,Phase 2a
158252,Discontinued in Preregistration
159000,Phase 2/3
59750,Investigative
190632,IND submitted
147217,IND submitted
107806,Discontinued in Phase 2b
73537,Phase 1b/2a
76647,Investigative
65667,Phase 1b/2a
55608,Phase 1/2
66542,IND submitted
93034,Discontinued in Phase 1
71156,Phase 1b
169308,Patented
141062,Patented
43592,Phase 2/3
63500,Phase 1b
161266,Phase 1/2a
137083,Phase 1/2a
185742,Phase 0
185825,Phase 2a
90891,Phase 0
53915,Phase 1/2a
51311,Investigative
16181,Phase 1/2
190300,Clinical trial
30661,Investigative
133139,Patented
136791,Discontinued in Phase 4
83200,Phase 0
120742,Approved (orphan drug)
159666,Phase 1b/2a
45435,Phase 1/2a
182905,Phase 2a
101836,Phase 1
99498,Phase 2
167888,Phase 0
157887,Phase 1
179180,Phase 1/2a
99365,Patented
171485,Investigative
8437,Phase 1b
113322,Discontinued in Phase 1
187612,Phase 1b
5096,Phase 2a
58623,Phase 2/3
66735,Patented
113808,Phase 1
103873,Phase 0
102569,Investigative
119358,Phase 1/2a
93135,Discontinued in Phase 2b
145781,Phase 2b
108962,Phase 1/2
103212,IND submitted
88594,Phase 1
60834,Phase 0
157653,Phase 1
122318,Approved
67729,Preclinical
111281,Phase 1
35514,Discontinued in Phase 4
179423,Discontinued in Phase 1
147121,Phase 1/2a
166500,Patented
155941,Phase 1/2a
30119,Phase 1b
41277,Phase 1
121573,Discontinued in Phase 1
94628,Discontinued in Phase 1
7077,Phase 1b/2a
170896,Phase 0
38478,Phase 2/3
128304,Phase 1
171800,Phase 2
174283,Discontinued in Phase 2
111373,Phase 1b
169266,Discontinued in Phase 1/2
161239,Discontinued in Preregistration
135797,IND submitted
172470,Phase 1/2
188046,Phase 0
42410,Phase 1
8212,IND submitted
143821,Patented
169166,Clinical trial
159546,Phase 0
94503,Phase 0
72855,Phase 2
153920,Phase 1b/2a
42831,Phase 2
186285,Phase 2b
138977,BLA submitted
108787,Phase 1/2a
166569,Phase 1/2a
84898,Phase 1/2
133962,Phase 1b
103569,Phase 1b/2a
146879,Discontinued in Phase 1
35639,Discontinued in Phase 1/2
155108,Phase 1b
57212,Clinical trial
126494,IND submitted
134422,Phase 1/2a
169026,Discontinued in Phase 1/2
30550,Phase 0
177508,Phase 2
106599,Discontinued in Phase 3
19794,Phase 0
52439,Phase 1b/2a
153484,Discontinued in Preregistration
92234,Phase 2b
136795,Phase 1/2a
114068,Phase 0
86811,Phase 1b
189424,Phase 4
156008,Discontinued in Phase 3
55962,Patented
100534,IND submitted
160109,Phase 2
131849,Discontinued in Phase 2b
60641,Discontinued in Phase 3
77347,Phase 1/2a
60023,Phase 2/3
56056,Discontinued in Phase 2/3
170443,Phase 0
4470,Investigative
161420,Patented
48890,Patented
59669,Discontinued in Phase 1/2
2001,Phase 1b
140455,Phase 2a
129010,Phase 1
16267,Phase 1
47347,Phase 0
58530,Investigative
11962,Discontinued in Preregistration
191289,IND submitted
63882,Discontinued in Phase 2
127365,Phase 0
105139,Discontinued in Phase 2b
172905,Discontinued in Phase 2
137013,Discontinued in Phase 2
142791,Phase 1/2
78911,Phase 3
176145,Discontinued in Phase 1/2
105311,Phase 1b
100928,Phase 1b
12175,Discontinued in Preregistration
75279,Patented
177839,Phase 1
121585,Phase 1/2
169601,Discontinued in Phase 2/3
113355,Phase 2a
35803,Discontinued in Phase 4
189283,Phase 2b
189054,Phase 2/3
56417,Investigative
99511,Phase 1
136879,Phase 1/2a
13800,Discontinued in Phase 1
111621,Discontinued in Phase 2b
116365,Discontinued in Phase 1
119397,Phase 1b/2a
31344,Discontinued in Phase 3
23834,Investigative
92865,Phase 1/2
78629,Phase 2a
180642,Phase 1
57692,Phase 1b
124362,Phase 1b
164219,Phase 1
57709,Discontinued in Phase 1/2
57853,Phase 1b/2a
116711,Phase 1b
72330,Phase 1b
175691,Discontinued in Phase 2
21832,BLA submitted
66189,Phase 1b
71534,Phase 1/2
100850,Phase 1/2a
24139,Discontinued in Preregistration
49416,Discontinued in Preregistration
173118,Discontinued in Phase 2/3
89048,IND submitted
172864,Discontinued in Phase 2
26177,Phase 2/3
45235,Phase 1/2a
115174,Phase 2
68453,Investigative
23275,Phase 0
98588,Phase 1/2a
96298,IND submitted
114535,Clinical trial
108887,Phase 1/2a
18085,Phase 1/2a
101858,Phase 1/2a
145208,Phase 1b
126971,Phase 1/2a
36133,Investigative
70463,Phase 0
86496,Phase 1b
115439,Phase 2/3
67631,Patented
48998,IND submitted
128408,Phase 0
22071,Phase 1b/2a
90096,Clinical trial
141317,Discontinued in Phase 2b
127743,Phase 1/2
161547,Discontinued in Preregistration
76685,Phase 1/2a
94479,Phase 1
177998,Discontinued in Phase 3
44970,Phase 2/3
182347,Discontinued in Phase 4
111975,Phase 1
27805,Discontinued in Phase 1
155236,Phase 2a
12427,Phase 1
5004,Investigative
72657,Phase 2
31480,Phase 0
149507,Phase 1/2
32971,Phase 2a
55898,Discontinued in Preregistration
73957,Discontinued in Phase 4
190456,Clinical trial
112224,Discontinued in Phase 3
152208,Phase 0
105410,Phase 2a
9299,Phase 1b
61630,Phase 1b
108321,Phase 1b
152527,Patented
45602,Phase 2/3
24619,Discontinued in Phase 4
91775,Phase 2a
4863,Phase 1b/2a
30159,Discontinued in Phase 2b
13505,Phase 0
25042,Phase 1/2
38957,Patented
180420,Phase 1b/2a
75002,Phase 1/2
24734,Phase 2/3
145095,Phase 2/3
122257,Phase 2
105155,Phase 1/2
144476,Discontinued in Phase 1/2
126655,Patented
65424,Approved (orphan drug)
177093,Phase 1/2
172612,Discontinued in Phase 2
90001,Discontinued in Phase 1/2
37782,Phase 1b
69960,Patented
45909,Phase 1/2a
53979,Phase 0
73567,Phase 1b
66223,Phase 1b/2a
134165,Discontinued in Phase 4
105188,Phase 0
102348,Phase 0
100385,Registered
98191,Patented
139081,Investigative
185472,Discontinued in Phase 3
104475,BLA submitted
159313,Clinical trial
39948,Phase 2
45559,Phase 2/3
128281,Discontinued in Phase 4
80087,Phase 2
107538,Discontinued in Preregistration
20229,Discontinued in Phase 2b
46650,Approved
22819,Discontinued in Phase 4
170765,Discontinued in Preregistration
22449,Discontinued in Phase 4
129790,IND submitted
512,Phase 1
154585,Phase 3
154995,Phase 2
57813,Discontinued in Phase 3
40144,Discontinued in Phase 2/3
18765,IND submitted
134031,Phase 1/2a
94508,Phase 1/2
171341,Phase 2a
136444,Phase 1/2a
51506,Phase 1b
160942,Phase 2
42513,Phase 2
56590,Phase 1b/2a
59723,Discontinued in Phase 4
58975,Phase 1b/2a
38554,Phase 2
75167,Patented
60170,Investigative
97323,Investigative
101729,Phase 2a
15184,Phase 1
54835,Discontinued in Phase 2b
106320,Phase 0
145162,Phase 2b
117288,Discontinued in Phase 1/2
10828,Discontinued in Phase 2b
56589,Phase 1b/2a
125845,Phase 1b/2a
101166,Patented
149257,Phase 2b
63899,Phase 1
11850,Phase 1
4373,Discontinued in Phase 2
55855,Discontinued in Phase 2b
143260,Discontinued in Phase 3
132008,Phase 2
50676,Phase 1b
68476,Phase 1/2
90522,Phase 2/3
16315,Phase 1
127347,Phase 1/2
88307,Phase 1/2a
35340,Discontinued in Phase 2
25979,Phase 0
18489,Preregistration
40031,Investigative
182249,Phase 1b/2a
100766,Phase 1/2a
110602,Discontinued in Phase 3
3353,Discontinued in Phase 2
31743,Discontinued in Preregistration
71522,Phase 1b/2a
155842,Discontinued in Phase 3
164818,Phase 1/2
124107,Phase 1/2
36305,Phase 1/2a
85880,Discontinued in Phase 2b
135056,Phase 0
55983,Phase 1b
55294,Phase 2
70358,Phase 1b/2a
76702,IND submitted
102915,IND submitted
170752,IND submitted
12468,Phase 0
43123,Investigative
168902,Clinical trial
165740,Discontinued in Phase 4
114637,Phase 1/2a
68879,Phase 1b
15391,Phase 1/2
156039,Discontinued in Phase 4
29661,Phase 0
102590,Investigative
79938,Phase 1b/2a
93862,Discontinued in Phase 3
18240,Phase 2a
141388,Discontinued in Phase 2b
140282,Phase 1/2
42636,Phase 2/3
4852,IND submitted
152850,Phase 1/2
82536,Discontinued in Phase 4
84264,Investigative
85603,Discontinued in Phase 3
112349,Discontinued in Phase 3
117657,Phase 2
150643,Phase 0
150106,Phase 1
45305,Phase 2/3
63535,Approved
59107,Discontinued in Phase 4
114783,Investigative
131072,Patented
159072,Approved
76972,IND submitted
50185,Discontinued in Phase 2b
50270,Phase 1b/2a
152092,Phase 1
186049,Preclinical
17280,Phase 2b
107451,Phase 0
11038,BLA submitted
150180,Investigative
2656,Discontinued in Phase 1/2
117284,Discontinued in Phase 1
130728,Phase 2
138909,BLA submitted
164664,Phase 1
127453,Discontinued in Phase 4
167079,Discontinued in Phase 1
99341,Phase 1
166700,Phase 1
133370,Discontinued in Preregistration
54837,Phase 0
67555,Phase 1/2a
55164,Phase 1b/2a
136604,Phase 2
38695,Discontinued in Preregistration
74876,Phase 1/2
101618,Phase 1/2a
125552,Phase 1b/2a
87877,Discontinued in Phase 3
142627,Investigative
93668,Phase 1/2
31695,Phase 1
138963,Phase 1/2a
65855,Phase 1b
120062,Approved
185126,BLA submitted
133034,Phase 1/2
15501,Phase 0
176878,Phase 1/2a
158158,Phase 1/2a
70540,Phase 1/2a
124577,Phase 1/2
161305,Phase 2a
151399,Phase 2
100273,Discontinued in Phase 4
30801,Patented
37121,Discontinued in Phase 1/2
57175,Discontinued in Phase 4
21705,Discontinued in Phase 3
174512,Discontinued in Phase 3
127114,Phase 0
145737,Phase 0
82318,Discontinued in Preregistration
60500,Phase 0
3579,Discontinued in Preregistration
117542,Discontinued in Phase 2b
73668,Phase 2/3
137389,Phase 2
82033,Clinical trial
117792,Investigative
19795,Discontinued in Preregistration
187123,Phase 2/3
157082,Clinical trial
191956,Clinical trial
25865,Phase 0
60486,Phase 1/2
120462,Approved (orphan drug)
161877,Phase 0
100404,Registered
160031,Investigative
162717,Phase 1/2a
35131,Discontinued in Phase 2
16750,Phase 0
62135,Discontinued in Preregistration
134778,Phase 0
34670,Phase 0
41075,Approved
182408,Discontinued in Phase 2
158583,Phase 1/2
133672,Phase 1/2a
184660,Phase 0
103467,Phase 1b
141784,Phase 2/3
179593,Phase 1
23253,Phase 2/3
91313,Discontinued in Phase 1
70550,Phase 1
13054,IND submitted
38260,Phase 2a
168827,Discontinued in Phase 1/2
131422,Discontinued in Phase 4
98458,Phase 1
180970,Phase 1b/2a
32511,Phase 2a
178428,Phase 0
123668,Phase 1b
161854,Patented
6625,IND submitted
166276,Discontinued in Phase 1/2
8761,Phase 0
107851,Discontinued in Phase 2b
27515,BLA submitted
134519,Phase 1/2
179976,Phase 1
19522,IND submitted
12477,IND submitted
76875,Phase 0
2016,Investigative
174338,Phase 1/2
125955,Phase 1b/2a
113507,Phase 1/2
178877,Discontinued in Phase 1
180010,Phase 1b
122547,Phase 1b
82347,Discontinued in Preregistration
1728,Approved
86128,Phase 1
55612,Phase 0
79693,Approved (orphan drug)
81921,Clinical trial
71090,Discontinued in Phase 1/2
91831,Investigative
98955,Phase 1/2a
90207,Phase 1b
109306,Phase 1/2
132989,Discontinued in Phase 4
105579,Phase 1
46989,Phase 1
184156,Phase 1
47245,Discontinued in Phase 1
143549,Phase 1b/2a
184239,BLA submitted
185406,IND submitted
128125,Patented
24740,Discontinued in Phase 4
84424,Discontinued in Phase 3
10821,Investigative
101181,Patented
116996,Discontinued in Preregistration
12662,Phase 0
113402,Phase 1/2
177347,Phase 2a
18053,Phase 3
48951,Phase 1/2a
28217,Phase 1
151005,Phase 0
114156,Phase 1b
174123,Phase 1/2
90054,Discontinued in Phase 1
53412,Phase 1/2
81906,Discontinued in Phase 1
79067,Phase 0
178909,Phase 1/2a
128592,Phase 1
134646,Phase 0
124042,Patented
66323,Phase 0
97573,Phase 1/2
63181,Patented
2429,Phase 1b/2a
9815,Preclinical
1479,Discontinued in Preregistration
50578,Phase 0
162925,Patented
18363,Phase 2
190002,Phase 1/2
3253,Phase 1/2
42320,Phase 1b/2a
121230,Phase 0
92149,Phase 2b
53281,IND submitted
9097,Discontinued in Phase 1
88889,Patented
8792,Discontinued in Phase 2/3
151193,Phase 2
23047,Investigative
49995,Phase 1/2a
116861,Investigative
132408,Discontinued in Phase 2b
79250,Patented
14434,Phase 1/2
39349,Phase 2
190141,Phase 2b
39808,Phase 1
158068,Phase 2a
94931,Discontinued in Phase 4
190689,Phase 1/2
58414,Phase 1/2
110445,Phase 1b/2a
126609,Phase 0
115293,Phase 2/3
148286,Phase 2a
91594,Discontinued in Phase 2
44942,Phase 1/2a
142817,Phase 1/2a
190955,Phase 1
157820,Discontinued in Phase 4
88346,Investigative
188519,Phase 1/2
50274,IND submitted
21485,BLA submitted
4395,Phase 1b/2a
112536,Discontinued in Phase 3
112441,Phase 1/2
7865,Phase 1
116755,Discontinued in Phase 2b
84267,IND submitted
61729,Phase 1b
73439,Phase 2a
52920,Phase 1b
108070,Investigative
155354,Phase 1
144327,Discontinued in Phase 2
73465,Phase 1b/2a
47483,Phase 0
136808,Phase 1/2a
8696,Investigative
80396,Phase 2
110462,Discontinued in Phase 2/3
20084,Phase 0
39824,Phase 2
162190,Phase 1/2
51838,IND submitted
29420,Phase 1/2a
25348,Phase 1
186703,Phase 2/3
7370,Discontinued in Phase 2
176429,Discontinued in Phase 4
149498,Phase 1b
122980,Discontinued in Preregistration
2791,Phase 1/2
44193,Phase 2/3
91795,Approved
189823,IND submitted
107931,Discontinued in Phase 2/3
36715,Discontinued in Phase 1
90636,Phase 2/3
44475,Phase 1/2a
132755,Discontinued in Phase 2/3
29337,Discontinued in Preregistration
156798,Preregistration
138541,BLA submitted
100592,Phase 1/2a
110339,Phase 3
78890,Phase 1b
164546,Phase 1/2a
172543,Patented
87703,BLA submitted
169395,Discontinued in Preregistration
3835,Approved
127227,Discontinued in Phase 1
135576,Phase 0
117865,Phase 1/2
43255,Phase 0
15286,Phase 1/2a
61557,IND submitted
168353,Phase 2
163785,Discontinued in Preregistration
47464,Discontinued in Preregistration
42127,Phase 2
109985,Patented
42323,Phase 1/2a
145321,Investigative
96140,Phase 1b
95409,Phase 1/2a
98031,Phase 1/2a
107724,Discontinued in Phase 2
72551,Investigative
137926,Phase 1/2a
73804,Phase 2
87578,Discontinued in Phase 3
109271,Phase 1/2a
121714,Phase 2
56560,Phase 1/2
108954,Phase 1/2a
46905,Phase 1
16626,Phase 1
124747,Phase 1b
56155,Phase 0
125814,Phase 1b
64087,Phase 1/2a
145671,Phase 1b
104512,Phase 0
24191,Phase 1/2
30443,Phase 2
117146,Discontinued in Phase 1
151234,Phase 2
36754,Discontinued in Preregistration
141437,Discontinued in Phase 2b
122159,Phase 1b/2a
182182,Phase 1
70769,Discontinued in Phase 2b
136928,Investigative
114098,Patented
80686,Discontinued in Phase 3
89079,IND submitted
276,Phase 2b
17585,Phase 1
76292,Phase 0
85666,Discontinued in Phase 3
169234,Phase 0
190303,Phase 2/3
138003,Investigative
156577,Phase 1b/2a
136106,Phase 1/2
186377,Phase 1b/2a
87458,Approved
4833,Investigative
191641,Phase 0
93945,Discontinued in Phase 1
52092,Phase 4
94897,Phase 1
54359,Discontinued in Phase 2b
126757,Patented
153814,Phase 1/2a
123208,Phase 1b
89306,Discontinued in Phase 3
72736,Investigative
49684,Phase 1b/2a
67172,Phase 1/2
58213,Discontinued in Phase 1/2
57795,Phase 2/3
168347,Discontinued in Phase 1
186883,Phase 2/3
73968,Phase 2/3
170833,Phase 0
152641,Patented
125252,Phase 1b/2a
109336,Approved
57698,Phase 0
91518,Discontinued in Phase 2
101282,Phase 1/2a
74720,Discontinued in Phase 4
154169,Phase 0
55191,Phase 0
108217,Phase 1b
113671,Discontinued in Preregistration
93308,Phase 1/2a
44183,Phase 2/3
139326,BLA submitted
74338,Discontinued in Phase 3
144610,Investigative
85013,Phase 1/2
72853,Investigative
115606,Phase 1b/2a
9258,Discontinued in Phase 2
180925,Phase 2b
36878,Phase 1b/2a
49541,IND submitted
163047,Investigative
64582,Investigative
54176,Discontinued in Preregistration
47455,Patented
65831,Discontinued in Phase 2/3
97575,Investigative
39932,Patented
25431,Discontinued in Phase 2/3
46117,Phase 1/2a
95332,Patented
54337,Phase 4
71270,Phase 0
13046,Phase 0
155373,Phase 1
150670,Phase 2
88819,Phase 1
124806,Phase 1
66963,Phase 1b
10122,Phase 1/2
82529,Phase 1/2
31707,Phase 1b/2a
612,Phase 1/2a
176991,Phase 1/2
93407,Phase 2b
64279,Phase 1
26156,Investigative
153243,Phase 1
101795,Investigative
59752,Approved (orphan drug)
72467,Phase 1/2
5907,Phase 1b/2a
160272,Phase 2b
108730,Patented
23923,Phase 1/2a
173728,Approved
167095,Discontinued in Phase 2
112069,Phase 1/2
150617,Phase 1
25407,Phase 1
140017,Phase 1b
64940,Phase 1/2
180880,Phase 1/2
5774,Phase 1/2
147122,Discontinued in Phase 2/3
62761,Patented
125553,Phase 1/2
129031,Patented
57661,Investigative
165479,Discontinued in Phase 1/2
143054,Investigative
39102,Discontinued in Phase 4
30900,Discontinued in Phase 4
109635,Discontinued in Phase 1/2
128874,Investigative
132373,Discontinued in Phase 4
185272,Discontinued in Phase 1
103681,Phase 1/2
20240,Phase 1b/2a
67504,Clinical trial
101668,Phase 1
63988,Phase 2a
88260,Patented
32304,Phase 2
182342,Phase 1
139306,BLA submitted
162023,Investigative
87083,Discontinued in Phase 1/2
89316,Phase 1/2
170581,Phase 0
162226,Discontinued in Phase 1/2
76801,Phase 1/2a
179400,Phase 2a
1784,Phase 2
168635,Discontinued in Phase 1
45290,Phase 2/3
112081,Phase 1/2
139303,Phase 1b
160777,Phase 1/2
114896,Phase 2
140261,Phase 1/2
1373,Approved
48502,Phase 1b/2a
121915,Discontinued in Phase 1
19757,Phase 0
61798,Discontinued in Phase 2b
164373,Phase 0
185139,BLA submitted
127790,Investigative
119182,Clinical trial
158024,Discontinued in Phase 1/2
67322,Discontinued in Preregistration
188175,Patented
162072,Investigative
111203,Phase 1/2
4860,Investigative
119779,Discontinued in Phase 1/2
109255,Investigative
118901,IND submitted
80806,Phase 1b/2a
83852,Phase 1/2a
133020,Discontinued in Phase 4
117973,Phase 2/3
25940,Phase 1
151195,Phase 2
72754,Investigative
76080,Phase 1/2a
172446,Discontinued in Phase 2/3
26345,Phase 2
68087,Phase 1b
143412,Phase 2b
1674,Approved (orphan drug)
177822,Discontinued in Preregistration
157598,Phase 1b/2a
161881,IND submitted
83029,Discontinued in Phase 4
2357,Phase 1b/2a
160938,Clinical trial
126814,Phase 1/2
146375,Phase 2a
4646,Phase 2a
27005,Phase 1b
131725,IND submitted
20184,Patented
120254,Approved
188914,Approved
116432,Investigative
163014,Discontinued in Preregistration
188074,Phase 2b
190291,IND submitted
79058,Phase 2a
165877,Discontinued in Phase 1/2
181832,Phase 1
90976,BLA submitted
37840,Phase 1b
51076,Phase 2/3
9147,Discontinued in Preregistration
160324,Phase 3
112742,Phase 1/2
154269,Phase 1/2
135012,Phase 0
7882,Phase 1
38584,Phase 1
164088,Phase 0
34560,Phase 1/2
19670,Phase 0
26653,Phase 1
161374,Investigative
161258,Discontinued in Preregistration
175618,Discontinued in Phase 3
60639,Phase 2
36432,Discontinued in Phase 4
12744,Discontinued in Phase 1
12149,IND submitted
180850,Phase 1b/2a
90511,Phase 1/2a
24482,Phase 1
83195,Phase 2
131183,Phase 1b
31345,Clinical trial
75484,Phase 1/2a
69048,Phase 1
190445,Phase 1b/2a
56764,Phase 1/2
57817,Phase 1/2a
173627,Approved
79653,Phase 2a
71489,Phase 0
117121,Investigative
153712,Phase 1/2a
62788,Phase 0
58515,Discontinued in Phase 2/3
188910,Phase 1/2
112584,Discontinued in Phase 3
187136,Clinical trial
57263,Phase 2/3
26157,Discontinued in Phase 2/3
70410,Phase 1
72267,Phase 1b
182074,Phase 2a
134609,Patented
132782,Phase 1/2
51234,Phase 1/2a
123958,Patented
141082,Discontinued in Preregistration
9342,Discontinued in Phase 3
150652,Phase 1
189871,Phase 1/2
16091,Phase 1b/2a
68112,IND submitted
43376,Phase 2/3
108618,Discontinued in Phase 1
181386,Phase 1b
129517,IND submitted
75582,Patented
90674,Phase 2/3
183589,Phase 1b
186771,Phase 4
34532,Phase 1b/2a
107926,Phase 1
122436,Phase 1/2
62427,Phase 0
184198,Discontinued in Phase 4
28227,Phase 1b/2a
180022,Discontinued in Preregistration
176444,Phase 1b
42055,Phase 1b
13667,Phase 1
42318,Phase 2a
62589,Phase 0
37964,Phase 1b
133469,Discontinued in Phase 1
105910,Phase 1b
41267,Discontinued in Phase 4
35784,Discontinued in Phase 4
67924,Clinical trial
103945,Patented
26948,Phase 1
57332,Phase 0
191898,Discontinued in Phase 2b
30337,Phase 1b
33427,Clinical trial
186754,Patented
67760,Phase 1/2
123165,Patented
26675,Phase 1b
14056,Phase 1
159634,Discontinued in Preregistration
82800,Discontinued in Phase 4
45571,Phase 1/2a
124294,Phase 0
164466,Phase 1/2
177142,Phase 1/2a
120765,Discontinued in Phase 2
83638,Discontinued in Phase 4
181969,Phase 1b/2a
141004,Discontinued in Phase 2b
185978,Phase 1/2a
97217,Phase 1/2a
33216,Phase 1b
11361,Phase 1b
90663,Phase 0
105677,Phase 1/2a
122953,Patented
180547,Discontinued in Phase 4
107542,Phase 1b
78992,Phase 2a
122367,Phase 0
56514,Phase 2
10528,IND submitted
36285,Phase 1/2a
89758,Phase 1b/2a
53422,Phase 2
130341,Phase 1/2
168843,Clinical trial
178567,Phase 2a
62749,Phase 0
86152,Discontinued in Preregistration
15351,Phase 0
82939,Phase 0
179367,Discontinued in Phase 3
87628,Phase 1/2
34426,Phase 1b/2a
169729,Phase 1
99735,Phase 1/2a
24496,Phase 0
144016,Phase 1/2
12635,Phase 1b/2a
169782,Phase 1/2a
57166,Phase 0
188781,Phase 1b/2a
49966,Phase 0
192029,Discontinued in Phase 3
166860,Phase 2a
82142,Clinical trial
40331,Investigative
124109,Phase 1
27926,Phase 1b/2a
174452,Phase 0
51210,Phase 1b/2a
60412,Phase 0
115234,Phase 1/2a
1734,Discontinued in Phase 1/2
174224,Phase 1/2
102142,Investigative
1190,Investigative
99738,Discontinued in Phase 2/3
81640,Phase 1
160568,Phase 1/2
63452,Phase 1b/2a
22432,Phase 1/2
162898,Discontinued in Phase 1
52694,Discontinued in Phase 2
88377,Phase 1
4604,Phase 1/2
169815,Phase 1/2a
158587,Phase 2b
155573,Phase 2
3281,Phase 1/2
141628,Discontinued in Phase 2b
67678,Phase 1b
160784,Phase 1/2a
14141,Phase 1/2
105489,Phase 1/2a
39051,Discontinued in Preregistration
185651,Patented
36452,Discontinued in Preregistration
46178,Phase 2/3
10445,Discontinued in Preregistration
118396,Clinical trial
33207,Phase 1
7299,Investigative
72245,Phase 0
92520,Phase 1
111533,Phase 0
103841,Phase 1/2
82530,Phase 1/2a
88998,BLA submitted
44240,Phase 2/3
125223,Phase 1b
82241,Phase 1
155395,IND submitted
145234,Phase 2
135786,Phase 2
181754,Phase 2a
143678,Investigative
52413,Phase 1
21564,Discontinued in Preregistration
113356,Patented
142543,Phase 3
154326,Patented
38434,Phase 1
45665,Phase 2/3
3275,Phase 0
50972,Phase 2/3
167986,Phase 1b
14634,Phase 1
27999,Phase 2/3
174088,Phase 1/2
80127,Investigative
13375,Phase 1/2
31392,Phase 1
105798,Phase 2
93575,Investigative
160629,Phase 3
93977,Phase 2b
188340,Discontinued in Phase 3
115408,Phase 1b/2a
5164,Preregistration
168494,Discontinued in Phase 1/2
189530,Phase 1/2a
33707,Discontinued in Phase 2
171749,Discontinued in Phase 2b
154115,Phase 0
18333,Phase 1/2a
87980,Discontinued in Phase 1
47780,Phase 1b/2a
118715,Clinical trial
49211,Phase 1/2
182312,Phase 1/2a
179939,Phase 1/2a
88627,Discontinued in Phase 4
102914,IND submitted
66499,Phase 0
30620,Investigative
125508,Discontinued in Phase 4
6101,Discontinued in Phase 2
64907,Approved (orphan drug)
147568,IND submitted
43473,Phase 2/3
70526,IND submitted
166415,Phase 1
141030,Discontinued in Preregistration
3962,Phase 1
151247,Phase 0
186479,Patented
129345,Phase 0
23829,Phase 2
46822,Discontinued in Phase 2/3
151677,Phase 2
87939,Phase 1/2a
69791,Phase 1/2a
103537,Phase 1b/2a
171639,Discontinued in Phase 2b
53553,IND submitted
49841,Phase 0
102153,Discontinued in Preregistration
103797,Discontinued in Phase 2b
24556,Phase 1
69442,Phase 1
138029,BLA submitted
41423,Phase 1/2a
187837,Patented
27588,Phase 2
81044,Patented
134449,Phase 1/2
128471,Discontinued in Preregistration
177542,Approved
68914,IND submitted
154038,Investigative
15199,Phase 1/2
73393,Phase 1b/2a
96805,Phase 2/3
81555,Approved
1778,Phase 1b/2a
122507,Discontinued in Phase 4
80971,Approved
98129,Phase 0
122067,Discontinued in Phase 1/2
57229,Phase 1/2a
116309,Phase 1/2
111672,Phase 1/2
21426,Phase 2a
38077,Discontinued in Phase 4
180082,Phase 1b
150464,Phase 1b
10154,Discontinued in Phase 2/3
185099,Discontinued in Phase 4
22681,Phase 1b/2a
21860,Discontinued in Phase 1/2
12852,Phase 0
168463,Clinical trial
121987,Approved
83232,Discontinued in Phase 4
95024,Discontinued in Phase 1
160735,Phase 1
86447,Phase 1
32034,Phase 0
142243,Patented
159400,Phase 0
20387,Discontinued in Phase 4
39037,Phase 0
160141,Phase 1b/2a
11376,Phase 2a
50909,Investigative
67090,Phase 1b/2a
64068,Phase 2/3
179167,Discontinued in Phase 1/2
150589,Phase 2
166546,Phase 1
180804,Phase 2a
82115,Clinical trial
120824,Approved
98070,Phase 1b
34986,BLA submitted
30793,Phase 0
94580,Discontinued in Phase 1
90283,Phase 1/2a
29308,Phase 1b/2a
69373,Discontinued in Phase 3
114867,Discontinued in Phase 2b
92294,Phase 2b
70242,Phase 2
38540,Phase 1/2
119701,Discontinued in Preregistration
86124,Phase 1/2
85569,Discontinued in Preregistration
152689,Patented
70432,Investigative
42134,Phase 1
177191,Phase 1/2a
113631,Phase 1b/2a
166199,Investigative
183091,Phase 1
15766,Phase 1/2a
126356,BLA submitted
152807,Phase 1b
168432,Discontinued in Phase 1/2
68220,IND submitted
162534,Phase 0
48488,Phase 3
112293,Phase 0
174775,Phase 2
84888,Phase 1/2
160886,Phase 1b/2a
136888,Phase 1/2
116965,Clinical trial
18882,Discontinued in Phase 3
186211,Phase 0
36294,Phase 1
24260,Phase 1
132889,Patented
118047,BLA submitted
152102,Discontinued in Phase 2/3
83940,Phase 1/2a
125133,Discontinued in Phase 4
21823,Discontinued in Phase 3
39337,Phase 0
153930,Phase 0
162805,Phase 1/2
31701,Patented
17180,IND submitted
34288,Phase 1/2
47458,Discontinued in Phase 2b
71689,Discontinued in Preregistration
144639,Discontinued in Phase 4
102057,Phase 1/2a
41509,Approved
135138,Phase 0
3339,Discontinued in Phase 2
2075,Approved
144607,Phase 2b
76569,Investigative
48996,Discontinued in Phase 4
122921,Phase 1
123418,Phase 1/2
50935,Discontinued in Preregistration
85101,Phase 0
32156,Phase 1b/2a
115061,Phase 2/3
162365,Preclinical
29415,Phase 1
162384,Patented
109567,Approved
164597,Phase 0
152131,Phase 1
122044,Approved
18775,Discontinued in Phase 2/3
169990,Investigative
167822,Discontinued in Phase 3
190190,IND submitted
17906,Phase 1/2a
43037,IND submitted
172939,Phase 0
78260,Discontinued in Preregistration
140986,Discontinued in Phase 4
50568,Phase 1b/2a
172310,Discontinued in Phase 2b
40740,Phase 1/2a
115159,Phase 1
32307,Phase 0
174711,IND submitted
32157,Phase 2
49553,Discontinued in Preregistration
34928,Phase 1b/2a
151832,Phase 2
126857,Discontinued in Phase 2b
50961,Phase 0
55092,Phase 1b/2a
110170,Investigative
85742,Discontinued in Phase 2b
27395,Discontinued in Preregistration
152280,Phase 2
148449,Phase 2/3
120904,Phase 2a
171173,IND submitted
45477,Phase 1/2a
180643,Discontinued in Phase 2b
167742,Phase 2
111376,Patented
120989,Phase 2a
126204,Phase 1/2
36257,Phase 1
171508,Phase 2a
90316,Phase 1b/2a
118062,Phase 1
132283,Phase 1b/2a
61742,Discontinued in Phase 4
159817,Phase 1b/2a
145146,Discontinued in Phase 2
188043,Phase 0
142556,Discontinued in Phase 2/3
34694,Patented
173140,Phase 0
140317,BLA submitted
167899,Patented
129885,Phase 0
27809,Phase 2/3
123359,Phase 1/2
50392,Phase 3
94447,Phase 2b
161733,Investigative
41836,Phase 0
149648,Discontinued in Phase 1
95954,Phase 1
19809,Discontinued in Preregistration
141348,Investigative
57225,Discontinued in Phase 3
57465,Investigative
181844,Discontinued in Phase 2b
182230,Phase 1/2
40491,Phase 1b/2a
5577,Investigative
121667,Discontinued in Phase 1
47670,Discontinued in Preregistration
71193,Phase 1b/2a
95385,Phase 1
117925,Phase 2/3
30225,Phase 1
125989,Discontinued in Phase 4
21720,Phase 0
183150,IND submitted
26201,Phase 0
43283,Phase 0
55948,Phase 1/2
179815,Phase 1
106935,Phase 0
139189,Approved (orphan drug)
1686,Discontinued in Phase 2
190216,Investigative
155959,Phase 1
79256,Phase 2a
80223,Phase 1/2a
74339,Discontinued in Phase 2b
7410,Phase 1b/2a
135176,Phase 0
113772,Phase 1b
90080,IND submitted
143296,Phase 1/2a
30959,Phase 1b
162705,Phase 1/2a
33575,Discontinued in Phase 2
16417,Phase 2b
185777,Phase 1b/2a
173578,Phase 1/2a
845,Phase 1
124947,Patented
156078,Discontinued in Phase 3
67121,Investigative
93963,Phase 2
87176,Discontinued in Phase 3
129075,Phase 1/2
108909,Discontinued in Preregistration
46271,Discontinued in Phase 2
135314,Phase 0
51905,Discontinued in Preregistration
79106,Phase 0
36304,Phase 1
155614,Phase 2a
174167,IND submitted
185725,Phase 0
82496,Patented
161191,Patented
78959,Phase 2a
133060,Phase 0
29776,Investigative
146733,Phase 2/3
5006,Phase 2/3
123392,Phase 1/2
78142,Investigative
144575,Discontinued in Phase 2/3
75381,Phase 0
170522,IND submitted
68121,Discontinued in Phase 1/2
162456,Patented
36402,Discontinued in Phase 4
40734,Phase 1
50086,IND submitted
89970,Phase 1b/2a
173158,Discontinued in Phase 2
38002,Phase 1
66666,Phase 2a
87221,Discontinued in Phase 1
66970,Phase 0
59112,Phase 1/2a
109807,Phase 2
144378,Discontinued in Phase 1/2
186384,Phase 4
101549,Phase 2a
46936,Clinical trial
155265,Phase 2/3
148438,Phase 2b
97167,Phase 1
1561,Phase 0
33195,Phase 1
69315,Discontinued in Phase 1/2
6821,Discontinued in Phase 2
14657,Phase 0
77419,Phase 1/2
189757,Phase 2/3
95917,Discontinued in Phase 3
148631,Phase 1b/2a
33636,Phase 1b
150386,Phase 1b
41540,Investigative
52963,Phase 1/2a
87292,Phase 2a
44156,Phase 1/2a
51446,IND submitted
164813,Phase 1/2
27488,Phase 1/2a
169633,Phase 3
186282,Phase 0
133076,Discontinued in Phase 4
98153,Investigative
83383,Phase 1/2
56265,Phase 0
5531,Phase 1/2
33238,Approved (orphan drug)
15163,Phase 1
18961,Phase 2
47399,Discontinued in Preregistration
145003,Phase 1b/2a
104593,Patented
116300,Phase 2a
21808,Phase 1/2
24177,Phase 1b
34244,Phase 1b/2a
137897,Phase 1/2
126069,Discontinued in Phase 4
134299,Phase 1b
83938,Phase 1b/2a
181407,Discontinued in Phase 2
39360,IND submitted
36405,Phase 1/2a
172476,Phase 0
17863,Phase 1b
1,Phase 1/2a
90344,BLA submitted
53695,Phase 0
152534,Phase 1/2a
181144,Discontinued in Phase 2b
188079,Phase 2b
127678,Phase 1/2
188115,Phase 1/2
74489,Phase 2
73408,Phase 2
132237,IND submitted
26986,IND submitted
156152,Phase 1/2
119971,Discontinued in Phase 1/2
135512,Phase 0
66286,IND submitted
174194,IND submitted
92547,Phase 1/2a
72436,Phase 2/3
39482,Investigative
179543,Phase 1/2a
88427,Phase 1
64991,Approved (orphan drug)
172564,Discontinued in Phase 2b
119283,Phase 1b/2a
90419,BLA submitted
62625,Discontinued in Preregistration
10296,Preclinical
62271,Phase 1
32636,Phase 2/3
53333,Discontinued in Preregistration
73311,Phase 1b/2a
139055,Discontinued in Phase 2
28197,Discontinued in Phase 1/2
139238,BLA submitted
24729,Phase 2
117950,Phase 3
11504,IND submitted
149888,Phase 1b
57677,Phase 1/2a
72777,Phase 2
83872,Phase 1
14792,Phase 1/2
104076,Phase 1/2
30156,Phase 2
56547,Investigative
104384,Patented
44851,Phase 1/2a
98400,Phase 2
88768,Phase 1
184008,Phase 1/2
160589,Phase 2a
37952,Phase 1/2a
21434,Phase 2a
81789,Phase 2
24293,Phase 1/2a
73493,Phase 1/2a
129351,Discontinued in Phase 1
160820,Phase 1/2a
170348,Phase 2/3
107200,IND submitted
28385,Phase 1/2
156084,Phase 1/2a
170657,Phase 1/2
78635,Discontinued in Phase 4
134771,Phase 0
70705,Phase 1/2
78936,Phase 0
19010,IND submitted
28320,Discontinued in Phase 4
89039,IND submitted
88794,Patented
168492,Phase 2b
32285,Patented
170863,Phase 0
108304,Phase 1/2a
11111,Discontinued in Phase 2b
98334,Phase 1b
89942,Phase 0
31801,Investigative
81962,Discontinued in Phase 2/3
15088,Phase 1
139977,Phase 1/2a
57673,Discontinued in Phase 3
18553,Phase 2a
100202,Phase 1
29918,Discontinued in Phase 2b
105377,Phase 1
5088,Phase 1b/2a
91353,Approved (orphan drug)
101339,Phase 2/3
40271,Phase 1b
103740,Phase 1b
161092,Phase 0
144065,Phase 1/2
102504,Application submitted
128339,Phase 1/2a
191296,Approved
52815,Phase 1/2
62074,Discontinued in Phase 4
166476,Phase 1
48950,Phase 0
39020,Discontinued in Preregistration
176900,Phase 1b
71855,IND submitted
66336,Phase 1
28564,Investigative
72996,IND submitted
83768,Discontinued in Preregistration
133195,Discontinued in Preregistration
166003,Phase 1b/2a
159733,Phase 1b/2a
51209,Phase 4
84087,Discontinued in Preregistration
103236,Patented
149540,Discontinued in Phase 2/3
141446,Patented
175274,IND submitted
51099,Phase 1/2a
136318,Phase 1/2a
7512,Investigative
191416,Phase 2a
176079,Discontinued in Phase 3
30203,Phase 2
67347,Discontinued in Phase 1
18409,Phase 2
64142,Phase 1/2
43981,Phase 1/2a
77118,IND submitted
68763,Phase 2b
65611,Discontinued in Phase 4
82740,Discontinued in Phase 2/3
109569,Discontinued in Phase 1/2
147457,Phase 2
56908,Phase 1/2a
124462,Phase 1b
144186,Discontinued in Phase 1/2
62577,Discontinued in Phase 3
43980,Phase 1/2a
62738,Discontinued in Phase 3
144796,Discontinued in Phase 2
36646,Phase 1
182204,Phase 2a
13766,Phase 0
148027,Phase 1/2a
102983,IND submitted
161832,Investigative
89768,Phase 2a
185245,Discontinued in Phase 4
83143,Investigative
26856,Phase 0
48049,Phase 2
23328,Phase 2/3
2614,Phase 1
178213,Phase 2a
170082,IND submitted
111067,Phase 2
43137,Discontinued in Phase 2
115754,Phase 2a
119361,Discontinued in Phase 2/3
100221,Phase 1
118540,BLA submitted
161260,Discontinued in Phase 4
137234,Discontinued in Phase 2b
25057,Phase 2
41641,Phase 1
96269,Discontinued in Phase 3
92677,Phase 1b
31818,Discontinued in Phase 2b
91732,Clinical trial
51424,Phase 1b
88472,Patented
49941,Phase 0
150108,Phase 1b/2a
119366,Discontinued in Phase 2
156565,Preclinical
708,Phase 1
173504,Phase 1
39642,Discontinued in Phase 2
128002,Phase 1
114878,Clinical trial
81444,Phase 1b
131321,Patented
72801,Phase 2
95901,Discontinued in Preregistration
134495,Phase 1b
92761,Phase 1/2
10549,IND submitted
140251,BLA submitted
137305,Phase 2
166920,Discontinued in Phase 1/2
51508,Phase 1
56143,Phase 0
87198,Discontinued in Phase 1
181149,Phase 1b/2a
7334,Discontinued in Phase 2
145947,Phase 1b
34336,Phase 1
155926,Phase 1/2a
52549,Phase 0
19563,IND submitted
155195,Phase 1b/2a
139033,Discontinued in Phase 2
30255,Phase 1
44630,Phase 1/2a
50873,Phase 1b/2a
132630,Discontinued in Preregistration
108557,Phase 1b/2a
80916,Phase 2a
2853,Discontinued in Phase 3
151850,Phase 1
35383,Discontinued in Phase 4
11049,Phase 1
132536,Phase 1/2
125090,Approved
94564,Patented
118156,Phase 2b
169952,Phase 0
97901,Investigative
147142,Phase 1
111018,Phase 1
9548,Phase 2
41503,Phase 1b/2a
108150,Phase 1b
54242,Patented
105213,Phase 0
83310,IND submitted
180062,Discontinued in Preregistration
139971,BLA submitted
184599,BLA submitted
145198,Phase 1b/2a
103667,Phase 0
21494,Approved (orphan drug)
14078,Phase 1
137755,Phase 1/2a
53265,Discontinued in Preregistration
186418,Patented
143843,Discontinued in Phase 4
157869,IND submitted
160176,Phase 2b
162142,Investigative
28779,Phase 1b/2a
178249,Phase 2a
150244,Patented
171687,Discontinued in Phase 2
182313,Phase 3
57438,Investigative
4961,Phase 2a
74358,Phase 1/2a
18452,Phase 1
46005,Phase 1/2a
75997,Investigative
173662,Phase 1
126237,BLA submitted
102055,Application submitted
705,Phase 2b
20831,Registered
154035,Discontinued in Phase 2b
18005,Discontinued in Phase 3
75851,Phase 1b
168643,Phase 1/2
144731,Phase 1b
89860,Discontinued in Preregistration
22686,Phase 0
127187,Phase 1/2a
77429,Patented
119253,Phase 2
93812,Discontinued in Phase 2b
39908,Phase 1
165086,Phase 1/2a
64384,Approved
103598,Phase 1/2
180383,Phase 1
160049,Phase 2
112389,Phase 0
129767,Discontinued in Preregistration
164645,Phase 1/2
48652,Phase 1
86564,Phase 1/2
96206,Discontinued in Phase 1/2
124565,Patented
9888,Phase 1/2
121033,Phase 2a
47818,Phase 1b
94870,Phase 1/2a
118751,Phase 2a
190018,Phase 1b
95001,Phase 1b
58869,Phase 1b/2a
85265,Discontinued in Phase 2b
62269,Phase 1b
127404,Phase 1
144654,Discontinued in Phase 4
171091,Patented
27306,Phase 1/2a
36110,Phase 2/3
30009,Discontinued in Phase 2/3
160681,Phase 1
47052,Phase 1
124942,Phase 1/2
91861,Discontinued in Phase 1
73187,Phase 1b
81635,Approved
94852,Patented
127391,Discontinued in Preregistration
45423,Phase 2/3
167428,Discontinued in Phase 1/2
181029,Phase 1/2
137835,Investigative
126208,Discontinued in Phase 3
58146,Phase 0
86997,Discontinued in Phase 3
75981,Phase 1b
124624,Phase 0
44188,Phase 1/2a
181291,Phase 1
12723,Phase 1
71492,Phase 1/2
56585,Phase 2
124949,Discontinued in Phase 4
130135,Phase 2/3
64503,Approved (orphan drug)
122058,IND submitted
131304,Phase 1/2
152992,Investigative
10,Discontinued in Phase 1/2
31394,IND submitted
61077,Investigative
141191,IND submitted
176743,Phase 2
161814,Investigative
151145,Phase 1b/2a
121477,Discontinued in Phase 1/2
184813,Phase 1/2
185132,Discontinued in Phase 4
95236,Patented
133052,Discontinued in Phase 3
32621,Patented
37349,Phase 1
102370,Phase 1/2a
48297,Phase 2
179795,Phase 1/2a
25122,Discontinued in Phase 2/3
32066,Phase 1b/2a
5119,Preregistration
63850,Clinical trial
113399,Phase 1b/2a
163754,Investigative
41612,Phase 1
93930,Phase 2a
176128,Phase 2b
158644,Discontinued in Phase 1
40920,Approved
42159,Phase 0
116136,Phase 2
104904,Phase 1b
181584,Phase 1
143133,Phase 2
179563,Phase 1/2
84143,Phase 1/2a
43771,Phase 1/2a
174518,IND submitted
81163,Discontinued in Phase 1
81587,Approved
13880,Phase 1
9688,Discontinued in Preregistration
172199,Investigative
5232,Phase 1b/2a
191893,Patented
168051,Phase 1b
141909,Patented
116332,Investigative
185605,Phase 0
54489,Discontinued in Preregistration
16987,Phase 1
170899,IND submitted
165533,Discontinued in Phase 4
130447,Phase 1/2a
13028,Phase 1
108025,Investigative
22314,IND submitted
127523,Discontinued in Preregistration
68044,Phase 1
27852,Phase 1
162553,Patented
182998,Discontinued in Phase 4
120221,Discontinued in Phase 2
55134,Patented
180361,Phase 1/2a
152273,Phase 2
143208,Phase 1b/2a
108082,Phase 2
53400,Discontinued in Phase 3
167717,Discontinued in Preregistration
77354,Phase 1b
39844,Discontinued in Phase 2b
97784,Phase 2
11927,Phase 1
40547,Phase 2/3
15833,Phase 1
112711,Discontinued in Phase 2
20048,Phase 0
132088,Phase 1/2
113274,Discontinued in Phase 1
44721,Phase 2/3
126807,Phase 1/2
30370,Phase 0
96873,Phase 1/2
178723,Phase 2a
142069,Discontinued in Preregistration
98256,Discontinued in Phase 2b
182059,Phase 2
92662,Phase 1/2
134231,Patented
73042,Phase 0
95248,Patented
84035,IND submitted
77366,IND submitted
63699,Approved (orphan drug)
182732,Phase 1
80258,BLA submitted
104554,Phase 0
158347,Phase 1b/2a
102099,Phase 1b
184196,Discontinued in Phase 4
79376,Phase 2a
159943,Phase 1b/2a
183045,Discontinued in Phase 2b
56812,Phase 1
31126,Investigative
29252,Phase 4
6073,Phase 4
19746,Phase 1
171479,Discontinued in Phase 2
152892,Investigative
73573,Phase 1b/2a
119502,Patented
74709,Phase 1/2a
23348,Phase 2
189280,IND submitted
147070,Phase 1b/2a
147374,Phase 2b
132082,Phase 1/2
104557,Investigative
3327,Phase 1b
126960,Discontinued in Phase 2b
34153,Patented
98600,Discontinued in Phase 2
22554,Phase 1/2a
80311,Phase 2
145786,Phase 2b
114595,Discontinued in Phase 1
187659,Phase 0
78746,Phase 3
21692,Phase 1/2
91579,Discontinued in Phase 1
175759,Phase 1
109379,Discontinued in Preregistration
128819,Discontinued in Preregistration
55471,Phase 1/2a
69899,Phase 1
27006,Phase 1b
156196,Phase 1/2a
80300,Phase 2a
181755,Phase 2a
145749,Phase 1b
79578,Phase 1b/2a
9545,Patented
51368,Discontinued in Phase 2b
57284,Phase 1
24983,Phase 2
89934,Phase 2/3
92575,Clinical trial
74554,Discontinued in Phase 4
96374,Phase 2b
15082,Phase 1/2
49574,Discontinued in Preregistration
100732,Phase 1b
128552,Phase 0
97138,Phase 1b
189043,IND submitted
51637,Discontinued in Phase 2/3
167540,Phase 1/2a
52091,Discontinued in Preregistration
173112,Phase 1b
35768,Phase 1/2
50144,Discontinued in Phase 2b
73001,IND submitted
29553,Phase 1b/2a
67989,Phase 2b
27621,Phase 1/2
132786,Phase 1b/2a
177015,Phase 1/2
176138,IND submitted
59774,Discontinued in Phase 3
140495,Phase 2a
163007,Discontinued in Phase 1/2
88455,Phase 1
142109,Discontinued in Phase 2b
62703,Phase 1b
99099,Phase 1
11356,Discontinued in Phase 2b
131862,Phase 1b/2a
183633,Phase 1/2
92479,Phase 4
55531,Phase 0
138913,Clinical trial
136228,IND submitted
154314,Investigative
186853,Phase 2/3
78949,Phase 2a
147173,Discontinued in Phase 2
43104,Discontinued in Phase 1/2
188934,Approved (orphan drug)
157020,Approved (orphan drug)
50960,Discontinued in Phase 2b
115983,Approved (orphan drug)
85896,Discontinued in Preregistration
62479,Discontinued in Phase 4
153873,Discontinued in Phase 2/3
182040,Phase 1/2a
151772,Phase 1
103748,Phase 1b
99393,Phase 1
4393,IND submitted
107999,Discontinued in Phase 1/2
79271,Phase 0
54699,Discontinued in Phase 2b
51774,Discontinued in Phase 2b
2117,Phase 2b
109170,Phase 1/2a
31,Phase 2
177751,Approved
101056,Investigative
71847,Phase 1b
53642,Phase 0
106807,Phase 0
122466,Phase 0
166048,Phase 1b
139283,BLA submitted
177752,Phase 1/2a
51437,Phase 0
172023,Discontinued in Phase 2
29254,Phase 4
145237,Phase 1b/2a
21342,Patented
138155,Approved (orphan drug)
156632,Clinical trial
76689,Phase 0
37932,Phase 1/2a
152889,Phase 1b/2a
13165,Phase 1/2a
46787,Phase 1/2
54312,Discontinued in Preregistration
21355,Phase 2
66732,Phase 1/2a
138425,BLA submitted
70963,Discontinued in Phase 3
29342,Phase 1b/2a
64643,Phase 1b/2a
141884,Patented
123369,Phase 1/2
65827,Preregistration
171108,Phase 0
120701,Discontinued in Phase 2
130856,Discontinued in Phase 2b
44242,Phase 2/3
93761,Phase 2
165008,Phase 1
59597,Phase 1b/2a
20990,Phase 1
81711,Phase 1
71729,Investigative
154012,Phase 2/3
88885,Phase 1/2a
36805,Discontinued in Phase 1
161235,Discontinued in Phase 1/2
379,Discontinued in Phase 2/3
106233,Phase 1/2a
140548,Patented
136919,Phase 1b/2a
74160,Discontinued in Phase 4
165430,Patented
144023,Investigative
31235,Phase 1
106883,Phase 2b
47367,Phase 0
53324,Phase 1b
137679,Investigative
39598,Phase 2
11935,Phase 1/2a
75700,Discontinued in Phase 1/2
3006,Phase 1/2a
96356,Phase 1b/2a
37287,Phase 2a
132868,Discontinued in Phase 1/2
87108,Patented
190121,Phase 2/3
50743,Phase 1/2a
17704,Phase 0
132920,Phase 0
21503,Patented
57607,Phase 1
5139,Investigative
97118,Phase 1b
134279,Phase 1
100787,Phase 1/2
127134,Phase 1/2
188511,Phase 1/2
61766,Discontinued in Preregistration
184921,Phase 1/2
132401,Discontinued in Phase 4
45296,Phase 2/3
80417,Discontinued in Phase 2
106916,Phase 0
18270,Phase 1/2
38345,Discontinued in Preregistration
52340,Discontinued in Preregistration
168881,Clinical trial
94532,Discontinued in Phase 1
67967,Phase 0
160387,Phase 3
127812,Discontinued in Phase 3
160129,Phase 1b/2a
163987,Phase 1
60849,Phase 1b/2a
186688,Patented
126720,Phase 1
117383,Discontinued in Phase 1
3300,Phase 1/2a
38405,Phase 1
42371,Discontinued in Phase 1
136798,Discontinued in Phase 2/3
134969,Phase 0
144756,Phase 1
137540,BLA submitted
1097,Phase 0
150021,Discontinued in Phase 2
13130,Phase 1b/2a
37018,Phase 1b/2a
140439,Phase 2/3
48781,Discontinued in Phase 2/3
189023,Phase 2b
186161,Patented
92092,Discontinued in Phase 2
119823,Approved (orphan drug)
36207,Discontinued in Phase 1
14314,Phase 1/2
158520,Phase 2b
90414,Phase 1b
39371,Phase 1b
179605,Discontinued in Phase 1
149301,Phase 1b
160391,Phase 2a
167623,Phase 1/2a
27837,Phase 2
34887,Patented
38539,Phase 0
125561,IND submitted
149519,Phase 2b
97160,Phase 1/2a
179317,Discontinued in Phase 2/3
144080,Phase 1/2
44098,Phase 2/3
118107,Phase 1/2a
2657,Phase 1b
44808,Phase 2/3
52441,Phase 1b
52192,Discontinued in Phase 4
113597,Patented
101526,Phase 1
37367,Discontinued in Phase 3
74946,Phase 1/2
155617,Patented
141328,Phase 2/3
20203,Clinical trial
56661,Phase 2
91302,Approved
43497,Phase 2/3
172744,Investigative
185082,Phase 0
51748,Phase 1/2a
116289,Phase 1/2a
172308,Phase 0
55244,Discontinued in Phase 2b
166924,Discontinued in Phase 1/2
153030,Phase 0
143679,Phase 1/2
14548,Phase 1
48160,Phase 1b
83488,Phase 1
168931,Discontinued in Phase 1/2
102859,IND submitted
73527,Clinical trial
11533,Phase 1/2
153199,Discontinued in Phase 3
110501,Phase 3
164119,Phase 2/3
139514,Phase 1/2a
108719,Patented
83570,Phase 0
170876,Phase 0
87705,Phase 1/2
65088,Phase 1b/2a
178055,Phase 1
168713,Discontinued in Phase 1/2
130900,Discontinued in Preregistration
162827,IND submitted
62200,Phase 2/3
67793,Discontinued in Phase 2
77612,IND submitted
177170,Phase 1/2
144154,Phase 1/2
161366,Discontinued in Phase 1/2
96558,Phase 1b/2a
86206,Phase 0
75674,Discontinued in Phase 1/2
56748,Discontinued in Phase 3
133395,Approved
84081,Phase 1
107184,Phase 1/2a
155880,Discontinued in Phase 4
58748,Phase 1/2a
81209,Clinical trial
17669,Phase 0
116813,Phase 1
116418,Discontinued in Phase 2/3
46416,Discontinued in Phase 4
132617,Discontinued in Phase 1/2
94575,Patented
16820,Phase 1/2a
26902,Phase 1b
86585,Phase 1/2
86798,Discontinued in Phase 1/2
80306,Phase 1b/2a
41370,Discontinued in Preregistration
154993,Investigative
66085,Phase 2a
16466,Phase 1
28621,Investigative
82809,Phase 1/2a
174046,Phase 1
22851,Phase 1/2a
50856,Phase 1/2a
130973,Discontinued in Phase 4
130816,Discontinued in Phase 2b
143936,Phase 1/2
75838,Phase 2/3
190495,Phase 1/2
27880,Phase 1/2a
47444,Discontinued in Phase 2b
12137,IND submitted
43961,Phase 2/3
25236,Phase 0
29728,Phase 0
29908,Phase 0
55095,Phase 1b
73530,Approved
174507,Phase 3
33087,Phase 1/2
154714,Phase 2
71308,Discontinued in Phase 1
27638,IND submitted
60254,Investigative
42733,Phase 1
49012,Phase 1/2
44234,Phase 2/3
44546,Phase 2/3
178460,Discontinued in Phase 2/3
121677,Discontinued in Phase 2b
146403,Phase 1b/2a
156409,Phase 1/2a
70508,Phase 2
174009,Discontinued in Phase 4
139235,Investigative
181145,Discontinued in Phase 2b
184651,Phase 0
27969,Phase 1b/2a
184597,Phase 1/2
176344,Phase 1/2a
118394,Discontinued in Phase 1/2
182826,Phase 2b
105517,Phase 1b
128946,Investigative
6799,Phase 2a
70227,Phase 2
178497,Phase 1/2
106611,Discontinued in Phase 3
122496,Phase 0
167855,Investigative
165193,Investigative
7693,Patented
148565,Discontinued in Phase 2/3
167754,Phase 1b/2a
130448,Phase 1b/2a
174318,Phase 3
170318,Phase 1b/2a
53859,Discontinued in Preregistration
77589,Patented
125271,Phase 1b/2a
126083,Phase 1b
30835,Clinical trial
143196,Phase 2a
119911,Investigative
5052,Phase 1b/2a
191745,IND submitted
73628,Investigative
9602,Investigative
145495,Phase 1/2
175900,Patented
68888,Discontinued in Phase 2
102580,Phase 1/2
114278,Phase 1b
58243,Phase 2/3
75489,Phase 1/2
162012,Investigative
184647,BLA submitted
87852,Discontinued in Phase 1/2
22135,Patented
59397,Investigative
99177,Discontinued in Phase 2/3
184486,Discontinued in Phase 4
38600,Phase 1/2a
128012,Phase 0
78069,Investigative
93640,Phase 2b
71721,Phase 1b
91303,Discontinued in Phase 2
188638,Phase 2/3
186026,Clinical trial
136659,Investigative
110826,Phase 1
35860,Phase 2a
13703,Discontinued in Phase 1
170375,IND submitted
75423,Phase 1/2a
86014,Phase 1
138615,Discontinued in Phase 2
149287,Phase 1
151500,Phase 1/2
82849,Phase 1/2a
92822,Discontinued in Phase 3
135189,Phase 0
45745,Phase 2/3
111279,Patented
59073,Discontinued in Phase 3
20233,Discontinued in Preregistration
94507,Phase 0
31084,Discontinued in Preregistration
125117,Discontinued in Preregistration
142564,Phase 1/2a
133514,Phase 1/2
137770,Phase 1b
163021,Discontinued in Preregistration
172167,Discontinued in Phase 2
23171,Phase 2a
124573,Phase 1/2
172137,Phase 2
125405,Phase 1b/2a
132993,Discontinued in Preregistration
166484,Investigative
132320,Discontinued in Phase 4
137037,Patented
154925,Phase 2
170296,Phase 0
69504,Phase 2/3
19226,Discontinued in Phase 2b
158357,Phase 1b
185840,Phase 2a
28276,IND submitted
79199,Phase 0
163712,IND submitted
47828,Discontinued in Phase 2/3
190123,Phase 1/2
91506,Approved (orphan drug)
98260,Phase 2
183335,Phase 1b/2a
72922,Phase 2/3
131927,Discontinued in Phase 4
137126,Phase 1b
55278,Discontinued in Phase 2
74054,Phase 1/2
127854,Phase 1/2
108330,Phase 1b
146297,Phase 2a
124259,Discontinued in Preregistration
111034,Discontinued in Phase 3
164636,Phase 1/2a
93368,Discontinued in Phase 3
166923,Discontinued in Phase 1
94576,Patented
24524,Phase 1/2
71380,Discontinued in Phase 1
191708,Phase 1
62211,Phase 1/2
44214,Phase 1/2a
135530,Phase 0
137974,Phase 1/2a
183026,Phase 2b
164760,Phase 1
28263,Phase 0
172131,Phase 1/2
139234,Investigative
20352,Phase 1/2
167745,Discontinued in Phase 2
90327,Approved (orphan drug)
119458,Phase 2
44518,Phase 1/2a
105701,Phase 1b
153056,Phase 1b/2a
45226,Phase 2/3
110038,Phase 1
27541,Phase 1/2
17798,Phase 0
177265,Phase 1b
36018,Phase 1b
156638,Phase 2a
66169,Phase 1b/2a
187526,Clinical trial
189510,Discontinued in Phase 3
77718,Discontinued in Phase 2
15249,Phase 0
181521,Phase 2a
33544,Phase 1b/2a
42741,Phase 1
132432,Discontinued in Phase 4
64901,Phase 2a
95247,Patented
151129,Phase 1
22296,IND submitted
4255,Preregistration
82648,Discontinued in Preregistration
152780,Approved
181586,Phase 1b
138470,BLA submitted
15604,Phase 1
148661,Phase 2b
73608,Phase 2/3
190732,Discontinued in Phase 3
33418,Approved (orphan drug)
158293,Phase 1b/2a
114836,Phase 1/2a
156356,Phase 1b
44125,Phase 1/2a
162352,Phase 1/2a
99340,Phase 0
141662,Patented
112945,Phase 1/2
174244,Discontinued in Phase 4
24213,Discontinued in Preregistration
184915,Phase 0
45872,Phase 2/3
163960,Discontinued in Preregistration
84063,Phase 0
155472,Phase 2
119516,Discontinued in Preregistration
167275,Discontinued in Phase 2
156800,Phase 0
79534,Discontinued in Phase 1/2
142149,Patented
134853,Phase 0
94174,Discontinued in Phase 3
126950,Phase 1/2
164611,BLA submitted
71938,Discontinued in Phase 1
136468,Phase 1/2
52662,Phase 1b
88790,Phase 1
30454,Discontinued in Preregistration
136717,Phase 2
62203,Phase 2/3
188413,BLA submitted
81061,Discontinued in Phase 2
12131,IND submitted
188127,Discontinued in Phase 1/2
184193,Phase 1
55035,Discontinued in Phase 2/3
25766,Discontinued in Phase 4
96039,Phase 1b
77816,Phase 0
163525,Discontinued in Phase 2
175420,Discontinued in Phase 1/2
94155,Phase 1b
145482,Phase 1/2a
31950,Phase 1b
20454,Phase 1b/2a
163828,Phase 1/2
1527,IND submitted
161474,Investigative
156654,Phase 2
149005,Phase 1/2
25124,Phase 2
117261,Investigative
103655,Clinical trial
52997,Discontinued in Phase 2/3
125600,Discontinued in Preregistration
91618,Clinical trial
36003,Phase 2a
97033,Investigative
120049,Phase 4
27954,Discontinued in Phase 4
87880,Discontinued in Phase 2/3
122512,Phase 0
76836,Phase 1/2a
19044,Discontinued in Preregistration
148951,Clinical trial
153033,Phase 1
141923,Discontinued in Phase 1
170359,Phase 0
74772,Discontinued in Phase 4
72462,Phase 2
149278,Phase 1/2
16697,Phase 1
102359,Discontinued in Preregistration
133361,Discontinued in Phase 1
105165,Phase 1/2
10132,Investigative
47855,Phase 1/2a
52746,Patented
97285,Investigative
179714,Discontinued in Phase 1/2
64053,Patented
176084,IND submitted
145142,Phase 1b/2a
95573,Phase 1/2
114081,Discontinued in Preregistration
64867,Clinical trial
177775,Phase 1b
44228,Phase 1/2a
15148,Phase 1b/2a
157224,Phase 1/2
96660,Discontinued in Phase 2b
166937,Investigative
103930,Phase 1/2a
121820,Discontinued in Phase 1
176950,Phase 1/2a
149747,Discontinued in Phase 2/3
163817,Phase 1
143324,Phase 2/3
142385,Investigative
161223,Phase 1
147495,Phase 1b/2a
56205,IND submitted
18845,IND submitted
61834,Discontinued in Phase 2b
144145,Phase 1/2
35653,Discontinued in Preregistration
60669,Discontinued in Phase 3
10790,Preclinical
128626,Phase 0
74699,Phase 1
125608,Discontinued in Phase 4
88151,Discontinued in Phase 1/2
177664,Phase 1/2a
118994,Phase 1b/2a
115361,Clinical trial
175446,Phase 1/2
58302,Phase 1/2
157290,Clinical trial
112481,Discontinued in Phase 3
22694,Phase 2
167503,Discontinued in Phase 2
25770,Phase 2/3
21159,Investigative
81507,Approved
68083,Phase 1
43420,Phase 1/2a
153813,Phase 1b
164580,Phase 1
36839,Phase 1
144805,Phase 2
138790,Discontinued in Phase 2
136445,Discontinued in Phase 4
39780,Phase 0
24826,Discontinued in Phase 2/3
36947,Discontinued in Phase 3
62906,Phase 1
24555,Discontinued in Phase 4
73811,Phase 2a
70718,Phase 1b
154986,Discontinued in Preregistration
328,Phase 2
31322,Discontinued in Preregistration
4556,Phase 2a
29362,Phase 2/3
85212,IND submitted
42896,Discontinued in Phase 1/2
53562,Patented
178437,Phase 2a
99614,Phase 1
186540,Phase 1b
30066,Phase 1b/2a
56121,Discontinued in Preregistration
121443,Phase 2
45882,Phase 2/3
125534,Phase 1/2a
83053,Phase 1
5894,Discontinued in Phase 2
23716,Discontinued in Phase 2/3
181940,Phase 1/2a
137983,Phase 1b
109387,Phase 3
58916,Phase 1/2a
170094,IND submitted
114057,IND submitted
75202,Phase 2a
79703,Phase 1
143916,Phase 2b
122545,Phase 0
93251,Phase 2b
17314,Phase 1/2
29646,Phase 2
8366,Patented
424,Phase 1
41599,Phase 1b
55162,Phase 1b/2a
30540,Discontinued in Phase 4
23486,Phase 1/2
60532,Phase 1
182072,Phase 2a
24844,Phase 2/3
96875,Investigative
113713,Phase 0
58440,Phase 1/2a
114418,Phase 1b/2a
54299,Discontinued in Phase 2b
70543,Phase 1b/2a
57642,Phase 0
159057,Approved
99891,Phase 1
129758,Phase 1/2
94472,Phase 2b
187026,Phase 2a
96596,Discontinued in Phase 3
130617,Patented
16020,Phase 0
82058,Clinical trial
174026,Phase 1b
82653,Discontinued in Phase 2/3
170372,Phase 0
166876,Phase 1b/2a
156645,Phase 1b/2a
37749,Phase 1/2
101004,Phase 1b/2a
136425,Discontinued in Phase 2
23259,Discontinued in Phase 2b
166015,Phase 1
123990,Investigative
99694,Phase 1
180571,Phase 2a
140700,Registered
1520,Phase 0
144908,Phase 1b/2a
173420,Phase 1
115042,Phase 1/2a
181909,Phase 2
16651,Phase 1
190011,Phase 2b
40956,Discontinued in Phase 2
138808,Phase 1/2a
56001,IND submitted
131527,Phase 1b/2a
65784,Phase 1b/2a
91144,Discontinued in Preregistration
40932,Approved
113311,Discontinued in Phase 3
77239,Phase 1/2
46004,Phase 1/2a
93108,Discontinued in Phase 3
75303,Patented
76230,Investigative
158232,Phase 0
85678,Discontinued in Phase 2b
3125,Investigative
124064,Phase 1b
43667,Phase 1/2a
21735,Patented
173023,Phase 0
181655,Phase 2a
183536,Discontinued in Phase 4
117362,Discontinued in Phase 2b
63945,Discontinued in Phase 2b
74400,Discontinued in Phase 4
65480,Phase 2/3
116279,Phase 2a
35951,Phase 2/3
45604,Phase 1/2a
37540,Discontinued in Phase 1
52609,Investigative
112634,Phase 1/2
158751,Approved
184561,Phase 1/2
57182,Phase 1/2
77995,Investigative
15826,Phase 0
74647,Patented
106596,Discontinued in Phase 2
12864,Phase 2b
25867,Phase 1b/2a
47361,Phase 0
89834,Patented
151253,Phase 1
128678,Phase 1/2
148711,Phase 2b
22288,Discontinued in Phase 3
8092,Phase 2
36493,Patented
43310,Phase 1/2a
149817,Discontinued in Preregistration
181235,Phase 1b
152194,Phase 2
63205,Discontinued in Preregistration
120334,Clinical trial
102242,IND submitted
45827,Phase 1/2a
123929,Discontinued in Preregistration
28780,Phase 1b/2a
69691,Discontinued in Phase 3
100859,Phase 2a
107045,Phase 1b
107330,Phase 0
155977,Phase 1b/2a
177096,Phase 1b/2a
155077,Patented
89537,Phase 1b
64229,Clinical trial
160754,Phase 0
178775,Phase 2a
35862,Investigative
137624,BLA submitted
112021,Phase 1/2
81532,Phase 2
117324,Discontinued in Phase 1
122999,Phase 0
112523,Discontinued in Phase 3
109963,Patented
38424,Phase 2
122069,IND submitted
131364,Phase 2
1195,Discontinued in Phase 4
89200,Discontinued in Phase 4
34305,Phase 1/2
142994,Phase 2b
102542,Approved
129689,Patented
175168,Phase 1/2
6835,Phase 2/3
11562,Phase 0
1996,Investigative
82694,Phase 0
182929,Phase 1/2
3487,Approved
149752,IND submitted
91905,Phase 1
188558,Clinical trial
48579,Discontinued in Phase 2b
139597,BLA submitted
6490,IND submitted
10973,Phase 2a
130049,Phase 2a
90386,Phase 0
21724,Phase 1b/2a
72586,IND submitted
98008,Phase 2
140329,Phase 1/2a
76790,IND submitted
90407,Phase 2a
144352,Discontinued in Phase 1/2
59282,Phase 1/2
3991,Discontinued in Preregistration
89979,Phase 0
141608,Investigative
50288,Discontinued in Phase 3
69818,Phase 1
166742,Phase 1
171155,Phase 1
114647,Phase 1/2a
110197,Phase 1b/2a
158964,IND submitted
128916,Phase 1
152110,Phase 2
153486,Phase 1b
57486,Phase 2/3
96123,Phase 1/2a
147735,Phase 2b
141308,Patented
59355,Discontinued in Phase 2/3
112321,Phase 1/2
55273,Phase 0
43408,Phase 2/3
100210,Approved
25590,Discontinued in Phase 2b
150265,Phase 2
167129,Investigative
89261,Discontinued in Phase 3
141796,Discontinued in Phase 2/3
1014,Discontinued in Phase 2b
83988,Phase 1
36008,Patented
176527,Phase 2
100267,Approved
67999,Phase 0
178753,Phase 1/2a
121080,Phase 1b
76556,IND submitted
42685,Phase 1
124845,Phase 1/2
76397,Phase 1b
115186,Phase 1b/2a
37212,Phase 2a
123826,Patented
51394,Phase 0
98809,Phase 1b
72379,Phase 1b
23510,Discontinued in Preregistration
42719,Discontinued in Phase 1
137684,Investigative
32260,Phase 1/2
79707,Investigative
178471,Phase 1/2
25847,Phase 1/2a
123075,Phase 1b
41191,Investigative
81022,Discontinued in Phase 3
120835,Discontinued in Phase 1/2
133523,IND submitted
48,Phase 1
70572,Phase 1/2
27073,Phase 1b/2a
53914,Phase 0
1766,Phase 2
125921,IND submitted
77442,Discontinued in Phase 1/2
143700,Phase 2b
188641,Phase 1/2
190778,Phase 1b
134020,Patented
92846,Phase 2
6450,Investigative
100631,Phase 1/2
185464,Phase 1/2a
30862,Phase 0
161219,Discontinued in Preregistration
123213,Phase 1b
13086,Phase 1/2
19999,IND submitted
32268,Phase 1/2
120992,Phase 1b
72142,Patented
136158,Phase 1b/2a
108008,Discontinued in Phase 2b
172799,Discontinued in Phase 2b
59321,Phase 0
181952,Phase 2a
100601,Phase 1/2
67580,Phase 1b
168961,Phase 2
119284,Phase 1b/2a
104589,Patented
101472,Phase 0
158970,Approved
45345,Phase 2/3
41673,Investigative
100654,IND submitted
180326,Phase 2b
133070,Phase 1
144483,Discontinued in Phase 2
74118,Phase 1/2a
184764,Phase 1/2
131169,Phase 1/2
173933,Discontinued in Phase 1/2
187000,Phase 0
147947,Phase 1/2
32876,Phase 1/2
149492,Discontinued in Phase 1
130338,Phase 1/2a
11161,Discontinued in Phase 2b
97834,Phase 1/2
155135,Phase 1b
68997,Phase 2a
60837,Discontinued in Phase 3
112763,Discontinued in Phase 3
9353,Phase 1b/2a
51374,Discontinued in Phase 3
55308,Discontinued in Phase 2b
155030,Clinical trial
172502,Discontinued in Phase 2
53916,Phase 1/2a
145937,Phase 2b
61314,Patented
43464,Phase 2/3
133254,Phase 1/2
172054,Phase 2a
177210,Phase 1b
164294,Investigative
115667,Discontinued in Preregistration
104234,Phase 1b/2a
114559,Phase 2
26104,Phase 1
65537,Phase 1b
182605,Phase 2a
61431,Patented
80910,Discontinued in Phase 3
69349,Discontinued in Phase 3
183969,Discontinued in Phase 4
140530,BLA submitted
90132,Phase 1b/2a
5045,Phase 1/2
63069,Phase 0
57152,Phase 1/2a
30085,Clinical trial
29775,Phase 1
147743,Phase 1b
158037,IND submitted
142061,Discontinued in Phase 2b
38611,Patented
65604,Discontinued in Phase 2b
87095,Phase 1/2
123602,Phase 1b
153734,Investigative
42983,Phase 1b
114218,Phase 0
68855,Phase 1
152003,Phase 0
165513,IND submitted
701,Phase 1/2a
66120,Approved
23750,Investigative
130625,Phase 1/2a
160510,Phase 1
76531,Discontinued in Phase 1/2
44451,Phase 1/2a
63861,Phase 1
95471,Phase 1
22213,Phase 0
69247,Discontinued in Phase 3
111459,Phase 1/2
67649,Discontinued in Phase 1
15986,Phase 1
157281,Discontinued in Phase 4
43050,Phase 0
108994,Discontinued in Phase 3
123180,Phase 1b
11736,Phase 2a
102669,Approved (orphan drug)
60784,Phase 1
93751,Phase 0
138824,Clinical trial
111978,Discontinued in Phase 3
84066,Phase 1/2
139970,BLA submitted
79506,Discontinued in Phase 1/2
188236,Discontinued in Phase 3
57510,Investigative
151444,Phase 0
59299,Discontinued in Phase 2/3
133306,Approved
141615,Discontinued in Phase 4
170541,Phase 0
98549,Phase 0
97487,Phase 1b
176305,Phase 1b
37632,Phase 2a
55615,Phase 1/2a
45465,Phase 2/3
24304,Phase 1/2
4371,Investigative
108623,Phase 1b/2a
156657,Discontinued in Phase 4
4114,IND submitted
132769,Discontinued in Preregistration
153415,IND submitted
126043,Phase 1b
82049,Phase 1b/2a
95972,Phase 2
13830,Phase 0
18511,Discontinued in Phase 3
71046,Discontinued in Phase 1/2
65981,Phase 2/3
15606,Phase 1/2
182327,Phase 1/2a
105562,Phase 1b/2a
34201,Phase 0
46604,Phase 1/2a
78403,Approved
56384,Phase 1b/2a
33966,Discontinued in Phase 1
42377,Phase 1b/2a
172443,Discontinued in Phase 2
62347,IND submitted
84788,Phase 1/2
43692,Phase 1/2a
14673,Phase 0
76404,IND submitted
99327,Phase 1/2a
42378,Phase 1b
171565,Discontinued in Phase 2/3
134200,Phase 1b
92075,Phase 0
73609,Phase 1b/2a
105278,Phase 2a
16352,Phase 1/2
113979,Patented
109490,Approved
113401,Phase 2a
51648,Discontinued in Phase 3
76199,Phase 1
102328,Phase 1/2a
45370,Phase 2/3
161660,Investigative
77440,IND submitted
112120,Phase 1
75283,Phase 0
103291,IND submitted
130093,Patented
1236,Investigative
14392,Phase 0
62782,Patented
56724,Phase 1b/2a
139203,Phase 1b
71676,Discontinued in Phase 3
132053,IND submitted
191327,Phase 2a
118128,Phase 1
118523,Discontinued in Preregistration
53672,Discontinued in Phase 3
59050,Investigative
70269,Investigative
172874,Phase 1
33227,Discontinued in Phase 2
48077,Discontinued in Phase 2b
145987,Clinical trial
111462,Phase 0
71739,Phase 1b
100825,Phase 1/2
179377,Phase 1/2a
8785,Discontinued in Phase 1
123431,Discontinued in Phase 4
70116,Phase 0
18289,Discontinued in Phase 2/3
84409,Investigative
159150,BLA submitted
18118,Discontinued in Phase 4
107104,Phase 2b
14871,Phase 0
4321,IND submitted
100032,Phase 1/2
15098,Investigative
121305,Phase 1b/2a
148881,Discontinued in Preregistration
28079,Phase 1/2a
147691,Phase 1b/2a
125995,Phase 1b/2a
101608,Phase 1
168959,Clinical trial
157671,Discontinued in Phase 4
67902,Discontinued in Phase 2
157075,IND submitted
176448,Phase 1b/2a
54698,Discontinued in Phase 2b
155990,Phase 1b/2a
22834,Phase 0
23688,Phase 2
176607,Phase 1/2
90679,Discontinued in Phase 2b
8837,Discontinued in Phase 1
166464,Patented
156374,Phase 1/2
85314,Discontinued in Preregistration
153322,Patented
116166,Phase 1b
130442,Investigative
155463,Phase 2
139608,Investigative
146899,Phase 1/2
86884,Phase 1/2a
12038,Investigative
70469,Phase 1b
72932,Phase 1b/2a
191008,Approved
57648,Phase 1
115837,Phase 1b/2a
174385,Phase 1/2
94770,Phase 1
66400,Phase 1
32058,Phase 1/2
83627,Patented
144372,Discontinued in Phase 2/3
176078,Discontinued in Phase 3
176407,Phase 1b/2a
58503,Phase 1
151345,Phase 1b/2a
13846,Phase 1/2a
126362,Phase 1b
163979,Phase 1
164285,Phase 1/2
151255,Phase 1
65257,Phase 1b
107993,IND submitted
124253,Phase 0
164969,Phase 1
118028,Discontinued in Phase 4
144592,Phase 1/2
104379,Phase 1/2a
151311,Phase 2
156444,IND submitted
140487,Phase 1
23393,Phase 2a
168087,Patented
107152,Discontinued in Phase 1/2
95881,Phase 1/2
128923,Patented
107715,Discontinued in Phase 2/3
25257,Discontinued in Phase 2b
126443,Phase 1b
184432,Phase 0
141598,Investigative
116500,Discontinued in Phase 3
11480,Investigative
31132,Phase 0
159034,Phase 2
100087,Phase 1
165834,Phase 1
129892,Phase 1b/2a
172010,Phase 2
34234,Phase 1
102757,Phase 1b
129550,Phase 1
114517,Phase 1/2a
134959,Phase 0
165936,Discontinued in Phase 1/2
183643,Phase 4
26199,Phase 1
50407,Phase 1b
87678,Phase 1
39561,Investigative
75466,Discontinued in Phase 1/2
122914,Discontinued in Preregistration
44717,Phase 1/2a
60340,Approved (orphan drug)
74714,Discontinued in Phase 3
106462,Approved
41297,Clinical trial
95026,Phase 1/2a
29589,Discontinued in Phase 1
181567,Phase 1/2a
101631,Investigative
86873,Discontinued in Phase 1/2
124872,Phase 1
136572,Investigative
52161,Phase 4
135771,Phase 2/3
81533,Phase 1
4558,Phase 2a
113013,Phase 2a
80838,Phase 1b/2a
148110,Discontinued in Phase 2
73960,BLA submitted
121498,Approved
39801,Discontinued in Preregistration
106606,Discontinued in Phase 4
125100,Discontinued in Phase 4
114016,Phase 1/2a
155295,Phase 1b/2a
68743,Discontinued in Phase 4
10672,Discontinued in Phase 2b
66481,Patented
145813,IND submitted
180122,Phase 1b
4006,Phase 0
95599,Phase 2
125853,Phase 1/2
157970,Phase 1/2
146634,Phase 0
91420,Discontinued in Phase 2b
75135,Patented
3017,Discontinued in Phase 2
109824,Phase 1
86277,Discontinued in Phase 4
115798,Phase 1/2a
55132,Phase 1/2
41755,Phase 1
28977,Investigative
54893,Phase 2
166669,Discontinued in Phase 2b
164797,Phase 1
78836,Phase 0
72569,Investigative
55397,Investigative
89283,Phase 1/2a
163270,IND submitted
40525,Phase 1/2a
37562,Discontinued in Phase 3
157287,Patented
71273,Phase 1b/2a
13774,Phase 0
180203,Phase 2a
72676,IND submitted
136099,Phase 1b
112718,Phase 1/2
191909,Discontinued in Phase 3
98640,Phase 1b/2a
84042,Investigative
58583,Phase 1b/2a
31594,Discontinued in Preregistration
60812,Phase 1
9011,Discontinued in Phase 2/3
176568,Phase 1b/2a
151347,Phase 1b/2a
41692,Investigative
36642,Phase 2a
32275,Phase 1b/2a
164883,Phase 0
50665,Phase 3
190766,Phase 2b
48308,Discontinued in Phase 2b
88407,Phase 1/2
109823,Discontinued in Preregistration
145285,Clinical trial
8598,IND submitted
160065,Discontinued in Phase 1/2
109817,Discontinued in Preregistration
28292,Discontinued in Phase 4
122559,Discontinued in Phase 4
73444,Phase 2
48854,Phase 1b
38716,Phase 1b/2a
26721,BLA submitted
181283,Phase 1
42255,Phase 1
138832,Phase 1/2a
180932,Phase 1
86163,IND submitted
2337,Discontinued in Preregistration
105584,Phase 1b/2a
137096,Investigative
77969,Phase 1
135432,Phase 0
156619,Phase 1b/2a
151109,Phase 2
61790,Discontinued in Phase 4
104616,Phase 0
185061,Discontinued in Phase 4
132549,Discontinued in Phase 2b
164094,Phase 1
156276,Phase 1b/2a
138121,Clinical trial
105075,Discontinued in Phase 2b
45147,Phase 1/2a
37536,Phase 1
59908,Phase 0
91290,Discontinued in Phase 2
164599,Phase 2/3
63085,Discontinued in Preregistration
29894,IND submitted
171588,Phase 1/2
566,Discontinued in Phase 2/3
82887,Discontinued in Phase 4
80914,Phase 2a
57657,Phase 1b/2a
57470,Discontinued in Phase 3
87662,Patented
110665,Discontinued in Preregistration
188788,Phase 2b
29542,Phase 1/2a
141971,Discontinued in Phase 1
133612,Phase 1b
40045,Discontinued in Preregistration
143681,Phase 1/2a
179876,Discontinued in Phase 2/3
10080,Investigative
149110,Phase 1/2a
169736,Patented
12241,Phase 0
134816,Phase 0
32729,Phase 1/2
177323,Phase 1/2a
32179,Phase 2
172892,Phase 2
120124,Discontinued in Phase 1/2
170685,Patented
16675,Phase 0
11657,Phase 1
35682,Phase 0
65652,Approved
35662,Phase 0
80979,Phase 1/2a
132164,Phase 0
151133,Phase 1
65256,Phase 1
185508,Phase 0
65271,Phase 2a
156187,Phase 1b
172160,Phase 1
104199,Phase 1/2a
81945,Discontinued in Phase 1
13235,Phase 0
137475,Phase 1/2a
109882,Phase 3
83998,Phase 1/2a
135828,Phase 2
152358,Patented
48914,IND submitted
117757,Phase 2
52388,Discontinued in Phase 2b
29880,Discontinued in Phase 4
92190,Phase 1b
91149,Approved
9480,Patented
162769,Phase 1/2a
112256,Discontinued in Phase 2
16225,Phase 2b
25892,Phase 1/2
179386,Phase 1
144520,Discontinued in Phase 1/2
134779,Phase 0
155328,Phase 2a
160640,Phase 1/2
55223,Phase 1b/2a
191730,Phase 1
31739,Phase 1b
96768,Phase 1/2a
70120,Discontinued in Preregistration
28128,Discontinued in Phase 4
22805,Phase 2
31193,Phase 2
84232,Discontinued in Preregistration
42564,Phase 2/3
188036,Discontinued in Phase 4
1466,BLA submitted
55184,Discontinued in Phase 4
136929,Discontinued in Phase 2
170760,Phase 1/2
170690,IND submitted
62865,Discontinued in Preregistration
35953,Phase 1/2a
120784,Clinical trial
115664,Phase 1/2a
107739,Discontinued in Phase 2
164360,Phase 2/3
46357,Phase 1b/2a
71613,Phase 1b
147321,Discontinued in Preregistration
76418,Phase 1/2a
185118,Phase 0
77965,Clinical trial
157784,Clinical trial
58230,Phase 0
112236,Discontinued in Phase 3
81859,Phase 2
18969,Discontinued in Phase 2/3
66793,Phase 1/2
49469,Discontinued in Phase 4
124835,Phase 1
148168,Investigative
5964,Investigative
177533,Phase 1b
72025,Phase 0
41992,Phase 1
156251,Phase 1b
117587,Discontinued in Phase 2/3
75860,Phase 1
44182,Phase 1/2a
99872,Phase 2
27501,BLA submitted
98128,Patented
120782,Approved (orphan drug)
122470,Phase 1b
149943,Discontinued in Phase 2
40793,Phase 0
100280,Discontinued in Phase 1
163815,Discontinued in Preregistration
95422,Phase 1/2
32251,Phase 1/2a
53455,Phase 1b/2a
92054,Discontinued in Phase 2
114946,Phase 1b/2a
58927,Phase 1
191907,Phase 2/3
61103,Phase 1b/2a
73665,Patented
121999,Phase 2
29049,Investigative
7255,IND submitted
87013,Phase 1b/2a
54806,Phase 1
118085,Discontinued in Phase 2/3
21848,Discontinued in Phase 1/2
35830,Discontinued in Phase 1/2
110460,Phase 1b/2a
147349,Investigative
31819,Phase 1/2
144416,Discontinued in Phase 1/2
127578,Investigative
127044,Phase 1
13427,Phase 0
92451,Phase 4
124784,Discontinued in Phase 4
142912,Phase 1/2a
71580,Discontinued in Preregistration
39467,Discontinued in Phase 2
177357,Phase 1b
71435,Phase 0
42319,Investigative
767,Patented
69709,Discontinued in Phase 3
38557,Patented
172599,Phase 2
76816,IND submitted
136969,Phase 2
69524,Phase 1b/2a
128588,Phase 0
4603,Phase 2a
169932,Discontinued in Phase 4
1140,Clinical trial
132613,IND submitted
109729,Discontinued in Preregistration
149451,Phase 2b
123202,IND submitted
141934,Investigative
69192,Phase 1
23781,Discontinued in Phase 4
93400,Phase 1b/2a
65046,Phase 1b/2a
68170,Phase 1b/2a
19126,Phase 2
27165,IND submitted
142138,Discontinued in Phase 4
138663,Investigative
40261,Patented
167276,Phase 1/2a
157304,Phase 2
55221,Phase 3
48592,Phase 2/3
21577,Phase 1/2a
20563,Phase 1b/2a
136312,Investigative
41953,Discontinued in Phase 1
190911,Phase 1
178521,Patented
8299,Patented
140581,Phase 2a
28024,Discontinued in Phase 4
146532,Phase 1b
37108,Phase 1b/2a
1221,Patented
186433,Phase 2/3
128260,Discontinued in Phase 2b
138236,Phase 1/2a
1599,Discontinued in Phase 4
92112,Phase 1/2a
121857,Discontinued in Phase 1
34872,Patented
168518,Approved
93364,Discontinued in Phase 3
92308,Phase 2
43763,Phase 1/2a
108214,Phase 0
72613,IND submitted
43660,Phase 1/2a
154777,Phase 3
121658,Discontinued in Phase 2b
12936,Discontinued in Phase 1
123956,Phase 0
122572,Patented
47513,Phase 1/2
17900,Phase 2/3
177774,Phase 1/2a
179434,Phase 1/2
43951,Phase 2/3
72457,Investigative
58039,Discontinued in Phase 2/3
49044,Phase 1b
63362,Patented
189589,IND submitted
77780,Phase 0
158729,Phase 1/2
118433,Discontinued in Phase 2/3
118416,Phase 2b
174841,Phase 1
176249,Phase 1b
8794,IND submitted
160265,Phase 2
108439,Phase 0
127226,Phase 1/2
87214,Phase 1/2
38262,Phase 1b
44547,Phase 1/2a
150841,Phase 0
148829,Discontinued in Phase 1
172927,Discontinued in Phase 3
37351,Phase 1
24397,Discontinued in Phase 4
186869,Patented
104681,Patented
87837,Phase 0
55466,Patented
34308,Phase 1/2a
75874,Phase 1/2a
173074,Discontinued in Phase 2
182587,Phase 2/3
92909,Phase 1b
88652,Phase 1/2
12209,Phase 1
89568,Phase 1
27147,Phase 1b/2a
43965,Phase 1/2a
53988,Phase 1/2
155234,Phase 2
158701,Clinical trial
55980,Phase 1b/2a
83965,Phase 1/2
128038,Phase 1/2
142333,Discontinued in Preregistration
105450,Phase 1b
104870,Phase 1b/2a
174709,Phase 1/2
39842,Discontinued in Phase 2
30460,Phase 0
35424,Discontinued in Preregistration
22918,Discontinued in Preregistration
190497,Phase 1b/2a
98502,Phase 1b
88591,Patented
32623,Phase 0
74454,Phase 1/2
78087,Investigative
53195,Phase 1b
146373,Phase 1b
64228,Phase 1
143353,Phase 1b/2a
86060,Phase 1
26808,Phase 0
43325,Phase 1/2a
83042,Phase 0
84593,Phase 1/2
63940,IND submitted
35215,Phase 2a
4058,Discontinued in Phase 2
43428,Phase 1/2a
83201,Investigative
82018,Discontinued in Phase 2/3
16565,Phase 1/2
4107,Phase 1b/2a
151896,Phase 1
173493,Discontinued in Phase 2
185634,Phase 4
37820,Phase 1b
25724,Phase 2a
158450,Phase 1
77250,Phase 1b
181143,Discontinued in Phase 2b
66983,Phase 1/2
76242,Phase 1b/2a
55552,Phase 1/2
167343,Discontinued in Phase 1
165719,Investigative
92293,Registered
13510,Phase 1
33181,Phase 1b/2a
162585,Phase 1/2a
113634,Phase 1
64342,Phase 1
8870,Discontinued in Phase 2/3
66225,Patented
190832,Approved (orphan drug)
62601,Patented
166553,Phase 1b
149014,Phase 1
125193,Phase 1/2
29191,Investigative
154651,Phase 1b/2a
153047,Phase 1
166722,Phase 1b/2a
56444,Phase 3
1655,Phase 0
175946,Discontinued in Phase 3
99765,Phase 0
95859,Phase 1/2
53201,Discontinued in Phase 2/3
23434,Phase 2
56566,Phase 0
54047,Phase 0
50702,Phase 2
106928,Discontinued in Phase 1/2
66844,Phase 0
122114,Discontinued in Preregistration
155565,Approved (orphan drug)
182463,Phase 3
32911,Phase 1/2
95417,Phase 1/2a
79178,Phase 0
188702,Phase 1/2
116150,Discontinued in Preregistration
118215,Phase 1
101863,Phase 2a
29516,Phase 3
6975,Investigative
186214,Patented
20678,Patented
179478,Phase 2a
175324,Discontinued in Phase 3
85920,Discontinued in Preregistration
110472,Phase 1b/2a
185311,Discontinued in Phase 3
62324,Phase 1b
68565,Phase 2a
190954,Approved
172037,IND submitted
172764,Phase 1/2
157720,Phase 2
12689,Phase 1
3362,IND submitted
186482,Patented
138590,Phase 1/2a
54588,Phase 1/2
6208,Phase 4
179953,Phase 1
116255,Discontinued in Preregistration
190999,IND submitted
133399,Discontinued in Phase 1
98267,Phase 1/2
168476,Patented
70069,Phase 2a
183828,Phase 1/2
79806,Phase 2
19158,Phase 1/2
61400,Phase 2a
149543,Patented
23108,Patented
162433,Investigative
37394,Phase 1
131677,Discontinued in Preregistration
73834,Phase 2a
184352,Discontinued in Phase 4
28183,Phase 1/2a
85726,Discontinued in Phase 3
219,Discontinued in Phase 1
181773,Phase 2a
39074,Phase 2
56051,Phase 1b
79011,Phase 1b
100436,Phase 1/2a
185315,Discontinued in Phase 3
189314,Phase 2/3
130175,Phase 1/2
149417,Phase 2a
142818,Phase 1b/2a
23051,Phase 1b/2a
161295,Phase 1/2a
84823,Phase 1/2
170885,Phase 1b/2a
148872,Phase 1b
56083,Phase 1/2
148380,Phase 1b/2a
85169,Phase 1b/2a
52307,Phase 1/2a
178091,Phase 0
89609,Phase 1b/2a
151037,Phase 2
125910,Phase 1b/2a
80149,Phase 2a
29045,Phase 1/2a
93194,Phase 1/2a
155039,Phase 2
4186,IND submitted
67770,Phase 2b
51961,Phase 1b/2a
23924,Phase 1/2a
16138,Phase 1/2
94052,Phase 1/2a
31451,Investigative
112308,Discontinued in Phase 3
79328,Phase 1b/2a
43711,Phase 2/3
79492,Approved (orphan drug)
180597,Discontinued in Phase 4
58088,Phase 0
99432,Discontinued in Phase 2/3
11043,Patented
141875,Discontinued in Phase 1
179553,Discontinued in Phase 1
176234,Discontinued in Phase 4
159255,Phase 1b/2a
66444,Discontinued in Phase 3
66533,Discontinued in Phase 2/3
49029,Discontinued in Phase 2/3
70142,Discontinued in Preregistration
80384,Phase 2a
117623,Discontinued in Phase 1
154634,Phase 2
87804,Discontinued in Phase 2
44146,Phase 2/3
124654,IND submitted
40343,Investigative
152146,Phase 1b/2a
132851,Discontinued in Phase 4
2056,Investigative
26634,Phase 0
132403,Discontinued in Phase 4
155099,Phase 1b
17495,Investigative
50965,Discontinued in Phase 3
175395,Phase 2
122273,Phase 0
102933,Investigative
146206,Phase 1
134125,Phase 1
20026,Phase 1
62449,Phase 0
180127,Phase 1/2a
181892,Phase 1
175107,Discontinued in Phase 4
165263,Phase 1/2
158545,Phase 2/3
116897,Phase 2
51542,Patented
98890,Phase 1b/2a
24579,Phase 1b
30762,Phase 1
85978,Discontinued in Phase 3
119117,Phase 1b/2a
33461,Phase 2a
185389,Discontinued in Phase 4
9670,Phase 1b
154966,Phase 1b/2a
177868,Phase 2b
51379,Investigative
68585,Investigative
30645,Phase 1
106674,Phase 1b
39621,Phase 1b
149439,Investigative
63348,Phase 0
80588,Clinical trial
16981,Phase 0
48362,Phase 1b
143023,Discontinued in Phase 1/2
51320,Discontinued in Preregistration
79456,Phase 2a
55123,Phase 0
136781,Discontinued in Phase 3
29250,Phase 4
138920,Phase 1/2a
163444,Phase 1/2
30846,Phase 1b/2a
17266,Phase 0
11774,IND submitted
99889,Phase 1b/2a
141900,Investigative
157068,Phase 1/2
29916,Phase 1b/2a
165977,Discontinued in Phase 1/2
124809,Phase 0
86543,Discontinued in Phase 1/2
9806,Phase 1
67415,Phase 1b
32018,Discontinued in Phase 1
13243,Phase 1
99287,Phase 1
127129,Discontinued in Phase 4
83216,Phase 1
182757,Discontinued in Phase 2
155831,Discontinued in Phase 3
59109,Discontinued in Phase 1/2
72293,Phase 0
112636,Phase 1
190708,Approved
185933,Phase 4
7045,Phase 4
64876,Clinical trial
144021,Phase 2
113119,Phase 2a
24358,Discontinued in Phase 2/3
148924,Phase 1/2a
10890,Phase 0
82592,Investigative
120310,Approved (orphan drug)
54376,Phase 1b/2a
132079,Phase 1/2
22165,Discontinued in Phase 2
138131,Discontinued in Phase 2
51990,IND submitted
172553,Phase 0
25709,Phase 1/2a
84789,Phase 1b/2a
106082,Phase 2a
103648,Phase 1/2
177890,Discontinued in Phase 1/2
144430,Phase 1/2a
95172,Phase 1/2a
135938,Phase 1/2
52126,IND submitted
171377,Phase 0
164140,Discontinued in Preregistration
120643,Discontinued in Phase 1/2
73733,Phase 1/2a
102993,Discontinued in Preregistration
125045,Phase 0
3448,IND submitted
9899,IND submitted
151874,Phase 2
80687,Investigative
115959,Discontinued in Phase 2
184275,BLA submitted
75534,Phase 1/2a
84622,Phase 1/2a
28655,Phase 1b
161548,Phase 1b
96932,Phase 1b/2a
105200,Phase 1b/2a
128010,Investigative
17764,Phase 3
119313,Phase 1b/2a
137494,Phase 1/2a
71329,Discontinued in Preregistration
80125,Discontinued in Phase 1
91779,Phase 1b
18664,Phase 2
16062,Phase 1/2
191800,Phase 1
107440,Phase 3
51100,Phase 1
144569,Phase 1b
29947,Phase 1b
64168,Discontinued in Preregistration
79093,Phase 2/3
110795,Phase 1/2
56911,Investigative
112343,Discontinued in Phase 3
188496,Discontinued in Phase 3
59434,Phase 0
158904,Approved
69187,Discontinued in Phase 3
93027,Phase 2
118117,Discontinued in Preregistration
172894,Phase 2a
31265,Phase 1
14313,Phase 1/2
117250,Phase 1/2
13021,Phase 1b/2a
44302,Phase 1/2a
89657,Phase 1b/2a
111076,Phase 1/2
46826,Discontinued in Phase 2
94587,Patented
173570,Phase 1/2a
149486,Phase 2b
105161,Phase 1
64512,Phase 1b/2a
155805,Phase 1b
40980,Investigative
116944,Discontinued in Phase 1
18976,Phase 0
154050,Discontinued in Phase 2b
108294,Phase 0
182328,Phase 1/2a
177992,Discontinued in Phase 4
57521,Investigative
175224,Discontinued in Phase 4
64374,Phase 2
109144,Discontinued in Phase 3
188992,Approved
137574,Phase 1b
191319,Phase 1
76789,Phase 1/2a
78672,Phase 0
42793,Discontinued in Phase 2/3
121032,Phase 0
79859,Phase 1/2a
90212,Clinical trial
39260,IND submitted
66662,Phase 3
71923,Discontinued in Preregistration
8977,Discontinued in Preregistration
182497,Discontinued in Phase 4
184667,Discontinued in Phase 3
69539,Phase 2b
112262,Phase 1/2
17298,Phase 1
113782,Phase 0
58966,Investigative
116736,Discontinued in Preregistration
40053,Phase 2/3
162509,Patented
142507,IND submitted
135248,Phase 0
115921,Phase 1b/2a
157812,Registered
111503,Phase 1/2
175776,Phase 3
141716,Patented
173966,Discontinued in Preregistration
190054,Phase 1/2
47280,Investigative
118261,Discontinued in Preregistration
71215,Discontinued in Phase 2b
68406,Discontinued in Phase 1/2
156473,Phase 1b
145156,Phase 2
69354,Phase 1
125646,Investigative
147557,Phase 1/2
43431,Phase 2/3
104113,Phase 0
28816,Phase 4
2105,Phase 2b
83233,Discontinued in Phase 2/3
99588,Phase 0
140725,Registered
19879,Discontinued in Phase 2b
1405,Discontinued in Phase 4
29884,Discontinued in Preregistration
49330,Phase 1b
30676,Patented
163286,Phase 1
116640,Discontinued in Phase 3
100947,Phase 1/2a
32679,Phase 2a
64446,Phase 1/2
105460,Phase 1b
47511,Approved (orphan drug)
4954,Phase 2/3
120230,Approved (orphan drug)
33066,Phase 1/2
17859,Phase 3
57391,Phase 2/3
4830,Investigative
131349,Patented
122275,Patented
58980,Phase 1b
172715,Discontinued in Phase 2b
18043,Phase 1/2
180696,Discontinued in Phase 2b
8736,Phase 1/2a
65239,Discontinued in Phase 2
114123,Patented
187981,Patented
150590,Phase 2
59754,Phase 2/3
109597,Discontinued in Preregistration
54154,Discontinued in Phase 2b
87554,Approved
111278,Phase 1/2a
178219,Phase 2a
26448,Phase 0
148447,Phase 1/2a
10484,IND submitted
177929,Phase 2/3
180710,Phase 2
43920,Phase 2/3
118722,Phase 2a
63342,Patented
97415,Phase 1/2a
110570,Discontinued in Preregistration
94429,Investigative
56551,Phase 0
51521,Investigative
90986,Discontinued in Phase 2/3
65025,Discontinued in Phase 2/3
52486,Phase 0
122529,Phase 0
186379,Preclinical
144166,Investigative
180438,Phase 2/3
59954,Phase 1/2
177807,Phase 1b
187274,Phase 2b
112364,Discontinued in Phase 2
101170,Phase 1/2
10492,Discontinued in Phase 2/3
18794,Discontinued in Phase 3
30459,Discontinued in Phase 2b
26597,Phase 1b
187516,Discontinued in Preregistration
156648,Discontinued in Phase 2
105553,Phase 1b/2a
86756,Discontinued in Phase 2b
135107,Phase 0
51802,Patented
137583,Investigative
53537,Discontinued in Preregistration
44705,Phase 2/3
120861,Discontinued in Phase 2
136858,Phase 1
98818,Phase 1b
78719,Phase 2/3
79164,Phase 3
123538,Phase 1b
140914,Discontinued in Phase 4
67823,Phase 0
110461,Phase 1b/2a
1424,Phase 1/2a
61501,Discontinued in Phase 1/2
67356,Patented
157296,Discontinued in Phase 1/2
62118,Investigative
65564,Phase 2/3
143326,Phase 2b
28368,Phase 1b
25642,Phase 2
77019,Phase 0
44742,Phase 1/2a
102953,Phase 1/2a
169723,IND submitted
75706,Phase 1
166422,Phase 1b/2a
57588,Phase 0
19901,Phase 0
158928,Clinical trial
81124,Discontinued in Phase 3
186106,Discontinued in Preregistration
42870,Phase 1/2
101276,Phase 1/2
67037,Investigative
87060,Phase 1b
191510,Phase 1/2a
110656,Patented
17558,Phase 0
64916,Approved
92780,Phase 1
135010,Phase 0
86553,Patented
185945,Phase 2a
165240,Phase 1
169238,Investigative
22119,BLA submitted
10110,Discontinued in Phase 2b
143272,Phase 1/2a
123736,Phase 1b
179395,Discontinued in Phase 2/3
100584,Phase 2
175660,Discontinued in Phase 1/2
167976,Investigative
149828,Phase 2/3
77943,Registered
120932,Phase 1/2a
129870,Phase 1/2
90241,IND submitted
48442,Discontinued in Phase 2b
61621,Phase 1b
66801,Patented
46368,Discontinued in Phase 2
43630,Phase 1/2a
79894,BLA submitted
192037,Patented
9681,Phase 1b/2a
30012,Phase 1
145602,Phase 2/3
134587,Phase 1
33878,Discontinued in Phase 1
49804,Discontinued in Phase 2b
50530,Phase 1b/2a
5669,Discontinued in Phase 2
35824,Discontinued in Phase 4
129145,Discontinued in Phase 4
118286,Discontinued in Phase 3
53183,Phase 1b/2a
144682,Phase 2b
113491,Phase 1
21245,Phase 1
190008,IND submitted
62676,Investigative
112686,Discontinued in Phase 3
145711,Investigative
44571,Phase 1/2a
82346,Phase 1
73961,Discontinued in Phase 4
186666,Phase 2a
9145,Discontinued in Preregistration
160314,Phase 3
25838,Discontinued in Phase 2/3
25150,Discontinued in Phase 4
129040,Phase 0
137002,Phase 1/2a
2877,Discontinued in Phase 2
92186,Phase 2
121651,Approved
18331,Phase 2a
42529,IND submitted
180331,Phase 1
132721,Patented
77166,Investigative
144403,Discontinued in Phase 4
144775,Phase 0
78831,Phase 0
55715,Discontinued in Phase 2/3
98106,Phase 1b/2a
191201,Phase 2a
43016,Discontinued in Phase 4
92673,Phase 1/2
68697,Phase 2b
130008,Phase 2
98839,Phase 1/2a
11442,Phase 1
10387,Preclinical
6560,Discontinued in Phase 2
29290,Phase 0
108356,Phase 1b
161910,Phase 1/2
62390,Phase 1
92768,Phase 1b/2a
124180,Phase 1
62933,Phase 1b/2a
142550,Phase 0
91078,Discontinued in Phase 2/3
104012,Phase 0
143673,Phase 1b/2a
138222,Investigative
173246,Discontinued in Phase 2/3
112471,Discontinued in Phase 2
41227,Approved
127786,Phase 1
132560,Discontinued in Phase 1/2
124832,Phase 1b/2a
135979,IND submitted
92721,Phase 1b/2a
145578,Investigative
93851,Phase 2b
140208,BLA submitted
55887,Phase 1/2a
77914,Investigative
61913,Discontinued in Phase 4
185811,Phase 4
151219,Phase 1/2
88467,Phase 1
179546,Phase 0
23752,Discontinued in Phase 2/3
42810,Investigative
122132,Phase 0
11491,Phase 2/3
170025,Discontinued in Preregistration
87417,Discontinued in Phase 3
77809,Discontinued in Phase 4
74193,Phase 1/2
188273,Phase 1/2
54053,Phase 1b/2a
150204,Phase 2/3
2144,Phase 2b
143854,Phase 2b
151929,Phase 1
109646,Discontinued in Phase 1/2
123398,Discontinued in Phase 4
94598,Patented
86879,Phase 1/2
66890,Investigative
171513,Discontinued in Phase 2b
78108,Clinical trial
37697,Discontinued in Phase 3
122783,Phase 0
13441,Phase 2b
132207,Discontinued in Phase 4
147544,Investigative
162091,Patented
44097,Phase 2/3
154000,Phase 3
143813,Phase 1b/2a
29922,Phase 1
42714,Patented
65010,Phase 1b/2a
171523,Discontinued in Phase 2/3
132169,Discontinued in Phase 1/2
55311,Discontinued in Phase 2b
124178,Phase 0
11363,Phase 1/2a
130821,Phase 1/2
134693,Phase 0
51414,Phase 1b/2a
142492,Phase 1b
84719,Phase 1b/2a
84240,Phase 1/2
142173,Patented
106019,Phase 2a
68393,Approved (orphan drug)
139561,Discontinued in Phase 2
81452,Phase 1b/2a
110946,Phase 1
133678,Phase 1/2a
145920,Investigative
25945,Phase 2
187620,Phase 1b
167121,Phase 4
5947,Phase 4
91588,Phase 1b
115262,Phase 1b
102284,Patented
191108,Investigative
148230,Investigative
80448,Clinical trial
5719,Phase 2/3
184487,Discontinued in Phase 4
78337,Investigative
131900,Discontinued in Preregistration
2507,Investigative
168408,Clinical trial
53798,Phase 1b/2a
56653,Phase 2
85831,Discontinued in Phase 2b
77080,IND submitted
95657,Phase 2/3
47569,IND submitted
166462,Phase 0
146802,Phase 1b
184088,Discontinued in Phase 4
53900,Phase 1b/2a
182802,Phase 2a
6162,Investigative
28470,Discontinued in Phase 2b
140789,Phase 3
162714,Patented
163670,Patented
174934,Discontinued in Phase 1/2
34705,Discontinued in Phase 3
150203,Discontinued in Phase 2/3
184749,Discontinued in Phase 4
59757,Phase 1b/2a
170393,Phase 0
98172,Discontinued in Phase 2b
128764,Discontinued in Phase 2b
159696,Phase 2b
93888,Discontinued in Phase 3
84427,Phase 1
107676,IND submitted
159869,Phase 2
144562,Phase 2
92642,Patented
58424,Phase 0
132814,Phase 1b/2a
26824,Phase 1b
183049,Phase 1b/2a
173229,Phase 2
46363,Phase 1/2
49605,Discontinued in Phase 3
121755,IND submitted
4897,IND submitted
95902,Phase 1/2a
135092,Phase 0
8922,Discontinued in Phase 2/3
100231,Approved
30217,Phase 1b
42286,Phase 1
140497,Phase 1/2
183416,Discontinued in Phase 4
52041,Discontinued in Preregistration
124901,Phase 1
4686,Investigative
31442,IND submitted
166148,Phase 1b
130239,Patented
139990,Clinical trial
48321,Phase 2
88262,Approved
159898,Discontinued in Preregistration
142521,Phase 3
134206,Discontinued in Phase 4
116783,Discontinued in Phase 1
155047,Discontinued in Phase 4
139009,Phase 1/2a
108687,Discontinued in Phase 2/3
149675,Phase 2b
63109,Phase 0
129324,Discontinued in Phase 3
32163,Phase 1/2
35710,Discontinued in Phase 1/2
27468,Phase 1/2a
71021,Phase 1b/2a
54843,Discontinued in Phase 2b
27076,BLA submitted
166706,Phase 2a
182132,Phase 1
186696,Phase 2a
99253,Phase 1
6142,Phase 2/3
11297,Phase 1
114563,Investigative
94552,Patented
113546,Patented
147242,Patented
2994,Phase 2a
167919,Investigative
28466,Patented
139460,BLA submitted
73327,Phase 1b
5770,IND submitted
52420,Phase 1/2a
114287,IND submitted
131286,IND submitted
37717,Discontinued in Phase 3
53069,Phase 0
27010,BLA submitted
104059,Phase 1/2a
3303,Phase 0
43467,Phase 1/2a
15597,Phase 0
106084,Phase 2/3
101382,Phase 0
48765,Phase 1b/2a
36775,Discontinued in Phase 1
33060,Phase 2
159628,Phase 1b
105510,Phase 1
88749,Phase 1
181831,Phase 1
79767,Approved
151177,Phase 1
164749,Phase 2/3
32931,Phase 2a
106686,Phase 1
13032,Discontinued in Phase 1
5686,Preclinical
59446,Phase 2/3
25160,Phase 1b/2a
87989,Phase 2/3
164756,Phase 1/2a
187898,Phase 0
191636,Phase 1
122427,Discontinued in Phase 4
187849,Patented
98998,Phase 2
113062,Phase 2a
91604,BLA submitted
96675,Phase 1b
101118,Phase 1/2
118305,Phase 1b/2a
13555,Phase 1
117173,Phase 1
133314,Discontinued in Preregistration
33178,Approved (orphan drug)
1238,Investigative
30084,Discontinued in Phase 3
25093,Phase 2
179494,Phase 0
102165,Approved (orphan drug)
88767,Discontinued in Phase 4
79107,Patented
52026,Phase 1b/2a
60479,Discontinued in Phase 4
109662,Phase 3
80214,Phase 2a
70039,Patented
35337,Phase 1/2
52984,Phase 1b
183524,Phase 2a
53780,Phase 1/2a
68343,Phase 0
146065,Clinical trial
27744,Phase 1
13414,Phase 1
34289,Patented
9307,Approved
125523,Phase 1b
145880,Phase 1/2
89897,Patented
118191,Discontinued in Phase 1/2
95718,Phase 1b
47969,Phase 0
17772,Phase 1/2a
99104,Phase 1
188824,Phase 1/2a
184043,Discontinued in Phase 4
91893,Discontinued in Phase 4
129257,Patented
88581,Phase 1
48843,Phase 1b
45132,Phase 1/2a
2927,Patented
138835,Discontinued in Phase 2
9151,Approved
33172,Phase 1b/2a
60269,Phase 1b/2a
167414,Discontinued in Phase 2
163123,Discontinued in Phase 2
110427,Phase 1b/2a
152536,Approved
114447,Phase 1/2
124543,Phase 1
165817,Discontinued in Phase 1/2
51393,Phase 1
174582,Phase 1/2
48577,Discontinued in Phase 2/3
106276,Discontinued in Preregistration
136547,Investigative
55565,Phase 1b/2a
74220,IND submitted
102875,IND submitted
71510,Phase 1/2
39210,IND submitted
148088,Discontinued in Phase 1
95808,Phase 2a
37815,Phase 1
122814,Investigative
131696,Phase 1/2
47647,Phase 1b
81699,Phase 1b/2a
95508,Phase 1b/2a
142090,Discontinued in Phase 4
38246,Phase 2a
97704,Discontinued in Phase 2
90585,Phase 0
51073,Phase 3
83748,Phase 1/2a
156852,Phase 0
42315,Phase 1
118164,Clinical trial
84879,Phase 1b/2a
92817,IND submitted
146632,IND submitted
20825,Phase 2b
79796,Phase 2a
153469,Discontinued in Phase 4
6030,Investigative
27139,Phase 1b
95934,Patented
118885,Phase 1b/2a
6746,Phase 1/2
1176,Investigative
67753,Approved (orphan drug)
189216,Phase 4
165277,Phase 1
7055,Discontinued in Phase 2
55151,IND submitted
183664,Phase 1b
92826,Discontinued in Phase 1
90843,Investigative
175667,Phase 0
154045,Phase 1b/2a
34997,Phase 2a
89221,Phase 1b
85217,Discontinued in Phase 2b
27546,Discontinued in Phase 3
170165,IND submitted
162808,Discontinued in Phase 2b
91066,BLA submitted
105380,Phase 1b
66098,Discontinued in Phase 2/3
18856,IND submitted
34,Phase 2b
80681,Phase 2a
135264,Phase 0
112108,Phase 1
128055,Discontinued in Phase 1
17569,Phase 2b
120246,Approved (orphan drug)
177876,Patented
56420,Discontinued in Preregistration
54203,Phase 1b/2a
185460,Discontinued in Phase 2
123115,Phase 2
183310,Phase 1b/2a
179893,Discontinued in Phase 1/2
158861,BLA submitted
32109,Phase 2a
164014,Phase 0
82955,Phase 0
124858,Phase 1b
130586,Investigative
124355,Discontinued in Phase 4
143388,Phase 2a
24230,Phase 1/2
155779,Phase 1b/2a
81660,Phase 1
150230,Phase 1b
5898,Phase 1b/2a
96102,Phase 1/2a
165889,Phase 1b
119730,Phase 2
7423,Phase 4
189761,Patented
47783,Phase 1/2
129559,Discontinued in Preregistration
43631,Phase 2/3
103046,Approved
109443,Discontinued in Preregistration
24842,Discontinued in Preregistration
25611,Phase 2
27832,Discontinued in Phase 1
130777,Phase 1b
65544,Phase 1/2a
42615,Discontinued in Phase 1
115822,Phase 1/2a
162302,Phase 1b/2a
5024,Phase 2a
123237,Phase 1/2
95761,Phase 1b
154057,Phase 0
9317,Discontinued in Phase 2b
105476,Phase 1/2
37273,Phase 1b/2a
137180,Investigative
67975,Phase 1/2
127722,Investigative
97863,Phase 1/2a
187669,Preclinical
109685,Discontinued in Preregistration
30137,Discontinued in Phase 2b
143659,Investigative
103683,Phase 2/3
127627,Patented
115086,Phase 2
56336,Phase 1
45779,Phase 1/2a
2618,Phase 1b/2a
86474,Phase 0
143175,Phase 1/2
131379,Phase 1/2
106445,Phase 1b
68903,Phase 1
31102,Phase 1
122201,Phase 1/2
143682,Phase 1b/2a
124336,Phase 2
153967,Phase 1/2a
14691,Phase 3
57366,Discontinued in Phase 3
103766,Phase 1b
73306,Phase 1/2a
50277,Discontinued in Phase 2/3
77357,Phase 0
4365,Investigative
33677,Phase 2a
141159,Discontinued in Phase 3
103168,Phase 1/2a
73481,Phase 1/2a
133861,Phase 1/2a
137634,Phase 1/2a
79047,Phase 2a
160853,Phase 0
96149,Phase 0
50941,Phase 1b/2a
129804,Discontinued in Phase 3
170244,Patented
73186,Phase 1b/2a
164569,Phase 2/3
85511,Discontinued in Phase 2b
93616,Phase 1/2
159199,Phase 1b/2a
54438,IND submitted
122270,Phase 1/2
1029,BLA submitted
152387,Phase 1b/2a
127056,Discontinued in Phase 3
126755,Phase 1/2a
37113,Discontinued in Phase 2b
83506,Phase 0
39384,Phase 1
94268,Phase 2a
145235,Phase 2b
109081,Discontinued in Preregistration
160446,Phase 2/3
83037,Phase 1
190252,Phase 1b
125,Phase 1
61137,Phase 1b/2a
136032,Phase 1b/2a
94649,Patented
45181,Phase 1/2a
32684,Patented
177601,Phase 1b
138956,Clinical trial
145448,Patented
56559,Phase 1/2a
8659,Clinical trial
46662,Discontinued in Phase 1/2
175023,Discontinued in Phase 4
170837,IND submitted
90972,Clinical trial
75362,Discontinued in Phase 1
171335,Phase 2/3
99579,Phase 1
67383,Discontinued in Phase 2/3
11892,Phase 1
110567,Phase 1/2
141118,Investigative
46515,Phase 1
47607,Phase 1b
183321,IND submitted
183781,Discontinued in Preregistration
88539,Phase 1
57073,Phase 1/2
32659,Phase 1/2
73492,Phase 2
161064,Phase 1
49759,Phase 1/2a
29465,Phase 3
148841,Patented
170065,Phase 1/2a
111468,Phase 1/2
81294,Phase 1b
77813,Phase 2
152654,Phase 1/2a
28431,Phase 0
64401,Discontinued in Phase 2b
162288,Phase 1
104594,Patented
71113,Phase 1b/2a
28862,Phase 0
173618,BLA submitted
91699,Phase 2a
1392,IND submitted
101125,Phase 1/2
22442,Patented
127926,Phase 1/2
3449,Phase 1/2
140705,Registered
24062,Discontinued in Phase 2/3
127772,Phase 0
58210,Investigative
25362,Phase 2/3
29269,Investigative
95800,Phase 1
191204,Phase 1/2a
144089,Phase 1/2
14554,Phase 1
57614,Phase 0
13968,Phase 0
99420,Patented
40677,Discontinued in Phase 4
57608,Phase 1b
46990,Discontinued in Phase 2/3
81540,Phase 1
114995,Discontinued in Preregistration
44798,Phase 1/2a
138179,Investigative
78502,Discontinued in Phase 2
38176,Phase 1/2
182308,Discontinued in Phase 2
124118,Phase 1/2
39522,Phase 2/3
120410,Phase 0
69526,IND submitted
34878,Phase 2a
74259,Discontinued in Phase 2b
6105,Phase 1b/2a
54776,Discontinued in Phase 4
186143,Phase 4
22219,BLA submitted
53531,Phase 1/2a
176692,Phase 1
81255,Approved
42016,Phase 1b/2a
189285,Phase 1/2
125852,Phase 1b/2a
33784,Phase 1b/2a
147672,Discontinued in Preregistration
59327,Discontinued in Phase 2/3
184137,Discontinued in Phase 4
65674,Phase 1/2a
177518,Phase 1b
182602,Phase 2a
4059,Investigative
169509,Phase 2
191038,Phase 2a
161841,Investigative
182425,Phase 2b
57049,Phase 1
160244,Phase 1
141609,Phase 1b
126243,Phase 1b
84136,Phase 2
52137,Discontinued in Preregistration
186974,Phase 2b
44868,Phase 1/2a
159369,Phase 1b/2a
114682,Phase 1b/2a
26068,Patented
51665,Phase 1
94051,Phase 1b
132499,Phase 1/2
43605,Phase 1/2a
32352,Phase 1/2
146720,Phase 1b/2a
49763,Phase 0
150161,Phase 1b
175822,Discontinued in Phase 2
601,Phase 1/2a
119763,Discontinued in Phase 1/2
44823,Phase 2/3
92079,Investigative
56467,Discontinued in Phase 2b
65780,Preclinical
91561,Phase 1/2
62579,Discontinued in Phase 4
141777,Phase 1b
54270,Phase 1b/2a
20499,Discontinued in Preregistration
92317,Discontinued in Phase 1
127245,Phase 1/2
111877,Phase 1b
32921,Discontinued in Phase 1
117494,Discontinued in Phase 3
123453,Phase 1
190378,Clinical trial
173827,Phase 1/2a
180393,Discontinued in Phase 2b
79754,BLA submitted
61049,Investigative
104060,Phase 2
86129,Discontinued in Phase 2/3
66177,Patented
109879,Phase 1
36012,Phase 1
115288,Discontinued in Phase 2
147515,Patented
182639,Phase 1/2a
110128,Phase 1/2a
112063,Discontinued in Phase 2
155976,IND submitted
94632,Phase 1/2a
95791,Discontinued in Preregistration
151458,Phase 1
178743,Discontinued in Phase 3
50400,Phase 1b
48323,Phase 0
154833,Phase 3
104284,Patented
143955,Phase 0
96608,Phase 1b/2a
103666,Phase 1/2
120172,Discontinued in Phase 1/2
71387,Discontinued in Preregistration
111071,Phase 1/2
95943,Phase 2/3
70293,Phase 1b/2a
75641,Phase 0
172970,Phase 1/2
77663,Discontinued in Phase 2
22623,Phase 1b
151596,Phase 2
76576,Phase 1/2a
140904,Phase 3
54507,Investigative
123878,Phase 1
48394,Patented
144496,Discontinued in Phase 1/2
120905,Investigative
180636,Phase 1b
76059,Phase 1b
93409,Phase 2b
7150,Phase 2/3
149552,Discontinued in Phase 2
40072,Phase 2
126887,Discontinued in Preregistration
140415,Phase 1/2a
153950,Phase 1/2a
179057,Discontinued in Phase 2/3
152391,Patented
6360,Investigative
27746,Phase 1/2
160834,Phase 1
135198,Phase 0
91692,Clinical trial
141408,Discontinued in Phase 2b
59957,Investigative
185177,Investigative
78100,Approved
98355,Phase 1b
122540,Discontinued in Phase 4
168952,Discontinued in Phase 3
22496,Phase 1b
19767,Phase 0
83188,Discontinued in Preregistration
124471,Patented
18696,Phase 1
67329,Discontinued in Phase 1
52775,Phase 1b/2a
153836,Investigative
173611,Phase 0
129916,Discontinued in Phase 3
87884,Phase 1b/2a
51761,Phase 1b
48274,Discontinued in Phase 2
151263,Discontinued in Phase 2/3
124358,Discontinued in Preregistration
165023,Phase 1/2
30943,Phase 0
115122,Approved (orphan drug)
132839,Discontinued in Phase 2/3
34830,Phase 2a
166019,Investigative
153641,Phase 0
136550,Phase 1
112184,Discontinued in Phase 2
147659,Discontinued in Phase 1
126592,Phase 0
142751,Phase 1b/2a
36357,Investigative
28670,Discontinued in Phase 2/3
168640,Discontinued in Phase 2
10180,Discontinued in Phase 2/3
4176,Investigative
98375,Phase 1/2
75053,Discontinued in Phase 4
121358,Patented
39199,Phase 2
130897,Investigative
9296,Discontinued in Phase 2/3
31916,Discontinued in Phase 3
57445,Phase 0
180658,Discontinued in Phase 2
14470,Phase 1
145253,Patented
54298,Discontinued in Phase 4
108710,Clinical trial
127872,Phase 1
186776,Clinical trial
49681,Phase 2
67396,Patented
104515,BLA submitted
122778,Phase 1b
78453,Phase 1/2
188147,Phase 1
54410,Phase 1b/2a
55407,Phase 0
146533,Clinical trial
101723,Investigative
92106,IND submitted
75081,Discontinued in Phase 4
49148,Phase 1/2
136361,Discontinued in Phase 4
69396,Phase 2/3
91003,Phase 0
110407,Phase 1b/2a
51920,Discontinued in Phase 4
120164,IND submitted
23288,Discontinued in Preregistration
145174,Phase 0
73106,Phase 1b/2a
142118,Patented
81045,Phase 2a
133477,Phase 1
64022,Phase 0
83254,Phase 1/2
113865,Discontinued in Preregistration
125799,Phase 1b
3398,Phase 1/2
56635,Phase 1/2a
188945,Phase 2b
3925,Discontinued in Preregistration
171634,Phase 2a
118007,Phase 1b
14143,Phase 1/2
113448,Phase 1
70766,Phase 0
54164,Discontinued in Phase 4
6471,Investigative
54209,Phase 1b
110127,Phase 0
96162,Discontinued in Phase 4
161855,Phase 1/2a
68175,Clinical trial
14127,Phase 1
6876,Investigative
15142,Phase 1
154412,Discontinued in Preregistration
101744,Phase 1/2
126827,Phase 1/2a
139031,Phase 1/2a
147004,Phase 1/2a
126244,Phase 1/2
106127,Phase 2/3
64651,Phase 2
108069,IND submitted
185109,Discontinued in Phase 4
101320,Phase 1/2
78329,Phase 1
174037,Phase 1b/2a
130983,Phase 0
148091,Phase 2a
2847,Phase 1/2
188779,Phase 1/2
153615,Phase 1/2a
135123,Phase 0
104977,Phase 0
2233,Discontinued in Phase 2
78615,Phase 1b
150777,Phase 1/2
21947,Discontinued in Phase 1/2
130677,Phase 2
98649,Phase 1/2a
165679,Investigative
17054,Phase 1
180746,Discontinued in Phase 2b
44128,Phase 2/3
69777,Phase 1b
173758,Discontinued in Phase 1
178035,Phase 1/2
69383,Phase 1b
118194,Phase 1/2a
147816,Phase 1b
82294,Phase 0
30640,Phase 0
42244,Phase 1b/2a
181431,Phase 1
18375,Phase 3
31774,Discontinued in Preregistration
124249,Phase 1/2
151962,Phase 0
68061,Phase 2b
57017,Discontinued in Phase 3
108345,Phase 0
45706,Phase 2/3
49883,Investigative
2611,Discontinued in Phase 1/2
134287,Patented
149964,Phase 1b
112060,Phase 1
151821,Discontinued in Phase 2/3
133766,Phase 1b
35288,Phase 1b/2a
188580,Phase 2b
180578,Phase 1/2a
56956,Phase 2/3
186015,Phase 2b
148939,Phase 2
152699,Discontinued in Phase 3
91628,Discontinued in Phase 2b
84944,Phase 1b/2a
95403,Phase 1/2
112475,Discontinued in Phase 3
165599,Investigative
11226,Discontinued in Phase 3
156477,Phase 1/2
118548,Phase 2a
93572,Discontinued in Phase 3
27714,Phase 1/2
143814,Discontinued in Preregistration
75464,IND submitted
155916,Phase 1
189467,Phase 1/2
97265,Phase 1/2
46030,Phase 1/2a
146968,Phase 0
182658,Discontinued in Phase 2
6903,Investigative
22139,Discontinued in Phase 2
65230,Phase 1
157630,Registered
3332,Patented
91115,IND submitted
145485,Phase 2/3
77910,Phase 1b
40496,Phase 1b
94318,Phase 1/2
139448,Phase 1/2a
97733,Investigative
8267,Phase 0
130814,Clinical trial
49083,Phase 0
82495,Investigative
23155,Phase 1/2
145387,Phase 1
105543,Discontinued in Phase 2/3
137390,Phase 1
114887,Phase 1/2a
103318,Investigative
127014,Discontinued in Phase 2b
98241,Phase 0
24100,Phase 2
16448,Phase 1/2
101900,Phase 1/2
88317,Discontinued in Phase 2/3
47220,Phase 1
28964,Phase 4
7684,Phase 0
67630,Phase 1/2
55742,Patented
123574,Discontinued in Preregistration
114615,Discontinued in Phase 1
122450,Approved
113469,Phase 2a
35910,Phase 1b
99347,Discontinued in Phase 2/3
93460,Phase 1/2
124898,Phase 1b/2a
57254,Discontinued in Phase 3
96883,Phase 1/2a
167950,Patented
97206,Phase 1b/2a
191438,Phase 1/2a
58619,Phase 1
118142,Phase 2a
178308,Phase 2b
20435,Phase 1b/2a
122313,Phase 1/2
163494,Investigative
151666,Phase 1b/2a
92830,Phase 1/2a
185,Phase 2
131430,Discontinued in Phase 1/2
51192,Phase 0
115271,Phase 2/3
168564,Discontinued in Phase 2
118491,Discontinued in Phase 2/3
183446,Discontinued in Phase 4
158551,Phase 1b/2a
101050,Phase 1/2
53489,Phase 2
26800,Phase 1b
134481,Phase 1b
150355,Clinical trial
106598,Discontinued in Phase 4
168945,Discontinued in Phase 1/2
163995,Discontinued in Preregistration
4103,Discontinued in Phase 2
86242,IND submitted
71053,Phase 1b/2a
52541,Investigative
158747,Phase 1
92606,Discontinued in Preregistration
46158,Phase 1/2a
146983,IND submitted
38606,Patented
124008,Phase 1/2
133866,Patented
84201,Phase 1/2a
138763,Phase 1b
2010,Discontinued in Phase 1
74086,Phase 1/2
280,Discontinued in Phase 2/3
169763,Phase 1/2a
126541,Patented
178897,Phase 0
191693,Phase 1
104481,Phase 1/2
63722,Phase 2a
152564,Approved
66585,Phase 2
45956,Phase 1/2a
125686,Investigative
182162,Phase 1/2a
90950,BLA submitted
176768,Phase 1b
8683,Phase 1/2a
29448,Phase 4
144149,Phase 2
19075,Phase 0
142436,Phase 1/2a
90687,Phase 1/2
150766,Phase 0
116579,Discontinued in Phase 3
161269,Discontinued in Preregistration
144032,Phase 1/2
711,Phase 1/2
119434,Phase 2
80109,Discontinued in Phase 2
137813,Phase 1/2
12006,Phase 2a
41469,Discontinued in Preregistration
31977,Discontinued in Phase 2b
54578,Phase 2
97047,Phase 1/2
98963,Phase 1/2
115796,Phase 2a
189169,Phase 1/2
99783,Phase 1
177966,Phase 0
187765,Phase 0
16723,Phase 1
173665,Phase 1b/2a
126469,IND submitted
135969,Preclinical
93227,Phase 2b
77564,Phase 1
55839,Phase 1b/2a
58272,Phase 1/2a
6218,Discontinued in Phase 2
75566,Phase 1b/2a
115031,Phase 1b
145408,Phase 0
127779,Phase 1/2
73503,Clinical trial
66330,Preclinical
26229,Investigative
120249,Phase 0
118655,Discontinued in Phase 1/2
65220,Phase 2a
62682,Patented
155461,Investigative
68595,Phase 1
630,Approved (orphan drug)
43498,Phase 2/3
136152,Preclinical
57753,Phase 0
93726,IND submitted
109166,Phase 0
161584,Patented
181446,Discontinued in Phase 2b
191897,Discontinued in Phase 3
57240,Clinical trial
157430,Discontinued in Phase 4
90570,BLA submitted
138422,Phase 1b
162285,Phase 1
152910,Phase 1
65697,Preregistration
60800,Phase 1b
84141,Phase 1b/2a
74643,Discontinued in Phase 2b
131342,IND submitted
90164,Phase 1b/2a
148835,Phase 1b
38045,Phase 2/3
176740,Phase 1
84048,Phase 1b/2a
88830,Investigative
89865,Investigative
44072,Phase 2/3
38311,Phase 0
135949,Phase 1/2
33450,Phase 2/3
184968,Phase 1/2
80021,Clinical trial
12869,Phase 0
62605,Discontinued in Preregistration
16944,Phase 0
79804,Clinical trial
55152,Phase 3
146779,Phase 1/2a
66014,Preclinical
180354,Phase 2a
10653,IND submitted
22391,Phase 2a
88969,Phase 1/2a
140982,Discontinued in Preregistration
88257,Phase 1/2
3879,Phase 1
52422,Discontinued in Phase 2
7871,Phase 1
191068,IND submitted
123513,Phase 1/2
7320,Phase 1b/2a
122404,Phase 1b
56874,Discontinued in Phase 2b
64519,Approved (orphan drug)
1639,Phase 2a
98132,Phase 1b/2a
161946,Discontinued in Phase 1/2
86766,Phase 1b
113610,Phase 1
137108,Phase 2
138698,Phase 1/2a
159892,Phase 1b
43727,Phase 2/3
121280,Phase 1/2a
4095,Investigative
156585,Phase 0
84704,Phase 1b/2a
119371,Phase 1b/2a
165179,Phase 1
110518,Phase 3
46769,Approved
180028,Discontinued in Phase 2
66686,Phase 0
185912,Patented
27427,Investigative
1414,Discontinued in Phase 2/3
119537,Discontinued in Preregistration
15354,Phase 1
173834,BLA submitted
42522,Phase 2
54745,Phase 3
100503,Phase 1/2
188553,Phase 0
173583,Phase 1
85029,Phase 1b/2a
185350,Approved
41709,Phase 1b
28051,Discontinued in Phase 1
3224,Discontinued in Phase 2b
104061,Phase 1/2
19844,Discontinued in Phase 2b
49654,Phase 1b
9717,Phase 1/2a
98010,Phase 0
100249,IND submitted
151894,Phase 1
80146,BLA submitted
138227,BLA submitted
14384,Phase 0
144612,Phase 1/2a
150053,Phase 1/2
138565,Phase 1b
3618,Approved
6344,Discontinued in Phase 2
47650,Phase 0
180214,Phase 3
103722,Phase 0
44351,Phase 2/3
9023,Phase 2/3
87685,Patented
121325,Phase 1b/2a
68400,IND submitted
64687,Approved (orphan drug)
171919,Discontinued in Phase 3
2549,Phase 1b
137802,Phase 1/2a
100560,Discontinued in Phase 1/2
124564,Discontinued in Preregistration
88866,Phase 1
127318,Phase 1/2
134056,Phase 1/2
64276,Phase 1/2
61675,Phase 1b
171020,Phase 2/3
32844,Phase 2a
41895,Phase 2
43505,Phase 2/3
190828,Phase 4
12015,Investigative
71358,Phase 0
174378,Discontinued in Phase 3
39317,Discontinued in Phase 2
12677,Phase 0
95812,Phase 1b
33057,Phase 2a
169936,Patented
169418,IND submitted
7048,IND submitted
63674,IND submitted
84414,Phase 1/2
134605,Phase 1/2a
103293,Phase 1/2
8040,Phase 1b
169,Phase 1
171480,Discontinued in Phase 2/3
178320,Phase 2
110301,Phase 1b/2a
179037,Discontinued in Phase 1/2
144583,Phase 1b/2a
11454,Phase 0
168840,Phase 1b/2a
15716,Phase 1
93671,Phase 1/2
151435,Phase 2
44360,Phase 2/3
107251,Phase 0
145163,Discontinued in Phase 1
153844,Phase 1/2
8601,Phase 1
18180,Discontinued in Phase 3
157329,Phase 1
105036,Discontinued in Phase 2b
122873,Discontinued in Preregistration
76817,Discontinued in Phase 1/2
61209,Patented
123725,Phase 0
77747,Investigative
159153,Phase 2
141840,Discontinued in Phase 2b
67501,Discontinued in Phase 1
123458,Phase 1/2
90384,Discontinued in Preregistration
122934,Patented
114979,Phase 1/2a
5649,Investigative
103787,Discontinued in Phase 2b
109233,Phase 2
148802,Patented
172749,Phase 1/2
170966,Phase 1
10847,Phase 1
60472,Phase 0
153071,Phase 1b/2a
23187,Phase 1
12770,Phase 3
116760,Discontinued in Phase 4
5497,Preregistration
97388,Discontinued in Phase 2b
37184,Phase 1
29873,Phase 2
58638,Phase 1/2
28428,Phase 0
82200,Discontinued in Phase 2/3
186215,Phase 2a
35700,Discontinued in Phase 1/2
179264,Discontinued in Phase 3
60072,Phase 1b
116316,IND submitted
184551,BLA submitted
191722,IND submitted
52636,Phase 3
128642,Phase 1/2
56146,Patented
67366,Patented
66172,Discontinued in Phase 3
86325,Phase 0
117860,Phase 1b
126923,Discontinued in Preregistration
79743,Discontinued in Phase 2
36063,Phase 1
77345,Phase 1/2a
51692,Phase 1b
158900,Phase 1
128998,IND submitted
134926,Phase 0
192058,Clinical trial
186460,Phase 0
134050,Phase 1/2a
144216,Discontinued in Phase 2/3
26114,Phase 1/2
114378,Phase 1
39487,Phase 0
161110,Discontinued in Phase 4
161001,Discontinued in Preregistration
89426,Discontinued in Preregistration
159996,Phase 2b
30938,Discontinued in Phase 2b
84308,Discontinued in Phase 3
46881,Approved
102007,IND submitted
35335,Discontinued in Phase 3
88252,Phase 1b/2a
88242,Phase 2/3
25519,IND submitted
141725,Discontinued in Phase 2b
153957,Approved
11171,Phase 0
110021,Phase 1
77871,IND submitted
190432,Phase 2/3
37294,Discontinued in Preregistration
161766,Discontinued in Phase 1/2
180793,Discontinued in Phase 2b
15842,Phase 3
48724,Discontinued in Phase 3
183124,Phase 2a
101820,Phase 1b
118262,Discontinued in Preregistration
72069,Phase 1b
100002,Phase 1b
8951,Discontinued in Phase 4
23631,Phase 1
80366,Phase 2
84532,Phase 1/2a
188751,Approved (orphan drug)
176001,Phase 1
180741,Phase 1
30277,Phase 1b
180996,Discontinued in Phase 2b
14228,Phase 1/2a
152058,Phase 1/2
185696,Clinical trial
33036,Phase 2a
167547,Discontinued in Phase 1
30971,Investigative
86168,Discontinued in Phase 4
24529,Discontinued in Phase 2/3
150561,Phase 0
9244,Phase 2/3
69646,Phase 3
148375,Phase 1/2
420,Phase 2
51857,Phase 2
135725,Phase 1/2
151766,Phase 0
63657,Phase 0
4070,Phase 2/3
60059,Discontinued in Phase 4
138798,BLA submitted
191089,Discontinued in Preregistration
102374,Approved
84509,Phase 1b/2a
70282,Phase 1
78607,Phase 2a
52052,Phase 1
58648,Phase 0
97717,Phase 1b
54460,Phase 1/2a
167006,Discontinued in Phase 2
104144,Patented
17002,Phase 1/2
171245,Phase 1/2
186986,Clinical trial
99789,Discontinued in Phase 2/3
30207,Phase 1b/2a
80041,Discontinued in Phase 1
55348,Phase 1/2
177706,Phase 2/3
190856,Phase 1b
89603,Phase 1b
156690,Phase 2a
137789,Discontinued in Phase 3
178804,Discontinued in Phase 1/2
189330,Approved
76214,Phase 0
25906,Investigative
20881,Discontinued in Preregistration
150493,IND submitted
13798,Phase 1
165888,Phase 1b
179753,Phase 0
161337,Phase 0
190551,IND submitted
178374,Phase 1/2a
134085,Phase 1/2a
131656,Patented
53834,Phase 0
83050,Phase 2
94958,Patented
110907,Phase 1/2
40411,Patented
78427,Investigative
166196,Discontinued in Phase 1/2
184109,Phase 0
169214,Phase 3
6132,Phase 1b/2a
86632,Investigative
21476,Approved (orphan drug)
45946,Phase 2/3
68126,Phase 2b
17828,Phase 1
10224,IND submitted
147842,Phase 2b
117975,Phase 1
51580,Discontinued in Phase 3
75296,Phase 1/2
184425,Discontinued in Phase 4
35551,Phase 0
95333,Patented
148277,Phase 2b
115020,Phase 2/3
97110,Phase 1b
176964,Phase 1b/2a
39416,Phase 1b/2a
68418,Phase 2a
144533,Phase 1
79285,Phase 2a
71863,Phase 0
103108,Phase 1/2
168964,Discontinued in Phase 1/2
138919,Phase 1/2a
118265,Phase 1
76554,Phase 1b/2a
140573,Phase 1b/2a
186764,Phase 2b
77417,Phase 0
118330,Phase 2b
119103,Discontinued in Preregistration
77027,Phase 0
124245,Phase 1
23395,Phase 1b
156728,Discontinued in Phase 4
147302,Phase 2b
100667,Phase 1/2a
69421,Discontinued in Phase 3
38992,Discontinued in Phase 2
185767,Investigative
60563,Discontinued in Phase 4
150994,Phase 2
76951,Phase 1/2
38173,Phase 1b
68158,Phase 1/2a
54768,Discontinued in Phase 2b
170789,Phase 2/3
133926,Discontinued in Phase 4
143060,Phase 2/3
150058,Phase 1/2
53432,Phase 1/2
55551,Investigative
131361,IND submitted
122992,Phase 1
145894,Phase 1
162050,Phase 1/2a
46017,Phase 2/3
183378,Phase 1/2
134618,Phase 1/2a
135305,Phase 0
67370,Phase 2
20556,IND submitted
23569,Phase 1b/2a
74442,Discontinued in Phase 4
191172,Phase 1/2
155925,Phase 1/2
170783,Phase 1/2
48923,Phase 1/2a
130229,Phase 1/2a
458,Phase 1/2a
115208,Phase 2/3
49878,Discontinued in Phase 3
17960,Preclinical
140808,Phase 1b/2a
60482,Phase 2/3
168406,Clinical trial
59148,Phase 1b
46322,Phase 1/2
41833,Discontinued in Phase 1
79597,Phase 2a
122382,Phase 1b
85394,Discontinued in Phase 2b
71646,Phase 0
147976,Clinical trial
164224,Patented
191569,Phase 2
142319,IND submitted
114148,Phase 0
40088,Phase 0
45343,Phase 2/3
97105,Phase 1b
55267,Phase 1/2a
91247,Phase 1b
132413,Patented
52827,Phase 1/2a
158291,Phase 1
56428,Phase 0
57419,Phase 2/3
60367,Discontinued in Phase 4
84069,Discontinued in Preregistration
151780,Phase 1
101360,IND submitted
40305,Phase 1
186976,Discontinued in Preregistration
10566,Phase 0
47202,IND submitted
188313,Phase 1b/2a
6470,Discontinued in Phase 2
85452,Discontinued in Preregistration
30544,Discontinued in Preregistration
4697,Discontinued in Phase 2
178030,Patented
136400,Phase 2
34973,Phase 2a
81246,Phase 1b
77792,Phase 0
18651,Discontinued in Phase 3
40990,Discontinued in Phase 2
13650,Phase 1
48452,Discontinued in Phase 3
149762,Phase 1b
36059,Phase 2a
81646,IND submitted
121735,Phase 2b
124967,Phase 1
128254,Phase 1/2
149829,Investigative
159644,Phase 1
142859,Discontinued in Phase 4
70785,Phase 2/3
186031,Phase 1
24273,Phase 2
43700,Phase 1/2a
144292,Discontinued in Phase 2
52902,Phase 1
36168,Phase 0
76286,Discontinued in Preregistration
48995,Discontinued in Phase 2b
105592,Phase 1b/2a
95877,Phase 2/3
1535,Phase 0
41528,Approved
123167,Discontinued in Phase 4
98273,Phase 1/2
145440,Phase 1b
126682,Phase 0
143752,Phase 1/2a
130720,Phase 2b
139402,Phase 1/2
73913,Phase 2/3
14659,Phase 0
123666,Phase 1/2
126515,Discontinued in Preregistration
114347,Phase 1/2
135203,Phase 0
75689,Phase 1/2a
18709,Discontinued in Phase 2/3
66657,Patented
68080,Phase 0
173603,Phase 1/2a
70518,Phase 1/2a
83871,Discontinued in Phase 2/3
80260,Patented
132302,Discontinued in Preregistration
151585,Phase 1b
104805,Discontinued in Preregistration
50791,Investigative
113215,Phase 1
59537,Investigative
148248,Phase 1b
89699,Phase 1/2
172166,Discontinued in Phase 2
125434,Phase 1b
129639,Discontinued in Phase 1
13819,Phase 1
5436,Investigative
30103,Phase 0
18712,Phase 0
142074,Phase 0
64707,Discontinued in Phase 2/3
156284,Phase 1
147239,Discontinued in Phase 2/3
149538,Phase 1/2a
68051,Phase 1b
35903,Phase 1/2a
77599,Phase 1b
151180,Phase 1
119923,Discontinued in Phase 1/2
93177,Phase 1/2
83538,Phase 0
164824,Phase 0
185490,Phase 1b
18228,Phase 1
26315,Phase 2
38711,Patented
36002,Phase 2a
69420,Investigative
119527,Phase 0
170365,Phase 1/2a
116352,Investigative
186784,Patented
148342,Phase 1/2
92605,Discontinued in Phase 2b
64230,Clinical trial
44307,Phase 1/2a
127017,IND submitted
17059,Phase 0
10731,IND submitted
52130,Phase 2
46340,Patented
190148,Phase 1b
45407,Phase 2/3
81896,Discontinued in Phase 1
98026,Phase 1b
49240,Phase 2/3
113851,Phase 1
36551,Discontinued in Phase 1/2
13145,Phase 1
29929,Phase 1/2
153355,Phase 1b
178049,Phase 2a
69211,Discontinued in Phase 3
146177,Discontinued in Phase 1
8767,Clinical trial
28532,Phase 0
11916,Phase 2a
188640,Phase 1b
183806,Discontinued in Phase 4
154542,Phase 1b/2a
105424,Phase 2a
56672,Discontinued in Phase 2b
103200,Investigative
3518,Approved (orphan drug)
23670,Discontinued in Phase 4
142268,Patented
155144,Phase 1b
96459,Phase 1/2a
165505,Phase 1
174746,Discontinued in Phase 2
118644,Phase 2
178470,Patented
146469,Phase 1b/2a
89592,Phase 1
182599,Phase 1b/2a
17590,Phase 1/2a
187431,Phase 4
122590,Patented
166259,Investigative
20528,Phase 1
185032,Phase 1
59089,Investigative
54461,Phase 1b/2a
4104,Investigative
10291,Phase 1/2
184938,Phase 0
141273,Phase 1b
125035,Phase 1/2
151379,Phase 1
107705,Discontinued in Preregistration
57041,Phase 0
88554,Phase 1/2
89445,Phase 2/3
125166,Phase 1
67481,Discontinued in Phase 1
6187,Phase 2/3
179175,Phase 1b
24373,Discontinued in Phase 4
186840,Phase 1b
119402,Phase 1b/2a
148971,Investigative
112954,Phase 0
188982,Phase 4
53841,Phase 1
139062,BLA submitted
147562,Phase 1/2
153140,Phase 1b/2a
8507,Phase 1
18385,Phase 1/2
11652,Phase 1
174843,IND submitted
27750,Phase 2/3
161091,Phase 0
120479,Approved (orphan drug)
98151,Phase 1/2
89061,IND submitted
169300,Phase 1
86778,Patented
184141,Phase 1/2
116266,Phase 2
183195,IND submitted
101955,Phase 1
21143,Phase 2/3
12392,Phase 1/2
137855,Discontinued in Phase 4
48916,Discontinued in Phase 2/3
149228,Discontinued in Phase 2/3
132969,Discontinued in Phase 2b
176881,Phase 2b
151519,Phase 2/3
34890,BLA submitted
91838,Discontinued in Phase 2b
72143,Phase 0
116548,Discontinued in Phase 1/2
26164,Phase 0
66511,Phase 1b/2a
136410,Phase 1
18335,Discontinued in Phase 2/3
60868,Phase 1
115735,Phase 1/2a
1134,Approved (orphan drug)
105620,Phase 1b/2a
65095,Phase 1b/2a
148235,Phase 1
102158,IND submitted
154391,Phase 1/2
50526,Discontinued in Preregistration
185495,Phase 2/3
144000,Phase 1/2
139051,Phase 1/2a
5451,Investigative
76612,IND submitted
26022,Phase 1b
146004,Discontinued in Phase 2
152366,Patented
72581,Phase 1b/2a
137473,Phase 2
72997,Investigative
182277,Phase 1/2a
106670,Discontinued in Preregistration
29571,Phase 1b
93231,Phase 1
13081,IND submitted
34329,Phase 1b/2a
119199,Phase 2b
125294,Phase 1b
105563,Phase 1b/2a
33801,BLA submitted
36822,Phase 2a
40217,Discontinued in Phase 2
45371,Phase 1/2a
190590,Phase 1b
130929,IND submitted
128919,Discontinued in Phase 1
101350,Phase 1b
54571,Discontinued in Phase 2b
123531,Phase 1
168693,Clinical trial
20356,Phase 1
168411,Phase 2
122776,Phase 0
33079,Phase 1/2
97677,Investigative
175469,Phase 1/2a
72198,IND submitted
68071,Phase 1
129887,Phase 1/2a
169245,Discontinued in Phase 1/2
79903,Investigative
114871,Phase 1b/2a
162049,Investigative
102037,Investigative
74937,IND submitted
33074,Phase 1b/2a
9206,Discontinued in Phase 2
47432,Discontinued in Phase 2b
15507,Phase 1
13796,Phase 1
3905,Discontinued in Preregistration
177056,Phase 1b
108545,BLA submitted
179493,Phase 0
67302,Discontinued in Preregistration
47752,Phase 1b
39097,Phase 2/3
154688,Phase 3
89725,Phase 0
147101,Phase 2b
94391,Phase 1b
27008,IND submitted
128119,Discontinued in Preregistration
170081,Phase 2b
178303,Phase 2/3
75884,IND submitted
129714,Discontinued in Phase 2/3
187244,Phase 2b
141083,Discontinued in Phase 1
92651,Discontinued in Phase 3
133227,Approved
18751,Phase 1
59075,Discontinued in Phase 2/3
176816,Phase 1b
159160,Clinical trial
1962,Discontinued in Phase 1
4987,IND submitted
63214,IND submitted
127031,Discontinued in Preregistration
17822,Phase 1
3570,Discontinued in Phase 2b
160605,Phase 0
62262,Investigative
55654,Phase 1b
89554,Phase 1
181075,Phase 2b
123609,Phase 1b
124417,Phase 1b
113548,Phase 0
2852,Phase 1/2a
129692,Discontinued in Phase 3
72007,Phase 0
31562,Discontinued in Preregistration
56484,Phase 1b/2a
169510,Discontinued in Phase 2/3
15747,Phase 3
129502,IND submitted
13339,Phase 1
50551,Discontinued in Phase 2b
109091,Discontinued in Preregistration
43520,Phase 2/3
179915,Phase 1/2a
136498,Phase 1/2a
189107,Phase 2/3
140667,Preregistration
61089,Discontinued in Phase 3
59095,Phase 1
50977,Investigative
188192,Phase 2b
135505,Phase 0
25040,Phase 1/2
121208,Patented
152221,Discontinued in Phase 2/3
133881,Patented
45725,Phase 1/2a
100186,Phase 1
2745,Phase 2
164490,Phase 1
33727,BLA submitted
117085,Clinical trial
162760,Phase 1b
85993,Phase 1b/2a
191827,Patented
164245,Phase 1/2a
142654,Phase 2a
117733,Phase 1
86578,Phase 1b/2a
132367,Phase 1b/2a
59705,Investigative
88499,Phase 0
137818,Phase 1
30377,Discontinued in Phase 2b
45053,Phase 1/2a
146832,Phase 1b/2a
120025,Phase 0
148693,Phase 1/2
125242,Phase 1b
152731,Discontinued in Phase 3
109398,Phase 3
166661,Discontinued in Phase 2
35533,Discontinued in Preregistration
128173,Discontinued in Phase 4
66271,Phase 1b/2a
74949,Phase 1/2
153748,Phase 1/2a
88176,Discontinued in Phase 3
17423,Phase 0
166781,Phase 0
182203,Phase 2a
58129,Discontinued in Phase 1/2
190176,Phase 1/2a
175193,IND submitted
106779,Phase 0
42158,Investigative
31709,Phase 1b
96611,Discontinued in Phase 3
31026,Phase 2
24918,Phase 2/3
174053,Discontinued in Phase 1
123834,Phase 1b
13659,Investigative
6143,Phase 1/2
148257,Discontinued in Preregistration
79812,Patented
70054,Phase 1b
126487,Discontinued in Preregistration
148388,Phase 2b
79413,Approved (orphan drug)
45393,Phase 2/3
143013,Phase 1b/2a
20444,Discontinued in Phase 4
44533,Phase 1/2a
185057,Phase 1
90923,Discontinued in Phase 2
20504,Phase 1/2
14588,IND submitted
132118,Phase 1
128852,Phase 0
58631,Discontinued in Phase 4
187448,Phase 1b
21976,Discontinued in Phase 1/2
105853,Phase 2/3
24806,Phase 1b
177836,Phase 1/2
73287,IND submitted
38215,Phase 0
28133,Discontinued in Phase 4
21373,Phase 1b/2a
101344,Discontinued in Preregistration
175319,Phase 0
110502,Phase 1b/2a
85597,Discontinued in Phase 3
102235,Phase 1/2
156659,IND submitted
61091,Discontinued in Phase 2/3
122236,Phase 1/2
13982,Phase 1
100508,Phase 1/2a
37701,Phase 1/2a
82040,Clinical trial
940,Patented
46110,Phase 1/2a
78192,Investigative
79503,Phase 1b
102140,Application submitted
65148,Phase 2/3
27802,Phase 2
7483,Phase 2/3
100738,Phase 3
43011,Investigative
122022,Phase 1/2
61374,Patented
22610,Phase 1
119021,Phase 2
12668,IND submitted
150671,Phase 2
171188,Phase 2/3
136077,IND submitted
150812,Phase 1
35875,Discontinued in Phase 1/2
20254,Discontinued in Phase 4
44322,Phase 2/3
28475,Phase 1/2a
124988,Phase 1b
154240,Phase 1/2a
121798,Phase 1b/2a
118731,Phase 2
32031,Phase 2
36629,Phase 1
93415,Investigative
73185,Phase 0
115597,Phase 1b/2a
37644,Phase 2
43909,Phase 1/2a
3461,Investigative
23260,Discontinued in Phase 4
417,Discontinued in Phase 1
113898,Phase 1
7266,Phase 1b/2a
143313,Phase 1b/2a
64764,Approved
113682,Phase 1
45153,Phase 2/3
30101,Investigative
152874,Phase 1b/2a
10044,Phase 1/2
163520,Investigative
190136,Approved
2531,Phase 1b
146918,Discontinued in Phase 1
76246,Discontinued in Phase 1/2
64020,Discontinued in Phase 2b
13475,Phase 1
157165,Phase 1b/2a
127683,Investigative
83909,Phase 1b/2a
86549,Phase 1/2
24387,Phase 1b/2a
125737,BLA submitted
187193,Phase 4
132119,Phase 1b/2a
163501,Discontinued in Preregistration
107039,Phase 1b
116198,Phase 2
79176,Phase 1b
118662,Phase 1/2a
73581,Patented
56605,Phase 0
112616,Discontinued in Phase 2
28577,Phase 1/2a
137801,Phase 1/2a
70295,Phase 1b/2a
117303,Discontinued in Phase 1
109029,Patented
43975,Phase 2/3
101560,Phase 1/2
130189,Patented
37581,Phase 1
1143,BLA submitted
18885,Discontinued in Phase 2/3
65126,Phase 0
155591,Phase 2
29110,Phase 4
83686,Phase 0
146578,Phase 0
110050,Phase 1
133292,Approved
118730,Registered
15061,Phase 0
18084,Phase 1
85879,Discontinued in Phase 3
104539,Investigative
7659,Discontinued in Phase 3
49160,Phase 1
114676,Discontinued in Phase 1
35764,Discontinued in Phase 4
5140,IND submitted
8664,Phase 1/2a
11026,Discontinued in Phase 3
14874,Phase 1
114870,Approved (orphan drug)
30759,Discontinued in Phase 2b
121901,BLA submitted
141275,Discontinued in Phase 1
182685,Phase 1b
127334,Phase 1/2
80732,Phase 2
68803,Discontinued in Phase 4
168379,Phase 0
186738,Phase 0
139290,Phase 1b
115733,Phase 2a
43541,Phase 1/2a
114173,Patented
141027,Discontinued in Phase 2b
102979,Application submitted
183980,Discontinued in Phase 4
140634,Phase 3
57933,Discontinued in Phase 1/2
11206,Discontinued in Phase 4
111843,Phase 1/2
133549,Discontinued in Preregistration
36891,Phase 1
156414,Phase 1/2
152770,Phase 1/2a
142002,Phase 0
54991,Phase 1/2
103341,Investigative
126447,Phase 1/2
93,Discontinued in Phase 2/3
101803,Phase 2a
296,Discontinued in Phase 1
63862,Phase 0
110677,Phase 1/2a
29382,IND submitted
42458,Phase 1
137136,Phase 2
98004,Discontinued in Phase 2b
134297,Phase 1/2a
157934,IND submitted
141964,Discontinued in Phase 2b
117736,Discontinued in Preregistration
120930,Phase 1b
103269,Investigative
128264,Phase 0
128716,Phase 0
72012,Discontinued in Preregistration
171321,Phase 1
85167,Phase 1/2a
127047,Discontinued in Phase 1
111154,Discontinued in Phase 3
96448,Discontinued in Phase 2b
120743,Investigative
86975,Phase 1/2
70706,Phase 2
26491,Phase 1
98317,Phase 2/3
125388,Discontinued in Phase 3
139888,Phase 1/2a
83046,Investigative
120630,Approved (orphan drug)
71766,Discontinued in Phase 4
110689,Discontinued in Preregistration
41627,Phase 0
81538,Approved
126874,IND submitted
55364,Phase 1b/2a
107453,Phase 1/2
50301,Discontinued in Preregistration
68731,Discontinued in Preregistration
180369,Phase 1b/2a
82974,Discontinued in Phase 4
117254,Discontinued in Phase 3
85946,Discontinued in Phase 2b
45058,Phase 2/3
84557,Phase 1/2a
152935,Phase 1
61890,Phase 1b
30884,IND submitted
189364,Clinical trial
71356,Phase 1b/2a
89581,Phase 1b/2a
63999,Phase 0
157052,Phase 1b/2a
62107,Phase 1b
55207,Phase 1/2a
47712,Phase 1b/2a
102965,Discontinued in Preregistration
176688,Phase 1b/2a
101859,Investigative
2569,Phase 1
83520,Investigative
72081,Phase 1b
88881,Patented
26236,Phase 1
59853,Phase 0
173359,Phase 0
63852,Approved
130969,Phase 0
62384,Discontinued in Phase 4
183217,Approved (orphan drug)
26197,Phase 2/3
13274,Investigative
31800,Discontinued in Preregistration
20995,Phase 2b
72303,Phase 1b
27649,IND submitted
151537,Phase 1
107369,Phase 1/2
85594,Discontinued in Phase 2b
87952,Phase 0
30512,Discontinued in Preregistration
148413,Discontinued in Preregistration
81276,Phase 1b
49917,Phase 3
26654,Phase 1/2a
33582,Phase 2/3
120234,Phase 0
51097,Phase 0
118057,Discontinued in Phase 4
96828,Discontinued in Phase 2b
159556,Discontinued in Phase 3
156614,Clinical trial
70164,Phase 1b/2a
73316,Investigative
21820,Discontinued in Phase 1/2
109467,Discontinued in Preregistration
154154,Discontinued in Phase 3
153590,Phase 1/2a
151650,Phase 1
84147,Phase 0
89298,Phase 1/2a
8489,Phase 1
158850,Phase 2
133286,Discontinued in Preregistration
5667,Investigative
56122,IND submitted
120651,Phase 0
34814,Phase 2
162289,Discontinued in Phase 2b
165349,Phase 0
28539,Discontinued in Preregistration
81079,Phase 1/2
184854,Phase 0
6195,Phase 1b/2a
156510,Clinical trial
20571,Discontinued in Phase 2b
86461,Phase 1
4137,Investigative
85821,Discontinued in Preregistration
136849,Phase 1/2a
131360,Phase 1/2
130240,Patented
79440,Clinical trial
80608,Phase 2a
30578,Discontinued in Phase 2b
116975,Discontinued in Phase 2b
20634,Phase 1/2a
129637,Patented
127516,Phase 1b/2a
82674,Phase 1/2
97581,Phase 1b
174212,Phase 0
74019,Discontinued in Phase 3
157650,Phase 1b/2a
32141,Phase 1/2
39807,Patented
150699,Phase 1/2
81258,Phase 1b
75043,Discontinued in Phase 2/3
50273,Discontinued in Preregistration
17332,Phase 1
137069,Discontinued in Phase 2
68308,Discontinued in Preregistration
22267,Phase 1b/2a
79810,BLA submitted
146836,Phase 1b/2a
65310,Phase 1/2a
108812,Phase 1
65410,Phase 2
113712,Phase 1
16092,Phase 1b/2a
12028,Phase 1b
41621,Phase 1
16516,Phase 3
127452,Discontinued in Phase 3
46014,Phase 1/2a
2214,Discontinued in Phase 2
130095,Phase 2a
89271,Phase 1
101131,Investigative
73276,Discontinued in Phase 1
137707,Investigative
134870,Phase 0
158767,IND submitted
28427,Phase 0
75388,Phase 1/2a
90299,Discontinued in Phase 3
132616,Discontinued in Phase 1/2
166667,Discontinued in Phase 2
8539,Discontinued in Phase 2b
118674,Phase 1b/2a
110085,Phase 1
55181,Discontinued in Phase 3
39073,Phase 2
178769,Discontinued in Phase 3
169421,Investigative
6992,Discontinued in Phase 2
7653,Discontinued in Phase 3
73086,Patented
86219,Discontinued in Phase 2/3
97055,Phase 1
106387,Patented
46772,Phase 4
185543,Phase 4
172530,Discontinued in Phase 2/3
125856,BLA submitted
86031,Phase 1b/2a
48693,Phase 3
141873,Phase 1b
168002,Phase 1b
23643,Phase 1b/2a
1063,Clinical trial
149785,Phase 1/2
13263,Phase 1
141994,Discontinued in Phase 4
176810,Phase 0
141936,Discontinued in Phase 2b
5890,Phase 2a
185158,Discontinued in Phase 3
28693,Investigative
35583,Discontinued in Preregistration
40886,Approved
129937,Discontinued in Phase 4
163669,Discontinued in Phase 2/3
121047,Phase 1b
61343,Phase 1
173615,Phase 0
16781,Phase 1
176632,Phase 1
33004,Phase 2/3
41511,Investigative
57830,Investigative
58564,Phase 0
90199,Approved (orphan drug)
125381,IND submitted
74750,Phase 1/2a
8996,Phase 1
152576,Approved
53580,Phase 1/2
129647,IND submitted
167985,Phase 0
86039,Phase 2
95962,Phase 2a
113665,Phase 0
124453,Patented
133521,Phase 1/2
89465,Phase 1/2a
121668,Discontinued in Phase 1
58520,Approved (orphan drug)
114074,Patented
25529,Discontinued in Phase 2/3
111859,Phase 2
58773,Discontinued in Phase 1/2
138586,Phase 1b
55341,Phase 0
176223,Investigative
116782,Discontinued in Phase 2b
54097,IND submitted
84594,Phase 1b/2a
161989,Investigative
44764,Phase 1/2a
56542,Discontinued in Phase 3
69590,Discontinued in Phase 2
78185,Phase 1
88925,Phase 0
132784,Discontinued in Phase 1/2
48291,Phase 1b/2a
83225,Phase 1/2
120943,Phase 1/2a
185888,Phase 1/2a
91504,Clinical trial
103567,Phase 1/2a
27335,IND submitted
72759,Phase 2
101281,Patented
104532,Patented
49911,Phase 1
161932,Investigative
102863,Discontinued in Preregistration
64287,Discontinued in Phase 2b
174409,Phase 1
28695,Phase 2
125128,Phase 1b/2a
117343,Discontinued in Phase 1
116651,Phase 1b
148114,IND submitted
106416,Phase 1/2
28611,Phase 1/2a
784,Discontinued in Phase 4
79295,Phase 1b/2a
37922,Phase 1/2a
54586,Patented
22009,Phase 0
7172,Discontinued in Phase 2
103672,Phase 1/2
55595,Investigative
121628,Phase 1b/2a
62628,Phase 1
45439,Phase 2/3
143199,Phase 1/2
55542,Patented
8127,IND submitted
117741,Investigative
154980,Discontinued in Preregistration
162644,Phase 1b
53964,Phase 2
121295,Phase 1/2a
187405,Phase 0
22355,Phase 2a
33419,Discontinued in Phase 2
131857,IND submitted
174545,IND submitted
147688,Phase 1
189230,Phase 2b
163544,Discontinued in Phase 1/2
114569,Phase 2
114209,Phase 1/2
41917,Phase 0
165012,Phase 1/2
120767,Approved (orphan drug)
12527,Phase 1
20515,IND submitted
153428,IND submitted
155658,Phase 2/3
105251,Phase 1
187444,Patented
35415,Discontinued in Phase 2b
97887,Phase 1/2a
8780,IND submitted
110083,Phase 1
65269,Discontinued in Phase 4
144924,Phase 1b/2a
97586,Phase 1b
19203,Phase 1b
145034,Phase 2b
183746,Discontinued in Phase 4
15455,Phase 2b
164396,Phase 1/2a
102137,Approved (orphan drug)
59157,Discontinued in Phase 3
8582,Phase 1/2
47180,BLA submitted
129822,Discontinued in Phase 2/3
9664,Phase 1/2
17702,Phase 0
154143,Investigative
38704,Phase 2
166603,Phase 1b
146591,Phase 2/3
28185,Phase 0
150443,Phase 1/2
171868,IND submitted
46924,Approved
48684,Phase 1
106731,Phase 1/2a
101871,Investigative
41954,Phase 1
172315,Phase 1b
119635,Discontinued in Preregistration
25498,Phase 0
19296,IND submitted
75789,Investigative
169543,Phase 0
130703,Phase 1b
96781,Investigative
79797,Clinical trial
113440,Phase 1/2
157302,Phase 1/2
6139,IND submitted
184265,Phase 0
179763,Phase 1/2
176637,Phase 1/2
37958,Phase 1/2a
149596,IND submitted
14081,Phase 0
21468,Investigative
112126,Phase 0
135792,Phase 1b/2a
158684,BLA submitted
62114,Discontinued in Phase 4
183937,Phase 1/2
66142,Phase 1/2a
140734,Phase 3
35552,Phase 0
191271,Patented
156452,Phase 1/2
98927,Phase 1/2a
135282,Phase 0
126339,Phase 1b
128420,Phase 0
151423,Discontinued in Phase 2/3
170241,Phase 2/3
108741,Patented
60098,Investigative
55216,Phase 1/2a
72201,Patented
21322,Phase 1
46219,Phase 1/2a
116633,Phase 1
7341,Investigative
176051,Discontinued in Phase 3
35566,Discontinued in Phase 3
36448,Investigative
147362,Phase 1/2
132461,Discontinued in Preregistration
99989,Phase 1b
173402,Discontinued in Phase 2b
169301,Patented
9416,Discontinued in Phase 1
73680,Phase 2/3
6377,Phase 1/2
117905,Phase 2b
63798,Phase 2a
49030,Discontinued in Preregistration
165833,Phase 1b/2a
145885,Phase 1/2
65333,Preclinical
42930,Phase 2
134071,Phase 1/2
16176,Phase 0
79174,Discontinued in Phase 4
13425,Phase 0
105246,Phase 1b
122031,Approved
180761,Phase 1/2a
34770,BLA submitted
166155,Phase 1
31288,Phase 0
70738,Phase 1b
170920,IND submitted
116501,Investigative
32953,Phase 1/2
57112,Phase 0
32631,Phase 3
150704,Discontinued in Phase 2/3
141587,Discontinued in Phase 1
169523,Phase 2
80392,Clinical trial
54687,Phase 1b
39045,Discontinued in Preregistration
97442,Phase 1/2a
187788,Phase 0
59012,Phase 0
15531,Phase 1b/2a
181076,Phase 2b
185071,Phase 0
149029,Clinical trial
72207,Phase 1b
150866,Phase 1b/2a
187540,Phase 0
50501,Investigative
62307,Phase 1
111160,Patented
115070,Phase 1/2
77099,Phase 1/2a
64411,Clinical trial
47591,Phase 1b
78118,Approved
152907,Investigative
88171,Approved
23441,Patented
132564,Phase 1/2
145195,Phase 2
181254,Phase 2a
58288,Phase 0
30432,Phase 1
121496,Discontinued in Phase 1
77035,Phase 1/2a
35065,Discontinued in Phase 3
50858,Discontinued in Phase 2
183861,IND submitted
148574,Phase 1b/2a
99817,Phase 1
15825,Phase 0
72091,Phase 1
95463,Phase 1/2
162955,Patented
138930,BLA submitted
52794,Discontinued in Phase 2b
136366,Discontinued in Phase 3
108740,Phase 1
30639,Discontinued in Phase 2b
138902,Approved (orphan drug)
69276,Investigative
91512,Phase 1b
120591,BLA submitted
137257,Discontinued in Phase 3
73176,Phase 1
86712,Discontinued in Phase 4
148001,Phase 1
189564,Approved
1398,Discontinued in Phase 4
180296,Discontinued in Phase 2b
123648,Discontinued in Phase 4
84098,Discontinued in Phase 4
164578,Phase 1/2
92453,Phase 1
111237,Discontinued in Phase 2b
88342,Phase 1/2
18465,Discontinued in Phase 3
168403,Phase 1b/2a
13893,Phase 1
154859,Phase 1b/2a
43127,Phase 1b/2a
83369,Phase 2
118102,Phase 1b/2a
76625,Phase 1/2a
82787,Phase 0
131747,Discontinued in Phase 2/3
134094,Discontinued in Phase 4
175601,Phase 1/2
56126,Discontinued in Phase 2b
59401,Phase 1b/2a
106186,Phase 2/3
84205,Phase 0
42312,Phase 1
185080,Phase 1
87871,Approved
162803,Clinical trial
103693,Phase 2a
157375,IND submitted
78790,Phase 3
2933,Discontinued in Phase 2
173785,Phase 1
175038,Discontinued in Phase 1/2
116318,Discontinued in Phase 2/3
34540,Phase 1
11731,Phase 1/2
26136,Discontinued in Phase 4
97373,Phase 0
132657,Discontinued in Preregistration
168573,Investigative
140560,Patented
79159,Phase 2/3
98479,Phase 1/2a
133443,Phase 1/2
143149,Patented
70042,Phase 2a
57955,Discontinued in Phase 2/3
179162,Discontinued in Phase 2/3
157893,Phase 1b/2a
183559,Phase 1b
168259,Phase 2
92856,Phase 1/2a
127249,IND submitted
78892,Phase 0
40466,Phase 1b/2a
172071,Discontinued in Phase 2/3
189056,Phase 1b
112632,Discontinued in Phase 3
14763,Phase 1b/2a
118442,Phase 1b/2a
143181,Phase 2
165270,Phase 1
11441,Phase 1
37362,Phase 2a
69758,Phase 1b/2a
24405,Phase 1/2a
21279,Phase 1b
127711,Discontinued in Preregistration
73429,Phase 1b/2a
139386,Approved (orphan drug)
24779,Discontinued in Preregistration
81040,Phase 2
98526,Phase 1b/2a
187791,Phase 4
29149,Phase 0
93833,Phase 2
129065,Discontinued in Phase 4
73877,Phase 1/2a
100784,Phase 2/3
96051,Discontinued in Phase 4
174252,Discontinued in Preregistration
117422,Discontinued in Phase 2b
11390,Investigative
5094,Investigative
65811,Discontinued in Phase 2
115974,Phase 1/2a
35457,Phase 1/2
30496,Patented
38007,Discontinued in Phase 3
32516,Patented
52423,Investigative
184473,Discontinued in Phase 4
86589,Discontinued in Phase 1
33308,Phase 1/2a
148031,Discontinued in Phase 2
15724,Phase 1b/2a
104697,Phase 1
38872,Phase 2
192007,Patented
125536,BLA submitted
45030,Phase 1/2a
58027,Phase 1
120446,Approved (orphan drug)
89136,IND submitted
80711,Phase 1
124553,Discontinued in Phase 4
71631,Phase 1b
8071,Patented
58145,Phase 0
124032,Phase 1b
163010,Patented
13578,Phase 1
185409,Phase 1b
52884,IND submitted
156581,IND submitted
129251,Discontinued in Preregistration
80221,Discontinued in Phase 2
190642,Phase 1b
172605,Discontinued in Phase 2b
131911,Phase 1/2
6075,Investigative
62099,Discontinued in Preregistration
4687,Preregistration
152229,Phase 2
8793,IND submitted
105931,Phase 1b
51396,Phase 0
164852,BLA submitted
43038,Phase 1b
27680,Patented
71515,Phase 1
181599,Phase 1b/2a
28063,Discontinued in Phase 4
146628,Discontinued in Phase 2
172007,Phase 0
127778,Phase 1/2
181335,Phase 1b
39375,Phase 1/2a
74294,Phase 1/2a
139088,Clinical trial
138652,Phase 1b
67076,Phase 0
98050,Phase 1b/2a
149272,Phase 1/2
91657,Approved (orphan drug)
162903,Phase 1/2a
39722,Phase 2/3
160263,Phase 1b
67355,Phase 1b
26790,Phase 0
159699,Phase 1b
179453,Discontinued in Phase 1/2
107752,Discontinued in Phase 2b
126794,Phase 1/2
170924,Phase 1
167317,Discontinued in Phase 1
58086,Discontinued in Phase 3
82017,Discontinued in Phase 1
172367,Investigative
123346,Phase 2
73046,Phase 2a
7449,Investigative
143747,Discontinued in Preregistration
164321,Phase 1/2
142336,Phase 2
107211,Phase 1/2a
165350,IND submitted
125916,BLA submitted
189750,Phase 2b
176666,Phase 0
74877,Phase 0
83417,Phase 1/2a
182161,Phase 1/2a
144240,Discontinued in Phase 2/3
95040,Phase 1/2a
31924,Phase 1/2a
166087,Patented
159875,Investigative
68018,Phase 2a
14609,Phase 1
64974,Discontinued in Phase 2b
113890,Phase 2
99556,Patented
106378,Phase 0
128198,Phase 1/2
56011,Phase 1/2
76462,Phase 2/3
165388,Discontinued in Phase 1
42374,Phase 2
2240,Patented
104635,Investigative
12965,Phase 0
127312,Phase 0
103111,Investigative
188284,Clinical trial
173837,Phase 2a
20478,Discontinued in Phase 2b
178529,Phase 1/2a
180084,Discontinued in Phase 2/3
92098,Discontinued in Phase 1/2
185318,Approved
83324,Phase 2/3
158325,Phase 1
73333,Phase 1b/2a
185160,Phase 1/2
10217,Discontinued in Phase 2b
111950,Phase 1/2
83210,Phase 1/2
172412,Phase 1
53108,Phase 1/2a
36157,Phase 1
42635,Phase 2
44664,Phase 2/3
45093,Phase 1/2a
24968,Phase 1/2
100795,Phase 1/2
108381,Phase 1b
71984,Phase 1/2
8325,Phase 2
170893,Phase 1b
93183,Phase 2
37665,Phase 2
87969,Discontinued in Phase 3
184685,Phase 1
47762,Discontinued in Phase 2b
168456,Discontinued in Phase 2
87340,Patented
94150,Discontinued in Phase 2b
15955,Phase 1
150190,Phase 1b/2a
191640,IND submitted
63617,Phase 1b/2a
141230,Patented
126904,Phase 1b/2a
153584,Phase 1/2a
29524,Discontinued in Preregistration
140873,Phase 1b/2a
87012,Discontinued in Phase 3
157319,Registered
167466,Discontinued in Preregistration
76413,Investigative
59065,Phase 1b/2a
133454,Discontinued in Preregistration
182224,Phase 2a
17587,Phase 1
184747,Phase 0
35166,Phase 2a
163663,Phase 1/2a
171334,Phase 1b
17452,Phase 1b/2a
94460,Discontinued in Phase 3
92218,Approved (orphan drug)
166300,Discontinued in Phase 4
151355,Phase 2
118337,BLA submitted
21837,Phase 1/2
31012,Phase 0
92797,Discontinued in Phase 3
88291,Discontinued in Phase 3
179610,Discontinued in Phase 1/2
26161,Phase 0
161457,Phase 0
22634,Discontinued in Phase 4
62028,Investigative
43938,Phase 2/3
8218,Patented
64515,Discontinued in Phase 2b
67657,Phase 1
160130,Phase 1b/2a
183151,Discontinued in Preregistration
44138,Phase 2/3
170159,Phase 2/3
55723,Phase 1/2a
77855,Investigative
59407,Phase 2/3
90707,Approved (orphan drug)
138962,Phase 1/2a
136620,Investigative
82430,Phase 1b/2a
179896,Phase 1/2
112933,Phase 1/2
94791,Patented
10504,Preclinical
135961,Phase 3
121138,Phase 2
172227,Discontinued in Phase 2b
189365,Phase 1/2
91554,Phase 1b
91797,Discontinued in Phase 2
174500,Phase 1
158648,Phase 0
188906,Phase 1/2a
172909,Discontinued in Phase 2/3
16283,Phase 1b/2a
77060,Phase 2/3
159834,Phase 1b/2a
68171,Phase 1
79772,Approved (orphan drug)
24174,Phase 2
62429,Phase 1
13161,Phase 1/2
142799,Phase 1b/2a
46688,Phase 4
162545,Patented
94328,Phase 2
137258,Phase 1
35496,Discontinued in Phase 3
64225,Phase 1b/2a
97304,Discontinued in Phase 2b
178871,Phase 0
124755,Phase 1/2
125720,Discontinued in Preregistration
73836,Phase 2/3
170952,Discontinued in Phase 1
145209,Phase 1/2a
56506,Phase 0
141692,Patented
38490,Phase 1/2a
27345,Phase 1/2a
127256,Phase 0
100988,Phase 1b
63686,Phase 1/2
34451,Phase 1b/2a
70258,Phase 2
181354,Phase 2a
22110,Discontinued in Phase 1/2
45082,Phase 2/3
63406,Phase 1
175003,Phase 1
141516,Investigative
41514,Phase 1
110905,Discontinued in Phase 4
14026,Phase 1/2
84866,Phase 0
12204,Phase 1/2a
130884,Patented
50257,Phase 3
141646,Investigative
146614,Phase 1/2a
146131,Phase 2
23076,Phase 1
131895,Phase 1b/2a
41928,Discontinued in Phase 1
19068,Discontinued in Phase 2/3
153812,IND submitted
88172,Discontinued in Phase 2
94944,Phase 1/2a
105673,Patented
96592,Phase 1
18974,IND submitted
172387,Phase 1/2
131771,Phase 1/2
75792,Discontinued in Preregistration
4738,Phase 2/3
83705,Phase 1b/2a
75673,Discontinued in Phase 1/2
167938,Phase 1b
64421,Approved (orphan drug)
10352,Phase 1
102779,Discontinued in Preregistration
62039,Discontinued in Phase 4
159531,Phase 1b
116244,Clinical trial
166348,Phase 1b
138795,Investigative
58634,Phase 2/3
66629,BLA submitted
123689,Phase 1/2
144357,Discontinued in Phase 1/2
21856,Phase 2b
136488,Investigative
162399,Discontinued in Preregistration
65774,Phase 1b/2a
179924,Discontinued in Phase 2/3
130488,Phase 0
189483,Phase 1b/2a
37612,Phase 0
108210,Phase 1b
164210,Phase 2/3
113454,Discontinued in Phase 4
85195,Phase 1/2
10418,Investigative
93045,Phase 2b
26517,BLA submitted
108267,Investigative
83114,Investigative
110446,Phase 3
47336,Clinical trial
54981,IND submitted
123466,IND submitted
100806,Patented
80235,Phase 1
24908,Phase 2
78113,Phase 1
84824,Phase 1b/2a
180325,Phase 2b
44726,Phase 1/2a
67635,BLA submitted
143788,Discontinued in Phase 3
3234,Patented
131384,Discontinued in Phase 1/2
48510,Discontinued in Phase 2b
143589,Phase 2
50944,Phase 1b
8480,IND submitted
32933,Phase 1b/2a
88888,Patented
33131,IND submitted
166576,Phase 1
96738,Phase 1b
71935,Phase 0
170151,Phase 1/2
128858,Phase 1/2
113330,Discontinued in Phase 3
28923,Phase 1b/2a
125208,Discontinued in Phase 4
50427,Investigative
25765,Phase 2
55666,Phase 2
132044,Discontinued in Phase 2b
111695,Phase 1/2
32689,Phase 2/3
49051,Discontinued in Phase 2/3
101937,Phase 1
88970,Investigative
132057,Discontinued in Phase 1/2
131305,IND submitted
31964,Phase 1b
46897,Approved
169666,Phase 1
106245,Phase 1b
132909,IND submitted
22228,Patented
167760,Phase 2
64316,Investigative
5909,Phase 1/2
153997,Phase 1b/2a
73688,Investigative
79942,Phase 1b/2a
51731,Phase 1/2a
73742,Approved (orphan drug)
181008,Discontinued in Phase 2
77909,Phase 1b
83800,Investigative
160466,Phase 0
187002,Phase 0
147257,Phase 2b
191362,Phase 2a
93609,Phase 1b
165510,Phase 1b
189706,Phase 1b
104215,BLA submitted
175425,Phase 3
100823,Phase 1/2a
778,Discontinued in Phase 4
181508,Discontinued in Phase 2
32454,Phase 0
84586,Phase 0
192044,Phase 2a
140741,Phase 2a
116731,Phase 1b
187270,Phase 0
148399,Phase 2b
30499,Phase 1/2
141084,Investigative
3082,IND submitted
106305,Preregistration
137778,Discontinued in Phase 2/3
161009,Patented
46986,Approved
35043,Phase 1b/2a
58913,Discontinued in Phase 1/2
136290,Phase 1/2a
168359,Phase 2b
71623,Phase 1
185866,Discontinued in Preregistration
33244,Phase 1b/2a
162358,Phase 3
111606,Phase 0
54756,Phase 1b/2a
25774,Phase 1/2a
185432,Discontinued in Phase 2b
24761,Phase 2
133182,Discontinued in Phase 1
115340,Clinical trial
34594,Phase 1/2
20681,Phase 1b/2a
118862,Phase 1/2a
138256,Phase 1b
24226,Phase 1/2
171271,Phase 1b
178037,Phase 1
36927,Phase 2a
70533,Discontinued in Phase 4
150742,Discontinued in Phase 2/3
121352,Phase 1/2a
110738,Discontinued in Preregistration
80322,Discontinued in Phase 3
62110,Discontinued in Phase 4
5015,Phase 2a
151805,Phase 0
166492,IND submitted
96612,Phase 2b
184992,Phase 1/2
68478,Discontinued in Preregistration
90502,Clinical trial
107458,Phase 1b
169005,Phase 3
64668,Phase 0
100190,Preclinical
83410,Phase 2
63098,Discontinued in Phase 3
67136,Patented
45123,Phase 1/2a
48561,Phase 1b/2a
128610,Phase 1/2
160017,Discontinued in Phase 1/2
124549,Phase 1b
110756,Phase 2
96513,Discontinued in Phase 3
175969,Discontinued in Phase 3
106781,Phase 1/2
51034,Discontinued in Phase 3
117883,Phase 1
46391,Phase 1/2
170399,Phase 1
181269,Phase 1b/2a
115161,Discontinued in Phase 2
122206,Phase 1b
86961,Phase 1b
2411,Phase 1b/2a
8149,IND submitted
101250,Discontinued in Phase 2
11758,Phase 1b
117283,Discontinued in Phase 1
594,Discontinued in Phase 2
67962,Phase 1
66561,Patented
51263,Phase 1/2a
144073,Phase 1/2
159379,Patented
143380,Discontinued in Phase 3
62445,Discontinued in Preregistration
126217,BLA submitted
159044,Phase 1b
6878,Phase 2a
108221,Phase 2
162697,Phase 1/2a
24237,Phase 0
106049,Phase 1/2a
169551,Phase 2
124837,Phase 1/2
86349,Discontinued in Phase 2b
23749,Phase 1/2
176617,Phase 2b
178861,Phase 1/2
89269,Phase 1/2
6609,Phase 1b/2a
65876,Phase 2/3
166813,Investigative
156806,Discontinued in Phase 4
109270,Phase 1/2
1735,Patented
170158,Phase 1b
176351,Phase 2
24214,Phase 1b
75309,Discontinued in Phase 2/3
153227,Discontinued in Phase 3
184839,BLA submitted
100326,Approved
86946,Phase 1b
175257,Phase 1/2
2671,Phase 1
13450,Phase 1/2
120808,Approved
170137,Phase 1/2a
46808,Phase 1/2
30508,Phase 0
59239,Phase 2/3
173340,Patented
53740,Discontinued in Phase 3
26519,Phase 1b
189201,Clinical trial
94601,Patented
8364,Phase 2
67061,Phase 3
91960,Phase 1b
63900,Phase 0
105281,Phase 1b
20512,IND submitted
64416,Phase 1/2a
124305,Phase 1/2
58011,Discontinued in Phase 2/3
7620,Phase 2
163336,IND submitted
5575,Phase 2/3
164122,Phase 1/2
71189,Phase 1b/2a
105716,Phase 1
157930,Approved (orphan drug)
67460,Phase 1b/2a
82250,Phase 2
183343,Phase 4
101213,Phase 1b
25992,Phase 2/3
177287,Phase 1b
69384,Investigative
116520,Discontinued in Phase 3
177061,Phase 2b
97706,Phase 1b
185738,Phase 1/2a
92109,Discontinued in Phase 1/2
72867,Phase 2
155672,Phase 2
5302,IND submitted
93091,Phase 1b
13939,Phase 1
136682,Phase 1/2a
118267,Phase 2
139706,BLA submitted
12580,Phase 3
49604,Phase 1
108358,Phase 0
175990,Phase 2
31067,Discontinued in Phase 2b
68919,Discontinued in Phase 1/2
178145,Phase 1b/2a
103852,Phase 0
64960,Phase 1/2
124831,Phase 2
157787,Registered
94109,Phase 2b
44,Discontinued in Phase 1/2
182310,Phase 2
139046,BLA submitted
46022,Phase 1/2a
71394,Phase 0
136203,Phase 0
115858,Phase 1b/2a
105561,Phase 1
94846,Phase 1/2a
170937,Patented
84450,Phase 0
165062,BLA submitted
5805,Investigative
25374,Phase 1/2
79540,Phase 2a
85677,Discontinued in Preregistration
10983,Phase 1b
20632,Phase 0
93228,Phase 2a
32269,Phase 2/3
734,Phase 1
71191,Discontinued in Phase 3
71795,Phase 0
180159,Phase 2/3
142614,IND submitted
177945,Approved
180779,Phase 1/2
20256,Phase 1
76015,Phase 1/2
78286,Investigative
92828,Phase 1b/2a
128020,Phase 1b/2a
175106,Discontinued in Phase 3
4589,Discontinued in Phase 2
76819,Phase 0
153725,Phase 1/2
167263,Discontinued in Phase 2
121272,Phase 1/2a
170680,Phase 1/2a
56845,Phase 0
51033,Discontinued in Phase 3
42975,Patented
94773,Phase 1b
188653,IND submitted
134177,Phase 1/2
161693,Investigative
105292,Phase 2b
64804,Phase 1
55201,Phase 0
50829,Discontinued in Phase 3
9005,IND submitted
113147,Patented
161984,Patented
101411,Phase 1b/2a
39471,Phase 1b
152116,Phase 2
66594,Patented
777,Discontinued in Phase 2
2753,Phase 1b/2a
112043,Discontinued in Phase 3
72254,Phase 1
154704,Phase 3
61721,Discontinued in Preregistration
118247,Phase 1b/2a
175795,Discontinued in Phase 2
133376,Approved
89074,BLA submitted
187550,Phase 2a
26644,Phase 1b
172110,Discontinued in Phase 2/3
165694,Phase 1
84047,Discontinued in Phase 3
31895,Discontinued in Preregistration
152875,Phase 2b
98323,Phase 1/2
142725,Phase 1b/2a
177952,Phase 1/2
32193,Phase 2a
47859,Phase 0
144962,Phase 2b
41603,Phase 1
127369,Patented
177859,Discontinued in Phase 1/2
80695,Discontinued in Phase 2
125894,Phase 1b
64897,Discontinued in Phase 2b
95880,Phase 1/2a
45734,Phase 1/2a
41558,Phase 2a
183659,Phase 2a
95909,Phase 1
190621,Preclinical
42154,Phase 1
28430,Phase 0
87492,Phase 0
29707,Phase 1b
27772,Phase 1/2
8631,Phase 2
67993,Phase 1/2
132162,Discontinued in Preregistration
104806,Phase 2a
87061,Phase 2
180455,Phase 2a
172985,Discontinued in Phase 2b
44818,Phase 2/3
90633,Approved (orphan drug)
1225,Discontinued in Phase 4
181856,Phase 2a
63484,Discontinued in Phase 4
63434,Phase 1
168015,IND submitted
101200,Phase 1/2a
80542,Discontinued in Phase 1/2
8773,Phase 1/2a
95799,Phase 1
26992,Phase 1
139132,Clinical trial
14383,Phase 1
159008,Approved
168460,Phase 1b/2a
98095,Phase 1/2
46360,Patented
23342,Phase 1/2
73678,Phase 2a
147730,Phase 1b/2a
185062,Discontinued in Phase 4
95720,Phase 2a
127439,Phase 1/2a
64730,Patented
100393,Investigative
188434,Phase 1/2a
122612,Phase 1b
173644,Approved
76803,Investigative
55309,Discontinued in Phase 2b
184805,Phase 0
1797,Discontinued in Phase 1/2
97758,Phase 0
115626,Approved (orphan drug)
40435,IND submitted
66872,Phase 3
161365,Phase 2a
15797,Phase 1/2
109039,Patented
6271,Phase 4
2284,Phase 1
155357,Phase 1
110088,Phase 1
35272,Phase 1/2
124720,IND submitted
188879,Preclinical
20597,Phase 2
7770,Phase 1
115851,Phase 1b
43836,Phase 1/2a
84003,Investigative
105886,Phase 0
56538,Phase 1b
23586,Phase 2/3
133511,Phase 1/2
148890,Discontinued in Phase 2
126376,BLA submitted
60874,Phase 2/3
147030,Phase 1b/2a
89668,Patented
62426,Phase 1
30730,Phase 0
54430,Phase 1b
985,Phase 2/3
2991,Phase 1b
11645,Phase 1/2a
52634,Discontinued in Preregistration
108665,Discontinued in Phase 2/3
167874,Phase 1/2a
135974,Phase 1b
41794,Approved
122264,Phase 0
114911,Discontinued in Preregistration
15957,Phase 1/2a
137292,Investigative
130067,Phase 2
28526,Phase 1/2
134724,Phase 0
120332,Discontinued in Phase 2
182522,Phase 2a
103185,Investigative
55663,Investigative
65818,Phase 2a
78997,Patented
159218,BLA submitted
91550,Phase 1b
49473,IND submitted
81564,Approved
178772,Discontinued in Phase 2/3
134897,Phase 0
148485,Phase 1/2a
88442,Phase 1/2
34759,Phase 2a
108135,Discontinued in Phase 2b
63009,Phase 0
23579,Phase 1b/2a
59128,Phase 0
183399,Phase 2a
116891,Phase 1b
161213,Phase 1
35024,Phase 1b/2a
164529,Discontinued in Preregistration
98856,Patented
93246,Phase 1/2a
50532,Phase 2/3
64663,Phase 1b/2a
71674,Phase 0
107723,Discontinued in Preregistration
114125,Patented
113046,Discontinued in Phase 1
100371,Discontinued in Phase 1/2
138074,Clinical trial
70701,Phase 2
60436,Phase 1b
33157,Phase 1b/2a
163533,Phase 1/2a
119259,Phase 1
58208,Phase 1
37107,Phase 2a
123225,Phase 0
21113,Phase 2/3
89590,Phase 1
145640,Discontinued in Phase 2
63019,Discontinued in Phase 4
160590,Phase 2/3
133591,Investigative
9997,Preclinical
54491,Discontinued in Phase 2/3
89784,Investigative
37623,Discontinued in Phase 2b
113895,Phase 2
134507,Phase 1/2a
41643,Discontinued in Phase 1
42345,Approved
87096,Phase 1b
126932,Phase 0
150703,Discontinued in Phase 2/3
28537,Discontinued in Preregistration
19977,Phase 2a
132246,Discontinued in Preregistration
162749,Phase 1/2a
6694,Phase 4
157747,Phase 1b/2a
148674,Phase 1b
40170,Discontinued in Preregistration
179067,Patented
49933,Discontinued in Preregistration
156873,Phase 1
159755,Investigative
53843,Phase 0
6569,Discontinued in Phase 2
47175,Approved
35911,Discontinued in Phase 1
34206,Phase 1/2a
158720,Phase 0
142618,Discontinued in Preregistration
107416,Phase 1b
105210,Phase 0
174228,Discontinued in Phase 1/2
85332,Discontinued in Preregistration
104058,Discontinued in Phase 4
157845,Phase 1/2a
64080,Approved
72877,Phase 2
172416,Patented
108281,Phase 1b
14605,Phase 1/2a
109384,Phase 1
111089,Phase 1
32146,Phase 1/2a
70676,Discontinued in Preregistration
111447,Patented
137341,Discontinued in Phase 3
40221,Phase 1b
20085,Phase 2a
132698,Phase 1/2
80970,Phase 2a
26674,Phase 1b
126148,Discontinued in Phase 3
154716,Phase 2/3
90269,Phase 1
177788,Phase 1b
19624,Phase 2a
81167,Clinical trial
83027,Investigative
119111,Phase 2
64806,Patented
118833,Phase 1/2a
68913,Phase 1b
17044,Phase 1
16240,Phase 1
9141,Discontinued in Phase 2
110117,IND submitted
50473,Phase 2
91349,Clinical trial
109210,Phase 1/2a
116863,Discontinued in Phase 1
4960,IND submitted
135218,Phase 0
30347,Discontinued in Phase 2b
151722,Phase 0
30617,Discontinued in Phase 2b
54257,Phase 1b/2a
134390,Phase 1
61417,Patented
73916,Discontinued in Phase 4
156107,Phase 1b/2a
101743,Phase 2/3
45217,Phase 2/3
9763,Preclinical
157051,Discontinued in Phase 1/2
4762,IND submitted
115850,Phase 1b
83475,Phase 1/2a
173264,Phase 1/2
40390,Phase 1/2a
82070,Phase 1b/2a
155921,Phase 1/2
5566,Phase 2/3
57671,Phase 2/3
1883,Approved
148836,Phase 1/2a
69632,Phase 1b/2a
17305,Investigative
153241,Discontinued in Phase 2b
50011,Phase 1/2a
28752,Phase 1/2a
150621,Discontinued in Phase 2/3
152162,Phase 0
24418,Discontinued in Phase 2/3
155300,Phase 1/2
183297,Discontinued in Phase 2
166449,Phase 1
80503,Phase 1/2a
165932,Phase 1b/2a
139175,BLA submitted
76485,Phase 0
6577,Phase 4
87196,Phase 1
5423,Phase 1/2
109400,Phase 2
38895,Discontinued in Preregistration
114398,Phase 1/2a
92398,Phase 1
181963,Phase 3
178357,Investigative
1768,Phase 2/3
117463,Discontinued in Phase 1
153161,Discontinued in Phase 3
79098,Phase 3
117965,Phase 2/3
34952,Phase 1b/2a
14096,Phase 0
96575,Discontinued in Phase 1
10574,IND submitted
76191,Phase 1/2
118791,Phase 1b/2a
142513,Phase 1b
188464,Phase 1/2a
88097,Phase 2a
136277,Discontinued in Phase 4
84699,Phase 1b/2a
104193,Phase 0
147744,Phase 1/2a
43221,Discontinued in Phase 4
395,Discontinued in Phase 1
6254,Discontinued in Phase 2
25842,Phase 1b
154047,Patented
128135,Discontinued in Preregistration
117814,Phase 0
56390,Phase 1b/2a
103429,Phase 1b/2a
103285,Approved (orphan drug)
161775,Phase 1/2a
35807,Phase 1/2
69052,Phase 3
77028,IND submitted
45566,Phase 1/2a
129302,Investigative
98006,Phase 1/2a
25602,Discontinued in Phase 2/3
181109,Phase 2
23251,Discontinued in Preregistration
43840,Phase 2/3
116185,Phase 1b/2a
77156,Discontinued in Phase 1/2
128259,Investigative
132215,Patented
28770,Phase 2
112764,Discontinued in Phase 3
86493,Patented
162360,Phase 1/2a
25923,Discontinued in Phase 2b
108952,Phase 1
111729,Discontinued in Phase 3
137609,Discontinued in Phase 2/3
58548,Approved (orphan drug)
178506,Phase 0
89936,Patented
58778,Phase 1/2
49729,Discontinued in Preregistration
41405,IND submitted
28739,Discontinued in Phase 2/3
76751,Investigative
44268,Phase 1/2a
102394,Investigative
175033,Phase 1/2
90102,BLA submitted
84487,Phase 1/2a
24608,Phase 1
91791,Preregistration
22670,Discontinued in Preregistration
113562,Phase 1
37857,Discontinued in Phase 3
91836,Phase 1b/2a
163362,Patented
72396,Phase 2
104167,IND submitted
185138,BLA submitted
123307,Phase 1b
139759,Discontinued in Phase 2
120403,Discontinued in Phase 1/2
188946,Phase 2b
168107,Phase 1/2a
156503,Phase 1/2
82260,Discontinued in Preregistration
188877,Patented
189211,Phase 2/3
88640,Patented
118339,Phase 1/2a
39443,Investigative
114940,Phase 1/2a
105294,Phase 1/2
98786,Phase 1/2a
131775,Discontinued in Phase 2/3
26846,Phase 1/2a
119083,Phase 2b
119822,Approved (orphan drug)
178980,Discontinued in Phase 2/3
8280,IND submitted
100401,IND submitted
132161,Patented
52353,Phase 1b/2a
44045,Phase 1/2a
122855,Phase 1
142027,Patented
92603,Approved (orphan drug)
36186,Discontinued in Phase 1
137867,Phase 1/2a
157774,Approved (orphan drug)
107499,Phase 2b
35274,BLA submitted
88659,Phase 1/2
59815,Phase 1b/2a
37993,Phase 2
17152,Phase 1
53250,Phase 1b/2a
121206,Phase 1
124262,Phase 1b
35182,Phase 1/2a
60951,Discontinued in Phase 2/3
135609,Phase 0
48636,Phase 1b
71285,Phase 0
105511,Phase 1/2a
92957,Discontinued in Phase 1
118249,Discontinued in Phase 1/2
121470,Discontinued in Preregistration
147776,Discontinued in Phase 1
30075,Phase 1
67696,Phase 1
182250,Phase 1b/2a
158842,Phase 1b/2a
106209,Phase 2a
52290,Patented
145167,Phase 1b
192041,Discontinued in Phase 2b
60197,Phase 1/2a
57168,Phase 0
15851,Phase 1/2a
150463,Phase 1b/2a
64288,Phase 0
63687,Approved
106446,Discontinued in Phase 3
47620,Phase 0
117526,Discontinued in Phase 1
152340,Patented
91470,BLA submitted
123639,Investigative
68813,Phase 1
56441,Discontinued in Phase 2/3
129239,Phase 1/2a
26812,Phase 1b
51790,Phase 2
42634,Investigative
24938,Phase 1b/2a
157220,Discontinued in Phase 2
118270,Phase 2/3
72209,Phase 0
185812,Phase 1b
29482,Phase 3
65241,BLA submitted
71873,Phase 1
122723,Phase 1
185360,Discontinued in Phase 1
15734,Phase 0
166132,Phase 1b/2a
145158,Phase 1b/2a
117934,Phase 3
32258,Phase 2/3
67683,IND submitted
68770,Phase 2a
76993,Phase 0
48796,Phase 2/3
163055,Discontinued in Phase 3
19930,Phase 2a
61330,Phase 1
77086,Phase 2/3
54369,IND submitted
141736,Phase 2/3
173801,Phase 1b/2a
103422,Phase 1b/2a
21997,Discontinued in Phase 2b
28645,Phase 0
57559,Phase 2/3
129551,Discontinued in Preregistration
37819,Phase 1/2
43041,Discontinued in Phase 1
22122,Approved (orphan drug)
148750,Phase 2b
87976,Phase 1b/2a
78886,Phase 0
161342,Investigative
21634,Phase 1/2
1593,Discontinued in Phase 4
40549,Phase 2
129641,Discontinued in Phase 4
9176,Discontinued in Phase 1
183024,Phase 2a
37490,Discontinued in Preregistration
152704,Approved
55046,Discontinued in Phase 4
128591,Phase 1/2a
6502,Phase 2/3
65514,Phase 2
35916,Investigative
145480,Clinical trial
119990,Approved (orphan drug)
133770,Phase 1/2
100256,Investigative
6600,Phase 1b/2a
13708,Phase 1b/2a
99041,Phase 1/2a
120748,Discontinued in Phase 1/2
92339,Phase 2
56846,Phase 0
42005,IND submitted
57711,Phase 2/3
174671,Phase 0
73460,Investigative
113142,Discontinued in Phase 2/3
101463,Discontinued in Phase 3
146130,Phase 1b/2a
35046,Phase 2a
66126,Approved (orphan drug)
4378,Phase 2/3
67874,Phase 2b
176639,Phase 1b
141795,Discontinued in Phase 2b
97457,Phase 0
77832,Phase 1b
123535,Phase 0
90479,Approved (orphan drug)
69563,Phase 1b
149931,Phase 2/3
152326,Phase 2a
14012,IND submitted
61579,Discontinued in Preregistration
131453,IND submitted
31236,Phase 2
185776,Discontinued in Preregistration
53477,Phase 0
183675,IND submitted
91057,Phase 1b
120453,Discontinued in Phase 4
163015,Discontinued in Preregistration
41801,Discontinued in Phase 1
156605,Discontinued in Phase 4
161236,Phase 1/2a
185068,Phase 1
5204,Phase 2a
172154,Discontinued in Phase 2/3
8360,Patented
103925,Patented
56720,Phase 2/3
45752,Phase 2/3
136616,BLA submitted
16348,Investigative
70264,Phase 1
148736,Phase 2/3
182078,Phase 1/2a
10482,Phase 1
83392,Discontinued in Phase 1/2
104908,Phase 0
91401,Discontinued in Phase 2b
171356,Discontinued in Phase 2/3
157167,IND submitted
176559,Phase 1/2
72419,Phase 1b/2a
5319,Investigative
105140,Phase 1/2
176220,Discontinued in Phase 4
33764,Phase 1/2a
129766,Phase 1/2
151122,Phase 0
159290,Phase 1/2
128723,Discontinued in Preregistration
180497,Discontinued in Phase 4
124461,Phase 1b
40821,Phase 1/2
163861,BLA submitted
144342,Discontinued in Phase 1/2
112513,Phase 1/2
31123,Phase 0
82842,Phase 0
10143,Phase 0
158224,Phase 1/2a
11357,Phase 1/2a
2489,IND submitted
15396,Phase 1
157595,IND submitted
164486,Phase 1/2a
101720,Phase 1/2
24388,Phase 0
158168,Phase 1b
9081,Discontinued in Preregistration
22334,Phase 0
35348,Phase 1/2
127077,Phase 0
105095,Discontinued in Phase 2b
126514,IND submitted
74296,Phase 1/2a
130734,Phase 2
153285,Phase 1/2
88513,Phase 0
2663,Phase 1b/2a
127765,Patented
48335,Phase 0
185633,Phase 4
141618,Patented
168129,Approved (orphan drug)
133852,Patented
704,Discontinued in Phase 2
131820,Discontinued in Phase 2b
47690,IND submitted
185510,Phase 2a
53877,Discontinued in Preregistration
156558,Phase 1b/2a
141584,Investigative
162419,Patented
58112,Phase 1b
79768,Phase 2a
128796,Discontinued in Phase 2b
126535,Discontinued in Phase 4
15240,Discontinued in Phase 1
87638,Patented
33187,Clinical trial
82726,Phase 0
6285,Phase 1b/2a
39894,Discontinued in Phase 2/3
81682,Phase 2
119341,Phase 1b/2a
42252,IND submitted
117691,Phase 1b
97286,Phase 1b
18178,Phase 1/2a
5465,Phase 2a
94584,Phase 1/2a
84,Phase 1/2a
29683,Phase 0
34209,Phase 1b/2a
163737,Phase 1/2
73626,Approved
32808,Phase 2
95358,Phase 1
190974,Phase 1/2
177948,Discontinued in Phase 2/3
35362,Phase 0
73348,Phase 2
45080,Phase 2/3
160278,Phase 1b/2a
45771,Phase 1/2a
85128,Phase 1/2
191452,Phase 2a
47194,Approved
125886,Investigative
150665,Phase 1b/2a
69474,Investigative
105214,Phase 0
142767,Phase 1/2
94733,Patented
65012,Phase 2/3
5866,Phase 4
93715,Phase 1b
139934,Discontinued in Phase 2
6332,Phase 1/2
116119,Phase 2
129050,Investigative
107397,Phase 1/2
116249,Phase 1b
41575,Phase 0
151944,Discontinued in Phase 2/3
162449,Patented
103360,Phase 0
119866,Phase 0
47763,Discontinued in Phase 2b
143212,Discontinued in Phase 3
86214,Investigative
16412,IND submitted
161379,Phase 2
17416,Phase 1
108384,Phase 1b
37444,Discontinued in Preregistration
51055,Phase 0
55824,Phase 1/2
79279,Phase 2a
60740,Clinical trial
62277,Phase 1b
89054,BLA submitted
166137,Discontinued in Phase 1/2
52973,Discontinued in Phase 2b
82646,Phase 1/2a
120945,Phase 2a
154637,Phase 2
151401,Phase 0
117056,Discontinued in Preregistration
88987,BLA submitted
94782,Phase 1
150596,Phase 2
42227,Phase 1/2a
147923,Phase 1
9185,Discontinued in Phase 4
28796,Phase 1/2a
96070,Phase 1b
101932,Phase 1
43747,Phase 1/2a
25001,Discontinued in Preregistration
92212,Discontinued in Phase 4
110534,Discontinued in Phase 2/3
28934,Phase 0
63084,Discontinued in Phase 4
35068,Phase 2/3
104998,Phase 1/2
177755,Phase 1b
171329,Phase 1/2
175175,Phase 1
107767,Discontinued in Phase 1
24002,IND submitted
188010,Phase 0
64393,Phase 1
104332,Phase 0
31662,Phase 1
127246,Phase 1/2
124407,Discontinued in Phase 4
43061,IND submitted
10650,Phase 0
162468,Investigative
151824,Discontinued in Phase 2/3
144439,Discontinued in Phase 4
115268,Discontinued in Preregistration
181774,Phase 2a
139113,BLA submitted
186245,Phase 2a
44241,Phase 2/3
136611,Phase 1b/2a
103091,Application submitted
121705,Discontinued in Phase 1
187008,Phase 0
130558,Phase 0
155655,Approved (orphan drug)
142780,Discontinued in Phase 3
184222,Discontinued in Phase 4
164394,Phase 1
120228,IND submitted
152108,Phase 1b/2a
180891,Phase 1
114350,Phase 1/2a
13810,Phase 0
169280,Phase 1
58368,Phase 0
155153,Phase 1b
180258,Discontinued in Phase 2
67979,Phase 1b
87073,Phase 1b/2a
187995,Phase 0
103050,Approved (orphan drug)
91204,BLA submitted
84864,Phase 1b/2a
92060,Phase 1b
31901,Investigative
102238,Approved (orphan drug)
13771,Phase 1
106736,Phase 1/2a
75523,Phase 0
166886,Phase 1/2a
169119,Phase 3
64047,Approved (orphan drug)
43874,Phase 2/3
25004,Phase 1/2
24507,Phase 2
114994,Discontinued in Phase 2
53627,Phase 0
6845,Phase 1/2
25654,Phase 2
7493,Phase 1/2
42884,Investigative
64560,Phase 1/2
84106,Phase 1b/2a
60943,Phase 1
148226,Discontinued in Phase 2
180739,Phase 1/2a
69833,Phase 1
36562,Phase 0
65047,Phase 4
86525,Phase 1/2
38801,Discontinued in Preregistration
181791,Phase 1
5115,Phase 1b/2a
22098,Phase 1/2
10037,Discontinued in Phase 2/3
110729,Phase 1
144942,Discontinued in Preregistration
121089,Phase 2b
100098,Approved
16970,Phase 1b/2a
1092,Investigative
25692,Discontinued in Phase 4
132435,Discontinued in Phase 4
120273,Phase 4
131027,Investigative
132013,Discontinued in Preregistration
96836,Discontinued in Phase 2
117567,Discontinued in Phase 2/3
87696,Discontinued in Phase 2/3
38164,Phase 0
24673,Phase 1/2a
61420,Phase 2a
156268,Discontinued in Phase 2b
184907,Discontinued in Phase 4
44952,Phase 2/3
143052,Phase 2a
123061,Phase 1/2
145784,Phase 1b/2a
175243,Discontinued in Phase 3
7360,Phase 4
11482,Discontinued in Phase 2/3
28191,Discontinued in Phase 2
150212,Phase 1b/2a
35747,Phase 1/2
159775,Phase 1b/2a
9310,Discontinued in Phase 2/3
89905,Discontinued in Preregistration
148389,Phase 0
61568,Phase 1
129141,IND submitted
114134,Phase 1/2a
113626,Phase 2
32202,Phase 0
96218,Phase 1/2a
58903,Phase 2/3
124185,Phase 1/2
140036,BLA submitted
165507,Phase 1
17977,Discontinued in Preregistration
52069,Discontinued in Preregistration
102460,Phase 0
15051,Phase 1b/2a
15952,Phase 1
15990,Phase 1/2
23584,Discontinued in Preregistration
29356,IND submitted
172504,Discontinued in Phase 2b
184529,Phase 0
116347,Discontinued in Phase 2/3
64191,Clinical trial
22763,Phase 2
106951,IND submitted
95412,Phase 1/2
89187,Discontinued in Phase 4
862,Phase 1/2
52819,Phase 1/2a
66303,Phase 1b/2a
154102,Discontinued in Phase 4
27049,Phase 1b
79101,Phase 0
102488,Phase 0
169371,Patented
166697,Phase 0
28420,Phase 1b
66287,Phase 1b/2a
57247,Phase 1
152919,Phase 1b/2a
39518,Investigative
176797,Phase 2b
120559,Approved (orphan drug)
91182,Discontinued in Preregistration
147104,Phase 1
18552,Discontinued in Phase 4
62254,Phase 1b/2a
54915,Investigative
39457,Patented
69183,Phase 1b
63777,Phase 2
35980,Phase 1b
108935,Phase 4
136812,BLA submitted
186170,Phase 2a
84191,Phase 1
46605,Discontinued in Phase 2b
88918,Phase 0
60716,Phase 1b
162369,Preclinical
39141,Phase 1b/2a
52354,Discontinued in Phase 2
24256,Phase 1/2a
150245,Patented
135603,Phase 0
162857,Clinical trial
82118,Clinical trial
122332,Phase 0
77341,Phase 1/2
26650,Phase 1b
7741,Phase 1
169625,IND submitted
136705,Discontinued in Phase 2
50338,Phase 1b/2a
41489,Phase 1
133105,Discontinued in Preregistration
117044,Discontinued in Phase 1
159740,Phase 1
79332,Discontinued in Phase 1
127483,Patented
93926,Phase 2b
48211,Phase 1
155695,Approved
4875,Investigative
158122,Phase 2b
130507,Phase 1/2
8442,Phase 2
12480,Phase 2b
35684,Discontinued in Preregistration
169663,Phase 2
58412,Phase 1/2a
89984,Phase 2/3
149981,Discontinued in Phase 2
35985,Phase 2a
6595,Phase 4
68810,Phase 1/2a
139546,BLA submitted
173295,Phase 1/2
108156,Phase 1/2
165242,BLA submitted
11336,Discontinued in Phase 2b
130934,Phase 0
63402,Patented
38978,Phase 2/3
85112,Phase 1/2a
89569,Phase 1b/2a
77731,Discontinued in Phase 2/3
120927,Phase 1b
180079,Phase 1/2
73482,Approved
69707,Phase 1b
25479,Discontinued in Phase 2b
64783,Discontinued in Phase 2/3
155649,Phase 2/3
149512,Phase 1/2
175491,IND submitted
11044,Discontinued in Phase 1/2
102325,Phase 1
169147,Clinical trial
125126,Patented
8320,Patented
177062,Phase 1
137953,Phase 1/2a
127396,Discontinued in Phase 2b
19913,Phase 2a
81561,Phase 1
54466,Patented
134438,Phase 1b
77219,Investigative
165607,Patented
169689,Phase 3
188029,Patented
130692,Phase 2
8576,Phase 1/2
153176,Discontinued in Phase 4
191151,Discontinued in Phase 4
74,Phase 1/2a
130620,Phase 1
93981,Phase 2b
24974,Discontinued in Phase 2/3
99024,Phase 0
190902,Phase 1b
61266,Patented
71426,Phase 1/2
164784,Phase 1/2
33040,Phase 2
109737,Preregistration
169635,Phase 2
31309,Phase 1/2
171934,Discontinued in Phase 2b
156322,Phase 1/2
68213,Approved (orphan drug)
135159,Phase 0
120773,Discontinued in Phase 4
134403,Discontinued in Phase 4
74988,Phase 1/2
19212,Phase 1b
14787,Phase 3
75177,Patented
21904,Discontinued in Phase 2
8885,Discontinued in Preregistration
128995,Patented
17053,Phase 1b/2a
61463,Patented
86541,Phase 1b
126418,IND submitted
177809,Phase 1/2
149640,Phase 1b/2a
33416,Phase 1/2a
146167,Phase 1
130180,Investigative
14680,Phase 0
144349,Phase 3
35263,Phase 2a
177369,Phase 2a
75161,IND submitted
134454,Patented
169771,Phase 0
156259,Discontinued in Phase 3
115486,Phase 1/2a
99067,Phase 1
40449,Phase 2
932,Clinical trial
159480,Phase 1b
39255,Phase 1
177986,Discontinued in Phase 3
187805,Phase 2a
145942,Phase 2b
23377,Phase 1/2
186453,Patented
11673,Investigative
74472,Phase 1/2a
56050,Phase 1b/2a
125784,Phase 1/2a
77887,Discontinued in Phase 2/3
163252,IND submitted
122887,Patented
30392,IND submitted
150892,Phase 1
190601,Phase 1b/2a
155661,Phase 2
137790,Phase 1
166770,Phase 1
95729,Phase 1/2a
160864,Phase 1b/2a
65802,Phase 1
98372,Phase 2
30234,Discontinued in Phase 3
172774,Discontinued in Phase 2b
136374,Phase 1/2a
110210,Phase 2
181662,Phase 1/2a
43347,Phase 1/2a
146009,Phase 2b
124916,Discontinued in Phase 4
187311,Phase 4
110627,Phase 1/2
71016,Phase 1b
89184,Phase 1/2a
27839,Phase 1/2a
102924,Application submitted
17093,Phase 1
26074,Discontinued in Preregistration
35303,Phase 1/2a
15496,Phase 0
112289,Discontinued in Phase 3
67552,Phase 1b
78806,Phase 2a
148504,IND submitted
176033,Phase 1/2
156989,Patented
58828,Approved (orphan drug)
140609,Phase 3
54286,IND submitted
87130,Discontinued in Phase 2
46954,Discontinued in Phase 1/2
113193,Phase 1/2
104895,Discontinued in Phase 2b
14955,Phase 1b/2a
82774,Phase 1/2
12222,Phase 1/2
152856,Phase 2/3
170247,Phase 0
86797,Investigative
189572,Clinical trial
144873,Discontinued in Phase 2
82008,Discontinued in Phase 1
152345,Patented
87178,Phase 1b
188783,IND submitted
165034,Phase 0
69173,Phase 1
182290,Phase 1/2a
63118,Discontinued in Phase 3
27072,Phase 1b
185106,Phase 0
1049,Discontinued in Phase 1
42662,Phase 0
70386,Phase 2
67391,Discontinued in Phase 1
154438,Discontinued in Preregistration
101954,Discontinued in Phase 2/3
2140,Phase 1b
155035,Clinical trial
70455,Phase 1
127311,Phase 1/2
26939,Phase 1b
135051,Phase 0
145588,Phase 1b/2a
91027,BLA submitted
24316,Phase 2
165487,Discontinued in Phase 1
61174,Phase 1b
175265,Phase 0
59250,Phase 2/3
103708,Phase 1b
116565,Clinical trial
58953,Phase 1b/2a
151096,Phase 1
118279,BLA submitted
133802,Phase 1
182245,Discontinued in Phase 2b
141658,Discontinued in Phase 4
81791,Phase 1
106743,Phase 2b
131035,Investigative
108810,Discontinued in Preregistration
115564,Phase 1b/2a
10896,Phase 0
89419,Phase 1/2
181186,Phase 1b
84279,Discontinued in Phase 3
75122,Phase 1/2a
157344,Registered
175496,Phase 1/2
136015,Phase 1b
38602,Discontinued in Phase 4
120323,Discontinued in Phase 1/2
140915,Discontinued in Phase 1
30242,IND submitted
88912,Phase 1/2a
151802,Phase 0
82088,Discontinued in Phase 2
112599,Phase 1
159639,Phase 1b
19600,Phase 1b/2a
41680,Approved
14814,Phase 1/2
37052,Discontinued in Phase 3
143945,Phase 1/2
157843,IND submitted
165843,Phase 1b/2a
139503,BLA submitted
149580,Phase 2/3
13916,IND submitted
47613,Phase 0
124848,Patented
60861,Phase 0
162851,Phase 1/2
27605,Phase 1b
182378,Phase 1/2a
86021,Phase 1b
135076,Phase 0
22974,Investigative
54565,Phase 0
56977,Phase 1b/2a
131392,Phase 2
51557,Phase 1b
163591,Discontinued in Phase 2
110887,Phase 1
51501,Discontinued in Phase 2/3
96071,Phase 1b
9780,Phase 1
180496,Discontinued in Phase 2b
73320,Phase 2/3
172105,Phase 1b
164250,Phase 1
102021,Phase 0
9017,Discontinued in Preregistration
190928,Investigative
143278,Phase 2b
144182,Phase 1/2a
59412,Phase 1
55058,Patented
170908,Phase 1/2
38440,Phase 1/2a
178918,Phase 1
99994,Phase 1b
80952,Clinical trial
3659,Approved (orphan drug)
186397,Patented
176887,Phase 2
191344,Phase 2a
135171,Phase 0
130393,Patented
64269,Approved (orphan drug)
184106,BLA submitted
99641,Patented
122673,Phase 1
93973,Phase 1b
167152,Discontinued in Phase 1/2
145537,Discontinued in Phase 2
144405,Discontinued in Phase 1/2
10250,IND submitted
5501,Phase 2a
6780,Phase 1b/2a
94662,Phase 1
19605,Phase 0
61163,Phase 1
132441,Patented
182543,Discontinued in Phase 2b
98175,Phase 1
69773,Phase 2b
92845,Phase 2
100333,Discontinued in Phase 1/2
175377,Discontinued in Phase 3
33821,Patented
179987,Phase 1/2a
93629,Discontinued in Phase 2b
108081,Discontinued in Phase 2b
159965,Phase 2
99514,Phase 1/2a
117051,Phase 1b
125178,IND submitted
177994,IND submitted
162348,Phase 1/2a
75116,Phase 1b/2a
95147,Discontinued in Phase 4
44856,Phase 2/3
57928,Phase 1
162440,Phase 1b/2a
189554,Phase 4
43613,Phase 1/2a
90493,Discontinued in Phase 1
170227,IND submitted
112676,Discontinued in Phase 2
98150,Phase 1
172639,Phase 1/2
154265,Patented
48094,Phase 1b/2a
191778,Phase 1
55419,Phase 1/2a
57000,Phase 1b/2a
180197,Discontinued in Phase 4
121060,Phase 2/3
153402,IND submitted
170366,Discontinued in Preregistration
54121,Phase 1b/2a
15268,Phase 3
51327,Phase 0
48655,Discontinued in Phase 2b
50929,Phase 1
56308,Phase 3
105176,Phase 1
176883,Phase 1/2
136102,Phase 1b/2a
66454,BLA submitted
64139,Approved (orphan drug)
82730,IND submitted
69049,Discontinued in Phase 4
83391,Discontinued in Preregistration
163837,Phase 1
188159,Investigative
40289,Phase 0
180253,Phase 2a
116696,Discontinued in Preregistration
37893,Phase 0
173297,IND submitted
170406,Discontinued in Phase 1
30822,Phase 1
41365,Phase 1/2
39076,Discontinued in Preregistration
156318,Phase 1/2
142144,Phase 2/3
54409,Phase 1b/2a
48852,Discontinued in Phase 2b
143249,Phase 1/2a
34123,Phase 0
142271,IND submitted
157259,Discontinued in Phase 1/2
168762,Discontinued in Phase 3
119843,Discontinued in Phase 1/2
181036,Phase 1b
17880,Patented
147315,Phase 1/2a
172961,IND submitted
49345,Investigative
43112,Discontinued in Phase 4
92187,Phase 1b/2a
128854,IND submitted
77596,Phase 1
90682,Discontinued in Phase 2
73123,Phase 1b/2a
68296,Phase 0
9842,Discontinued in Phase 2/3
145254,Discontinued in Preregistration
167029,Discontinued in Phase 1
95106,Phase 1
191911,Patented
168178,Phase 2
164123,Phase 1/2
173466,Patented
80793,Phase 2a
120282,Phase 0
5554,IND submitted
15854,Phase 1
146509,Phase 1/2
45657,Phase 2/3
42821,Phase 1
19445,Phase 0
80762,BLA submitted
175225,Patented
109909,Discontinued in Phase 2/3
107511,IND submitted
19570,IND submitted
181015,Phase 1b/2a
135194,Phase 0
115437,Approved (orphan drug)
161083,Phase 1
84441,Phase 0
48837,Phase 1b
148220,Phase 1/2
12611,Phase 1
183174,Phase 2a
187783,Phase 2
120937,Phase 1b
96617,Discontinued in Phase 1/2
33558,Phase 2/3
158992,Phase 0
58149,Discontinued in Phase 3
134802,Phase 0
97284,Discontinued in Phase 2
61069,Discontinued in Phase 1/2
172835,IND submitted
117626,Discontinued in Phase 1
109055,Phase 1/2a
20911,Phase 1/2a
87750,Discontinued in Phase 1
21103,Phase 2/3
163249,IND submitted
89721,Phase 2
74786,Discontinued in Phase 3
491,Phase 1/2a
80135,Discontinued in Phase 2
111968,Discontinued in Phase 2
85399,Discontinued in Phase 3
119086,Discontinued in Preregistration
110211,Phase 1
183849,Phase 2a
88706,Phase 1
153984,Phase 1
74710,Phase 1/2
35716,Discontinued in Phase 3
142696,Phase 1/2a
70276,Phase 1b/2a
145595,Phase 2a
119495,Discontinued in Preregistration
183255,IND submitted
29810,Investigative
131881,Patented
83378,Discontinued in Phase 2/3
14398,IND submitted
396,Discontinued in Phase 1/2
141899,Discontinued in Phase 1
125878,IND submitted
131223,Phase 1b/2a
174101,Phase 0
3884,Discontinued in Preregistration
28206,Phase 1/2a
132935,Discontinued in Phase 4
31177,Phase 1b
98162,Phase 1b/2a
48609,Phase 0
189949,Phase 1/2
152876,Phase 2/3
124584,Investigative
105516,Phase 1b
122721,Phase 1/2
54494,Discontinued in Phase 2b
142730,Phase 2b
172377,Discontinued in Phase 2
171424,Phase 2a
72560,Investigative
8774,Approved
112428,Discontinued in Phase 3
43670,Phase 1/2a
179161,Discontinued in Phase 2/3
4140,Investigative
52558,Discontinued in Phase 2
28216,Discontinued in Phase 2
92616,Patented
137995,Phase 1/2a
31911,Discontinued in Preregistration
24952,Discontinued in Phase 4
117493,Phase 1
92982,Discontinued in Phase 1
72775,IND submitted
84292,Phase 0
116295,Discontinued in Phase 2
30897,Phase 1b/2a
187312,Phase 1b
44153,Phase 2/3
9008,Approved
163257,Investigative
24607,Phase 0
75357,Phase 1/2a
97625,Phase 0
164380,Discontinued in Preregistration
16110,Phase 1
2969,Patented
123444,Phase 1b
129436,Phase 0
181624,Phase 2a
60614,Discontinued in Phase 3
137347,Phase 1/2
81198,Phase 1b
72253,Phase 1
140378,Phase 1/2a
104086,Patented
158189,Phase 1/2
70068,Phase 2/3
75727,Phase 0
48008,Phase 1/2a
167966,Patented
184388,Discontinued in Phase 4
21078,Phase 2
100346,Approved
181295,Discontinued in Phase 2b
57927,Discontinued in Phase 2/3
40642,Discontinued in Phase 2
43803,Phase 1/2a
50030,Patented
78465,Phase 0
79568,Phase 2a
133801,Discontinued in Phase 4
122460,Discontinued in Phase 4
188118,Phase 2/3
131335,Phase 1b/2a
180057,Phase 1
96711,Phase 1/2
130027,Phase 1/2
54199,Discontinued in Preregistration
61703,Discontinued in Preregistration
126374,Phase 1b
57910,Phase 1/2
143777,Phase 1/2a
46714,Approved
31380,Discontinued in Phase 4
33065,Phase 1/2
169829,IND submitted
147765,Phase 0
190917,Discontinued in Phase 4
136810,Phase 0
110049,Phase 1
46618,Patented
76507,Phase 0
152278,Phase 2
82538,Phase 1
120217,Phase 0
64543,Phase 1/2a
158097,Phase 2
188612,Phase 2/3
185128,Phase 1
47933,Phase 1b/2a
175913,Phase 0
155169,Phase 1b/2a
125277,BLA submitted
54414,Phase 1b/2a
47702,Discontinued in Phase 3
101189,Phase 2a
66,Discontinued in Phase 1/2
29071,Phase 0
157848,Phase 1/2
127485,IND submitted
72838,IND submitted
170917,Phase 0
63904,Phase 1b/2a
108187,Investigative
88350,Patented
25591,Discontinued in Phase 4
66178,Phase 1
52195,Investigative
17990,Discontinued in Phase 2/3
168760,Discontinued in Phase 1/2
186699,Phase 0
188447,Clinical trial
145601,Discontinued in Phase 2
22799,Phase 2
182807,Discontinued in Phase 2
60622,Phase 2/3
146553,Investigative
118597,Discontinued in Phase 1/2
125521,IND submitted
174481,Phase 2b
69564,Investigative
49767,Phase 1/2a
159260,Patented
162303,Patented
24217,Phase 1
150344,Phase 2b
89089,Investigative
121268,Phase 1/2a
137737,Patented
7460,Discontinued in Phase 2
107686,Patented
16375,Phase 1/2
166079,Investigative
114686,Discontinued in Phase 1
24469,Discontinued in Phase 2/3
59651,Phase 1
152331,Phase 2/3
3779,Approved
171343,Patented
182650,Phase 1b/2a
3269,Discontinued in Phase 2
81970,Clinical trial
2825,Discontinued in Phase 3
186731,Patented
132274,Discontinued in Preregistration
162241,Phase 0
91226,Approved
37595,Discontinued in Preregistration
163650,Patented
18032,Phase 2a
133987,Phase 1/2
71682,Phase 0
187417,Patented
107615,Phase 1
116288,Phase 1/2
110090,Phase 1
53176,Phase 1/2a
117009,Discontinued in Phase 1/2
73575,Clinical trial
90142,Phase 2/3
177639,Phase 1b
128161,Patented
85397,Discontinued in Phase 2b
156647,IND submitted
81090,Phase 1/2a
146217,Phase 1b
148078,Phase 1
84558,Phase 1/2
75342,Discontinued in Phase 1/2
144263,Clinical trial
31677,Phase 1b/2a
32773,Phase 2/3
90484,Phase 2/3
54988,Phase 1b/2a
80159,Approved
163997,Phase 1
136072,Phase 1b/2a
6515,Discontinued in Phase 2
182812,Phase 1/2a
59779,Discontinued in Phase 4
178572,Phase 1/2a
169100,Phase 3
182930,Phase 1/2
140291,Investigative
176041,Discontinued in Phase 1/2
178559,Phase 0
12582,Phase 0
131250,Phase 1
127918,IND submitted
180830,Phase 1/2
159268,Discontinued in Phase 1
71145,Phase 1b/2a
53660,Phase 2/3
52908,Phase 3
186498,Phase 0
110645,Phase 0
31030,Phase 0
39567,Discontinued in Phase 2
109303,Phase 1/2a
169748,Phase 1/2
176323,Phase 2
27647,Investigative
135471,Phase 0
64615,Approved
611,Phase 1
122290,Phase 2
157237,Phase 1
35865,Phase 0
98819,Phase 1
11188,BLA submitted
106662,Discontinued in Phase 3
24726,Phase 1b/2a
131791,IND submitted
190782,Phase 1/2
126089,Discontinued in Phase 4
98614,Phase 1b
157516,Clinical trial
98504,Phase 1/2a
56814,Discontinued in Phase 3
148930,Discontinued in Phase 2
91154,Discontinued in Phase 2b
151529,Phase 1
149093,Phase 1
124097,Phase 1b
18822,Phase 1
184504,Phase 0
185566,Discontinued in Preregistration
145297,Phase 1/2a
137594,Phase 1
171815,Discontinued in Phase 2
67147,Phase 0
56963,Phase 1/2
72656,Phase 1/2
154238,Discontinued in Phase 2b
146415,Phase 1b
180583,Phase 1
78664,Phase 2/3
11196,Phase 1
130061,Phase 2a
49286,Phase 0
104175,BLA submitted
12870,Phase 0
188502,Phase 2b
109643,Discontinued in Preregistration
28809,Discontinued in Phase 2/3
186955,Phase 0
131507,Discontinued in Phase 4
4019,Phase 1/2
25252,Phase 2/3
66248,Phase 2b
18101,Phase 2a
136154,Phase 1/2
177873,Discontinued in Phase 2b
23494,Discontinued in Phase 2/3
4412,Phase 2a
163251,Phase 1/2
110065,Phase 1
107947,Discontinued in Phase 1
10583,Discontinued in Phase 2/3
92759,Phase 2b
38219,Phase 1b
98452,Discontinued in Phase 2b
148704,Phase 1b/2a
129776,Phase 0
76750,Investigative
84238,IND submitted
60397,Discontinued in Phase 1/2
92786,Phase 2a
139557,Phase 1/2
51544,Phase 1/2a
98674,Phase 1/2a
100023,Phase 2/3
112056,Discontinued in Phase 3
20196,Patented
175508,Phase 0
76839,Phase 1b
123696,Phase 1
54948,Phase 3
36342,Discontinued in Phase 3
177312,Phase 1/2a
124699,Phase 2
163422,Phase 1b/2a
138096,Clinical trial
44260,Phase 1/2a
87208,Discontinued in Phase 1/2
103095,IND submitted
41890,Discontinued in Phase 1
107626,Phase 1b
77947,Registered
107422,Phase 1/2a
19583,Investigative
21000,Phase 1
155702,Phase 2
81221,Clinical trial
116030,Phase 2
82263,Investigative
170775,Phase 1
110925,Discontinued in Phase 2b
51413,Phase 3
149362,IND submitted
159859,Phase 1b/2a
167382,Discontinued in Preregistration
188738,Phase 2b
58049,Phase 1b/2a
131990,Discontinued in Phase 1/2
123240,Phase 1b
127569,Phase 1/2
52852,Phase 1b
158917,Phase 1
173480,Phase 2
175883,Phase 0
57653,Discontinued in Phase 1/2
108795,Phase 3
42317,Phase 2
96792,Phase 1b/2a
464,Phase 2
132135,Phase 1/2
13884,Phase 1b/2a
123420,Phase 1
142599,Phase 1/2
34753,Discontinued in Phase 3
119146,Phase 1b/2a
43889,Phase 2/3
116411,Phase 1b
174568,Discontinued in Phase 4
96022,Phase 1/2a
162758,Discontinued in Phase 4
7317,Investigative
6725,Phase 2a
109506,Preregistration
169062,Phase 3
32507,Phase 1b/2a
117804,Phase 1b/2a
58626,Discontinued in Phase 3
43412,Phase 1/2a
182748,Discontinued in Phase 4
101228,Phase 1b
69561,Phase 1b
185290,Approved
126637,IND submitted
6356,Phase 2a
147425,Discontinued in Phase 1
154964,Phase 2/3
73831,Phase 1b
157440,IND submitted
167316,Discontinued in Phase 1/2
60873,Discontinued in Phase 1/2
173502,Discontinued in Phase 2b
163297,Clinical trial
183211,Discontinued in Preregistration
120207,Approved (orphan drug)
85461,Discontinued in Preregistration
43552,Phase 2/3
7929,Phase 1/2
126995,Discontinued in Preregistration
49774,Patented
126014,Phase 1b
155296,Discontinued in Preregistration
95986,Discontinued in Phase 4
29312,Preclinical
114390,Discontinued in Preregistration
137146,Phase 1
108807,Phase 2b
104716,Phase 2
75249,Discontinued in Phase 4
13399,Phase 1/2
171368,Discontinued in Phase 2
180124,Discontinued in Phase 2b
167290,Phase 4
135039,Phase 0
68522,Discontinued in Preregistration
158912,BLA submitted
160617,Phase 2/3
140416,Phase 1b
114532,Phase 1b/2a
38348,Phase 2
48356,Phase 2/3
75755,Phase 1/2
165770,Phase 2
126192,Phase 1b/2a
142317,Patented
139332,BLA submitted
127409,Discontinued in Phase 4
139603,Phase 1/2a
10428,Phase 1b
156499,Phase 1b
76037,Discontinued in Phase 1/2
158458,Phase 1
142490,Discontinued in Phase 2/3
153954,Phase 1b
16786,Phase 0
33637,Phase 1b/2a
15909,Phase 1
57484,Approved (orphan drug)
56191,Discontinued in Phase 2b
24073,Discontinued in Phase 2b
108717,Discontinued in Phase 1
170285,Phase 2/3
56678,Discontinued in Phase 4
163522,Discontinued in Phase 1/2
181373,Phase 2a
53700,Discontinued in Preregistration
139896,Phase 1b
138258,Phase 1/2a
76437,Phase 1/2a
137905,Patented
127699,Patented
182975,Phase 2b
79974,Phase 2
165553,Discontinued in Phase 1
153567,Investigative
46666,Approved
40568,Investigative
40078,Phase 2/3
55808,Discontinued in Preregistration
42886,Phase 1/2
18200,Phase 1/2a
113699,Phase 1/2
69673,Discontinued in Phase 3
78226,Approved
3436,Discontinued in Phase 2b
163330,Patented
147873,Phase 1b/2a
187367,Phase 1b/2a
78052,Investigative
70474,Phase 1
78036,Clinical trial
23291,Phase 2/3
51773,Discontinued in Phase 2/3
146515,IND submitted
63533,Phase 2a
178711,Phase 1/2a
11074,Phase 1
139800,Phase 1/2a
12120,Phase 1
24060,Phase 1b/2a
108637,Investigative
185997,Clinical trial
161807,Discontinued in Preregistration
168709,Discontinued in Phase 4
186094,Patented
61413,Patented
66555,Investigative
162886,Discontinued in Phase 2
145509,Phase 1b/2a
100538,Phase 1/2a
148422,Discontinued in Phase 2
148326,Phase 1b
53248,Phase 3
93506,Phase 1/2a
28763,Investigative
24096,Phase 2a
108572,Phase 1
133623,Phase 1/2a
155386,Phase 0
6089,Phase 1/2
28083,Clinical trial
133120,Discontinued in Phase 1/2
32698,Phase 2a
25239,Phase 0
119072,Discontinued in Phase 4
140018,Phase 1/2
85673,Discontinued in Phase 2b
150599,Phase 2
164829,Discontinued in Preregistration
81669,Phase 1b/2a
38509,Phase 0
176343,Patented
99691,Phase 1/2a
68455,Discontinued in Phase 2b
126433,Phase 1/2
1546,Phase 1
5156,Discontinued in Phase 2
187232,Patented
20913,Discontinued in Phase 1
160219,Phase 1b/2a
129735,Patented
187290,Phase 1b
60207,Phase 1b/2a
93873,Phase 2b
103387,Patented
115539,Discontinued in Phase 2
186726,Phase 2a
161306,Discontinued in Phase 1/2
3215,Phase 1b
173487,Discontinued in Phase 2b
86628,Patented
96452,Phase 1
135338,Phase 0
154678,Phase 1b/2a
166022,Phase 1b/2a
65037,Phase 2a
124680,Phase 1/2
110869,Phase 1b
28948,Phase 1b
94737,Phase 1b
109636,Discontinued in Preregistration
191592,Phase 4
105211,Phase 1b/2a
3,Phase 0
15355,Phase 1
66839,Patented
86174,Investigative
190097,Phase 1/2
20453,Phase 1b/2a
38590,Phase 1/2a
169676,Phase 0
76706,Phase 1/2
182167,Phase 1/2a
68577,Discontinued in Preregistration
45188,Phase 1/2a
17278,IND submitted
185362,Approved
104670,Phase 0
74726,Phase 1/2a
14917,Phase 1
817,Discontinued in Phase 1
4823,Discontinued in Phase 2
161874,Investigative
169125,Phase 1b/2a
110201,IND submitted
184033,Phase 1/2
104936,Discontinued in Phase 2b
65599,Preclinical
154628,Phase 2/3
114038,Phase 1b
137211,Discontinued in Phase 4
60411,Phase 1
34882,Phase 1b
155869,Discontinued in Phase 4
10298,Phase 1b
102198,Investigative
156985,IND submitted
81892,Phase 1
29127,Phase 2
67233,Discontinued in Phase 2/3
20928,Phase 1/2a
24200,Phase 0
96139,Phase 1/2a
98935,Phase 1
112534,Phase 0
127125,IND submitted
116836,Discontinued in Preregistration
183930,Phase 0
162666,Investigative
104773,Phase 1/2
74891,Phase 0
135826,Phase 1/2
14356,Phase 1
88416,Patented
137491,Discontinued in Phase 4
183312,Discontinued in Phase 2
72451,IND submitted
18307,Phase 2
170207,IND submitted
162446,Phase 1b/2a
162555,Investigative
94988,Discontinued in Phase 1
107681,Phase 1b/2a
94493,Phase 1b
85532,Discontinued in Phase 2b
29698,Patented
26309,Phase 0
187626,Phase 2a
115249,Phase 1b/2a
181893,Discontinued in Phase 2b
66466,Phase 0
83543,Phase 2
68312,Phase 2b
3301,Discontinued in Phase 3
74930,Discontinued in Phase 1
142861,Patented
47448,Phase 1/2a
93952,Phase 2b
162757,Phase 1/2a
143779,Investigative
107729,Discontinued in Phase 2
139437,BLA submitted
16358,Phase 0
54559,Discontinued in Phase 2b
144738,Patented
101317,Phase 1b
12200,Phase 1/2
72466,Investigative
187287,Clinical trial
5011,Preregistration
36194,Phase 1
41242,Discontinued in Phase 1/2
12058,Discontinued in Phase 2/3
153259,Patented
31534,Discontinued in Preregistration
161512,Investigative
88082,Discontinued in Phase 1/2
172857,Discontinued in Phase 2b
30313,Phase 1
65655,Discontinued in Phase 2
56359,Phase 0
42766,Phase 0
50783,Phase 0
140007,Phase 1b
146677,Phase 2
10491,Preclinical
42379,Phase 1/2a
90856,Clinical trial
106361,Phase 0
80399,Phase 1b
110913,Discontinued in Phase 3
32977,Phase 2
123630,Phase 1
130616,Phase 1/2a
177861,Approved (orphan drug)
16941,Phase 0
173813,Approved
88028,Phase 2a
56192,Discontinued in Phase 2b
109540,Phase 4
43159,Phase 1b
184894,Discontinued in Phase 4
86661,Phase 1b
29364,Phase 0
96926,Phase 2
5374,IND submitted
145639,Phase 1/2a
180226,Phase 2b
94367,Phase 2b
90622,Discontinued in Phase 2/3
56905,Phase 0
120345,Phase 0
124065,Phase 1b
62083,Discontinued in Phase 4
70556,Patented
20923,Phase 1
55642,Phase 1b/2a
167119,Discontinued in Phase 2
183146,Discontinued in Phase 4
116443,Discontinued in Phase 1
152342,Discontinued in Phase 3
49063,Discontinued in Phase 2b
126131,Phase 1b
44862,Phase 1/2a
10278,Phase 1/2
10397,Phase 0
27688,Discontinued in Phase 2b
46472,Phase 1
157183,Patented
16479,Phase 1
105991,Patented
14630,Phase 0
81964,Clinical trial
189408,Approved
188206,Clinical trial
180682,Phase 1
117694,Discontinued in Phase 3
54058,Phase 1
170844,Phase 1/2
10055,IND submitted
96921,Investigative
182472,Phase 2a
138563,BLA submitted
75540,Phase 1b/2a
61353,Patented
18861,Phase 1
10701,Phase 1b/2a
173775,Clinical trial
18710,IND submitted
35441,Phase 0
29334,Phase 2/3
39134,Phase 1
85826,Discontinued in Phase 2b
54673,Discontinued in Phase 2b
114042,Phase 1
68397,Discontinued in Phase 1/2
85409,Discontinued in Phase 2b
12667,Phase 1
22333,IND submitted
187334,Phase 2b
55897,Discontinued in Phase 2b
1941,Phase 1/2a
85543,Discontinued in Phase 3
84825,Phase 0
80292,Discontinued in Phase 3
127298,Phase 1/2
120564,IND submitted
163820,Phase 2a
96062,Discontinued in Phase 1/2
91928,Phase 1
125159,Phase 1b
153364,Phase 1b
9127,Phase 2/3
22725,Phase 2
168279,Discontinued in Phase 1
42879,Patented
13749,Phase 1/2a
181769,Phase 1b/2a
86846,Discontinued in Phase 2b
97875,Phase 1/2a
135617,Phase 0
115648,Phase 1b/2a
170171,Phase 1b/2a
103189,Discontinued in Preregistration
152591,Discontinued in Phase 3
63104,Discontinued in Phase 4
69908,Phase 1
8575,Phase 1/2
189773,Clinical trial
139881,Clinical trial
163721,Phase 1/2
166825,Phase 1/2
10870,Phase 0
127949,Discontinued in Phase 4
55916,Discontinued in Phase 3
22907,Phase 1b/2a
12673,Phase 2b
119048,Phase 0
188211,Investigative
170627,IND submitted
86347,Discontinued in Preregistration
187502,Phase 0
97425,Investigative
108814,Phase 1/2a
10704,Investigative
51428,Discontinued in Phase 3
65465,Phase 1b
110389,Phase 1b/2a
140275,BLA submitted
160642,Phase 1/2a
165882,Phase 1b/2a
67671,Phase 1
40507,Investigative
16646,Phase 0
28339,Discontinued in Phase 3
66413,Phase 1b
36135,IND submitted
11242,Investigative
76279,Phase 1/2a
188174,Phase 1/2a
46703,Phase 1/2
76363,Patented
75664,Phase 1/2a
5934,Phase 1b/2a
49442,Phase 1b/2a
31367,Discontinued in Phase 2b
47348,Discontinued in Phase 1/2
104785,Phase 1/2a
22518,Phase 1/2a
27365,Discontinued in Phase 3
40499,Phase 2
100211,IND submitted
184321,Phase 1/2
30300,Discontinued in Phase 4
189136,Phase 1/2a
150419,Phase 1
2983,Patented
68426,Discontinued in Phase 1/2
2277,Phase 2
27560,Discontinued in Phase 3
4305,Phase 1b/2a
131231,Discontinued in Phase 4
76165,Phase 1/2a
24401,Phase 2/3
31270,Phase 0
183874,Phase 1b
67980,Phase 1
53278,Discontinued in Phase 3
157955,Phase 1b/2a
145278,Phase 2b
52001,Discontinued in Preregistration
128449,Patented
25316,Phase 2
111627,Phase 1/2
72217,Phase 1
170759,Phase 1b/2a
167014,Phase 4
191685,IND submitted
191308,Phase 2a
89734,Phase 1/2
38338,Phase 1/2a
108824,Discontinued in Preregistration
102432,Phase 0
158690,BLA submitted
20104,Phase 2
13201,Phase 0
145849,Discontinued in Phase 2
94166,Phase 1/2a
65067,Discontinued in Phase 2
115202,Phase 1/2a
57680,Approved (orphan drug)
128446,Phase 0
28760,Investigative
15004,Investigative
31124,IND submitted
33463,Clinical trial
141828,Investigative
113486,Phase 1
18346,Phase 2a
62404,Discontinued in Phase 4
185569,Preclinical
130320,Phase 1/2
89415,Phase 2/3
7558,Phase 4
164314,Patented
13114,Phase 1/2
36017,Phase 1b
108057,IND submitted
82727,Investigative
137638,Discontinued in Phase 2/3
133441,Discontinued in Phase 1
98285,Phase 1/2a
35735,Discontinued in Phase 3
74991,Phase 1/2
129466,IND submitted
52395,Discontinued in Phase 2b
73041,Phase 0
99555,Phase 1/2a
32812,Phase 0
136005,Phase 1/2
49461,Discontinued in Phase 2/3
6319,IND submitted
142904,Phase 1b/2a
70498,Phase 0
72756,Phase 2
127403,Phase 1/2a
74286,Phase 1/2a
183733,Phase 4
152165,Phase 0
54267,Discontinued in Preregistration
108842,Phase 1/2a
162345,Preclinical
3808,Discontinued in Phase 2b
62951,IND submitted
62721,Patented
18744,Phase 1b
78488,Discontinued in Phase 1/2
167100,Discontinued in Phase 1/2
155776,Discontinued in Phase 3
13152,Phase 2b
98442,Phase 1b/2a
177305,Phase 1b/2a
110310,Phase 1b/2a
69702,Phase 2/3
76953,Phase 1
22147,Phase 2/3
37897,Discontinued in Phase 3
26539,Phase 1
161796,Phase 0
136075,Phase 1/2
179508,Phase 1/2a
188106,Discontinued in Phase 4
146410,Phase 2b
1714,Phase 2/3
14427,Investigative
117195,Discontinued in Phase 2b
187481,Patented
164655,Discontinued in Preregistration
79633,Discontinued in Phase 2
168766,Discontinued in Phase 4
180423,Phase 2a
47306,Patented
117302,Discontinued in Phase 2b
60776,Phase 0
185319,Discontinued in Phase 3
35354,Discontinued in Phase 4
108566,Discontinued in Phase 2/3
187214,Phase 2b
168452,Discontinued in Phase 2
121727,Approved
174189,Discontinued in Phase 3
28981,Investigative
187707,Clinical trial
69274,IND submitted
128026,IND submitted
29892,Phase 1
88211,Phase 1/2
178641,Discontinued in Phase 2/3
171816,Discontinued in Phase 2/3
179804,Discontinued in Phase 2b
14813,Phase 1/2
184223,Discontinued in Phase 4
59708,Phase 1b
131542,Discontinued in Phase 1/2
180217,Phase 1/2a
71267,Phase 1/2
11032,Patented
80328,Phase 2a
76283,Investigative
133190,Phase 1
65413,Phase 1b
168629,Discontinued in Phase 3
126390,Phase 2
116664,Discontinued in Phase 1
76195,Phase 0
31653,Discontinued in Preregistration
148820,Phase 1
118987,Discontinued in Preregistration
172356,Phase 1b
95203,Phase 1b/2a
17457,Phase 0
165797,Discontinued in Phase 1/2
134062,Patented
40140,Phase 1/2
120977,Phase 0
57083,Phase 2
74753,Phase 1/2
188276,Phase 1b
7207,Phase 4
102619,IND submitted
144721,Investigative
46179,Phase 1/2a
175635,Phase 1/2
81830,Phase 1
109812,Discontinued in Preregistration
36731,Discontinued in Phase 1/2
155813,Phase 1b/2a
46722,IND submitted
19381,Investigative
119123,Phase 1/2a
62987,Phase 0
494,Discontinued in Phase 1
67127,Phase 0
51804,Phase 0
86127,Phase 1b/2a
99746,Phase 1
56923,Phase 1b/2a
20231,Discontinued in Phase 3
54928,Phase 1/2
31230,Discontinued in Preregistration
1149,Investigative
165537,Investigative
104730,Phase 1b
114839,Phase 1
138534,BLA submitted
40385,IND submitted
15402,Phase 1
44968,Phase 2/3
184896,Phase 1/2
178225,Phase 1b/2a
171191,Phase 0
140608,Phase 1b/2a
6322,Phase 2/3
174956,Phase 1/2a
177326,Phase 1b
66704,Phase 3
27307,Discontinued in Preregistration
127564,Phase 0
82113,Discontinued in Phase 1
12536,Phase 1/2
46441,Phase 1/2
33632,Phase 1/2a
35254,Phase 1/2a
187208,Phase 1/2a
60111,Discontinued in Phase 2/3
70716,Phase 1/2
145496,Discontinued in Phase 2
125609,Discontinued in Phase 4
34541,Phase 0
98265,Investigative
122603,Phase 0
1552,Discontinued in Phase 1/2
38824,Phase 2
144795,Discontinued in Phase 2/3
91423,Phase 0
118692,Discontinued in Phase 3
144598,Discontinued in Phase 4
10881,Phase 1
105373,Phase 1b
123174,Phase 1b
126286,Investigative
5383,IND submitted
113669,Patented
100879,Discontinued in Preregistration
139450,Discontinued in Phase 2
4010,Patented
101860,Phase 1
134409,Phase 1/2a
128349,IND submitted
93856,IND submitted
139139,Phase 1/2a
121392,Phase 1/2a
142871,Phase 1b/2a
53997,Phase 4
164514,Phase 1
50452,Phase 1
24205,Phase 2
81371,Clinical trial
13056,Phase 2b
50954,IND submitted
126294,Phase 1/2a
82647,Phase 1
42889,Patented
39458,Phase 1/2
16050,Phase 1
34110,Phase 1/2a
114253,Phase 1
120365,Discontinued in Phase 2
137271,Phase 1/2a
185025,Discontinued in Phase 3
23141,Phase 1b
170710,IND submitted
52474,Patented
95428,Phase 1/2
67643,Phase 1
139268,Phase 1b
131243,Discontinued in Phase 2/3
181325,Phase 2b
51815,Phase 1
158227,Phase 1/2a
35825,Discontinued in Phase 3
188146,Phase 1/2a
30489,Discontinued in Phase 2b
184151,Discontinued in Phase 3
175532,Phase 0
71254,Phase 2
27450,Discontinued in Preregistration
111565,Phase 1/2a
170027,Discontinued in Preregistration
176374,Phase 1/2a
108811,Discontinued in Preregistration
182183,Phase 1
159077,Phase 0
30725,Phase 1
121166,Phase 2b
131919,Phase 1b/2a
170841,Phase 0
45799,Phase 2/3
187278,Phase 0
116709,Discontinued in Phase 1/2
134169,Phase 1/2
46107,Phase 1/2a
60870,Investigative
180340,Phase 1/2a
147120,Phase 1/2a
148468,Phase 1
71444,Phase 1/2
176210,Phase 1b/2a
113903,IND submitted
101359,Phase 1/2
54305,Phase 2
145777,Phase 1
171431,Discontinued in Phase 2b
143686,Phase 2b
129624,Discontinued in Phase 2b
157661,IND submitted
122608,IND submitted
150971,Phase 1
113297,Phase 2/3
152266,Phase 1b/2a
96226,Discontinued in Phase 3
170741,Phase 1/2
185600,Phase 2a
26334,Discontinued in Phase 4
118671,Phase 1
77447,Phase 1
182524,Phase 2a
83533,Phase 1/2a
74444,Investigative
46861,Approved
128999,IND submitted
168984,Discontinued in Phase 2
82205,Clinical trial
64667,Discontinued in Phase 2b
40361,Patented
152501,Patented
131491,Phase 1/2
162812,Clinical trial
183979,Phase 0
93646,Phase 1/2a
172489,Discontinued in Phase 2/3
39577,Discontinued in Phase 4
144835,Discontinued in Phase 2
137420,Phase 1/2
108713,Discontinued in Phase 2/3
93344,Discontinued in Phase 2b
105044,Phase 1b
173823,Phase 0
119947,Phase 0
103907,IND submitted
91180,BLA submitted
50426,IND submitted
91461,Phase 0
53463,Phase 1/2a
98159,Phase 1b
75850,Phase 0
163151,Investigative
131209,Investigative
38592,Discontinued in Phase 2
137363,Phase 1/2a
134354,Phase 1b
125068,Phase 1/2
124560,Phase 1b
171062,Phase 2/3
184785,Discontinued in Phase 4
42353,Phase 1
137265,Discontinued in Phase 2
134654,Phase 0
118226,Approved
154279,Investigative
91292,BLA submitted
63751,Phase 1b/2a
36370,Patented
102144,Patented
59375,Phase 1
159115,Clinical trial
11269,Discontinued in Phase 1/2
183171,Discontinued in Preregistration
3663,Discontinued in Preregistration
167267,Phase 4
135724,Phase 1b/2a
26414,Investigative
21298,Discontinued in Phase 4
91644,Approved
123256,Phase 1
14624,Phase 1/2
79314,Discontinued in Phase 1
113743,Discontinued in Preregistration
81686,IND submitted
8375,Investigative
162191,Patented
140146,BLA submitted
148788,Phase 2b
50461,Phase 3
495,Discontinued in Phase 1/2
184471,Phase 0
146955,Phase 2b
149138,Phase 1b/2a
146825,Phase 2/3
118326,Phase 1b/2a
161651,Investigative
145073,Phase 2b
149420,Phase 1b
121093,Phase 2/3
178799,Discontinued in Phase 1
56639,Investigative
156090,Discontinued in Phase 3
150675,Phase 2
76504,IND submitted
86462,Phase 0
57602,Phase 1/2
9853,Discontinued in Phase 2b
143790,Discontinued in Preregistration
59463,Phase 2/3
126337,BLA submitted
103012,Patented
187567,Patented
113298,Phase 2a
72008,Phase 1b/2a
88145,Patented
153090,Patented
166850,Phase 2
169698,Phase 2
120408,Approved
16956,Phase 1b/2a
184723,Phase 0
5281,Preregistration
83075,Investigative
1313,Approved
39202,Discontinued in Phase 4
108530,Discontinued in Phase 1
117861,Phase 1b
78670,Phase 1b
160720,Phase 3
177125,Discontinued in Phase 4
121258,Patented
149623,Phase 1/2
182260,Phase 2
36923,Phase 1b/2a
141332,Patented
28022,Discontinued in Phase 1/2
49523,Phase 1b
137109,Phase 2
17066,Phase 1b/2a
116847,Discontinued in Phase 2/3
130471,Phase 1/2
107113,Phase 1b
139339,Phase 1/2a
136651,Discontinued in Phase 4
6361,Phase 4
70658,Discontinued in Preregistration
17756,IND submitted
53131,Discontinued in Phase 2/3
7012,IND submitted
39417,Discontinued in Phase 2
94950,Phase 1
158371,Discontinued in Preregistration
6202,IND submitted
114568,Phase 1/2a
75930,Phase 1b/2a
186576,Phase 2a
188411,Preclinical
24366,Patented
13041,Phase 0
76156,Discontinued in Preregistration
81298,Discontinued in Phase 3
41699,Approved
1038,Discontinued in Phase 2/3
151229,Phase 2
3632,Approved
76120,Phase 1
124965,Phase 1/2
162381,Discontinued in Preregistration
13668,Phase 1
86047,Phase 1b/2a
110848,Patented
148569,Discontinued in Preregistration
148381,Phase 1/2
30864,Discontinued in Phase 3
118374,Phase 2a
138599,Phase 1b
78461,Phase 0
89962,Discontinued in Phase 2
172630,Discontinued in Phase 2b
145425,Phase 0
24876,Discontinued in Phase 2/3
188382,Phase 1/2a
166052,Phase 1b/2a
10808,Investigative
47230,Clinical trial
139805,Approved (orphan drug)
132717,Discontinued in Phase 2b
86441,Phase 0
104980,Phase 1/2
191794,Phase 1
182165,Phase 1b/2a
171727,Phase 1b
110224,Phase 1/2a
49352,Phase 1/2
3995,IND submitted
28391,Phase 1/2a
46250,Patented
138910,BLA submitted
106247,Phase 1b
106931,Phase 1b
141295,Phase 1/2
175694,Phase 0
187562,Patented
191551,Phase 1
31649,Phase 1b
129839,Discontinued in Preregistration
154358,Phase 1b/2a
74192,Discontinued in Phase 4
129018,Investigative
46955,Phase 1/2
58102,Phase 2/3
188362,BLA submitted
164000,Phase 2/3
112793,Discontinued in Phase 3
132626,Discontinued in Phase 4
147293,Phase 2/3
81855,Approved
9404,Phase 1/2a
190074,Phase 4
140020,Phase 1/2a
144152,Phase 1/2
156598,Discontinued in Phase 4
104731,Phase 1/2
174255,Discontinued in Phase 2
141396,Investigative
88757,Phase 1/2
187975,Discontinued in Phase 4
111862,Discontinued in Phase 2b
162145,Phase 2a
14390,Phase 0
147790,Phase 1/2
34344,Phase 0
184829,Phase 0
131323,Phase 1/2
185637,Clinical trial
149469,Investigative
22795,Phase 1
12747,Phase 1b/2a
3987,Phase 0
104802,Discontinued in Phase 2b
163005,Phase 1/2a
25301,Phase 1/2
156446,Phase 1b
91499,Phase 0
19480,Phase 1
136514,Phase 1/2a
19842,Phase 1/2
37878,Phase 1/2a
89737,Phase 1/2
70166,Phase 1b/2a
71867,Phase 0
30630,Discontinued in Phase 4
176123,Discontinued in Phase 2
38115,Discontinued in Phase 4
13108,Phase 1
139171,Phase 1b
85911,Discontinued in Preregistration
32843,Phase 1b/2a
178546,Phase 1/2a
126712,Discontinued in Phase 2b
31846,Investigative
75350,Phase 0
60941,Phase 1b/2a
124486,Patented
85176,Phase 2b
130998,Discontinued in Preregistration
148862,Phase 2b
165309,Discontinued in Preregistration
79701,Phase 2a
163952,BLA submitted
17477,Phase 0
185754,Phase 4
168854,Phase 0
95886,Investigative
3575,Approved (orphan drug)
187903,Discontinued in Phase 4
97505,Phase 2/3
140639,Phase 3
61271,Phase 1
44568,Phase 2/3
10969,Phase 1
152881,Phase 1b/2a
161429,Investigative
2285,Phase 1b/2a
112820,Discontinued in Phase 2
27763,Phase 1b
105412,Phase 1
138959,BLA submitted
166906,Phase 2b
9112,Approved
86705,Phase 1/2
181410,Phase 2
143835,Phase 2a
149908,IND submitted
111306,Phase 1
77848,Phase 2/3
65495,Preclinical
111230,Phase 1b
149594,Phase 2/3
155483,Phase 2
180575,Phase 2b
174049,Discontinued in Phase 1
150037,Phase 2b
164620,Discontinued in Preregistration
56344,Phase 2
174176,Phase 1/2
122385,Investigative
77390,Discontinued in Phase 1/2
67320,Phase 2
184820,Discontinued in Phase 4
93451,Discontinued in Phase 1
69219,Phase 1b
101236,Investigative
101648,Phase 1/2
16232,Phase 1/2
143299,Investigative
154330,Phase 1b/2a
175530,Phase 2
126236,BLA submitted
108239,Discontinued in Phase 1/2
124977,Phase 1/2
175652,IND submitted
49035,Phase 1b/2a
185666,Clinical trial
38491,Phase 1b/2a
127253,Discontinued in Phase 2b
40315,Phase 1/2a
21546,Phase 0
112743,Phase 1
188422,IND submitted
106213,Discontinued in Preregistration
122536,Phase 1b
141213,Patented
155535,Approved (orphan drug)
154877,Phase 2
99558,Phase 1
22108,Discontinued in Phase 2
42218,Phase 2
97555,Phase 1/2a
59045,Discontinued in Phase 3
94444,Phase 1
69292,IND submitted
143536,Phase 1/2a
65023,Phase 1b
183286,Discontinued in Preregistration
140200,Approved (orphan drug)
57086,Discontinued in Phase 3
144222,Discontinued in Phase 1/2
23123,Discontinued in Phase 2/3
74467,Discontinued in Phase 2b
188054,Phase 0
13958,Phase 0
125253,Phase 1/2
162765,Phase 1/2a
26751,BLA submitted
175665,Phase 2
124677,Phase 0
14212,Phase 3
49209,Investigative
12067,Phase 2/3
76394,Phase 1/2a
180684,Phase 1
143802,Phase 1b/2a
123879,Discontinued in Phase 4
6879,Phase 1b/2a
90202,Phase 1b/2a
11923,Phase 2/3
66684,Phase 0
181401,Phase 2a
22503,Phase 2
58726,Investigative
83110,Phase 1/2a
64950,Phase 1
41629,Phase 1b/2a
81357,Approved
31143,Discontinued in Preregistration
70712,Phase 2
99673,Phase 0
184885,Phase 1/2
83911,Phase 1/2a
112040,Discontinued in Phase 2
1877,Phase 1/2a
123961,IND submitted
92766,Discontinued in Phase 3
42809,Discontinued in Phase 2/3
53329,Phase 2
83531,Phase 1b/2a
137585,Phase 2
91277,Approved (orphan drug)
121207,Phase 1/2a
136314,Phase 1b
69028,Phase 1
68599,Discontinued in Preregistration
48227,Phase 1/2a
19047,Discontinued in Phase 3
136343,Discontinued in Phase 4
114080,Discontinued in Phase 3
153320,Phase 1/2
73419,Clinical trial
62325,Phase 1b
127933,IND submitted
83133,Investigative
55781,Discontinued in Preregistration
148138,Phase 0
133760,Phase 1
159413,Patented
60821,Phase 1b/2a
30090,Discontinued in Phase 4
107091,IND submitted
20076,Phase 1/2
153637,Phase 1/2a
68737,Phase 2a
177574,Phase 2/3
88197,Discontinued in Phase 1/2
86318,Discontinued in Phase 4
52501,Phase 3
49685,Investigative
118169,Phase 1/2a
175702,Discontinued in Phase 3
94148,Discontinued in Phase 3
49582,Phase 1b/2a
89418,Phase 1/2a
113519,IND submitted
86451,Phase 1
148378,Phase 1/2a
119548,Approved
29771,Investigative
9994,Phase 0
33980,Phase 1b/2a
47503,Discontinued in Phase 2/3
168782,Investigative
64329,Approved (orphan drug)
14376,Discontinued in Phase 1
145476,Phase 1b
139327,BLA submitted
119087,Discontinued in Preregistration
134910,Phase 0
179583,Discontinued in Phase 1/2
139500,Phase 1b
135652,Phase 1b
93425,Discontinued in Phase 1
57714,Phase 1/2
103404,Phase 1b
173058,Phase 1/2
119668,Approved
90063,Approved (orphan drug)
11086,Discontinued in Phase 2b
100307,Approved
188966,Approved
25514,Phase 1/2a
45207,Phase 2/3
106690,Discontinued in Phase 3
34904,Phase 1b/2a
41828,Phase 1/2a
144941,Patented
13326,Phase 1
84599,Phase 1b/2a
70064,Phase 1b
97236,Phase 2
60487,Phase 1b/2a
133184,Phase 1/2
19167,Discontinued in Phase 2/3
58678,Phase 0
177401,Phase 1b
70488,Phase 1
90037,Discontinued in Phase 2b
161139,Discontinued in Preregistration
115006,Phase 2
81707,Approved
167930,Phase 1/2
183457,Approved (orphan drug)
97987,Phase 1/2a
126146,Investigative
99629,Phase 0
94295,Phase 1/2
182842,Phase 1
190965,Investigative
98875,Phase 1
139789,BLA submitted
71245,Phase 1b/2a
25907,Phase 2
45116,Phase 1/2a
183824,Phase 2a
12292,Phase 3
165796,Discontinued in Phase 1/2
17630,Phase 1
63310,Phase 1/2a
11598,Phase 1
102000,Application submitted
64448,Phase 2/3
128083,Discontinued in Preregistration
164163,Phase 0
2872,IND submitted
56282,Phase 0
124661,Approved
64968,Phase 1b/2a
23946,Phase 2
176936,Phase 1b
160614,Phase 0
60430,Phase 1/2
178369,Investigative
111334,Discontinued in Phase 2b
189342,Phase 1b
17103,Phase 1
9229,Approved
159729,Discontinued in Phase 1/2
83361,Phase 0
175980,Discontinued in Phase 4
79629,Clinical trial
50475,Phase 1b
176805,Phase 1/2
13307,Phase 1b/2a
125171,Phase 1b/2a
172556,Phase 2
38747,Phase 2
11741,Phase 1/2a
178766,Phase 0
40904,Discontinued in Phase 4
149453,Discontinued in Phase 1
178182,Phase 2/3
42957,IND submitted
174111,Phase 1
155764,Phase 1b/2a
131457,Discontinued in Phase 2b
169681,IND submitted
176403,Phase 1/2
105426,Phase 1
171159,Phase 1/2
21239,Phase 1
20977,Phase 0
11677,Phase 1/2
55175,Discontinued in Phase 2b
73476,Phase 2/3
38508,Phase 1
188629,Clinical trial
107226,Phase 1/2a
149812,Phase 1/2a
82078,Discontinued in Phase 1
139425,Phase 1/2
96876,Phase 1b/2a
31356,Phase 2
111572,Phase 2
160684,Phase 3
4126,Phase 2a
139321,Approved (orphan drug)
149245,IND submitted
97952,Phase 2
13432,Phase 0
91774,BLA submitted
103393,Patented
103700,Phase 1b
5877,Investigative
171561,Discontinued in Phase 2
162102,Investigative
149957,Phase 1b
121330,Patented
60984,Approved (orphan drug)
50631,Investigative
167570,Discontinued in Phase 2
120327,Investigative
3076,Phase 1/2a
148070,Discontinued in Phase 2
61187,Phase 1
107719,Discontinued in Phase 2
40471,Phase 1b
164415,Discontinued in Preregistration
32425,Phase 2a
178713,Phase 0
873,Phase 2a
186205,Phase 0
62727,Phase 0
103451,Phase 1b
173015,Phase 0
136323,Investigative
86,Phase 2
143963,Patented
16654,Phase 0
47351,Phase 0
177719,Phase 1/2a
36909,Phase 2
34016,Phase 1b
107448,Phase 0
175322,Discontinued in Phase 3
44806,Phase 1/2a
130010,Patented
111166,Discontinued in Phase 2b
10568,Discontinued in Phase 2b
38011,Phase 2
13338,Phase 1
53550,Discontinued in Phase 4
87447,Phase 1b/2a
46330,Patented
161068,BLA submitted
98316,Phase 2
164668,Phase 1/2
157679,Phase 1
78460,Discontinued in Phase 1/2
107561,Phase 1b
21802,Discontinued in Phase 1/2
10022,Discontinued in Phase 2b
101178,Phase 1/2
86832,Discontinued in Phase 4
164619,Discontinued in Preregistration
171182,Phase 1/2
124051,Phase 1/2
10053,Phase 1
56298,Discontinued in Phase 2
112628,Discontinued in Phase 2
7985,Phase 2
179655,Discontinued in Phase 2b
3693,Discontinued in Phase 4
152323,Phase 2/3
125605,Phase 1b/2a
2201,Discontinued in Phase 2
9308,Patented
148036,IND submitted
165223,Investigative
52297,Phase 3
186528,Phase 0
125898,IND submitted
63330,Phase 1/2a
72891,Phase 2
48625,Phase 3
99849,Phase 1
77841,Patented
118435,Discontinued in Preregistration
60591,Discontinued in Phase 4
85344,Discontinued in Preregistration
84527,Phase 1/2a
79700,Patented
11105,Phase 1/2
136127,Phase 1b
44576,Phase 2/3
18062,Phase 1/2a
143180,Phase 2/3
108076,Phase 2
36269,Patented
133142,Discontinued in Preregistration
29750,Investigative
33258,Phase 2/3
69783,Phase 1/2a
29911,Investigative
113994,Phase 1
134994,Phase 0
79287,Discontinued in Phase 1
22581,Phase 1b
162010,Phase 1/2a
162630,Discontinued in Phase 4
92513,Phase 1b/2a
110901,Discontinued in Phase 2b
118368,Phase 1/2a
150298,IND submitted
26343,Discontinued in Phase 2/3
117405,Clinical trial
187388,Phase 1/2a
17974,Phase 1/2
91050,Approved (orphan drug)
21257,Phase 1
27920,Phase 1/2a
47263,Patented
12346,Phase 1/2
136526,Phase 1/2a
75321,Phase 0
129254,Phase 1/2
54691,Phase 1b
186343,Phase 2/3
48112,Discontinued in Phase 4
171707,Discontinued in Phase 2b
48629,Phase 1b/2a
3243,Phase 1b
138416,Discontinued in Phase 2
99205,Phase 1
184879,Phase 0
141315,Discontinued in Phase 2b
139207,Phase 1/2a
175270,Discontinued in Phase 3
103310,Discontinued in Preregistration
64089,Phase 1
146811,Phase 2/3
190284,Phase 1b
126722,Phase 1/2
108755,Phase 1b/2a
53726,Phase 1b/2a
43848,Phase 2/3
158483,Phase 1b/2a
54219,Discontinued in Phase 2/3
34010,Discontinued in Phase 1
177830,Discontinued in Phase 4
5628,Phase 1b/2a
85796,Discontinued in Phase 2b
11607,Discontinued in Phase 2b
34048,Approved (orphan drug)
39013,Phase 0
39441,Phase 1b/2a
42839,Investigative
118762,Phase 1b/2a
33025,Phase 2/3
146503,Phase 1/2
47410,Patented
141087,Discontinued in Phase 3
88684,Phase 1
28710,Phase 1b/2a
120270,Approved
176188,Discontinued in Phase 2
97886,Phase 1b
91505,Approved (orphan drug)
89638,Patented
51177,Phase 2
54294,Phase 1b
187949,Discontinued in Phase 2
91645,Discontinued in Phase 2
74998,Discontinued in Phase 2b
93480,Phase 1/2a
14676,Phase 0
92629,Phase 0
156513,Preclinical
77744,Phase 0
160955,Phase 1/2
18157,Discontinued in Phase 3
35719,Discontinued in Phase 1/2
36726,Phase 1
7907,Phase 1
128788,Phase 0
187427,Phase 1b/2a
144210,Discontinued in Phase 1/2
130529,Phase 1b/2a
52431,Discontinued in Preregistration
168258,Discontinued in Phase 2/3
67615,Phase 1
176780,Phase 1b
1382,Approved (orphan drug)
7412,Phase 1/2
28588,Phase 1b
71430,Phase 0
160598,Phase 2a
187371,Phase 4
85234,Discontinued in Phase 2b
66856,Phase 1/2
32600,Patented
69364,IND submitted
23736,Phase 1
114582,Phase 1b/2a
98621,Phase 1/2a
85753,Discontinued in Phase 2b
12926,Phase 1
1533,Discontinued in Phase 4
64765,Phase 2
107642,Discontinued in Phase 3
10732,Discontinued in Phase 2b
51729,Discontinued in Preregistration
103453,Discontinued in Phase 2/3
57781,Phase 0
116752,Investigative
357,Discontinued in Phase 2/3
170123,IND submitted
154677,Phase 2
11855,Phase 1
181468,Phase 1/2a
186808,Patented
172598,Phase 2
112958,Phase 1/2
169264,Phase 1
82667,Discontinued in Phase 1/2
141910,Investigative
115635,Clinical trial
21497,Investigative
187440,Phase 1b
49087,Phase 1/2a
108963,Discontinued in Phase 2
175743,Phase 1/2
162470,Investigative
104318,Discontinued in Phase 4
41,Phase 1/2a
32967,Phase 3
113001,Phase 1b
918,Discontinued in Phase 2
12187,Discontinued in Preregistration
164780,Phase 2/3
78273,Discontinued in Phase 3
165371,Phase 0
128614,Phase 1
105013,Phase 1b/2a
118479,Phase 1b/2a
163719,Discontinued in Phase 2b
28692,Investigative
136464,Phase 2
161388,Phase 1b
34977,Discontinued in Preregistration
189059,Patented
24667,Phase 1
126465,IND submitted
55906,Phase 2
183261,IND submitted
141758,Patented
166362,Phase 1b/2a
156948,Phase 1b/2a
37462,Phase 0
180632,Phase 1
10346,IND submitted
167805,Phase 1
171299,IND submitted
74986,Clinical trial
104747,Phase 2
178130,Patented
56622,Patented
133398,Discontinued in Preregistration
57814,Discontinued in Phase 3
153423,Discontinued in Preregistration
102848,IND submitted
36225,Discontinued in Phase 3
38562,Phase 0
119886,Approved (orphan drug)
71260,Phase 0
16892,IND submitted
79400,Phase 2a
57403,Phase 2/3
139176,Clinical trial
133053,Discontinued in Phase 3
57987,Discontinued in Phase 4
125922,Phase 1b
53377,Phase 1
118959,IND submitted
153505,Phase 1
97054,Phase 1b
185716,Discontinued in Preregistration
85734,Discontinued in Preregistration
90560,Phase 2/3
80113,Approved (orphan drug)
42590,Phase 0
96936,Phase 1/2a
180211,Phase 1/2a
86516,Discontinued in Phase 2b
1842,Phase 1/2a
117240,Discontinued in Phase 3
117471,Phase 1b
16668,Phase 1b/2a
117551,Phase 1b
119788,Discontinued in Phase 1/2
109587,Phase 2
70548,Discontinued in Preregistration
75,Phase 2
125311,Phase 1b
1274,Phase 1
91501,Discontinued in Phase 1
5080,Phase 2/3
15410,Phase 1
66459,Investigative
36648,Discontinued in Phase 2b
105304,Phase 1b
55019,Phase 1b/2a
103483,Phase 1b
69684,Phase 2/3
128822,Phase 1/2
48320,Phase 2
9015,IND submitted
13430,Phase 0
44293,Phase 1/2a
145530,Investigative
63497,Phase 1b
26249,Phase 1b
9522,Phase 2
3548,Approved
153494,Phase 1
171192,Phase 0
89139,Phase 1/2a
37356,Phase 1
148918,Phase 0
160435,Phase 1/2a
128599,Patented
133,Phase 2b
188324,Clinical trial
17975,Phase 1
138515,BLA submitted
132234,Discontinued in Phase 4
39787,Phase 0
5337,Investigative
75063,IND submitted
95673,Phase 1b
99266,Phase 1/2a
32208,Phase 1/2a
50621,Phase 0
151604,Phase 0
35334,Discontinued in Phase 4
144139,Patented
186085,Phase 0
77942,Registered
62982,Patented
191019,Phase 1
14702,Phase 1
161196,Phase 1/2a
39847,Phase 2
41354,Phase 1/2
2995,Phase 0
142853,Phase 1b/2a
175798,Discontinued in Phase 1/2
19929,Phase 0
82563,Investigative
104279,Phase 1/2a
76267,Phase 1b
82715,Phase 2/3
128404,Discontinued in Phase 2b
158276,Phase 1b/2a
151236,Phase 2
90954,Discontinued in Preregistration
129618,Phase 1/2
168173,Discontinued in Phase 2/3
174406,Discontinued in Phase 4
118387,Phase 2b
179421,Discontinued in Phase 2/3
63161,Patented
163749,Discontinued in Preregistration
115661,Phase 1b
93944,Discontinued in Phase 1
114435,Phase 0
150560,Phase 1b
159114,Phase 1b/2a
14613,Phase 1/2a
68760,Phase 1
170725,Phase 1b
73531,Phase 1b
79771,Discontinued in Phase 2
134096,Phase 1
6939,Investigative
127972,Discontinued in Phase 2b
154503,IND submitted
118986,Discontinued in Preregistration
98800,Patented
141247,Phase 1/2
81122,Phase 1b/2a
161822,Investigative
73437,Patented
49404,Discontinued in Phase 4
48396,Discontinued in Preregistration
179238,Discontinued in Phase 3
29152,Phase 1/2a
171268,Phase 1/2a
183346,Discontinued in Preregistration
15787,Phase 1
131603,Phase 1/2
175786,Phase 1
106350,Phase 0
53089,IND submitted
187543,Phase 2/3
84445,Phase 0
15746,Phase 3
125664,Phase 1/2
96412,Phase 2
168683,Phase 0
107310,Phase 1/2a
109704,Preregistration
33100,Phase 1/2
152774,Phase 1/2a
160763,Phase 0
158334,Phase 2a
14622,Phase 1/2
75924,Phase 1/2a
22287,Phase 1b/2a
116810,Phase 1/2
188622,Approved (orphan drug)
15556,Phase 3
164229,Discontinued in Preregistration
157952,Phase 1/2
121431,Phase 2b
119642,Discontinued in Phase 2b
63046,Phase 1
32078,Phase 1/2
8434,Phase 1b
137940,BLA submitted
67526,Phase 1b
37900,Phase 1b
28479,Investigative
99295,Phase 1b/2a
45986,Phase 2/3
143876,Phase 2/3
48790,Discontinued in Phase 3
190992,Phase 1/2
137316,BLA submitted
51944,Phase 1/2a
129381,Phase 0
77552,Phase 1
32752,Phase 2/3
111826,Discontinued in Phase 3
81425,Clinical trial
98405,Investigative
191753,Phase 1
110468,Discontinued in Phase 2/3
20473,Phase 1b/2a
87746,Phase 1b/2a
126379,Phase 1b
53126,Phase 1b/2a
29,Phase 1/2a
130473,Patented
28573,Discontinued in Preregistration
181201,Phase 2a
80680,Patented
188182,Phase 1/2
22285,Phase 1b
61530,Phase 2
155097,Phase 1b/2a
165005,Phase 1/2
177378,Phase 1/2a
4661,Discontinued in Phase 2
75501,Phase 1/2a
126087,Phase 1/2
29723,Phase 2
82392,Discontinued in Phase 2/3
143900,Phase 2/3
77289,Phase 1/2
140920,Phase 2/3
123100,Patented
36741,Phase 1
80885,Phase 2a
71221,Phase 1b/2a
59426,Investigative
32553,Phase 2a
107622,IND submitted
131417,IND submitted
79673,Phase 2a
70299,Phase 1
136167,IND submitted
162774,Discontinued in Phase 4
191200,Phase 2a
6463,IND submitted
145797,Phase 2/3
175787,IND submitted
64945,Approved (orphan drug)
12398,Phase 1
2602,Discontinued in Phase 1/2
145051,Clinical trial
94928,Discontinued in Phase 1
174863,Discontinued in Phase 3
155973,Discontinued in Phase 3
9811,Discontinued in Phase 3
17709,Phase 0
95078,Patented
63678,Discontinued in Phase 2b
187404,Phase 4
131601,Patented
99186,Phase 1
159059,Approved
148349,Phase 2b
42935,Phase 1b
19599,IND submitted
13048,Phase 0
155969,Discontinued in Phase 2b
28832,Investigative
164338,Phase 1/2
175722,Phase 3
82048,Clinical trial
21753,Phase 1b/2a
106851,Phase 0
31414,Discontinued in Preregistration
21571,BLA submitted
69129,Phase 1b
169924,Investigative
133347,Discontinued in Phase 1
184847,Discontinued in Phase 4
130267,Patented
166392,Phase 1b/2a
73364,Investigative
84832,Phase 1/2a
81119,Clinical trial
92987,Phase 1b
47555,Patented
130630,Phase 0
48933,Phase 2
177957,Discontinued in Phase 2
148747,Phase 1b/2a
191060,Phase 1/2a
23152,Discontinued in Phase 4
109782,Phase 3
127464,Discontinued in Phase 2b
24943,Phase 0
173509,Phase 0
180324,Phase 2a
55997,Discontinued in Phase 3
52942,IND submitted
192081,Phase 1/2
122796,Phase 0
148652,Phase 1b/2a
33596,Phase 1/2a
112480,Phase 1
182195,Discontinued in Phase 2b
28129,Discontinued in Phase 3
174951,IND submitted
153472,Phase 1/2
109778,Discontinued in Phase 1/2
160747,Phase 3
72425,IND submitted
72556,Investigative
107985,Discontinued in Phase 2/3
132796,Discontinued in Preregistration
181843,Discontinued in Phase 2b
63869,Discontinued in Phase 2b
65289,Phase 1
58459,Discontinued in Phase 2/3
144312,Discontinued in Phase 2/3
91540,Clinical trial
62207,Phase 0
99377,Phase 1
43811,Phase 1/2a
57270,Investigative
20714,Phase 1/2a
56700,Phase 0
152552,Approved
85088,Phase 1/2
112295,Discontinued in Phase 3
94040,Discontinued in Phase 3
155248,Phase 1b
132173,IND submitted
28623,Phase 2
1290,Patented
150685,Phase 0
175117,Patented
180467,Phase 1/2a
68365,Approved (orphan drug)
191293,Discontinued in Phase 1
111494,Phase 1b
100343,Approved
65347,Discontinued in Phase 4
81113,Clinical trial
87741,Phase 0
926,Phase 0
127276,Phase 0
115397,Phase 2/3
142820,Phase 2/3
73723,Phase 1b
166699,Phase 1/2
130128,Phase 2
39160,IND submitted
113825,Phase 1
95911,Phase 0
79322,Phase 1b/2a
60878,Phase 1/2
54333,Discontinued in Phase 2/3
114826,BLA submitted
85703,Discontinued in Phase 2b
105481,Phase 1/2
1830,Phase 1/2a
9525,Discontinued in Phase 2b
5061,Phase 1b/2a
112093,Phase 1/2
148665,Phase 1b/2a
138016,Phase 1/2a
154641,Phase 3
56061,Phase 0
159565,Phase 1b
129335,Discontinued in Preregistration
135850,Phase 1b/2a
103754,Phase 0
104338,Discontinued in Phase 4
74555,Phase 1/2
106761,Discontinued in Phase 2b
133744,Discontinued in Phase 4
173642,Approved (orphan drug)
127438,Phase 0
172148,Discontinued in Phase 2
827,Phase 1
18468,Phase 2
89370,Phase 2/3
37891,Phase 1/2
57881,Phase 1b/2a
109101,Discontinued in Preregistration
97797,Phase 1/2
177077,Discontinued in Phase 3
179555,Phase 2a
78807,Phase 2/3
171583,Discontinued in Phase 3
118646,Phase 1b/2a
713,Phase 2
41842,Phase 1b
186239,Patented
53889,Discontinued in Phase 4
31836,Phase 2
182281,Phase 1
149799,Phase 1b/2a
46628,Approved
107294,Phase 0
140948,Patented
78214,Investigative
39119,Discontinued in Phase 2b
34186,Phase 1/2
44620,Phase 1/2a
108502,Phase 1b/2a
4676,Phase 1/2
94945,Phase 1
122984,Phase 1b/2a
3157,Discontinued in Phase 2
85560,Discontinued in Preregistration
9558,Patented
190084,Approved
190900,Phase 2/3
118488,Phase 1/2a
50374,Phase 0
60986,Phase 2/3
66365,Phase 1b
8313,Phase 2
133401,Phase 1/2
102344,IND submitted
70008,Phase 1/2a
40492,Discontinued in Phase 2
29682,Phase 1
84385,Phase 1/2
733,Phase 0
117268,Discontinued in Phase 1/2
169410,Phase 1
13663,Phase 1/2
9223,Discontinued in Preregistration
175570,Phase 1
146132,Phase 2b
82846,IND submitted
96316,Discontinued in Phase 3
32578,Phase 2
187533,Patented
157342,Clinical trial
178734,Phase 1b
132506,Phase 1b/2a
183680,Phase 1b/2a
47292,Discontinued in Phase 3
109990,Phase 1b
171446,Phase 1/2
12698,Investigative
177057,Phase 1/2
38815,Phase 1/2a
153522,Phase 1b
176034,Discontinued in Preregistration
115876,Discontinued in Phase 2
137756,Phase 1/2
41907,Phase 1
148621,IND submitted
95549,Discontinued in Preregistration
159297,Approved
129809,Discontinued in Phase 3
162455,Patented
81825,Approved
143565,Phase 2
99407,Phase 1
82564,Phase 0
178254,Phase 1/2a
117305,Clinical trial
32145,Phase 1/2a
122768,Phase 0
121485,Phase 2
18504,Phase 1/2
123353,Phase 0
8646,Phase 1/2a
3928,IND submitted
155920,Phase 0
175549,Patented
117081,Investigative
162552,Investigative
107049,Phase 1b
181213,Phase 3
37077,Phase 2a
114772,Phase 1/2a
164054,Investigative
120596,IND submitted
114071,IND submitted
79406,Phase 1b/2a
109295,Phase 2
135046,Phase 0
129424,Phase 1b/2a
145821,Phase 1b/2a
159932,Phase 1
191491,Discontinued in Phase 1
177789,Phase 1b/2a
174505,Phase 2
174048,Discontinued in Phase 1
91721,Discontinued in Phase 2
83158,Phase 0
163930,Discontinued in Preregistration
44535,Phase 2/3
49445,Phase 1b/2a
128080,Discontinued in Phase 2b
87511,Phase 0
102404,Phase 0
159982,Discontinued in Preregistration
187165,Phase 0
75542,IND submitted
189200,Approved
132454,Phase 1
169642,Phase 2
82243,Phase 0
61528,Phase 1/2
132852,Discontinued in Phase 4
69620,Discontinued in Phase 2/3
64268,Clinical trial
69272,Phase 1b/2a
141794,Discontinued in Phase 2b
98971,Phase 1b
174790,Phase 1/2
152915,Phase 2b
154618,Phase 2
182340,Phase 1/2a
64292,Phase 2a
116732,Investigative
148459,Phase 1/2
90532,BLA submitted
166354,Phase 1
57353,Investigative
34396,Phase 1b/2a
139329,BLA submitted
126928,Discontinued in Phase 2b
141217,Phase 0
117628,Discontinued in Phase 1/2
138383,BLA submitted
169549,Phase 3
136479,Phase 1/2
133067,Phase 1b/2a
60707,Phase 2/3
163232,IND submitted
107215,Phase 0
52380,Discontinued in Phase 3
128464,Phase 0
161911,Investigative
50870,Phase 1b/2a
23595,Discontinued in Preregistration
46478,Phase 2
52114,Discontinued in Phase 2b
92220,Phase 2
155449,Investigative
72640,IND submitted
110699,Phase 1/2
16579,Phase 0
130968,Phase 0
155329,Phase 0
129525,Phase 0
40809,Phase 1/2a
160256,Phase 1
122505,Patented
22229,Discontinued in Phase 2b
356,Phase 1
24784,Phase 1/2a
144696,Phase 1
53973,Discontinued in Preregistration
50547,Discontinued in Phase 2/3
8967,Discontinued in Phase 1
98229,Phase 1/2a
123022,Phase 1/2
178557,Phase 0
77620,Discontinued in Preregistration
90277,Discontinued in Phase 2
24840,Phase 2
157762,Phase 1/2
138059,Phase 1b
51939,Phase 0
84285,Phase 1b/2a
169765,Discontinued in Preregistration
38808,Phase 1/2
191370,Phase 1/2
149137,Phase 1b/2a
62513,Phase 1b/2a
165337,IND submitted
117490,Phase 1/2
145071,Investigative
32944,Phase 1/2
81723,Phase 1
40472,Phase 2
27162,IND submitted
4464,Investigative
118447,Phase 1
149077,Phase 1/2
183502,Approved (orphan drug)
119171,Phase 2b
59830,Discontinued in Phase 3
183382,Approved (orphan drug)
19364,IND submitted
114139,Phase 1
25036,Discontinued in Phase 4
190599,Phase 1/2
136892,Phase 1/2a
167286,Discontinued in Preregistration
114518,Phase 1/2a
98108,Phase 1b/2a
140908,Phase 1b
184,Phase 1/2a
153419,Discontinued in Preregistration
181589,Phase 1/2a
170315,Phase 1
189390,Clinical trial
68799,Phase 1
150131,Phase 1/2
9228,Discontinued in Phase 1
185704,Patented
91176,Discontinued in Phase 2/3
94924,Patented
169526,Phase 1
167878,Phase 1b
89642,Patented
79552,Clinical trial
75364,Investigative
162588,Phase 1b
189421,Phase 1/2
124962,Phase 1b
11476,Discontinued in Preregistration
138190,Phase 1b
11862,Phase 2a
58298,Phase 2/3
35161,Discontinued in Phase 3
12889,Investigative
84786,Phase 0
28714,Phase 0
154066,Discontinued in Phase 4
7593,Investigative
156,Phase 2
152254,Phase 1
31072,Phase 1
176186,Discontinued in Phase 2
64209,Phase 2a
135980,Phase 1/2
93384,Phase 2a
176271,Clinical trial
30528,Discontinued in Phase 2b
2072,Investigative
122163,Discontinued in Phase 4
74349,IND submitted
135694,Phase 1b
104096,Phase 1/2
188773,Patented
148502,Phase 2/3
30476,Phase 1/2a
71902,Discontinued in Phase 1
179296,Phase 2a
50303,Phase 1/2a
42622,Phase 0
59245,Phase 1/2a
181045,Discontinued in Phase 2b
131312,Discontinued in Phase 4
54091,Phase 1/2a
109625,Discontinued in Preregistration
147498,Phase 1b/2a
136638,Phase 1/2a
125988,Discontinued in Phase 3
400,Phase 1
116132,Phase 2a
81939,Clinical trial
131861,Discontinued in Phase 1/2
35021,Phase 2a
175708,Phase 1/2
51167,Phase 1/2a
148803,Discontinued in Preregistration
83589,Phase 1b/2a
101353,Patented
3241,Discontinued in Phase 2
181877,Phase 1/2a
186387,Clinical trial
79309,Phase 2a
101093,Phase 1b
121350,Patented
159087,Phase 1
49800,Discontinued in Phase 2/3
173755,Phase 0
85723,Discontinued in Phase 3
40994,Phase 1/2a
48918,Discontinued in Phase 2b
71416,Discontinued in Phase 1
174133,Discontinued in Phase 3
50113,Phase 0
185059,Phase 0
83236,Phase 2
143971,Patented
51631,Phase 1b
190397,Clinical trial
2088,Phase 2
153314,Phase 1/2
91857,Discontinued in Phase 2b
90184,Discontinued in Phase 3
171355,Discontinued in Phase 2/3
8570,Phase 1/2
593,Discontinued in Phase 1
31422,Phase 1
116329,Discontinued in Phase 1/2
149339,Phase 2a
134148,Phase 1/2
12340,Phase 1
52450,IND submitted
174249,IND submitted
84995,Phase 0
62000,Discontinued in Preregistration
172393,Phase 0
32354,Discontinued in Phase 1
30892,Phase 0
174137,Discontinued in Phase 4
91111,Approved
10174,Phase 1/2
120899,Investigative
130434,Phase 0
253,Discontinued in Phase 1/2
174269,Discontinued in Phase 3
79863,Phase 2
134199,Phase 1/2a
157594,Clinical trial
24640,Discontinued in Phase 2/3
24458,Phase 2
121095,Phase 1b
121043,Phase 0
97045,Phase 1/2a
93319,Phase 2
56808,Discontinued in Phase 2b
2286,Phase 2
87038,Discontinued in Phase 1/2
40327,Discontinued in Phase 4
160764,Phase 3
10623,Phase 1b/2a
51092,Discontinued in Phase 2/3
88204,Phase 1/2
138778,BLA submitted
70421,Phase 1b/2a
139003,BLA submitted
18755,Phase 1b
71503,Phase 0
110176,Phase 1/2a
145674,Phase 1b
102168,Application submitted
156458,Phase 1b/2a
114700,Investigative
162712,Phase 1b
57638,Discontinued in Phase 3
32254,Phase 1b/2a
3444,Phase 0
31725,Phase 1
69532,Phase 1
62190,Phase 2/3
137058,Phase 1/2a
68660,Phase 2a
103721,IND submitted
54210,Phase 1b
11475,IND submitted
111075,Phase 1/2
91348,Phase 1/2
48313,Discontinued in Phase 3
56859,Phase 2
96325,Discontinued in Phase 2b
19299,Patented
22723,Phase 0
182075,Phase 2b
95695,Phase 1b
74806,Phase 1/2
177748,Phase 1b
53166,Phase 0
67972,Phase 0
117352,Investigative
119648,Approved
84195,Phase 1/2
81461,Clinical trial
174014,Discontinued in Phase 3
8039,Phase 1
11440,Discontinued in Preregistration
161698,Phase 1b
109279,Phase 2/3
143120,Phase 1b/2a
63516,Discontinued in Phase 3
67921,Phase 1/2
129992,IND submitted
1572,Discontinued in Preregistration
47098,Discontinued in Phase 1/2
169047,Discontinued in Phase 3
5079,Phase 1b/2a
131337,Discontinued in Phase 4
178643,Discontinued in Phase 1
141294,Discontinued in Preregistration
94886,Patented
5572,IND submitted
56662,Phase 1b/2a
181668,Phase 1/2a
104055,BLA submitted
154596,Phase 2/3
26713,Phase 1
97476,Phase 2
114221,Patented
36152,Phase 1
66275,Phase 0
6146,Discontinued in Phase 2
132356,Patented
28357,Phase 1/2
54842,Discontinued in Phase 4
45577,Phase 2/3
78431,Phase 1/2
153988,Investigative
51213,Phase 1b/2a
191099,Phase 1/2
79334,BLA submitted
77968,IND submitted
129661,IND submitted
184340,Discontinued in Phase 4
4462,Preregistration
97489,Phase 1/2
76419,Phase 1/2
78710,Phase 0
18280,Discontinued in Phase 3
163319,IND submitted
49476,Phase 2
96692,Phase 2
50540,Phase 1b
14088,Discontinued in Phase 1
99941,Phase 1b
29713,Phase 0
182864,Phase 3
115885,Phase 1/2a
79819,Investigative
114734,Discontinued in Phase 3
190500,Approved
137666,Discontinued in Phase 2/3
7569,Investigative
56896,Discontinued in Preregistration
132558,Phase 1/2
168286,Phase 2
38073,Phase 1/2a
8309,Patented
181017,Phase 1/2a
22047,Investigative
175506,Phase 3
157403,Phase 1/2a
86767,Investigative
179649,Phase 0
84467,Phase 1/2a
173370,Discontinued in Phase 2/3
71073,Phase 1b/2a
39868,Investigative
113807,IND submitted
59918,Investigative
172570,Discontinued in Phase 2
104807,Patented
135121,Phase 0
74570,Discontinued in Phase 4
120556,Discontinued in Phase 1/2
127156,Phase 1b/2a
113237,Clinical trial
88244,Approved
129467,Discontinued in Preregistration
46358,BLA submitted
82773,Phase 2/3
184397,Phase 0
192010,Clinical trial
136330,Phase 1/2a
150601,Phase 0
153826,Phase 1
115298,Clinical trial
165968,Phase 1b
146133,Phase 1b/2a
30926,Phase 1/2
80063,Phase 1b
32230,Phase 1/2a
120909,Investigative
138847,Clinical trial
115901,Phase 2/3
4345,Preregistration
93165,Discontinued in Phase 1
178801,Phase 2a
182731,Phase 1
13392,Phase 0
43612,Phase 1/2a
85557,Discontinued in Preregistration
33708,Phase 1b
76123,Phase 1/2a
185658,Phase 0
185702,Patented
121061,Phase 2
23165,Phase 1
152446,Discontinued in Phase 4
32080,Phase 2/3
36098,Patented
43261,Preregistration
85781,Discontinued in Phase 2b
20490,Phase 1
29031,Phase 4
78090,Clinical trial
167173,Discontinued in Phase 1
139183,Phase 1/2a
111768,Phase 1/2
34077,Phase 1b/2a
84991,Phase 0
18114,Phase 1
34442,Patented
27255,Patented
179724,Approved (orphan drug)
78386,Discontinued in Preregistration
13954,Phase 1/2
105239,Phase 1b
119750,Phase 2
78854,Patented
156772,Preregistration
15945,Phase 1/2
40013,Phase 0
78665,Phase 1b
44206,Phase 1/2a
49239,Phase 1b/2a
141531,Discontinued in Phase 2/3
140704,Phase 3
114673,Investigative
62637,Discontinued in Phase 3
171326,Phase 1b/2a
43701,Phase 1/2a
128447,Phase 1/2a
91737,Phase 2a
178426,Phase 1/2a
68243,Phase 1
82631,Phase 1
151711,Phase 2
130795,Phase 1b
189251,IND submitted
25671,Phase 1/2
17437,Phase 1b/2a
95316,Phase 1/2a
69278,Discontinued in Phase 2/3
75195,Patented
29749,Phase 1/2
29367,Phase 2/3
129645,IND submitted
83605,Discontinued in Preregistration
134265,Phase 1
113306,Phase 2a
134468,Patented
65499,Discontinued in Phase 2
68407,Phase 1
71668,Discontinued in Phase 1
190596,Phase 1b
28032,Phase 2/3
146423,Patented
123866,Phase 1b
185790,Phase 1b
177908,Phase 1/2a
62450,Phase 1/2a
86882,Patented
165645,Phase 1b/2a
189541,Phase 0
155943,Discontinued in Phase 2b
93478,Phase 1b/2a
24054,Phase 1b/2a
168781,Discontinued in Phase 3
114199,Discontinued in Preregistration
118196,BLA submitted
100475,Phase 1/2a
132442,Discontinued in Preregistration
93603,Discontinued in Phase 2b
37502,Discontinued in Phase 3
3214,Phase 1b
112000,Phase 1
156298,Discontinued in Phase 3
87506,Phase 2/3
168897,Phase 1b/2a
26120,Discontinued in Phase 2/3
138316,BLA submitted
100014,Phase 2
60024,Phase 0
72070,Patented
52396,Discontinued in Phase 4
88947,Phase 1/2a
160757,Phase 1/2
42081,IND submitted
97022,Phase 1/2a
130834,Phase 1/2a
178468,Phase 1/2a
102465,Phase 1
42045,Phase 0
139508,BLA submitted
113047,Clinical trial
133294,Discontinued in Phase 1
114387,Patented
103261,Phase 1/2a
142395,Phase 1
53051,Phase 1b/2a
84640,Phase 0
138948,Investigative
44910,Phase 1/2a
168741,Discontinued in Phase 1/2
110892,Phase 1/2
122884,Phase 2
184177,Phase 1/2
143468,Phase 2/3
102776,Phase 1/2a
62581,Patented
80729,Approved (orphan drug)
156975,Patented
143009,Phase 1/2a
23876,Phase 1b
60918,Phase 0
114408,Phase 1
111593,Phase 1
131172,Discontinued in Preregistration
75735,Phase 1/2a
88609,Phase 1
97671,Phase 1
165813,Phase 1b/2a
44117,Phase 1/2a
134179,Discontinued in Phase 4
119237,Clinical trial
121264,Phase 1/2a
153219,Investigative
9565,Phase 0
147021,Investigative
170652,Phase 0
65498,Phase 1b/2a
22646,Phase 0
87182,Patented
5691,Phase 1b/2a
89891,Patented
54166,IND submitted
191058,Discontinued in Phase 1
120609,Phase 4
38831,Investigative
29103,Phase 4
186021,Phase 4
116959,Discontinued in Phase 3
51198,Discontinued in Phase 2
65606,Approved (orphan drug)
119073,Discontinued in Preregistration
166685,Phase 1/2
56571,Investigative
158769,BLA submitted
1212,Phase 1/2a
185034,Phase 0
183209,Phase 2a
188610,Clinical trial
8316,Patented
42735,Discontinued in Phase 1
177824,Phase 1
81420,Phase 1b
135169,Phase 0
79681,Phase 2a
100434,Phase 2
100809,Phase 2
45352,Phase 2/3
179759,Phase 1
173763,Approved
170412,Patented
86051,Phase 2
173271,Phase 2
161372,Investigative
188383,Patented
53921,Phase 1
89996,Phase 1b
113692,Phase 0
113386,Phase 1
13098,Phase 1/2
79722,Phase 2
69208,Phase 1
77873,Phase 2
177676,Phase 1b
151993,Phase 2a
110390,Discontinued in Phase 2/3
100641,Patented
12190,Phase 1/2
100258,Phase 1
128368,Discontinued in Phase 2b
108100,Phase 2
113182,Phase 1
117578,Discontinued in Phase 2/3
8842,Discontinued in Phase 2
8713,Clinical trial
68863,Discontinued in Preregistration
128604,Discontinued in Phase 3
165195,Discontinued in Preregistration
56970,Phase 0
174322,Discontinued in Phase 3
129313,Patented
53216,Phase 2
52149,Phase 1b/2a
7079,Phase 1/2
167295,Discontinued in Phase 1
105017,Phase 0
33160,Phase 1b/2a
8278,Phase 1b
93330,Phase 1/2
6910,Phase 4
180228,Phase 1/2a
86757,Discontinued in Phase 4
69998,Phase 2
89714,Phase 2
45047,Phase 2/3
49439,Discontinued in Preregistration
179430,Phase 1/2a
49023,Investigative
147251,Discontinued in Phase 2/3
95313,Phase 1b
138459,Phase 1/2a
24778,Phase 1
96680,Phase 1b/2a
166056,Discontinued in Phase 1/2
19220,Phase 1
79483,Investigative
168419,Patented
186044,Phase 2b
111837,Discontinued in Phase 2b
86086,BLA submitted
171493,Patented
17448,Discontinued in Phase 1
31945,Phase 1/2a
173077,Discontinued in Phase 2/3
10212,Discontinued in Phase 3
64475,Phase 2a
30616,Investigative
139174,BLA submitted
5949,Investigative
92802,Phase 1b/2a
60686,Investigative
30151,Investigative
140297,BLA submitted
59255,Phase 1b/2a
165820,Discontinued in Phase 4
124087,Phase 1b
34636,Phase 0
94728,Phase 1/2a
96990,Phase 1/2a
132260,Phase 2
187879,Discontinued in Phase 4
105660,Discontinued in Phase 4
3699,Investigative
102740,Phase 0
38630,Phase 1
108301,Phase 2
96106,Phase 1/2a
183850,Phase 1b/2a
128054,Phase 1/2
53932,Phase 2
136481,Discontinued in Phase 2
146128,Phase 1
10430,Phase 0
76366,Phase 1/2a
47014,Discontinued in Phase 1
5582,Phase 2a
169078,Discontinued in Phase 1/2
61313,Phase 1
117899,Phase 1
77369,Phase 0
70437,Phase 1
132449,Discontinued in Phase 1/2
74036,Discontinued in Phase 4
127934,Investigative
91134,Discontinued in Phase 2b
158651,Approved
17758,IND submitted
182189,Phase 1/2a
122030,Approved
158343,Phase 1b/2a
94997,Patented
157983,Discontinued in Phase 4
144259,Discontinued in Phase 4
21549,Phase 1b/2a
95869,Phase 1
104558,Patented
160043,Investigative
61436,Phase 2a
57200,Phase 1
96556,Phase 2b
37709,Phase 1/2
17924,Phase 2/3
174606,Discontinued in Phase 1/2
96821,Phase 1b
53165,Phase 0
113797,Phase 0
37691,Phase 1/2a
23446,Phase 1
142588,Phase 1
180774,Phase 2a
112273,Phase 1/2
4063,Phase 2a
185175,Investigative
95696,Phase 1b
102640,Investigative
47025,Phase 2/3
65649,Discontinued in Phase 2/3
7797,Phase 1b/2a
95320,Patented
188193,Phase 1/2
49789,Phase 1b
124608,Phase 1
131942,Phase 1/2
90701,Phase 0
134780,Phase 0
93618,Phase 2a
107598,Phase 1b
86690,Phase 1/2
5821,Phase 4
13859,Phase 1
118406,Discontinued in Preregistration
177745,Phase 1b/2a
64220,Phase 2/3
58464,Approved (orphan drug)
20119,Discontinued in Phase 4
108450,Investigative
82834,Phase 1
190336,Phase 1/2a
25289,Phase 2/3
154783,Phase 1b/2a
81375,Approved
112,Phase 2
60755,Discontinued in Phase 2/3
61698,Discontinued in Phase 2b
47375,Phase 0
54576,Phase 2
118768,Discontinued in Preregistration
20467,Phase 1/2
57027,Phase 0
102001,Phase 1/2a
104513,Phase 0
33317,Phase 2a
180247,Discontinued in Phase 4
9032,Discontinued in Phase 1
102020,Phase 1/2
191212,IND submitted
93503,Discontinued in Phase 1
33855,Phase 1
176093,Phase 1/2
107781,Discontinued in Phase 3
122577,Phase 1/2
181512,Phase 1/2a
140219,Phase 1/2a
138803,Clinical trial
125474,Phase 1b
160774,Phase 3
11764,Discontinued in Preregistration
125463,Phase 1b
76077,Patented
133446,Approved
69701,Phase 2b
111857,Phase 1
170850,Phase 2/3
14093,Phase 1
86631,Phase 1b
158642,Phase 1
140082,Phase 1b
136818,Phase 1b
94696,Patented
91248,Discontinued in Phase 2b
160380,Phase 0
42878,Phase 1b
40339,Phase 0
72398,Investigative
46525,Discontinued in Phase 4
167312,Phase 1/2a
52079,Phase 1/2a
46052,Phase 1/2a
1053,Discontinued in Phase 1/2
70252,Investigative
84907,Phase 1/2a
57787,Discontinued in Phase 2/3
13570,Phase 1/2
177153,Phase 1/2
163981,BLA submitted
150022,Discontinued in Phase 2
68817,Phase 1
103052,Phase 1/2
84589,Phase 1b/2a
114918,Phase 2
104942,Phase 1b/2a
117266,Discontinued in Phase 1
157526,Registered
135356,Phase 0
150151,Phase 1b/2a
405,Phase 2
12718,Phase 0
68351,Phase 1
15881,Phase 1
159868,Phase 1b
170018,Patented
78928,Phase 2/3
146560,Phase 2
172402,Discontinued in Phase 2
21082,Phase 1/2a
161212,Phase 0
105632,Phase 1b/2a
29950,Phase 0
191185,Discontinued in Phase 1
44361,Phase 2/3
131830,Phase 1/2
46137,Phase 2/3
4532,Phase 1/2
154470,Discontinued in Phase 2b
45863,Phase 2a
21841,BLA submitted
176338,Phase 1b/2a
175965,Phase 3
171167,Phase 2/3
131454,IND submitted
44221,Phase 1/2a
58850,Discontinued in Phase 3
157765,IND submitted
99023,Phase 1/2
102626,Approved
8843,Discontinued in Phase 2
16994,Phase 3
49230,Patented
164761,BLA submitted
80207,Phase 1
132869,Discontinued in Phase 1/2
155662,Phase 2
19071,Phase 2
88762,Phase 1
129968,Phase 0
96755,Phase 1/2a
120864,Clinical trial
121433,Phase 1
113282,Phase 1
81385,Discontinued in Phase 1
94231,Discontinued in Phase 1
179311,Phase 0
69921,Investigative
156432,Phase 1b/2a
75139,Patented
79688,Approved (orphan drug)
83312,Phase 1/2
98746,Phase 2
160870,Phase 1/2a
58257,Phase 0
171390,Phase 1b
139422,Phase 1b
28873,Phase 1b
170,Discontinued in Phase 2/3
81404,Phase 1b/2a
76703,Phase 1/2a
137941,BLA submitted
128205,IND submitted
159252,BLA submitted
155982,Discontinued in Phase 2b
160490,Phase 2a
100100,Registered
52367,Phase 1b/2a
2711,Phase 1b
177064,Phase 1
107008,Discontinued in Phase 4
66722,Investigative
46880,Approved
104414,Phase 1b/2a
153035,Discontinued in Phase 2/3
12656,Phase 0
81324,Phase 1b
58458,Discontinued in Phase 3
66526,IND submitted
148834,Clinical trial
122310,Phase 1
90736,Discontinued in Phase 2/3
183060,Phase 2
121062,Phase 1b
165841,Discontinued in Phase 4
70794,Phase 0
154074,Patented
146084,Phase 2/3
146276,Discontinued in Phase 2
87704,Discontinued in Phase 1
136435,Investigative
161173,Phase 1
30716,Phase 1/2
137680,BLA submitted
1731,Discontinued in Phase 2
12588,Phase 1/2a
44580,Phase 1/2a
50217,Discontinued in Phase 3
178056,Phase 1
120000,Clinical trial
181276,Phase 2b
154020,Phase 2/3
14137,Investigative
51135,Phase 1
148801,Phase 0
159610,Discontinued in Preregistration
139714,Discontinued in Phase 2
99351,Phase 1/2a
147153,Phase 1b
90301,Phase 1b
52156,Phase 1/2a
130535,Phase 1/2a
72911,IND submitted
25997,Discontinued in Phase 2b
167399,Phase 4
170889,Discontinued in Phase 1
29411,Phase 1
81097,Discontinued in Phase 1
24035,Phase 1/2a
85961,Discontinued in Phase 2b
317,Phase 2
70028,Phase 1b
66625,Discontinued in Phase 2
166893,Phase 0
13901,Phase 1
97194,Phase 1/2a
66029,Discontinued in Phase 2
123960,Phase 1
105291,Phase 2a
102968,Phase 1/2
123568,Phase 0
13682,Phase 1
106529,Phase 2b
255,Phase 2
13424,Phase 0
187794,Phase 3
79800,Approved (orphan drug)
21687,Approved (orphan drug)
82627,Phase 2
7886,Clinical trial
166602,Patented
75174,Phase 2a
157854,Clinical trial
36769,Discontinued in Preregistration
12177,IND submitted
81055,Approved
183455,Phase 1b/2a
188058,Phase 0
191199,Phase 1
136390,Phase 0
117461,Investigative
151163,Phase 0
7065,Investigative
42515,Approved
5716,IND submitted
155391,Phase 0
100812,Phase 1/2a
55878,Patented
67828,Patented
27240,Patented
39784,Phase 0
189318,Phase 1/2a
10766,Phase 1b
21894,Phase 0
75559,Phase 1/2a
141668,Patented
95853,Phase 2a
30276,Phase 2
52757,Phase 0
183705,IND submitted
48071,Investigative
72216,Discontinued in Phase 3
190848,Phase 2/3
83509,Phase 0
40988,Investigative
17593,Investigative
88474,Phase 1
103397,Phase 1/2a
31269,Discontinued in Phase 2/3
174421,Discontinued in Phase 1/2
173635,BLA submitted
105509,Phase 1/2
113456,Phase 1b/2a
28802,Phase 1b
22535,Phase 0
62630,Phase 1/2a
21910,Discontinued in Phase 3
38023,Phase 1b/2a
99141,Phase 2
189636,Approved (orphan drug)
10247,Phase 0
36799,Discontinued in Preregistration
161983,Investigative
46297,Phase 1b/2a
128276,Phase 0
20759,Phase 1/2a
166964,Phase 1/2a
18022,Phase 1
159340,Phase 2
77062,Investigative
170861,Phase 1
71731,Phase 1
158829,Phase 2
112447,Discontinued in Phase 2
37661,Discontinued in Phase 2
117449,Discontinued in Phase 1/2
116994,Discontinued in Phase 3
121791,Discontinued in Phase 2b
47956,Phase 1b
168218,Discontinued in Phase 2/3
13194,Phase 1
21778,Phase 0
114674,Discontinued in Phase 3
1165,Discontinued in Phase 4
119647,Discontinued in Phase 2b
48764,Phase 2/3
72432,Phase 2
40003,Phase 2/3
90778,Phase 1b/2a
20359,Phase 1b/2a
99412,Phase 1/2a
159031,BLA submitted
177510,Phase 1/2a
128086,Phase 0
38212,Phase 1b
134840,Phase 0
190834,Phase 1/2
55869,Phase 2
13359,Phase 1
55182,Discontinued in Phase 3
7159,Phase 2/3
176199,Phase 1b/2a
152853,Phase 1b/2a
161806,Discontinued in Phase 1/2
11521,Phase 1/2a
150764,Phase 0
140695,Registered
68307,Phase 0
172324,Investigative
187797,Clinical trial
30568,Phase 0
116792,Investigative
89248,Discontinued in Phase 4
78176,Approved (orphan drug)
5725,IND submitted
64561,Approved
31744,Discontinued in Preregistration
119610,Discontinued in Preregistration
64253,Approved (orphan drug)
43615,Phase 2/3
90319,Phase 0
7300,IND submitted
93878,Phase 2a
51906,IND submitted
157645,Discontinued in Phase 4
35132,Phase 1
38953,Phase 2/3
48212,Phase 1/2a
92444,Phase 1
49906,Discontinued in Phase 2
153946,Phase 1/2
163790,Phase 2a
3849,Investigative
114641,Phase 0
133843,Discontinued in Phase 4
192101,Phase 1b/2a
154297,Investigative
15254,Phase 0
184365,Discontinued in Phase 4
57675,Discontinued in Phase 2/3
67939,Phase 1/2
85696,Discontinued in Phase 3
14020,Phase 3
7142,Phase 1/2
116482,Discontinued in Phase 2b
70117,Discontinued in Phase 4
47772,Discontinued in Phase 4
168083,Phase 1b
180043,Phase 1/2a
174835,Discontinued in Phase 3
29225,Phase 1/2a
148684,Phase 0
166807,Phase 2
81331,Discontinued in Phase 1
171662,Discontinued in Phase 2
77279,Phase 0
28071,Phase 2
71773,Phase 0
51751,Discontinued in Preregistration
127285,IND submitted
192042,Discontinued in Phase 2
83943,Discontinued in Phase 2
120066,Discontinued in Phase 3
176744,Phase 1b
1072,Discontinued in Phase 1/2
12581,Phase 0
68926,Phase 3
167787,Approved (orphan drug)
177517,Phase 1b
65038,Phase 2/3
101787,Investigative
77626,Phase 1
92314,Discontinued in Phase 4
104935,Discontinued in Phase 2b
59042,Phase 0
10076,Discontinued in Phase 2/3
19753,Discontinued in Phase 2b
80858,Phase 2a
22546,Phase 2
161925,Phase 2a
181825,Phase 2b
183597,Discontinued in Phase 2
106874,Patented
103855,BLA submitted
156801,Phase 1b/2a
165755,Phase 1
113122,Discontinued in Phase 2/3
53335,Discontinued in Phase 2/3
148821,Phase 1b/2a
13411,Phase 0
117618,Discontinued in Phase 2/3
3981,Phase 1
89500,Discontinued in Preregistration
133797,Patented
82958,Phase 0
104844,Discontinued in Phase 3
106930,Patented
120281,Phase 0
107736,Discontinued in Preregistration
163076,Discontinued in Phase 2/3
41779,Phase 0
72137,Phase 0
120745,Phase 0
176491,Phase 1b/2a
164542,Phase 1/2
32914,Phase 2
101919,Investigative
88589,Phase 1/2
181294,Discontinued in Phase 2b
110576,Phase 1
113643,Investigative
132615,Discontinued in Phase 2/3
38969,Discontinued in Phase 2b
120226,Discontinued in Phase 3
56537,Phase 0
68017,Preclinical
48330,Patented
70001,Discontinued in Phase 2b
93008,Discontinued in Phase 1
173461,Discontinued in Phase 2b
59145,Investigative
62570,Phase 1
107267,Phase 1/2a
132400,Phase 2
46653,Phase 1
70802,Phase 2b
25663,Phase 1/2a
57890,Discontinued in Phase 3
111478,Discontinued in Phase 2b
88708,Phase 1/2
164958,Phase 0
156431,IND submitted
17844,Phase 0
35855,Phase 1/2a
162577,Phase 1/2a
46521,Phase 1/2a
101292,Phase 1b
128335,Discontinued in Preregistration
190251,Phase 2/3
42866,Phase 1b
85958,Discontinued in Phase 2b
18733,Phase 1b
93079,Phase 2
27537,Phase 1/2
52434,Phase 1b/2a
166851,Phase 0
10047,Investigative
39351,Discontinued in Preregistration
27694,Discontinued in Phase 2b
75047,Phase 1/2
167848,Phase 2a
125574,Phase 1/2a
1419,Discontinued in Preregistration
21562,Discontinued in Preregistration
70549,Discontinued in Phase 3
188948,Clinical trial
146936,Phase 1b/2a
120059,Phase 0
10714,Phase 1b/2a
83067,Phase 1b/2a
98251,Phase 1/2a
25458,Phase 0
64495,Clinical trial
3823,Discontinued in Phase 3
118293,Discontinued in Phase 2
144881,Phase 1
135493,Phase 0
61493,Discontinued in Phase 1
59302,Investigative
37698,Phase 1/2a
125818,IND submitted
40476,Discontinued in Preregistration
34971,Phase 1b/2a
46108,Phase 1/2a
16586,Phase 1b/2a
183743,BLA submitted
166324,Phase 1b/2a
18357,Discontinued in Phase 2b
95290,Phase 1/2a
147885,Phase 1b/2a
96502,Phase 1b/2a
159089,Approved
139114,Phase 1b
160175,Investigative
78687,Phase 1b
28102,Phase 2a
98009,Phase 2/3
80879,Phase 1
179544,Phase 1/2a
43010,Phase 1b
9054,Discontinued in Preregistration
174765,Discontinued in Preregistration
3380,Discontinued in Phase 2b
186236,Clinical trial
49408,Phase 2/3
61268,Phase 1
147224,Phase 2b
107552,Phase 3
143247,Phase 1/2
92377,Phase 2
22608,Phase 2
163926,Phase 1/2
109982,Phase 1b
118244,Phase 1
166143,Phase 1b/2a
52669,IND submitted
167865,Investigative
164708,Phase 1
5689,IND submitted
56788,Phase 2/3
155745,Phase 1b
136700,BLA submitted
63782,Phase 1/2
125238,IND submitted
173257,Patented
166457,Investigative
117580,Discontinued in Phase 3
40577,Discontinued in Phase 4
190493,Approved (orphan drug)
92288,Phase 2
23515,Patented
169872,Phase 1b/2a
58931,Phase 2/3
94356,Discontinued in Phase 3
168559,Discontinued in Phase 1
37541,Discontinued in Phase 1/2
151876,Phase 2
156597,Phase 1b
115360,Phase 1/2a
130219,Patented
74559,Discontinued in Phase 1/2
123563,Discontinued in Phase 4
75266,Discontinued in Phase 1
153942,Preregistration
144052,Phase 0
38906,Investigative
146227,Phase 0
131487,Patented
173360,Discontinued in Phase 2b
192050,Phase 2a
91500,Phase 1/2
21597,Approved (orphan drug)
172332,Patented
48480,Phase 1
73225,Approved (orphan drug)
53447,Phase 1/2a
99906,Phase 1b
50516,Phase 1/2a
189980,Approved
14006,Phase 0
23435,Discontinued in Phase 4
169756,Phase 1b/2a
85804,Discontinued in Phase 3
165830,Phase 2
182935,Phase 1b
136645,Patented
163740,Phase 1
189439,Phase 2b
90438,Clinical trial
96665,Phase 2/3
17981,Discontinued in Phase 4
26852,Phase 1/2a
52265,Phase 2
33516,Phase 1b
65093,Discontinued in Phase 2
14086,Phase 1
88576,Phase 0
93093,Phase 2b
157541,Discontinued in Phase 4
106208,Phase 2a
130043,Phase 2
153918,Phase 1/2a
134931,Phase 0
150667,Phase 1b/2a
97254,Phase 0
166325,Phase 1b/2a
34611,Phase 1/2
1458,Discontinued in Phase 4
53371,Phase 1/2a
163609,IND submitted
75102,Phase 1b/2a
187792,Phase 1/2a
247,Discontinued in Phase 2/3
75042,Discontinued in Phase 1
129204,Phase 1
49412,Phase 1b/2a
137687,Discontinued in Phase 4
144671,Phase 1b
183745,Phase 1b/2a
191767,Phase 1
81002,Phase 1b/2a
187920,Discontinued in Phase 4
114394,Phase 1b/2a
62925,Discontinued in Preregistration
120385,Phase 4
140828,Phase 1b/2a
55537,Discontinued in Preregistration
87982,Phase 2a
170923,Patented
86345,Phase 0
13597,Phase 1b/2a
60684,Clinical trial
162908,Patented
4217,Phase 1/2
144070,IND submitted
189782,Phase 2/3
185457,Discontinued in Phase 2b
170890,Phase 1/2a
185648,Phase 1/2a
156399,Phase 1/2
137746,Phase 1/2a
59369,Investigative
136636,Phase 1/2
83525,Discontinued in Phase 4
44133,Phase 1/2a
137427,Investigative
153299,Investigative
112660,Phase 1
9915,Discontinued in Phase 3
115923,Phase 2/3
50756,Discontinued in Phase 2b
174135,Discontinued in Phase 4
136252,BLA submitted
96077,Phase 1b
120925,IND submitted
177685,Approved
100340,Discontinued in Preregistration
130137,Discontinued in Preregistration
94456,Discontinued in Phase 3
100516,Investigative
147063,Phase 0
150318,Phase 1/2a
143956,Phase 0
152984,Phase 1/2a
182995,Discontinued in Phase 2b
129188,Discontinued in Phase 2b
84226,Phase 1
58977,Investigative
171132,Phase 1
146153,Phase 1/2
19970,Discontinued in Phase 2b
65531,Phase 2a
137300,Investigative
48654,Discontinued in Phase 3
99840,Discontinued in Phase 2b
98237,Investigative
90459,Phase 1/2
188288,Discontinued in Phase 3
63926,Clinical trial
152305,Approved (orphan drug)
60676,Approved (orphan drug)
47729,Phase 1b/2a
86417,Phase 2
52019,Phase 1
96305,Phase 1b
14742,Phase 1/2
161427,Discontinued in Preregistration
116708,Discontinued in Phase 1/2
169539,Phase 1
82141,Discontinued in Phase 1
19443,IND submitted
99181,Phase 1/2a
33315,Phase 1
185028,Phase 1/2
149832,Phase 0
83855,Discontinued in Preregistration
266,Phase 2
31275,Phase 1
17556,Phase 0
81503,Phase 1
93997,Discontinued in Phase 1
43082,Phase 0
45744,Phase 2/3
65711,Discontinued in Phase 3
44774,Phase 1/2a
143865,Phase 1b/2a
107268,Phase 1/2
102710,Approved
144830,Phase 1b/2a
35687,Phase 1/2
109791,Phase 1
43453,Phase 1/2a
148059,Phase 2/3
135658,Phase 1/2
154270,Phase 1/2a
154723,Phase 1b/2a
66818,Patented
30857,Discontinued in Phase 2b
189489,Patented
51107,Investigative
105668,Phase 1/2a
74215,Investigative
183608,BLA submitted
90260,Discontinued in Phase 3
25769,Phase 2/3
157792,Discontinued in Phase 2
131316,Discontinued in Phase 2b
78741,Phase 2/3
55306,IND submitted
104303,Investigative
9220,Discontinued in Phase 2
3476,Investigative
158479,Phase 1b/2a
160805,Phase 2a
50290,IND submitted
116458,Discontinued in Phase 2/3
86857,Investigative
24110,Discontinued in Phase 2b
56031,Phase 1
187120,Phase 0
121648,Discontinued in Phase 1
154287,Investigative
92360,Phase 2
182900,Phase 1b/2a
153808,Phase 1b
16457,Phase 1
39543,Investigative
138735,BLA submitted
112608,Discontinued in Phase 3
98088,Discontinued in Phase 2b
110736,Phase 1/2
58607,Phase 2/3
49731,Discontinued in Phase 2/3
141724,Discontinued in Phase 2/3
31640,Investigative
93655,Discontinued in Phase 2b
155372,Phase 2b
85688,Discontinued in Phase 2b
175123,Discontinued in Phase 1/2
90652,Patented
30345,Phase 1
107758,Discontinued in Phase 4
68036,Discontinued in Phase 2
92767,Phase 2
118904,Registered
56414,Phase 2
173027,Discontinued in Phase 2b
124891,Phase 1b
104646,Phase 0
160284,Phase 2b
95211,Patented
189605,Patented
138570,Discontinued in Phase 2
68086,Phase 1/2a
110851,Phase 2
91956,Phase 1
19853,Phase 1
53881,Discontinued in Phase 2/3
153441,IND submitted
26875,Phase 1/2a
92021,Phase 0
51805,Patented
69319,Discontinued in Phase 3
158594,Phase 1/2
113146,Phase 2a
80605,Phase 2a
173560,Phase 1/2a
138657,Phase 1/2a
22166,Discontinued in Phase 2
117569,Discontinued in Phase 1/2
64782,Phase 0
124873,Phase 1
173131,Patented
49458,IND submitted
106552,Approved
15072,Phase 2b
66429,Phase 1b
54420,Discontinued in Phase 3
43000,Discontinued in Phase 4
73140,Investigative
28264,IND submitted
21084,Phase 2/3
76206,Patented
130257,Discontinued in Preregistration
103406,Discontinued in Phase 2/3
73084,Phase 1/2a
21467,Investigative
15638,Phase 0
93586,Phase 1
54192,Phase 1/2
94212,Phase 2b
39747,Phase 2/3
112369,Phase 1/2
156397,Discontinued in Preregistration
120687,Approved (orphan drug)
94370,Phase 1/2
162445,Patented
46559,Phase 1/2
131632,Phase 0
24125,Phase 2
79302,Discontinued in Phase 1
180852,Phase 2a
75274,Phase 2
65019,Phase 1b
103070,Phase 1/2a
179974,Discontinued in Preregistration
178908,Discontinued in Phase 1/2
107130,Phase 1
128532,Discontinued in Phase 3
59038,Discontinued in Phase 3
174935,Discontinued in Phase 2
164171,Phase 1/2
71823,Patented
116717,Phase 2
64202,Investigative
27470,Phase 0
14188,Phase 1b/2a
137903,Investigative
69655,Discontinued in Phase 3
163739,Phase 1
59648,Clinical trial
141799,Phase 1
132792,Phase 2
184418,BLA submitted
158553,Phase 2b
184004,Discontinued in Phase 4
86205,Phase 0
84504,Phase 1b/2a
159741,Discontinued in Phase 1/2
115857,Approved (orphan drug)
158442,Phase 1b
132949,IND submitted
138844,BLA submitted
68049,Discontinued in Phase 1
40040,Phase 1/2a
166525,Phase 1b
96638,Phase 0
154730,Phase 2
54880,Phase 4
74987,Discontinued in Phase 2/3
7276,Phase 2/3
59594,Investigative
157691,Patented
184501,Phase 1/2
97982,Phase 0
105189,Phase 1b/2a
175510,Discontinued in Phase 3
132599,Discontinued in Phase 4
121051,Phase 1b
71125,Phase 1b/2a
156606,Discontinued in Phase 1
158738,Phase 1b
177823,Phase 1b/2a
7954,Phase 1/2
142316,Patented
15790,Phase 0
92174,Phase 3
154632,Phase 3
19811,Phase 0
188506,Clinical trial
27919,Phase 2
105959,Phase 2/3
1899,Approved
118874,Phase 1
118036,Phase 1b
183638,Approved (orphan drug)
116886,Discontinued in Phase 1
100075,Patented
145822,Phase 1b/2a
77618,Discontinued in Phase 1/2
191127,Patented
154693,Phase 2
137331,Investigative
23425,Phase 1b/2a
71398,Discontinued in Phase 1
12885,Phase 1/2a
54028,Discontinued in Phase 4
8331,IND submitted
152091,Phase 1
20349,Discontinued in Phase 4
189729,Phase 1/2
109728,Phase 3
90156,IND submitted
125298,IND submitted
119479,BLA submitted
122461,Phase 1/2
175273,Phase 1
133579,Investigative
21821,Discontinued in Phase 4
32740,Phase 2a
142227,Discontinued in Phase 2b
15060,Phase 0
186430,Phase 0
103347,Patented
104248,Phase 1/2a
121767,Patented
63968,Phase 1
37564,Discontinued in Preregistration
33342,Phase 2/3
117627,Discontinued in Phase 2/3
100718,Phase 1/2a
8944,Phase 1
50747,Phase 1b
153410,IND submitted
160500,Phase 2/3
60497,Phase 0
166398,Investigative
114601,Phase 0
40730,Phase 1
7698,Patented
76693,Phase 0
119198,Phase 2
152664,Approved
66781,Phase 0
21296,Phase 1
107714,Discontinued in Phase 4
55453,Discontinued in Phase 3
186305,Phase 2a
190793,Phase 1/2
176610,Discontinued in Phase 2
30290,Investigative
70462,Phase 0
30813,Discontinued in Preregistration
21007,Phase 2
75346,Discontinued in Phase 2
71586,Discontinued in Phase 4
39919,Discontinued in Phase 2/3
154858,Phase 2
143969,Phase 1/2
128892,Discontinued in Phase 3
81020,Discontinued in Phase 3
83368,IND submitted
124266,Investigative
19021,IND submitted
173309,Phase 0
130187,Patented
12904,Phase 1
47704,Discontinued in Phase 4
171411,Discontinued in Phase 2
6825,Phase 1b/2a
78319,IND submitted
66916,Phase 0
83303,Phase 0
145430,Phase 2b
2039,Approved
186123,Patented
40090,Phase 1/2
84457,Phase 1/2a
42724,Phase 2/3
115907,Clinical trial
22582,Discontinued in Phase 2/3
36548,Phase 1b/2a
164499,Discontinued in Preregistration
178996,Phase 1
70030,Patented
149808,Phase 1b
68758,Discontinued in Phase 4
128269,Patented
189713,Approved (orphan drug)
57135,Phase 1
91444,BLA submitted
161046,Discontinued in Phase 4
3159,Phase 1b
100143,Discontinued in Phase 1/2
162086,Discontinued in Phase 1/2
23490,Phase 1/2
29644,Discontinued in Preregistration
37324,Discontinued in Preregistration
114782,Phase 1/2a
161513,Investigative
3578,Discontinued in Phase 4
140477,Phase 1
183838,Phase 4
30973,Phase 0
175885,Phase 2b
105045,Approved (orphan drug)
17547,Phase 1b/2a
170796,Phase 1
187455,Phase 2b
4801,Phase 2/3
58168,Phase 1b
169842,Phase 0
91833,Approved
26666,Phase 1/2a
4841,Discontinued in Phase 2
170474,Phase 2/3
155380,Phase 0
155752,Phase 2
127272,Discontinued in Phase 3
157806,Phase 1b/2a
38843,Investigative
145596,Phase 1b
45040,Phase 2/3
61464,Phase 2a
75370,Phase 0
76674,Patented
140755,Registered
191347,Discontinued in Phase 1
112035,Phase 1
74404,Discontinued in Phase 4
103771,Phase 1/2
156897,Patented
135653,Phase 3
144491,Clinical trial
20211,IND submitted
118859,BLA submitted
177094,Phase 1/2a
32060,Discontinued in Phase 1
90402,Clinical trial
40795,Discontinued in Phase 2/3
179301,Patented
31219,Phase 1/2
48232,Discontinued in Phase 3
130279,Phase 2/3
151391,Phase 2
415,Phase 1/2a
45350,Phase 1/2a
138086,Discontinued in Phase 2
95323,Phase 1b/2a
130768,Phase 2b
48857,Discontinued in Phase 3
125613,Phase 1/2
52104,Phase 1b
146573,Phase 1b
12617,Phase 1
84177,Investigative
166194,Phase 1
152375,Phase 1b/2a
127668,Discontinued in Phase 3
106839,IND submitted
92690,Investigative
141466,Discontinued in Phase 4
149423,Discontinued in Phase 2/3
6610,Phase 2/3
30685,Clinical trial
157690,Discontinued in Phase 4
70219,Phase 1
94709,Patented
148895,Phase 2b
13149,IND submitted
120045,Discontinued in Phase 1/2
48238,Discontinued in Phase 2b
183906,IND submitted
138417,Discontinued in Phase 2
67804,IND submitted
139527,BLA submitted
178073,Patented
141907,Patented
4046,Phase 1/2
176643,Phase 1/2
46372,Phase 0
124910,Phase 1/2
182478,Phase 1/2a
31530,Discontinued in Phase 4
98461,Investigative
181095,Discontinued in Phase 2b
6246,Investigative
168765,Approved
132781,IND submitted
101783,Investigative
77511,Discontinued in Preregistration
57081,Phase 2
140662,Preregistration
169172,Discontinued in Phase 2
170962,IND submitted
135038,Phase 0
14704,Phase 1
22731,Phase 2
101121,Phase 0
87561,Phase 0
129678,Discontinued in Phase 2/3
62168,Investigative
57932,Approved (orphan drug)
164025,Discontinued in Preregistration
17316,Phase 1
111440,Phase 1
57418,Phase 0
161601,Investigative
40602,Discontinued in Phase 4
119514,Patented
81476,Patented
149542,Phase 0
182017,Phase 1/2a
117870,Phase 1
50950,Phase 1b/2a
100704,Phase 2
172405,Discontinued in Phase 2/3
77789,Phase 2
96439,Patented
113749,Phase 0
66121,Phase 0
75569,Discontinued in Phase 1/2
97331,Phase 1/2a
81082,Discontinued in Phase 3
166573,Phase 1b
36072,Phase 1b
161912,Investigative
67953,Phase 2b
101944,Phase 0
62571,IND submitted
66599,Phase 1b/2a
61254,Patented
155686,Approved
82292,Investigative
128549,Discontinued in Phase 2b
154120,Discontinued in Phase 4
48126,Patented
4335,Investigative
40883,Investigative
122095,Investigative
72393,Investigative
75217,IND submitted
86518,Phase 1b/2a
39025,Phase 1/2a
109590,Discontinued in Phase 2/3
74831,Patented
185628,Phase 0
41017,Discontinued in Phase 1/2
123827,Discontinued in Phase 4
32700,Phase 2a
177123,Phase 1/2
23916,Discontinued in Phase 4
119275,Discontinued in Phase 4
26323,Phase 1b
18439,Phase 2a
155192,Investigative
111312,Phase 1/2
160846,Phase 3
32884,Phase 1b/2a
69540,Phase 2/3
106655,Discontinued in Phase 4
13783,Phase 1/2
191840,Phase 2a
117291,Phase 1b
75189,IND submitted
83271,Phase 1b/2a
140923,Patented
103739,Phase 1
50079,Phase 1/2a
137512,BLA submitted
152687,Discontinued in Phase 3
122747,Approved
71029,Phase 1b/2a
133047,Discontinued in Phase 4
146039,Phase 1b/2a
146610,Phase 1b
114986,Phase 1/2
25298,Discontinued in Phase 4
73009,IND submitted
4256,Discontinued in Phase 2
162262,Phase 1b/2a
186709,Preclinical
158870,Approved
16445,Phase 1/2
124725,Phase 1b
5082,Investigative
28393,Phase 1
57839,Phase 2/3
33326,Phase 0
127071,Investigative
17987,Phase 2a
168316,Discontinued in Phase 2b
105123,Phase 1/2
91979,Phase 1b
13852,Investigative
71672,Phase 1/2
155424,Phase 1b
161202,Phase 0
164257,Phase 1
128405,Discontinued in Phase 2b
54434,Discontinued in Phase 3
19643,Phase 2a
124812,Phase 1/2
178355,Discontinued in Phase 2
67741,Phase 1
137626,Discontinued in Phase 2b
86687,Patented
1028,Clinical trial
8846,IND submitted
157154,IND submitted
83267,Phase 1/2
99422,Phase 1
165795,Phase 1
89994,Discontinued in Preregistration
36663,Discontinued in Phase 2b
29654,IND submitted
42097,Phase 1
106693,Phase 1b
26776,Phase 1b
115987,Phase 1/2a
79738,Phase 2a
134264,Phase 1
92470,Discontinued in Phase 2b
39395,Discontinued in Preregistration
130145,Phase 1/2a
60405,Investigative
80031,Phase 2
133071,Phase 1b/2a
46479,Phase 2
155036,Phase 1
115739,Clinical trial
158856,Phase 0
53535,Phase 1b
60420,Phase 1
160672,Phase 1
180829,Phase 1/2
4794,Investigative
64217,Phase 2a
159452,Discontinued in Preregistration
190279,Phase 1/2
169328,Phase 2/3
14987,Phase 1/2a
84108,Phase 1/2
175874,Phase 1/2a
155532,Phase 2
113369,Clinical trial
15631,Phase 1
14995,Phase 1
184349,Phase 1
8077,Patented
186192,Phase 0
70076,Phase 0
95984,BLA submitted
70638,Phase 1/2
167693,Phase 2
49232,Phase 1/2a
38132,Phase 0
114567,Phase 1/2a
57292,Phase 1/2a
170945,Phase 1
131037,Patented
131888,Discontinued in Phase 1/2
62574,Discontinued in Phase 3
163121,Discontinued in Phase 2
31098,Discontinued in Phase 3
84973,Phase 1/2
27819,Phase 2
173472,Discontinued in Phase 3
191719,Phase 1
170330,Phase 0
16639,Phase 1/2
119707,Discontinued in Phase 2b
82065,Clinical trial
37039,Discontinued in Preregistration
136940,Phase 2
57106,Discontinued in Phase 3
10558,Phase 1b/2a
12130,Phase 1/2
161780,Discontinued in Phase 4
124906,Phase 1
24439,Phase 1
120090,Phase 0
37141,Phase 1
189815,Preclinical
12699,Investigative
179884,Discontinued in Phase 2/3
22030,Phase 3
127767,Discontinued in Phase 1
143824,Phase 1/2a
81486,Phase 1/2
164367,Phase 1/2
7131,Phase 1b/2a
98098,Phase 1b
136840,BLA submitted
164690,Phase 2/3
77481,IND submitted
90899,Approved (orphan drug)
17825,Phase 1
33341,Phase 2a
163983,Phase 0
144967,Phase 2b
124530,Investigative
158476,Phase 1b
188608,Phase 2b
172149,Discontinued in Phase 2
41442,Phase 1/2
107389,Discontinued in Phase 2b
169697,Phase 0
122965,Phase 1b
58928,Phase 0
52356,Phase 1
5592,Phase 1b/2a
112613,Discontinued in Phase 3
52116,Discontinued in Phase 2b
167058,Discontinued in Preregistration
187999,Discontinued in Preregistration
124194,Phase 1/2
19704,Phase 0
125738,Investigative
117323,Discontinued in Phase 1
182235,Phase 1b
181554,Phase 2a
34343,Phase 1b/2a
108305,Phase 1b
31958,Phase 0
55461,Phase 2
52847,Phase 1b/2a
116831,Phase 1b
74731,Phase 1
63052,Phase 1b/2a
165839,Investigative
185632,Phase 1b
60370,Phase 2/3
133796,Patented
86850,Phase 1b
141421,Discontinued in Preregistration
152582,Phase 1/2a
125433,Phase 1/2
185576,Clinical trial
57822,Phase 2/3
72642,Phase 2
185137,Phase 1/2
152067,Phase 1b/2a
105107,Discontinued in Phase 4
24007,Phase 1/2a
130215,Patented
116457,Phase 2
65357,Phase 2/3
158599,Phase 1b/2a
21619,Investigative
95291,Discontinued in Phase 4
122295,Discontinued in Phase 4
12000,Phase 1
36671,Discontinued in Phase 1/2
8302,Investigative
122672,Discontinued in Phase 4
116581,Investigative
37917,Discontinued in Phase 3
12304,Phase 1
105733,Phase 1b/2a
138342,BLA submitted
59220,Approved (orphan drug)
18173,Discontinued in Phase 2b
170240,Discontinued in Preregistration
128972,Discontinued in Phase 2b
177219,Phase 2
122353,Discontinued in Preregistration
175961,Discontinued in Phase 2
93428,Phase 1/2a
167636,Patented
90607,Discontinued in Phase 1
76374,IND submitted
118896,Phase 2a
97650,Phase 1b
164243,Phase 1/2
160989,Phase 1b
140085,Phase 1/2
56496,Phase 0
143656,Phase 1/2a
165040,Discontinued in Preregistration
48407,Phase 1/2a
176760,Phase 1b/2a
2098,Phase 1b
143187,Phase 2a
42655,Discontinued in Phase 1
135196,Phase 0
51834,Phase 1b/2a
7607,Phase 1/2
84997,Phase 1/2a
112581,Phase 0
136301,Phase 1/2
153656,Phase 1
148513,Phase 1b/2a
113727,Phase 2
170186,IND submitted
64951,Clinical trial
120096,Clinical trial
101119,Discontinued in Preregistration
179170,Phase 1/2a
30807,Phase 1b/2a
156247,Discontinued in Phase 3
172323,Discontinued in Phase 2/3
179034,Discontinued in Phase 1
101013,Phase 1/2
178914,Phase 1/2
57924,Phase 0
92168,Patented
69098,Discontinued in Phase 2/3
18330,Phase 2
111256,Patented
67669,IND submitted
155229,Phase 1b
19216,Phase 1b
143804,Phase 2/3
44865,Phase 2/3
112796,Discontinued in Phase 2
118778,Phase 1/2a
151488,Phase 0
103583,Phase 2/3
12186,Phase 1/2
118429,Approved
106147,Phase 2/3
30974,IND submitted
87430,Phase 2a
47137,Discontinued in Phase 2/3
73714,Phase 2a
57917,Phase 1b/2a
116362,Discontinued in Phase 2b
102012,Phase 0
155678,Phase 2/3
146598,Phase 1b/2a
23991,Discontinued in Preregistration
107809,Discontinued in Phase 2/3
115817,Phase 2/3
51667,Phase 0
19986,Phase 1/2
157634,Discontinued in Phase 1/2
98238,Phase 1b
40297,Phase 2
88575,Phase 1/2
17528,Phase 1
20442,Discontinued in Preregistration
190157,Phase 1/2
32479,Phase 2/3
73441,Phase 1b/2a
135555,Phase 0
14246,Phase 1
172688,Discontinued in Phase 2b
144904,Phase 1/2
191810,Phase 0
89398,Discontinued in Preregistration
76351,Phase 0
118362,Discontinued in Preregistration
44581,Phase 1/2a
26186,Discontinued in Phase 4
9593,Approved
103713,Investigative
170784,Discontinued in Phase 1
169475,Discontinued in Phase 2/3
101303,Phase 1b
118089,IND submitted
84763,Phase 1/2
146053,Phase 2
130368,Phase 1/2
56381,Phase 2
119983,Approved (orphan drug)
108350,Phase 0
105186,Phase 1
95611,Phase 2a
165723,Phase 1b/2a
18302,Discontinued in Phase 4
179095,Phase 1/2
163594,Phase 2b
106489,Approved
134984,Phase 0
96639,Phase 1
44407,Phase 2/3
131178,Phase 1b/2a
45307,Phase 1/2a
141474,Phase 0
163667,Phase 2b
30027,Phase 1b/2a
153669,Discontinued in Phase 2/3
135697,Phase 1/2
138153,Discontinued in Phase 2
149407,Phase 2
75125,Patented
48513,Phase 0
149920,Phase 2b
188103,Phase 1/2
129717,IND submitted
18929,Discontinued in Phase 2/3
57676,Phase 1
13553,Phase 1
118654,BLA submitted
4037,Phase 1/2
55998,Discontinued in Phase 3
191645,Phase 1
146671,IND submitted
152336,Patented
52365,Phase 3
5589,Investigative
81106,Discontinued in Phase 3
110392,Phase 3
14840,Phase 1
104511,Phase 1b
45582,Phase 1/2a
14099,Phase 0
64554,Phase 0
143985,Phase 1/2
148753,Investigative
100694,Phase 2/3
152693,Patented
29433,IND submitted
181224,Phase 2a
92215,Discontinued in Phase 1
12598,Phase 1/2a
60139,Discontinued in Phase 2/3
130186,Patented
142606,Phase 2a
89839,Phase 1b/2a
36217,Phase 0
117769,Discontinued in Phase 1/2
16265,Phase 1
130662,Phase 1b
2021,Phase 1b
117637,Phase 2
44002,Phase 2/3
99517,Discontinued in Phase 2/3
132210,IND submitted
182940,Phase 1/2a
120798,Approved (orphan drug)
56108,Phase 2
130042,Phase 3
31005,Phase 1
166446,Patented
184333,Phase 1/2
43548,Phase 1/2a
122393,Phase 1
143008,Phase 1/2a
61140,Phase 1
41474,Phase 2
118203,Discontinued in Preregistration
76701,Patented
99271,Phase 1
115299,Clinical trial
131451,Discontinued in Phase 4
184180,Phase 0
26163,Phase 1b/2a
57234,Phase 2/3
27214,Phase 1b
8656,Phase 1b/2a
6819,Investigative
64232,Approved
146770,Phase 1/2a
110399,Phase 3
58408,Approved (orphan drug)
152444,Patented
145617,Investigative
35703,Discontinued in Preregistration
59025,Discontinued in Phase 1/2
130731,Phase 2
173352,Phase 1/2
89918,Patented
32586,Phase 1/2a
156920,IND submitted
69071,Phase 2b
6145,Phase 4
81732,Phase 2
38252,Phase 2b
183648,Phase 1/2
63649,Approved
62686,Phase 1
4717,IND submitted
166342,Phase 1b/2a
102421,Phase 1/2a
162810,Phase 1/2
124372,Patented
107590,Phase 1/2a
185083,Phase 0
2359,Discontinued in Phase 1/2
148514,Phase 1b/2a
186471,Phase 4
62080,Phase 1b
112758,Discontinued in Phase 3
38433,Phase 1
88379,Phase 1/2
128582,Investigative
66976,Patented
30844,Discontinued in Preregistration
24862,Discontinued in Phase 2/3
173897,Approved (orphan drug)
11115,Phase 1/2
25081,Phase 1/2
74172,IND submitted
25016,Phase 1b/2a
104945,Approved (orphan drug)
124335,Phase 1b
183342,Discontinued in Phase 2
105793,Discontinued in Preregistration
191584,Phase 2
93832,Discontinued in Phase 3
117308,Discontinued in Phase 1/2
188012,Discontinued in Phase 4
184567,Phase 0
187183,Phase 2/3
159263,Approved
11622,Phase 1
152725,Patented
145116,Phase 1b/2a
175428,Discontinued in Phase 4
144289,Phase 3
93906,Phase 1/2a
142462,Phase 0
175670,Phase 0
66853,Phase 0
25008,Investigative
157725,IND submitted
2976,Phase 1b
70736,Phase 1/2
50889,Discontinued in Phase 2/3
176243,Clinical trial
170232,Phase 0
1516,Phase 0
108768,Discontinued in Phase 2/3
78974,Phase 0
94778,Patented
3960,Phase 1
108126,Phase 2
150467,Discontinued in Phase 1
128385,IND submitted
2108,Phase 2b
150850,Phase 1
103737,IND submitted
186848,Phase 1/2a
2328,Discontinued in Preregistration
56912,Phase 1
25049,Phase 1b/2a
46607,Patented
8346,Phase 1b
34845,Phase 1b
150550,Clinical trial
146032,Phase 0
21589,Discontinued in Phase 3
33768,Phase 1b
114792,Phase 1/2a
158612,Phase 1b
158934,Phase 1
100366,Registered
77395,Phase 0
2817,Investigative
12583,Phase 0
160843,Phase 1
164342,BLA submitted
22368,IND submitted
172588,Discontinued in Phase 2b
135902,Phase 1/2
167551,Discontinued in Phase 2
170916,Patented
59710,Discontinued in Phase 3
112095,Phase 1
38994,Discontinued in Phase 2b
76559,Phase 0
14402,Phase 3
73054,Phase 2/3
38398,Phase 2
90841,Preclinical
20324,Discontinued in Phase 2/3
38351,Discontinued in Preregistration
141375,Discontinued in Phase 4
55924,Discontinued in Phase 2b
184845,Discontinued in Phase 4
150219,Investigative
98553,Phase 1/2
1759,Phase 2/3
161384,Investigative
93968,Discontinued in Phase 2b
45737,Phase 2/3
61942,Discontinued in Phase 2b
48100,Discontinued in Phase 2/3
41800,Phase 1b/2a
86255,Phase 0
185553,Patented
163704,Discontinued in Phase 1/2
50649,Phase 0
121412,Phase 1/2a
188516,Phase 1/2a
5523,Investigative
86368,Discontinued in Phase 3
40855,Patented
105901,Phase 1b/2a
148321,Phase 2b
30853,Phase 0
36035,Phase 1b
2747,Phase 1b
77686,Patented
138550,Approved (orphan drug)
189362,Phase 2b
180715,Phase 1b/2a
33576,Phase 1b
132642,Phase 1/2
45287,Phase 2/3
91384,Clinical trial
101322,Phase 1b
16562,Phase 1
189193,Approved (orphan drug)
182735,Phase 1b
81263,Clinical trial
166258,Investigative
122957,Phase 0
73589,Phase 1/2a
184617,Discontinued in Phase 4
57903,Discontinued in Phase 4
53383,Discontinued in Preregistration
191237,Phase 2a
8069,Phase 2
191542,Phase 2a
96365,Discontinued in Phase 1/2
84526,Phase 0
122019,Discontinued in Phase 2b
172876,IND submitted
21392,Phase 2
47699,Phase 1/2a
110528,Discontinued in Phase 2/3
20420,IND submitted
150440,Patented
177192,Phase 1b
48052,Phase 1b/2a
92710,Phase 1/2a
59251,Phase 2/3
23388,Phase 1b/2a
42224,Investigative
142658,Phase 2b
20944,Phase 2b
43862,Phase 1/2a
153706,Phase 1b
19460,Phase 0
124225,IND submitted
184363,Phase 0
93463,Phase 1/2
44209,Phase 2/3
113840,Discontinued in Phase 3
178631,Phase 1
30711,Patented
113157,Phase 2a
190899,Phase 1/2
105047,Discontinued in Phase 4
182209,Phase 2
145687,Phase 1/2a
92427,Phase 4
124570,Patented
169360,Phase 2a
162290,Phase 1/2
101737,Phase 2
89246,Discontinued in Phase 3
183101,Phase 2a
1635,Discontinued in Phase 1/2
69726,Investigative
180727,Phase 1/2a
119376,Discontinued in Preregistration
88835,Phase 1/2a
55262,Patented
95710,Investigative
174720,Phase 2
35646,Discontinued in Phase 3
133049,Discontinued in Preregistration
153029,Phase 1b/2a
51639,Discontinued in Phase 2b
83173,Phase 0
110383,Phase 1b/2a
168721,Phase 0
81951,Phase 1b/2a
39181,Investigative
123015,Phase 1b
126303,Phase 1b
44365,Phase 1/2a
13144,Phase 0
134914,Phase 0
88979,Patented
124284,Phase 1/2
182966,Phase 1b/2a
180485,Phase 1b
67774,Phase 1b/2a
78639,Phase 0
165952,Phase 1b/2a
144763,Phase 0
50496,Phase 2/3
105789,Phase 2a
84489,Phase 1b/2a
14245,Phase 1
113458,Phase 2a
26611,Phase 1
134147,Patented
178085,Patented
180921,Phase 2a
15808,Phase 1
114051,Patented
62266,Investigative
78860,Phase 2a
100642,Phase 1b
31280,Investigative
73069,Phase 0
141483,Discontinued in Phase 2b
45605,Phase 1/2a
152787,Discontinued in Phase 3
5126,Phase 1/2
139451,Discontinued in Phase 2
54181,Phase 0
105058,Phase 1/2
23968,Phase 1/2
76560,IND submitted
107986,Discontinued in Phase 2b
102727,Application submitted
190904,Phase 1/2a
152069,Phase 2
86427,IND submitted
170780,Phase 1b/2a
69716,Discontinued in Phase 2
13635,Phase 3
70278,Phase 1b/2a
15512,Phase 1
25418,Discontinued in Phase 2/3
81997,Discontinued in Phase 2/3
146202,Investigative
56842,Discontinued in Phase 2
178622,Discontinued in Phase 1/2
54955,Phase 2
127252,Discontinued in Phase 2b
24658,Phase 1b
77761,Discontinued in Phase 4
107332,Phase 1b
68625,Phase 1b
82492,Discontinued in Preregistration
80955,Phase 2
27012,Phase 1b
115401,Phase 2
10532,Phase 1b
125186,Patented
123849,Phase 0
131779,Phase 1b/2a
126493,IND submitted
31129,Phase 1/2
71698,Phase 1b/2a
58224,Phase 1b
120985,Phase 1b
122472,Patented
23062,Phase 1b
38705,Phase 1
52651,Phase 1b
65317,Discontinued in Phase 2
2352,Phase 1b/2a
48811,Phase 0
133432,Approved
100271,Registered
149865,Discontinued in Phase 2
144308,Discontinued in Phase 1/2
114503,Investigative
119801,Phase 0
140776,Phase 2a
39341,Phase 1b/2a
55802,Phase 2
186257,Phase 1b/2a
103317,Phase 1/2a
134150,Discontinued in Phase 4
80866,Phase 1b/2a
156756,Phase 1/2
128518,Patented
143443,Investigative
4064,Phase 1/2
65744,Phase 1/2
85680,Discontinued in Preregistration
84062,Patented
80913,Phase 2a
152597,Patented
151825,Phase 1b/2a
123527,Phase 0
81088,Discontinued in Phase 3
189294,Phase 4
50231,Phase 1/2
31931,Phase 1/2a
2018,Discontinued in Phase 1
96708,Phase 1b/2a
93599,Phase 2
166557,Phase 1/2
63033,Phase 1b/2a
41054,IND submitted
116982,Discontinued in Phase 2b
54162,Discontinued in Phase 4
189309,Phase 2b
13200,Phase 0
118275,Discontinued in Preregistration
147360,Discontinued in Preregistration
190324,Phase 2b
51260,Phase 0
53057,Phase 2
101433,Phase 1b/2a
91551,Phase 1b
100930,Phase 1/2
34452,Discontinued in Phase 2/3
107100,Phase 1/2a
179191,Phase 2a
131817,IND submitted
187423,Phase 2/3
38730,Phase 1
17254,Phase 1
5722,Phase 4
147215,Phase 2/3
105229,Approved (orphan drug)
183873,Phase 1/2
154657,Phase 3
181880,Phase 1/2
130658,Phase 1
137646,Phase 1/2a
154331,Phase 1b/2a
65929,Phase 2/3
38971,Phase 1b
183460,Phase 1b/2a
94262,Phase 1/2
74873,Patented
187168,Patented
93924,Phase 1
98695,Patented
8361,Phase 0
81380,Phase 1b/2a
100030,Phase 2
173194,Discontinued in Phase 2b
112192,Phase 1
31411,Investigative
143901,Phase 2
146745,Discontinued in Phase 2
11807,Phase 1/2a
191831,Discontinued in Phase 3
157560,Discontinued in Phase 4
163985,Phase 1/2
161186,Phase 1/2a
148189,Discontinued in Phase 2
165887,Patented
1230,IND submitted
2750,IND submitted
166734,Phase 2a
45995,Phase 1/2a
117127,Discontinued in Phase 2/3
173838,Clinical trial
121403,Phase 1/2a
5827,Phase 2/3
16059,Investigative
111443,Phase 1/2
125642,Phase 1b
146545,Phase 1/2a
68362,Discontinued in Phase 3
67556,Phase 0
16472,Phase 1
172484,Discontinued in Phase 2
5971,Phase 2a
25898,Discontinued in Phase 2/3
89233,Discontinued in Phase 4
69825,Patented
148668,Phase 1b/2a
106500,Discontinued in Phase 2b
106428,Patented
47817,Phase 1b
130635,Patented
95980,Phase 1b
21644,Discontinued in Phase 2
125590,Phase 1b/2a
46164,Phase 1/2a
163086,Investigative
87110,Phase 1/2
39768,Investigative
175269,Discontinued in Phase 3
171885,Phase 2
109864,Approved
116111,Phase 2a
100762,Phase 1b
123168,Phase 1
46352,Phase 1/2
58155,Discontinued in Phase 4
175184,Phase 0
165931,Phase 2
178330,Phase 2
88180,Phase 1/2
184315,Phase 0
96905,Phase 1b
125209,Discontinued in Phase 4
148376,Phase 1/2
171205,Phase 1/2a
11163,BLA submitted
138802,Clinical trial
162138,Phase 1b
106748,Phase 0
134190,Phase 1/2
50343,Discontinued in Phase 2/3
47905,Discontinued in Phase 3
100987,Phase 1b
69311,Phase 1b
135886,Preclinical
34437,Phase 1
174728,Discontinued in Phase 3
42624,Phase 1/2
78404,Discontinued in Preregistration
155814,Discontinued in Phase 4
67632,Patented
141108,Investigative
76853,Phase 1/2a
119000,Discontinued in Preregistration
138444,Phase 1b
80222,Phase 1b/2a
82166,Clinical trial
4702,Phase 2a
138551,Approved (orphan drug)
63233,Phase 1b/2a
18194,Phase 2a
40300,Phase 1/2a
191977,Patented
183888,Phase 1/2
20181,Patented
52832,Phase 1
173814,Approved
139316,Phase 1/2a
82056,Phase 1b/2a
46774,Approved
176644,Phase 1
47522,Phase 1/2a
98134,Phase 1b/2a
1323,Approved
137449,Phase 1/2
33430,Approved (orphan drug)
139438,BLA submitted
119922,Discontinued in Phase 3
9850,Discontinued in Phase 2b
190059,Clinical trial
167559,Discontinued in Phase 1
146028,Phase 1/2a
84576,Phase 0
76384,Phase 2/3
57775,Phase 1
115605,Approved (orphan drug)
30007,Phase 1b
113045,Discontinued in Phase 3
7465,Phase 2/3
6859,IND submitted
131228,Discontinued in Phase 4
131826,Discontinued in Preregistration
43387,Phase 1/2a
91029,Phase 1/2
11886,Phase 1
72282,Discontinued in Preregistration
94133,Phase 2b
75059,Phase 0
58377,Phase 1/2a
181056,Phase 2a
162580,Phase 1b
45088,Phase 2/3
74586,Discontinued in Phase 4
59374,Discontinued in Phase 3
82900,Phase 0
161473,Investigative
70353,Phase 0
75331,Phase 1
71457,Phase 1b
60260,Phase 1/2a
60580,Phase 0
9757,Discontinued in Phase 3
148029,Phase 1b/2a
116747,Discontinued in Phase 2/3
13887,Phase 1
111496,Patented
99661,Phase 1
58195,Phase 1
119913,Phase 0
83930,Phase 1
166412,Phase 1b/2a
12065,Phase 1/2a
141056,Investigative
182743,Discontinued in Phase 2b
168517,Phase 1b/2a
114115,Phase 1
6869,Phase 2a
109482,Discontinued in Preregistration
80153,Discontinued in Phase 1
189515,Phase 0
176571,Phase 1/2
150780,Phase 1/2
86706,Phase 1b
80897,Approved (orphan drug)
1493,Approved
77665,Investigative
79221,Phase 0
26223,Discontinued in Phase 4
45741,Phase 1/2a
168946,Discontinued in Phase 2
11031,Discontinued in Preregistration
13393,Phase 0
44321,Phase 2/3
879,Phase 2a
117154,Discontinued in Phase 3
15859,Phase 1
66574,IND submitted
73987,Phase 1b
157757,Phase 1
186925,Phase 0
130532,Investigative
120266,Phase 0
79828,Approved (orphan drug)
122013,Phase 2
125144,Phase 1/2
108452,Discontinued in Phase 1
185904,Phase 4
35879,Phase 2
158045,Phase 2
160847,Phase 1/2a
181708,Discontinued in Phase 2
172403,Discontinued in Phase 2
98557,Phase 1b
148190,Phase 2/3
74950,Phase 2a
113545,Phase 0
59598,Discontinued in Phase 3
15615,Phase 1
93533,Phase 1b
98751,Investigative
59052,Approved (orphan drug)
44200,Phase 2/3
6376,Phase 2/3
94883,Discontinued in Phase 4
127998,Phase 1/2
165293,Phase 1/2
42754,Investigative
156423,Discontinued in Preregistration
71110,Discontinued in Phase 1/2
46015,Phase 2/3
83936,Phase 1/2
108300,Phase 0
1575,Discontinued in Phase 2/3
118074,BLA submitted
22141,Patented
47304,Phase 0
29774,IND submitted
159900,Phase 2b
165534,Discontinued in Phase 1/2
149213,Phase 2b
144896,Phase 1b
95005,Phase 1
57524,Phase 1b
181648,Discontinued in Phase 4
94430,Discontinued in Phase 3
159148,Phase 1b/2a
123911,Phase 1
38928,Phase 2/3
72118,Discontinued in Phase 1
148187,Discontinued in Phase 2
91422,Clinical trial
90916,Discontinued in Preregistration
151462,Discontinued in Phase 2/3
1300,Discontinued in Phase 2
52392,Phase 1
11150,Discontinued in Phase 3
105984,Phase 1/2
50522,Patented
94464,Discontinued in Phase 1
115717,Phase 1/2a
143980,Phase 0
58258,Phase 0
117534,Discontinued in Phase 3
178319,Phase 2/3
166763,Phase 1b
28488,Discontinued in Preregistration
116050,Phase 1/2a
180564,Phase 3
144705,Phase 0
179027,Phase 0
185967,Clinical trial
171883,Phase 1/2
185824,Patented
90829,Phase 1b
37594,Discontinued in Preregistration
43577,Phase 2/3
31712,Discontinued in Preregistration
119159,Discontinued in Phase 4
30981,Patented
109653,Phase 2
98210,Phase 1b
79275,Phase 1b
17289,Phase 1/2
148191,Investigative
178143,Phase 2/3
28575,Phase 1/2a
138578,BLA submitted
101772,Phase 1b
50659,Phase 1
36929,Phase 1
154193,Discontinued in Phase 2b
146408,Phase 1b/2a
17100,Phase 1/2a
112278,Discontinued in Phase 3
136310,Discontinued in Phase 3
192066,Discontinued in Phase 2
173912,Phase 1
93813,Phase 1b/2a
47225,Discontinued in Phase 2b
157842,Discontinued in Phase 1/2
79873,Discontinued in Phase 1
20150,Clinical trial
95411,Phase 2
167116,Discontinued in Phase 1/2
161720,Investigative
73456,Phase 2
122896,Phase 1/2
146437,IND submitted
116231,Phase 1/2a
162910,Phase 1/2
55639,Phase 1/2a
85131,Phase 0
139599,Phase 1b
19875,Phase 0
25414,Phase 1/2
155600,Approved
78438,Phase 1
175687,Discontinued in Phase 2
81070,Phase 1
145007,Discontinued in Phase 1
806,Discontinued in Phase 3
123645,Phase 1/2
112920,Discontinued in Phase 3
25943,Investigative
143948,Phase 0
95796,Phase 2
141100,Discontinued in Phase 2b
67558,Phase 1/2
148165,Phase 2b
185512,Phase 1b
134596,Phase 1/2
176984,Phase 1b
11241,Clinical trial
182333,Phase 1
191186,Phase 1/2a
127876,Phase 1b/2a
109357,Discontinued in Preregistration
28167,Discontinued in Phase 2/3
88341,Phase 1
38401,Discontinued in Preregistration
50750,IND submitted
55746,Patented
188970,Phase 2b
96538,Phase 1b/2a
185484,Phase 4
133168,Discontinued in Phase 3
125436,BLA submitted
147926,Phase 2b
96589,Discontinued in Phase 1/2
191209,Phase 1/2a
33804,Phase 1b
108183,Discontinued in Phase 2
98637,Phase 1/2
185757,Clinical trial
141874,Discontinued in Preregistration
188886,Discontinued in Phase 3
159924,Phase 2b
43107,Investigative
159514,Phase 1b
104868,Discontinued in Phase 3
152272,Phase 2
32786,Phase 1b/2a
128934,Phase 1/2
135080,Phase 0
173179,Discontinued in Phase 3
100847,Phase 1/2a
24534,Phase 1
156642,Preregistration
114629,Phase 2
2896,Phase 2a
168780,Patented
141619,Patented
17978,Phase 2a
154593,Phase 3
82940,Investigative
6079,Phase 2/3
122828,Phase 1/2
41036,Discontinued in Phase 4
32759,Phase 1b/2a
110359,Phase 1b/2a
53956,Phase 1/2
131809,IND submitted
141678,Discontinued in Preregistration
121681,Approved (orphan drug)
116529,Discontinued in Phase 1/2
119521,Phase 0
148702,Phase 1
6781,Phase 2a
108457,BLA submitted
129943,Discontinued in Preregistration
84469,Phase 1b/2a
42430,Phase 0
127133,Patented
120449,Phase 4
10391,Phase 1
124232,Approved
154095,Patented
21222,Investigative
80958,BLA submitted
8529,Phase 1/2a
117010,Phase 1/2
190714,Phase 2b
82764,Discontinued in Preregistration
58453,Phase 0
975,Discontinued in Phase 1/2
16921,Investigative
34099,Patented
94981,Phase 1
144031,Investigative
118911,Phase 1
136669,Discontinued in Phase 3
33702,Phase 2/3
50129,Phase 1b
2219,Approved
12631,Phase 1/2
115511,Phase 1/2
64381,Clinical trial
42180,Phase 1b/2a
34721,Phase 1/2
77176,Phase 0
132988,Phase 2
129849,Phase 0
73201,Patented
78668,Discontinued in Phase 4
3980,IND submitted
32150,Phase 1b/2a
149454,Phase 1b
192083,Discontinued in Phase 2/3
104290,Phase 1/2a
1744,Patented
85182,Phase 1
71656,Phase 0
94491,Discontinued in Phase 1
153131,Phase 1
77159,Phase 1/2
135970,Preclinical
65285,Discontinued in Phase 2/3
177699,Phase 2a
53603,Phase 1b
75863,Phase 1/2a
121851,Phase 1/2
118356,Phase 1b/2a
26498,Phase 1/2a
48381,Discontinued in Phase 3
79450,Discontinued in Phase 1/2
190262,Phase 1/2
120676,IND submitted
86963,Discontinued in Phase 1/2
66584,Phase 2b
185843,Phase 4
6629,Phase 1/2
183933,Discontinued in Phase 4
139641,BLA submitted
133277,Discontinued in Phase 1
120720,Clinical trial
71650,Discontinued in Phase 1
96252,Phase 1b/2a
145810,Discontinued in Phase 2
90074,Discontinued in Phase 2/3
38920,Discontinued in Preregistration
127260,Phase 1
88840,Patented
63612,Phase 2/3
94583,Discontinued in Phase 4
79249,Phase 0
186081,Phase 4
190395,IND submitted
128180,Discontinued in Phase 3
16454,Phase 0
80376,Discontinued in Phase 3
167353,Discontinued in Phase 1
122253,Investigative
8159,Phase 1b
61810,Phase 1b
132590,Phase 1b/2a
181107,Discontinued in Phase 2
149714,Phase 2b
6641,Discontinued in Phase 2
111077,Phase 0
60247,Phase 2/3
169649,Phase 2
86700,Phase 1b
122634,Phase 1/2
110258,Phase 1b/2a
157099,Discontinued in Phase 4
181367,Phase 1/2a
138128,Phase 1/2a
68967,Phase 1b
19230,Discontinued in Phase 2b
52398,IND submitted
127373,Discontinued in Phase 4
153063,Discontinued in Phase 2/3
171644,Discontinued in Phase 2
151793,Phase 2
38270,Phase 2
45379,Phase 1/2a
126903,Discontinued in Phase 1
29170,Discontinued in Phase 2/3
108547,Patented
2945,Phase 1/2
120544,Clinical trial
157520,Phase 1b/2a
45039,Phase 2/3
166853,Phase 1/2
81504,Approved
67998,Phase 1
27454,Phase 2
86929,Phase 1/2a
61364,Phase 1
58798,Investigative
164110,Discontinued in Preregistration
58873,Phase 0
87289,BLA submitted
142914,Phase 1b/2a
31040,Investigative
163826,Phase 1/2a
65075,Phase 1b
183796,Discontinued in Preregistration
7120,IND submitted
180874,Phase 2a
170343,Discontinued in Phase 1
89235,Phase 2/3
55435,Phase 1/2a
96886,Phase 1b
124515,Phase 1/2
318,Discontinued in Phase 1
33275,Discontinued in Phase 2
89355,Phase 2/3
74563,Discontinued in Phase 2b
134965,Phase 0
98673,Phase 1/2a
136273,Phase 1/2
34704,Patented
160775,Phase 1/2a
166655,Discontinued in Phase 2b
175749,Phase 3
106447,Phase 2a
137776,Investigative
6339,Phase 1b/2a
79960,Phase 2a
44658,Phase 2/3
117995,Phase 1/2a
159166,Clinical trial
45362,Phase 2/3
56043,Phase 2
13102,Phase 0
186002,Patented
156378,Phase 1/2a
151593,Phase 2
152228,Phase 1b/2a
148324,Investigative
13748,Phase 1/2a
116655,Discontinued in Phase 2b
131909,Patented
145013,Phase 1b
131600,Patented
22532,Discontinued in Phase 2/3
142775,Phase 1b/2a
107870,Discontinued in Phase 3
142420,Discontinued in Phase 2b
129417,Phase 0
25199,Phase 0
153442,Phase 1
88059,Discontinued in Phase 1/2
1358,Discontinued in Phase 2
175589,Phase 0
45056,Phase 2/3
6459,Investigative
166202,Phase 1b/2a
183428,BLA submitted
88626,Patented
67273,Discontinued in Phase 2/3
96834,Phase 0
128746,IND submitted
57964,Phase 1/2a
135887,IND submitted
57969,Investigative
176756,Phase 1b
150476,Discontinued in Phase 2/3
173866,Phase 1
110242,Investigative
144650,Phase 0
13319,Discontinued in Phase 1
45238,Phase 1/2a
45406,Phase 1/2a
128463,Phase 1/2
1144,Discontinued in Phase 1
109802,Phase 1
94346,Phase 2a
30708,Discontinued in Phase 2b
142290,Phase 0
67618,Patented
170411,Phase 2/3
170817,Phase 1
92000,Discontinued in Phase 2
35319,Discontinued in Phase 1/2
116273,Phase 1/2a
8078,Patented
186675,Phase 2b
185671,Phase 1
29126,Investigative
11924,Phase 2
92617,Investigative
177481,Phase 1b/2a
171865,Discontinued in Phase 2b
45397,Phase 1/2a
63659,Clinical trial
125884,Phase 1/2
71539,Phase 0
84510,Phase 0
4170,Phase 1b/2a
8777,Discontinued in Phase 2
85488,Discontinued in Preregistration
31212,Phase 1
13879,Phase 1/2
172050,Phase 1/2
72336,Phase 1b
172252,Discontinued in Phase 2b
110212,Phase 1/2a
25515,Phase 1/2a
63881,Approved (orphan drug)
56838,Phase 0
82099,Discontinued in Phase 1
166629,Phase 1/2
66606,IND submitted
61843,Discontinued in Phase 2b
175718,Discontinued in Phase 2
31923,Phase 1/2
49996,Phase 1b
33853,Phase 1b
59676,Clinical trial
37089,Phase 2
142934,Investigative
96622,Phase 1b/2a
147356,Discontinued in Phase 2/3
6813,Investigative
20996,Phase 1/2a
119570,Discontinued in Preregistration
139864,Phase 1/2
45884,Phase 1/2a
172563,Discontinued in Phase 2b
139278,Investigative
153076,Patented
154800,Phase 3
124750,Patented
64297,Clinical trial
126290,Phase 1b/2a
57457,Discontinued in Phase 1/2
80441,Clinical trial
148755,Phase 1b
30923,Phase 2
123190,Phase 1
156755,Patented
32003,Phase 1b/2a
172522,Discontinued in Phase 2b
61504,Phase 1/2
56962,Patented
115525,Phase 1/2a
1163,Phase 1/2
127095,Phase 1/2
75972,Patented
33962,Phase 1b/2a
170849,Discontinued in Preregistration
158192,Phase 1/2
16069,Phase 1
25138,Discontinued in Preregistration
94522,Phase 1/2
76960,Patented
92592,Phase 2
46356,Investigative
117583,Discontinued in Phase 1
77845,Discontinued in Phase 4
136243,Phase 1/2a
187698,Phase 0
145094,Discontinued in Phase 2/3
48180,Discontinued in Phase 4
104609,Patented
122519,Patented
106354,Phase 0
53596,Phase 1b
65152,Phase 0
103689,Discontinued in Phase 1/2
46003,Phase 1/2a
88545,Phase 1
77616,Phase 0
63563,Phase 2a
73675,Phase 1b
95161,Phase 1
42417,Phase 1/2a
100092,Discontinued in Phase 3
46659,IND submitted
135223,Phase 0
118412,Phase 2
14428,Investigative
28833,Investigative
62532,Phase 1b
69109,Phase 1b
68108,Discontinued in Phase 2
177485,Phase 1b
63384,Discontinued in Phase 4
150454,IND submitted
82062,Clinical trial
185789,Patented
81739,Phase 2
61734,Discontinued in Phase 2b
22719,Phase 2
55957,Phase 1b/2a
24596,Phase 1/2
11342,IND submitted
133918,Phase 1/2a
104396,Phase 1/2
77076,IND submitted
132708,Phase 2
25262,Phase 1/2
70176,Phase 0
77070,Phase 1/2a
179769,Phase 1
4747,Phase 2/3
96522,Phase 1
163507,Phase 1/2a
79112,Phase 0
10817,Discontinued in Phase 2/3
41653,Phase 2a
58838,Investigative
85828,Discontinued in Phase 2b
117869,Phase 1/2a
191769,IND submitted
185367,Discontinued in Phase 3
115616,Phase 1/2
151933,Phase 1
2051,Approved
6164,Discontinued in Phase 2
133862,Phase 1/2a
41170,Phase 1/2a
164392,Phase 1/2
7342,Phase 4
104083,Investigative
101636,Phase 1/2
44835,Phase 1/2a
191074,Phase 2a
75798,Phase 0
173345,Discontinued in Phase 2b
76040,IND submitted
74462,Phase 1/2a
117573,Phase 1
16818,Phase 1
8290,Phase 2
94435,Discontinued in Phase 3
94642,Phase 1/2a
128061,IND submitted
123642,Phase 1b
92898,Phase 2
78051,Investigative
9284,Discontinued in Phase 2
191305,IND submitted
37694,Phase 1b
102653,Investigative
142774,Phase 2a
97125,Phase 1/2
145261,Phase 1/2
26516,Phase 1/2a
159284,Phase 1b/2a
78627,Phase 0
91133,Phase 1b
69541,Phase 1b
157039,Phase 1/2a
157421,Phase 2
144981,Discontinued in Preregistration
73143,Discontinued in Preregistration
67929,Discontinued in Phase 1
111539,Phase 1/2
20744,Phase 2
132486,Discontinued in Phase 4
190296,Phase 2b
106835,Phase 0
29177,Phase 4
191642,Phase 0
95952,Investigative
169636,Discontinued in Phase 2/3
145667,Phase 1b/2a
83115,Phase 0
157074,Clinical trial
108403,Phase 1/2a
149258,Discontinued in Phase 1
79305,Discontinued in Phase 1
22443,Phase 1/2a
121404,Phase 1/2a
159864,Phase 2b
133904,Phase 1/2a
173165,Investigative
58123,Discontinued in Phase 2/3
50800,Phase 3
124221,Patented
30830,Investigative
187654,Patented
94551,Patented
7204,Phase 2/3
20603,Phase 1b
38430,Phase 0
20186,Clinical trial
42920,Discontinued in Phase 4
187630,Phase 0
144600,Discontinued in Phase 2/3
134923,Phase 0
187021,Phase 1
134545,Phase 1
48153,Phase 1b/2a
22506,Phase 1b/2a
40021,Phase 1b
22424,Phase 0
73931,Discontinued in Phase 4
38,Discontinued in Phase 2/3
121135,Phase 1b
144155,Phase 0
105074,Phase 1/2
10886,Phase 0
151314,Phase 2
50398,Phase 1b/2a
12774,Phase 0
136618,Discontinued in Phase 2b
19366,Phase 2/3
136188,Phase 3
84631,Phase 0
189220,Approved (orphan drug)
168715,Phase 2
111251,Phase 1/2
73108,Patented
52846,Phase 1b/2a
23180,Phase 2/3
43932,Phase 1/2a
96103,Phase 1/2a
44151,Phase 2/3
9386,Patented
152532,Approved
187571,Patented
66729,Phase 2a
134906,Phase 0
155832,Phase 1/2
95804,Phase 1b
106199,Phase 1
145997,Phase 1/2
85416,Discontinued in Preregistration
73209,Discontinued in Preregistration
191675,IND submitted
134875,Phase 0
162221,Investigative
188899,Phase 2/3
48226,Phase 1b
166054,Phase 1
2353,Phase 1
7283,Phase 2/3
141829,Discontinued in Preregistration
161029,Discontinued in Preregistration
135005,Phase 0
126126,Investigative
46589,Discontinued in Phase 2b
14783,Phase 2b
60250,Discontinued in Phase 3
16331,Phase 1/2a
76527,Phase 1b
69375,Phase 2a
42887,Phase 1b
108903,Discontinued in Phase 2
44358,Phase 1/2a
138478,Phase 1/2a
16227,Phase 3
153294,Phase 1
97964,Phase 1b/2a
126384,Phase 1
39628,Phase 2/3
127431,Investigative
3458,Phase 0
152074,Phase 2
178141,Phase 2
6752,Phase 2a
140580,Registered
95117,Patented
41652,Phase 1b
89873,Patented
43166,Phase 1b
102807,Discontinued in Preregistration
186368,Phase 1/2a
191937,Phase 2/3
83079,Phase 2
167227,Discontinued in Phase 2
56302,Phase 0
136132,Phase 3
33113,Discontinued in Preregistration
91883,Discontinued in Phase 1
78010,Approved
127289,Discontinued in Phase 2b
47207,Phase 1/2
133422,Phase 1/2
4579,Preregistration
73942,Discontinued in Preregistration
37206,Phase 1
88030,Patented
166752,Phase 2
60032,Approved (orphan drug)
46191,Phase 2/3
22235,Phase 2
142961,Phase 1/2a
52152,Phase 1/2
87261,Phase 1/2
32923,Phase 1/2a
21422,Phase 2a
37948,Phase 1/2a
43192,IND submitted
117877,Phase 1b/2a
26263,Phase 1/2
153323,Phase 1/2
181027,Phase 1/2a
156061,Phase 1/2
97856,Phase 1b/2a
89337,Discontinued in Phase 4
102213,Phase 1
66643,Discontinued in Phase 2
127563,Phase 1/2
1332,Discontinued in Phase 2
55791,Phase 1/2a
174320,Phase 0
28182,Phase 2
42799,Discontinued in Phase 1
109585,Phase 3
44185,Phase 2/3
29727,Phase 1b/2a
70110,Investigative
57538,Investigative
94390,Phase 1/2a
55812,Phase 1/2
73423,Phase 1b
16083,Phase 1
42970,Phase 0
168524,Phase 2
18328,Preregistration
55490,Discontinued in Preregistration
78320,Approved (orphan drug)
47844,Phase 2/3
177147,Phase 1/2
182862,Phase 1/2a
86102,Phase 1b
17318,Phase 0
15102,Phase 1/2
124422,Phase 1
138533,Phase 1b
40313,Phase 0
8798,Discontinued in Phase 2
35805,Discontinued in Phase 2b
87785,Discontinued in Phase 3
174363,Discontinued in Phase 1/2
177526,Phase 1b
117176,Discontinued in Preregistration
92781,Phase 2b
103958,Discontinued in Phase 4
3914,IND submitted
157586,Discontinued in Phase 4
37649,Phase 1
11524,Phase 1b
163267,Investigative
24598,Phase 1/2
75597,Phase 0
99246,Patented
113131,Discontinued in Phase 3
162340,Discontinued in Phase 2b
106787,Phase 1/2a
103099,IND submitted
150893,Phase 1
157745,Phase 1
3331,Phase 0
124722,Phase 1/2
70991,Discontinued in Phase 3
11232,Patented
77795,Investigative
156413,Phase 1/2
35969,Phase 2/3
169192,Discontinued in Phase 1/2
117916,Phase 1b/2a
8184,Patented
62171,Phase 2/3
121482,Patented
13914,Phase 1
1027,Clinical trial
22564,Phase 1/2a
96893,Investigative
170901,Phase 1
42034,Investigative
42220,Phase 1
146631,Investigative
161060,Phase 1
171802,Phase 2a
107597,Phase 1b/2a
63284,Discontinued in Phase 4
41499,Phase 0
178857,Phase 1/2a
184904,Discontinued in Phase 4
11520,Phase 2a
174718,Discontinued in Phase 1/2
4325,Phase 1/2
138926,Investigative
30916,Investigative
30655,Clinical trial
61203,Patented
127107,Investigative
13162,Phase 1/2
178188,Phase 2b
68005,Approved (orphan drug)
79902,Discontinued in Phase 3
108244,Phase 0
125019,Phase 1/2
141890,Discontinued in Phase 2b
3806,Approved (orphan drug)
11878,Discontinued in Phase 2/3
77673,Investigative
112051,Discontinued in Phase 2
147041,Phase 1b
17779,Phase 1
36533,Phase 1b/2a
42091,Investigative
167963,Patented
105470,Phase 3
106810,IND submitted
135832,Phase 1/2
148239,Phase 1b/2a
71529,Phase 1b
165192,Phase 1/2
73446,Approved
132172,Phase 1/2
111158,Phase 1b
115241,Phase 1b
120517,Discontinued in Phase 4
1034,Discontinued in Phase 1
35567,Phase 1/2
61021,Investigative
104853,Discontinued in Preregistration
49727,Phase 1b
56618,Phase 2
62632,Phase 1b/2a
92618,Patented
91,Approved (orphan drug)
176133,Discontinued in Phase 3
162117,Phase 0
62234,Phase 2
94383,Discontinued in Phase 2b
50330,Phase 1b/2a
173262,Discontinued in Phase 3
100959,Phase 2
174225,Discontinued in Preregistration
135190,Phase 0
39573,Phase 2
28709,Phase 1b/2a
59122,Discontinued in Phase 3
183344,Phase 2a
84118,Phase 0
45906,Phase 2a
49296,Phase 1
99909,Phase 1b
70927,Investigative
32832,Phase 0
11966,Patented
159586,Discontinued in Preregistration
180999,Phase 1b/2a
191867,Discontinued in Phase 3
154624,Phase 3
35545,Discontinued in Phase 2b
54278,Phase 1b
91968,Phase 1/2a
23712,Phase 1/2
4011,Phase 1/2
139522,Phase 1b
84803,Phase 1/2
64567,Phase 1b/2a
118034,Registered
99509,Phase 1
110670,Phase 0
121779,Phase 1b/2a
106313,Phase 1/2a
189959,Phase 2b
117319,Discontinued in Phase 3
146956,Phase 2b
14414,Phase 1
71928,Discontinued in Preregistration
186797,Phase 1b/2a
79734,Discontinued in Phase 4
140718,Phase 1b/2a
38567,Discontinued in Phase 2
189575,Phase 2/3
386,Phase 2b
159837,Discontinued in Phase 1/2
153774,Phase 1b
136173,Phase 1/2
173265,Phase 1/2
102027,Application submitted
92914,Phase 1/2
40056,Investigative
127191,Discontinued in Phase 1
25175,Discontinued in Preregistration
123358,Phase 1/2
122218,Phase 1b
165827,Patented
59993,Phase 0
115033,Phase 1/2
130888,Investigative
24168,Phase 2
78197,Phase 1/2
120483,Discontinued in Phase 1/2
167327,Phase 4
91038,Phase 1b/2a
78193,Investigative
80501,Discontinued in Phase 2
95389,Patented
54348,Phase 1b
32001,Phase 2b
148493,Phase 1/2
142460,Phase 1
103589,Discontinued in Phase 1/2
52974,Discontinued in Preregistration
84858,Phase 1/2
24013,Phase 1b/2a
70742,Phase 1/2
112161,Phase 0
148076,Phase 2b
97528,Discontinued in Phase 2b
79245,Phase 2a
152833,Patented
53604,Discontinued in Phase 3
83496,Discontinued in Phase 4
24146,Phase 1/2a
182723,Phase 2a
22675,Phase 1/2a
63087,Phase 0
119903,Approved (orphan drug)
23615,Phase 2a
10613,Investigative
187619,Patented
150432,Phase 1b
163734,Phase 1/2
22363,IND submitted
119363,IND submitted
47838,Discontinued in Phase 3
95292,Phase 1/2a
179591,Phase 1b
153169,Phase 2
65192,Phase 1b/2a
122829,Phase 0
122562,Phase 0
158260,Phase 1/2
164947,Phase 1
32171,Phase 1b/2a
695,Phase 2
162543,IND submitted
159093,Approved
163692,Phase 2b
40000,Phase 1/2a
42128,Phase 2a
74551,Patented
8695,Clinical trial
30541,Investigative
23290,Phase 2/3
125314,Phase 1/2a
189747,Clinical trial
156492,Phase 1
81386,Phase 1b/2a
32583,Phase 1/2
38566,Phase 1b/2a
80270,Phase 2a
46913,Phase 1/2
185489,Patented
184360,Phase 0
76478,IND submitted
113552,Discontinued in Phase 3
117374,Discontinued in Phase 3
77796,Phase 1b
117616,Discontinued in Preregistration
175421,Discontinued in Phase 2
144424,Discontinued in Phase 1/2
52567,Discontinued in Preregistration
188343,Clinical trial
88149,Discontinued in Phase 2
118143,Discontinued in Phase 2/3
43099,Phase 0
163335,Phase 1
41404,Discontinued in Preregistration
53895,Investigative
184402,Discontinued in Phase 4
176000,Discontinued in Phase 2/3
187339,Preclinical
58781,Investigative
62488,Phase 0
43634,Phase 2/3
43134,Phase 1b
129002,Phase 1/2
182818,Phase 1/2a
125260,Discontinued in Phase 4
94315,Phase 2b
131589,Discontinued in Phase 4
27887,Phase 1b
131618,Discontinued in Phase 4
57835,Phase 1
56104,Phase 3
171926,Phase 2
104293,Phase 0
61551,IND submitted
129924,Patented
112090,Phase 0
49922,Phase 1b/2a
148067,Phase 1b/2a
178005,IND submitted
151383,Discontinued in Phase 2/3
182394,Discontinued in Phase 2b
17325,Phase 0
25347,Phase 0
150162,Phase 1/2a
74827,Patented
121664,Approved
2428,Phase 0
160330,Phase 1
183032,Phase 1
155510,Approved
126545,Discontinued in Phase 4
16710,Phase 0
126178,IND submitted
28884,Discontinued in Phase 2/3
141529,Phase 0
149340,Phase 1b
15278,Phase 1
126615,Discontinued in Phase 1
90023,Approved (orphan drug)
16015,Phase 1
3552,Investigative
62734,Discontinued in Phase 4
57149,Discontinued in Phase 1/2
143304,Phase 1b/2a
133977,Phase 1b
170059,Phase 1b/2a
115188,Phase 2/3
129298,Phase 1
178112,Phase 1/2
147943,Phase 0
92514,Phase 1/2
78780,Phase 1b
82691,Phase 1b/2a
181160,Phase 2
42423,IND submitted
142263,Discontinued in Preregistration
99557,Patented
19103,Phase 1/2
141942,Discontinued in Preregistration
186987,Clinical trial
91783,Phase 1b
164453,Phase 1/2
29512,Phase 1b/2a
34517,Phase 0
92279,Phase 1
48159,Phase 1/2a
60198,Investigative
13295,Phase 0
118424,BLA submitted
87596,Approved
103259,Application submitted
69492,Investigative
189212,Phase 1b
187300,Phase 0
68161,Preregistration
75246,Phase 2
64789,Approved
173807,Phase 1b
174776,Phase 0
123728,Discontinued in Phase 4
108947,Phase 3
84770,Phase 0
119449,Phase 2
110148,Phase 1/2
20449,Phase 1b/2a
31719,Discontinued in Phase 2b
178462,Discontinued in Phase 1
120716,Discontinued in Phase 1/2
72895,Phase 2/3
99106,Phase 1/2a
67183,Phase 2a
42616,Phase 1/2
76644,Phase 2/3
179253,Phase 1b
21702,Discontinued in Phase 2
71372,Phase 1/2
71654,Phase 1/2
130148,Phase 2b
7918,Phase 1
97979,Phase 1
40867,IND submitted
118443,Phase 1b/2a
134019,Phase 1b
54103,Phase 0
45335,Phase 2/3
72675,Phase 2
122063,Phase 1b
112900,Phase 1
74911,Patented
19279,Investigative
54867,Phase 1/2a
16420,Phase 3
163090,Discontinued in Phase 4
146229,Discontinued in Preregistration
169546,Phase 1
136419,Patented
141673,Phase 0
32009,Phase 1b/2a
189981,Clinical trial
85209,IND submitted
40831,Phase 1/2a
107488,Discontinued in Phase 1/2
60468,Phase 0
190690,Clinical trial
15348,Phase 0
17168,Phase 0
67133,Patented
38926,Discontinued in Preregistration
172887,Phase 1/2
136534,Discontinued in Phase 2b
137724,Phase 2
144176,IND submitted
191499,Phase 1
92757,Phase 2b
121159,Phase 2/3
124496,Approved
9429,Discontinued in Phase 1
8892,Phase 1/2
188615,Phase 1/2
80843,Phase 2
45498,Phase 2/3
151089,Phase 1
65979,Phase 1b/2a
147308,Discontinued in Phase 1
100660,Phase 1
183657,Discontinued in Phase 2
17883,Investigative
134373,Phase 1/2a
65212,Phase 1b/2a
78883,Phase 2a
172341,Phase 1/2
122706,Phase 1
38191,Phase 1b
128835,Investigative
74520,Phase 1/2a
163570,Discontinued in Phase 2
98592,Discontinued in Phase 2b
83969,Phase 1/2a
68994,Phase 1
176398,Phase 1/2a
149802,Phase 2b
30633,Discontinued in Preregistration
10609,Discontinued in Phase 2/3
43690,Phase 2/3
115601,Phase 1/2a
163245,Discontinued in Preregistration
4017,Patented
126732,Discontinued in Phase 3
32458,Phase 2/3
68644,Discontinued in Phase 4
145858,Phase 1b/2a
69016,Phase 3
81262,Discontinued in Phase 3
116492,Investigative
70876,Phase 1/2
110607,Patented
97488,Phase 2
147458,Phase 2b
23474,Phase 1b
43386,Phase 2/3
154745,Phase 3
168175,Approved (orphan drug)
159484,Patented
178321,Phase 2/3
162083,Investigative
169217,Patented
154561,Phase 3
15154,Phase 0
175092,Discontinued in Phase 1/2
130835,Phase 0
8118,Discontinued in Phase 4
125257,BLA submitted
160602,Phase 3
55943,Phase 1/2
20899,Registered
180163,Phase 3
53392,Phase 1b
66987,Patented
103710,Phase 1/2a
188494,Phase 1/2
140152,Phase 1/2a
16446,Phase 1/2
151760,Phase 2
129903,Phase 1/2
137556,Phase 2
40813,Phase 1b
143106,Phase 1b/2a
136739,Phase 1/2a
52188,Phase 1
99306,Phase 0
113189,Discontinued in Phase 1/2
129665,Discontinued in Phase 2b
17512,Phase 0
108013,Discontinued in Phase 2b
73878,Approved
152244,Phase 0
114393,Discontinued in Preregistration
182068,Phase 1/2a
67309,Discontinued in Phase 1
39070,Discontinued in Preregistration
53461,Phase 1b
163169,Phase 2
117997,Phase 2a
32730,Phase 1/2
189020,IND submitted
99979,Phase 1
140547,Phase 0
2736,Phase 2
43910,Phase 1/2a
76324,Discontinued in Phase 1/2
136131,Phase 1/2
90312,Clinical trial
22786,Phase 1/2a
149190,Phase 2/3
170834,Phase 0
145780,Phase 2
54346,Phase 1b
14745,Phase 1
97351,Investigative
49526,IND submitted
85390,Discontinued in Phase 3
65712,Phase 1b/2a
43921,Phase 2/3
38559,Phase 1
43579,Phase 1/2a
140534,BLA submitted
103883,Investigative
47864,Phase 1/2a
146711,Phase 2b
65254,Phase 2
43128,Discontinued in Phase 4
141297,Phase 1b
40701,Discontinued in Preregistration
117504,Discontinued in Phase 1
79893,Phase 1
101390,Discontinued in Phase 2b
91678,Patented
14790,Phase 1
111304,Patented
6280,Phase 4
65145,Discontinued in Phase 2
129585,Phase 1/2
70083,Phase 1/2a
80936,Discontinued in Phase 3
125948,Discontinued in Phase 4
24324,Discontinued in Preregistration
176711,Phase 1b
121881,Patented
157800,Approved (orphan drug)
112297,Phase 1/2
161117,Discontinued in Phase 1/2
179481,Phase 1/2a
110504,Discontinued in Phase 2/3
43301,Preregistration
84446,Phase 0
10632,Investigative
170806,Phase 1/2a
21304,Phase 1
149660,Patented
161010,Phase 1b
156240,Phase 1/2a
126209,Discontinued in Phase 4
113991,Phase 2
8530,Phase 0
35374,Discontinued in Phase 4
29327,Phase 1b
145580,Phase 2b
20268,IND submitted
50221,IND submitted
56498,Phase 0
66959,Phase 0
111421,Phase 1/2a
40554,Phase 2
70848,Phase 1/2
26553,BLA submitted
124751,Discontinued in Phase 4
131230,Discontinued in Preregistration
119261,Discontinued in Preregistration
116870,Phase 1/2
171984,Discontinued in Phase 2/3
15506,Phase 1
182070,Phase 1b/2a
112375,Discontinued in Phase 2
44154,Phase 2/3
164851,BLA submitted
143036,Phase 2/3
56515,Phase 1b/2a
46068,Phase 1/2a
19877,Phase 2a
91139,Discontinued in Phase 1
23476,Phase 2/3
101868,Phase 1b
53774,Phase 0
97227,Phase 1/2
6768,Investigative
60702,Patented
175728,Discontinued in Phase 3
79057,Phase 0
48537,Phase 1
46673,Approved
57233,Discontinued in Phase 1/2
81437,Clinical trial
38789,Phase 0
85150,Phase 0
136341,Discontinued in Phase 2
80855,Investigative
82330,Phase 0
115934,Phase 1b
132380,Discontinued in Phase 2b
6307,Phase 4
100448,Phase 1b
78251,Phase 1/2
122663,Phase 1/2
87332,Phase 1b/2a
179700,Phase 1/2a
44684,Phase 1/2a
133943,Phase 1
88380,Phase 0
91745,Phase 1b
32999,Patented
125009,Phase 1/2
163655,Discontinued in Phase 2
48681,Phase 1b/2a
102052,Investigative
34831,Phase 2/3
61611,Phase 1b
180293,Discontinued in Phase 2b
94819,Phase 1b/2a
191042,Phase 1/2a
151741,Discontinued in Phase 2/3
26656,Phase 1b
73730,Approved (orphan drug)
175524,Discontinued in Phase 1/2
34115,Phase 1
45044,Phase 1/2a
167882,Phase 1
79001,Phase 0
164130,Phase 1
67963,Phase 0
172703,Investigative
11723,Phase 1/2a
189127,Phase 2b
35011,Discontinued in Phase 2
44502,Phase 1/2a
132867,Discontinued in Phase 2/3
183462,Discontinued in Phase 2
178552,Phase 1b
189158,Phase 2/3
103638,Phase 1/2
59766,Discontinued in Phase 3
21710,Discontinued in Phase 2
180784,Phase 1
6299,Discontinued in Phase 2
42375,Phase 2a
26451,BLA submitted
50437,Discontinued in Preregistration
166567,Phase 1/2
123597,Phase 1
124327,Phase 0
153025,Phase 1
80205,Phase 2a
150029,Phase 1
84071,Investigative
172680,Phase 1/2
139262,BLA submitted
2823,Phase 1b
116901,Investigative
148313,Phase 1
5320,IND submitted
188384,Phase 4
57261,Discontinued in Phase 1/2
55625,Discontinued in Phase 2/3
17108,Phase 1/2a
114272,Discontinued in Phase 3
93156,Discontinued in Phase 3
23185,Discontinued in Phase 2b
104821,Phase 1/2a
71182,Discontinued in Phase 1/2
5587,Preregistration
174062,Phase 1/2
29530,Phase 1
55740,Discontinued in Preregistration
21792,Discontinued in Phase 3
71783,Patented
161790,Phase 1/2
117313,Phase 1
13591,Phase 1/2
73686,Approved
93320,Discontinued in Phase 1
166795,Phase 0
16643,Phase 1
51187,Phase 1/2a
61947,Investigative
189898,Phase 1/2
75837,Phase 1/2a
60642,Discontinued in Phase 3
165340,Phase 1
124730,Patented
148214,Discontinued in Phase 2/3
152974,Phase 0
89305,Discontinued in Phase 3
28561,Discontinued in Preregistration
131137,Phase 1
105174,Phase 1b
51647,Discontinued in Phase 2b
109436,Discontinued in Phase 2/3
82659,Phase 1/2
144760,Investigative
189321,Preclinical
158630,Phase 2/3
101570,Phase 1/2a
48749,Phase 1b/2a
63385,Discontinued in Preregistration
28307,Phase 2a
86350,IND submitted
78016,IND submitted
132277,IND submitted
101206,Investigative
52232,Phase 2/3
131798,Discontinued in Preregistration
85860,Discontinued in Preregistration
534,Phase 1
164474,Investigative
16684,Phase 1b/2a
29485,Phase 1b
86390,Investigative
149059,Phase 1b/2a
158145,Investigative
178417,Patented
131552,Discontinued in Phase 1/2
129857,Discontinued in Phase 4
55790,Phase 1b
184311,BLA submitted
169183,Approved
107975,IND submitted
35062,Phase 1/2a
151623,Discontinued in Phase 2/3
790,Discontinued in Phase 4
92228,Phase 1
60431,Phase 1b/2a
44387,Phase 1/2a
78927,Phase 2a
87892,Patented
11660,Patented
137018,Phase 1/2a
37055,Discontinued in Preregistration
118235,Discontinued in Phase 2
122359,Patented
169305,Discontinued in Preregistration
69989,Discontinued in Phase 2b
148047,Phase 2b
54744,Phase 3
142972,Discontinued in Phase 3
31658,Discontinued in Phase 2b
53614,Phase 1b
14631,Phase 0
115501,Phase 1b/2a
133149,Investigative
20415,Phase 1b/2a
20699,Phase 1b/2a
78121,Investigative
3183,Phase 1
45321,Phase 2/3
166651,Discontinued in Phase 2b
32453,Patented
58347,Discontinued in Phase 2/3
28894,Phase 4
4527,Investigative
129616,Phase 0
68578,Discontinued in Phase 4
41946,Approved
3787,Discontinued in Phase 2b
117262,Discontinued in Phase 2b
3344,Phase 2a
43243,Phase 1/2
171383,Phase 2a
170282,Discontinued in Preregistration
45213,Phase 1/2a
118208,Registered
17736,Discontinued in Phase 1
21356,Phase 2
67262,Discontinued in Preregistration
32743,Phase 1/2
47129,Phase 3
167239,Discontinued in Phase 2
97094,Phase 2
160336,Phase 1/2a
134335,Phase 1
13415,Discontinued in Phase 1
60664,Phase 0
174460,Discontinued in Phase 4
131523,Discontinued in Phase 2/3
24074,Discontinued in Phase 4
134626,Discontinued in Phase 3
169080,Phase 1/2
2773,Discontinued in Phase 1/2
59334,Phase 2/3
4270,Phase 2a
105413,Phase 1/2
161072,Clinical trial
87663,Phase 1/2a
165378,Phase 1b/2a
80500,Approved (orphan drug)
26700,Phase 0
86980,Discontinued in Phase 2
54626,IND submitted
108805,Discontinued in Phase 2
44626,Phase 2/3
88278,BLA submitted
16052,Phase 1/2a
112029,Phase 0
7441,Phase 4
108167,Phase 0
184981,Phase 1/2
24150,IND submitted
177760,Phase 1b
183031,Phase 1
120642,Discontinued in Phase 3
38156,Phase 1/2
180521,Phase 2a
150372,Discontinued in Phase 2
98513,Phase 2/3
58062,Phase 0
26344,Phase 1b/2a
72753,IND submitted
146998,Investigative
178512,Discontinued in Phase 2/3
95261,Patented
48759,Discontinued in Preregistration
24610,Phase 0
17894,Phase 2/3
137630,Phase 1b
79858,Phase 1b/2a
169467,Phase 2
68922,Phase 1
69695,Phase 1
176834,Phase 0
8667,Phase 2
98801,Phase 0
2589,Discontinued in Preregistration
148778,Phase 2b
88584,Patented
98080,Phase 1b/2a
147971,Discontinued in Phase 1
184694,BLA submitted
88519,Phase 1/2
69022,IND submitted
21353,Phase 1b/2a
46600,Phase 1/2a
110244,Phase 1
175333,Patented
63170,Phase 1/2a
56676,Phase 1/2
158807,Phase 1b/2a
140375,Phase 1/2a
78099,Approved
73004,Phase 1b/2a
122990,Phase 0
74517,Phase 1/2a
12544,Phase 1
99312,Phase 1b/2a
39058,Phase 1
169694,Phase 1
154534,Phase 1b/2a
114392,Discontinued in Phase 3
56153,Phase 1
59550,Discontinued in Phase 3
139256,Investigative
163349,Phase 1/2
75627,Phase 0
160966,Phase 1/2
157208,Phase 1b/2a
154746,Phase 2
28389,Patented
122008,Phase 1b/2a
6025,Phase 2/3
109660,Preregistration
125618,IND submitted
158739,Phase 1b/2a
151230,Phase 2
48847,Discontinued in Phase 2/3
79231,Phase 1b
24988,Phase 2
150130,Phase 1/2
42404,IND submitted
147305,Phase 1b/2a
31754,IND submitted
56060,Discontinued in Phase 2b
162783,Phase 2
61291,Phase 1
5543,Discontinued in Phase 2
6952,Phase 2/3
30969,Discontinued in Phase 2/3
73077,Phase 1/2a
76970,Phase 1b/2a
171440,Discontinued in Phase 2/3
187389,Phase 0
65826,Phase 1b/2a
184697,Phase 1
58136,Clinical trial
99729,Phase 1
30549,Discontinued in Phase 2b
126975,Discontinued in Phase 1
7022,Phase 2a
95500,Phase 2/3
140440,Phase 2/3
174998,Discontinued in Phase 3
108055,Investigative
84420,Patented
114835,Phase 1/2
9319,Clinical trial
135820,Phase 1b/2a
48338,Phase 0
146808,Phase 1/2a
22796,Phase 1b/2a
177979,IND submitted
24219,Phase 1/2a
47328,Clinical trial
37328,Phase 1b/2a
114978,Phase 2/3
14592,Phase 2b
39198,Phase 2
15307,Phase 1
7531,Phase 4
20500,Phase 1/2
120460,Discontinued in Phase 1/2
90718,Phase 1b
166782,Phase 1/2
105647,Investigative
8165,Phase 0
113068,Phase 1
51094,Discontinued in Phase 2b
27495,Discontinued in Phase 3
59621,Investigative
134367,Phase 1/2a
156140,Phase 1/2
169683,Phase 0
125407,Phase 1/2
49351,Phase 1/2a
143667,Phase 2a
79945,Approved (orphan drug)
145238,Phase 1b/2a
118494,Discontinued in Preregistration
85991,Phase 2
53185,Phase 1b/2a
163087,Phase 1/2a
117935,Investigative
124292,Discontinued in Preregistration
22366,Phase 1/2
176828,Phase 1b
164494,Patented
121965,Phase 1/2
39285,IND submitted
50618,Discontinued in Phase 2b
184053,Discontinued in Phase 4
142870,Phase 2a
2442,Phase 1b/2a
144851,Discontinued in Phase 1
461,Discontinued in Phase 1
145168,Clinical trial
140972,Patented
2354,Investigative
184838,BLA submitted
66726,Phase 0
4267,IND submitted
182979,Phase 1/2
332,Phase 2
52917,Phase 1b
175700,Discontinued in Phase 3
127055,Discontinued in Preregistration
157978,Phase 1/2
50347,Discontinued in Phase 2b
1321,Approved
178674,Discontinued in Phase 1/2
1656,Approved
178240,Phase 2
153996,Phase 0
57737,Discontinued in Phase 1/2
11474,Phase 2
49920,Phase 2/3
182321,Phase 2a
52473,Investigative
152014,Phase 1
125670,Phase 1b/2a
3132,Phase 1/2a
113691,Investigative
176464,Phase 1
34842,BLA submitted
61050,IND submitted
111720,Phase 1/2
84488,Phase 1/2
75958,IND submitted
175516,Phase 1
128203,Patented
9967,Discontinued in Phase 3
171572,Phase 1
178162,Phase 2/3
50156,Phase 2
31211,Investigative
40913,Discontinued in Phase 2/3
113339,Phase 1
148057,Phase 1/2a
64793,Approved (orphan drug)
160722,Phase 0
16701,IND submitted
55455,Discontinued in Phase 2b
171679,Phase 0
49736,Discontinued in Phase 2b
43326,Phase 1/2a
21703,Discontinued in Phase 1/2
152636,Approved
96723,Phase 1/2
143411,Discontinued in Preregistration
172952,Discontinued in Phase 2/3
109538,Phase 1
91987,Phase 1b/2a
5146,Preregistration
158796,Phase 2
85945,Discontinued in Phase 3
49182,Phase 1b/2a
145994,Patented
151342,Discontinued in Phase 2/3
13613,Phase 1
78662,Phase 2a
125766,Investigative
118993,Phase 1b/2a
119357,Approved
26221,Phase 1
142908,Phase 2a
99688,Patented
162305,Approved
140198,Discontinued in Phase 2
134214,Phase 1b
101697,Investigative
169259,Approved
128077,IND submitted
70046,Phase 1b
128939,Discontinued in Preregistration
43444,Phase 1/2a
82428,Phase 1
22176,Phase 2/3
113721,Discontinued in Preregistration
161635,Phase 1/2a
175484,Discontinued in Phase 3
78144,Clinical trial
168607,Phase 0
63005,Discontinued in Preregistration
102541,Investigative
141201,Phase 1b
12090,Phase 1
124743,Phase 0
68113,Approved
135672,Phase 1/2
58632,Approved (orphan drug)
113094,Discontinued in Phase 1/2
191424,Phase 1/2
33616,Phase 1b/2a
185429,Phase 1/2a
11715,Discontinued in Phase 2/3
31927,Investigative
90033,Discontinued in Phase 4
132732,Phase 1/2
120490,Phase 0
181498,Discontinued in Phase 4
159773,Phase 2
149945,Phase 2/3
156019,Phase 1/2a
120091,Phase 0
75411,Phase 0
25113,Discontinued in Phase 4
159888,Phase 2b
126438,IND submitted
4984,Preregistration
160453,Phase 1/2a
31968,Phase 1
61150,Investigative
155896,Phase 1b/2a
191552,Preclinical
40649,Phase 2
129922,Patented
137051,Investigative
110364,Phase 1b/2a
167001,Phase 4
52948,Phase 1b/2a
52206,Patented
69393,Phase 2a
130100,Phase 1/2
164334,Phase 1/2
123882,Phase 1
15565,Phase 1/2a
156271,Phase 1
149152,Phase 0
149608,Phase 2b
189608,Phase 1/2a
35041,Discontinued in Phase 3
13587,Phase 1
169971,Phase 1/2a
139274,Discontinued in Phase 2
48849,Discontinued in Phase 2/3
130502,Phase 1b/2a
139552,BLA submitted
97530,Phase 1b
77884,Phase 2/3
157855,IND submitted
5647,Phase 2a
107154,Patented
177470,Phase 1b/2a
83609,Discontinued in Phase 4
138468,BLA submitted
95241,Phase 1b
187496,Clinical trial
117705,Clinical trial
8157,Phase 0
51762,Phase 1b
55831,Discontinued in Preregistration
20700,Phase 1/2
95103,Patented
40538,Phase 0
100489,Investigative
103325,Investigative
27601,Phase 1/2
110195,Discontinued in Phase 2/3
39823,Phase 2
134710,Phase 0
103953,Phase 0
21888,Phase 1b/2a
21009,Phase 1b/2a
127286,IND submitted
153365,Phase 1b
80757,Approved (orphan drug)
31823,Phase 2
10934,Phase 0
168991,Investigative
172296,Discontinued in Phase 3
103139,Discontinued in Preregistration
135132,Phase 0
85686,Discontinued in Preregistration
148946,Discontinued in Phase 1
100954,Discontinued in Preregistration
37243,Phase 1b/2a
31942,Phase 2a
92675,Phase 1b
177090,Discontinued in Phase 2b
182804,Phase 2a
118281,Phase 1/2a
77464,Phase 1b/2a
170639,Discontinued in Preregistration
18747,Discontinued in Preregistration
120330,Phase 0
28697,Phase 2
60853,Investigative
180918,Phase 1/2a
124455,Phase 1
175682,Phase 1/2
93521,Phase 2
103514,Phase 1/2
31464,Discontinued in Phase 3
115834,Discontinued in Phase 2
10902,Phase 0
109661,Phase 4
10177,Investigative
141633,Phase 1b
138100,BLA submitted
56735,Discontinued in Phase 2/3
32577,Phase 2
158489,Phase 1
15728,Phase 0
62346,Phase 2/3
176867,Phase 1b
92610,Phase 1b/2a
69486,Phase 2/3
175527,Phase 1/2
160068,Phase 2b
182773,Phase 2a
99319,Patented
49264,Phase 1
178456,Phase 0
173139,Phase 1/2
146688,Phase 1b
113004,Phase 1
145716,Phase 1/2a
81787,Approved
31192,Phase 0
84026,Phase 1/2a
49040,Phase 1b
175086,IND submitted
127718,Investigative
134584,Discontinued in Phase 4
20315,Phase 1/2
37371,Phase 1
115967,Phase 2
135668,Phase 1b/2a
183780,IND submitted
115878,Approved (orphan drug)
8391,Phase 1
34953,Discontinued in Preregistration
129353,Discontinued in Phase 4
127235,Discontinued in Preregistration
149715,Phase 0
47684,Phase 1b
3956,Discontinued in Phase 1
122665,Phase 1/2
72935,Phase 1/2
144725,Phase 0
22162,Discontinued in Phase 3
161195,Discontinued in Phase 1/2
12626,Phase 1
118637,Discontinued in Phase 4
111628,Phase 1/2
190384,Phase 1/2a
69377,Phase 2b
125212,Phase 1b/2a
12384,Phase 2b
129605,Discontinued in Phase 4
191322,Investigative
81065,Approved (orphan drug)
178039,Patented
129218,Phase 1/2
71001,Phase 1b/2a
31213,Phase 0
6048,Investigative
27294,Discontinued in Preregistration
102146,Phase 1/2a
56549,Phase 2
66881,Investigative
67124,Phase 3
129338,Investigative
51351,Phase 1b/2a
96766,Phase 1b
114304,Phase 1/2a
61379,Phase 1/2
120505,Phase 0
156077,Discontinued in Phase 3
153145,Phase 1
183198,Phase 1/2
155528,Phase 2/3
107444,Phase 1b
155978,Phase 1b
48210,Patented
123987,Phase 1/2
12259,Phase 0
22416,IND submitted
37876,Phase 1/2
73596,Phase 2/3
10085,Phase 0
27249,Patented
155227,Phase 2a
91544,Approved (orphan drug)
79063,Patented
52833,Phase 0
90257,Phase 1b
90980,Phase 1b
103405,Phase 1/2a
100170,Discontinued in Phase 3
133278,Approved
82230,Phase 1
120076,Discontinued in Phase 1/2
152942,Phase 1/2a
157272,Discontinued in Phase 2
97524,Phase 1/2a
63848,Phase 1
167979,Patented
185011,Phase 1
20016,Phase 1
31796,Phase 1/2a
59395,Phase 1b/2a
191658,Phase 1
103044,IND submitted
60216,Phase 0
54536,Phase 1/2a
171559,Phase 1b
31376,Phase 1/2a
19239,Patented
161577,Phase 0
172851,Phase 2
26540,Phase 1/2a
30010,Phase 0
147439,Phase 1/2
159069,Phase 1/2
184468,Phase 0
138472,Clinical trial
33328,Phase 1b/2a
172275,Discontinued in Phase 2
54564,Discontinued in Phase 2b
121427,Phase 0
984,Phase 2/3
105506,Phase 1/2a
152646,Phase 1/2a
164098,Phase 1/2
43641,Phase 2/3
180374,Phase 2a
111401,Phase 1
80288,Patented
109366,Discontinued in Preregistration
33819,Phase 1b/2a
179662,Discontinued in Phase 1/2
157486,Phase 2
103343,Discontinued in Phase 2b
168592,Investigative
138289,Investigative
176042,Discontinued in Phase 2
52418,Phase 0
85639,Discontinued in Phase 3
160599,Phase 2/3
134027,Phase 1
140844,Phase 3
130401,Discontinued in Phase 1
16598,Phase 0
157175,Phase 1b/2a
176242,Clinical trial
117446,Discontinued in Phase 1
142593,Phase 1
53227,Phase 1/2a
69094,IND submitted
142399,Phase 1/2a
133868,Phase 1/2a
99910,Phase 2
159912,Phase 2b
83379,Phase 1
45891,Phase 1/2a
126434,Phase 1b
27359,Discontinued in Preregistration
57016,Phase 1
122850,Phase 1b
159483,Phase 3
2938,Phase 2a
55688,Phase 1
89123,IND submitted
20730,Patented
91876,Discontinued in Phase 2b
87058,Phase 2
113623,Discontinued in Preregistration
108823,Phase 4
96437,Discontinued in Phase 2b
48747,Phase 1/2a
47132,Approved
166843,Discontinued in Phase 4
143017,Phase 1b/2a
22562,Phase 1/2
132505,Discontinued in Phase 1/2
115537,Phase 1/2
12622,Phase 0
77913,Discontinued in Phase 1
67279,Discontinued in Phase 1
131637,Discontinued in Phase 1/2
152202,Phase 0
162547,Discontinued in Preregistration
4903,Preregistration
124823,Phase 1b
26698,Phase 1b
183155,Phase 1b/2a
35465,Discontinued in Phase 3
131181,Phase 2
132165,IND submitted
1506,Discontinued in Preregistration
133355,Approved
1684,Phase 2a
83030,Discontinued in Phase 2/3
165217,Phase 1
97840,Phase 2
10606,IND submitted
970,Clinical trial
147243,Discontinued in Preregistration
145972,Phase 1
49676,Discontinued in Phase 4
172670,Discontinued in Phase 2
178867,Phase 1/2a
75520,IND submitted
180653,Phase 2a
132738,Discontinued in Phase 4
184650,Phase 0
89595,Phase 1b
191866,Clinical trial
62950,Phase 1/2a
181458,Discontinued in Phase 2
84207,Patented
188521,Phase 1b/2a
108314,Phase 1b
140237,Phase 1b
104703,Phase 1
156653,Phase 1
135260,Phase 0
170200,Phase 1b
69789,Phase 1/2a
45161,Phase 2/3
18637,Discontinued in Preregistration
18507,Phase 2a
120923,Investigative
133520,Phase 1/2
119248,IND submitted
74477,IND submitted
49991,Phase 1b/2a
36431,Discontinued in Phase 4
175049,Phase 0
168036,Patented
157318,Registered
81160,Discontinued in Phase 3
187600,Phase 0
85076,Phase 0
49815,Investigative
35712,Phase 0
48671,Phase 1/2a
48244,Phase 1
172157,Investigative
173281,Phase 1b
25595,Phase 1/2
130633,Phase 1/2
181637,Phase 2/3
117042,Discontinued in Phase 2b
120292,IND submitted
143728,Phase 1/2a
185850,Phase 1b
67166,Phase 1/2
171960,Discontinued in Phase 3
111144,Phase 1/2
17071,Phase 1
89522,Discontinued in Phase 4
46420,Phase 1/2
184035,BLA submitted
92436,Phase 0
136694,Phase 1/2a
120102,Approved (orphan drug)
51918,Discontinued in Phase 3
133057,Patented
121265,Phase 1b/2a
5442,Investigative
55773,Phase 1b
22240,Phase 1
3539,Phase 1/2a
34716,Phase 2b
182763,Phase 3
37776,Phase 1/2
50689,Phase 0
79151,Patented
181333,Phase 1
181123,Phase 2a
53928,Phase 3
36156,Phase 1b/2a
77140,Investigative
104517,Discontinued in Phase 4
4016,Phase 0
160486,Phase 3
180788,Phase 2/3
16205,Phase 1
3419,Investigative
55293,Phase 2
34898,Phase 2
86473,Phase 1
115348,Phase 1/2
97563,Phase 1/2
76337,Phase 0
113523,Investigative
114326,Phase 1b
24899,Discontinued in Phase 2/3
167812,Discontinued in Phase 3
186186,Phase 2a
168647,Patented
172116,Discontinued in Phase 2b
36858,Discontinued in Phase 2b
151823,Discontinued in Phase 2/3
52726,Discontinued in Phase 2b
134716,Phase 0
176892,Phase 1b/2a
92490,Discontinued in Phase 3
138766,Phase 1/2a
6697,IND submitted
62866,Phase 1
59117,Investigative
172170,Discontinued in Phase 3
81562,Phase 2
8336,Investigative
66465,Patented
85358,Discontinued in Phase 2b
116613,Phase 1
159765,Discontinued in Phase 1/2
30262,Phase 1
90519,Approved (orphan drug)
59613,Discontinued in Phase 1/2
54239,Phase 0
39870,Discontinued in Preregistration
93253,Phase 2b
129024,Phase 1
86819,Phase 1/2
42609,Discontinued in Phase 2/3
122033,Patented
24504,Phase 1b/2a
119095,Clinical trial
26219,Discontinued in Phase 2b
178515,Phase 2a
169177,Phase 0
147849,Phase 1b/2a
78220,IND submitted
25,Approved (orphan drug)
46142,Phase 1/2a
6954,Investigative
126574,Phase 0
30823,Phase 0
117651,Phase 1b
15946,Phase 1/2
94366,Phase 1
123519,Phase 1
19687,Discontinued in Preregistration
152141,Discontinued in Phase 2/3
184969,Phase 1/2
47141,Discontinued in Phase 2
18246,Phase 1/2a
72598,Phase 2/3
66719,Phase 0
42900,Investigative
46091,Phase 1/2a
48782,Discontinued in Phase 2b
94545,Phase 1b
122904,Phase 1
164854,Phase 0
135131,Phase 0
170016,Patented
185127,BLA submitted
92683,Phase 1b
67499,Discontinued in Phase 1
189473,Phase 1/2
1839,Phase 2a
39147,Phase 2/3
20654,Patented
35804,Discontinued in Phase 4
68805,Phase 1
157509,Patented
7873,Patented
132270,Discontinued in Phase 1/2
116599,Discontinued in Phase 4
131338,Discontinued in Phase 4
82503,Discontinued in Preregistration
138653,Phase 1b
56739,Discontinued in Phase 2b
87416,Approved
140770,Registered
77457,Phase 1b
17526,Phase 1/2
188827,Preclinical
6620,Phase 1/2
100802,Phase 1/2
110786,Discontinued in Phase 4
159532,Phase 1b/2a
114196,Phase 0
80580,Phase 2a
156229,Discontinued in Phase 2b
56436,Phase 1/2
34522,Phase 1
161257,Discontinued in Phase 1/2
170616,Discontinued in Phase 1
13518,Phase 1
89602,Phase 1
122368,Phase 1/2
26043,Phase 1/2
49011,Phase 1/2a
51360,Discontinued in Phase 3
132521,Discontinued in Phase 2b
135033,Phase 0
165502,IND submitted
71096,Phase 1b
84295,Phase 0
65274,Discontinued in Phase 1
13205,Phase 1/2
87673,Discontinued in Phase 2/3
12524,Phase 0
52814,Phase 0
626,Discontinued in Phase 1
114811,Phase 1/2
69681,Phase 2a
14098,Phase 0
101972,Application submitted
86633,Discontinued in Phase 1/2
173291,Investigative
116665,Clinical trial
129771,Investigative
89159,Phase 2/3
177167,Phase 1b
1957,Phase 1b
16867,Phase 0
191735,IND submitted
103122,Patented
68369,Discontinued in Phase 1/2
104123,Investigative
12776,Phase 1/2
21351,Phase 2
82628,Phase 2/3
115611,Phase 2
183794,Phase 2a
5129,Discontinued in Phase 2
74691,Discontinued in Phase 2b
157801,Discontinued in Phase 4
145840,Phase 1/2
148382,Discontinued in Phase 2
28073,Phase 1/2
89885,Phase 0
127421,Patented
172643,Phase 2a
7082,Discontinued in Phase 2
180125,Discontinued in Phase 1
9982,IND submitted
134309,Phase 1/2
742,Discontinued in Phase 2/3
72437,Phase 1b/2a
32857,Phase 2/3
70704,Phase 1/2
85509,Discontinued in Preregistration
59444,Approved (orphan drug)
105623,Phase 1b/2a
75595,Discontinued in Phase 1/2
92024,Phase 1b
55344,Phase 1/2a
70011,Phase 0
69171,Discontinued in Phase 1/2
79087,Phase 3
160635,Phase 2/3
15515,Phase 1b/2a
8868,Discontinued in Phase 2
77952,Discontinued in Phase 3
7795,Phase 1/2
47283,Phase 0
174259,Discontinued in Phase 1/2
96709,Phase 1b
162161,Investigative
26827,Phase 1/2
139165,Discontinued in Phase 2
135229,Phase 0
152533,Patented
64224,Discontinued in Phase 2
40336,Patented
34024,Approved (orphan drug)
9072,Discontinued in Phase 1
1666,Phase 2a
25593,IND submitted
128640,Discontinued in Phase 3
54808,Phase 1/2a
130033,Patented
99900,Phase 1
167634,Phase 1/2a
84512,Phase 1/2a
78172,Approved
18973,Discontinued in Phase 2/3
17101,Phase 1/2a
135344,Phase 0
72453,Phase 2
111286,Discontinued in Phase 2b
179005,Discontinued in Phase 2/3
88817,Phase 1
158673,Clinical trial
41106,Approved
78252,Clinical trial
170853,Patented
43992,Phase 2/3
113645,Patented
17285,Phase 1
59658,Phase 0
126569,Discontinued in Phase 2b
104229,Phase 1/2a
56393,Discontinued in Preregistration
176030,IND submitted
180213,Phase 3
130874,Phase 1b
83299,Phase 1b/2a
145102,Phase 1/2a
94669,Phase 1
19058,Discontinued in Phase 3
53086,Patented
168362,Patented
179341,Discontinued in Phase 3
21105,Phase 1/2
175831,Phase 2b
10774,Phase 0
77921,Phase 1
133912,Discontinued in Phase 4
106634,Discontinued in Phase 4
4444,Preregistration
134602,Phase 1/2
153508,Discontinued in Phase 4
116578,Discontinued in Phase 2/3
188488,Phase 4
98671,Phase 1/2a
177739,Phase 2
126844,Phase 0
186602,Phase 0
174577,Patented
5417,Discontinued in Phase 2
109326,Phase 2
28138,Phase 2/3
108136,Phase 2
88025,BLA submitted
71618,Phase 1/2
46151,Phase 2/3
100937,Phase 1/2a
27888,Phase 1
167053,Discontinued in Phase 1
125373,Phase 1/2
143820,Phase 2b
18928,Phase 2
182496,Discontinued in Phase 2b
172562,Discontinued in Phase 2b
68226,Discontinued in Phase 1/2
22991,Discontinued in Phase 4
374,Discontinued in Phase 1/2
131177,Investigative
69830,Phase 1
1294,Phase 1
4710,Phase 1b/2a
20464,Phase 1b/2a
33088,Phase 2/3
23739,Phase 1/2a
180939,Phase 1/2a
178246,Discontinued in Phase 1
183628,Phase 4
131025,Phase 0
72092,Phase 1/2
62068,Discontinued in Phase 2b
166394,Phase 1
146992,Phase 1b/2a
144212,Discontinued in Phase 1/2
125237,BLA submitted
174968,Phase 0
109034,Discontinued in Phase 3
160618,Phase 1
40987,Approved
121283,Phase 1/2a
36955,Discontinued in Phase 1
82355,Phase 1/2
161310,Phase 1/2
55570,Phase 1b/2a
9687,Phase 1b/2a
175865,Discontinued in Phase 3
360,Phase 1/2a
190376,Phase 2b
42146,Phase 2
49588,Phase 1b
15014,Phase 0
164375,Phase 1/2
68129,Phase 1b/2a
86734,Phase 1/2a
55816,Phase 0
38082,Discontinued in Preregistration
132678,Phase 1
186294,Phase 4
146537,Discontinued in Phase 2/3
43440,Phase 2/3
91239,Approved (orphan drug)
126006,Investigative
157194,Discontinued in Phase 2
142245,Patented
68667,IND submitted
138368,Phase 1/2a
44004,Phase 1/2a
129794,Phase 1/2
74508,Investigative
48735,Phase 1/2
112237,Phase 1/2
150140,Phase 2/3
99866,Phase 1
117602,Discontinued in Phase 2b
171045,Phase 0
105975,Discontinued in Phase 4
52968,Phase 1
14399,Phase 2b
7007,Phase 1/2
135446,Phase 0
87437,Phase 2/3
41713,Phase 1b
72420,IND submitted
151078,Phase 2
92590,Phase 1b
115848,Phase 1/2a
158164,Patented
64122,Patented
38799,Phase 2
156214,Phase 1/2a
82069,Clinical trial
174377,Discontinued in Phase 3
20729,Preregistration
134312,Phase 1b
134770,Phase 0
105587,Phase 1b/2a
168591,Discontinued in Phase 3
151302,Discontinued in Phase 2/3
185699,Patented
129856,Phase 1b/2a
152106,Phase 1b/2a
83774,IND submitted
78143,Phase 1/2
171899,Discontinued in Phase 2
110732,Phase 2
90039,Discontinued in Phase 1/2
150619,Phase 1
39452,Discontinued in Phase 4
97370,Phase 1b
12084,Phase 1
61555,Discontinued in Phase 1/2
176998,Phase 1/2a
165057,Phase 1/2
3538,Phase 0
186034,Patented
113962,Phase 2
161637,Phase 0
71343,Phase 1b
146991,Phase 1b/2a
99972,Phase 1
184497,Discontinued in Phase 4
79351,Discontinued in Phase 2
91539,Clinical trial
186790,Phase 0
160575,Phase 3
41035,IND submitted
94134,Phase 2b
143878,Phase 2b
39669,Discontinued in Phase 2b
147286,Phase 1/2a
191141,BLA submitted
139143,Discontinued in Phase 2
99376,Phase 1
156954,Registered
9652,Phase 2
58834,Phase 1/2
146867,Phase 2b
99166,Patented
142504,Phase 1
110843,Phase 1/2
4474,IND submitted
136215,Phase 1/2a
102877,Investigative
40899,Approved
17402,Investigative
99529,Phase 1
97328,Phase 1/2a
157367,Phase 1
37297,Phase 0
104148,Phase 1/2a
176181,Phase 1b/2a
56382,Phase 2
170337,Phase 0
115720,Phase 2
60804,Phase 0
67328,Approved (orphan drug)
36788,Phase 1b/2a
46296,Investigative
133722,Phase 1/2a
70829,IND submitted
176381,Discontinued in Phase 4
151897,Phase 1/2
133637,Phase 1/2a
159022,Investigative
183624,Phase 2a
106304,Phase 2a
109265,Phase 2
92354,Approved (orphan drug)
67427,Discontinued in Phase 1
45700,Phase 1/2a
173186,Phase 2
173584,Phase 1/2a
111149,Phase 0
186523,Phase 2/3
48458,Phase 2
82463,Discontinued in Preregistration
159497,Phase 1b
170704,Phase 1b
148984,Phase 2b
85205,Phase 2/3
93853,Phase 1/2
76525,Phase 0
92627,Patented
27769,Discontinued in Phase 3
83209,Phase 1/2
108231,Discontinued in Phase 1/2
11676,Phase 1
132315,Phase 1b/2a
39454,Phase 2
140951,IND submitted
168716,Discontinued in Phase 2
175938,Phase 3
114120,Phase 1
61730,Discontinued in Preregistration
45402,Phase 2/3
30816,Phase 1b/2a
62830,Phase 1/2a
142255,Phase 1
175600,Phase 1/2
49641,Discontinued in Phase 2b
122853,Phase 1/2
60399,Phase 2/3
95594,Phase 1/2
106246,Phase 1b
51355,Phase 1/2a
123099,Patented
177482,Phase 1b
140363,Phase 1/2a
100074,Phase 1b
164951,Phase 1/2
99846,Patented
114628,Phase 1/2a
151043,Phase 0
183182,IND submitted
190381,Phase 2/3
97450,Phase 0
59105,Phase 1/2a
180202,Phase 2a
115438,Phase 1b/2a
86716,Phase 2
102970,IND submitted
99928,Phase 1
40506,Investigative
129458,Phase 1/2
83837,Discontinued in Preregistration
36938,Phase 1b/2a
70234,Phase 1
111622,Discontinued in Phase 2b
170838,Phase 1
24611,Investigative
56858,Phase 2
96584,Phase 2b
29923,Phase 0
66205,Phase 1b
92094,Phase 1/2a
150002,Phase 2a
110803,Phase 2
38373,Phase 2
135071,Phase 0
105834,Phase 1b
76390,IND submitted
182965,Phase 1b/2a
73522,Phase 2a
68201,Phase 1b
71842,Phase 1b/2a
185527,Investigative
159276,Approved
10891,Phase 1
71307,Phase 1b
110966,Phase 1b
160290,Phase 0
144158,Investigative
84054,Phase 1b/2a
105820,Patented
184155,BLA submitted
72302,Phase 1/2
186742,Phase 1b
132023,Phase 1/2
3397,Phase 1/2a
56231,Investigative
51441,Discontinued in Phase 3
175896,IND submitted
94591,Phase 1b/2a
119386,Approved
104723,Phase 2
130235,Investigative
100153,Approved
66986,Patented
18878,IND submitted
43259,Phase 0
53625,Phase 2
43937,Phase 2/3
7843,Phase 1
136211,Phase 0
126895,Discontinued in Preregistration
80999,Approved
117829,Phase 1b
79017,Phase 1b
134570,Discontinued in Phase 4
60176,Phase 1/2a
149320,Discontinued in Phase 2
87677,Phase 1b/2a
125674,Phase 1/2a
169399,Approved (orphan drug)
64092,Discontinued in Preregistration
87111,Phase 1b
174644,Phase 0
45156,Phase 1/2a
65466,Phase 1/2a
175522,Patented
146820,Phase 1b/2a
177259,Phase 2a
93473,Discontinued in Phase 2b
150325,Phase 1/2
145985,Phase 2a
84255,Phase 1/2
16923,Investigative
158875,Phase 1b/2a
173506,IND submitted
175901,Phase 1/2a
38854,Phase 2
162573,Phase 1/2a
76611,Phase 0
17400,Investigative
34956,Phase 2b
149796,Phase 1b/2a
39130,Phase 0
185149,Phase 1/2
95642,Phase 2
135682,Phase 1b/2a
175555,Discontinued in Phase 1/2
38834,Phase 1
140423,Phase 1/2a
54446,Patented
92473,Phase 1
41496,Phase 2
112575,Phase 1
75311,Phase 0
178003,Phase 1
11409,Discontinued in Phase 2/3
145768,Phase 1/2
20069,Phase 1
145752,Phase 1b
169038,Phase 1b/2a
132679,Phase 1b/2a
76414,Patented
990,Clinical trial
190868,Phase 2b
185369,Discontinued in Phase 4
100102,Discontinued in Phase 4
35644,Discontinued in Preregistration
79244,Phase 0
43033,Patented
92979,Discontinued in Phase 2b
185517,Clinical trial
86379,Discontinued in Preregistration
85411,Discontinued in Phase 3
144291,Discontinued in Phase 2
44066,Phase 2/3
151568,Phase 0
134249,Discontinued in Phase 4
141810,Phase 0
167305,Discontinued in Phase 1
110143,Phase 1
67910,Phase 2a
65032,Discontinued in Phase 2/3
147843,Phase 0
61176,Phase 1b
178828,Phase 2a
148516,Phase 2b
148644,Phase 2/3
48385,IND submitted
23585,Phase 1b
44230,Phase 1/2a
167094,Discontinued in Preregistration
24561,Phase 1/2
106436,Phase 1/2
105112,Phase 1/2
93088,Phase 1b/2a
798,Phase 1b/2a
37622,Discontinued in Phase 3
100108,Discontinued in Phase 2
21658,BLA submitted
185891,Patented
130339,Patented
80227,Phase 2
113063,Phase 1
120388,IND submitted
119874,Discontinued in Phase 3
180914,Phase 3
152010,Phase 1
76364,Discontinued in Preregistration
106545,Discontinued in Phase 2b
86942,Patented
143794,Discontinued in Phase 4
45024,Phase 2/3
59166,Phase 2/3
144253,Phase 3
17575,Phase 0
63179,Discontinued in Phase 4
148967,Discontinued in Phase 2
15353,Phase 1
148710,Phase 2b
55939,Phase 0
8199,Phase 0
95062,Phase 1/2a
173744,Approved (orphan drug)
112322,Phase 1/2
150208,Phase 1/2
90964,Discontinued in Phase 2/3
162065,Phase 2a
40500,Phase 1/2a
175817,Phase 1/2
38393,Investigative
128267,Phase 1/2a
39510,IND submitted
45551,Phase 2/3
98915,Phase 1b
20619,Phase 1b/2a
98812,Phase 1/2a
135819,Phase 1b
174401,Phase 0
68995,Discontinued in Phase 3
108323,Investigative
21065,Phase 1/2
22742,Discontinued in Phase 4
190491,Preclinical
87590,Phase 1/2
1008,Clinical trial
109205,Phase 1/2
54385,Phase 0
7145,Discontinued in Phase 2
31694,IND submitted
190591,Phase 1/2
35579,Discontinued in Phase 1/2
177095,Phase 1b
34644,Phase 0
74632,Phase 1/2a
16390,Phase 1
128346,Discontinued in Phase 2b
68523,Discontinued in Phase 4
18953,Phase 1b
97726,Phase 1/2a
173914,BLA submitted
99874,Discontinued in Phase 4
21288,Phase 0
176307,Investigative
19272,Phase 1
155268,Phase 1/2
52967,Investigative
41930,Investigative
35136,Patented
131671,Phase 1b/2a
25525,Phase 1/2
30334,Discontinued in Preregistration
38275,Phase 1b
75547,Phase 1/2
90780,Clinical trial
114621,Phase 0
73768,Phase 2
140713,Phase 1b/2a
81259,Discontinued in Phase 1
108654,Discontinued in Phase 2/3
112243,Discontinued in Phase 2
137529,Phase 2
74501,Phase 1/2a
189286,Clinical trial
135355,Phase 0
145129,Clinical trial
154808,Phase 3
165959,Investigative
17737,Discontinued in Phase 1
143751,Phase 1/2
67515,IND submitted
34942,Phase 1b
75628,Phase 1/2
36475,Patented
172297,Discontinued in Phase 3
2026,Discontinued in Phase 1
66806,Investigative
164311,BLA submitted
111066,Phase 1
136156,Phase 1b
190041,Phase 1/2
24244,Phase 2a
108041,Phase 1/2
138303,Phase 1/2a
140351,Phase 1b
27461,Patented
189497,Phase 2/3
21752,Phase 1b/2a
130480,Phase 1/2
156495,Phase 1/2a
5812,Phase 4
80665,Clinical trial
184937,Phase 1
62209,Phase 1/2a
81764,Approved
145593,Phase 1b
37671,Phase 1
143170,Discontinued in Phase 4
142738,Discontinued in Phase 4
187688,Phase 1b
155616,Approved
37807,Discontinued in Phase 3
131921,IND submitted
123261,Phase 1/2
122740,IND submitted
103844,Patented
23240,Phase 1b/2a
36245,Phase 0
137007,Investigative
158403,Phase 2/3
168646,Discontinued in Phase 1/2
47883,Phase 1b/2a
158874,Phase 1b
132291,Discontinued in Phase 4
138384,Clinical trial
34732,Phase 2/3
122439,Patented
123039,Phase 1/2
52735,Discontinued in Phase 2b
147869,Phase 1/2
62871,IND submitted
15938,Phase 3
92974,Discontinued in Phase 3
80158,Phase 2a
40803,Phase 0
98606,Phase 2
39438,Phase 0
165634,Phase 1
89636,Patented
75794,Phase 1/2a
112141,Phase 1/2
111,Phase 2b
141010,Discontinued in Phase 4
55202,Patented
79262,Discontinued in Phase 4
20327,Phase 1
91800,Discontinued in Phase 2b
184464,Phase 1/2
121724,Discontinued in Phase 1
19569,Patented
186557,Phase 1b/2a
107342,IND submitted
119349,Phase 1b/2a
153598,Phase 1/2
165904,Phase 1b/2a
33948,Patented
125141,Phase 1/2
147940,Phase 1/2a
92211,Phase 1
153197,Phase 2
190883,Approved (orphan drug)
92900,Discontinued in Phase 3
129977,Patented
5551,Preregistration
93269,Discontinued in Phase 1
166967,Phase 4
25139,Phase 1b
186225,Phase 2b
8355,Discontinued in Phase 3
51941,Phase 0
5532,Investigative
80508,Phase 2
23071,Patented
23869,Phase 1b/2a
47162,Discontinued in Phase 2
26904,Phase 1
143740,Discontinued in Phase 3
65298,Phase 2a
35286,Phase 2a
33912,Phase 1/2
22112,Phase 0
149186,Phase 1b
72735,IND submitted
3859,Discontinued in Phase 4
45712,Phase 2/3
55696,Phase 3
97158,Phase 1b
190905,Patented
94762,Phase 1/2a
81353,Clinical trial
116527,Discontinued in Phase 2/3
182030,Phase 1/2
152809,Patented
8178,IND submitted
75163,Patented
178628,Phase 1/2
39072,Phase 2/3
134043,Phase 1/2
130086,Phase 2/3
35748,Phase 1/2
42788,Phase 2/3
33259,Clinical trial
116172,Approved (orphan drug)
58839,Phase 1
100835,Phase 1/2a
31301,Investigative
78120,Investigative
12378,Phase 1
173243,Discontinued in Phase 2
87098,Discontinued in Phase 1/2
102940,Phase 1/2
77413,Phase 1/2a
58346,Discontinued in Phase 3
163539,Discontinued in Phase 2
39287,Phase 0
49344,Phase 1b/2a
54046,Patented
45444,Phase 1/2a
47667,Investigative
150896,Phase 1
158167,Phase 1/2a
177289,Approved
138785,Phase 1b
5361,Investigative
139636,BLA submitted
86165,Phase 0
37657,Phase 0
107571,Phase 1/2a
184292,Discontinued in Phase 4
135716,Phase 2
37067,Discontinued in Phase 3
121884,Phase 2
103106,Approved (orphan drug)
93894,Phase 1b/2a
182520,Phase 1b/2a
124095,Phase 1/2
25283,Discontinued in Phase 2/3
119405,Phase 2
187459,Preclinical
139875,Phase 1b
169402,Investigative
158626,Discontinued in Preregistration
160438,Phase 1
37311,Phase 1
11429,Phase 1/2a
108359,Phase 0
132067,Discontinued in Phase 4
15070,IND submitted
5362,Preregistration
131380,Phase 0
153975,Discontinued in Phase 2/3
141515,Discontinued in Phase 1
180644,Discontinued in Phase 2b
39907,Patented
70978,Discontinued in Phase 1/2
84086,Phase 1
22349,Phase 2a
104950,Discontinued in Preregistration
158561,Phase 1b
169780,Discontinued in Phase 2
38887,Phase 0
173450,Discontinued in Phase 2
62567,Phase 0
20501,Discontinued in Phase 4
109862,Phase 2
175462,Phase 1
41029,Approved
131838,Phase 1
94579,Phase 1b/2a
12735,Phase 1
119165,Registered
92006,Phase 1b
93561,Phase 2b
75463,Phase 1/2
138644,BLA submitted
39010,IND submitted
148903,Phase 1b/2a
24769,Phase 1b
17525,Phase 1/2
155150,Phase 1b/2a
65547,Preclinical
23083,Phase 1/2
80185,Phase 2a
34147,Phase 1/2a
80123,Phase 1
25259,Phase 1
86192,Discontinued in Preregistration
148115,Phase 2b
78049,Investigative
104045,Patented
173520,Patented
66826,Patented
124234,Discontinued in Preregistration
137410,Phase 1/2a
77592,Phase 1/2a
134185,Phase 1/2a
29554,Phase 1b
40017,Discontinued in Phase 2
173422,IND submitted
123773,Patented
89218,Discontinued in Phase 4
37856,Phase 1/2
4369,Phase 2a
13062,Phase 0
144113,Phase 1/2
116774,Discontinued in Phase 3
133778,Phase 1/2a
26496,Phase 0
22243,Phase 2/3
27860,Phase 1b
161569,Investigative
179025,Phase 0
96023,Phase 1/2a
165508,Discontinued in Phase 4
148196,Phase 1
37114,Discontinued in Preregistration
17544,Discontinued in Phase 1
78975,Patented
144471,Discontinued in Phase 2
104720,Phase 1/2a
38316,Phase 0
87943,Phase 2/3
72087,Phase 1b
85899,Discontinued in Preregistration
43510,Phase 1/2a
19277,Investigative
25383,Phase 2/3
139748,Clinical trial
102567,IND submitted
37908,Phase 1/2a
153245,Discontinued in Phase 4
74481,Phase 1/2
130275,Phase 1b/2a
85981,Discontinued in Phase 3
92061,Investigative
106565,Patented
2100,Phase 2
74521,Phase 2
119450,Phase 2
115068,Clinical trial
67084,Phase 0
175716,Phase 1/2
185814,Phase 4
86446,Phase 0
33927,Investigative
184197,Discontinued in Phase 4
122649,Investigative
66044,Phase 2
158710,Phase 2
101594,Phase 1/2a
29335,Phase 1/2a
21362,Phase 2a
32979,Phase 0
49725,Phase 2
94586,Patented
35479,Discontinued in Phase 1/2
6674,Phase 1/2
89872,BLA submitted
33957,Phase 2
162026,Discontinued in Phase 1/2
50599,Phase 1b/2a
7335,Investigative
159852,Phase 2b
104206,Patented
40553,Phase 2/3
38130,Patented
14895,Phase 1
132085,Discontinued in Phase 1/2
128847,Discontinued in Phase 1
20737,Phase 1/2
54587,Phase 1/2a
81953,Clinical trial
30905,Phase 1
170743,Phase 1/2a
142112,Investigative
123464,Discontinued in Phase 4
43603,Phase 1/2a
20728,Discontinued in Preregistration
90932,Clinical trial
35172,Phase 2b
78483,Phase 1/2
20177,Patented
56910,Discontinued in Phase 2
186157,Investigative
67259,Discontinued in Phase 1
113270,Phase 1
99231,Phase 0
156878,Phase 0
17706,Phase 1
148178,Patented
84015,Discontinued in Phase 4
61803,Investigative
157817,IND submitted
68541,Investigative
29734,Discontinued in Preregistration
59737,Phase 1b
28490,Phase 1/2a
160779,Phase 2/3
188233,Phase 1/2
107149,Phase 1b/2a
18041,Phase 2
188533,Phase 1/2
70133,Phase 1/2
15175,Phase 0
87888,Discontinued in Phase 1
137451,Phase 1b/2a
128951,Phase 1/2a
36504,Discontinued in Phase 1/2
40197,Phase 2
7791,Discontinued in Phase 2
75805,Phase 0
7274,Phase 2a
107717,Clinical trial
20278,Phase 1b/2a
185262,Approved
95435,Phase 1/2a
122607,Phase 1
9916,Phase 0
57611,Phase 1
88497,Phase 1
178822,Discontinued in Phase 3
126822,IND submitted
51852,Discontinued in Phase 3
189400,Phase 1/2a
132084,Discontinued in Phase 1/2
72145,Phase 1
157433,Phase 1
157437,Discontinued in Phase 4
51056,Phase 0
42676,Phase 2/3
158625,Phase 1
60203,Phase 2/3
28859,Phase 0
5222,Phase 2a
99294,Phase 2
116932,Investigative
6947,Discontinued in Phase 2
29421,Phase 1b/2a
170267,Phase 0
26711,Phase 1b
3217,Discontinued in Phase 3
143676,Phase 2a
165449,IND submitted
86307,Discontinued in Preregistration
169384,Phase 2/3
191205,Discontinued in Preregistration
168445,Discontinued in Phase 1
76477,Phase 1/2
27261,Patented
85704,Discontinued in Preregistration
13469,Phase 1/2
170589,Phase 0
183988,Phase 0
55794,Discontinued in Phase 3
91448,Discontinued in Preregistration
144634,Patented
94406,Phase 2
19953,Discontinued in Preregistration
185532,Phase 0
130356,Investigative
149845,Investigative
43001,Patented
136430,Phase 1/2a
69346,IND submitted
191802,Discontinued in Phase 1
103558,BLA submitted
74845,Patented
140835,Registered
107935,Discontinued in Phase 2
18506,Discontinued in Preregistration
121542,Phase 2
92529,Phase 1
55220,Phase 3
183511,Discontinued in Preregistration
38473,Phase 2
86684,Phase 1/2
12541,Phase 1b/2a
13297,Phase 0
28853,Phase 1b/2a
62546,Phase 1
61143,Phase 2/3
80655,Phase 1
52629,Phase 1
112907,Discontinued in Phase 3
10216,IND submitted
50092,Phase 1b/2a
153019,Phase 1
178029,Patented
170770,Phase 0
21124,Phase 2/3
124690,Phase 0
143305,Phase 1b/2a
88676,Discontinued in Phase 4
1139,Discontinued in Phase 1
182925,Phase 2b
63574,Phase 2/3
186745,Phase 0
105710,Phase 1/2a
82783,Discontinued in Phase 1/2
8388,Phase 1/2
188930,Phase 4
10742,Phase 0
145706,Phase 1b/2a
28550,Discontinued in Phase 2b
121912,Phase 1b/2a
99165,Patented
166160,Discontinued in Phase 4
167397,Phase 4
182606,Phase 2a
70324,Phase 1b/2a
161377,Phase 0
179547,Phase 0
29175,Phase 4
162841,Phase 1/2
123097,Phase 1b
58365,Phase 1b/2a
175474,Discontinued in Phase 1/2
85057,Phase 1/2a
82235,Patented
163777,Phase 1
97811,Phase 1
130265,Phase 1/2a
85138,Phase 1/2
115585,Phase 1b/2a
12118,Phase 1b
153066,Phase 1
154669,Phase 2
170162,Phase 0
111323,Phase 1/2
105859,Phase 1b/2a
48620,Phase 1/2a
86154,Investigative
187607,Phase 1b/2a
129953,Discontinued in Phase 3
63174,IND submitted
144833,Discontinued in Phase 2/3
52737,Discontinued in Preregistration
78887,Patented
109169,Patented
142203,Discontinued in Phase 2b
13294,Phase 0
133738,Phase 1b
70374,Phase 1b/2a
167443,Discontinued in Phase 2
178371,Phase 1
127496,Discontinued in Phase 3
94173,Investigative
82470,Phase 2
84364,Discontinued in Phase 2/3
42731,Phase 2
136965,Discontinued in Phase 2/3
147085,Phase 0
185067,BLA submitted
146498,Discontinued in Phase 2/3
60817,Discontinued in Phase 1/2
16819,Phase 1
7912,Phase 1
184140,Phase 1/2
98681,Phase 2/3
116798,Discontinued in Phase 2/3
83458,Phase 1/2a
133644,Phase 1/2
58492,Approved (orphan drug)
191531,Phase 1/2
3852,Phase 1
3330,Phase 2a
6170,Phase 1/2
22816,Discontinued in Phase 4
141976,Phase 2/3
175165,Phase 1
166147,Patented
47459,Phase 2
115984,Phase 1b/2a
101850,Phase 2b
173593,Approved
165596,Discontinued in Phase 1/2
111928,Phase 1
181006,Phase 2a
145707,Phase 2b
9274,IND submitted
85610,Discontinued in Phase 2b
31446,Phase 2
48225,Phase 1b
85705,Discontinued in Phase 3
67392,Discontinued in Preregistration
154022,Phase 1b
173040,Discontinued in Phase 2b
47036,Discontinued in Phase 2
93927,Phase 2b
167102,Discontinued in Phase 2
17193,Phase 1/2
105168,Patented
155818,Phase 2
104410,Phase 1/2a
581,Phase 2
132181,IND submitted
43512,Phase 2/3
118912,Discontinued in Preregistration
103904,Patented
64359,Phase 1b/2a
3015,Phase 1/2
66163,Phase 0
144684,Discontinued in Preregistration
107106,Phase 0
179787,Phase 1/2
6077,Phase 2a
179728,Phase 1/2
191788,Phase 1
132336,Discontinued in Phase 1/2
99119,Phase 0
137456,BLA submitted
57178,Phase 2/3
109194,Phase 1/2
154583,Phase 1b/2a
135566,Phase 0
128348,Phase 0
108243,Investigative
24072,Phase 1/2a
91141,BLA submitted
165289,Phase 2
67852,Clinical trial
88994,IND submitted
51942,Phase 0
68864,Discontinued in Phase 2/3
86704,Phase 1/2a
86770,Discontinued in Phase 2
30610,Phase 0
154567,Phase 1b/2a
42770,Patented
53518,Discontinued in Preregistration
157590,Phase 2
20933,Registered
132659,Discontinued in Phase 4
131599,Patented
51215,Phase 1b/2a
71154,Discontinued in Phase 1/2
24696,Phase 2/3
57125,Phase 1b/2a
66324,Discontinued in Phase 1/2
151184,Discontinued in Phase 2/3
75092,Phase 2
89716,Phase 1/2
173736,BLA submitted
176482,Phase 1/2a
17580,Phase 1/2a
69337,Discontinued in Phase 3
70886,Phase 1b/2a
60478,Investigative
23379,Phase 1/2
13015,Phase 1/2
87848,Approved
186461,Patented
65457,Discontinued in Phase 2
72442,IND submitted
28080,Phase 0
11082,Patented
142314,Phase 0
127977,Phase 0
37556,Discontinued in Phase 1/2
127277,Patented
104626,Phase 0
168893,Discontinued in Phase 1/2
91973,Discontinued in Phase 2
146231,Phase 1/2
18199,Phase 1
13313,Phase 0
47886,Phase 1b
73565,Phase 1/2a
36204,Discontinued in Phase 3
95671,Phase 1
6844,Phase 2/3
60744,Phase 1b
178991,Phase 1/2
150145,Phase 1
61620,Phase 1b
85466,Discontinued in Phase 2b
27099,IND submitted
159822,Phase 1b/2a
46035,Phase 1/2a
7632,Phase 2
166753,Phase 0
32949,Phase 2a
102862,Discontinued in Preregistration
185715,Phase 2b
126738,Phase 1/2
157524,Clinical trial
58745,Discontinued in Phase 1/2
28166,Phase 2
23246,Phase 1b/2a
145869,Phase 1b
97472,Discontinued in Phase 2b
40028,Phase 2/3
179155,Phase 0
81306,Phase 1b
28493,Discontinued in Preregistration
181807,Discontinued in Phase 2
178613,Discontinued in Phase 3
176306,Patented
57004,Discontinued in Phase 3
148079,Phase 1
36058,Phase 2a
7069,Phase 2/3
12184,Phase 1/2
99524,Phase 1
36407,Investigative
162309,Phase 3
44015,Phase 2/3
52255,Phase 1/2a
178207,Investigative
29877,Phase 1b/2a
120595,Discontinued in Phase 1/2
190791,Phase 2b
67539,IND submitted
149666,Phase 1b/2a
50906,Phase 2
78598,Phase 2/3
186086,Clinical trial
183087,Phase 2/3
119530,Phase 0
47512,Discontinued in Phase 2/3
129513,Phase 1/2
153840,Registered
152406,Investigative
35633,Discontinued in Phase 4
22746,Phase 1/2
151645,Phase 0
157976,Discontinued in Phase 4
169534,IND submitted
71583,Phase 1b
9796,Discontinued in Phase 3
68562,Phase 1
74138,Discontinued in Phase 4
53917,Phase 1b/2a
133435,Phase 1
133605,Discontinued in Phase 4
89185,Discontinued in Phase 3
23719,Phase 0
109763,Phase 2
52440,Phase 1b
156771,Phase 2
118866,Discontinued in Phase 3
127386,Phase 1/2
140392,Investigative
170009,Phase 2b
68152,Phase 1
178615,Discontinued in Phase 2/3
58173,Phase 0
91315,Approved (orphan drug)
117895,Discontinued in Phase 1
27504,BLA submitted
111951,Phase 1
91323,Phase 1b
140324,Phase 1b
107181,Discontinued in Phase 2b
50554,Phase 1b
26484,Phase 0
68348,Phase 2b
59312,Clinical trial
31561,Investigative
69604,Phase 1
190286,Approved (orphan drug)
16009,Discontinued in Phase 1
36190,Discontinued in Phase 3
140366,Phase 1b
76408,Phase 1/2
97340,Discontinued in Phase 2
37041,Phase 1
146619,Discontinued in Preregistration
46462,Phase 1b
16927,Phase 1/2
74981,Patented
109549,Phase 1
127704,Discontinued in Phase 3
16696,Phase 0
96822,Phase 1b
21272,Discontinued in Phase 4
180824,Phase 2a
144586,Phase 1/2a
125623,Phase 1b
85402,Discontinued in Phase 3
17786,Investigative
178846,Phase 0
15062,Phase 0
108684,Discontinued in Phase 1
125408,Discontinued in Phase 3
143420,Phase 2/3
22745,Discontinued in Phase 4
189590,Approved
61807,Discontinued in Phase 2b
8789,Phase 2/3
8502,Approved
71454,Discontinued in Preregistration
38166,Phase 1/2
171515,Discontinued in Phase 2b
35351,Phase 0
109282,Discontinued in Phase 2/3
134817,Phase 0
133081,Discontinued in Phase 2b
34216,Phase 1
111875,Phase 1/2
158801,IND submitted
1500,Discontinued in Phase 2/3
132707,Phase 1b/2a
13445,Phase 0
113442,Phase 2a
167705,Discontinued in Phase 2/3
172828,Investigative
16032,Phase 2b
39266,Phase 1b/2a
33597,BLA submitted
70574,Phase 2
181297,Discontinued in Phase 4
57591,Discontinued in Phase 2/3
25674,Investigative
74885,Discontinued in Phase 4
4729,Phase 2a
115010,Phase 1b
125592,Phase 1b/2a
97951,Phase 1
94934,Patented
37312,Phase 0
149238,Phase 1b/2a
98366,Phase 1/2a
41616,Investigative
160161,Discontinued in Phase 1/2
157864,Registered
2375,Phase 1b/2a
99878,Phase 1/2
62893,Phase 1b/2a
176462,Phase 0
183179,Phase 2a
121674,Phase 0
89073,BLA submitted
164026,Discontinued in Preregistration
170594,Phase 1/2
75467,Phase 0
111001,Discontinued in Phase 4
111883,Discontinued in Phase 2
134456,Phase 1/2
31867,Phase 1b
137925,Phase 1/2
17864,Discontinued in Phase 4
2898,Patented
37374,Phase 2
150195,Phase 1b
139705,Clinical trial
172623,Phase 1
112411,Discontinued in Phase 2
140688,Phase 1b/2a
57036,Phase 1/2
132612,Phase 0
126613,Patented
140774,Phase 3
151588,Phase 1b
21595,Phase 3
176430,Discontinued in Phase 2
116406,Discontinued in Phase 1
182932,Phase 1
63047,Phase 0
40910,Approved
3748,Investigative
172358,Discontinued in Phase 2
45836,Phase 1/2a
76597,Patented
19478,Discontinued in Phase 2b
120856,Approved
135370,Phase 0
28382,Phase 1/2a
75931,Phase 1/2a
175313,Discontinued in Phase 2
85156,Phase 0
16469,Phase 1/2
180066,Phase 1b
178051,Patented
32198,Phase 1b/2a
148572,Investigative
75238,Discontinued in Phase 1
117181,Investigative
27599,Phase 1b/2a
133061,IND submitted
67523,BLA submitted
124254,Patented
153346,Patented
35448,Phase 1/2
17811,Phase 1
38635,IND submitted
54341,Phase 1b/2a
120545,Phase 4
54036,Phase 1b/2a
23084,Investigative
33145,Phase 1b/2a
183016,Phase 1b/2a
128262,Investigative
101158,Phase 3
169454,Discontinued in Phase 2/3
59639,Discontinued in Phase 4
5682,Phase 1b/2a
187128,Phase 0
140646,Phase 2a
84936,Phase 0
189310,Phase 2b
77183,Phase 0
30366,Phase 2
118894,Phase 1/2a
96259,Discontinued in Phase 1/2
78832,Patented
76780,IND submitted
20221,Phase 1b/2a
40816,Phase 0
30190,Phase 0
187395,Phase 2b
31250,Investigative
188358,Phase 4
107732,Discontinued in Phase 4
51139,Discontinued in Preregistration
130749,Phase 2
41069,Discontinued in Phase 4
92266,Discontinued in Phase 1
87811,Discontinued in Phase 2/3
19434,Phase 0
130055,Phase 2
175103,Phase 0
50822,Discontinued in Phase 2b
69734,Discontinued in Phase 2
50862,Patented
89810,Patented
132701,Discontinued in Phase 1/2
23387,Phase 1
89630,Phase 0
11302,Discontinued in Preregistration
146332,Phase 2b
93735,Phase 1b/2a
12734,Phase 1
30530,Investigative
69832,Phase 1b
22318,Phase 1/2
131198,Phase 1b
123830,Discontinued in Preregistration
119756,Discontinued in Phase 2b
29902,Phase 0
150375,Investigative
54468,Phase 1/2a
17708,Phase 0
113609,Phase 1
179275,Patented
21758,Patented
23826,Discontinued in Phase 2/3
64204,Phase 0
14435,Phase 1
95893,Phase 1b
27650,Patented
163716,Phase 1b/2a
129055,Discontinued in Preregistration
124813,Phase 1b
152601,Patented
71292,Phase 1/2
124877,Phase 1/2
115504,Phase 1/2a
77988,Phase 1/2
130449,Phase 1
116778,Discontinued in Phase 2/3
10867,Phase 1
54230,Discontinued in Phase 4
122403,Phase 1/2
63737,Approved (orphan drug)
64321,Phase 1b/2a
93739,Phase 1b
121953,Discontinued in Phase 1
16886,Phase 0
16533,Phase 1/2a
129815,Phase 1/2a
65268,Approved (orphan drug)
141747,Discontinued in Phase 2b
127830,Investigative
186277,Patented
81913,Discontinued in Phase 1/2
56335,Phase 1/2a
14265,Phase 1/2
115534,Phase 1b/2a
26264,Phase 1/2a
34444,Phase 1/2a
130162,Patented
55652,Discontinued in Phase 2b
93725,Phase 1
58508,Phase 0
54695,Discontinued in Phase 2b
77883,IND submitted
100058,Phase 1b
20472,Phase 1b/2a
95160,Phase 1/2a
149868,Investigative
14858,Phase 1b/2a
181452,Phase 2a
108697,Patented
65841,Discontinued in Phase 3
46114,Phase 2/3
121817,Phase 1b/2a
53656,Phase 3
12233,Phase 1
55987,Discontinued in Phase 2b
128914,Phase 0
139692,Discontinued in Phase 2
121157,Phase 1b
69944,Phase 1
161076,Phase 1/2a
145844,Phase 1b/2a
109487,Discontinued in Preregistration
115373,Discontinued in Preregistration
79428,Phase 2a
163213,Patented
26423,Phase 0
146102,Phase 2a
26439,BLA submitted
130736,Clinical trial
67959,Clinical trial
138192,Phase 1/2a
60670,Discontinued in Phase 3
109085,Phase 1/2a
167043,Discontinued in Phase 1
10619,IND submitted
66852,Phase 0
73982,Phase 1/2
46530,Phase 0
156758,Phase 2
107188,Phase 3
167384,Phase 1/2a
46483,Phase 2b
72439,Investigative
64513,Phase 2a
187410,Phase 1b
141400,Phase 2/3
68597,Phase 1/2
159407,Phase 1b/2a
126984,Discontinued in Phase 3
119023,Phase 1b/2a
98869,Phase 1/2a
179578,Discontinued in Phase 2/3
273,Phase 2
28720,Phase 1/2a
111392,Phase 1/2
81458,Phase 1b/2a
118924,Discontinued in Phase 3
190459,Phase 2/3
95523,Phase 2/3
129223,Discontinued in Preregistration
153264,BLA submitted
91070,Patented
42835,Phase 2
183147,Discontinued in Phase 2
160871,Discontinued in Phase 4
93820,Phase 1
91908,Phase 1/2
133772,Discontinued in Phase 4
54497,Phase 0
122346,Phase 1/2
72928,IND submitted
32570,Phase 1b/2a
75592,Phase 1b/2a
17910,Phase 2/3
121972,Discontinued in Phase 1
55518,Phase 1b
50667,Phase 1b/2a
1314,Discontinued in Phase 2/3
76325,Phase 0
3309,Phase 1
117136,Discontinued in Preregistration
158672,Phase 1b/2a
16908,Phase 1/2a
59377,Phase 0
71641,Phase 1
161504,Patented
99213,Phase 1/2
98729,Phase 1/2a
162617,Phase 1/2a
84296,IND submitted
54860,Phase 1/2
160019,Investigative
66456,Phase 2b
94725,Phase 1b
152085,Phase 0
140474,Phase 1/2
89841,Phase 1b/2a
161315,Phase 1/2a
34976,Phase 1b/2a
3012,IND submitted
151121,Phase 0
128621,Discontinued in Phase 2b
121694,Phase 2
176603,Phase 1b
150689,Phase 1
11558,IND submitted
22490,Phase 1/2a
87812,Phase 1/2
143043,Phase 2a
27132,IND submitted
4278,Phase 1b/2a
150296,Phase 2/3
144156,Phase 0
9460,Discontinued in Phase 2b
149581,Phase 0
13654,Phase 1/2a
157643,Phase 1b/2a
183295,Phase 1b/2a
177017,Discontinued in Phase 4
69893,Phase 1
95672,Phase 1b
128390,Phase 1/2
27424,Discontinued in Preregistration
179168,Discontinued in Phase 1/2
166696,Phase 2
127104,Discontinued in Phase 2b
57844,Phase 1
102954,Investigative
150881,Phase 0
62739,Discontinued in Phase 4
77962,Discontinued in Preregistration
80778,Phase 1b/2a
24799,Phase 2a
51303,Phase 1/2a
145245,Phase 1b
69055,Phase 1b
5967,Investigative
94692,Phase 1/2a
3904,Discontinued in Preregistration
50812,Phase 1b
149823,Phase 1b/2a
38063,Phase 2/3
29603,Phase 1b
121308,Phase 1/2a
132420,Discontinued in Phase 1/2
8197,Patented
155326,IND submitted
65228,Phase 2
21701,Discontinued in Phase 2
83292,Phase 1
155670,Approved
134042,Phase 1/2
113978,Patented
4899,Phase 1b/2a
128683,Discontinued in Preregistration
99107,Phase 2
111617,Phase 1
185749,Preclinical
76540,Phase 2/3
74663,Patented
56111,Phase 2
50346,Discontinued in Phase 2b
7541,Discontinued in Phase 2
179254,Phase 1b
183127,Approved (orphan drug)
25154,Phase 1/2a
167209,Discontinued in Phase 1
10444,Investigative
103312,Investigative
133209,Discontinued in Preregistration
128676,Discontinued in Phase 3
75944,Investigative
47295,Investigative
167969,Patented
178349,Phase 1
70383,Phase 2/3
125246,Investigative
179814,Discontinued in Phase 4
90750,Phase 2/3
118607,Discontinued in Phase 2/3
41487,Phase 1/2a
8010,Patented
60477,Phase 1/2a
41860,Phase 0
103329,Discontinued in Preregistration
147141,Phase 0
14725,Phase 1
80267,Investigative
191853,Phase 2/3
59679,Phase 1
127587,Discontinued in Phase 1
187402,Phase 1b
183855,IND submitted
104046,Patented
180920,Phase 1b/2a
15770,Investigative
62060,Discontinued in Phase 4
160709,Phase 0
81597,Approved
19723,Discontinued in Preregistration
52656,Discontinued in Phase 2/3
179217,Phase 2a
135999,IND submitted
149113,Phase 0
173852,Phase 1b/2a
10258,Discontinued in Phase 2/3
145805,Phase 1b/2a
185286,Approved
109891,Preregistration
168728,Discontinued in Phase 4
33837,Phase 1b/2a
170809,Phase 1b
87649,Phase 0
174992,Phase 0
87241,Phase 1
82009,Clinical trial
185571,Phase 4
79755,Phase 1b
3391,Investigative
150456,Phase 0
21659,BLA submitted
68532,Phase 2b
170675,Phase 1b/2a
107756,Discontinued in Phase 2/3
9462,Clinical trial
76048,Investigative
97307,Phase 1
176209,Investigative
154759,Phase 1b/2a
33931,Patented
5631,Investigative
155001,Discontinued in Preregistration
83002,Phase 1
146561,Phase 2b
147824,Discontinued in Phase 2
52166,Phase 1b/2a
98932,Phase 2
154141,Phase 1/2a
89112,BLA submitted
104495,BLA submitted
154646,Phase 1b/2a
181578,Phase 1/2a
160055,Investigative
50060,Phase 1b
73989,Phase 1b/2a
162418,IND submitted
97699,Phase 1
72781,Investigative
98597,Phase 2/3
156600,Phase 1/2
103964,Patented
151179,Phase 1
16738,Phase 1/2
93066,Phase 1
130784,Clinical trial
144419,Clinical trial
75372,Discontinued in Phase 1
186019,Preclinical
126203,Phase 1b
127255,Discontinued in Preregistration
103021,Discontinued in Preregistration
158808,Phase 1b/2a
153741,Phase 1
60836,Phase 0
125416,BLA submitted
2622,Phase 1b/2a
115214,Clinical trial
86164,Investigative
141832,Phase 2/3
76049,Investigative
118925,Phase 2a
162192,Investigative
82016,Clinical trial
55124,Phase 1b/2a
37843,Phase 0
126587,IND submitted
91577,Clinical trial
25433,Discontinued in Phase 4
116385,Discontinued in Phase 1
54637,Discontinued in Phase 4
122655,Phase 1/2
160913,Phase 1
64423,Phase 2
80416,Approved (orphan drug)
121647,Phase 1b/2a
7394,Phase 1/2
59616,Phase 1/2a
68096,Phase 2b
181271,Phase 2a
128098,IND submitted
14734,Phase 0
88386,Phase 1/2
21978,BLA submitted
65229,Preclinical
144790,Phase 1/2a
116961,Investigative
62922,Patented
28718,Phase 0
19554,Phase 0
4193,Discontinued in Phase 2
33109,Phase 2/3
121312,Phase 1/2a
167273,Investigative
173854,Phase 2a
58845,Phase 0
5903,Discontinued in Phase 2
181249,Phase 1b/2a
71975,Phase 0
56512,Phase 3
75911,Phase 1/2
153292,Phase 1
93931,Phase 1/2
25757,Phase 0
181223,Phase 2a
73505,Phase 1/2a
23423,Phase 0
91546,BLA submitted
21192,Phase 0
139370,BLA submitted
94123,Discontinued in Phase 2b
144729,Discontinued in Preregistration
177234,Approved (orphan drug)
69259,Discontinued in Phase 3
169522,Phase 0
89801,Patented
149589,Phase 1b/2a
144993,Investigative
76567,Phase 1/2a
66630,BLA submitted
186159,Phase 0
62458,Discontinued in Phase 3
191837,Discontinued in Phase 3
14063,Phase 0
16039,Phase 1
93614,Phase 2b
83810,Investigative
64330,Phase 2a
103628,Phase 1/2
79656,Phase 2a
107604,Phase 1/2a
59636,Phase 1
106747,Phase 1
35713,Discontinued in Preregistration
181720,Phase 1b/2a
153572,Phase 1b/2a
76275,Phase 1/2
150576,Phase 1
87823,Patented
185865,Phase 2b
6804,Investigative
37558,Phase 1b/2a
41753,Phase 1/2a
93459,Phase 2b
57320,Phase 1/2a
175286,Discontinued in Phase 2
111812,Phase 2
133587,Investigative
63412,Phase 1b/2a
77439,Phase 1/2a
49117,Discontinued in Preregistration
84571,Phase 0
19816,Phase 2
96360,Phase 2b
171737,Investigative
160692,Phase 3
33080,Phase 1b
132104,Patented
70289,Phase 0
20653,Phase 2
90920,BLA submitted
98802,Phase 2
73255,Approved (orphan drug)
121803,Approved
105196,Phase 1b/2a
80577,Phase 2a
189759,Phase 1/2
20286,Discontinued in Phase 2/3
133683,Phase 1b
145606,Phase 1/2
60629,Investigative
77649,Investigative
75518,Discontinued in Phase 1/2
92607,Phase 1b
51500,Discontinued in Phase 2/3
45612,Phase 1/2a
71291,Phase 1/2a
13500,Phase 1b/2a
172727,Phase 2a
4625,Discontinued in Phase 2
100758,Phase 1/2
75690,Phase 1/2a
53040,Phase 1/2a
187457,Phase 1b/2a
71662,Phase 1b/2a
29954,IND submitted
164663,Phase 1
180096,Phase 1/2
57595,Discontinued in Phase 4
108228,Phase 0
138646,BLA submitted
79431,Approved
179143,Phase 1/2a
53595,Phase 1b/2a
182322,Phase 2a
78426,Investigative
100139,Phase 0
58180,Phase 1
167902,Patented
167134,Phase 4
65199,Phase 1b/2a
125499,Phase 1b
126588,Discontinued in Phase 3
90208,Phase 1b/2a
46471,Phase 1/2
79168,Phase 2a
38942,Discontinued in Phase 2
61269,Patented
138923,Discontinued in Phase 2
182970,Phase 1b/2a
169380,Phase 0
165979,Investigative
131265,Patented
110044,Phase 1
9243,Phase 1/2
36873,Discontinued in Phase 2b
144167,IND submitted
122770,Patented
150845,Phase 0
74623,Discontinued in Phase 1/2
177166,Phase 1/2a
60750,Phase 0
114505,Discontinued in Phase 1
49872,Discontinued in Phase 2b
115818,Phase 2/3
101187,Phase 1b
76306,Phase 2/3
138296,Clinical trial
52374,Phase 1b
64462,Phase 1
24605,Phase 1b/2a
16718,Phase 1
150683,Phase 0
80411,Approved
78567,Phase 0
182417,Phase 1/2a
7734,Phase 0
58281,Phase 1b/2a
105738,Phase 0
7421,Phase 1/2
45441,Phase 2/3
98456,Phase 2
165171,Phase 1
56376,Phase 3
100228,Preclinical
11557,Phase 1/2
40825,Phase 1/2a
125563,Phase 1b
73597,Phase 1b/2a
61794,Investigative
23271,Discontinued in Phase 2/3
94241,Phase 2b
24296,Discontinued in Phase 4
177435,Phase 2a
154188,Investigative
49254,IND submitted
164230,Discontinued in Preregistration
47532,Discontinued in Preregistration
25825,Discontinued in Phase 2/3
34385,Phase 1/2a
84287,Phase 1/2a
132453,IND submitted
6326,Discontinued in Phase 2
137375,Phase 1/2
33627,Phase 1
58079,Phase 1b/2a
73648,Phase 2
45743,Phase 2/3
11127,Discontinued in Preregistration
75550,Phase 1/2
98947,Investigative
54580,Phase 1b/2a
106122,Discontinued in Phase 4
14712,Investigative
10127,Preclinical
87302,Discontinued in Phase 3
188365,Phase 1b/2a
117849,Phase 1/2
71611,Phase 0
138015,Phase 1b
38841,Phase 1b/2a
173849,Phase 1
7444,IND submitted
76700,Patented
150806,Phase 0
29722,Phase 0
71102,Discontinued in Phase 1/2
155919,Discontinued in Phase 3
150331,Phase 1/2
103947,IND submitted
69245,Phase 1
83213,Phase 1b/2a
57099,Phase 1b/2a
17533,Phase 1b/2a
8509,Discontinued in Phase 2b
80748,Phase 2a
74736,Discontinued in Phase 4
129852,Phase 1
129194,Investigative
117624,Discontinued in Phase 1
95631,Discontinued in Phase 3
187192,Phase 1b
41285,BLA submitted
26210,Discontinued in Phase 4
159754,Discontinued in Preregistration
118296,Phase 2
5100,Investigative
90562,Phase 1b
8925,Discontinued in Preregistration
4580,Discontinued in Phase 2
165916,Discontinued in Phase 1/2
105455,Phase 1/2a
33964,Patented
99161,Patented
96391,Phase 1/2
3396,Phase 1/2a
1436,Approved (orphan drug)
172385,Phase 0
24446,IND submitted
176415,Phase 1/2
105050,Discontinued in Preregistration
19348,IND submitted
134300,Patented
1410,Discontinued in Phase 2/3
99129,Phase 0
164274,Phase 1
175826,Discontinued in Phase 2
170720,Phase 1/2
178318,Phase 2b
107484,Discontinued in Phase 4
85507,Discontinued in Phase 2b
173655,Phase 2a
134813,Phase 0
32902,Phase 1/2a
146232,Investigative
95461,Discontinued in Preregistration
150514,Phase 1/2a
123571,Phase 1b
33535,Clinical trial
118676,Phase 2/3
135515,Phase 0
142876,Discontinued in Phase 3
52112,Discontinued in Phase 2/3
1573,Phase 1/2
137098,Phase 1b
152041,Phase 0
66357,Discontinued in Phase 2/3
49300,Phase 1/2a
179036,Phase 2a
132858,Discontinued in Phase 1/2
20427,Phase 1
185969,Patented
71864,Phase 1b/2a
179562,Patented
104371,Phase 1b
111782,Phase 1/2a
27499,BLA submitted
42071,Phase 2a
155344,Phase 1/2a
96296,Discontinued in Phase 4
123774,Phase 1b
41658,Phase 1/2a
167256,Discontinued in Phase 1/2
79809,Phase 1
190343,IND submitted
113674,Phase 2
41248,Discontinued in Phase 1/2
142251,Discontinued in Phase 2b
111027,Phase 1/2
135262,Phase 0
69880,Phase 1b
77754,Discontinued in Phase 2
39715,Phase 1/2a
62448,Phase 0
69445,Discontinued in Phase 3
10012,Phase 1b/2a
178965,Phase 1/2
45550,Phase 1/2a
140271,Phase 1b
384,Discontinued in Phase 1
77712,Phase 1b
155505,Approved (orphan drug)
189100,Phase 2b
78504,Discontinued in Phase 1/2
92229,Discontinued in Phase 4
102990,Approved
179867,Phase 1/2a
116560,Discontinued in Phase 4
32531,Phase 2/3
58167,Phase 1
33426,Phase 2/3
140720,Registered
151859,Phase 1
76100,Investigative
88116,Phase 1
152436,Patented
117378,Discontinued in Phase 2/3
45099,Phase 1/2a
57564,Phase 1
113003,Phase 1/2
136759,Phase 1/2
147396,Phase 2/3
140827,Preregistration
173474,Phase 1/2
126250,Phase 1b/2a
43822,Phase 1/2a
154574,Phase 1b/2a
191313,Discontinued in Phase 4
48637,Phase 2
138752,Phase 1b
121271,Phase 1/2a
29384,Phase 2/3
77378,Discontinued in Preregistration
179056,Discontinued in Phase 3
78213,Investigative
16374,Phase 1/2
72233,Discontinued in Phase 4
86000,Phase 1/2
190364,Approved (orphan drug)
118088,Discontinued in Preregistration
83436,Discontinued in Phase 2/3
38853,Phase 2/3
94360,Discontinued in Phase 1
44936,Phase 2/3
164565,Discontinued in Preregistration
157001,Patented
136906,Phase 1/2a
126806,Phase 1/2
79327,Phase 2a
179327,Patented
39583,Phase 1/2
164590,Discontinued in Preregistration
110862,Phase 0
40901,Discontinued in Phase 2
55573,Phase 2
187255,Phase 0
16685,Phase 1
82872,Investigative
175911,Phase 3
20578,Phase 1b/2a
177906,Phase 1
152952,Discontinued in Phase 2b
34415,Phase 0
30571,Investigative
121246,Patented
110717,Phase 0
14371,Phase 0
131106,Phase 2
119596,Discontinued in Preregistration
174737,Phase 1/2
185233,Discontinued in Phase 4
116818,Discontinued in Phase 2/3
84966,Phase 0
89351,Discontinued in Phase 3
99418,Phase 0
168402,Investigative
89799,Phase 2/3
88372,Phase 1/2
67931,Phase 0
82364,Phase 1
43474,Phase 2/3
4227,Investigative
86068,Phase 1
179745,Phase 1/2a
166190,Phase 2
132117,IND submitted
71239,Discontinued in Phase 2b
22342,Phase 1/2
23612,Investigative
142299,Discontinued in Phase 2b
5574,Phase 1b/2a
57610,Discontinued in Phase 3
152325,Phase 2a
77277,Phase 1/2
116069,Phase 2a
77934,Registered
164709,Discontinued in Preregistration
51545,Discontinued in Phase 2b
5008,Phase 2/3
148937,Phase 1
109620,Phase 2
93496,Phase 2
68386,Phase 1b/2a
76937,Phase 1/2a
108200,Phase 1/2a
7451,Discontinued in Phase 2
97353,Phase 1b
12469,Phase 0
104449,Phase 1/2a
54701,Phase 0
65621,Phase 1b
117318,Discontinued in Phase 2/3
27710,Phase 1b/2a
137197,Phase 1/2
10503,Discontinued in Phase 2b
155360,Phase 1/2a
82963,Phase 2
181616,Phase 1b/2a
16653,Phase 0
117509,Discontinued in Phase 1/2
129429,IND submitted
176370,Discontinued in Phase 2
4867,Preregistration
32603,Phase 1/2
110864,Phase 1/2
149636,Phase 2b
115422,Phase 2
126464,IND submitted
82868,Phase 0
144506,Phase 3
41579,Phase 1b/2a
44212,Phase 1/2a
76548,Phase 1/2a
82144,Discontinued in Phase 2
109132,Phase 1/2
28786,Phase 0
38423,Phase 2
179280,Phase 1b
59944,Phase 1
15206,Phase 0
67041,Phase 0
47047,Approved
182992,Phase 1
155789,Phase 1b
106620,Discontinued in Phase 2
114965,Phase 1/2
169079,Discontinued in Phase 2
42548,Phase 2/3
137861,Discontinued in Phase 2/3
139798,Phase 1/2
71151,Discontinued in Phase 3
112955,Discontinued in Phase 3
162796,Phase 1b
115115,Phase 1b
78236,IND submitted
185398,Approved
118486,BLA submitted
36756,Phase 1
156854,Discontinued in Phase 1/2
99539,Patented
51045,Investigative
105661,Phase 2/3
64305,Clinical trial
87018,Patented
165443,Discontinued in Phase 1
23851,Discontinued in Phase 2b
169072,Discontinued in Phase 1
34514,Phase 0
129836,Discontinued in Phase 3
22617,Phase 1b/2a
169087,Phase 1b/2a
154786,Phase 2
106891,Phase 0
15704,Phase 1
183409,Phase 1b
134719,Phase 0
27611,Phase 1/2
172390,Phase 2a
125161,IND submitted
152098,Phase 1/2
163469,Discontinued in Phase 2/3
181011,Phase 1/2a
131101,Phase 1b/2a
187586,Clinical trial
78608,Phase 2a
23943,Phase 1b/2a
140242,Discontinued in Phase 2
98422,Phase 1/2a
148800,Phase 2/3
699,Phase 1
140565,Discontinued in Phase 2/3
46657,Discontinued in Phase 1
87760,Discontinued in Phase 1/2
106595,Discontinued in Phase 3
10170,Phase 1
4483,IND submitted
13140,Phase 0
33722,Phase 0
130805,Phase 1b/2a
55577,Discontinued in Preregistration
75041,Patented
160539,Phase 3
107910,Discontinued in Phase 2/3
11462,Investigative
32320,Phase 2a
186448,Patented
97080,Discontinued in Phase 2b
55243,Discontinued in Phase 2b
157549,Phase 1
30721,Investigative
95515,Phase 1
160374,Phase 2/3
96920,Discontinued in Phase 2
112944,Discontinued in Phase 3
171615,Phase 1
118772,BLA submitted
77726,Phase 1/2a
143555,Discontinued in Phase 4
154251,Investigative
177560,Phase 2
52611,Phase 1/2
120019,Discontinued in Phase 1/2
118763,Phase 2/3
77505,Discontinued in Preregistration
186886,Discontinued in Preregistration
174207,Phase 2
85202,Phase 1
44256,Phase 2/3
190450,IND submitted
52860,Discontinued in Phase 2/3
168574,Phase 1b/2a
6500,Phase 2a
129062,Phase 1/2
177047,Phase 1b
181617,Phase 1/2a
164953,Investigative
100025,Phase 1b
92917,Phase 1/2
40737,Phase 0
71659,Phase 1
180481,Phase 1
50907,Phase 0
169954,IND submitted
122503,Phase 1b
95268,Phase 1/2a
129571,Patented
178837,Phase 1b
74972,Clinical trial
22534,Phase 2
189398,Phase 4
174931,Discontinued in Phase 2
96194,Discontinued in Phase 4
159777,Discontinued in Phase 1/2
59894,Phase 2/3
92138,Phase 1/2a
50988,Phase 0
148268,Phase 2/3
35975,Phase 1/2
120161,Phase 4
148633,Phase 2b
177452,Phase 1b
8724,Phase 0
42304,Phase 1/2a
49326,Discontinued in Phase 2b
158798,Phase 1
147323,Phase 1/2
165536,Phase 0
137561,Phase 1/2
17022,Phase 1/2
11600,Phase 1b/2a
36995,Discontinued in Preregistration
186860,Phase 2a
90700,Clinical trial
139802,Discontinued in Phase 2
37862,Phase 1b
42169,Phase 1b
39916,Phase 1b/2a
65091,Discontinued in Phase 2/3
37591,Phase 0
1096,Approved
128791,Discontinued in Preregistration
13885,Phase 1b/2a
30457,Phase 1b
179843,Phase 1/2a
188013,Investigative
74841,Patented
60272,Phase 0
177773,Approved
94849,Phase 1
94920,Phase 1/2a
177959,Phase 2/3
65463,Preclinical
67187,Phase 1/2
12917,Phase 1/2
114225,IND submitted
184925,Phase 0
115317,Phase 2
78339,Investigative
182513,Phase 3
6650,Discontinued in Phase 2
22489,Phase 1/2
1117,Phase 2/3
75186,Phase 1b/2a
73906,Discontinued in Phase 4
38476,Discontinued in Preregistration
70399,Phase 2/3
36054,Phase 1b
14151,Phase 1
2583,Phase 2
176150,Discontinued in Phase 2
23463,Phase 0
161927,Discontinued in Preregistration
57738,Phase 2/3
149165,Phase 2/3
178101,Phase 1/2a
73335,Clinical trial
27914,Phase 1b
19123,Discontinued in Phase 2/3
77567,Phase 1
61407,Patented
156479,Phase 1
155611,Phase 2
160907,Phase 1
163458,Phase 2
95490,Investigative
77262,IND submitted
127639,Discontinued in Preregistration
174676,Discontinued in Phase 4
95155,Phase 1b/2a
87570,Patented
5042,Phase 2a
39009,Phase 1
138503,Phase 1/2a
184522,Discontinued in Phase 3
46541,Phase 1/2
165856,Discontinued in Phase 1/2
138031,Clinical trial
151324,Phase 0
141218,Discontinued in Phase 2b
102429,Investigative
1907,Approved
153777,Phase 0
111905,Discontinued in Phase 3
140912,Investigative
98773,Phase 0
148106,Phase 1b/2a
172869,Discontinued in Phase 2/3
170253,Phase 0
71359,Phase 0
40393,Investigative
44320,Phase 2/3
16953,Phase 1/2
175934,Discontinued in Phase 2
167698,Phase 1/2a
115541,Discontinued in Preregistration
105071,Phase 1/2a
7466,Phase 1/2
123147,Phase 1b
158497,Phase 1b/2a
39676,Discontinued in Preregistration
160542,Phase 0
132891,Phase 1/2
189188,Phase 1/2a
144121,Phase 1/2
76383,Phase 1/2a
153941,Discontinued in Phase 2/3
157951,Patented
74858,Discontinued in Phase 2b
43859,Phase 1/2a
154512,Discontinued in Phase 2b
158160,Phase 1b
137343,Investigative
80134,Phase 1b/2a
83431,Discontinued in Preregistration
118006,Phase 2
150246,Discontinued in Preregistration
185334,Approved
120795,Phase 0
147670,Phase 0
123034,Patented
67750,Discontinued in Phase 4
169137,Phase 1/2
46101,Phase 1/2a
125464,Phase 1/2
74657,Phase 1/2
131638,Phase 1b/2a
172294,Discontinued in Phase 2b
146897,Phase 1b/2a
83101,Discontinued in Preregistration
184034,BLA submitted
119031,BLA submitted
178903,Discontinued in Phase 1
87843,Phase 1/2
122364,Phase 0
33895,Discontinued in Preregistration
152456,Phase 0
59008,Phase 1b
52579,Phase 1/2a
142677,Phase 1b/2a
124037,Phase 0
183201,Discontinued in Preregistration
6565,Phase 2/3
123129,Phase 1/2
29246,Discontinued in Phase 2/3
97344,Patented
69847,Phase 1
125929,Discontinued in Phase 4
185010,Phase 1
189568,Phase 2b
41524,Phase 1/2a
146000,Phase 1b/2a
83449,Discontinued in Preregistration
132730,Phase 1b/2a
15230,Phase 1
27423,Phase 1/2a
70527,Discontinued in Phase 3
133537,IND submitted
18930,IND submitted
79370,Discontinued in Phase 3
151475,Phase 2
103421,Discontinued in Phase 2/3
48953,Phase 1b/2a
125791,Phase 1b
140312,Investigative
167166,Discontinued in Preregistration
69216,Phase 2/3
131998,Phase 1/2
3465,Discontinued in Phase 2
158186,Phase 1/2
180740,Phase 1/2a
71233,Phase 1b/2a
41135,Discontinued in Phase 4
5379,Investigative
85441,Discontinued in Phase 2b
143746,Discontinued in Preregistration
73959,Approved (orphan drug)
129944,Discontinued in Phase 3
168318,Approved (orphan drug)
51752,Phase 3
79361,Phase 1
89314,Phase 1/2
139696,Investigative
123295,Phase 1b
41615,Phase 2a
48893,Discontinued in Phase 2b
187246,Discontinued in Preregistration
82761,Phase 1/2
27956,Phase 2
102212,Phase 1/2
156401,Phase 1
30182,Discontinued in Preregistration
37139,Phase 1
59059,Phase 1b/2a
40389,Phase 0
115828,Phase 1b/2a
136633,Phase 2
54560,Discontinued in Phase 2b
43044,IND submitted
90250,Clinical trial
180886,Phase 1b
31671,Patented
150369,Phase 1b/2a
184448,Discontinued in Phase 4
190903,Phase 1/2
161378,Phase 1b
188353,Phase 2/3
161254,Discontinued in Phase 4
150620,Phase 1
142296,Discontinued in Phase 2b
13301,Phase 1/2
170455,Phase 0
123321,Phase 1
939,Discontinued in Phase 1/2
136157,Phase 3
166640,Patented
87343,Approved
169550,Phase 0
155891,Discontinued in Phase 4
111142,Discontinued in Phase 2b
172679,Phase 0
127566,Phase 1/2
177316,Phase 1b/2a
55121,Phase 2
62238,Investigative
159840,Phase 2b
66319,Phase 1b/2a
170378,Phase 1
47553,Phase 1
3384,Phase 1/2a
89197,Phase 1/2a
32488,Phase 2a
101565,Investigative
37410,Phase 2
105010,Discontinued in Preregistration
191103,Phase 1
5270,Phase 1/2
173563,Phase 1
176238,Phase 1b/2a
126717,Phase 0
74008,Phase 1/2
83362,Discontinued in Preregistration
27565,Phase 1b
120286,Approved (orphan drug)
19163,Phase 0
169306,Discontinued in Phase 4
26281,Phase 1b
175916,Discontinued in Phase 3
45077,Phase 1/2a
184300,Phase 0
101049,Phase 1b/2a
74203,Phase 1/2
79341,Discontinued in Phase 1
129320,Phase 0
176511,Phase 1/2
94323,Phase 1
23289,Phase 1b
106888,Phase 0
180176,Phase 2b
26134,Discontinued in Phase 2/3
168276,Discontinued in Phase 2b
126495,IND submitted
125003,Phase 0
58165,Investigative
22218,Clinical trial
98423,Phase 1/2a
92744,Discontinued in Phase 3
190290,Discontinued in Phase 3
65504,Phase 1b/2a
160114,Discontinued in Preregistration
72280,Discontinued in Phase 1
2066,Discontinued in Phase 1
79403,Approved
112122,Discontinued in Phase 3
98077,Phase 1/2
99714,Phase 0
72502,Investigative
97760,Discontinued in Phase 2
186097,Investigative
141309,Patented
91219,Phase 1/2
56180,Phase 1b/2a
89800,BLA submitted
59264,Phase 0
64154,Clinical trial
6270,Investigative
105646,Phase 2
140302,Phase 1b
173391,Phase 1/2
133365,Phase 1
61560,Phase 2
6504,Investigative
126210,Phase 1b/2a
115093,Phase 1b/2a
98493,Phase 0
30127,Phase 1b
191762,Phase 0
96664,Phase 2
112825,Phase 1/2
180239,Phase 1/2a
159169,Phase 2
191391,Phase 1
7106,Phase 1/2
145909,Clinical trial
46016,Phase 2/3
77267,Phase 1/2a
148523,Phase 1b
33662,Phase 0
37132,Phase 0
170981,Phase 0
59841,Phase 1b/2a
122500,Phase 1/2
128795,Discontinued in Preregistration
73132,Investigative
109172,Phase 1/2a
62677,Discontinued in Phase 3
188462,Phase 4
114227,Phase 1/2
135990,Phase 1b/2a
161749,Investigative
29148,Phase 0
69410,Discontinued in Phase 2
177885,Approved (orphan drug)
43184,Discontinued in Preregistration
3971,IND submitted
131158,Phase 1/2a
96463,Discontinued in Phase 1/2
3677,Discontinued in Preregistration
45854,Phase 1/2a
69004,IND submitted
101990,Investigative
182447,Discontinued in Phase 4
77963,Phase 0
56232,Phase 1/2
144171,Patented
81721,Phase 1
120675,Discontinued in Phase 1/2
108469,Phase 1b/2a
158043,Phase 0
143694,Discontinued in Preregistration
33646,Approved (orphan drug)
147400,Phase 1/2
41994,Phase 1b
112951,Discontinued in Phase 2
49046,Phase 1b/2a
49623,Phase 1/2a
48730,Phase 2
136095,Preclinical
101545,Phase 2
80003,Phase 2
62839,Discontinued in Phase 4
81396,Phase 1b
55954,Phase 0
101575,Phase 2a
28144,Phase 2
141076,Discontinued in Phase 2b
157042,Phase 1/2
134246,Phase 1/2
73355,Phase 2a
102525,Phase 1
64155,Approved (orphan drug)
98244,Phase 1b/2a
1793,Phase 2
154177,Phase 1/2a
144987,Phase 1b/2a
11680,Discontinued in Phase 2/3
161231,Patented
55193,Investigative
102306,Approved (orphan drug)
94816,Patented
35604,Discontinued in Preregistration
66583,Phase 1b
4254,Investigative
73268,Investigative
134455,Patented
188762,Phase 2b
81513,Phase 1
52951,Phase 1/2
58038,Discontinued in Phase 3
24245,Phase 1b/2a
97999,Phase 1/2a
66524,Discontinued in Phase 2b
46590,Patented
38842,Discontinued in Phase 2
115034,Phase 1/2a
54141,Phase 1b
76393,Phase 1/2
168509,Discontinued in Phase 2
6445,IND submitted
65901,Phase 1b/2a
4014,Patented
84919,Phase 1b/2a
74819,Discontinued in Phase 2/3
87365,Approved
114181,Phase 1
143600,Phase 1b/2a
129100,Phase 1b/2a
86324,Patented
40792,IND submitted
66701,Investigative
149130,Phase 0
73814,Approved (orphan drug)
87759,Phase 2/3
48479,Investigative
75251,Patented
104232,Phase 0
169814,Phase 1b/2a
34384,Discontinued in Phase 2/3
71126,Discontinued in Phase 1/2
179013,Phase 1/2a
139297,Discontinued in Phase 2
89776,Phase 1/2
178278,Phase 2b
56707,Investigative
177274,Phase 2
138454,Phase 1b
23772,Phase 2/3
148424,Phase 2/3
91630,Phase 1b
189506,Approved (orphan drug)
80546,Discontinued in Phase 3
66554,Preclinical
40536,Patented
101965,Phase 0
153969,Phase 1/2a
29035,Phase 4
30122,Discontinued in Preregistration
32988,Phase 3
118891,Phase 1/2a
138704,Approved (orphan drug)
20649,Phase 1b/2a
121934,Discontinued in Phase 1
30545,Phase 1
83641,Discontinued in Phase 4
177386,Phase 1b
59011,Phase 1
121579,Phase 0
74812,Phase 2
58685,Phase 1/2a
110080,Phase 1
77298,Patented
136834,Phase 1/2a
133051,Discontinued in Phase 4
167535,Discontinued in Phase 1
76774,Phase 2/3
31398,Discontinued in Phase 3
107514,Phase 1b
81969,Discontinued in Phase 2/3
9457,Phase 2
107509,Phase 1/2
128612,Discontinued in Phase 3
96258,Phase 1b/2a
108326,Phase 0
22403,Phase 2a
24860,Investigative
102774,IND submitted
169438,Phase 0
77958,Preregistration
107701,Discontinued in Phase 2
34492,Phase 1/2
59503,Phase 2/3
44850,Phase 2/3
103198,Discontinued in Preregistration
75473,Phase 1/2a
54029,IND submitted
29878,Phase 0
57392,Phase 0
183736,Discontinued in Preregistration
186708,Phase 0
107608,Phase 2b
31095,Phase 1
17670,Phase 0
93272,Phase 1/2a
72295,Phase 0
168287,Phase 1b/2a
149693,Phase 1b
152734,Phase 1/2a
102363,Application submitted
3124,IND submitted
41504,Phase 1b
83178,Phase 2
94283,Discontinued in Phase 1
14681,Phase 1
172935,Phase 2
136727,Patented
150715,Phase 2
156633,IND submitted
62314,Investigative
116052,Phase 2
98725,Phase 1b
12641,Phase 0
139610,Phase 1b
11632,Phase 1b
92489,Phase 1
13077,Phase 1/2a
149716,Phase 1
41465,Phase 1
76765,Discontinued in Phase 1/2
148053,Phase 1b
184230,Phase 0
150072,Phase 1b/2a
81960,Clinical trial
63479,Discontinued in Phase 4
110582,Phase 1b
42343,Phase 1
83220,Investigative
113982,Discontinued in Preregistration
2215,Phase 1b
2715,Discontinued in Preregistration
15539,Phase 0
163143,Phase 1
86796,Phase 1b
42118,Discontinued in Phase 1
96561,Discontinued in Phase 1/2
159226,Patented
158895,BLA submitted
161118,Discontinued in Preregistration
127461,Phase 1/2
7864,Phase 1
89974,Phase 0
63035,Phase 1b
35386,Discontinued in Phase 3
114972,Discontinued in Phase 2/3
31897,Phase 1b
136112,Phase 1/2
85259,Discontinued in Phase 2b
54366,Discontinued in Phase 4
98494,Phase 2
6402,Phase 1b/2a
132443,Phase 1/2
53845,Phase 0
85682,Discontinued in Phase 2b
125911,Phase 1b
69110,Phase 1b/2a
164196,Phase 1/2
124447,Phase 1/2
158919,Approved
157751,IND submitted
91198,Clinical trial
33862,Discontinued in Preregistration
98517,Investigative
41490,Approved
110097,Phase 0
121660,Discontinued in Preregistration
68241,Phase 2b
2070,Discontinued in Phase 1
81679,Phase 1b/2a
37238,Phase 1b/2a
122241,Patented
21119,Phase 1b/2a
51640,Discontinued in Phase 2b
138116,BLA submitted
5729,Phase 1/2
56507,Phase 1
108413,Phase 1b
119888,Clinical trial
116293,Phase 1/2
149373,Phase 2b
158393,Phase 1
5414,Phase 1/2
102068,Phase 0
139946,Clinical trial
75239,Discontinued in Phase 2/3
163214,Phase 2
47191,Approved (orphan drug)
134391,Phase 1
113154,Phase 2a
105016,Discontinued in Phase 2b
59084,Phase 1/2a
124157,Discontinued in Phase 4
163656,Discontinued in Phase 3
79829,Discontinued in Phase 2
62247,Phase 1b/2a
72383,Phase 1/2
93232,IND submitted
179362,Phase 1/2a
121566,Phase 1/2
43084,IND submitted
13083,IND submitted
22418,Phase 0
23098,Phase 1b/2a
176214,Clinical trial
75790,Patented
97383,Phase 1/2a
14113,Phase 2b
107798,Discontinued in Phase 3
50992,Phase 1/2a
58699,Phase 1
21350,Patented
111709,Phase 1b
95367,Phase 1
23624,Phase 2/3
11756,IND submitted
71591,Phase 1
58791,Phase 2/3
120648,Approved
147018,Discontinued in Phase 2
79961,Phase 2a
169602,Phase 1
165598,Investigative
26403,Phase 1/2a
38794,Discontinued in Phase 2/3
22282,Discontinued in Phase 1
92774,Discontinued in Phase 1
95075,Discontinued in Phase 4
22024,Discontinued in Phase 4
191918,Phase 2a
79097,Discontinued in Phase 4
142312,Phase 2/3
57820,Approved (orphan drug)
16396,Phase 1b/2a
33664,Phase 1b/2a
90510,Clinical trial
9520,Discontinued in Phase 1
190398,IND submitted
168483,Discontinued in Phase 1
179790,Discontinued in Phase 4
146226,Phase 2/3
87079,Phase 1/2a
187418,Phase 1b
93129,IND submitted
70823,Discontinued in Preregistration
41368,Phase 1b
142810,Discontinued in Phase 4
32540,Phase 1/2
154159,Phase 1/2a
116824,Discontinued in Phase 1
68712,Discontinued in Preregistration
129969,IND submitted
25098,Discontinued in Phase 2/3
107824,Discontinued in Phase 2b
17966,Discontinued in Phase 2b
37008,Discontinued in Phase 2b
130756,Phase 2b
68138,Clinical trial
174403,Discontinued in Phase 3
6481,IND submitted
138730,Phase 1b
150144,Phase 0
46094,Phase 1/2a
93148,Phase 1/2
48106,Phase 1b
155420,Phase 1
149913,Phase 1b/2a
187331,Phase 0
59335,Phase 2/3
190529,Phase 0
139571,BLA submitted
79666,Phase 2
10201,Discontinued in Phase 2b
104208,Phase 1/2a
85099,Phase 1b/2a
45677,Phase 1/2a
182684,Phase 1
3239,Phase 1/2
116988,Discontinued in Phase 1/2
155900,Phase 1b/2a
82271,Discontinued in Preregistration
173317,Phase 0
43252,Phase 1/2a
117961,Phase 2/3
47564,Phase 0
137087,Phase 1b/2a
184294,Discontinued in Phase 4
94560,Phase 1/2a
172960,IND submitted
87204,Approved
128364,Discontinued in Phase 2b
163237,Phase 1b
65057,Discontinued in Phase 2
104525,Investigative
53662,Phase 1b/2a
84515,Phase 0
117135,Discontinued in Phase 2b
72160,Patented
129147,Phase 1/2a
80400,Patented
71894,Phase 1/2
16918,Phase 1/2a
80572,Discontinued in Phase 3
40067,Discontinued in Phase 2
68639,Phase 1
31048,Phase 0
141746,Discontinued in Phase 2b
57035,Phase 1/2a
104925,Approved (orphan drug)
163478,Phase 1/2a
50688,Discontinued in Phase 2b
185390,Approved
164381,Phase 1/2
7847,Phase 1
100235,Discontinued in Phase 4
132065,Discontinued in Phase 4
83011,Phase 1/2a
63905,Phase 2a
125263,Phase 1b
121947,Approved (orphan drug)
146124,Investigative
107012,Discontinued in Phase 1/2
118598,BLA submitted
178925,Discontinued in Phase 3
60743,Phase 1
133252,Discontinued in Phase 1
139988,BLA submitted
17716,Phase 1
138081,Phase 1b
149304,Phase 1/2a
88624,Phase 1/2
25568,Phase 2
174099,Phase 2
164113,Investigative
136013,IND submitted
168126,Discontinued in Phase 1
130663,Phase 1
38354,Phase 2
165130,Discontinued in Phase 4
97316,Patented
44934,Phase 1/2a
12661,Phase 0
22226,Discontinued in Phase 2b
124522,IND submitted
148136,Discontinued in Phase 2/3
152834,Discontinued in Phase 3
136365,Patented
78311,Phase 1
137025,Phase 2
34309,Phase 1b/2a
48242,Phase 1/2a
151502,Discontinued in Phase 2/3
152170,Phase 1
161611,Patented
20498,Phase 1
65258,Phase 1/2a
149939,Phase 1b/2a
109141,Discontinued in Preregistration
64947,Phase 1b/2a
36416,Phase 1/2a
80150,Discontinued in Phase 1/2
123661,Patented
5586,Investigative
109695,Phase 3
110178,IND submitted
3372,Phase 2a
9521,Phase 1/2a
73260,Approved
11895,Discontinued in Phase 2b
59587,Phase 2/3
155964,Phase 1b/2a
130325,Phase 1/2a
54993,Discontinued in Preregistration
178725,Discontinued in Phase 1/2
185215,Discontinued in Phase 3
32427,Phase 2a
104597,Patented
69985,Phase 1/2
49821,Investigative
126893,Discontinued in Phase 2b
10448,Discontinued in Phase 2b
120963,Phase 1b
64313,Approved (orphan drug)
27177,Phase 1b/2a
66854,Phase 0
126519,Phase 1/2
102486,Approved
173765,Phase 1b/2a
100754,Phase 2/3
146147,Discontinued in Phase 2/3
181515,Phase 1b/2a
36725,Discontinued in Preregistration
39169,Discontinued in Phase 2b
62985,Discontinued in Preregistration
51622,Phase 1b/2a
112788,Discontinued in Phase 3
13402,Phase 1/2
92645,Discontinued in Phase 2
134134,Phase 1/2
28245,Phase 0
3821,Approved
230,Discontinued in Phase 1
105500,Patented
15378,Phase 1
180487,Phase 2/3
11092,Investigative
169711,Phase 0
84539,Phase 1b/2a
5944,Phase 2a
156723,Phase 1b/2a
74608,Discontinued in Phase 4
77532,Discontinued in Preregistration
114396,Phase 1/2a
114895,Phase 1/2a
80865,Discontinued in Phase 2
86352,IND submitted
111536,Phase 1
28868,Phase 1/2a
100341,Discontinued in Phase 3
128974,Phase 1
32273,Phase 1
137125,Discontinued in Phase 2
141850,Discontinued in Preregistration
142906,Discontinued in Preregistration
62680,Patented
107533,Phase 1b
135757,Phase 2/3
66513,Patented
120079,Approved (orphan drug)
33441,BLA submitted
96684,Phase 1/2a
48628,Phase 2/3
58015,Discontinued in Phase 4
118736,Phase 2b
177781,Phase 1b
23797,Investigative
89808,Phase 2/3
8965,Discontinued in Preregistration
21444,Phase 2
120667,Phase 0
182989,Phase 1/2a
133103,Discontinued in Phase 4
13434,Phase 1
172118,Phase 1
83747,Phase 1/2
134849,Phase 0
99397,Phase 1b/2a
97374,Phase 2
99659,Patented
87089,Phase 1/2
16010,Phase 1b/2a
153564,Phase 1b
30729,Discontinued in Phase 2b
2722,Phase 1
140254,Clinical trial
115374,Approved (orphan drug)
5622,Investigative
8574,IND submitted
53523,Phase 1b/2a
61439,Patented
116422,Discontinued in Phase 2b
81410,Phase 1b/2a
13369,Investigative
30515,Phase 1
123260,Phase 1/2
19791,Discontinued in Preregistration
144252,Discontinued in Phase 2/3
94844,Discontinued in Phase 1
18535,Preclinical
27211,Phase 1b
53936,Phase 1b
23343,Investigative
136962,Phase 1/2a
153111,Phase 1b/2a
16286,Phase 1
55266,Patented
40501,Discontinued in Preregistration
88259,Patented
135183,Phase 0
154847,Phase 1b/2a
162224,Patented
3066,Patented
133104,Discontinued in Phase 4
158406,Clinical trial
53538,IND submitted
174553,Discontinued in Phase 2
33761,Phase 2a
72341,Phase 1/2
33911,Discontinued in Phase 1
91513,Phase 1b
113947,Phase 1
9184,IND submitted
161713,Investigative
20074,Phase 2a
60965,Investigative
191294,Phase 1/2a
71501,Phase 1
119222,Phase 0
148639,Clinical trial
46818,Approved
155953,Phase 1b
17776,Phase 1
65114,Phase 1b/2a
34589,Phase 1/2a
187433,Phase 4
1959,Approved
80064,Patented
117069,Discontinued in Phase 1
51539,Investigative
6962,Phase 1/2
175453,Phase 2b
76018,Phase 1/2
102935,Phase 1/2
157407,Phase 1
102638,Discontinued in Preregistration
42980,Investigative
18374,Preregistration
135473,Phase 0
118223,Phase 1/2a
98945,Phase 1/2
124413,Phase 0
33344,Phase 1/2a
178435,Discontinued in Phase 1
189078,Clinical trial
103380,Phase 1b
28486,IND submitted
160397,Phase 1/2
116494,Discontinued in Phase 3
103946,Patented
34287,Phase 0
157062,Discontinued in Phase 1/2
12253,Phase 1b/2a
160785,Phase 0
76342,Phase 1/2a
44560,Phase 2/3
40663,Phase 0
34064,Discontinued in Phase 2
170154,Discontinued in Phase 1
186483,Patented
167858,Phase 1/2a
163442,Discontinued in Phase 2b
120291,Discontinued in Phase 1/2
12859,Phase 1
139700,BLA submitted
183578,Approved (orphan drug)
191847,Phase 2/3
47479,Phase 1
18404,Discontinued in Phase 2/3
63608,Phase 2a
93441,IND submitted
28915,Phase 2
46918,Approved
85214,Discontinued in Phase 2b
66904,Patented
12189,Discontinued in Preregistration
73777,Phase 1b/2a
96081,Approved (orphan drug)
96570,Phase 2b
17469,IND submitted
185915,Phase 2a
43849,Phase 2/3
54721,Discontinued in Preregistration
117458,Discontinued in Phase 2/3
17639,Discontinued in Phase 1
155496,Approved
103577,Phase 1b/2a
63986,Discontinued in Phase 2/3
19290,Discontinued in Phase 3
178292,Phase 2/3
52303,Phase 1b/2a
10647,Preclinical
111355,Phase 2
5339,Phase 2a
112678,Phase 0
100596,Patented
99623,Phase 1/2a
183200,Phase 1b/2a
131906,Discontinued in Phase 1/2
44582,Phase 1/2a
134727,Phase 0
114914,Phase 2/3
179818,Phase 1/2a
134799,Phase 0
38589,Phase 0
167056,Discontinued in Phase 1/2
191504,Investigative
99435,Phase 0
163376,Phase 0
181767,Phase 1/2a
42938,Phase 0
66703,Patented
179432,Patented
54926,Patented
191053,IND submitted
104548,Phase 0
43624,Phase 2/3
179947,Phase 1/2a
58524,Phase 1/2a
130331,Investigative
134347,Discontinued in Phase 4
186605,Phase 2a
178939,Phase 1/2
168586,Phase 1/2
117077,Phase 2
112911,Phase 1
121855,Phase 1b/2a
149191,Phase 0
88325,Discontinued in Phase 1
114084,Phase 1b
78097,Approved (orphan drug)
148252,Phase 1/2a
89120,IND submitted
48887,Investigative
81153,Approved
54995,Phase 1/2a
122167,Phase 0
130041,Phase 3
99381,Discontinued in Phase 2/3
44161,Phase 2/3
105334,Phase 2b
64408,Phase 1/2
23160,Discontinued in Phase 2/3
51328,Phase 0
1989,Phase 1/2a
28675,Phase 4
144793,Phase 1
8943,Approved
40340,Phase 1/2
38975,Phase 1/2a
85582,Discontinued in Phase 3
83642,Phase 2
78410,Approved (orphan drug)
33149,Phase 2a
185623,Phase 2
171510,Patented
125777,BLA submitted
163845,Discontinued in Preregistration
168305,Phase 1b/2a
37733,Phase 0
164478,Phase 0
145250,Discontinued in Phase 2/3
109604,Phase 1
5390,Discontinued in Phase 2
183702,Discontinued in Phase 2
22511,Discontinued in Preregistration
150398,Discontinued in Phase 2/3
189632,Phase 4
178831,Phase 1/2a
73066,Phase 1/2a
102645,Phase 1/2a
138882,Investigative
69457,Discontinued in Phase 3
45838,Phase 1/2a
119367,IND submitted
179640,Patented
163320,Investigative
46586,Approved (orphan drug)
165868,Phase 1b
173299,Patented
177187,Phase 2/3
58219,Phase 1b/2a
133271,Approved
46622,Patented
75616,Phase 0
150459,Phase 1b/2a
142884,Phase 2a
178310,Phase 2
31063,Phase 1
166377,Discontinued in Phase 1/2
129755,IND submitted
8450,Discontinued in Phase 2/3
158344,Phase 1b/2a
75227,Phase 0
143947,Phase 0
15906,Phase 0
62466,Phase 1
115553,Phase 1/2
41060,Phase 1/2a
180168,Phase 1/2a
7104,Phase 1b/2a
2993,Discontinued in Phase 3
152760,Approved
40771,Phase 1
28888,Phase 4
68970,Investigative
43238,Phase 1/2a
68776,Discontinued in Phase 4
40493,Investigative
98566,Phase 1/2a
69200,Phase 1b/2a
147905,Patented
91865,Phase 1/2
29701,IND submitted
179665,Patented
120880,Phase 2a
148789,Phase 2b
100471,Patented
36230,Phase 1/2
79885,Discontinued in Phase 2
87007,Investigative
96105,Phase 1
149472,Phase 1b/2a
176958,Discontinued in Phase 2
165969,Phase 1b
11721,Phase 1b
103570,Phase 1/2
116195,Phase 2a
129138,Discontinued in Phase 2b
75235,Discontinued in Phase 4
11904,Phase 1
34120,Phase 1b/2a
113642,Patented
90665,Clinical trial
122968,Patented
97607,Phase 1/2a
185887,Patented
13941,Phase 1/2a
96774,Phase 1b
11177,Discontinued in Preregistration
18984,Discontinued in Phase 2/3
71064,Phase 1b
125056,Phase 1b
63677,Phase 2a
17775,Phase 1
2514,Phase 1b/2a
157387,IND submitted
49193,Phase 0
183714,Phase 2a
165494,Phase 1
94329,Investigative
115556,Phase 1b
5699,Phase 2a
76113,Phase 1/2
38533,Phase 1
127300,Phase 1b/2a
67137,Patented
190338,Approved (orphan drug)
133753,Phase 1b
95728,Phase 1b/2a
72670,Phase 2/3
37182,Phase 2a
107260,Discontinued in Phase 4
105421,Phase 1/2a
118636,Discontinued in Phase 2/3
22427,Phase 2a
150124,Phase 1/2a
130495,Phase 0
9598,Discontinued in Phase 1
157037,IND submitted
111437,Phase 0
147168,Investigative
186789,Phase 0
16943,Phase 0
50697,Discontinued in Preregistration
61761,Discontinued in Phase 2b
176823,Phase 1/2
54087,Discontinued in Phase 2b
156837,Phase 1b/2a
12355,Phase 0
47282,Phase 1b
95329,Phase 1
5590,IND submitted
103865,Patented
172035,Phase 1
42435,Phase 1b
87156,Phase 1b
99636,Discontinued in Phase 2/3
11414,Investigative
13127,Discontinued in Phase 1
34708,Phase 2/3
132003,Phase 1b/2a
110099,Phase 0
108028,Investigative
115496,Phase 1/2a
169811,Phase 1/2
36166,Phase 1
126780,Discontinued in Phase 2b
10064,Phase 1b/2a
73956,Discontinued in Phase 4
53072,Phase 1/2
4407,Investigative
78124,Investigative
157919,Phase 1b/2a
152651,Discontinued in Phase 3
64725,Approved (orphan drug)
147441,Investigative
91019,Phase 1b
74961,Phase 0
7176,Phase 1b/2a
158879,IND submitted
1001,Approved
184727,Discontinued in Phase 3
170110,Patented
48241,Phase 0
163953,Phase 0
89342,Discontinued in Preregistration
76558,Discontinued in Phase 1/2
170085,Investigative
7248,Phase 1b/2a
119295,Discontinued in Phase 1
166393,Phase 1b/2a
133998,Phase 1
44633,Phase 2/3
165249,Discontinued in Preregistration
513,Phase 1/2a
62967,Phase 0
115602,Discontinued in Phase 2
7687,Patented
60218,Phase 0
83643,Phase 2/3
108671,Phase 1
100308,Approved
6874,Phase 4
169387,Discontinued in Phase 4
104334,Phase 1b/2a
150942,Discontinued in Phase 2/3
173000,Phase 1/2
93386,Phase 1/2a
178974,Phase 0
108769,Investigative
82757,Patented
141986,Discontinued in Phase 2b
105250,Phase 2a
52246,IND submitted
6995,Phase 2a
62616,Investigative
98378,Phase 1b
7888,Phase 1
57051,Phase 1/2a
53548,Phase 1/2
127536,Discontinued in Phase 2b
101306,Phase 1/2
15910,Phase 1
91663,Phase 1b
147453,Phase 0
112720,Phase 1
7673,Discontinued in Phase 3
150852,Phase 1
129219,Phase 1/2
30296,Phase 1/2
137165,Phase 2
92572,Phase 1b
22118,Phase 2/3
75435,Phase 1/2a
148011,Phase 1b
148988,Phase 2a
45755,Phase 1/2a
124169,Phase 0
131772,Phase 0
12474,Phase 1
148975,Phase 1
181031,Phase 1
107240,Phase 1/2a
172769,Phase 2a
84498,Phase 1/2
168755,Discontinued in Phase 1/2
90938,BLA submitted
139746,BLA submitted
146946,Phase 0
150073,Phase 1b/2a
49777,Discontinued in Phase 2b
126430,Phase 1b/2a
165752,Phase 1b/2a
148636,Investigative
81738,Approved
4353,Investigative
47076,IND submitted
137729,Phase 1/2
117510,Phase 1/2
132087,Phase 1b/2a
62286,Investigative
166389,Phase 1b
97937,Phase 1/2
29891,Investigative
80068,Discontinued in Phase 4
53816,Discontinued in Phase 2b
101638,Phase 1b
183387,Discontinued in Phase 2
28741,Discontinued in Phase 2/3
97409,Phase 1/2a
97465,Phase 1b
184503,BLA submitted
113985,Discontinued in Preregistration
182783,Phase 1
38015,Phase 2/3
111586,Discontinued in Phase 3
134717,Phase 0
65520,Preclinical
190115,Phase 2b
104485,Patented
134076,Patented
85745,Discontinued in Phase 2b
144410,Phase 3
186473,Phase 4
152573,Patented
140975,IND submitted
13625,Phase 1
4614,Investigative
48738,Patented
121786,Patented
45933,Phase 1/2a
65077,Discontinued in Phase 2/3
119010,Phase 1/2a
10660,Preclinical
113508,Phase 1b
161455,Phase 1/2a
24058,Phase 2
165684,Phase 1b/2a
72032,Phase 1/2
23454,Investigative
167477,Investigative
62918,Discontinued in Phase 3
65987,Discontinued in Phase 2/3
4404,Phase 1b/2a
187862,Phase 0
69630,Phase 2/3
104207,IND submitted
50574,Patented
179507,Phase 1/2a
7565,Phase 1/2
86761,Phase 2
162922,Phase 1/2
23873,Phase 2
31383,Discontinued in Preregistration
986,Clinical trial
10378,Phase 1
158692,IND submitted
42489,Phase 2a
104914,Phase 1/2
137845,Discontinued in Phase 3
192054,Discontinued in Phase 1/2
20637,Phase 2
44998,Phase 1/2a
42185,Phase 2a
16523,Phase 1/2a
17085,IND submitted
52032,Phase 1b
5074,Preregistration
116562,Discontinued in Phase 2b
179957,Discontinued in Phase 1
148320,Phase 2b
158799,Phase 2
188302,Phase 1b
49294,Discontinued in Phase 2
148853,Phase 2/3
75683,Phase 1/2a
30866,Phase 1/2a
83290,Discontinued in Phase 4
74277,Phase 1/2a
22800,Phase 2
166077,Discontinued in Phase 1/2
21197,Phase 1
70443,Phase 1
31334,IND submitted
162590,Discontinued in Phase 4
165501,Discontinued in Phase 2
116865,Clinical trial
129039,Phase 1/2
11284,Discontinued in Phase 2/3
183205,Phase 1b/2a
112662,Discontinued in Phase 3
144244,Discontinued in Phase 2
184423,Phase 0
45754,Phase 2/3
39474,Phase 2
61964,Discontinued in Preregistration
124698,Phase 1b
29887,Phase 1b
29696,Phase 1/2
25313,Phase 0
39233,Phase 1/2
164207,Phase 0
95317,Phase 1
160488,Phase 0
132798,IND submitted
11711,Phase 1
112730,Phase 1/2
181647,Discontinued in Phase 4
87680,BLA submitted
47252,Approved
19872,Phase 1
141889,Phase 0
55915,Phase 1b
15227,Phase 1b/2a
5378,Phase 1/2
112677,Phase 0
167778,Phase 1b/2a
142664,Phase 1b/2a
870,Phase 1/2
64418,Phase 1
73681,Phase 1b/2a
169397,Discontinued in Phase 4
146120,Discontinued in Phase 2
56090,Patented
107605,Phase 1/2a
190015,Phase 1/2
22632,Phase 1
110205,Phase 1/2
69162,Phase 2/3
169354,Discontinued in Preregistration
129319,Patented
18632,Discontinued in Phase 2/3
88976,Phase 1/2a
189015,Phase 1b/2a
6422,Phase 1/2
56870,IND submitted
150173,Phase 1b/2a
70902,Phase 1b/2a
114291,Patented
140843,Phase 1b/2a
119340,Phase 2
187871,Discontinued in Preregistration
51831,Phase 1/2a
27637,IND submitted
17440,Phase 1
181714,Phase 3
117789,Discontinued in Phase 1/2
69000,Phase 2/3
87456,Phase 1/2a
188137,Patented
139375,Clinical trial
20550,IND submitted
68823,Phase 1
23910,Phase 2
94743,Patented
14607,Phase 1
134306,Phase 1
42974,Phase 1b
18039,Phase 1/2a
5026,Phase 2a
64074,Phase 1/2a
67303,Discontinued in Phase 2/3
54512,Phase 1b/2a
147193,Investigative
153563,Phase 1/2
76528,Phase 1b/2a
33630,Phase 2/3
20197,Patented
35613,Discontinued in Phase 4
153464,IND submitted
121121,Phase 2a
74330,Discontinued in Phase 4
44470,Phase 1/2a
100901,Phase 1/2
45416,Phase 2/3
63599,Phase 1b/2a
34473,Phase 0
24501,Phase 2
143436,Phase 2a
3044,Discontinued in Phase 2b
50766,IND submitted
139026,Phase 1b
65653,Phase 1
97907,Phase 1b
131187,Phase 0
30875,Phase 1
92587,Discontinued in Phase 2b
139991,Clinical trial
188312,Phase 1/2
174234,Phase 2
32284,Phase 2
143110,Phase 2b
125243,Phase 1b
39444,Discontinued in Phase 2b
166510,Phase 1b
147361,Phase 1/2
5891,Phase 1/2
105280,Phase 1/2
182307,Discontinued in Phase 2
98568,Phase 2
87262,Phase 0
191097,Discontinued in Preregistration
177603,Phase 1b
41160,Discontinued in Phase 1/2
182945,Discontinued in Phase 2b
7899,Phase 1/2
169699,Discontinued in Phase 2/3
11583,Investigative
149313,Investigative
133235,Discontinued in Phase 1
20108,Approved (orphan drug)
151256,Phase 1
163490,Phase 2b
7330,Phase 2/3
34650,Phase 0
164372,BLA submitted
65745,Phase 1b/2a
137259,Investigative
82264,Patented
43563,Phase 1/2a
38758,Phase 1
67082,Phase 3
140717,Preregistration
139368,Phase 1b
54579,Phase 0
144968,Discontinued in Phase 1
123035,Discontinued in Phase 4
105621,Phase 1
102208,Phase 0
75618,Phase 1b/2a
158732,Approved
20516,Discontinued in Phase 2b
148731,Phase 1b/2a
65595,Phase 1b
130297,Discontinued in Phase 2/3
84756,Phase 0
127697,Discontinued in Phase 4
25392,Phase 1b/2a
120437,Discontinued in Phase 4
176006,Phase 1/2
41276,BLA submitted
4978,IND submitted
131945,Discontinued in Phase 1/2
181517,Phase 1/2a
37618,Phase 1b/2a
135948,Phase 1b/2a
2307,Phase 1b/2a
116064,Discontinued in Phase 2
35118,Phase 2a
123670,Phase 1b
141340,Discontinued in Phase 2b
8746,Phase 1b/2a
85995,Phase 2
176021,Phase 0
3296,Discontinued in Phase 2b
54591,Phase 0
171298,IND submitted
126106,Investigative
147306,Phase 2b
131786,Discontinued in Phase 4
57683,Phase 2/3
90038,Discontinued in Phase 1/2
65069,Phase 1b
117160,Discontinued in Phase 4
46756,Approved
47289,Phase 0
141154,Discontinued in Preregistration
82376,Discontinued in Preregistration
131814,Discontinued in Phase 4
183651,IND submitted
26923,IND submitted
27990,Discontinued in Phase 4
54144,Phase 1b
43270,Phase 1/2a
174202,Discontinued in Phase 2
181326,Phase 2b
143064,Phase 1b/2a
3589,Approved (orphan drug)
79591,Phase 1
65588,Phase 1/2
20089,IND submitted
28067,Phase 2/3
100204,Discontinued in Phase 1
64471,Patented
126876,Discontinued in Phase 3
76108,Phase 1/2a
127382,Phase 1/2
90769,Approved
31768,Phase 0
28278,Discontinued in Phase 4
46947,Phase 1
188351,Phase 1/2
94727,Discontinued in Phase 4
129449,Discontinued in Phase 3
7869,Phase 1/2
100289,Approved
139790,BLA submitted
16273,Phase 0
83380,Discontinued in Phase 4
167833,Discontinued in Phase 3
52976,Phase 4
40516,Phase 1b/2a
122412,Phase 1/2
365,Phase 2
70898,Discontinued in Preregistration
18722,Phase 1b
38764,Phase 0
136035,IND submitted
9027,IND submitted
52793,Discontinued in Phase 2/3
175945,Discontinued in Phase 4
182625,Phase 2b
3769,Investigative
184711,Phase 0
22653,Phase 2a
24235,Phase 1b/2a
179575,Discontinued in Phase 3
25127,Phase 1b/2a
66692,Patented
190146,Phase 2/3
182500,Phase 1b/2a
179043,Phase 1/2
54477,Phase 1b/2a
36399,Patented
147297,Phase 0
177646,Phase 2
100391,Investigative
108786,Phase 1/2a
130014,Phase 2a
157740,Discontinued in Phase 2
132148,Phase 2
90661,Phase 0
11971,Phase 1/2a
74506,Discontinued in Phase 4
13106,Phase 1
20237,Phase 1
4783,Phase 2/3
162722,Investigative
101657,Phase 2a
32591,Phase 1b/2a
64107,Clinical trial
70870,Phase 1/2a
22841,Discontinued in Phase 2/3
93375,Phase 1b
53631,Phase 1/2
120577,Phase 4
160300,Phase 1/2a
57165,Phase 0
25366,Phase 1/2a
81093,Approved
23006,Phase 1/2
96163,Discontinued in Phase 4
159204,Phase 1b/2a
77260,Discontinued in Phase 1/2
89032,BLA submitted
35486,Discontinued in Phase 3
162713,Phase 1/2a
46518,Phase 2
105127,Phase 1/2
88543,Discontinued in Phase 4
192024,Discontinued in Phase 2
145052,Phase 1b
188821,Phase 2/3
34432,Phase 0
52125,IND submitted
85607,Discontinued in Phase 2b
146491,Investigative
12185,IND submitted
175531,Phase 2
75011,Discontinued in Phase 4
84276,Discontinued in Phase 4
48025,Phase 2
157968,Registered
97989,Phase 0
162124,Patented
113275,Clinical trial
158948,Phase 2
39859,Phase 0
51297,Discontinued in Phase 2/3
161578,Phase 1b
184484,Discontinued in Phase 4
72611,Phase 1/2
19829,Phase 0
137133,Discontinued in Phase 2/3
8117,Discontinued in Phase 3
169846,Phase 1
111919,Discontinued in Phase 2
21220,Discontinued in Phase 3
92347,Phase 1
1362,Discontinued in Phase 2
662,Phase 2
70939,Discontinued in Phase 3
183512,IND submitted
82970,Phase 0
1450,Discontinued in Phase 4
74295,Investigative
39766,Phase 1b/2a
128724,Discontinued in Phase 2b
158589,Phase 2/3
184584,Phase 1/2
178267,Investigative
111409,Discontinued in Phase 4
102333,Approved (orphan drug)
130966,Discontinued in Phase 4
137094,Discontinued in Phase 2b
165514,Phase 0
49222,Phase 0
91340,Approved
120892,Phase 2a
103002,Discontinued in Preregistration
57118,Patented
79871,Phase 1
29860,Phase 0
61072,Phase 1/2a
47801,Phase 0
131572,Patented
69422,Discontinued in Phase 2/3
52566,Discontinued in Preregistration
143063,Phase 1b/2a
90836,BLA submitted
179483,Patented
135709,Phase 3
124777,Phase 1/2
84795,Phase 0
189962,Clinical trial
150807,Phase 0
56439,Phase 1/2a
41776,Discontinued in Phase 1
20833,Patented
98576,Patented
180998,Discontinued in Phase 4
30422,IND submitted
121602,Phase 2b
122985,Phase 1/2
22185,Phase 1/2
175733,IND submitted
52175,Phase 1b
58686,Investigative
179240,Discontinued in Phase 2/3
169171,Phase 2
162197,Phase 0
166414,Phase 1
157852,Approved (orphan drug)
98012,Discontinued in Phase 2
159552,Investigative
165064,Patented
60508,Approved (orphan drug)
65741,Discontinued in Phase 4
13398,Phase 1/2
153992,Phase 1/2a
138733,BLA submitted
113970,Phase 1
87143,Discontinued in Phase 1/2
65634,Phase 1b/2a
26530,Phase 1b
164266,Discontinued in Preregistration
67942,Phase 1/2
157706,Clinical trial
4490,Discontinued in Phase 2
168947,Phase 1/2
8790,Discontinued in Phase 2
98535,Phase 1/2a
55718,Discontinued in Phase 2b
1819,Approved
159509,Phase 0
157303,Phase 1
88747,Phase 1
94372,Phase 2a
184654,Discontinued in Phase 4
171490,IND submitted
128112,Discontinued in Phase 2b
126325,Phase 1b/2a
7047,Investigative
128176,Phase 0
124646,Phase 1/2
168203,Approved
14722,Phase 1/2
179070,Phase 1/2
3001,Phase 1/2
82342,Phase 1b/2a
4123,IND submitted
158724,Clinical trial
35785,Discontinued in Phase 3
119194,Preregistration
32562,Phase 1/2
165094,Phase 0
120158,Approved (orphan drug)
114837,Investigative
156630,Approved (orphan drug)
143198,Investigative
129768,Discontinued in Phase 3
70246,Phase 1b/2a
175308,Discontinued in Phase 1/2
154538,Phase 2
6656,Phase 1/2
141072,Discontinued in Phase 2b
161564,Patented
189139,Preclinical
33148,Phase 1b/2a
152447,IND submitted
160463,Phase 2a
156338,Discontinued in Phase 3
27253,Discontinued in Phase 2
159476,Phase 1
44875,Phase 1/2a
78888,Discontinued in Phase 4
89695,Phase 1/2
20299,Phase 1
141350,Patented
40254,Phase 2
97453,Investigative
98037,Phase 2/3
146855,Phase 1/2
157171,Patented
138255,BLA submitted
81305,Clinical trial
53761,Phase 2
183797,IND submitted
134110,Phase 1
128134,IND submitted
22358,Phase 0
152538,Phase 1/2a
169223,Clinical trial
108677,BLA submitted
70774,Phase 2b
14128,Phase 1
154977,Phase 1b/2a
108660,Phase 1
77083,Phase 1/2
165701,Discontinued in Phase 4
3938,Phase 1
96403,Phase 1/2a
47149,Approved (orphan drug)
183832,Approved (orphan drug)
111102,Phase 0
150521,Phase 1/2
18485,Phase 2a
168267,Discontinued in Phase 2/3
156831,Phase 1b
151768,Phase 0
111509,Phase 0
64456,Phase 1
111815,Phase 1/2
23919,Phase 2/3
99793,Phase 1/2a
119368,Phase 2
87716,Discontinued in Phase 3
84034,Phase 0
48205,Phase 1b/2a
180973,Phase 2a
9678,Phase 1b/2a
37621,Phase 1
136691,Phase 1/2a
181790,Phase 1/2a
60149,Phase 1b/2a
50863,Phase 1
46790,Approved
125606,Investigative
5833,IND submitted
133914,Phase 1
56544,Discontinued in Phase 4
41597,Investigative
169459,Phase 0
89266,Phase 1b
64664,Phase 1b/2a
109086,Phase 0
168985,Phase 1/2
171484,Investigative
90574,Discontinued in Preregistration
87996,Phase 1/2
187384,Patented
141235,Patented
11901,Phase 1b
127662,Discontinued in Phase 2b
159901,Phase 1b/2a
74466,Discontinued in Phase 3
43861,Phase 1/2a
7060,Phase 2a
159658,Discontinued in Preregistration
183492,Discontinued in Phase 2
111129,Discontinued in Phase 3
171753,Phase 1/2
161836,Phase 0
174848,Phase 1/2
62584,Discontinued in Phase 4
147250,Phase 1/2
115304,Phase 1b
130876,Phase 1b
130391,Patented
178942,Phase 1b
168778,Phase 0
27941,Discontinued in Phase 2/3
32002,Phase 1b/2a
113730,Phase 1
121927,Phase 1/2
160703,Phase 1/2a
99424,Phase 1
28066,Phase 1b/2a
98668,Phase 1b/2a
146736,Discontinued in Preregistration
20358,Phase 1b/2a
25984,Phase 1b/2a
140216,Phase 1/2
177342,Phase 1b
179914,Phase 1/2a
120232,Approved
85139,Phase 1b/2a
134576,Phase 1/2a
107052,Phase 1b
149210,Phase 1
84962,Phase 1/2a
86056,Phase 1
267,Approved (orphan drug)
22376,Phase 0
129191,Discontinued in Preregistration
105617,Phase 1b/2a
85974,Discontinued in Preregistration
91054,Phase 2/3
17916,Phase 1/2a
23154,Phase 1/2
133698,Patented
46678,Discontinued in Phase 1
125866,Investigative
34897,Discontinued in Phase 3
147008,Patented
56085,Phase 0
123761,Discontinued in Phase 4
33394,Approved (orphan drug)
112366,Phase 0
174668,Phase 0
164554,Phase 0
99210,Phase 1b/2a
120166,Approved (orphan drug)
71473,Discontinued in Preregistration
71050,Discontinued in Phase 1/2
188431,Phase 2/3
123944,Phase 1
91368,BLA submitted
160811,Phase 1/2a
56318,Phase 1b/2a
26442,Phase 0
81033,Discontinued in Phase 2
104194,Phase 1b/2a
6713,Discontinued in Phase 2
19195,Discontinued in Phase 1/2
143166,Discontinued in Preregistration
116358,Discontinued in Phase 2/3
7642,Phase 2
63817,Approved
148880,Patented
82293,Patented
92791,IND submitted
70867,Investigative
176548,Phase 1
45556,Phase 1/2a
66694,Patented
144412,Discontinued in Phase 1/2
94717,Phase 1
122724,Discontinued in Phase 4
6091,Phase 4
93199,Phase 2b
144919,Phase 1
179604,Discontinued in Phase 2/3
148978,Phase 2
85360,Discontinued in Phase 3
81320,Phase 1b/2a
137593,Discontinued in Phase 3
10593,IND submitted
186223,Phase 2/3
128937,Phase 1/2
40541,Phase 1b/2a
185551,Phase 0
166914,Discontinued in Preregistration
166638,Phase 0
25939,Phase 0
77765,Phase 2
119153,Clinical trial
98683,Phase 1/2
170153,Phase 1/2
41813,Approved
121173,Phase 1
86534,Phase 1/2
136997,Phase 2
108586,Phase 1
24461,Phase 1b/2a
136973,Phase 1/2
141705,Phase 1b
146877,Phase 2b
176955,Phase 1/2
101209,Discontinued in Preregistration
177746,Phase 1b
67944,Phase 1
186073,Phase 2/3
179094,Patented
50264,Phase 1b
153209,Phase 1b/2a
72527,Phase 1b/2a
5105,Phase 2a
122300,Phase 1/2
55314,Phase 1b
116188,Phase 1/2
94670,Patented
89371,Phase 1b/2a
170568,Phase 0
78179,Phase 1/2
35854,Phase 1/2a
53403,Discontinued in Phase 2/3
39711,Patented
42188,Phase 1b
49525,Discontinued in Preregistration
117980,Phase 2
35154,BLA submitted
178651,Patented
53010,IND submitted
104659,Patented
138718,Phase 1b
164639,Phase 1
139466,Phase 1b
97035,Phase 1/2
94960,Patented
108906,Phase 4
31220,Investigative
54092,Phase 1/2
189910,Clinical trial
13354,Phase 1/2
110034,Phase 1
151841,Phase 0
57570,Phase 2/3
90051,Discontinued in Preregistration
23883,Phase 2/3
178518,Discontinued in Phase 1/2
125462,Phase 1b
31039,Phase 1/2
14971,Phase 1
89947,Phase 1b/2a
186932,Patented
163800,Phase 1
29274,Phase 2
128931,Phase 1/2
98411,Phase 1b
177081,Phase 1/2
79582,Phase 2
96078,Discontinued in Phase 1/2
23637,Phase 1/2a
146075,Phase 1/2
126366,Investigative
85505,Discontinued in Phase 2b
153668,Approved
86287,Discontinued in Phase 4
30141,Patented
105020,Phase 1/2
22847,Phase 2/3
10401,Discontinued in Phase 2/3
129105,IND submitted
5290,Preregistration
51443,Discontinued in Phase 2b
140768,Phase 1b/2a
77684,Phase 0
159450,Discontinued in Preregistration
117835,Phase 1
164965,Phase 1/2a
131538,IND submitted
165284,Investigative
18780,Discontinued in Preregistration
57398,Investigative
155130,Investigative
149923,Investigative
185110,Discontinued in Phase 4
70499,Phase 0
9347,Patented
63226,Phase 1
17261,Phase 1
70776,Discontinued in Phase 2b
6611,Phase 1/2
40610,IND submitted
177776,Phase 2a
159609,Discontinued in Phase 1/2
30775,Clinical trial
53001,Phase 0
156553,Discontinued in Phase 4
136378,Discontinued in Phase 2/3
13143,Phase 0
106108,Discontinued in Preregistration
101265,Discontinued in Phase 1/2
162495,Patented
149496,Phase 1b
50402,Phase 1b
19922,Phase 0
54799,Phase 1/2a
127011,Discontinued in Phase 1
56575,Phase 1/2a
61786,Discontinued in Phase 4
47487,Discontinued in Phase 4
175332,Discontinued in Preregistration
126520,Phase 0
95638,Phase 1/2
166004,Phase 1b/2a
20283,Phase 1b/2a
97057,Phase 2/3
149723,Phase 1b
50168,Phase 1/2
129063,Discontinued in Phase 1
33851,Discontinued in Phase 4
96607,Patented
141694,Investigative
186063,Patented
168816,Phase 0
136565,Discontinued in Phase 2
55129,Discontinued in Preregistration
14501,Phase 1
169985,Phase 2b
36636,Phase 1
71758,Discontinued in Phase 1
179287,Phase 0
54657,Phase 1
45241,Phase 2/3
82825,Phase 0
12023,Phase 1/2a
47355,Phase 0
85702,Discontinued in Phase 3
137895,Phase 1/2a
147812,Phase 1b/2a
36360,Patented
93302,Phase 2b
16006,Phase 1
123750,Phase 1
90229,Clinical trial
168990,Discontinued in Phase 3
163138,Investigative
81575,Approved
20457,Discontinued in Phase 2
61871,Discontinued in Phase 4
91269,Phase 0
165341,Discontinued in Phase 2/3
29952,Phase 1
101436,Phase 0
94853,Patented
175634,Phase 1/2
3657,Investigative
40652,Discontinued in Phase 4
174732,Phase 1
149950,Phase 1
46972,Discontinued in Phase 1
77428,Patented
45554,Phase 2/3
148451,Patented
168698,Discontinued in Phase 1/2
67108,Phase 1/2
12908,Phase 0
67848,Clinical trial
133012,Phase 1/2
99807,Investigative
156342,Phase 1b
7754,Phase 0
115310,Discontinued in Preregistration
70809,Phase 2b
120078,Approved (orphan drug)
85368,Discontinued in Preregistration
100869,Phase 2
40892,Investigative
6012,Investigative
156765,Discontinued in Phase 1/2
157897,Phase 1b
17857,Phase 2b
27589,Phase 1b/2a
164864,Investigative
14877,IND submitted
146495,Phase 1b
136961,Phase 1/2a
48143,Phase 1
83625,Phase 0
58487,Discontinued in Phase 2/3
33073,Phase 1b/2a
31780,Phase 0
146460,Phase 2/3
158705,Phase 1b/2a
52086,Patented
92779,Phase 1b
51336,Phase 1
3010,Phase 0
175427,Phase 0
71555,Phase 0
101788,Phase 1
180887,Phase 2/3
24517,Discontinued in Phase 2b
159520,IND submitted
138845,BLA submitted
135149,Phase 0
136683,Phase 1/2a
163407,Discontinued in Phase 2b
84340,Phase 1/2
28434,Phase 0
158135,Patented
126052,Phase 1b/2a
87526,Approved
32102,Discontinued in Phase 1
33352,Phase 1b/2a
21842,Approved (orphan drug)
142863,Phase 1/2
46718,BLA submitted
55931,Discontinued in Phase 2b
36724,Discontinued in Preregistration
25971,Investigative
28878,Phase 1b
132925,Discontinued in Phase 1/2
132151,Discontinued in Phase 4
157746,Phase 2
14690,Phase 3
26570,Phase 1/2a
177004,Phase 1
59421,Phase 1b/2a
68567,Discontinued in Phase 4
53239,Investigative
120356,IND submitted
30671,Investigative
11584,Discontinued in Preregistration
138510,Phase 1b
50188,Phase 3
60157,Phase 1b/2a
56363,Phase 1/2a
97210,Phase 1b/2a
118729,Phase 0
7009,Phase 4
79686,Phase 1b/2a
87048,Patented
84423,Phase 0
34912,Phase 1/2
114521,Phase 0
177954,Phase 1/2
120780,Discontinued in Phase 1/2
103202,Approved (orphan drug)
69125,Phase 2b
72104,Phase 1/2
130565,Phase 1b/2a
48640,Discontinued in Phase 3
138336,BLA submitted
139804,Approved (orphan drug)
54252,Phase 0
187627,Patented
105390,Phase 2b
178245,Phase 1b/2a
99991,Phase 2/3
115466,Clinical trial
60274,Phase 0
189003,Phase 2/3
99225,Phase 1/2a
90262,Phase 1b
1811,Phase 2
29476,Discontinued in Phase 2
57805,Phase 1b/2a
67285,Phase 1b
3441,Discontinued in Phase 3
154781,Phase 2
51504,Discontinued in Phase 2b
70510,Phase 1b/2a
60568,Phase 1/2a
128783,IND submitted
44882,Phase 2/3
137703,Phase 1b/2a
133611,Phase 1/2a
2851,Phase 1b
189315,Phase 2/3
6822,Investigative
156685,IND submitted
52675,Phase 0
171576,Patented
91056,Phase 1b
36163,Phase 1b/2a
25054,Phase 0
177058,Phase 1/2a
28630,Phase 2
134993,Phase 0
42769,Discontinued in Phase 2/3
81637,Approved
67819,Phase 0
189978,Discontinued in Phase 3
89244,Phase 1/2a
60549,Phase 1b/2a
78776,Phase 0
127380,Discontinued in Phase 3
49761,Phase 1
190242,IND submitted
31657,Phase 1b
116357,Phase 2
179357,Phase 1b
911,Clinical trial
189447,Phase 1/2
57417,Phase 0
9942,Phase 0
20118,Investigative
29889,Discontinued in Phase 2b
76189,Phase 1b
128375,Phase 1/2a
130290,Phase 1/2a
94880,Discontinued in Phase 1
173135,Discontinued in Phase 2b
47008,Approved
49879,Discontinued in Phase 2b
143566,Phase 2b
137892,Phase 2
175217,Discontinued in Phase 2/3
1659,Discontinued in Phase 2
38800,Phase 1/2a
61552,Phase 1/2
169148,Discontinued in Phase 1
147626,Phase 1b
37874,Phase 1b
37861,Phase 1/2a
25089,Phase 1
3176,Phase 2a
53437,Phase 0
57808,Phase 0
171519,Discontinued in Phase 2
41205,Approved
18496,Discontinued in Phase 2/3
48891,Phase 1
54501,Discontinued in Phase 4
120855,IND submitted
145133,Discontinued in Phase 2/3
6309,Investigative
144472,Discontinued in Phase 2
102097,Discontinued in Preregistration
158647,Phase 2/3
146113,Phase 1/2
44787,Phase 1/2a
135580,Phase 0
16409,Phase 1
75609,Patented
90996,BLA submitted
42937,Patented
54713,Phase 2
170445,Phase 1/2
92921,IND submitted
67306,Patented
43478,Phase 1/2a
91634,BLA submitted
128178,Phase 1/2
99970,Phase 1b
48573,Discontinued in Preregistration
54195,Phase 1/2
14062,Phase 0
151552,Phase 2
170519,Phase 0
182453,Phase 2a
172747,Discontinued in Phase 2b
89890,BLA submitted
22491,Phase 1/2
138690,BLA submitted
154736,Phase 3
134951,Phase 0
58718,Phase 2/3
105313,Phase 2a
5046,Investigative
180261,Phase 1/2a
118977,Phase 1/2a
6364,IND submitted
177436,Phase 1b
175256,Phase 1
13590,Phase 1/2
165728,Phase 1b
76252,Phase 1/2
59221,Discontinued in Phase 1/2
35822,Phase 0
47090,Approved
102459,Phase 1/2
23596,Discontinued in Phase 4
182661,Phase 1/2a
29161,Phase 1b
182469,Phase 1b/2a
71829,Phase 1b
47868,Phase 1
115264,Phase 1/2
104155,BLA submitted
39229,Phase 2
123257,Phase 1/2
191361,Patented
66924,Patented
87215,Phase 1/2
78941,Phase 0
106934,Phase 1
77653,Phase 1/2
162540,Investigative
85007,Phase 1/2a
121583,Phase 2b
174022,Phase 1b/2a
61604,IND submitted
117079,Discontinued in Phase 3
185609,Patented
141579,Discontinued in Phase 2b
43489,Phase 2/3
29688,Discontinued in Phase 2b
115614,Clinical trial
43190,IND submitted
134755,Phase 0
69658,Phase 1
100263,Discontinued in Phase 2
66522,Preclinical
142508,Discontinued in Phase 2/3
89462,Discontinued in Preregistration
184644,Phase 1/2
106400,Phase 1
15660,Phase 1/2a
14583,Phase 0
190199,Phase 2/3
91130,Phase 2/3
42708,Phase 2/3
10952,Phase 0
71491,Discontinued in Preregistration
130460,Investigative
18467,Phase 3
106842,Phase 1b
185190,Approved
20565,Phase 1
78224,Discontinued in Preregistration
136432,Investigative
21167,IND submitted
20402,Discontinued in Phase 2b
97740,Phase 1b/2a
20852,Investigative
103,Phase 1
40918,Discontinued in Phase 1/2
139231,Discontinued in Phase 1/2
179678,Phase 0
68457,Phase 1
169883,Discontinued in Preregistration
89929,Phase 1b/2a
73627,Phase 1b
177729,Approved
147155,Phase 2a
89697,Patented
189854,Phase 2b
19189,Discontinued in Phase 1
65754,Preclinical
53978,Patented
131447,Phase 1b/2a
165262,Phase 0
59083,Phase 2/3
130080,Phase 2
191330,Phase 1/2a
177206,Phase 1b/2a
166271,Phase 2
127160,Phase 0
156641,Phase 1b/2a
76118,IND submitted
1208,Investigative
118201,Discontinued in Phase 2/3
50497,Phase 2
67803,Phase 1
123341,Approved
145059,Discontinued in Preregistration
3045,Discontinued in Phase 2
77538,Discontinued in Preregistration
180329,Phase 1/2
128051,Phase 1/2a
135297,Phase 0
36327,Investigative
162800,Phase 1b
9659,Patented
189207,Phase 1/2
30272,Discontinued in Preregistration
168327,Approved (orphan drug)
180121,Phase 1
56703,Phase 1/2a
7313,Phase 1/2
121554,Discontinued in Phase 1
39123,Phase 2
59701,Phase 1b/2a
37000,Discontinued in Phase 1
157016,Phase 1/2
173016,Phase 1/2
122888,Phase 1
68411,Phase 1b
57686,Phase 1/2
141186,Patented
174017,Discontinued in Phase 3
42841,Investigative
103686,Phase 1/2
138567,Phase 1/2a
92931,Discontinued in Phase 1
184039,Phase 0
9207,Discontinued in Phase 2
174936,Phase 2
11636,Phase 2
147930,Phase 2b
48497,Phase 1b
15484,Investigative
110743,Phase 1/2
177622,Phase 2a
54682,Phase 1b/2a
3421,Phase 1/2
166408,Phase 1b
191170,Approved
62966,Phase 1
97779,Phase 1/2a
164212,Phase 1/2
186953,Phase 4
49354,Phase 0
7302,Phase 1b/2a
164524,Phase 0
85611,Discontinued in Preregistration
182714,Phase 3
103036,Application submitted
25463,Phase 2
97931,Phase 1/2a
177171,Phase 1/2
20156,Patented
152226,Phase 1b/2a
107436,Phase 1/2
88043,Phase 1/2
162397,Investigative
51412,Phase 3
179068,Patented
97245,Phase 1/2a
83443,Phase 1/2
30703,Phase 0
50594,Discontinued in Preregistration
67573,Phase 1
176071,Phase 2
54814,Phase 2
141151,Phase 1/2
46978,Clinical trial
10329,Discontinued in Phase 3
92349,Phase 1/2
105224,Phase 1b/2a
183942,Phase 0
177566,Phase 1b
122741,Discontinued in Preregistration
25699,Phase 1/2a
139131,BLA submitted
81387,Approved
10539,Discontinued in Phase 2b
19835,Phase 1
115761,Clinical trial
124603,Patented
154763,Phase 1b/2a
63121,Patented
102491,Phase 1/2a
91025,Discontinued in Phase 1
157203,Discontinued in Phase 4
152506,Investigative
131498,Phase 1b/2a
91771,Approved (orphan drug)
90696,Phase 1b/2a
9043,Discontinued in Preregistration
15369,Phase 1/2
84698,Phase 1/2
100223,Discontinued in Phase 1/2
58505,Phase 1b
162315,Discontinued in Phase 4
42284,Phase 1/2a
102948,Investigative
66067,Preclinical
128137,Discontinued in Phase 4
97995,Patented
123928,IND submitted
125270,Phase 1b/2a
117156,Discontinued in Preregistration
4802,Phase 1/2
153046,Investigative
96851,Phase 1/2
74708,Discontinued in Phase 4
75653,Phase 0
46417,Discontinued in Phase 4
47015,Discontinued in Phase 2
189110,Phase 1/2a
96049,BLA submitted
113781,Phase 1b/2a
188972,Phase 2b
64694,Phase 1/2
77498,Phase 1
155366,Phase 1/2a
157853,Discontinued in Phase 4
163497,Discontinued in Phase 2
124753,IND submitted
99863,Patented
82298,Phase 1/2a
189852,IND submitted
67435,Phase 1b
2475,Phase 2
144295,Discontinued in Phase 4
84722,Phase 1/2a
130928,Discontinued in Preregistration
57032,IND submitted
110757,Discontinued in Phase 2b
15498,Phase 1
69705,Phase 1b
143495,Phase 1b/2a
17106,Phase 1
141538,Discontinued in Preregistration
76330,Phase 1/2
60034,Phase 2/3
113650,Phase 2
12694,Phase 1/2a
91647,IND submitted
140668,Phase 1b/2a
4681,IND submitted
68851,Discontinued in Preregistration
47639,IND submitted
22485,IND submitted
52226,Discontinued in Preregistration
147726,Phase 0
67844,Phase 2b
75360,Phase 0
109965,Patented
129325,Discontinued in Phase 4
23302,Phase 1/2
153331,Investigative
65910,Preclinical
89144,Phase 2/3
36009,Phase 0
129593,Discontinued in Phase 2b
101195,Phase 1b
173582,Phase 1/2a
128736,Phase 1
92576,Approved (orphan drug)
38909,Phase 1
108624,Patented
22396,Phase 1/2
4684,Phase 2a
188579,Patented
14669,Phase 1
139383,Phase 1/2a
72585,Phase 2
59712,Phase 0
37047,Phase 2a
41495,Phase 1
252,Discontinued in Phase 1
98252,Phase 1/2a
57812,Phase 0
83684,Investigative
161667,Discontinued in Preregistration
26398,Phase 2
5619,Phase 1b/2a
19467,IND submitted
3601,Investigative
507,Phase 2b
85110,Phase 0
53935,Phase 1b/2a
55729,IND submitted
92065,Discontinued in Phase 2
73851,Clinical trial
164955,Discontinued in Preregistration
145287,Phase 1/2a
161318,Phase 1b
90448,Phase 1b
155791,Phase 1b/2a
392,Phase 1/2a
42538,Investigative
43953,Phase 2/3
91211,Discontinued in Phase 3
93880,Phase 1/2a
89046,BLA submitted
76949,Phase 0
153348,Phase 1/2a
43942,Phase 1/2a
143419,Investigative
46237,Phase 1b/2a
88738,Patented
154393,Phase 1b/2a
45491,Phase 1/2a
181752,Phase 2a
74055,Investigative
127340,Phase 0
95518,Phase 1b
31630,Phase 0
186954,Phase 4
37785,Phase 1
178535,Discontinued in Phase 3
139083,Phase 1b
60396,Approved (orphan drug)
131812,Phase 2
33012,Phase 2a
23627,Phase 1/2a
117948,Discontinued in Preregistration
56889,Phase 2
30177,Phase 1b/2a
3767,Discontinued in Phase 3
140124,BLA submitted
56882,Discontinued in Phase 3
6042,Phase 1b/2a
4956,Investigative
113187,Phase 1
108357,Phase 1b
172560,Phase 0
175921,Phase 1
70770,Discontinued in Phase 3
167351,Phase 4
178530,Phase 1/2a
139656,BLA submitted
105111,Phase 1/2a
69511,Discontinued in Phase 3
43342,Phase 1/2a
57867,Phase 2/3
53534,Phase 1b/2a
121740,Approved
177160,Phase 1
27685,IND submitted
166335,Phase 1
148060,Phase 0
2473,Phase 0
138047,Investigative
52476,Discontinued in Preregistration
8176,Phase 1b
139931,Phase 1/2
24568,Phase 1b/2a
169095,Phase 2
106192,Discontinued in Preregistration
187102,Phase 1b
6843,Phase 1b/2a
84677,Phase 1/2a
4025,Phase 2a
168909,Phase 1/2
81576,Investigative
142379,Phase 1
65087,Discontinued in Preregistration
8615,Phase 0
108593,Investigative
6462,Investigative
33781,Phase 1b
6199,Phase 4
46810,Clinical trial
17046,Phase 1/2
146550,Discontinued in Phase 2
141190,Investigative
161494,Investigative
93899,Phase 2b
53406,Discontinued in Phase 2b
11957,Phase 1/2a
132230,Phase 1
33562,Approved (orphan drug)
151233,Phase 2
165883,Phase 1b/2a
138697,Phase 1b
128500,Phase 0
185911,Phase 1
188119,Phase 2/3
140412,Investigative
81011,Phase 2
106972,Phase 0
70511,Discontinued in Preregistration
63339,Discontinued in Phase 4
93882,IND submitted
125902,Phase 1b
109200,Phase 0
18432,Phase 1b/2a
152836,Phase 2
8060,Patented
181425,Phase 2b
66913,Patented
131135,Phase 1b
13010,Phase 1
21292,Phase 1b
162971,Discontinued in Phase 1/2
79004,Phase 2a
118854,Discontinued in Preregistration
139300,Investigative
76029,Phase 1/2
52240,Phase 1b
170360,Phase 1b/2a
110601,Discontinued in Phase 3
107845,Discontinued in Phase 2/3
40820,Phase 1/2
143254,Phase 2b
135681,Phase 3
110154,IND submitted
174516,Phase 1
175603,Patented
130631,Investigative
91940,Phase 0
1640,Phase 2
151699,Phase 1
104636,Phase 0
78303,Investigative
155734,Phase 1b
74027,Phase 1/2
100948,Phase 3
38360,IND submitted
41532,Phase 0
32804,Phase 2/3
115003,Phase 1/2a
112989,Discontinued in Phase 1
687,Discontinued in Phase 2/3
124098,Phase 1b
50455,Phase 1
105217,Phase 0
42641,Discontinued in Phase 2/3
140260,Phase 1/2
7243,Phase 4
116719,Discontinued in Phase 3
173410,Discontinued in Phase 2
152572,Approved
134491,Phase 1/2
88135,Phase 1/2
82739,Discontinued in Phase 4
178712,Phase 1/2a
110995,Phase 2
190771,Phase 2/3
87580,Phase 0
190525,IND submitted
8928,Discontinued in Phase 1
55764,Phase 3
83834,Phase 1/2
46362,Phase 1/2
138936,BLA submitted
112946,Phase 1/2
85395,Discontinued in Preregistration
31418,Discontinued in Phase 2b
165317,IND submitted
162354,Phase 3
105987,Phase 2
53045,Phase 4
175505,Phase 0
175581,Phase 1/2
65984,Phase 1
42758,Phase 0
11635,Phase 2/3
4116,Phase 1b/2a
20362,Discontinued in Phase 2/3
107025,Discontinued in Phase 2b
7556,Phase 1/2
9427,Discontinued in Phase 2/3
113871,Phase 2
139446,Phase 1/2
33144,Phase 1b
187709,Patented
43454,Phase 1/2a
146830,Phase 1
39286,Patented
85304,Discontinued in Phase 2b
146045,Phase 2/3
100605,Discontinued in Phase 1/2
61927,Phase 1/2a
26288,Phase 2/3
41740,Investigative
132011,Discontinued in Phase 4
10099,IND submitted
21538,Phase 1b/2a
150263,Phase 1
107510,Discontinued in Preregistration
22865,Discontinued in Phase 2/3
80911,Investigative
88940,Phase 1/2a
124856,Phase 1b
129205,Patented
85675,Discontinued in Phase 2b
148932,Investigative
117453,Phase 1
72618,IND submitted
35245,Phase 1b
51146,Phase 1b/2a
107105,Phase 1b
175835,Discontinued in Phase 3
67469,Discontinued in Phase 1
60055,Discontinued in Phase 2/3
49897,Phase 1
138617,Approved (orphan drug)
185701,Phase 0
42604,Phase 2/3
47734,Patented
130396,Patented
14362,Phase 1
22142,Discontinued in Phase 3
150462,Phase 1b/2a
22504,Phase 2
7129,IND submitted
6325,Phase 4
59471,Discontinued in Phase 4
114182,Phase 1b
15577,Investigative
73228,Clinical trial
26737,Phase 1
137235,Phase 1/2
132083,Discontinued in Phase 2/3
169341,Discontinued in Phase 4
112460,Discontinued in Phase 2
180110,Discontinued in Preregistration
88183,Phase 1b/2a
86275,Phase 0
137104,Investigative
44973,Phase 1/2a
114968,Phase 1b
71850,Discontinued in Preregistration
123078,Investigative
61779,Discontinued in Phase 2b
163807,Phase 1
26845,Phase 1
54218,IND submitted
18693,Discontinued in Phase 2/3
21517,Phase 0
28831,Investigative
149475,Discontinued in Phase 2
127261,Patented
84314,Phase 1b/2a
64171,Phase 2a
94534,Phase 1/2a
118407,Discontinued in Preregistration
144264,Discontinued in Phase 2/3
178215,Phase 1b/2a
117944,Discontinued in Preregistration
53294,Patented
87484,Discontinued in Phase 1/2
182861,Phase 1/2a
66036,Phase 1
83654,Phase 0
141097,Phase 0
12509,Phase 1/2
132385,Patented
29121,Investigative
133664,Phase 1/2a
159346,Approved
28919,Phase 1b/2a
107036,Discontinued in Phase 4
64893,Phase 2a
36292,Discontinued in Phase 4
140248,Phase 1b
93482,Phase 1
49658,Phase 1b/2a
99417,Phase 1/2
74652,Investigative
134764,Phase 0
144540,Clinical trial
113918,Phase 1b
116739,Discontinued in Phase 3
137774,Phase 1/2a
16661,Phase 1/2
135597,Phase 0
137550,Phase 1/2a
145642,Phase 0
132824,Discontinued in Preregistration
147724,IND submitted
2498,IND submitted
190092,Clinical trial
112538,Phase 1/2
143284,Discontinued in Phase 3
45796,Phase 1/2a
117280,Discontinued in Phase 4
161726,Discontinued in Phase 1/2
58239,Discontinued in Phase 4
46293,Phase 1/2
90308,Discontinued in Preregistration
123521,Phase 1/2
5179,Phase 2/3
80847,Phase 1b
104230,Phase 1/2a
10627,Discontinued in Preregistration
163454,Phase 2/3
88405,Phase 1
76912,Phase 1/2a
186919,Preclinical
64784,Discontinued in Phase 2/3
176807,Phase 1b
80095,Phase 1
146767,Clinical trial
152751,Discontinued in Phase 3
62786,Phase 1
8814,Phase 1/2
3109,Patented
152214,Phase 1
162777,Phase 1/2a
153283,Phase 0
129572,Phase 0
140181,Investigative
170801,Phase 1b/2a
54374,Phase 2
40117,Discontinued in Phase 2
100413,Phase 1
36103,Phase 0
16218,Phase 1
171962,Phase 1/2
137971,Phase 1b
139212,Investigative
44380,Phase 1/2a
37347,Phase 2a
95326,Phase 1/2a
8264,Patented
55073,Phase 1b/2a
187313,Phase 4
157321,Phase 1b/2a
42521,Phase 1/2a
885,Phase 2a
160018,Discontinued in Preregistration
41744,Discontinued in Phase 1
114294,Discontinued in Preregistration
73373,Phase 1/2a
180411,Phase 1/2a
54825,Phase 2
171882,Phase 1/2
69853,Phase 1
152784,Approved
103130,Approved
110198,Phase 2
34017,Phase 1b/2a
129463,Patented
84283,Phase 1/2
86754,Discontinued in Phase 1
119818,Phase 0
7699,Phase 0
104417,Discontinued in Phase 4
114744,Discontinued in Phase 3
165512,Discontinued in Phase 1/2
172793,IND submitted
23404,Patented
173447,Discontinued in Phase 2b
183546,IND submitted
106469,Approved
187169,Patented
74516,Discontinued in Phase 4
120502,Approved (orphan drug)
191461,Phase 1/2a
39215,Phase 1/2a
34916,Phase 1
177046,Phase 1/2a
13100,Phase 0
189628,Phase 1b
140493,Phase 1/2
91702,Phase 1b
84924,Phase 1b/2a
53367,Phase 0
67981,Preclinical
14652,Phase 1b/2a
10846,Phase 0
24830,Phase 1
95754,Investigative
150656,Phase 1
105271,Phase 2b
49224,Phase 1/2a
165658,Investigative
84144,Phase 1
64106,Phase 2/3
32564,Discontinued in Phase 1
113571,Investigative
46811,Approved
177428,Phase 2
109517,Preregistration
75234,Phase 1/2a
117179,Discontinued in Phase 3
154711,Phase 1b/2a
13736,Phase 1/2
31584,Discontinued in Phase 3
188060,Phase 2b
88079,Approved
7326,Investigative
155525,Approved (orphan drug)
143579,Discontinued in Phase 4
26823,BLA submitted
120434,Discontinued in Phase 3
54324,Phase 1/2a
181743,Discontinued in Phase 2b
151001,Phase 0
48078,Discontinued in Preregistration
102797,Discontinued in Preregistration
175994,Phase 0
174907,Discontinued in Phase 1/2
149515,Discontinued in Phase 2
113474,Discontinued in Phase 1
22917,Discontinued in Phase 4
120384,Clinical trial
2080,Phase 1b
143491,Investigative
38546,Phase 1b
97249,Phase 1/2a
6728,Phase 1/2
44692,Phase 1/2a
91489,Investigative
78207,Approved
57586,Phase 0
116355,Discontinued in Phase 2b
188536,Phase 1b
48963,Discontinued in Preregistration
180186,Phase 1b
171119,Phase 1/2
99208,Phase 1/2a
89101,Clinical trial
8804,Discontinued in Phase 2
77175,Phase 0
22957,Phase 2/3
46276,Investigative
129523,Discontinued in Preregistration
188320,Phase 2b
21744,Discontinued in Phase 1/2
118683,BLA submitted
40981,Discontinued in Phase 4
30284,IND submitted
94100,Discontinued in Phase 1
1269,IND submitted
76298,Discontinued in Phase 1/2
149890,Phase 1/2a
171495,Discontinued in Phase 2
109455,Phase 2
129379,Discontinued in Preregistration
138103,Phase 1b
84303,Investigative
178977,Discontinued in Phase 3
28141,Phase 1b/2a
55515,Discontinued in Phase 2b
1971,Approved
144784,Discontinued in Phase 2/3
66038,Phase 1/2a
190810,Discontinued in Phase 3
182741,Phase 1
139490,Phase 1/2
160715,Phase 2a
25555,Phase 1
101971,Application submitted
58817,Phase 0
187265,Phase 2a
158185,Phase 1/2a
167751,Approved (orphan drug)
65854,Phase 1
54784,Phase 1b/2a
74379,Phase 1/2
5810,Phase 1/2
187633,Phase 2/3
170075,IND submitted
131579,Discontinued in Phase 2/3
128034,Phase 1/2
140428,Phase 1
131390,Phase 1
62810,Phase 1/2
179247,Phase 1/2a
147518,Phase 1/2
33312,Phase 1b
92795,Investigative
80660,Phase 2a
167480,Phase 1/2a
43158,Phase 1/2
181850,Phase 1b/2a
81923,Phase 1b/2a
132844,Phase 1/2
161103,Phase 1
74418,Discontinued in Phase 3
153591,Phase 2a
10956,Phase 0
99974,Phase 2
36277,Investigative
22080,Discontinued in Phase 1/2
39643,Investigative
113942,Phase 1b
83203,Discontinued in Phase 4
180834,Phase 1
126475,Patented
75815,Investigative
104031,Phase 1b
50125,Phase 1b/2a
55692,Phase 1/2a
16136,Phase 1/2
163473,Phase 1b
87180,Phase 1b
41492,IND submitted
8445,Phase 2
181105,Phase 2a
79586,BLA submitted
53649,Phase 1
72271,Phase 1/2
11537,Phase 1/2a
101388,Phase 0
134988,Phase 0
129183,Phase 1/2
1481,Approved (orphan drug)
140285,Phase 1/2
75900,Phase 1/2a
75444,Phase 1
64538,Phase 1
30539,Phase 1b/2a
11875,Phase 1/2
83416,Phase 1b/2a
45931,Phase 1/2a
48171,Discontinued in Phase 2b
81525,Approved
15982,Phase 0
85598,Discontinued in Phase 2b
15013,Phase 1
29084,Phase 1/2a
100648,Phase 3
4206,Phase 1b/2a
146693,Discontinued in Phase 2/3
136147,IND submitted
149514,Discontinued in Phase 2
47663,Phase 1b
151270,Phase 2
187565,Phase 2a
22922,Phase 1
123497,Discontinued in Phase 4
6705,Investigative
13234,Phase 0
150520,Phase 1/2
36040,Phase 2a
147192,Phase 1b
51129,Phase 1b/2a
54182,Patented
7209,Investigative
63897,Phase 1/2a
151641,Phase 0
78889,Phase 3
89343,Phase 1/2a
110092,Phase 1
158120,Phase 2a
51426,Phase 1b/2a
27027,Phase 1b
100492,Phase 1b
54731,Phase 1/2a
12701,Phase 1/2
20642,Phase 1/2a
37224,Phase 2
155194,Patented
79868,Patented
182686,Phase 1b
57583,Phase 1
133602,Discontinued in Preregistration
61886,Discontinued in Phase 4
140916,Investigative
59213,Discontinued in Phase 3
170532,Discontinued in Phase 1
164226,Phase 1/2
139067,Clinical trial
19213,Phase 1b
65968,Discontinued in Phase 2b
71709,Phase 1b
42421,Approved
484,Discontinued in Phase 1/2
20527,Phase 0
23097,Phase 2a
178354,Phase 1
134072,Phase 1/2a
97698,Phase 1b
103623,Phase 2a
114351,Phase 2
132961,Discontinued in Phase 4
125572,Phase 1b/2a
50799,Discontinued in Preregistration
145705,Phase 1b/2a
95038,Phase 1/2a
175661,Phase 1/2
69680,Discontinued in Phase 2
72767,Investigative
47713,Investigative
105921,Phase 1/2
23558,IND submitted
97515,Phase 1b
34799,Phase 1/2a
156244,Phase 1/2
3051,Phase 0
141984,Discontinued in Phase 2b
85947,Discontinued in Preregistration
112982,Phase 1b
81965,Phase 1b/2a
143627,Discontinued in Phase 4
62877,Discontinued in Phase 3
108676,Discontinued in Phase 2/3
57660,Clinical trial
113818,Phase 2
129419,Phase 1/2a
28495,Investigative
94659,Patented
175060,Phase 1/2
99131,Patented
61127,Phase 2/3
164041,BLA submitted
37150,Discontinued in Phase 1
77885,Phase 2
92426,Discontinued in Phase 3
78884,Phase 2/3
20403,Phase 1
28312,IND submitted
76380,Phase 1
27238,Discontinued in Phase 2/3
9042,Discontinued in Phase 4
58429,Discontinued in Phase 3
30719,Phase 1b
153055,Phase 1b/2a
86108,Phase 1/2
189846,Phase 1/2
56235,Phase 1/2a
49891,Phase 1/2
121575,Approved
45136,Phase 2/3
58303,Phase 1b/2a
160405,Phase 3
28050,Phase 1b
53314,Discontinued in Preregistration
46991,BLA submitted
157201,Phase 1b/2a
188961,Phase 1/2
115941,Approved (orphan drug)
156427,Phase 1
10733,Phase 1/2
159566,Phase 2
34707,Phase 1b/2a
69365,Phase 1b
140031,BLA submitted
138813,Discontinued in Phase 2
128557,Patented
7656,Phase 2
181613,Phase 3
114333,Phase 1b/2a
177229,Phase 1b
2404,Discontinued in Phase 1/2
71858,Phase 1/2
67644,Phase 1/2
103625,Clinical trial
29195,Investigative
45488,Phase 2/3
61946,Discontinued in Preregistration
56868,Discontinued in Phase 3
40742,Discontinued in Phase 2
155321,Phase 1
150879,Phase 2
133256,Discontinued in Phase 1
76802,Investigative
125829,Discontinued in Phase 4
108394,Phase 1/2a
4872,Phase 1b/2a
94363,Phase 1b
80336,Clinical trial
52503,Phase 1b/2a
68332,Patented
74613,Phase 1/2a
35017,Discontinued in Phase 3
82359,Phase 0
108442,Phase 1
117032,Investigative
186992,Patented
165583,Discontinued in Phase 2/3
132170,Phase 1b/2a
16220,IND submitted
169202,Approved
171394,Discontinued in Phase 2
17885,IND submitted
146178,Phase 1b
41375,Phase 2
136927,Phase 1/2
157799,Phase 1b/2a
11534,Investigative
28740,Discontinued in Phase 2/3
109176,Investigative
178042,Patented
191194,IND submitted
82460,Phase 1/2a
34849,Discontinued in Phase 3
126863,Phase 1/2a
163291,IND submitted
42557,Phase 1
63017,Discontinued in Phase 3
92596,Discontinued in Phase 2b
27845,Phase 2/3
148812,Discontinued in Phase 2
115368,Phase 1b/2a
98363,Phase 1/2a
96262,Discontinued in Phase 1/2
187908,Discontinued in Phase 4
138868,Clinical trial
21374,Phase 2a
48387,Investigative
152198,Phase 2
31498,Phase 0
158633,Phase 1b/2a
99841,Investigative
159973,Phase 1b/2a
152258,Phase 1
163647,Phase 2b
106028,Phase 1/2a
126834,Discontinued in Phase 2b
81309,Approved
130838,Phase 1b
170961,Phase 0
96192,BLA submitted
191871,Phase 2/3
136502,Phase 0
43562,Phase 2/3
22698,Phase 2/3
147234,Phase 1b
40301,Discontinued in Preregistration
34617,Phase 1b/2a
73850,Approved (orphan drug)
188737,Phase 2b
98737,Phase 2/3
87424,Phase 1b/2a
43302,Phase 1/2a
155245,Phase 2/3
155081,Phase 1b
24289,Phase 2/3
11344,Phase 1b
115261,Phase 1b/2a
96476,Discontinued in Phase 3
122124,Phase 1b
77584,Phase 1b
14179,Phase 0
159503,IND submitted
43831,Phase 2/3
90716,Discontinued in Phase 2b
184494,Phase 0
60706,Phase 2/3
165967,Patented
94706,Patented
185060,Discontinued in Phase 4
85748,Discontinued in Phase 2b
13839,Phase 1
151035,Phase 2
75960,Discontinued in Phase 1/2
130999,IND submitted
125154,Phase 1b
94700,Discontinued in Phase 1
133560,IND submitted
98643,Phase 1/2a
71737,Phase 0
42910,Phase 1b
113077,Phase 1b/2a
19362,Phase 2a
141548,Patented
28137,Phase 2/3
172673,Discontinued in Phase 2b
99577,Phase 1
156691,Phase 1
127549,Patented
64641,Approved (orphan drug)
60675,Discontinued in Phase 4
120576,Clinical trial
78696,Phase 2a
172947,Discontinued in Phase 2
152455,Patented
91785,Discontinued in Phase 1
72604,IND submitted
52873,IND submitted
151357,Phase 2
94539,Patented
135298,Phase 0
77534,Phase 1
36717,Phase 2a
99500,Discontinued in Phase 2/3
109123,Discontinued in Phase 2
85591,Discontinued in Phase 2b
108290,Phase 1b
179128,Phase 1/2a
128418,Discontinued in Phase 2b
65344,Discontinued in Phase 2b
180188,Phase 2/3
148992,Phase 1/2a
173625,Approved (orphan drug)
70454,Phase 0
47011,Discontinued in Phase 2/3
152071,Phase 2
142043,Discontinued in Phase 1
174877,Discontinued in Phase 1/2
88718,Discontinued in Phase 4
126632,Discontinued in Phase 3
136224,Phase 1/2a
97002,Phase 0
157008,Phase 1
110973,Discontinued in Phase 2b
135482,Phase 0
182208,Discontinued in Phase 2
118026,Phase 2a
177164,Phase 1b
63639,Phase 2a
80896,Clinical trial
182405,Phase 2a
178262,Phase 2/3
61396,Phase 2/3
52488,Phase 1/2a
189137,Patented
64294,Phase 1/2
67257,Discontinued in Phase 1
11702,IND submitted
156546,IND submitted
34677,Patented
169774,Phase 1b
106618,Discontinued in Phase 4
161662,Patented
157628,Clinical trial
36571,Phase 1
165478,Discontinued in Phase 4
106708,Phase 1/2a
26868,Phase 0
73544,Investigative
23744,Discontinued in Phase 4
32396,Discontinued in Phase 1
81929,Clinical trial
178472,Phase 1/2
58816,Phase 0
83162,Investigative
15926,Phase 0
123763,IND submitted
16353,Phase 1/2
116076,Clinical trial
87660,Phase 2a
123799,Phase 0
144633,Patented
46218,Phase 2/3
183995,Discontinued in Phase 4
75312,Phase 1b/2a
191265,Phase 1
40388,Phase 0
12269,Phase 1
182202,Phase 2a
83309,Phase 0
99404,Patented
114653,Investigative
171072,Phase 0
64838,Clinical trial
76434,Phase 1/2
13670,Phase 0
48352,Phase 3
1505,Phase 1
141208,Phase 2/3
43796,Phase 1/2a
127657,Patented
151716,Phase 2
166650,Patented
38141,Phase 1/2
81973,Discontinued in Phase 1
31946,Phase 2/3
79918,Phase 2
141029,Discontinued in Phase 2b
34400,Phase 1b/2a
119164,Phase 0
88087,Discontinued in Phase 2/3
344,Approved (orphan drug)
140944,Phase 2/3
3596,Approved (orphan drug)
160634,Phase 2a
22523,Discontinued in Phase 4
80342,BLA submitted
153729,Phase 1/2a
24500,Investigative
24411,Phase 1/2
52233,Phase 1b/2a
53971,Phase 1/2
124880,Phase 0
28462,Investigative
53571,Phase 0
129810,Investigative
125857,BLA submitted
154906,Phase 2
79171,Phase 1b
188148,Phase 1/2a
44021,Phase 1/2a
183938,BLA submitted
143194,Discontinued in Preregistration
116514,Discontinued in Phase 3
75987,Phase 0
142955,Discontinued in Preregistration
64747,Approved (orphan drug)
140123,Clinical trial
56049,Phase 2
128414,Phase 1/2
187767,BLA submitted
11828,IND submitted
117597,Phase 2
116666,Discontinued in Phase 1
100966,Investigative
191030,Investigative
142279,Phase 1
105002,Phase 1b/2a
149882,Discontinued in Phase 1
15059,Phase 0
112875,Phase 1
143688,Phase 1b/2a
132866,Phase 1/2
29267,Investigative
71298,Discontinued in Phase 3
41088,Discontinued in Phase 1
57659,Phase 1b/2a
178718,Discontinued in Phase 3
117701,Investigative
71854,Patented
172959,Phase 1/2
92282,Discontinued in Phase 1
184732,Phase 0
179007,Discontinued in Phase 1
175861,Discontinued in Phase 3
162779,Phase 1
120859,Patented
112936,Phase 1
96220,Phase 1b
27060,Phase 1b
16658,Phase 1
4805,Discontinued in Phase 2
21110,Phase 1b/2a
157015,Patented
65616,Phase 2/3
68030,Clinical trial
83840,Phase 0
6448,Phase 2/3
37797,Discontinued in Phase 3
70335,Phase 2/3
116001,Discontinued in Phase 2
124937,Phase 0
51317,Investigative
137023,Investigative
7241,Phase 1/2
62765,Discontinued in Preregistration
149633,Phase 2/3
170201,Phase 2/3
77771,Investigative
28417,Phase 1
133389,Discontinued in Phase 1
941,Phase 1/2
106798,Phase 0
173892,Phase 1b
122991,Phase 1
166027,Patented
52496,Phase 1/2a
102295,Phase 1b
19154,Discontinued in Preregistration
27536,Phase 0
121695,Phase 2
190443,Phase 1/2
67973,Discontinued in Phase 2
129935,Discontinued in Preregistration
28342,Phase 1b
134039,Discontinued in Phase 4
135259,Phase 0
175247,IND submitted
98590,Phase 1/2a
169502,Phase 2
13453,Phase 1/2a
80455,Phase 1b
103433,Phase 1
110234,Phase 2
144030,IND submitted
130013,Phase 2a
59237,Phase 0
163640,Phase 2b
128929,Discontinued in Phase 4
35219,Phase 1b
100908,Phase 1/2
70302,Phase 2
188378,Phase 2/3
9689,Discontinued in Preregistration
148301,Phase 1b/2a
80249,Discontinued in Phase 2
152078,Phase 2
18253,Discontinued in Preregistration
159305,Phase 2
117806,Phase 1
73191,Discontinued in Preregistration
163989,Discontinued in Preregistration
24569,Phase 2
150209,Phase 1/2
4493,Phase 2a
75760,Phase 2/3
99535,Patented
81835,Approved
135737,Phase 3
138058,Phase 1b
164278,Phase 1/2
169018,Phase 2
93195,Phase 1b
191554,Phase 2
81141,Approved
134465,Phase 1/2a
190170,Clinical trial
28769,Phase 2
112373,Discontinued in Phase 3
156073,Discontinued in Phase 2b
176486,Phase 0
135605,Phase 0
31851,Phase 0
169339,Phase 2a
188732,Approved
176393,Discontinued in Phase 4
29241,Discontinued in Phase 2/3
21594,Discontinued in Phase 2
52522,Discontinued in Phase 2b
79487,Approved
151021,Discontinued in Phase 2/3
147247,Phase 1/2a
139467,Phase 1b
38702,Discontinued in Phase 4
65525,Discontinued in Phase 2
83569,Patented
95398,Phase 0
105782,Phase 1/2a
145314,Phase 1b/2a
100627,Phase 1b
137308,Phase 1/2
166274,Phase 1
8855,Discontinued in Phase 1/2
70285,Investigative
75777,Discontinued in Phase 1/2
84002,Phase 0
14998,Phase 1/2a
41825,Investigative
74816,Discontinued in Phase 2
13306,Phase 1
28806,Phase 1b
113030,Phase 1
166634,Investigative
185985,Phase 2b
120036,IND submitted
71015,Discontinued in Phase 3
163404,Discontinued in Preregistration
132492,Discontinued in Phase 2b
169788,Patented
104456,Phase 1/2
93490,Phase 1/2a
155250,Phase 1/2a
65522,Approved
16324,Phase 3
154445,IND submitted
19720,Phase 1
27840,Phase 0
174410,IND submitted
42503,Phase 1b/2a
17312,Phase 1/2
36139,IND submitted
174658,Patented
186101,Patented
178788,Phase 1
1428,Discontinued in Phase 4
131288,Discontinued in Phase 2b
160921,Phase 2a
66222,IND submitted
148718,Phase 1b
108931,Discontinued in Phase 2
164556,Phase 1/2
159486,IND submitted
33823,Clinical trial
91827,Phase 1/2
59271,Discontinued in Phase 2/3
151847,Phase 0
148580,Phase 2/3
188099,Preclinical
92099,Discontinued in Phase 2
70196,Phase 1b/2a
17171,Phase 0
21541,Discontinued in Phase 1/2
140294,BLA submitted
95722,Phase 2a
49686,Phase 0
186203,Phase 4
71881,Phase 0
152249,Phase 1
102016,Phase 1/2
186922,Phase 1b
99018,Phase 0
43788,Phase 1/2a
79105,Phase 1b
31432,Phase 0
114733,Investigative
143151,Phase 1/2
110341,Phase 1b/2a
19244,Phase 1
4962,Phase 1b/2a
36389,Patented
191290,Phase 2a
132434,Discontinued in Preregistration
72518,Phase 1b/2a
103275,Phase 1/2a
74487,Investigative
115663,Phase 1/2
191839,Patented
125975,Phase 1b/2a
165466,Phase 1b
30789,Discontinued in Phase 2/3
105374,Phase 1b
150668,Phase 1b/2a
172692,Phase 1b
176926,Phase 1/2a
114097,Phase 0
145176,Discontinued in Preregistration
143767,Discontinued in Phase 1/2
80644,Clinical trial
77394,Phase 1
113831,IND submitted
65503,Discontinued in Phase 4
61414,Phase 2a
9450,Approved
6966,Investigative
92217,Phase 2b
59904,Phase 1b
54925,Discontinued in Preregistration
117505,Clinical trial
24632,Discontinued in Phase 4
39680,Phase 1
180312,Phase 1/2a
95596,Phase 1b/2a
135686,Phase 1/2
80603,Investigative
134430,Discontinued in Phase 4
100759,IND submitted
11041,Approved (orphan drug)
9693,Discontinued in Preregistration
99147,Phase 1/2a
163060,Investigative
105253,Phase 1b
142546,Phase 1b
28139,Phase 2/3
93985,Phase 1
142628,Phase 2/3
126224,Phase 1/2
112774,Phase 0
47179,Discontinued in Phase 2/3
18342,Phase 1/2
130569,Phase 0
20328,Discontinued in Preregistration
135241,Phase 0
31772,IND submitted
46077,Phase 1/2a
108828,Phase 1/2a
149822,Phase 1b/2a
25051,Phase 0
177348,Phase 1b
150089,Patented
133056,Investigative
22234,Phase 1
125788,Discontinued in Phase 3
86529,Discontinued in Phase 1
53472,Discontinued in Phase 2/3
58441,Phase 1b/2a
83739,Discontinued in Preregistration
83698,Phase 1
33838,Patented
63154,IND submitted
134854,Phase 0
165664,Phase 1b/2a
8359,Phase 2
66464,Phase 1/2
155849,Phase 1b
15617,Phase 0
68902,Phase 1
46632,Phase 1
52134,Phase 0
348,Phase 1/2a
50620,Discontinued in Phase 2b
147693,Phase 1b/2a
54688,Phase 1b/2a
56234,Phase 1
163141,Discontinued in Phase 4
55588,Phase 1
60799,Phase 1
174930,Discontinued in Phase 1/2
77851,Discontinued in Phase 2/3
37198,Phase 1b/2a
141428,Patented
38001,Discontinued in Phase 3
21880,Patented
6777,Investigative
34409,Phase 1b/2a
117964,Discontinued in Preregistration
149444,Phase 1
121333,Phase 1b/2a
40462,Phase 0
164427,Phase 1/2
92135,Phase 2
8635,Phase 0
126196,BLA submitted
99560,Phase 1
128681,Patented
95339,Discontinued in Phase 4
122170,Phase 1/2
175212,Discontinued in Phase 4
30034,Discontinued in Preregistration
190306,Phase 1/2a
155700,Approved
53582,Phase 1
189755,Phase 1/2
141377,Phase 2/3
50209,Discontinued in Phase 2/3
105856,Discontinued in Preregistration
101043,Phase 1/2
156327,IND submitted
17242,Phase 1/2
90747,Approved (orphan drug)
157213,Phase 2
84731,Phase 0
115970,Clinical trial
119867,Phase 0
74078,Phase 1/2a
68537,Phase 1b
86172,Discontinued in Preregistration
64088,Investigative
159821,Phase 2
76075,Investigative
30542,IND submitted
3107,Phase 0
183243,Phase 1/2
63509,Phase 1b/2a
49785,Phase 1b/2a
155847,Discontinued in Phase 4
164194,Phase 0
174115,Phase 1/2
68579,IND submitted
60831,Phase 1
177840,Patented
170150,Phase 1b/2a
48231,Phase 1b
115489,Phase 2
161710,Phase 1/2
43794,Phase 2/3
119575,Discontinued in Preregistration
191631,Phase 1/2
10720,Phase 1/2
45137,Phase 2/3
159779,Investigative
37012,Phase 0
112357,Phase 1/2
187024,Patented
67402,Discontinued in Preregistration
472,Discontinued in Phase 1
110476,Phase 3
82986,Discontinued in Phase 1/2
27861,Phase 1
113293,Discontinued in Phase 1
40178,Phase 2/3
86304,Patented
189516,Phase 2b
5073,Investigative
113372,Phase 1
12557,Phase 1
109486,Phase 3
136579,Phase 1/2a
39018,Investigative
59260,Phase 1b
15917,Phase 1
61569,IND submitted
78526,Discontinued in Preregistration
154013,Phase 1
86457,Phase 1
163321,Phase 1
137732,Phase 1/2a
3902,Phase 1
175485,Discontinued in Phase 3
84396,Phase 1b
81657,Approved
1019,Discontinued in Phase 2/3
97052,Discontinued in Phase 2b
168123,Discontinued in Phase 2/3
36762,Phase 2a
160850,Phase 2a
129089,Discontinued in Phase 2b
32675,Phase 1b/2a
93391,Phase 2
94968,Phase 1/2a
185382,Approved
44628,Phase 1/2a
135382,Phase 0
161629,Investigative
33849,Patented
66865,Phase 0
102963,Phase 1/2
73389,Patented
16574,Phase 1
67353,Discontinued in Phase 2b
136145,Phase 1/2
71324,Phase 1b/2a
70195,Phase 2
116632,Investigative
4693,Phase 2/3
8772,Phase 1/2a
127315,Discontinued in Preregistration
56885,Discontinued in Preregistration
14940,Phase 1b/2a
143733,Phase 2
126431,Phase 1b/2a
28653,Phase 1/2a
64921,Approved (orphan drug)
37270,Discontinued in Phase 1
64372,Phase 2/3
71415,Phase 1b
44223,Phase 2/3
9415,Patented
191423,Phase 1/2
26032,Phase 1/2a
70439,Phase 0
52014,Discontinued in Phase 2
152,Phase 2
168855,Discontinued in Phase 1/2
32558,Patented
74191,Discontinued in Phase 1/2
138319,Clinical trial
81558,Approved
126335,Phase 1b/2a
15337,Discontinued in Phase 1
148538,Discontinued in Phase 2
120512,Clinical trial
99178,Patented
85130,Phase 0
184091,Discontinued in Phase 4
162431,Patented
48277,Phase 1
32055,Phase 0
30934,Discontinued in Preregistration
31705,Discontinued in Phase 1/2
116765,Clinical trial
175164,Phase 1
17019,Investigative
19143,Discontinued in Preregistration
36990,Phase 2
67840,IND submitted
145774,IND submitted
154572,Phase 2/3
129918,Investigative
113847,Phase 2
85406,Discontinued in Phase 2b
12498,Phase 1
45934,Phase 1/2a
14104,Phase 0
90127,Discontinued in Preregistration
101124,Phase 1b/2a
143890,Discontinued in Preregistration
135426,Phase 0
82575,Phase 1b/2a
51059,Phase 1/2a
102897,Phase 1b
149654,Phase 1b
44947,Phase 1/2a
7081,Phase 4
35656,Discontinued in Phase 3
179138,Discontinued in Phase 1
22938,Discontinued in Phase 2/3
24523,Phase 1/2
82147,Phase 1b/2a
91287,Discontinued in Phase 2b
13488,Phase 0
115902,Phase 2/3
89152,Phase 1/2a
62999,Discontinued in Phase 4
145450,Phase 1/2
71581,Discontinued in Preregistration
9762,Discontinued in Phase 2b
79664,Clinical trial
126227,Phase 1/2
45318,Phase 1/2a
41696,Phase 1/2a
6262,Phase 4
150054,Investigative
152518,Phase 1b
6539,Phase 1/2
89070,BLA submitted
109448,Discontinued in Phase 1/2
122262,Discontinued in Phase 4
50813,Phase 2
24170,Phase 2a
137659,Discontinued in Phase 4
90078,Clinical trial
38608,Phase 1/2
160553,Phase 2a
141528,Discontinued in Phase 2b
131975,Phase 1b/2a
23563,Phase 1/2a
16074,Phase 1
179398,Discontinued in Phase 1
8560,Phase 2
140809,Phase 3
50692,Phase 1
38138,Phase 1b
116624,Discontinued in Phase 1
7339,Phase 2/3
139167,Approved (orphan drug)
76549,Phase 1/2
182356,Phase 2a
42004,Discontinued in Phase 1
61204,Phase 1
13255,Phase 0
77799,Discontinued in Preregistration
36997,Phase 0
188357,Patented
65383,Phase 2/3
141304,Phase 2/3
92691,Investigative
71469,Phase 1b
171504,Phase 1/2
13103,Phase 1
155676,Approved
169304,Phase 2a
109477,Phase 2
175622,Discontinued in Phase 2/3
15528,Discontinued in Phase 1
45087,Phase 2/3
105333,Phase 2a
60210,Investigative
171054,Phase 1/2
106013,Phase 1/2a
111868,Phase 1/2
96238,Discontinued in Phase 1/2
153062,Patented
137534,Phase 1/2a
85996,Phase 1/2
138549,Discontinued in Phase 2
121128,Phase 1b
135707,Phase 1b
89990,Phase 2/3
100890,Discontinued in Phase 1/2
79140,Patented
74393,Phase 2
158072,Registered
47531,Phase 1/2
94693,Phase 1
29468,Phase 1b
134526,Phase 1/2
135842,Phase 2
101861,Phase 2a
154732,Phase 2/3
162915,Phase 1/2a
180105,Phase 1
106008,Phase 2
133334,Approved
84158,Investigative
102800,Phase 1/2
132279,Discontinued in Phase 2/3
119769,Phase 0
46664,Approved
28184,Phase 1/2a
17166,Phase 1
7584,Investigative
86353,Patented
76632,Phase 1b/2a
150016,Phase 1/2a
55081,Discontinued in Phase 2/3
98137,Phase 1b
11748,Phase 1
66969,Patented
130120,Phase 2a
56237,Discontinued in Phase 2/3
81499,Phase 1/2a
169481,Phase 2
61114,Phase 0
34528,Phase 1b/2a
87733,Approved
740,Approved (orphan drug)
98279,Phase 1/2a
28924,Phase 1b/2a
32701,Phase 1/2
160918,Phase 1
93221,Phase 1b
183520,Phase 1b/2a
48150,Phase 1b/2a
162503,Patented
134823,Phase 0
87911,Discontinued in Phase 1
70788,Phase 2b
660,Discontinued in Phase 1/2
80251,Phase 1/2a
101021,Phase 1/2
69935,Phase 1
96925,Phase 0
103535,Phase 1/2a
151633,Phase 2
150955,Phase 2
14205,IND submitted
92132,Phase 2b
87711,Approved
10921,Phase 1
169854,Phase 1/2
166076,Discontinued in Phase 1/2
25911,Phase 1b
16768,Phase 1
34534,Phase 0
74395,Phase 1/2
11259,Discontinued in Phase 2/3
127947,Discontinued in Phase 1
112136,Discontinued in Phase 2
53530,Phase 1b
1090,Discontinued in Phase 2b
159001,Phase 1/2
175894,Phase 1
60883,Phase 1
83464,Discontinued in Phase 4
179102,Phase 1/2a
34758,Phase 2a
134707,Phase 0
79735,Investigative
191741,Phase 1
79297,Phase 2a
88879,Investigative
10195,Patented
116697,Phase 2
52280,Phase 0
61013,Discontinued in Phase 1/2
95392,Phase 1/2
184371,BLA submitted
143055,Phase 1/2
175136,Discontinued in Phase 4
180736,Phase 1b
115137,Phase 1b/2a
172291,Patented
171302,Phase 1
124540,Phase 1/2
104574,Patented
91041,Phase 0
38579,Phase 2
68892,Phase 2/3
17519,Phase 0
53442,Discontinued in Phase 2
169461,Discontinued in Phase 2/3
21909,Patented
27430,Discontinued in Phase 2b
123113,Phase 0
50474,Phase 1b/2a
142240,Phase 2/3
164162,BLA submitted
133321,Discontinued in Preregistration
187576,Discontinued in Preregistration
24222,Discontinued in Phase 4
175993,Phase 2b
69677,Phase 1
149595,Investigative
115172,Clinical trial
124574,Phase 0
156571,Phase 1b
122749,Discontinued in Preregistration
89588,Phase 1
12444,Phase 1b/2a
155023,Phase 1/2a
76023,Investigative
69888,Patented
184844,Discontinued in Phase 4
29933,Phase 2
161739,Phase 2
132358,Discontinued in Preregistration
174344,Phase 0
190738,Phase 2b
186067,Investigative
58236,Phase 1
114434,Patented
112826,Phase 1/2
188229,Preclinical
64010,Phase 1/2
147148,Phase 1b/2a
80086,Phase 2
127647,Investigative
64082,Phase 1
160412,Phase 0
1553,Approved
86450,Phase 0
154908,Phase 2/3
97792,Patented
183364,Phase 1b
91725,Phase 0
70924,Discontinued in Phase 3
158568,Phase 1b/2a
2483,Phase 1b/2a
156825,Preregistration
126860,Phase 0
41834,IND submitted
184991,Discontinued in Phase 4
121064,Phase 1/2a
172923,Discontinued in Phase 2
52141,Phase 1
123405,Phase 1b
10938,Phase 0
138712,BLA submitted
109889,Discontinued in Preregistration
55203,Phase 0
64847,Phase 1/2a
129562,Phase 0
403,Phase 1/2a
47372,Phase 0
134101,Phase 1/2a
78345,Discontinued in Phase 3
189552,Phase 1/2a
102399,IND submitted
82044,Clinical trial
11410,Discontinued in Phase 2b
106786,Phase 1b
128373,Phase 0
57280,Phase 0
173668,BLA submitted
22186,Phase 1/2a
58998,Phase 2/3
5415,Investigative
61625,Discontinued in Phase 4
77399,Phase 1/2a
35051,Phase 1b
170218,Phase 1/2a
114040,Phase 1/2a
161389,Investigative
37436,Discontinued in Phase 1/2
20223,Phase 0
79377,Clinical trial
38110,Discontinued in Phase 1/2
12657,Phase 0
106444,Approved (orphan drug)
106564,Discontinued in Phase 3
169654,Phase 3
19041,Phase 1b
89989,Phase 2a
122659,Phase 1/2
149463,Phase 2/3
99550,Phase 1b/2a
163372,Investigative
8436,Phase 2/3
81523,Phase 1
112433,Discontinued in Phase 3
107060,IND submitted
82621,Investigative
79267,Phase 2a
175371,Phase 3
61395,Phase 1/2a
58485,Discontinued in Phase 3
53826,IND submitted
165853,Phase 1b/2a
23399,Discontinued in Preregistration
180446,Discontinued in Phase 2b
153740,Phase 1b
113108,Phase 2a
82966,Phase 1
133847,Phase 1/2a
132299,Patented
7749,Phase 0
116008,Phase 1/2a
77188,Phase 1/2
32780,Phase 1b/2a
137651,Investigative
60409,Phase 1b/2a
6743,Phase 2a
44588,Phase 1/2a
29010,Phase 1/2a
29091,Phase 1b
61808,Discontinued in Phase 4
181864,Phase 3
47560,Phase 0
67805,Phase 1b
24240,Phase 0
98789,Phase 1/2a
29913,Discontinued in Preregistration
192072,Phase 1
85108,Phase 1/2
144714,Discontinued in Preregistration
124586,Discontinued in Phase 4
156064,Discontinued in Phase 3
77581,Phase 1
167435,Phase 4
181989,Phase 1/2a
128868,Discontinued in Phase 2b
126061,IND submitted
160934,Phase 1/2
68214,Phase 1
191180,Investigative
119085,Phase 1
76866,Phase 1b/2a
118665,Discontinued in Phase 2/3
172374,Patented
57188,Phase 1b
9883,Patented
72798,Investigative
118503,Phase 2b
164538,Phase 0
41050,Discontinued in Phase 1/2
18533,Discontinued in Phase 3
144739,Patented
142327,Phase 1
125482,Phase 1b
94193,Phase 1
154044,Patented
92183,Phase 2b
3229,Phase 1b
167254,Phase 4
72890,Phase 1/2
35216,Phase 1b/2a
58023,Phase 1b/2a
3379,Phase 1/2
68267,Phase 1b/2a
35045,Phase 2a
3564,Discontinued in Phase 4
142560,Phase 1
93529,Discontinued in Phase 1
156918,Clinical trial
79585,Phase 1
112337,Discontinued in Phase 3
171830,Discontinued in Phase 2
179401,Discontinued in Phase 1/2
84438,Phase 1/2
88502,Phase 1
178204,Phase 1/2a
137333,Phase 2
164933,Phase 1/2
161322,Investigative
57886,Investigative
168416,Phase 2b
191590,Investigative
177817,Phase 1/2
53577,Phase 1b/2a
63948,Discontinued in Phase 2/3
55613,Phase 0
65146,Phase 1/2
46404,Phase 2b
93257,Phase 1
108888,Discontinued in Phase 2
2809,Phase 1b
26879,IND submitted
83354,Phase 1/2
154752,Phase 3
96606,Phase 1
35403,Discontinued in Preregistration
164145,Discontinued in Preregistration
109996,Phase 1b
21408,Phase 2
100521,Patented
88303,Phase 1/2
40470,Discontinued in Preregistration
104002,BLA submitted
174608,Phase 1/2
27503,BLA submitted
86418,Investigative
107029,Phase 1b
32968,Phase 1b/2a
92077,Phase 1b/2a
20682,Phase 1/2a
42035,Phase 1b/2a
45178,Phase 2/3
169519,Phase 1
103338,Discontinued in Preregistration
188520,Phase 1/2
99494,Phase 1
42498,Phase 2
20895,Phase 1/2a
120584,Approved
113085,Clinical trial
151842,Phase 0
64123,Approved (orphan drug)
127374,Discontinued in Phase 2/3
184261,Phase 1/2
113526,IND submitted
10133,IND submitted
160426,Phase 1/2a
141394,Discontinued in Preregistration
81128,Phase 1b/2a
50267,Phase 1/2a
136527,Phase 1b/2a
8903,Discontinued in Phase 1
9257,Phase 2/3
141241,Phase 0
41591,Phase 2
93379,Phase 2b
166802,Phase 1/2a
188744,Phase 1b
176211,Phase 2/3
29593,Discontinued in Phase 2b
139445,Phase 1b
70012,Phase 1/2a
107190,Phase 0
146512,Discontinued in Phase 2
115769,Phase 1/2a
189634,Phase 1/2a
186048,Phase 0
82903,Phase 0
134894,Phase 0
59982,Phase 1/2
180419,Phase 1b/2a
99504,Phase 1/2a
138046,Investigative
31507,Phase 1b
112019,Discontinued in Phase 3
180255,Phase 2a
95341,Phase 1
20305,Discontinued in Phase 2/3
149419,Clinical trial
190454,Phase 2b
103857,Discontinued in Phase 4
188760,IND submitted
34087,Phase 1/2a
37988,Phase 1/2a
42179,Phase 1
82151,Discontinued in Phase 2/3
4546,IND submitted
177168,Phase 1b/2a
156280,Discontinued in Preregistration
171354,Discontinued in Phase 2/3
139809,Phase 1b
131516,Patented
53545,Phase 0
171306,Phase 1/2
47725,Phase 0
179540,Phase 1b
161633,Investigative
142557,Phase 1b
125928,Discontinued in Phase 3
24717,Phase 2
29652,Phase 1
40426,Discontinued in Preregistration
166526,Phase 1b
161331,Investigative
136352,Phase 2
16444,Investigative
54184,Phase 0
49318,Phase 1b/2a
72664,Investigative
180688,Phase 2/3
136517,Discontinued in Phase 2/3
109405,Discontinued in Preregistration
69453,Phase 1b
180235,Phase 1b
142572,Phase 0
4350,Phase 1b/2a
174205,Discontinued in Phase 1/2
84686,Phase 0
87395,Phase 0
60299,Phase 1
106768,Phase 3
152510,Investigative
147988,Phase 1/2a
38469,Discontinued in Phase 2b
52160,Phase 3
50654,Discontinued in Phase 2
80513,Phase 2a
95394,Phase 1
164637,Phase 1/2
97506,Phase 0
171689,Discontinued in Phase 2
7778,Phase 1b/2a
97750,Phase 1/2a
140891,Phase 2a
34159,Phase 1b/2a
42006,Investigative
78933,Phase 3
148394,Phase 2b
42568,Phase 1/2
138800,BLA submitted
44062,Phase 1/2a
20407,Phase 1b/2a
94058,Phase 1/2
181175,Phase 2b
27957,Discontinued in Phase 2/3
168917,Approved
17074,Phase 0
116423,Discontinued in Phase 1
5996,Phase 2/3
139639,Clinical trial
42876,Discontinued in Preregistration
153240,Phase 0
128745,IND submitted
148128,Phase 1b
92262,Phase 1
189701,Phase 1/2
4810,Phase 2/3
102966,Approved (orphan drug)
97399,Phase 1/2a
141570,Phase 0
154389,Patented
67266,Patented
56957,Phase 2
140926,Investigative
15344,Phase 0
9253,Discontinued in Phase 1
74680,Phase 1/2a
76767,Phase 0
107476,Phase 0
5445,Investigative
59867,Phase 2/3
152259,Phase 1
126152,Phase 1b/2a
47872,Phase 1/2a
88863,Phase 1/2a
122479,Phase 0
174047,Phase 1
41042,Approved
169612,Phase 3
25558,Phase 1/2
71446,Phase 1b/2a
174253,Patented
184755,BLA submitted
105788,Phase 2a
125673,Phase 1
140301,BLA submitted
37001,Discontinued in Phase 2
155746,Phase 1b/2a
126749,Discontinued in Phase 2b
173300,Discontinued in Phase 2
183829,Phase 1b
7121,Phase 2a
61676,Discontinued in Preregistration
186549,Phase 0
190818,Phase 2b
137313,Discontinued in Phase 3
140073,Phase 1b
187349,Patented
131134,Phase 1b
24379,Investigative
94504,Phase 1
7390,IND submitted
65129,Discontinued in Phase 2/3
156569,IND submitted
3498,Approved (orphan drug)
126823,Discontinued in Phase 4
106180,Patented
66478,IND submitted
11054,IND submitted
166142,Phase 1b/2a
92281,Phase 1/2
84329,Phase 1
121850,Discontinued in Preregistration
4876,Preregistration
16280,Phase 1
32017,Phase 2/3
87946,Discontinued in Phase 3
74678,Phase 1/2
103041,Phase 1/2a
137601,Discontinued in Phase 2
104578,Phase 0
143771,Discontinued in Preregistration
19472,Phase 0
15071,Phase 2b
129744,Phase 1
167183,Phase 4
113461,Phase 2a
137021,Discontinued in Phase 2/3
61465,Patented
20621,Phase 2
176715,Phase 1/2
4297,Phase 2a
144159,Investigative
188480,Clinical trial
97149,Phase 0
69584,Discontinued in Phase 2/3
41362,Phase 1b
157754,Phase 1b/2a
45033,Phase 2/3
78984,Phase 1b
72865,IND submitted
72875,IND submitted
62672,Phase 1b/2a
87127,Investigative
123790,Phase 1b
164251,BLA submitted
60495,Phase 1
135213,Phase 0
124623,Phase 1/2
61205,Phase 1
41128,Approved
17379,Phase 3
63685,Phase 2a
53348,Discontinued in Phase 4
62675,Phase 1/2a
65955,Phase 2/3
41854,Investigative
145940,Phase 1b/2a
103615,Clinical trial
182755,Phase 2a
191622,Phase 1
77493,IND submitted
24360,Discontinued in Phase 4
12367,Phase 1
174275,IND submitted
121125,Phase 1b
67141,Patented
60334,Discontinued in Phase 3
130154,Phase 1
12651,Phase 1b/2a
133685,Patented
39028,Phase 2/3
49971,Phase 1/2a
81091,Discontinued in Phase 1
159502,Phase 2
26548,Phase 1b
187953,Investigative
42773,Phase 1
172019,Discontinued in Phase 2b
29747,Discontinued in Phase 2b
141823,Phase 1
187249,Preclinical
185820,Phase 1b
182860,Phase 2
115897,Discontinued in Phase 2
71561,Phase 0
165287,Phase 0
175079,Discontinued in Phase 3
60428,Phase 1/2a
143318,Investigative
163966,Discontinued in Preregistration
121866,Phase 2
109877,Discontinued in Phase 1/2
143949,Phase 2
176857,Phase 2b
49643,Discontinued in Preregistration
131084,Phase 1/2a
46307,Phase 1b/2a
162830,Clinical trial
126889,IND submitted
12925,Phase 1b/2a
49283,Phase 1/2a
169944,Patented
53706,Phase 0
6001,Phase 4
26936,Phase 1b
179743,Phase 1/2a
171784,IND submitted
75020,Phase 2a
161734,Investigative
41254,Discontinued in Phase 1/2
47043,Phase 1/2a
32094,Phase 2
64367,Approved (orphan drug)
105340,Phase 2a
6159,Phase 1b/2a
159456,Discontinued in Preregistration
142343,IND submitted
100408,Investigative
5135,Phase 1/2
165771,Phase 2
128465,Patented
121413,Phase 1b/2a
131120,Phase 0
94442,Phase 1/2a
173379,Phase 1
34945,Discontinued in Phase 3
109907,Discontinued in Preregistration
136511,Discontinued in Phase 4
137921,Phase 2
90487,Phase 1b
160537,Phase 1
65591,Phase 2/3
114200,Discontinued in Phase 3
164627,Phase 0
79132,Phase 1b
182833,Phase 1
179863,Phase 1
161589,Investigative
68678,IND submitted
54074,Phase 1b
164027,Phase 0
32159,Patented
153039,Phase 1
147332,Phase 2/3
106251,Phase 2a
170492,Discontinued in Preregistration
101734,Phase 1b
153439,Phase 1/2
183910,Phase 1b/2a
159045,Phase 1b/2a
152660,Approved
101495,Phase 1b/2a
97200,Discontinued in Phase 2
77400,Investigative
103922,BLA submitted
61727,Discontinued in Phase 4
186224,Phase 2b
114274,Phase 2
1968,Investigative
66681,IND submitted
90710,BLA submitted
154245,Phase 0
113922,Phase 1
106253,Phase 2/3
158683,Approved
16949,Phase 1/2
61800,Phase 1b
173685,BLA submitted
169470,Phase 1
167115,Discontinued in Phase 1
24101,Discontinued in Phase 4
142050,Phase 0
156324,Discontinued in Phase 3
43793,Phase 2/3
22464,Phase 0
163163,Phase 2
14710,Phase 1/2a
16191,Phase 1
28105,Phase 2/3
78903,Phase 0
163793,Phase 1/2
128343,Discontinued in Phase 1
149012,Phase 2b
166466,Investigative
105737,Phase 1
96864,Discontinued in Phase 2
136344,Phase 1b/2a
49247,Phase 1/2a
127948,Phase 1b/2a
114026,Patented
14645,Phase 1/2
111086,Phase 1b
172759,Discontinued in Phase 3
104070,Phase 1/2a
9440,Discontinued in Phase 2/3
34565,Phase 0
2533,Phase 1
190321,Phase 0
45154,Phase 2/3
166990,Phase 4
125750,Phase 1b/2a
89444,Phase 2/3
129068,Phase 0
180606,Phase 2a
49466,Phase 1b
13085,Phase 1/2
25066,Phase 2/3
185134,Discontinued in Phase 3
10874,Phase 0
174967,Phase 2b
48875,Phase 1/2a
172818,Phase 1b
101999,Application submitted
102878,Approved
84422,Discontinued in Phase 2/3
146790,Phase 0
142633,Phase 1b/2a
130477,Phase 0
75694,Phase 0
84369,Phase 1/2
89312,Discontinued in Preregistration
70402,Phase 2
113923,Phase 1
167844,Phase 0
183072,Phase 2a
38475,Phase 1/2a
133761,Phase 1
188806,Phase 1/2
113425,Discontinued in Phase 3
4671,Investigative
49988,Phase 2/3
95451,Phase 1
167473,Discontinued in Phase 1
142252,Discontinued in Phase 2b
124779,Phase 1/2
90779,Clinical trial
14760,Discontinued in Phase 1
16163,Phase 1
126124,Phase 1/2
67318,Approved (orphan drug)
142565,Phase 3
101673,Investigative
32640,Phase 2
152990,IND submitted
140707,Preregistration
175391,Phase 1/2
183294,Phase 2a
141055,Phase 1/2
149573,Phase 2a
52074,Phase 0
52296,Phase 3
111714,Phase 1
136584,Phase 1/2a
164900,Phase 2
30482,Discontinued in Preregistration
44522,Phase 2/3
190345,Clinical trial
83797,Discontinued in Preregistration
91273,Clinical trial
78612,Patented
103973,Phase 0
30753,Discontinued in Preregistration
115687,Discontinued in Phase 2
46226,Phase 2/3
42176,IND submitted
70997,Phase 1b/2a
31093,Phase 1
92700,IND submitted
78673,Phase 2a
189520,Clinical trial
181141,Phase 1
123752,Phase 1/2
134018,Phase 1b
71673,Phase 1b
124734,Phase 1/2
104483,Investigative
71313,Phase 1b
172914,Discontinued in Phase 2b
35791,Phase 0
61821,Investigative
96254,Discontinued in Phase 3
191931,Phase 2/3
169230,Discontinued in Phase 1/2
191547,Discontinued in Phase 1/2
185191,Discontinued in Phase 3
184345,Phase 1/2
174439,Phase 1/2
12370,Phase 0
102092,IND submitted
156609,Discontinued in Phase 1/2
35627,Phase 1
181997,Discontinued in Phase 4
74483,Discontinued in Phase 2b
77641,Phase 1
166164,Phase 1b/2a
104188,Phase 1/2a
187237,Investigative
5954,Phase 1/2
45466,Phase 2/3
113764,Phase 0
66557,Phase 1b
34383,Phase 1b/2a
101765,Phase 2a
43886,Phase 1/2a
81351,Approved
85773,Discontinued in Preregistration
105422,Phase 1b/2a
55054,Phase 2
165698,Investigative
141419,Discontinued in Phase 1
19745,Phase 1
186866,Clinical trial
117292,Investigative
2122,Phase 1b
70541,Phase 2
134640,Phase 0
189166,Phase 1/2a
6472,IND submitted
117395,Discontinued in Phase 2b
113956,Phase 0
18963,IND submitted
120522,Phase 0
119725,Discontinued in Preregistration
141161,Phase 2/3
7467,Investigative
138364,BLA submitted
109583,Preregistration
20725,Phase 2
140758,Phase 1b/2a
95002,Phase 1/2a
46320,Patented
159902,Phase 1b/2a
143480,Phase 1b/2a
146166,Phase 0
43970,Phase 2/3
93050,IND submitted
84336,Phase 1
63039,Discontinued in Phase 4
91297,Preregistration
131378,Discontinued in Preregistration
168649,Investigative
183989,Phase 0
103316,Application submitted
187273,Phase 2/3
139124,Investigative
133353,Approved
85669,Discontinued in Phase 3
136279,Patented
68222,Phase 1b/2a
103007,Application submitted
153201,Phase 1/2
99352,Patented
106118,Phase 1/2a
53931,Phase 1b/2a
181592,Phase 1
149777,Patented
137299,Phase 1/2a
83982,Discontinued in Preregistration
169466,Phase 0
9561,Phase 2
151668,Phase 1b/2a
809,Phase 1/2
170735,Phase 1
163239,Discontinued in Phase 2/3
43318,Phase 1/2a
131759,Discontinued in Phase 4
144208,Discontinued in Phase 2
173322,Phase 1b
30805,Clinical trial
182962,Phase 1/2a
170860,Patented
21493,BLA submitted
176858,Phase 0
48972,Phase 1b
69044,Discontinued in Phase 2/3
128792,Discontinued in Phase 3
139408,Approved (orphan drug)
3233,Phase 0
177005,Discontinued in Phase 4
18990,Discontinued in Phase 2/3
132325,Discontinued in Phase 2b
183654,Phase 2a
155008,Discontinued in Phase 2b
90888,Discontinued in Phase 2/3
88607,Phase 1
50678,Phase 1b/2a
114211,Phase 1
109563,Phase 3
91192,Discontinued in Phase 2b
71055,Discontinued in Phase 3
98335,Phase 1/2a
127978,Phase 0
117560,Discontinued in Phase 4
108185,Phase 1b
69097,Discontinued in Phase 3
188158,Discontinued in Phase 3
10223,IND submitted
46162,Phase 2/3
133643,Patented
182358,Discontinued in Phase 2
49005,Investigative
110251,Phase 1
167086,Phase 4
185084,Discontinued in Phase 4
159375,Phase 1/2
145812,Investigative
40242,Discontinued in Phase 2
103634,Phase 2b
77880,Phase 1b/2a
64618,Phase 1/2
130990,Phase 0
21441,Phase 1b/2a
34619,Phase 0
182578,Phase 1/2a
22021,Discontinued in Phase 2
173214,Patented
142541,Discontinued in Phase 2/3
170306,Phase 2/3
100425,Discontinued in Phase 2
111506,Discontinued in Phase 4
180267,Phase 1/2a
133333,Discontinued in Phase 1
45803,Phase 1/2a
7199,Discontinued in Phase 2
31359,Discontinued in Phase 2/3
145643,Patented
34790,Phase 2
144918,Phase 0
21347,Phase 1
60781,Discontinued in Phase 3
74064,Discontinued in Phase 4
157872,Discontinued in Phase 4
34038,Approved
181692,Phase 1
94301,Phase 2
85812,Discontinued in Preregistration
80418,Phase 1b/2a
19618,Phase 2
56554,Patented
105454,Phase 1/2
10019,Discontinued in Phase 2b
135976,Phase 1b/2a
40076,Discontinued in Preregistration
18912,Discontinued in Preregistration
108441,Phase 1b
134305,Discontinued in Phase 4
10369,Phase 1/2
57181,Phase 1b/2a
101073,Phase 1/2
22718,Phase 1b/2a
146798,Phase 1b/2a
86082,Phase 1
85854,Discontinued in Preregistration
25527,Investigative
131698,Phase 1
45157,Phase 1/2a
107703,Discontinued in Phase 2
34005,Discontinued in Preregistration
15015,Phase 0
167662,Phase 2
2588,IND submitted
48779,Discontinued in Phase 2/3
77010,Investigative
63392,Phase 1b/2a
124778,Phase 1/2
130499,Phase 1/2a
24463,Investigative
16043,Phase 1/2a
62222,Phase 1/2
55886,Phase 0
182789,Phase 1/2a
33476,Phase 1/2a
184909,Phase 1/2
176454,Discontinued in Phase 2
80550,Phase 2a
64775,Patented
153480,IND submitted
154932,Phase 2/3
173971,Discontinued in Preregistration
184566,Phase 0
131476,Phase 2
130178,Phase 1
165855,Phase 1
183840,IND submitted
42525,Phase 1
50383,Investigative
118816,Phase 1
182179,Phase 1/2
130170,Phase 1/2a
184603,Phase 0
152206,Phase 0
116328,Discontinued in Phase 1/2
166253,Phase 1b/2a
147312,Phase 1b
41817,Phase 0
40153,Phase 2/3
175609,Discontinued in Phase 1/2
116187,Phase 1b
136971,Phase 1/2a
35249,Phase 1
59777,Phase 1/2a
48516,Phase 1
81954,Clinical trial
7352,Discontinued in Phase 2
36392,Discontinued in Phase 3
39685,IND submitted
37481,Discontinued in Phase 1/2
52767,Phase 1
6683,Phase 1/2
77787,Discontinued in Preregistration
70232,Phase 1
73706,Approved (orphan drug)
43182,Phase 1b
48967,Phase 1b/2a
11929,Phase 1/2
158699,IND submitted
55908,Phase 1b/2a
152680,Approved
52821,Phase 1
132029,Discontinued in Phase 1/2
106826,Phase 0
7631,Discontinued in Phase 3
64307,Approved (orphan drug)
4362,Investigative
103192,Phase 1/2
177616,Phase 1b
166141,Discontinued in Phase 4
53744,Discontinued in Phase 2/3
35012,Phase 1
87376,Phase 1/2
163797,Phase 1/2
61998,Phase 1b
33547,Clinical trial
39864,Phase 0
77959,Preregistration
165463,Patented
61331,Phase 1
27417,Discontinued in Phase 3
33870,Phase 1b/2a
175435,Phase 1
39931,Investigative
132457,Discontinued in Phase 4
118152,Phase 1b/2a
111547,Phase 2
182257,Discontinued in Phase 2
149060,Phase 1b/2a
147390,Phase 1b
33280,Phase 1b/2a
115538,Phase 1/2a
62293,Phase 1b
79457,Phase 2a
185481,Phase 4
172398,Phase 1b
36714,Phase 2
101617,Phase 2
62340,IND submitted
175753,Discontinued in Phase 3
102296,Phase 1/2
57945,Phase 1b/2a
15426,Phase 0
128842,Phase 0
122324,Phase 1b/2a
124073,Phase 1b/2a
41910,IND submitted
112895,Discontinued in Phase 3
78348,Phase 1
147929,Phase 1b/2a
141488,Investigative
166847,Phase 1b
184731,BLA submitted
133630,Phase 1/2
89236,Phase 1b
112665,Phase 0
125904,Phase 1/2
126645,Phase 0
47343,Phase 0
136981,Patented
176225,Phase 2/3
40487,Phase 0
102999,Investigative
7143,Investigative
187149,Phase 0
9485,Discontinued in Phase 3
104487,IND submitted
131991,Patented
23101,Phase 2
29822,Discontinued in Preregistration
178592,Discontinued in Phase 1
9188,Discontinued in Phase 2
132931,Phase 1b/2a
19373,Phase 1/2a
14600,Phase 1/2
151996,Phase 2a
89508,Phase 1/2a
12040,Discontinued in Phase 2/3
140802,Preregistration
109126,Phase 0
175748,Phase 0
9318,Phase 0
136159,Phase 1/2
41608,Phase 0
101629,Phase 2
81674,Approved
142708,Discontinued in Phase 3
69980,Phase 1
48853,Phase 0
69217,Phase 1b
183482,IND submitted
8688,Phase 0
119768,Approved
159949,Phase 1b/2a
8345,Phase 1/2
145431,Phase 1b/2a
98082,Phase 1b
89925,Phase 2/3
161530,Phase 1/2a
190484,Phase 2/3
123712,Patented
94707,Patented
151194,Phase 2
64714,Phase 2/3
63182,Patented
59740,Phase 0
26116,Phase 1/2a
23286,Phase 2
153309,Investigative
175156,Phase 2b
153810,Phase 1/2
180430,Phase 1/2
170869,Phase 1/2a
47893,Discontinued in Preregistration
70857,Phase 1b/2a
47317,Phase 1/2
69403,Discontinued in Phase 3
26179,Patented
11541,Phase 1b
35642,Phase 0
130328,Phase 1b/2a
49861,Phase 2
4235,Phase 1/2
187551,Phase 4
48420,Phase 3
151315,Phase 2
71034,Discontinued in Phase 1/2
122287,Discontinued in Preregistration
128274,Discontinued in Phase 2b
100498,Phase 3
62052,Phase 1b
6317,Discontinued in Phase 2
38055,Discontinued in Phase 2b
181509,Phase 2
151200,Phase 2
150820,Phase 1
32169,Phase 3
172036,IND submitted
150871,Phase 2
168850,Discontinued in Phase 1/2
72828,Phase 2
191,Phase 1
150159,Phase 1b
45654,Phase 1/2a
50351,Phase 1/2a
32712,Phase 1/2a
78516,Discontinued in Phase 4
78659,Phase 1b
41909,Discontinued in Phase 1
66836,Phase 1/2
17358,Phase 1
106463,Phase 1b
74979,IND submitted
27283,Discontinued in Preregistration
163,Phase 2
192055,Patented
166636,Phase 1/2a
121245,Phase 1b/2a
121606,Approved (orphan drug)
107032,IND submitted
74664,Phase 1/2a
67718,Phase 1b/2a
122323,Phase 2
160480,Phase 1/2a
139677,Phase 1b
46683,Discontinued in Phase 1/2
165347,Discontinued in Phase 1/2
58804,Phase 1/2a
82216,Clinical trial
32349,Phase 0
80193,Discontinued in Phase 2
129437,Patented
33271,Clinical trial
165556,Discontinued in Phase 1/2
189737,Preclinical
90010,Clinical trial
125729,Discontinued in Phase 4
14778,Phase 1
166660,Phase 1/2a
165577,Discontinued in Phase 4
180249,Phase 1b/2a
183762,Discontinued in Phase 2
3822,Discontinued in Phase 2b
22730,Discontinued in Phase 2/3
94371,Phase 2b
109962,Phase 1b
46147,Phase 1/2a
185519,Patented
131259,IND submitted
61500,Phase 2
107647,Phase 1
73015,Investigative
121545,Phase 2b
47901,Phase 0
27903,Phase 0
159460,Phase 1
39856,Investigative
120201,Phase 0
156514,Investigative
106710,Phase 1
154337,Phase 1
185802,Phase 0
119932,Discontinued in Phase 1/2
189488,IND submitted
162203,Investigative
103105,Discontinued in Preregistration
88070,Phase 1
71010,Discontinued in Phase 1/2
173869,Phase 1b/2a
1121,Clinical trial
123162,Phase 1/2
35484,Discontinued in Preregistration
146786,Phase 2/3
173351,Phase 0
109613,Discontinued in Phase 1/2
29302,Phase 1b/2a
20107,IND submitted
161332,Investigative
13645,Phase 1/2a
42442,IND submitted
100832,Phase 1/2a
32649,Phase 1/2a
157066,Discontinued in Phase 4
155254,Phase 2/3
755,Patented
188733,Clinical trial
27237,Patented
70165,Phase 1b/2a
9173,Discontinued in Preregistration
169614,Phase 2
134720,Phase 0
14355,Phase 1
84146,Discontinued in Phase 2
19633,Discontinued in Preregistration
129890,Phase 1/2
21398,Phase 2a
143056,Phase 1/2a
173090,Discontinued in Phase 2
102173,Phase 1/2a
92177,Phase 1
132240,Discontinued in Phase 2b
186288,Phase 0
120024,Approved
4970,Phase 2a
26803,Phase 1
431,Phase 2
11933,Phase 1/2a
52150,Discontinued in Phase 2
78294,Phase 1
134857,Phase 0
6702,Investigative
90911,Discontinued in Phase 1
160249,Phase 1b/2a
13980,Phase 1b/2a
162146,Discontinued in Phase 1/2
87471,Phase 1
119505,Patented
69939,Investigative
5405,Phase 1/2
119288,Phase 1
90140,BLA submitted
51422,Phase 1b
176749,Phase 2b
171855,Discontinued in Phase 2
96161,BLA submitted
107772,Discontinued in Preregistration
10917,Phase 1
170742,Discontinued in Phase 1
190829,Preclinical
165588,Phase 1b
170148,Phase 0
140377,Investigative
130531,Phase 0
142136,Investigative
88832,Patented
77103,Discontinued in Phase 1/2
149789,Phase 2/3
178235,Phase 1b/2a
85412,Discontinued in Phase 2b
92049,Phase 1/2a
126171,Phase 1b
124775,Phase 1/2
131642,Phase 1
161870,Phase 1/2
139285,BLA submitted
58993,Phase 1/2a
70106,Discontinued in Phase 4
133885,Discontinued in Phase 4
189052,Clinical trial
124124,Discontinued in Phase 4
41443,Phase 1
127457,Patented
182234,Phase 1
177394,Phase 1b
1879,Approved
54245,Discontinued in Preregistration
36044,Patented
147696,Phase 2b
71825,Phase 0
5419,IND submitted
27476,Discontinued in Preregistration
92469,Phase 1
9546,Discontinued in Phase 1
126071,Phase 1b
85123,Phase 1/2
100884,Phase 2
93617,Phase 2b
67420,Phase 1b/2a
1432,Discontinued in Phase 1
127308,Discontinued in Phase 3
153759,Phase 1/2
25700,Phase 1/2a
84799,Phase 1b/2a
9177,Approved
27583,Phase 2
83302,Phase 1/2a
189265,Phase 1/2
73271,Discontinued in Phase 3
26766,Phase 0
178024,Phase 1/2
131649,IND submitted
33083,Patented
52705,Phase 3
18593,Phase 2
119274,Discontinued in Phase 2/3
160233,Discontinued in Phase 1/2
169382,Discontinued in Phase 4
43604,Phase 1/2a
43222,Discontinued in Phase 4
47470,Phase 1
145515,Phase 1b
30166,Investigative
65505,Phase 2a
110569,Discontinued in Preregistration
69750,Phase 1
142793,Phase 1/2a
69761,Phase 1/2a
142057,Phase 0
64874,Phase 1
179685,Phase 2a
159389,Discontinued in Phase 3
92888,Phase 1/2
62531,IND submitted
23309,Discontinued in Phase 2/3
164587,Phase 1
141239,IND submitted
1122,Clinical trial
180722,Phase 2a
141891,Discontinued in Phase 2b
55620,Phase 1/2
127701,IND submitted
179336,Phase 1/2a
171387,Discontinued in Phase 2b
179675,Phase 0
138759,Clinical trial
56916,Phase 1/2a
184096,Phase 0
131541,Discontinued in Phase 2b
174384,IND submitted
44009,Phase 2/3
42753,Discontinued in Phase 2/3
32456,Phase 1/2
15456,Phase 2b
81593,Phase 1
54161,Discontinued in Phase 4
5401,IND submitted
185724,Phase 4
148752,Phase 1b
114073,Phase 0
83788,Phase 2/3
106366,Phase 0
901,Discontinued in Phase 1/2
131949,IND submitted
94524,Phase 1/2
94213,Phase 2b
167529,Phase 4
141093,Patented
80507,Phase 2
182645,Discontinued in Phase 2b
34646,Patented
53817,Phase 0
69290,Phase 1b/2a
96599,Phase 1/2a
156125,Discontinued in Phase 2b
21348,Patented
143453,Phase 1b/2a
77171,Phase 1/2a
58886,Phase 2/3
48566,Phase 1b
191350,Approved
73337,Phase 1/2a
12670,IND submitted
119883,Phase 0
31226,Phase 1/2a
24006,Phase 1/2
148952,Phase 1b
182184,Phase 1
58381,Discontinued in Phase 1/2
48193,Discontinued in Preregistration
105244,IND submitted
30161,Investigative
5803,Phase 4
103148,Application submitted
91183,Preregistration
25314,Investigative
109104,Discontinued in Phase 3
78564,Phase 2a
18111,Discontinued in Phase 3
45878,Phase 1/2a
150515,Discontinued in Phase 2/3
15793,Phase 0
78945,Phase 1b
114931,Discontinued in Phase 2/3
118139,Approved
190168,Phase 2b
103711,Patented
57375,Phase 2/3
57700,Phase 0
5819,Phase 1/2
1745,Phase 0
120193,Phase 4
40415,Phase 1/2a
53819,Phase 1/2a
148990,Clinical trial
28662,Phase 1b
39279,Phase 2
100921,Investigative
22411,IND submitted
78031,Investigative
153570,Phase 1
34796,Phase 1
2824,Phase 1/2a
44720,Phase 2/3
188958,Phase 1/2
91110,BLA submitted
89731,IND submitted
176060,Phase 1/2
117644,Discontinued in Phase 1
120375,Investigative
104766,Phase 1b
18597,Phase 1/2
115567,Phase 1/2a
167819,Discontinued in Phase 3
143062,Phase 2a
154945,Phase 3
123907,Phase 2
88696,Patented
66058,Phase 2/3
73025,Phase 1/2
72059,Phase 0
91094,Phase 1b
82146,Clinical trial
126930,Investigative
134712,Phase 0
17759,Phase 2b
94848,Phase 1/2a
37098,Discontinued in Phase 2b
46871,Phase 1/2
105254,Phase 1b
45607,Phase 2/3
14687,Phase 2b
186252,Phase 0
133765,Phase 1/2a
50454,Patented
107848,Discontinued in Phase 4
118560,Phase 2/3
67589,Patented
118596,BLA submitted
151350,Phase 2
172517,Phase 2a
30796,Investigative
154579,Phase 1b/2a
53516,Phase 1/2a
68460,IND submitted
38280,Phase 2b
172945,Phase 1b
108286,Phase 0
14456,Phase 1
93898,Phase 1
111604,Phase 1/2
150721,Phase 0
39402,Discontinued in Phase 4
73241,Discontinued in Phase 3
161192,Phase 0
183877,Approved (orphan drug)
79145,Phase 0
173172,Patented
69841,Phase 1
143379,Phase 2a
185039,Discontinued in Phase 4
125780,Discontinued in Preregistration
49111,Phase 1/2a
149769,Phase 1b
14476,Phase 1b/2a
34701,Phase 1b
129125,Discontinued in Phase 2b
117709,Discontinued in Phase 1/2
41349,Discontinued in Preregistration
69058,IND submitted
3534,Patented
63917,Clinical trial
187425,Phase 2b
74417,Phase 1/2
52269,Investigative
122499,Phase 0
33477,BLA submitted
52632,Phase 1/2a
38359,Phase 1
150949,Phase 2
68164,Discontinued in Preregistration
1013,Discontinued in Phase 1/2
88382,Discontinued in Phase 4
121634,Patented
59770,Phase 0
138257,Phase 1b
61539,IND submitted
38421,Phase 1b
91993,Discontinued in Phase 2
131482,Discontinued in Preregistration
32605,Phase 2/3
55011,Phase 1/2a
59489,Phase 0
89850,Phase 2
81705,Approved
4939,Preregistration
126154,Phase 1/2a
42665,Discontinued in Phase 2/3
122685,Phase 1b
32380,Phase 1b/2a
30082,Phase 0
162080,Discontinued in Phase 4
54959,Phase 1/2a
102015,Phase 1b
38269,Phase 1b
172647,Discontinued in Phase 2b
32641,Phase 2
88791,Phase 1
5389,Preregistration
3423,Discontinued in Phase 2
20588,IND submitted
49612,Phase 2/3
162464,Phase 1b
150963,Phase 0
87402,Phase 1
101754,Phase 2b
118272,Phase 2b
149413,Phase 2b
108806,Phase 2b
74759,Patented
15292,Investigative
162755,Phase 1
26983,Phase 1b
44222,Phase 1/2a
13986,Phase 0
96197,Phase 0
41258,Phase 1/2a
12416,Phase 1/2
127180,Discontinued in Phase 2b
158383,Phase 2b
115609,Phase 1/2a
131657,Patented
140724,Phase 3
77629,Phase 1b
126380,Discontinued in Preregistration
65259,Discontinued in Phase 2/3
49851,Phase 1b/2a
22524,Phase 1/2
124260,Phase 1/2
88023,Phase 1
45159,Phase 2/3
185064,Phase 1/2
16118,Phase 0
147862,Phase 1/2a
95802,Investigative
158862,IND submitted
114404,Phase 1
118936,Phase 1b/2a
68938,Phase 1
87019,Phase 1/2a
62117,Discontinued in Preregistration
120085,Discontinued in Phase 4
68866,Phase 1
20437,IND submitted
1226,Investigative
128117,Discontinued in Phase 3
54422,IND submitted
150918,Phase 2
156192,Phase 1/2
125227,Phase 1/2
47424,Discontinued in Preregistration
136197,Phase 1b
25550,Patented
144281,Discontinued in Phase 1/2
188096,Phase 1
129036,Discontinued in Phase 3
78660,Phase 0
103345,Patented
162767,Phase 2
39876,Discontinued in Preregistration
41884,Phase 1b
33095,Phase 1b/2a
82312,Phase 1
141353,Phase 2/3
124494,Phase 1b
42715,Phase 2
1942,Discontinued in Phase 1
64871,Phase 1b/2a
3247,Phase 0
52940,Discontinued in Phase 4
128540,Discontinued in Phase 3
187850,Phase 0
139361,Phase 1/2a
42063,Investigative
30642,Phase 1
10843,Phase 1
143268,Phase 2b
126818,IND submitted
177275,Phase 1b
8432,Phase 0
35189,Phase 2a
147727,Phase 1
60331,Phase 2/3
109388,Discontinued in Preregistration
100086,Phase 0
23779,Phase 1
150113,Phase 1b
20662,Patented
171936,Phase 1b
147408,Discontinued in Phase 2
91992,Discontinued in Phase 2
110351,Phase 3
97590,Phase 0
163687,IND submitted
88783,Phase 1
5205,Phase 1b/2a
191820,Discontinued in Phase 1
49503,Phase 1/2a
145551,Phase 2b
106512,Preregistration
42486,Phase 0
141642,Phase 0
70189,Investigative
109544,Discontinued in Preregistration
109096,Phase 0
42567,Discontinued in Phase 1
51398,Phase 0
50778,Patented
23161,Discontinued in Phase 2/3
117889,Phase 2b
114666,Discontinued in Phase 1
64706,Phase 0
18852,Discontinued in Phase 2/3
35296,Phase 1/2
33922,Discontinued in Phase 1
3691,Discontinued in Preregistration
142020,Investigative
58446,Investigative
42633,Discontinued in Phase 2/3
104816,Phase 1b/2a
141265,Phase 0
186897,Clinical trial
49463,Discontinued in Phase 2b
43515,Phase 1/2a
56811,Phase 1/2a
61918,Phase 1/2a
11842,Discontinued in Phase 2/3
49308,Phase 2/3
182652,Phase 2a
94140,Phase 1/2a
90572,BLA submitted
49389,Discontinued in Preregistration
9260,Discontinued in Phase 2/3
163649,Discontinued in Phase 1/2
77143,Patented
90540,Clinical trial
2857,Patented
149736,Phase 2/3
92343,Phase 2
66461,Phase 1/2a
105023,Phase 2
180645,Discontinued in Phase 2b
184725,Discontinued in Phase 4
175011,Discontinued in Phase 1/2
104556,Patented
184590,Phase 0
460,Phase 2
62861,Patented
35927,Phase 1b
18314,Phase 1
112755,Phase 1
60885,Phase 1b/2a
132577,Discontinued in Phase 2b
131739,Patented
130778,Clinical trial
163012,Phase 1/2
6247,IND submitted
57346,Phase 2/3
109069,Patented
43606,Phase 1/2a
142915,Investigative
18278,Phase 2a
33330,Phase 2/3
74674,Discontinued in Phase 3
183846,IND submitted
164091,Phase 1/2
41246,Investigative
128616,Discontinued in Phase 2b
7761,IND submitted
176938,Phase 1/2a
40996,Approved
55119,Investigative
143116,Discontinued in Phase 3
94413,Discontinued in Phase 1
178975,Phase 0
44158,Phase 1/2a
138804,BLA submitted
58985,Phase 0
8542,Phase 0
164472,Phase 1/2
70113,Patented
72002,Phase 1/2
106295,Investigative
96382,Phase 1
102003,Investigative
151150,Phase 2
187677,Clinical trial
92756,Phase 2b
91367,Discontinued in Phase 1
79345,Phase 2a
24321,Discontinued in Phase 2/3
106327,Phase 0
44046,Phase 1/2a
132915,Patented
87296,Approved
50363,Phase 0
124625,Phase 1b
143465,Phase 1/2a
155509,Phase 2/3
64325,Discontinued in Phase 2b
183178,Phase 4
131796,Patented
128641,Discontinued in Phase 4
6389,Discontinued in Phase 2
169598,Phase 3
141813,Patented
169934,IND submitted
185405,Investigative
143998,Investigative
46431,Phase 1/2
58103,Phase 2/3
136936,Investigative
116390,Phase 1/2
7024,Phase 2/3
15916,Phase 1b/2a
83480,Phase 0
142275,Discontinued in Phase 2b
72329,Phase 1/2
29458,IND submitted
123898,Phase 0
81605,Approved
188900,Phase 1b
97997,Phase 1b
88926,Phase 1/2a
129703,Discontinued in Preregistration
178366,Phase 1
29051,Investigative
81847,Approved
140513,Discontinued in Phase 2
89958,Phase 1b/2a
142008,Discontinued in Phase 2/3
40711,Patented
173122,Investigative
119996,Discontinued in Phase 1/2
151590,Phase 2
62336,IND submitted
162914,Patented
110706,Phase 1
76058,Phase 0
33685,Phase 1b/2a
116037,Phase 1/2a
182485,Phase 1b
147438,Discontinued in Preregistration
154397,Discontinued in Preregistration
158247,Phase 2a
5739,Investigative
133025,Discontinued in Phase 2b
102391,Application submitted
67254,Clinical trial
66076,Phase 1b/2a
105722,Phase 1b
57609,Phase 1b/2a
47515,Phase 1
45338,Phase 2/3
176859,Phase 1/2
77195,Patented
90175,Approved (orphan drug)
101022,Phase 1b
145569,Investigative
109125,Phase 1/2a
30386,Phase 1/2a
149135,Phase 2b
53746,Discontinued in Phase 2b
11912,Patented
35625,Discontinued in Phase 3
154001,Patented
124354,Patented
17682,Phase 1
123840,Phase 1b
56751,Investigative
69941,Phase 1
171628,Phase 0
77053,Phase 0
50328,Phase 2/3
190406,Phase 2/3
32196,Phase 2a
142196,Patented
71608,Phase 1b/2a
15128,Phase 1
32455,Phase 0
86637,Discontinued in Phase 4
100552,Phase 1b
10450,IND submitted
16603,Phase 1
186165,Phase 2b
40344,Discontinued in Phase 2b
151785,Phase 1b/2a
139106,BLA submitted
154161,Investigative
66817,Phase 1b/2a
30988,Patented
178564,Discontinued in Phase 2/3
17923,Phase 1/2
141918,Discontinued in Preregistration
124818,Phase 1
18615,Discontinued in Preregistration
64165,Phase 1
7691,Phase 1
175176,Phase 1/2
53532,Phase 1b
107231,IND submitted
109707,Discontinued in Preregistration
120561,Phase 4
118990,Phase 0
105865,Phase 0
6938,Discontinued in Phase 2
121390,Patented
83551,Discontinued in Phase 4
62385,Discontinued in Phase 4
67240,Phase 2
47983,Phase 0
38869,Discontinued in Phase 2b
44499,Phase 1/2a
129987,Patented
109808,Discontinued in Preregistration
89709,Phase 1/2
139288,BLA submitted
189046,IND submitted
191540,Investigative
170321,Phase 1/2
150044,Phase 1b
189878,Investigative
70908,Phase 1/2a
137785,Phase 1/2
16327,Phase 1
163338,Phase 1b/2a
107923,Discontinued in Phase 2b
137689,Phase 1/2a
97745,Phase 1b
92164,Discontinued in Phase 1
30328,Phase 0
172765,Phase 1/2
73414,Phase 2a
49403,Discontinued in Phase 2b
68636,Phase 1b
77960,Approved (orphan drug)
175040,Phase 1/2
60060,Approved (orphan drug)
76577,Phase 0
12884,Phase 1/2a
161063,Patented
15039,Phase 1
51321,Discontinued in Preregistration
159161,Approved
79657,Clinical trial
176057,IND submitted
186590,Phase 2a
101719,Phase 2a
136688,Phase 2
23706,IND submitted
142954,Discontinued in Preregistration
77142,Patented
139545,Phase 1b
136554,Phase 1/2a
69122,Discontinued in Phase 2
10175,Discontinued in Phase 2b
91246,Phase 1b
177805,Phase 1/2
39061,Patented
83573,Phase 1/2
57560,Phase 0
112083,Phase 1
175905,Phase 1/2
15302,Phase 0
105305,Phase 2a
8116,Patented
156065,Discontinued in Phase 3
25109,Discontinued in Phase 2b
29282,Phase 1b/2a
130085,Phase 2/3
58080,Clinical trial
95214,Phase 1
167235,Discontinued in Phase 1
169316,Phase 1
6853,Phase 2/3
123660,Patented
84049,Phase 2
21419,Phase 2
172083,Discontinued in Phase 2
12875,Phase 1/2a
72179,Phase 1
98596,Phase 2
67723,Phase 1
96352,Discontinued in Phase 2b
128580,Discontinued in Phase 2b
122765,Phase 1/2
28549,Phase 0
45805,Phase 1/2a
40238,Phase 0
156733,Phase 1b/2a
167424,Discontinued in Phase 1/2
91456,Phase 1b/2a
99802,Phase 1
138279,Phase 1b
93021,Phase 1/2
175771,Discontinued in Phase 1/2
52349,Phase 0
9400,IND submitted
188822,Phase 1b
10615,Discontinued in Phase 3
162359,Discontinued in Phase 2/3
75636,Discontinued in Preregistration
115458,Approved (orphan drug)
44574,Phase 1/2a
131153,Phase 1/2
19185,Discontinued in Phase 1/2
22748,Phase 1/2
174838,Discontinued in Phase 4
143617,Phase 1b/2a
128295,Investigative
75095,Discontinued in Phase 4
81,Phase 1
102424,Patented
10230,Discontinued in Phase 2b
107337,Phase 1b
74746,Discontinued in Phase 3
54900,Discontinued in Phase 2/3
151064,Discontinued in Phase 2/3
23414,Phase 1/2
150794,Phase 2
145373,Phase 1/2
41720,IND submitted
156272,Discontinued in Phase 3
180173,Phase 2a
57023,Investigative
169659,Phase 1
74282,Discontinued in Phase 4
126594,Phase 1/2
91179,BLA submitted
97132,Phase 1/2a
89896,Discontinued in Preregistration
51824,Phase 2/3
79875,Investigative
82100,Clinical trial
150954,Phase 2
74583,Investigative
21162,Patented
134763,Phase 0
30535,Discontinued in Phase 1
160096,Phase 1b
13199,Phase 0
153575,Phase 1/2a
162912,Phase 0
121363,Phase 1/2a
26296,Discontinued in Preregistration
149211,Phase 1b/2a
72011,Phase 0
56781,Discontinued in Phase 2b
176546,Phase 0
149219,Discontinued in Phase 1
152401,Phase 1b/2a
127504,Discontinued in Phase 2b
55861,Discontinued in Phase 3
182849,Phase 1b/2a
12593,Phase 1
51872,Phase 0
27032,BLA submitted
81073,Phase 1
69401,Phase 1b
187292,Patented
148215,Phase 2/3
79795,Approved
176112,IND submitted
124386,Investigative
126338,IND submitted
78283,Investigative
35336,Discontinued in Phase 3
52843,Phase 1b/2a
89952,Phase 2
12821,Phase 1/2
190504,Phase 2b
37886,Phase 1/2
130543,Phase 1/2
108058,Investigative
122979,Investigative
7833,Phase 1b/2a
133814,Discontinued in Phase 4
146986,Phase 1
99617,Phase 2
147732,Phase 1b/2a
44410,Phase 2/3
140618,Phase 1b/2a
109174,Phase 1/2
31354,Discontinued in Preregistration
181489,Phase 1/2a
168062,Patented
133716,Discontinued in Phase 4
40033,Phase 1
162267,Discontinued in Phase 2/3
136226,Investigative
47198,Approved
64774,Phase 0
78357,Investigative
119663,Approved
92127,Discontinued in Phase 4
89660,Patented
8776,Phase 2/3
92694,Phase 1b
87563,Phase 1
76595,Investigative
123461,Phase 0
147551,Discontinued in Phase 2/3
85454,Discontinued in Phase 2b
90664,Phase 1/2
157250,Phase 1/2
76346,Phase 1b/2a
162148,Phase 1b
110927,Phase 1/2
2145,Discontinued in Phase 4
118633,Phase 1/2a
73153,Phase 0
185054,BLA submitted
79240,Discontinued in Phase 4
22072,Phase 1b/2a
119467,Phase 1
144840,Phase 0
128865,Phase 1/2
58688,Approved (orphan drug)
154882,Phase 2
46499,Phase 2
5165,Discontinued in Phase 2
40106,Investigative
181998,Discontinued in Phase 4
96985,Phase 1/2
170263,Phase 1b
135676,Preclinical
133375,Discontinued in Phase 1
175725,Discontinued in Phase 4
150110,Phase 2b
178657,Phase 1
118187,Discontinued in Preregistration
147150,Phase 2b
24919,Phase 2/3
10405,Investigative
169239,Phase 1b/2a
184648,Phase 0
83675,Phase 1
107862,Discontinued in Preregistration
87134,Phase 1/2
157994,Registered
186566,Clinical trial
150876,Phase 2
165082,Phase 0
64795,Phase 1b/2a
136382,Phase 1
171776,Discontinued in Phase 2/3
92321,Patented
190862,Discontinued in Phase 3
33852,Phase 1b/2a
7062,Investigative
156426,Phase 1/2
30563,Phase 2
34578,Patented
36721,Phase 1
70122,Phase 1/2
8214,Patented
154474,Discontinued in Preregistration
46843,Discontinued in Phase 2/3
107217,Phase 1b
185697,Clinical trial
51967,Phase 1/2a
108777,Phase 1b/2a
60559,Discontinued in Phase 2/3
104615,Investigative
97486,Phase 2
111989,Discontinued in Phase 3
38371,Phase 1b
5363,Discontinued in Phase 2
97326,Phase 1/2a
109947,Discontinued in Phase 4
129160,Discontinued in Phase 2b
34643,Phase 0
33297,BLA submitted
99964,Phase 1
119219,IND submitted
42660,Phase 2/3
150905,Phase 1b/2a
156334,Phase 1/2
92769,Investigative
158342,Phase 1
66427,Patented
98349,Investigative
169314,Phase 2/3
71612,Phase 1b/2a
142998,Discontinued in Preregistration
2287,Discontinued in Phase 1/2
119609,Discontinued in Phase 4
43281,Preregistration
64888,Phase 0
137134,Discontinued in Phase 2/3
137492,Phase 2
135853,IND submitted
76020,Phase 2/3
165660,Discontinued in Phase 4
77834,Phase 1/2a
157798,Phase 2
31646,Phase 1/2
83554,Discontinued in Phase 4
12633,Phase 1
187987,Discontinued in Preregistration
101751,Investigative
97888,Phase 1/2a
61738,Phase 1b
162383,Patented
61162,Investigative
138609,Phase 1b
98038,Phase 0
146163,Investigative
23867,Phase 0
25586,Phase 1
25417,Discontinued in Phase 2/3
6430,Phase 2/3
96411,Patented
180135,Phase 1b
99200,Patented
182266,Phase 1b/2a
133658,Phase 1/2
54015,Discontinued in Phase 2/3
179776,Phase 1
136185,Phase 3
33883,Investigative
117500,Discontinued in Phase 4
99537,Phase 0
28557,Phase 1b
113629,Phase 0
94953,Phase 1b
160266,Phase 1b/2a
102652,IND submitted
104273,Phase 0
179750,Phase 1/2a
165675,Phase 1
131393,Discontinued in Phase 4
154569,Phase 3
24857,Phase 1/2
118153,Phase 1b/2a
70330,Phase 1
72885,Phase 2
175252,Patented
90626,Phase 1/2
91666,Discontinued in Phase 2b
107998,Phase 1
41665,Phase 0
26702,Phase 1/2a
71201,Phase 1b/2a
146835,Phase 1b/2a
96207,Discontinued in Phase 1/2
92956,Discontinued in Phase 1
80563,Phase 2
74833,Discontinued in Phase 2/3
127048,Phase 1b/2a
166038,Investigative
118364,BLA submitted
51666,Phase 0
65278,Phase 2/3
8663,Phase 1/2a
94699,Phase 1b/2a
177261,Phase 1b/2a
110812,Phase 1/2
83404,Investigative
39943,Investigative
159816,Phase 2b
122129,Phase 1
132069,IND submitted
160395,Phase 3
97559,Phase 1
117434,Discontinued in Phase 3
37806,Phase 1/2
153099,Phase 1b/2a
86405,Phase 2
165370,IND submitted
174031,Phase 1b/2a
20245,Phase 1b/2a
119740,Phase 2
64483,Phase 2a
164819,Phase 1
176529,Phase 1/2
21639,Approved (orphan drug)
160954,Phase 2a
122986,Patented
175788,IND submitted
174729,Discontinued in Phase 4
90123,Approved (orphan drug)
63991,Approved
33063,Phase 0
104573,Patented
9606,Approved
103730,Phase 0
135461,Phase 0
91935,Investigative
90230,Clinical trial
134534,Phase 1/2a
61719,Phase 1b
90872,Discontinued in Phase 2
138360,BLA submitted
179152,Phase 1
23188,IND submitted
15325,Phase 1b/2a
53618,Discontinued in Phase 3
60387,Phase 2/3
81343,Discontinued in Phase 1
65348,Phase 1b/2a
167196,Discontinued in Phase 1/2
90486,Phase 1b
144605,Phase 0
9767,Phase 1
44058,Phase 2/3
120301,Discontinued in Phase 2
61006,Discontinued in Phase 3
47849,Investigative
154611,Phase 1b/2a
160144,Phase 1b
33703,Clinical trial
60911,Phase 1
60005,Discontinued in Phase 1/2
156312,Discontinued in Phase 4
10267,Phase 0
103215,Phase 1/2
125287,Phase 1/2
148549,Phase 2
85295,Discontinued in Phase 2b
142315,Patented
163970,Phase 2/3
9782,IND submitted
16301,Phase 1
48042,Discontinued in Phase 3
32904,Phase 3
17516,Phase 0
107443,Phase 2b
44564,Phase 1/2a
78157,Investigative
111678,Phase 0
24535,Phase 1b/2a
162051,Patented
24408,Phase 1
148177,Phase 0
138464,Investigative
158328,Phase 1/2
176982,Discontinued in Phase 2
58666,Phase 1/2
33193,Phase 1b/2a
139694,Approved (orphan drug)
80926,Phase 2
69505,Phase 1b
181876,Phase 2b
109244,Phase 1/2
45711,Phase 2/3
77554,Patented
130804,Phase 2b
81710,Phase 1
13220,Phase 1
36378,Investigative
50109,Phase 1b/2a
74993,IND submitted
171162,Discontinued in Phase 1
166023,Phase 1b/2a
188870,Clinical trial
139681,BLA submitted
186330,Phase 1b
29002,Phase 0
54526,Phase 0
82000,Phase 1b/2a
24165,Phase 1b/2a
44174,Phase 1/2a
106803,Phase 1
60132,Phase 0
105837,Phase 1/2
64427,Approved (orphan drug)
151190,Phase 2
58021,Phase 1b/2a
98742,Phase 1b
52197,Phase 2
37235,Discontinued in Preregistration
128738,Phase 1/2
39555,Phase 0
58135,Phase 1b/2a
174075,Phase 3
148600,Clinical trial
118388,Phase 2b
53092,Phase 1/2
32077,Phase 0
87318,Phase 1/2a
27363,Phase 2
83822,Phase 1b/2a
185442,Discontinued in Phase 2b
160723,Phase 1/2a
179064,Discontinued in Phase 1/2
106881,Phase 1b
1720,Phase 2a
643,Discontinued in Phase 2/3
54762,IND submitted
137398,Phase 1
84889,Phase 1b/2a
52021,Discontinued in Phase 2b
6057,Investigative
120213,Discontinued in Phase 4
1654,Patented
51615,Discontinued in Preregistration
132840,Discontinued in Phase 1/2
151374,Phase 1
126488,Discontinued in Phase 3
56684,Phase 2
70089,Phase 1b
22050,Discontinued in Phase 2
8321,Discontinued in Phase 3
105270,Phase 2a
130932,Patented
94012,IND submitted
155154,Phase 2
190485,Phase 2/3
131407,Phase 1/2
68042,Phase 1b/2a
190941,Phase 1
142559,Phase 1
122928,Phase 0
181885,Phase 1b
29633,Phase 2
99927,Phase 2/3
30202,Phase 0
133456,Phase 1
54481,Phase 1b
39208,Phase 1/2
176212,Phase 1b/2a
150387,Phase 2b
39410,IND submitted
79839,Phase 1b
135172,Phase 0
157366,Phase 2a
125719,Phase 1b
81077,Phase 1b/2a
181565,Phase 1b/2a
7407,Investigative
44784,Phase 2/3
98923,Phase 1/2
115480,Phase 1b/2a
181197,Discontinued in Phase 4
131557,IND submitted
52336,Phase 1b/2a
112075,Discontinued in Phase 2
11672,Phase 2
168775,Discontinued in Phase 2
118948,Phase 1/2a
131203,Phase 0
163200,Patented
177982,Discontinued in Preregistration
43304,Phase 1b
42897,Clinical trial
151337,Phase 1/2
119925,Discontinued in Phase 4
88137,Phase 1b/2a
49356,Phase 0
6540,Investigative
157693,Phase 1
104411,Phase 1b
155914,Phase 1/2a
66997,Patented
185560,Phase 0
102871,IND submitted
15215,Phase 0
57720,Phase 1b
162206,Discontinued in Phase 1/2
74684,IND submitted
90121,Investigative
73135,Discontinued in Preregistration
138758,Clinical trial
23117,Phase 1/2
182231,Phase 1
14097,Phase 0
40001,Discontinued in Preregistration
189247,Phase 1/2
3311,Discontinued in Phase 2
84535,Phase 0
127116,Phase 1
23058,Phase 2
177693,Phase 1b
18606,Phase 2
174165,Phase 1
136296,Phase 2
42661,Phase 1
161283,Investigative
1148,Discontinued in Phase 2/3
18381,Discontinued in Phase 2/3
15784,Phase 0
163625,Patented
128072,Discontinued in Phase 3
33603,Phase 1
91360,Phase 1b
125815,Phase 1b/2a
177567,Phase 2a
116468,Discontinued in Phase 1/2
48312,Phase 1
160032,Phase 2b
21151,Phase 1/2a
153430,Discontinued in Phase 4
158060,Approved (orphan drug)
168339,Phase 1/2
28793,Phase 1/2a
189877,Clinical trial
185428,Preclinical
189772,Approved
58569,Discontinued in Phase 3
23228,Phase 1/2
176932,Phase 1
3255,Discontinued in Phase 2
73975,BLA submitted
2561,IND submitted
169530,Phase 2
42506,Phase 1b/2a
85859,Discontinued in Phase 2b
90201,Discontinued in Phase 2
91042,Clinical trial
91591,Discontinued in Phase 2b
148729,Phase 1/2a
23921,Phase 1
146211,Phase 1b/2a
128962,IND submitted
104337,Discontinued in Phase 4
166156,Discontinued in Phase 1/2
140118,BLA submitted
6259,Phase 2/3
102154,Approved (orphan drug)
116928,Discontinued in Phase 1/2
31933,Phase 1
180622,Phase 2a
146121,Discontinued in Phase 2
83900,Discontinued in Phase 2/3
147432,Phase 1/2a
32110,Phase 2a
16844,Phase 0
180771,Phase 2a
51991,Investigative
164003,Phase 1/2
188484,Phase 1b
50361,Phase 2
49682,Phase 2
112038,Discontinued in Phase 3
85033,Phase 1/2
60155,Phase 1
63184,Discontinued in Phase 4
23949,Phase 1b/2a
141237,Patented
128663,Phase 1/2a
120858,Patented
76959,Investigative
162788,Phase 1b
151090,Phase 1
123499,IND submitted
164714,Investigative
142199,IND submitted
142078,Investigative
182449,Phase 1b/2a
65583,Phase 2a
68608,Phase 1/2
79384,Clinical trial
141249,Phase 1b
175872,Discontinued in Preregistration
11954,IND submitted
161916,Phase 0
72202,Phase 1b/2a
160884,Phase 0
185001,Discontinued in Phase 4
163418,Phase 1/2a
179203,Phase 1
132497,Patented
75165,Discontinued in Phase 4
190675,Approved (orphan drug)
93958,Phase 1/2a
72400,Phase 2/3
125054,Phase 1b
22756,Phase 2
78935,Phase 0
130417,Phase 1/2
133079,Discontinued in Phase 4
3091,Discontinued in Phase 3
150255,Discontinued in Phase 2
11425,Phase 1
123577,Phase 2
50147,Phase 1/2a
38804,Phase 2
172514,Phase 2
49504,Phase 1/2a
177675,Phase 1/2a
44103,Phase 2/3
65683,BLA submitted
53546,Phase 1b
64854,Phase 1b/2a
61007,Discontinued in Phase 2/3
142477,Phase 3
14810,Investigative
50945,Phase 1b
44561,Phase 2/3
38128,Phase 1b
47723,Phase 0
67816,Clinical trial
104256,Phase 1/2
54473,Phase 3
77788,Phase 2/3
139018,BLA submitted
29076,Phase 0
74562,Discontinued in Phase 3
29467,IND submitted
178604,Phase 1b
4009,Patented
178360,Phase 2b
57075,Phase 1b/2a
6590,Phase 2a
138788,Phase 1/2a
101513,Discontinued in Preregistration
74403,Discontinued in Phase 2b
63394,Phase 1
143329,Phase 1b/2a
167590,Phase 4
99674,Phase 1/2a
90471,Phase 0
41727,Phase 0
17609,Phase 1
123089,Phase 0
105383,Phase 2b
185821,Phase 0
102103,Investigative
186949,Preclinical
70901,Phase 1b/2a
89213,Phase 1b/2a
112338,Discontinued in Phase 3
191538,Investigative
49500,Phase 1/2
1007,Clinical trial
87277,Discontinued in Phase 1/2
131586,Phase 1
171767,Discontinued in Phase 2b
175334,Phase 1/2a
101088,Phase 1/2
91358,Phase 2/3
157047,Discontinued in Phase 4
100684,IND submitted
111609,Discontinued in Phase 3
71240,Phase 1b
60793,Phase 1b/2a
135252,Phase 0
70296,Phase 1
77976,Investigative
132559,Discontinued in Phase 2/3
49696,Phase 0
148028,Phase 1b/2a
68197,Preclinical
70720,Discontinued in Preregistration
34894,Phase 1b
127632,Discontinued in Phase 3
94317,Phase 2b
164157,Phase 1/2
99174,Phase 1/2a
108853,Discontinued in Phase 4
9812,Phase 0
118601,Phase 1/2a
165654,Phase 1
135591,Phase 0
9624,Discontinued in Phase 1
144278,Phase 3
104367,IND submitted
142539,Phase 0
156566,Investigative
51281,Phase 1b/2a
128548,Discontinued in Phase 2b
2149,Phase 1/2
9961,Phase 0
156844,Phase 1b/2a
140420,Phase 1/2a
178114,Phase 1
104204,Patented
93292,Discontinued in Phase 2b
112041,Phase 0
2162,Discontinued in Phase 2b
187061,Patented
89308,Discontinued in Phase 4
76936,Discontinued in Preregistration
53414,Discontinued in Phase 4
40578,Phase 2/3
96217,Phase 1/2
91485,Phase 1/2
155775,Phase 1b/2a
13781,Phase 1/2
102393,Phase 1b
135922,Phase 3
150012,Discontinued in Preregistration
18308,Phase 2a
55066,Patented
45613,Phase 1/2a
158754,Phase 0
33566,Phase 0
76226,Phase 1/2
50468,Phase 1b
21608,Phase 1b/2a
157098,Approved (orphan drug)
22846,Phase 2/3
95540,Phase 1b
164058,Phase 0
54717,Investigative
24435,Discontinued in Preregistration
73350,Approved
121977,BLA submitted
135115,Phase 0
140830,Registered
112153,Phase 1/2
105830,Phase 2a
59568,Phase 1b
183390,IND submitted
113951,IND submitted
135573,Phase 0
12042,Phase 2a
169396,Discontinued in Preregistration
106848,Phase 1/2a
99201,Phase 1
179477,Phase 2a
110860,Phase 1/2
163980,Phase 1
160402,Phase 1
119751,Discontinued in Phase 2b
112964,Discontinued in Phase 2
39321,Phase 1b
74635,Phase 1/2
109343,Phase 3
134655,Phase 0
140989,Discontinued in Preregistration
49338,IND submitted
167324,Phase 1/2a
175021,Phase 2b
179527,Discontinued in Phase 1
13549,Phase 1/2a
113120,Phase 1
124147,Phase 1
57428,Approved (orphan drug)
101855,Investigative
134475,Phase 1
174438,IND submitted
140950,Investigative
126865,Patented
95562,Phase 1b
66000,Phase 2a
174793,Patented
90850,Discontinued in Phase 2/3
82073,Clinical trial
125868,Discontinued in Phase 3
78317,Discontinued in Phase 2b
138240,Discontinued in Phase 2
60368,Approved (orphan drug)
132532,Discontinued in Phase 1/2
104951,Phase 1/2a
76614,Phase 1
117027,Discontinued in Phase 2/3
85103,Phase 1/2
99760,Patented
147876,Discontinued in Phase 2
181174,Phase 2a
31520,Investigative
135245,Phase 0
64920,Patented
39729,Phase 2
17216,Phase 1/2
27029,Phase 1b
2383,Phase 0
60665,Phase 0
97247,Phase 1/2a
79473,Phase 1
46503,Phase 2b
84667,Phase 1/2a
85620,Discontinued in Preregistration
74441,Phase 2
60524,Phase 0
166903,Phase 2b
160225,Phase 1b/2a
66297,Phase 1b/2a
133728,Phase 1/2a
21784,Approved (orphan drug)
99929,Phase 1b
151329,Phase 1
188459,Phase 1/2
121619,Phase 2
123298,Patented
189514,IND submitted
86759,Phase 1/2
67505,Phase 1b
156006,Phase 1/2a
122742,Phase 1/2
4403,Phase 2a
122837,Discontinued in Phase 4
176099,Phase 0
65845,Discontinued in Phase 4
44503,Phase 2/3
85191,Phase 1/2
90651,Preclinical
132062,Phase 1
93247,Phase 1b
161278,Phase 1b
15519,Phase 1
11569,Phase 1/2
97664,Phase 1/2a
168239,Approved
1186,Investigative
39421,Phase 1b
12033,Investigative
22466,Phase 2
163589,Phase 2b
109227,Phase 1/2
55903,Phase 1b/2a
13872,Phase 0
48717,Phase 0
24562,Phase 1/2a
8013,IND submitted
20110,Phase 2a
137700,Phase 1/2
125564,Phase 1/2
19651,Discontinued in Preregistration
121039,Phase 2
144560,Phase 1/2
485,Phase 2b
163530,IND submitted
30338,Discontinued in Phase 2b
141351,Discontinued in Phase 4
117631,Phase 1b
25112,Discontinued in Preregistration
126790,Phase 0
173602,Patented
139905,BLA submitted
130597,Phase 1/2
141484,Discontinued in Phase 2/3
135809,Phase 1/2
190318,Approved
20791,Phase 2b
40023,Phase 2
101019,Phase 1b/2a
152107,Phase 1b/2a
71205,Phase 1b/2a
51754,Phase 1b/2a
91841,Phase 0
169365,Phase 0
128029,Discontinued in Phase 4
85988,Phase 1/2a
145680,Phase 2/3
184437,Discontinued in Phase 4
124439,Phase 1
67143,IND submitted
43835,Phase 1/2a
188389,Phase 1/2
104329,Phase 1/2a
53710,Phase 0
164445,Discontinued in Preregistration
162056,Phase 0
173053,Discontinued in Phase 3
128560,Phase 1b/2a
119130,Discontinued in Phase 4
81016,Patented
115384,Phase 2
12958,IND submitted
90725,Phase 1/2
155157,Investigative
186154,Patented
187937,Discontinued in Phase 2
11234,Discontinued in Phase 2/3
48608,Phase 0
129999,Phase 2/3
14375,Discontinued in Phase 1
61244,Phase 1
111180,Phase 1/2
108945,Discontinued in Phase 2
69189,Discontinued in Phase 1/2
1396,Phase 0
36841,Phase 1
42391,Phase 1
62010,Investigative
182050,Phase 1b/2a
95408,Phase 1/2a
5993,Discontinued in Phase 2
24040,Discontinued in Phase 4
31248,Discontinued in Phase 2b
191630,Phase 0
3235,Patented
168888,Discontinued in Phase 1/2
68228,Phase 1
128060,Phase 0
52314,IND submitted
182296,Discontinued in Phase 2b
182671,Phase 2a
65143,Discontinued in Phase 3
11070,Patented
28727,Phase 1b
177704,Phase 1b
78387,Approved
70561,Phase 1
190747,Phase 1/2
27195,IND submitted
83847,Phase 1/2
2556,Phase 2
58889,Phase 1b/2a
109898,Discontinued in Phase 2/3
67890,Phase 1
20314,Phase 1/2
91620,Approved (orphan drug)
24544,Phase 2
111516,Phase 1/2
13538,Phase 3
23489,Phase 1/2a
161485,Phase 2a
57920,Phase 0
109426,Discontinued in Phase 1/2
163347,Phase 0
108198,Phase 0
9421,Discontinued in Phase 2b
43781,Phase 1/2a
152804,Phase 2
128606,Phase 1/2
13621,Phase 0
116997,Phase 2
25716,Phase 2/3
94664,Discontinued in Phase 1
69624,Phase 1
40123,Phase 2
75164,Phase 1/2a
13985,Phase 0
103891,Phase 1b
31049,Phase 1b
173488,Discontinued in Phase 2b
137348,Investigative
116057,Phase 1/2
163603,Discontinued in Phase 2
142427,Phase 1
60823,Phase 1b/2a
8788,Phase 1
108266,Phase 1b
162123,Investigative
33766,Approved (orphan drug)
111772,Phase 1/2
164200,Discontinued in Preregistration
164322,Phase 1/2
21979,IND submitted
179895,Phase 1/2
54817,Phase 1b/2a
55357,Phase 4
145623,Phase 1b/2a
189087,Preclinical
135184,Phase 0
29216,Phase 0
155940,Phase 1b
75220,Phase 1/2a
125143,Phase 1/2a
51948,Phase 1
22437,Discontinued in Preregistration
65447,Discontinued in Phase 2
57514,Phase 2/3
152346,IND submitted
137081,Phase 2
183453,Phase 1/2
85653,Discontinued in Preregistration
153109,Phase 1
115506,Phase 2
2987,Phase 1/2
156082,Phase 1b
11384,Phase 1b/2a
99814,Phase 1
27779,Phase 1b
151743,Discontinued in Phase 2/3
42076,Phase 1/2a
67517,Phase 1
10598,Patented
119089,Discontinued in Phase 1
131389,IND submitted
136467,Phase 1/2a
168170,Phase 1b
120889,Investigative
109665,Discontinued in Preregistration
52511,Phase 1/2a
43740,Phase 1/2a
55068,Phase 0
56115,Phase 1b
34094,Phase 1b/2a
161587,Discontinued in Preregistration
152211,Phase 1
57371,Discontinued in Phase 4
82949,Phase 1/2
108449,Discontinued in Phase 2b
40234,Phase 1
124484,Phase 0
115283,Phase 1b
169772,Phase 1b/2a
166608,Phase 1/2
127534,Phase 1
122664,Phase 0
99649,Phase 1
37384,Discontinued in Preregistration
62989,Phase 0
16423,Phase 0
20981,Discontinued in Phase 1/2
180797,Discontinued in Phase 4
175036,Patented
117183,Discontinued in Phase 1
18510,Discontinued in Phase 3
137823,Phase 1/2
27496,Phase 0
60886,Discontinued in Phase 3
30068,Discontinued in Phase 2b
140525,Discontinued in Phase 2/3
142813,Patented
9139,Phase 1
124769,Phase 1
11687,Phase 1/2a
102641,Approved (orphan drug)
80928,Phase 2
183776,Discontinued in Phase 4
108690,Patented
158281,Phase 2b
167582,Discontinued in Phase 2
130288,Patented
189603,Phase 1/2
72628,Investigative
178694,Discontinued in Phase 2/3
32655,Phase 2a
163723,Investigative
8260,Phase 1/2
59685,Phase 0
111906,Discontinued in Phase 3
18383,Phase 1
135870,Phase 2
178527,Phase 1
29979,Discontinued in Phase 2b
10935,Phase 1
68745,Discontinued in Preregistration
76873,Phase 1/2
175503,Phase 2
85160,Phase 0
93719,Phase 2b
186382,Phase 1b
11227,Discontinued in Phase 4
24902,Phase 2
15866,Investigative
45090,Phase 2/3
149971,Phase 0
27570,Phase 1b
70070,Discontinued in Preregistration
35022,Phase 2a
56028,Phase 1
19471,Patented
156104,Discontinued in Phase 3
31883,Phase 2
65079,Preclinical
147714,Investigative
146809,Phase 1/2a
178733,Phase 1b
58899,Phase 1
71963,Phase 1
124824,Phase 1b
129660,Discontinued in Phase 2b
48870,Patented
125272,Phase 1b/2a
101188,Phase 3
105790,Phase 2/3
123509,Phase 0
171378,Phase 1/2
89225,Phase 1/2a
124058,Discontinued in Phase 4
116286,Clinical trial
181134,Phase 1
187485,Phase 2b
15132,Phase 1b/2a
28006,Phase 1b/2a
169776,Patented
138860,Investigative
145948,Clinical trial
57705,Phase 1/2a
122039,Phase 2b
135632,Phase 2
172523,Discontinued in Phase 2b
17443,Phase 1
79559,Phase 1b
22929,IND submitted
108235,Investigative
85229,Discontinued in Phase 2b
89467,Phase 1/2a
61057,Phase 0
190994,Investigative
142226,Discontinued in Phase 2b
93345,Phase 1b/2a
144712,Phase 2b
40781,Phase 1
80780,Approved (orphan drug)
49970,Phase 0
77801,Phase 2
166673,Discontinued in Phase 2
52028,Phase 2/3
26388,Phase 2
97294,Phase 1b/2a
86574,Discontinued in Phase 1
144415,Discontinued in Phase 4
47116,Discontinued in Phase 2/3
101255,Phase 1b
129329,Patented
12530,Phase 1
79733,Discontinued in Phase 1
68504,Phase 1b
174983,Phase 1/2a
65777,Phase 1b
35089,Discontinued in Phase 3
152192,Phase 2
70872,Phase 1b/2a
31932,Phase 2
177404,Phase 1b/2a
131128,Phase 1/2a
118290,Discontinued in Preregistration
137356,Investigative
35696,Discontinued in Phase 3
119974,Approved (orphan drug)
51679,Phase 1
161375,Phase 1/2a
181949,Phase 1b/2a
117489,Discontinued in Phase 1/2
124766,Phase 1b/2a
154691,Phase 1b/2a
17190,Phase 1
107126,Phase 0
77876,Phase 0
86755,Discontinued in Phase 2
180333,Phase 1
46538,Phase 2
118042,Discontinued in Preregistration
11925,Investigative
93326,Phase 1
158382,Phase 1/2
69942,Patented
33446,Phase 0
168340,Phase 2b
103233,Phase 1/2a
85999,Phase 2
51921,IND submitted
72541,IND submitted
180223,Phase 2a
122983,Phase 2
188495,Phase 1b/2a
77984,IND submitted
66527,Phase 1b/2a
90639,Phase 1b
65872,Discontinued in Phase 1
173626,Approved
61033,Discontinued in Phase 3
109143,Discontinued in Phase 2
43640,Phase 2/3
106927,Phase 1/2a
2587,Phase 1
109853,Approved
97018,Phase 1/2a
18797,Discontinued in Phase 2/3
140195,Phase 1/2
168151,Phase 2
127957,Discontinued in Phase 4
170431,Phase 1b
16106,Phase 1b/2a
30051,Patented
104877,Discontinued in Preregistration
155809,Discontinued in Phase 3
133649,Phase 1
32278,Phase 2a
139225,Phase 1b
175597,Phase 1
61605,Investigative
92019,Discontinued in Phase 1/2
186838,Patented
146754,Phase 1b/2a
176772,Phase 1b/2a
108731,Discontinued in Phase 2/3
160959,Discontinued in Phase 4
145763,Phase 1/2
100350,Phase 1b/2a
33405,BLA submitted
91828,Discontinued in Preregistration
101914,Phase 1b
75150,Phase 1/2a
12076,Discontinued in Phase 2/3
173905,Phase 2a
88408,Phase 0
130668,Phase 1
44747,Phase 1/2a
11849,Phase 1/2a
51874,Patented
83749,Phase 1
82399,Phase 1
25643,Phase 0
113141,Discontinued in Phase 2/3
99087,Phase 1
14100,Phase 0
29783,Phase 2
44376,Phase 2/3
191437,Discontinued in Phase 1
44180,Phase 1/2a
88231,Phase 1
122795,Phase 1/2
48043,Discontinued in Phase 2b
170864,Phase 1b/2a
15542,Phase 0
67796,Phase 1/2a
4941,Investigative
85747,Discontinued in Phase 3
48255,Phase 0
126003,Phase 1b
34407,Phase 1/2
95190,Phase 1
49068,Phase 2/3
48039,Phase 1/2a
185031,BLA submitted
136437,Phase 2
188542,Phase 1/2a
108491,Phase 1b/2a
156835,Phase 1
121110,Phase 2a
120029,Discontinued in Phase 1/2
105711,Phase 1/2
148420,Phase 1/2
128859,Phase 1/2
92335,Phase 2/3
669,Phase 2
57561,Discontinued in Phase 3
126562,Phase 1
57912,Clinical trial
117328,Discontinued in Phase 1/2
112067,Discontinued in Phase 3
53071,Phase 1/2a
165115,Phase 1/2a
46712,Approved
127868,Phase 0
174455,Phase 0
100734,Phase 2
102335,Application submitted
155439,Phase 1b
52583,Phase 1b
184086,Phase 0
101432,IND submitted
158471,Phase 2/3
42453,Phase 2
156686,IND submitted
153880,IND submitted
115133,Phase 1/2
78957,Phase 0
68303,Phase 1b
133188,Discontinued in Preregistration
169634,Phase 0
32671,Phase 1/2a
170562,Phase 0
140790,Registered
84192,Discontinued in Phase 3
177538,Phase 2
56138,IND submitted
40636,Patented
189833,Phase 1/2
42771,Phase 2
99479,Phase 1
32723,Phase 1b/2a
119884,Discontinued in Phase 2
34573,Phase 1
59354,Discontinued in Phase 3
15722,Phase 1b/2a
59326,Discontinued in Phase 3
7811,Phase 1b/2a
97520,Phase 1b/2a
161004,Phase 1/2a
188811,Clinical trial
36451,Discontinued in Preregistration
161166,Phase 1/2a
38735,IND submitted
92165,Phase 2/3
34263,Phase 1/2a
11348,Phase 1b/2a
1576,Phase 0
135036,Phase 0
117545,Discontinued in Phase 1
174733,Phase 1
119669,Discontinued in Phase 4
89344,Phase 1/2
36889,Discontinued in Preregistration
72018,Discontinued in Phase 4
176102,Phase 0
27780,Phase 1
108966,Phase 0
67984,Discontinued in Preregistration
10248,Phase 1
140807,Preregistration
138401,Phase 1b
12276,Phase 0
54254,Patented
123714,Discontinued in Phase 4
176687,Phase 1b
123400,IND submitted
90413,Discontinued in Phase 2b
40974,Approved
27821,Phase 1/2a
162620,Phase 1b
1246,Investigative
177034,Phase 1/2a
125931,Phase 1b
3620,Discontinued in Phase 3
113790,Discontinued in Preregistration
14397,IND submitted
40777,Investigative
134461,Phase 1
101504,IND submitted
42198,Phase 1
146800,Phase 2b
119851,Phase 0
168938,Clinical trial
125340,Discontinued in Phase 4
2941,Patented
32137,Phase 2
19734,Phase 1/2
179231,Phase 1/2a
138903,Approved (orphan drug)
63252,Phase 1b/2a
163675,Discontinued in Phase 1/2
127357,IND submitted
178248,Phase 2b
79512,Phase 2a
96014,Discontinued in Phase 1/2
174558,Phase 2
151461,Discontinued in Phase 2/3
37584,Phase 2
97765,Phase 0
153993,Discontinued in Phase 2/3
16617,Phase 1/2
24848,Phase 1/2a
86533,Phase 1b/2a
148245,Phase 1b
59868,Phase 1/2a
113083,Discontinued in Phase 3
83281,IND submitted
4260,Phase 1b/2a
74661,Phase 1/2a
135779,Phase 3
71839,Phase 1
114420,Phase 1b
124402,Phase 2
56261,Discontinued in Phase 2/3
165902,Phase 1b/2a
122501,Phase 1/2
92278,Phase 1/2a
192008,Phase 2a
157647,IND submitted
56455,Phase 1/2a
106623,Discontinued in Phase 3
58415,Phase 1b/2a
113213,Phase 1
181293,Discontinued in Phase 2b
61608,Discontinued in Phase 2b
4085,Discontinued in Phase 2
163247,Phase 1b/2a
166193,Phase 1b/2a
119497,Phase 0
33522,Phase 2/3
113664,Phase 1
179157,Phase 0
8854,Phase 2/3
77746,Investigative
152588,Approved
101824,Phase 1
58981,Phase 1b/2a
64648,Clinical trial
79146,Phase 2a
164264,Investigative
108714,Investigative
156454,Discontinued in Phase 3
12614,Phase 1
163248,Clinical trial
92894,IND submitted
49847,Discontinued in Preregistration
70206,Phase 2/3
90766,Patented
118506,Discontinued in Preregistration
890,Patented
113561,Phase 1/2
28747,Phase 4
162967,Patented
146807,Phase 1b
136506,Discontinued in Phase 2b
2659,Phase 1
115099,Discontinued in Phase 2
129908,Discontinued in Phase 3
122211,Phase 1
149554,Discontinued in Phase 2
2254,Phase 1
46739,BLA submitted
93339,Phase 2
148960,Phase 1/2
100394,Patented
185574,Phase 4
56872,Discontinued in Phase 2b
35025,Discontinued in Preregistration
84765,Phase 0
173508,Phase 0
72946,IND submitted
177188,Phase 1b
36991,Phase 1
44366,Phase 1/2a
101333,Phase 1b
101105,Phase 1/2a
73167,Discontinued in Preregistration
141514,Discontinued in Preregistration
2377,Discontinued in Phase 1/2
39430,Phase 1
61333,Phase 1
44677,Phase 1/2a
65881,Phase 1b
147216,Investigative
10453,Discontinued in Phase 2/3
158121,Phase 2b
12133,IND submitted
77636,IND submitted
139468,Phase 1/2
62798,Discontinued in Phase 3
21960,Investigative
82936,Phase 1/2a
184926,Phase 0
130444,Phase 1/2
163009,Patented
43446,Phase 1/2a
138326,Phase 1/2a
46710,Phase 2/3
13929,Phase 1/2
13710,Phase 1
119518,Phase 0
40667,Discontinued in Phase 2
134542,Discontinued in Phase 4
141977,Phase 2/3
96759,Phase 1b
32436,Phase 1/2
112527,Phase 1
104918,Phase 1/2
120362,Phase 0
191682,Phase 1
43928,Phase 2/3
101873,Phase 2a
174693,Phase 2
103279,IND submitted
49434,Phase 1
147433,Phase 1/2a
177600,Phase 2a
174530,Discontinued in Phase 2
139259,Phase 1b
61102,Phase 1/2
29416,Investigative
142108,Discontinued in Phase 2b
41181,Phase 1/2a
34295,Phase 1b/2a
169974,IND submitted
79924,Patented
35756,Discontinued in Phase 2b
138099,Clinical trial
30878,Discontinued in Phase 2b
160619,Phase 0
37383,Discontinued in Phase 2b
71987,Phase 0
5842,IND submitted
91729,Clinical trial
152400,Phase 1b/2a
17796,Phase 1
475,Phase 2
28881,Discontinued in Phase 2/3
79850,Phase 2a
125106,Phase 0
175971,Discontinued in Phase 3
188920,Phase 2b
106530,Preregistration
168797,Phase 0
101696,Phase 1/2
129653,Patented
187142,Patented
37805,Phase 1
4663,IND submitted
52328,Discontinued in Phase 3
147287,Phase 1b/2a
65865,BLA submitted
157892,Phase 1/2
169257,Investigative
73091,Phase 1b/2a
43285,Preregistration
85456,Discontinued in Phase 2b
76336,Patented
20072,Approved (orphan drug)
152021,Discontinued in Phase 2/3
6766,Phase 4
171195,Phase 1
116620,Discontinued in Phase 3
157436,Approved (orphan drug)
190527,Clinical trial
45453,Phase 1/2a
151029,Phase 2
83677,Phase 1b/2a
131810,Phase 1
43656,Phase 2/3
88371,Phase 1
18674,Phase 1/2
183223,Phase 4
169370,Phase 2/3
96784,Patented
95751,Phase 1/2a
168325,Discontinued in Phase 2b
129700,Discontinued in Phase 2b
65318,Discontinued in Phase 2/3
125586,Investigative
6272,Discontinued in Phase 2
47614,Phase 1b
173445,Discontinued in Phase 2b
163079,Discontinued in Phase 2
154809,Phase 3
170572,Phase 1/2
21632,Patented
94977,Phase 1b
190739,Phase 2b
187933,Patented
124389,Phase 1
184308,Phase 1/2
111126,Phase 0
140065,Phase 1/2a
106958,Patented
15521,Phase 0
186514,Patented
71052,Phase 1b
159865,Phase 1b/2a
12645,Phase 1
133641,Phase 1b
122231,Phase 0
48141,Phase 0
184633,Phase 1/2
130832,Discontinued in Phase 2b
179134,Discontinued in Phase 3
7153,Phase 4
61453,Patented
151853,Phase 1
23244,Phase 2
89001,BLA submitted
122847,Investigative
47537,Phase 0
183013,Phase 3
69555,Phase 2a
58335,Phase 1
141908,Patented
65013,Discontinued in Phase 2
87507,Discontinued in Phase 1/2
132611,Phase 1/2
141674,Discontinued in Phase 2/3
26271,Phase 2
99522,Patented
69069,Phase 2a
60662,Discontinued in Phase 3
88294,Discontinued in Phase 2/3
63725,Approved
19121,Discontinued in Preregistration
44225,Phase 2/3
8075,Phase 2
150465,Phase 2b
58107,Phase 1b/2a
55192,Phase 1b/2a
30179,Phase 1b
83660,Phase 1/2
59410,Discontinued in Phase 3
29113,Phase 1/2a
115423,Phase 1/2a
99022,Phase 1/2a
149224,Clinical trial
2390,Investigative
134998,Phase 0
77558,Phase 1
42200,Discontinued in Phase 1
161583,Investigative
159774,Phase 1b/2a
72905,Phase 1b/2a
171537,Discontinued in Phase 2
12223,Phase 1/2
51723,Phase 0
158359,Phase 1
137386,Discontinued in Phase 2/3
168737,Discontinued in Phase 2
52132,Phase 1b/2a
151776,Phase 1
10095,Discontinued in Phase 3
158089,IND submitted
18503,Phase 1
133707,Phase 1/2a
189537,IND submitted
22356,IND submitted
11088,BLA submitted
78276,Phase 1
42571,Phase 2
59876,Phase 1b
64386,Phase 1
188161,Discontinued in Phase 1
83331,Phase 1/2a
56377,Phase 3
164170,Discontinued in Preregistration
155836,Discontinued in Phase 4
146212,Phase 1b/2a
163514,Investigative
139629,Approved (orphan drug)
91629,Discontinued in Phase 2b
171266,Phase 1/2
114359,IND submitted
95592,Phase 1b/2a
66414,IND submitted
189441,Phase 1/2
74513,Phase 1/2
152376,Investigative
131438,Phase 1/2
31125,Phase 1
17761,Phase 2b
97851,Phase 1b
166639,Discontinued in Phase 2b
94985,Patented
165333,Discontinued in Phase 1
157484,Phase 1/2
113465,Clinical trial
126095,Phase 1b/2a
96308,Discontinued in Phase 3
167389,Discontinued in Phase 1
36302,Discontinued in Phase 3
170206,IND submitted
126956,Discontinued in Phase 3
50142,Discontinued in Phase 2b
119616,Discontinued in Preregistration
95217,Phase 1b
133042,Phase 1
134407,Phase 1/2a
112251,Phase 1
162622,Discontinued in Phase 4
112574,Phase 1/2
179436,Phase 1b
73798,Phase 2a
18848,Discontinued in Phase 2/3
40282,Patented
52649,Phase 2
172359,Discontinued in Phase 2
137362,Phase 1
118444,Phase 2/3
59175,Phase 1
154199,Discontinued in Phase 3
30842,Discontinued in Preregistration
121738,Approved (orphan drug)
113763,Investigative
76523,Phase 1/2
120711,Investigative
93155,Investigative
129071,IND submitted
80426,BLA submitted
38218,Phase 2a
113974,Phase 0
97552,Phase 1/2a
142828,Discontinued in Phase 3
54958,Phase 1b/2a
189974,Approved (orphan drug)
38060,Phase 1/2a
132645,Discontinued in Phase 1/2
136107,Phase 2/3
80326,Phase 2a
154099,Phase 1/2a
12311,Investigative
58059,Phase 1
155103,Investigative
132592,Phase 1/2
132648,Phase 1/2
162041,Investigative
182174,Phase 2a
90261,Discontinued in Phase 3
10688,Phase 1b/2a
115957,Phase 1/2
173499,Discontinued in Phase 2/3
1180,Investigative
62112,Discontinued in Phase 3
109845,Discontinued in Preregistration
108427,Phase 1/2a
64708,Discontinued in Phase 2/3
154528,Phase 3
34676,Phase 1
186117,Clinical trial
123311,Phase 0
185876,Clinical trial
174218,Discontinued in Phase 4
111370,Discontinued in Phase 3
85825,Discontinued in Phase 3
39346,Phase 1b
191773,Phase 0
144231,Discontinued in Phase 2
144958,Phase 1
190315,Phase 1b/2a
126314,Phase 1b
72971,Phase 1
2887,Investigative
186424,Patented
3136,Patented
136242,Phase 1
77276,Phase 1/2a
95141,Patented
136777,Phase 1/2
23265,Phase 1/2
61884,Investigative
70174,Phase 2
105035,Discontinued in Phase 2b
84887,Phase 1/2a
160696,Phase 1/2a
20064,Phase 0
127472,Phase 0
101624,Phase 1/2
63165,Discontinued in Preregistration
122886,Phase 1/2
149655,Phase 1/2a
78298,Approved
174966,Phase 3
121547,Phase 1/2
61762,Discontinued in Phase 2b
181913,Phase 3
117634,Discontinued in Phase 3
58532,Phase 1b
165256,Discontinued in Preregistration
186705,Phase 2b
127500,Discontinued in Phase 2b
98966,Phase 1b
45997,Phase 1/2a
103363,Patented
155294,Phase 1/2
169376,Discontinued in Phase 4
50611,Phase 1b
11455,Phase 2/3
152096,Phase 1
101585,Phase 2a
151292,Phase 1
102018,Investigative
190244,Phase 2b
113725,Phase 1
168296,Phase 1b/2a
142067,Discontinued in Phase 1
114275,Phase 1/2
133717,Discontinued in Phase 4
15316,Phase 1
157755,Patented
171412,Discontinued in Phase 2b
173953,Discontinued in Preregistration
91117,Phase 0
25963,Discontinued in Preregistration
172797,Discontinued in Phase 2
106007,Phase 1/2a
63437,Discontinued in Phase 3
15303,Phase 0
18348,Discontinued in Phase 4
65688,Phase 2a
3188,Phase 1/2a
143320,Phase 1/2a
115985,Phase 2a
80482,BLA submitted
87866,Phase 1/2
20800,Patented
108165,Phase 1b
153981,Patented
101574,Phase 2b
108247,Discontinued in Phase 1/2
166773,Discontinued in Phase 4
187661,Patented
4194,Investigative
106981,Phase 1b/2a
101459,Phase 1b
25472,Phase 1b
177877,Phase 0
132719,Investigative
11980,Discontinued in Preregistration
10494,Phase 0
11145,Patented
35462,Phase 0
84397,Phase 2
157427,IND submitted
107493,Phase 1/2a
188525,Clinical trial
98272,Phase 2
179952,Phase 1/2
166740,Phase 1/2
80236,Discontinued in Phase 3
158727,Phase 2
20625,Phase 1b/2a
121430,Discontinued in Phase 2b
178050,Patented
72660,Phase 2
101005,Phase 1/2
2946,Discontinued in Phase 2b
113540,Phase 1
170322,Discontinued in Phase 1
6817,Phase 2/3
50948,Phase 1b
147534,Phase 1b/2a
8209,Phase 1/2
1087,Discontinued in Phase 1
143430,Discontinued in Preregistration
126987,Phase 1/2
157521,Patented
18707,Phase 1/2
102270,IND submitted
165030,Phase 1
149217,Phase 2b
173847,Approved
97191,Phase 1/2a
90520,BLA submitted
58537,Phase 0
98019,Phase 1b
120986,Phase 1
75894,Patented
178929,Discontinued in Phase 1
180044,Discontinued in Phase 2
79298,Phase 1b/2a
98992,Discontinued in Phase 2
103473,Phase 1b/2a
162548,Phase 1b/2a
28075,Phase 0
61665,Phase 1b
30779,Phase 1b
159243,Patented
46361,Discontinued in Phase 2
62811,IND submitted
91963,Discontinued in Phase 1
115716,Phase 2
155382,Phase 1/2a
117810,Phase 1/2a
40029,Phase 2
189907,Phase 2b
127531,Discontinued in Preregistration
161402,Investigative
36073,Discontinued in Phase 1
178364,Discontinued in Phase 4
80001,Approved (orphan drug)
22947,Phase 2
117892,Phase 1b
48908,Phase 1b
105636,Phase 1
69267,Phase 2a
70673,Phase 2
110221,Phase 1b/2a
21496,Investigative
46013,Phase 1/2a
142936,Phase 1/2a
12218,Investigative
35638,Phase 1/2
17538,Phase 0
143236,Discontinued in Phase 3
61535,Discontinued in Phase 1
78194,Approved (orphan drug)
92874,Discontinued in Phase 3
15718,Phase 1
155893,Phase 1b
165091,BLA submitted
117911,Discontinued in Phase 1
138636,Discontinued in Phase 2
38622,Phase 2/3
138077,Clinical trial
181100,Phase 1b/2a
92140,Phase 2b
43409,Phase 2/3
5709,Phase 1b/2a
108062,Phase 1/2
177618,Phase 2
141070,Investigative
63189,Phase 0
2484,Phase 2
4337,Discontinued in Phase 2
48431,Phase 1/2a
74832,Discontinued in Phase 1
141992,Investigative
151055,Phase 1
183451,Discontinued in Preregistration
108921,Phase 4
85547,Discontinued in Phase 2b
154155,Patented
9871,Phase 1
92500,Phase 0
80764,Patented
163583,IND submitted
138017,Phase 1/2a
117872,Phase 1b/2a
20988,Investigative
83301,Phase 1/2a
14152,Phase 1
75181,Patented
167270,Discontinued in Phase 2
155774,Phase 2
94041,Phase 2
184382,BLA submitted
107636,Phase 2b
170274,Phase 0
37699,Phase 1/2
96897,Phase 0
112927,Discontinued in Phase 2
117223,Discontinued in Phase 1
9166,Phase 2/3
123385,Phase 1/2
10718,Discontinued in Preregistration
181728,Phase 1/2a
42149,Phase 1b/2a
76486,Phase 1/2
54980,Discontinued in Phase 4
142526,Phase 1
162657,Phase 1/2a
135027,Phase 0
54635,Phase 1/2a
168668,Investigative
100245,Discontinued in Preregistration
66092,Phase 4
52346,Phase 0
6740,Discontinued in Phase 2
3760,Discontinued in Phase 3
48601,Discontinued in Preregistration
87249,Phase 1/2a
116894,Discontinued in Phase 3
151608,Phase 0
174997,Discontinued in Phase 3
74037,Phase 1/2a
120578,Discontinued in Phase 3
140642,Preregistration
4486,Phase 2/3
7477,Phase 4
63647,Phase 2a
103688,Phase 1/2
26209,Phase 2
118493,Discontinued in Preregistration
168001,Patented
88908,Phase 1
182410,Phase 2
121212,Phase 1b
186627,Clinical trial
79619,Phase 1
106583,Discontinued in Phase 3
30109,Phase 1/2
42643,Phase 2
72952,Investigative
176949,Phase 1/2
175043,Discontinued in Phase 2
77717,Phase 2
77693,Phase 2
96151,Phase 1b
53075,Discontinued in Phase 2b
141220,Discontinued in Phase 2b
53871,Phase 1/2a
66406,BLA submitted
150600,Phase 2
61760,Discontinued in Phase 4
165620,Discontinued in Phase 4
168228,Approved (orphan drug)
21201,Phase 0
155936,Phase 2/3
162988,Phase 1/2
22726,Phase 2
47452,Phase 1
87876,Approved
32288,Phase 1/2
27091,Phase 1
32441,Phase 1
28241,Phase 2a
127164,Discontinued in Phase 3
10612,Phase 1
170302,Phase 1/2a
53513,Phase 1
184936,Phase 1
22572,Phase 0
60295,Phase 1
53273,Phase 0
18046,Discontinued in Preregistration
65403,Discontinued in Phase 4
45581,Phase 1/2a
32504,Phase 1
144898,Phase 1/2a
56719,Phase 1b/2a
42002,Phase 1
83296,Phase 1/2
163511,Phase 2b
157929,Phase 1b/2a
24578,Phase 1b/2a
47542,Phase 0
34086,Phase 1b/2a
143710,Phase 2b
5250,Phase 1b/2a
3586,Discontinued in Preregistration
66652,Patented
75622,Discontinued in Phase 1/2
29478,Phase 1b/2a
138618,Investigative
67006,Phase 1b/2a
145742,Phase 2b
4595,Phase 1/2
60913,Phase 1b/2a
23790,Discontinued in Phase 2/3
24430,Phase 1b/2a
86537,Patented
179883,Phase 1/2a
137346,Discontinued in Phase 2b
54950,Phase 2
156700,Discontinued in Phase 2
66942,Phase 1b
171728,Discontinued in Phase 2
61685,Discontinued in Preregistration
96657,Phase 1/2a
68438,Phase 1
61344,Patented
41464,Phase 1/2
10164,Investigative
32634,Phase 2a
41389,Phase 1b
13974,Phase 1/2
90591,Discontinued in Phase 1
17159,Discontinued in Phase 1
167506,Phase 4
46262,Phase 1/2
119582,Discontinued in Phase 2b
141607,Phase 1
181159,Phase 2
107047,Phase 0
9524,Discontinued in Phase 3
8457,Discontinued in Phase 2/3
58331,Phase 1b/2a
68695,Investigative
1345,Approved
124781,Phase 0
8847,Discontinued in Preregistration
35928,Phase 1b
167117,Investigative
184995,BLA submitted
83113,Phase 0
142762,Discontinued in Preregistration
134581,Patented
4584,Phase 1b/2a
87737,Discontinued in Phase 1/2
95419,Phase 1/2
46946,Approved
25698,Patented
59592,Clinical trial
34485,Phase 1b/2a
82612,Patented
74143,Discontinued in Phase 1/2
127906,Phase 0
171573,Phase 1
56584,Phase 2
146896,Phase 1/2a
52430,Discontinued in Preregistration
36884,Phase 1
187158,Phase 0
91076,Phase 1b/2a
100518,Phase 1/2
126047,Phase 1/2
121911,Approved
111092,Phase 2
99895,Phase 2/3
23619,Phase 2
145337,Phase 1b/2a
116177,Phase 2
158307,Phase 2/3
129917,Discontinued in Phase 3
190522,Phase 1/2
91687,Phase 0
90678,Discontinued in Phase 2b
179682,Discontinued in Phase 2b
174926,Phase 1/2
169158,Phase 0
50377,Phase 0
57748,Phase 1b
125697,BLA submitted
159468,Phase 2
83746,Phase 2
26036,Phase 1
81763,Phase 1
78029,Discontinued in Phase 2
53102,Discontinued in Phase 2
137936,Investigative
87207,Phase 2/3
66930,Patented
67512,Phase 1b
108175,Discontinued in Phase 2
17327,Phase 0
160844,Phase 0
7053,Investigative
150080,Phase 2a
90770,Approved
29481,Phase 2/3
29429,Phase 1b/2a
174554,Phase 1
45372,Phase 1/2a
9789,Preclinical
119773,Discontinued in Phase 1/2
117184,Discontinued in Phase 1
121557,Phase 2
18174,Discontinued in Phase 2/3
121940,Phase 0
174735,IND submitted
189642,Approved
163316,Patented
117678,Discontinued in Phase 2/3
189184,Phase 2/3
161312,Investigative
155945,Phase 1
135687,Phase 2/3
142107,Discontinued in Phase 2b
192109,Phase 1/2
9640,Discontinued in Phase 1
156086,Discontinued in Phase 2b
27726,Phase 1/2
112995,Patented
138339,BLA submitted
156234,Discontinued in Phase 3
120882,Phase 2a
181396,Discontinued in Phase 2b
87177,Discontinued in Phase 4
25739,Discontinued in Phase 4
47985,Investigative
17899,Phase 2/3
17202,Phase 1
126989,Patented
61405,Patented
140168,BLA submitted
173197,Phase 1b
39378,Phase 2/3
176173,Phase 1b/2a
39927,Discontinued in Phase 4
116208,Phase 1b
107628,Discontinued in Phase 1/2
53315,IND submitted
77948,Discontinued in Phase 4
37040,Discontinued in Preregistration
136911,Investigative
92840,Phase 1/2a
82543,Phase 1/2
130114,Phase 3
14451,Phase 1
156779,Phase 1/2a
32789,Patented
99343,Phase 1
10120,IND submitted
39544,Discontinued in Phase 2b
184774,Discontinued in Phase 4
39118,Investigative
158668,Approved
63435,Phase 1b/2a
51826,Phase 1b/2a
8239,Phase 2
157442,Phase 1b/2a
143717,Phase 1b/2a
100329,Phase 0
92350,Discontinued in Phase 1
93865,Phase 1b/2a
92719,Discontinued in Phase 3
90853,Phase 0
177078,Discontinued in Phase 2/3
62421,Patented
18185,Phase 2a
155362,Phase 0
45445,Phase 1/2a
30693,Discontinued in Preregistration
92404,Phase 2b
164275,Phase 1/2a
97109,Phase 1/2a
42230,Phase 1
30414,Discontinued in Phase 4
85309,Discontinued in Phase 3
37123,Phase 1b/2a
89809,BLA submitted
20379,IND submitted
159337,Approved (orphan drug)
66504,Phase 2b
187420,Phase 0
134226,Phase 1/2a
12441,Phase 1/2
186676,Discontinued in Preregistration
40720,Discontinued in Preregistration
150937,Phase 1
179982,Discontinued in Preregistration
151717,Phase 2
163542,Phase 2b
54183,Phase 0
36606,Phase 1
98266,Phase 1b
38874,Phase 2
78623,Patented
33583,Clinical trial
166489,Phase 0
91525,Preregistration
107455,IND submitted
91994,Phase 0
18351,Preregistration
144462,Discontinued in Phase 1/2
61578,Investigative
96425,Patented
23608,Phase 0
120455,Investigative
35734,Discontinued in Phase 4
78599,Phase 1b
36804,Phase 2
165483,Phase 1
188235,Phase 1b/2a
167860,Patented
4241,Phase 2a
110207,Discontinued in Phase 2b
21378,Phase 2a
186827,Phase 1b/2a
187463,Phase 4
89673,Phase 1b/2a
110678,Phase 1/2a
137282,Phase 1/2a
125671,Phase 1b
82713,Discontinued in Phase 4
79989,Phase 2a
31444,Discontinued in Preregistration
44235,Phase 1/2a
182051,Phase 2a
60292,Clinical trial
120294,Approved (orphan drug)
96491,Discontinued in Phase 1/2
138365,BLA submitted
76697,Phase 1/2a
130759,Phase 1b
114237,Phase 1b/2a
22020,Discontinued in Phase 2
21982,Phase 1/2
9996,Discontinued in Phase 2b
68721,Discontinued in Phase 4
173106,Phase 0
4237,Preregistration
72073,Phase 1
15153,Phase 0
65592,Phase 1b/2a
3990,Phase 1
93670,Phase 2a
110082,Phase 1
12266,Phase 1b/2a
76053,Phase 1/2a
96868,Patented
118750,Discontinued in Phase 3
38504,Phase 2
139049,Phase 1b
40071,Phase 1b
131142,Phase 1/2a
183292,Approved (orphan drug)
123491,Phase 1/2
147211,Phase 1/2
82555,Phase 0
1125,Discontinued in Phase 1
92671,Phase 1/2
91899,Phase 1b
20012,Phase 0
185627,Phase 1b/2a
80365,Approved (orphan drug)
80556,Approved (orphan drug)
162259,Patented
72504,Phase 2
4520,Phase 2a
134803,Phase 0
56173,Phase 4
66616,Phase 2b
134164,Discontinued in Phase 4
166831,Clinical trial
59926,Phase 1/2
103682,Phase 1/2
12504,Investigative
115973,Phase 1/2
90667,Discontinued in Phase 1
114476,Discontinued in Phase 1
58830,Phase 2/3
73745,Phase 1/2a
88433,Phase 1
124506,Discontinued in Phase 4
154831,Phase 1b/2a
179756,Phase 1/2a
173863,BLA submitted
48831,Phase 1b/2a
130266,Phase 1/2a
8889,Discontinued in Phase 1
57097,Phase 1b/2a
54391,Phase 1/2a
11965,Phase 1/2
128383,Patented
7166,Phase 2a
191659,Phase 1
78072,Clinical trial
28269,Phase 0
171743,IND submitted
190687,Phase 2b
98853,Investigative
139676,Phase 1b
78399,Discontinued in Phase 3
50653,Phase 1b/2a
172161,Phase 1
152754,Phase 1/2a
63344,Discontinued in Phase 4
28632,Phase 1b/2a
118080,BLA submitted
65735,BLA submitted
34791,Patented
27023,Phase 1b
146155,Phase 1/2a
47088,Phase 2a
34323,Patented
60136,Phase 0
81152,Phase 1b/2a
8691,Phase 1b/2a
123791,Phase 0
188006,Phase 0
91542,Clinical trial
31794,Discontinued in Phase 3
32039,Discontinued in Phase 1
163432,Phase 2
96304,Phase 2b
173855,Clinical trial
135454,Phase 0
130169,Phase 1/2a
183122,Phase 2a
17263,Phase 1
58948,Clinical trial
69467,Phase 2b
16287,Phase 1
154196,Phase 0
161174,Discontinued in Phase 4
117495,Discontinued in Phase 2b
38029,Phase 2
90272,Phase 0
90296,Phase 1b
159914,Phase 1b/2a
108051,IND submitted
158488,Phase 2/3
107566,IND submitted
191718,Phase 1
21828,Phase 1b/2a
115149,Phase 2
120256,Clinical trial
8693,Clinical trial
14338,Phase 1/2
186529,Preclinical
146376,Phase 1b
185619,Phase 0
15894,Phase 1/2
38084,Discontinued in Phase 4
65736,Approved (orphan drug)
16610,Phase 3
108331,Investigative
617,Phase 2b
171645,Discontinued in Phase 2
37335,Phase 2
152705,Patented
23349,Phase 0
8308,Phase 2
120318,Approved (orphan drug)
71545,Discontinued in Preregistration
154784,Phase 3
100779,Phase 2
37231,Phase 1
179616,Phase 1/2
77839,Discontinued in Phase 2/3
9764,Discontinued in Phase 2/3
154923,Phase 1b/2a
53934,Phase 1b/2a
105389,Phase 2a
34470,Phase 1/2a
111147,Phase 1/2
5434,Preregistration
191953,Patented
14841,Phase 1
113921,Phase 1/2
169358,Phase 1
44941,Phase 1/2a
141311,IND submitted
26566,Phase 1b
52363,Discontinued in Preregistration
54794,Patented
184930,Discontinued in Phase 4
74183,Investigative
47412,Discontinued in Preregistration
67095,Patented
48455,Investigative
11716,Discontinued in Phase 2/3
63544,Phase 1
18565,Discontinued in Phase 2/3
35622,Phase 0
163954,Phase 0
129973,Discontinued in Phase 4
133982,Discontinued in Phase 4
28097,Discontinued in Phase 2/3
154673,Phase 3
5815,IND submitted
33527,Discontinued in Phase 2
6591,Phase 1b/2a
145324,Clinical trial
30826,Patented
44175,Phase 2/3
105552,Phase 1
64271,Phase 2
55912,Phase 1b/2a
179621,Phase 1/2a
189010,Phase 1/2a
102976,Investigative
25758,Investigative
161273,Phase 1
42405,Investigative
103273,Discontinued in Preregistration
99396,Phase 2
187239,Phase 0
105357,Phase 1/2
156520,Investigative
106262,Phase 1
134160,Patented
185208,Discontinued in Phase 1
88915,Phase 1
123243,Investigative
143569,Phase 1b/2a
128371,Discontinued in Preregistration
140716,Phase 2a
25271,Phase 1b/2a
12692,Phase 1/2a
16967,Discontinued in Phase 1
3367,Discontinued in Phase 2
42225,Phase 1b/2a
12014,Phase 2
162375,Investigative
145377,Phase 1b/2a
56998,Phase 1b/2a
164858,Phase 1
150461,Phase 2b
149685,Phase 2b
120393,Phase 0
39775,Phase 1/2a
45492,Phase 1/2a
9453,Discontinued in Phase 2/3
188918,Phase 2b
120180,IND submitted
108095,Discontinued in Phase 2b
49799,Discontinued in Phase 2/3
6460,Phase 4
55482,Discontinued in Phase 2
44252,Phase 1/2a
172794,Patented
96380,Discontinued in Phase 2/3
123096,Phase 1/2
46461,Phase 1/2
133594,BLA submitted
124869,Discontinued in Phase 4
181238,Phase 2/3
50993,Phase 1b/2a
78917,Phase 2/3
178807,Patented
116160,Clinical trial
37579,Discontinued in Preregistration
177139,Phase 2a
123887,Phase 1/2
102397,Phase 1/2a
50561,Discontinued in Preregistration
139784,Investigative
157256,Discontinued in Phase 1
111190,Discontinued in Phase 2b
115071,Phase 1/2a
134700,Phase 0
87577,Approved
149126,Phase 2/3
183694,Phase 1b
162413,Patented
189339,Phase 1/2
50814,Phase 1b/2a
29189,Phase 1/2a
13270,Phase 1/2a
22262,Phase 1
6189,Investigative
36916,Phase 1
68621,Discontinued in Preregistration
64075,Phase 0
12413,Phase 1/2
34537,Discontinued in Phase 2/3
145946,Phase 2a
75178,Phase 1/2a
134768,Phase 0
39297,Phase 2/3
171552,Patented
37692,Phase 1b
92020,Discontinued in Phase 2
177155,Phase 1b
154506,Discontinued in Phase 2b
104237,Discontinued in Phase 4
186206,Clinical trial
83454,Phase 0
42811,Phase 2
89111,BLA submitted
119299,Approved
11452,Phase 1b
151297,Phase 1
191602,Phase 4
137694,Discontinued in Phase 2/3
49332,Phase 1
60231,Phase 2/3
120149,Discontinued in Phase 4
130596,Phase 0
51708,Discontinued in Phase 2b
42010,Discontinued in Phase 1
132999,Patented
185378,Approved
181968,Phase 1/2a
20545,Phase 0
34360,Phase 1b/2a
79444,Phase 2
122574,Phase 1
152994,Discontinued in Phase 2b
160761,Phase 2/3
138412,Phase 1/2a
12163,IND submitted
152132,Phase 1
128800,Discontinued in Phase 2b
88683,Discontinued in Phase 4
100007,Phase 2/3
94080,Phase 1
165042,Phase 1/2
84781,Phase 0
51656,Phase 1b/2a
93333,Phase 1/2
77360,Phase 1b/2a
60454,Phase 2/3
170586,Phase 1
104159,Phase 1/2a
66070,Phase 2
153876,Phase 1b
121605,Approved (orphan drug)
85790,Discontinued in Phase 2b
162809,IND submitted
45259,Phase 1/2a
174721,Phase 2
102548,Phase 1/2
132810,Phase 1/2
119899,Phase 0
132947,Phase 1/2
132716,Discontinued in Phase 2b
129161,Discontinued in Phase 3
7665,Discontinued in Phase 3
143942,Investigative
70678,Phase 0
163389,Patented
113800,Phase 1/2
121615,Patented
140619,Phase 3
161144,Discontinued in Phase 4
183966,Phase 0
63843,Approved (orphan drug)
38043,Discontinued in Phase 2b
133405,Discontinued in Preregistration
109,Discontinued in Phase 1
2038,Discontinued in Phase 1
120223,Approved (orphan drug)
153368,Discontinued in Phase 4
13841,Phase 1
82817,IND submitted
24812,Phase 1/2a
140528,Patented
51701,Discontinued in Preregistration
43311,Phase 0
155845,Phase 1b/2a
120,Discontinued in Phase 1
103690,Discontinued in Phase 1/2
33118,Discontinued in Phase 4
149188,Phase 1/2a
158719,Approved
32834,Phase 1/2
78872,Phase 2a
160245,Discontinued in Phase 1/2
56038,Phase 2
121001,Phase 2b
169031,Approved
91903,Investigative
102434,Approved (orphan drug)
50835,Investigative
44894,Phase 1/2a
142285,Discontinued in Preregistration
146522,Phase 2/3
69502,Phase 3
31875,Phase 1
144519,Discontinued in Phase 2
81218,Phase 1b/2a
97643,Phase 1
124285,Phase 1b
13869,Phase 0
101245,Phase 1/2
118545,Approved
80856,Phase 2a
78002,IND submitted
35428,Phase 1/2
168341,Phase 0
69784,Investigative
50196,Phase 1b
133671,Patented
160261,Phase 1b/2a
80925,Approved (orphan drug)
56172,Phase 3
19359,Patented
15669,Phase 1/2a
52103,Phase 1/2a
73321,Phase 1b/2a
10933,Phase 1
146471,Discontinued in Phase 2
145956,Discontinued in Preregistration
147763,IND submitted
150761,Phase 0
57990,Phase 2/3
156921,Discontinued in Phase 1/2
173174,Discontinued in Phase 2
86978,Discontinued in Phase 1/2
64681,Phase 1b/2a
15795,Phase 1
127717,IND submitted
39435,IND submitted
60956,Approved (orphan drug)
110938,Discontinued in Phase 3
97389,Phase 1/2a
99508,Phase 1
129090,Investigative
177985,IND submitted
162482,Phase 1b
23478,Patented
35691,Phase 0
140872,Preregistration
23262,IND submitted
166413,Phase 1b/2a
89219,Phase 2/3
12290,Phase 3
102405,Discontinued in Preregistration
136195,IND submitted
165233,Phase 1/2
32177,Phase 1b/2a
46150,Phase 1/2a
156464,Phase 1/2
184350,Phase 0
119682,Discontinued in Phase 2b
120452,IND submitted
132255,Phase 1b/2a
158885,Approved
2719,Discontinued in Phase 1/2
64018,Phase 1b/2a
115647,Approved (orphan drug)
36940,Discontinued in Phase 1
76665,Phase 1/2
119300,Phase 1/2a
153026,Phase 1/2a
165403,IND submitted
99447,Phase 2
120547,Discontinued in Phase 1/2
85468,Discontinued in Phase 2b
163262,Clinical trial
70121,Investigative
67971,Discontinued in Phase 2b
57463,Phase 1b/2a
175800,Phase 2
143415,Phase 1/2
135247,Phase 0
3947,Discontinued in Preregistration
136843,Phase 1/2
18742,Discontinued in Phase 2/3
74727,Patented
58398,Phase 0
7649,Discontinued in Phase 3
56307,IND submitted
52210,Phase 0
51589,Investigative
145418,Discontinued in Phase 2/3
26718,Phase 0
126721,Patented
69831,Patented
33089,Discontinued in Phase 1
80917,BLA submitted
134521,Phase 1/2a
36419,Patented
3745,Discontinued in Phase 2b
157909,Discontinued in Phase 1/2
45650,Phase 2/3
69013,Discontinued in Phase 3
190701,Approved (orphan drug)
60114,Investigative
11699,Phase 1/2a
163610,Phase 1/2a
10745,Discontinued in Phase 2b
45002,Phase 2/3
60385,Phase 0
48177,Discontinued in Phase 3
190233,Approved (orphan drug)
111945,Phase 0
40269,Discontinued in Phase 2b
180936,Phase 1b
32694,Phase 3
129591,Investigative
91685,IND submitted
54723,Phase 1/2a
114215,IND submitted
65978,Phase 1
148929,Discontinued in Phase 2
154388,Discontinued in Preregistration
25957,Patented
43989,Phase 1/2a
174532,Phase 2
130782,Phase 2
127083,Discontinued in Phase 1
98084,Phase 1/2a
140220,Discontinued in Phase 2
186774,Phase 4
18100,Phase 2
85774,Discontinued in Phase 2b
39881,Investigative
126108,Discontinued in Phase 3
29545,Discontinued in Phase 1
35891,Phase 1b
111530,Discontinued in Phase 4
139531,BLA submitted
63855,Approved
110762,Discontinued in Phase 4
26429,Phase 1b
37329,Phase 2
34312,Phase 1b/2a
39990,Phase 1/2a
181389,Phase 1/2a
168637,Discontinued in Phase 1/2
102440,Phase 1/2a
178555,Phase 1/2a
39992,Discontinued in Phase 2
182981,Phase 1
8864,Discontinued in Phase 1
25752,Phase 1b/2a
58382,Phase 2/3
32749,Phase 0
9167,Discontinued in Phase 2
112658,Phase 1/2
95025,Phase 1b
50009,Phase 0
82123,Discontinued in Phase 2
146903,Phase 2/3
188527,Phase 0
41151,Approved
185539,Preclinical
39024,Phase 2
99483,Discontinued in Phase 2/3
112543,Discontinued in Phase 2
46591,Phase 0
13746,Phase 1
149449,Phase 1b/2a
142111,Phase 1
132372,Phase 2
61924,Discontinued in Phase 2b
90222,Discontinued in Phase 3
44666,Phase 2/3
60061,Discontinued in Phase 1/2
151232,Phase 2
95640,Phase 1b/2a
76715,Phase 0
94946,Patented
152665,Patented
187089,Phase 0
36928,Phase 1b/2a
10614,IND submitted
162424,Patented
51350,Phase 1b/2a
16158,Phase 1/2
70096,Phase 2a
85438,Discontinued in Phase 3
4700,Phase 2a
115747,Phase 1/2
115523,Phase 2a
42798,Phase 0
34835,Phase 1b
32845,Phase 2a
154009,Discontinued in Phase 4
152083,Phase 0
40142,Discontinued in Phase 2
73461,Patented
28463,Phase 1b
191078,Phase 1/2a
182904,Phase 2a
177069,Phase 1/2
54861,Phase 0
82781,Phase 0
64492,Phase 1/2a
148056,Phase 1/2a
58089,Phase 0
88671,Phase 1
182430,Phase 1/2
59218,Investigative
168582,Phase 2
134985,Phase 0
72266,Phase 1/2
9002,IND submitted
45433,Phase 2/3
118783,Discontinued in Preregistration
129038,Phase 1/2
161646,Discontinued in Phase 1/2
99826,Phase 1
44439,Phase 2/3
95484,Phase 1/2a
145934,Phase 1
37065,Phase 2
77858,Phase 1/2
123368,Discontinued in Preregistration
167491,Discontinued in Phase 2
147918,Investigative
45533,Phase 1/2a
102586,Approved (orphan drug)
65376,Phase 2a
159047,Clinical trial
106650,Discontinued in Phase 4
49400,Phase 1
47316,Phase 1/2
146040,Phase 1b/2a
126351,Phase 1b/2a
135868,Phase 1/2
98938,Phase 1b
11615,Phase 1/2
177922,Phase 1/2
140408,Phase 1/2a
115789,Phase 1/2
51202,Patented
149534,Phase 2a
102613,Approved (orphan drug)
179016,Patented
29765,Phase 1
190646,Phase 4
79645,Phase 2a
76382,Phase 1/2
191188,Approved
57580,Phase 1b
128300,Phase 0
186265,Phase 0
73221,Discontinued in Preregistration
148426,IND submitted
130277,Phase 1/2a
93620,Phase 1/2a
48692,Phase 3
190568,Phase 4
10232,Discontinued in Phase 2/3
62461,Patented
91694,Clinical trial
17188,Phase 3
135430,Phase 0
905,Discontinued in Phase 2/3
62250,Phase 1/2a
150885,Phase 0
69641,Phase 1
114429,Phase 1b/2a
172218,Phase 1/2
117512,Investigative
131722,Phase 1b/2a
49295,Investigative
55270,Patented
169175,Phase 1/2
140672,Preregistration
17648,Phase 0
112415,Discontinued in Phase 3
109713,Discontinued in Preregistration
180545,Discontinued in Phase 2b
31528,Phase 0
166833,Phase 1b
124361,Phase 1b
19529,Phase 0
185837,Phase 1b/2a
184245,Discontinued in Phase 4
148602,Phase 1/2a
105521,Phase 1b
187408,Patented
134776,Phase 0
7845,Patented
50946,Phase 1b
151453,Phase 1
101573,Phase 2a
175073,Phase 0
146175,Phase 2b
63013,Phase 1b/2a
58675,Phase 1
152238,Phase 2
99684,Phase 1/2a
79268,Phase 2a
93760,Discontinued in Phase 2b
159018,Phase 1/2
138287,Approved (orphan drug)
74777,Phase 2
47020,BLA submitted
41119,Approved
180721,Phase 2a
77336,IND submitted
167677,Phase 2
91371,Phase 1/2
167603,Phase 4
101046,Phase 0
107841,Discontinued in Phase 2/3
183183,Phase 1/2
166043,Phase 1b/2a
172884,Discontinued in Phase 3
53434,Phase 0
74755,Discontinued in Phase 2b
55321,IND submitted
38358,Phase 1/2
117528,Discontinued in Phase 1/2
133028,Patented
3008,Phase 2a
133363,Discontinued in Preregistration
16096,Phase 1
89723,Phase 1/2
8679,Investigative
92911,Phase 2b
89649,Phase 1b/2a
160724,Phase 2a
173337,Phase 1
157232,IND submitted
138226,BLA submitted
187873,Patented
19040,IND submitted
164743,Investigative
102183,Phase 1b
18119,Discontinued in Phase 3
78189,Approved
66004,Phase 1
109795,Discontinued in Preregistration
152860,Phase 1/2
50607,Phase 1/2a
164553,Phase 0
150810,Phase 1
75630,Phase 2/3
121386,Patented
13847,Investigative
14555,Phase 1b/2a
98434,Phase 1b
11418,Phase 0
31885,Discontinued in Preregistration
135933,Phase 3
87743,Phase 1/2
133324,Phase 1/2
77106,IND submitted
28907,Investigative
145393,Phase 1b/2a
161183,Phase 1
25535,Phase 0
6567,Investigative
24511,Phase 2/3
32823,Phase 2a
108542,Phase 1
88399,Phase 1
76491,Investigative
169826,Phase 1/2
169853,Phase 1/2
141902,Patented
46856,Phase 4
119536,Phase 0
139345,Investigative
94872,Phase 1/2a
112347,Phase 1
30144,Discontinued in Phase 3
99053,Phase 0
152929,Phase 1b/2a
163715,Phase 1/2a
151392,Phase 2
80301,Clinical trial
155871,Phase 1b
90726,Discontinued in Preregistration
99803,Phase 1/2a
164601,Phase 1/2
28595,Discontinued in Phase 2/3
99651,Phase 2
45114,Phase 2/3
179099,Phase 1
126516,Discontinued in Phase 3
107278,Discontinued in Phase 3
186717,Clinical trial
130323,Phase 1b/2a
172477,Phase 0
106579,Discontinued in Phase 3
57532,Phase 0
101956,Phase 0
112882,Phase 0
64981,Clinical trial
117311,Phase 1b
26049,Phase 2/3
158001,Phase 1/2a
15671,Investigative
145910,Phase 1b
25067,Phase 2/3
82660,Phase 1
162539,Patented
47937,Phase 0
114741,Phase 0
29034,Phase 4
67612,Phase 0
134346,Discontinued in Phase 4
79920,Phase 2
170182,Phase 0
129493,Patented
163747,Phase 1
113568,Phase 1
90028,Phase 2/3
176170,Discontinued in Phase 1/2
134220,Discontinued in Phase 4
41769,Phase 1b/2a
84343,Phase 1b/2a
26139,Phase 2/3
121872,Approved (orphan drug)
89049,IND submitted
173671,Phase 1b
106070,Phase 1/2a
105184,Phase 1b
106464,Discontinued in Phase 4
60515,Phase 1b/2a
121020,Phase 1/2a
117290,Phase 1/2
31399,Phase 1/2
140772,Preregistration
21527,Discontinued in Phase 1/2
17162,Phase 1b/2a
77104,Discontinued in Phase 1/2
41434,Phase 1/2a
156914,Phase 2
15043,Phase 0
49857,Phase 1b
71253,Phase 1b/2a
81681,Phase 1
31238,Discontinued in Phase 2b
61867,Discontinued in Phase 4
62812,Phase 1b/2a
52670,IND submitted
175918,Discontinued in Phase 4
191783,IND submitted
88022,Phase 1b/2a
41381,Discontinued in Preregistration
65202,Phase 2
145833,Phase 1/2a
186164,Phase 2b
139954,Phase 1/2a
180472,Phase 2a
183401,Discontinued in Phase 4
108569,Patented
55711,Phase 1b/2a
129874,Phase 1/2
127560,Discontinued in Phase 3
74150,Phase 1/2
62003,Discontinued in Phase 4
46233,Phase 1/2
150320,Discontinued in Phase 2/3
66096,Phase 2
56197,Phase 0
190499,IND submitted
58525,Phase 1b/2a
7223,Phase 1/2
22692,Phase 1b
141335,IND submitted
25356,Phase 1b
75097,Patented
113254,Discontinued in Phase 3
176524,Phase 1
142538,Phase 1
163051,Discontinued in Phase 3
65874,Phase 1
141448,Phase 2/3
103661,Phase 1/2
77350,Patented
166736,Phase 1b/2a
170037,Investigative
2004,Investigative
11419,Phase 2/3
106590,Discontinued in Phase 4
82702,Phase 2
91318,BLA submitted
117593,Phase 1
10094,IND submitted
104791,Phase 1/2a
147825,Phase 2/3
175777,Phase 2b
11404,Discontinued in Preregistration
128139,Phase 1/2
121468,Discontinued in Phase 2b
145560,Phase 1/2a
16433,Phase 1
190784,Discontinued in Phase 3
171875,Discontinued in Phase 2b
65206,Phase 1/2
105464,Phase 1/2a
151829,Phase 2
26564,Phase 1/2a
115866,Clinical trial
151628,Phase 1b/2a
89016,BLA submitted
64244,IND submitted
82290,Discontinued in Phase 1/2
16629,Phase 1/2a
162739,Phase 1
97960,Phase 0
128149,IND submitted
93126,Phase 1/2a
168232,Phase 2
150396,Phase 1/2a
24335,IND submitted
55452,Phase 1
166607,Discontinued in Phase 4
73063,Phase 0
176384,Phase 1b
95519,Phase 1b
24082,Phase 1/2
106345,Phase 0
95654,Phase 2a
34369,Phase 1
49758,Patented
119681,Discontinued in Preregistration
79242,Phase 1b
28850,Phase 1b/2a
25215,Phase 2/3
124063,Phase 0
163860,Phase 1
82214,Discontinued in Phase 2/3
38317,Phase 1/2
190775,Patented
53519,Discontinued in Preregistration
190215,Clinical trial
36322,Discontinued in Phase 3
20342,IND submitted
187297,Investigative
44811,Phase 1/2a
17915,Phase 2/3
62973,Phase 1b/2a
94265,Phase 2b
99001,Phase 1/2
27500,BLA submitted
121005,Phase 2/3
95932,Phase 1
154878,Phase 1b/2a
97032,Discontinued in Phase 2
92624,Phase 0
124940,Phase 1/2
6496,Phase 4
161783,Investigative
180950,Phase 1b/2a
6986,Phase 2a
100729,IND submitted
121360,Phase 1/2a
156536,Clinical trial
50234,Patented
90180,Phase 2/3
28274,Discontinued in Phase 4
170493,Phase 2/3
135423,Phase 0
152779,Discontinued in Phase 3
12964,Phase 3
25194,Investigative
146700,Investigative
23397,Phase 2
21698,Discontinued in Phase 3
146717,Phase 2b
45728,Phase 2/3
89981,Phase 2/3
10343,Phase 1/2
38251,Phase 2a
76631,Phase 1b
126122,Phase 1b
17659,Phase 1
42736,Phase 1/2
38091,IND submitted
167259,Discontinued in Phase 1
81900,Clinical trial
128571,Phase 1/2
90416,Discontinued in Phase 2/3
173394,Phase 1/2
121147,Phase 1b
105692,Phase 1/2a
60079,Phase 2/3
29724,Discontinued in Phase 3
133559,Investigative
107813,IND submitted
167164,Discontinued in Phase 1/2
50874,Phase 1b/2a
132002,Phase 1b/2a
53411,Phase 1/2a
91517,Phase 1b
1700,Phase 0
67288,Approved (orphan drug)
115485,Phase 2
88960,Phase 0
185155,Phase 1
141233,Phase 2/3
107617,Phase 1b
191691,Phase 1/2
181868,Phase 1/2a
69268,Phase 3
56726,Phase 1b/2a
115488,Clinical trial
163584,Phase 1/2a
189161,Phase 1/2
128049,Phase 0
160298,Phase 1/2
155408,Phase 1
38139,Phase 0
28754,Phase 1/2a
62034,Phase 1b
97470,Phase 1/2a
63032,Phase 1b/2a
88623,Phase 1
144066,Phase 1/2
182247,Discontinued in Phase 4
191013,Phase 1
52411,Phase 1/2a
119621,Discontinued in Preregistration
2572,Phase 0
60572,Clinical trial
121160,Phase 2
54965,Discontinued in Preregistration
135011,Phase 0
182922,Phase 2a
15603,Phase 1
118410,Phase 1
189135,Phase 1/2
94449,Phase 2b
126277,BLA submitted
9927,Phase 1/2
80344,Patented
62588,Phase 0
71004,Phase 1b
71710,Phase 0
77575,Discontinued in Preregistration
152382,IND submitted
62883,Phase 1b
152332,Phase 2/3
140433,Phase 1/2
44873,Phase 2/3
105324,Phase 1b
3816,Discontinued in Phase 3
118999,Discontinued in Preregistration
51869,Phase 0
52703,Discontinued in Preregistration
88021,Phase 0
162472,Investigative
89851,Discontinued in Preregistration
58679,Phase 2/3
20320,Phase 1b/2a
75233,Patented
54584,Discontinued in Preregistration
99658,Patented
132996,Discontinued in Phase 2b
96878,Phase 1b
167668,Patented
114612,Phase 1b/2a
78894,Phase 2a
180621,Phase 2a
39158,Phase 1/2
58014,Investigative
78842,Phase 0
18487,Discontinued in Phase 3
114711,Phase 0
28840,Phase 2
49636,Phase 1
50938,Phase 1b/2a
176229,Clinical trial
170888,Phase 1/2
116360,Discontinued in Phase 3
9377,Discontinued in Phase 1
61740,Investigative
166195,Phase 1
69922,Phase 1b
166749,Phase 1b
120671,Clinical trial
121100,Phase 2b
51083,Phase 1/2a
98931,Phase 1
165707,Patented
11566,Discontinued in Preregistration
13825,Phase 2b
57315,Discontinued in Phase 4
43370,Phase 2/3
66012,Phase 1/2
54679,Phase 1b/2a
119586,Discontinued in Preregistration
96,Phase 1/2a
99180,Phase 1
101756,Phase 1/2
56379,Phase 1b/2a
179528,Discontinued in Phase 1
45768,Phase 2/3
43560,Phase 2/3
121560,Phase 0
101440,Phase 1b/2a
71691,Phase 1b
15332,Phase 1
111996,Discontinued in Phase 3
15453,IND submitted
39635,IND submitted
109338,Discontinued in Phase 2
34955,Phase 1b
34601,Phase 1b/2a
97471,Phase 1/2a
167132,Phase 1/2a
96385,Phase 0
91065,BLA submitted
89689,IND submitted
147958,IND submitted
142184,Investigative
48276,Phase 1/2
116287,Phase 2
187761,Phase 4
119105,Discontinued in Phase 2
56029,Phase 0
94818,Phase 1
85379,Discontinued in Phase 2b
164719,Phase 2/3
138620,Phase 1b
27706,Phase 1b/2a
93100,Phase 1/2a
92483,Phase 4
154096,Phase 1/2a
187428,Phase 0
119545,Discontinued in Preregistration
121154,Phase 2a
86638,Phase 1b/2a
89719,Phase 1b
176091,Discontinued in Phase 2
172748,Phase 1/2
132647,Phase 1b/2a
6181,Phase 4
175714,Discontinued in Phase 2
117863,Clinical trial
88537,Phase 1
188563,Phase 1/2
39017,Discontinued in Phase 2
91102,BLA submitted
26678,Phase 1/2a
110158,Investigative
7844,Phase 1b
153378,IND submitted
12202,Phase 1/2
110641,Discontinued in Preregistration
1259,IND submitted
42823,Discontinued in Phase 1
129410,Investigative
89036,IND submitted
15478,Phase 1/2a
38907,Patented
105540,Discontinued in Phase 2/3
177194,Phase 1b
43373,Phase 1/2a
88349,Phase 1/2
116793,Phase 1
98842,Phase 1/2a
155199,Phase 2
63654,Discontinued in Phase 2
183944,Discontinued in Phase 4
74965,IND submitted
75148,Phase 2
138848,BLA submitted
12470,Phase 0
115443,Phase 2
157644,Approved (orphan drug)
136675,Phase 1/2
106695,Phase 0
140087,Phase 1/2a
5318,Discontinued in Phase 2
28388,Investigative
157450,Phase 1
122955,Discontinued in Phase 4
159618,Phase 1b/2a
191191,Phase 1/2a
180001,Phase 1
163611,Phase 1/2a
29678,Discontinued in Phase 2b
129393,IND submitted
104910,Discontinued in Preregistration
135901,IND submitted
73359,Clinical trial
66283,Investigative
94595,Discontinued in Phase 4
144108,Phase 0
179832,Phase 1
103738,Phase 0
142585,Discontinued in Phase 2b
155991,Phase 1b
125312,Phase 1b/2a
79526,Phase 2
187178,Phase 1/2a
31410,Discontinued in Phase 4
25368,Discontinued in Phase 2b
107737,Discontinued in Phase 2
189063,Approved (orphan drug)
37376,Discontinued in Phase 1/2
71047,Discontinued in Phase 3
75449,Phase 1/2a
4821,Investigative
126175,Phase 1b/2a
143638,Phase 2b
65026,Preclinical
74598,Phase 1/2
87219,Phase 1
158546,Phase 1
139921,BLA submitted
188479,Phase 1/2
70842,Phase 1b
165211,BLA submitted
50759,Phase 1/2a
29791,IND submitted
170668,IND submitted
164483,Phase 1/2
65758,Phase 1b/2a
96228,Patented
133542,BLA submitted
60860,Phase 0
26538,Phase 0
165587,Patented
66186,Preclinical
59141,Phase 1b/2a
158494,Phase 2/3
71481,Patented
172641,Phase 2
14153,Phase 1
161671,Patented
76098,Phase 2/3
33569,Phase 2a
97902,Phase 1b
72818,Phase 1/2
10319,Phase 0
74211,Discontinued in Phase 2b
39369,Discontinued in Phase 2b
169220,Phase 1b/2a
128803,Discontinued in Preregistration
46500,Phase 1/2
17505,Phase 1/2
126666,Phase 1/2
182683,Phase 1
176074,Phase 2b
73718,Approved (orphan drug)
23411,Discontinued in Phase 4
89536,Phase 1/2
21794,Discontinued in Phase 2b
27387,Discontinued in Preregistration
157700,IND submitted
98035,Phase 1
32459,Discontinued in Phase 1
56000,Discontinued in Phase 4
171718,Phase 2a
131081,Investigative
23805,Discontinued in Phase 4
123623,Phase 1/2
561,Discontinued in Phase 1/2
33044,Phase 1/2
100383,Approved
59991,Phase 1
33963,Phase 1b
61498,Phase 1/2
91918,Phase 1/2a
54779,Investigative
186273,Patented
770,Discontinued in Phase 3
141206,Patented
106259,Phase 1/2a
154228,Discontinued in Phase 4
155570,Approved
119039,Phase 1/2a
100764,Phase 1b/2a
103614,Phase 2b
122803,Patented
58696,Clinical trial
162847,Phase 2b
114371,Phase 1/2
142755,Phase 2a
31672,Phase 0
190006,Approved
80408,Phase 2a
48063,Phase 0
171796,Phase 0
36867,Phase 2a
140054,BLA submitted
58394,Discontinued in Phase 3
145787,Discontinued in Phase 1
76585,Phase 0
56304,Phase 1/2a
141489,Phase 1b
67106,Phase 0
124651,Patented
74659,Discontinued in Phase 2b
151286,Phase 0
76497,Phase 1/2
145226,Phase 2/3
166291,Phase 2
64245,Phase 1b/2a
139710,Phase 1/2
89544,Investigative
130840,Discontinued in Phase 2b
118462,Discontinued in Phase 2/3
180904,Phase 2a
182470,Phase 1b/2a
97874,Phase 1b
93788,Discontinued in Phase 1
94215,Phase 2b
48797,Phase 2
134105,Patented
85827,Discontinued in Preregistration
167886,Patented
153151,Phase 1
161461,IND submitted
134538,Patented
124687,IND submitted
60774,Discontinued in Phase 3
185942,Phase 0
134425,Phase 1b
91553,Discontinued in Phase 2b
52268,Phase 1b/2a
46202,Phase 2/3
57966,Phase 1/2
71472,Discontinued in Preregistration
13151,Phase 2b
57137,Phase 0
179378,Phase 1/2a
36214,Discontinued in Phase 1
185916,Phase 2a
909,Phase 2/3
98981,Phase 1/2a
152937,Discontinued in Phase 2
154504,IND submitted
160919,Phase 1b/2a
59254,Phase 1/2
90549,Phase 1/2a
10243,Discontinued in Phase 2b
177544,Phase 1b
18445,Phase 2
168536,Phase 1b/2a
4432,Phase 2a
166798,Phase 0
70407,Phase 1b/2a
76784,Phase 1/2
71968,Phase 1b/2a
155443,Discontinued in Preregistration
83575,Phase 1/2
1580,Phase 1
101983,Phase 1/2
35809,Discontinued in Phase 1/2
174702,Discontinued in Phase 4
37761,Phase 1/2a
181316,Phase 1b/2a
63788,IND submitted
146273,Phase 1b/2a
121969,Phase 1b/2a
107420,Phase 0
137935,Approved (orphan drug)
184147,Phase 0
191213,BLA submitted
54864,Phase 0
12005,Phase 1/2a
65173,Phase 1b/2a
176294,Phase 1b/2a
87534,Phase 0
94084,Phase 1/2
15625,Discontinued in Phase 1
10014,Phase 1
20790,Phase 0
85064,Phase 1b/2a
104023,Investigative
136363,Patented
135641,Phase 1/2
134861,Phase 0
67446,Phase 0
49495,Phase 1/2a
99339,Phase 1
122818,Phase 2
48737,Discontinued in Preregistration
2658,Phase 1b/2a
20122,Clinical trial
155581,Phase 2
32848,Phase 1/2
120929,Phase 2
2915,Investigative
150678,Phase 2
70253,Investigative
169813,Phase 0
178681,Phase 1b
160063,Phase 1b/2a
56497,Phase 0
50341,Discontinued in Preregistration
148760,Discontinued in Phase 2/3
97598,Phase 2
136199,Phase 3
84394,Phase 1
2007,Approved
89210,Phase 1/2a
35037,Phase 1/2a
488,Phase 1
149442,Phase 0
162933,Phase 1/2a
175478,Phase 0
129655,Discontinued in Preregistration
41162,Approved
48808,Phase 1/2
92910,Phase 1
9559,Discontinued in Phase 1
92864,Phase 2a
32946,Phase 3
176254,Phase 1b/2a
738,Phase 2b
188032,Phase 1b
77163,Phase 1/2a
186045,Phase 2b
68940,Phase 1
42173,Phase 1
22983,Investigative
173055,Phase 1/2
58818,Phase 0
76543,Investigative
5467,Phase 2/3
88531,Phase 1
49159,Investigative
26960,Phase 1b/2a
111104,Phase 1
7144,Phase 4
45390,Phase 1/2a
156337,Discontinued in Phase 3
52664,Phase 1
127036,Discontinued in Phase 2b
172185,Discontinued in Phase 2b
66079,Discontinued in Phase 4
16137,Phase 1/2
175640,Phase 0
167027,Phase 4
172839,Discontinued in Phase 2
83614,Phase 2/3
120915,Investigative
27331,Patented
187779,Phase 0
86134,Investigative
181184,Phase 1
92388,Approved (orphan drug)
73235,Discontinued in Phase 3
119633,Approved
29077,Phase 0
191029,Phase 1/2a
105433,Phase 1b
152635,Discontinued in Phase 3
102081,Approved (orphan drug)
39832,Patented
17787,Investigative
87560,Phase 1/2
66380,Discontinued in Phase 3
7703,Patented
159426,Phase 1/2
65250,Phase 1/2
154938,Phase 2
170781,Phase 1/2
82286,Phase 1/2a
78459,Phase 0
173280,Phase 1b
190477,Phase 0
3862,Discontinued in Preregistration
190760,Approved
4814,Discontinued in Phase 2
27273,Phase 1b/2a
146882,Phase 2a
42250,Approved
172449,Discontinued in Phase 2/3
42744,Phase 1/2
32980,Phase 0
153214,Investigative
91497,Patented
15923,Phase 0
76918,Phase 1b/2a
21754,BLA submitted
163956,Phase 1/2
126750,Investigative
130958,Investigative
181092,Phase 1
151746,Phase 1b/2a
129761,Patented
43204,Discontinued in Preregistration
51806,Patented
30869,Phase 1b
39918,Investigative
170408,Discontinued in Preregistration
98111,Phase 1/2a
139242,Clinical trial
146006,Phase 2/3
144297,Discontinued in Phase 1/2
61023,Phase 1
97403,Phase 1b
178116,Investigative
127128,Discontinued in Phase 3
41649,Discontinued in Phase 1
60933,Phase 1b/2a
159170,Phase 2
104970,Discontinued in Preregistration
131713,Patented
5769,Investigative
160647,Phase 3
41880,Phase 1b
148965,Phase 1b/2a
12929,Phase 0
90049,Discontinued in Phase 2
121421,Phase 1b/2a
175495,Patented
90897,Approved (orphan drug)
34944,Patented
107722,Discontinued in Phase 4
159154,Phase 1/2
130791,Phase 2
29287,Phase 0
33445,Phase 1b/2a
68706,Investigative
53379,Phase 1/2
16946,Phase 1
48793,IND submitted
161590,Phase 1/2
10185,IND submitted
93637,Phase 1b
74229,Phase 1/2a
6427,IND submitted
73790,Approved (orphan drug)
139115,Phase 1b
45829,Phase 1/2a
122739,Phase 1
87271,Patented
10602,Discontinued in Phase 3
146025,Phase 1b
24187,IND submitted
142257,Phase 1b
67433,Discontinued in Phase 2/3
85883,Discontinued in Phase 2b
139580,Phase 1/2a
2735,Phase 1b/2a
31956,Phase 2b
94288,Phase 1
110780,Phase 2
20300,Phase 1
49972,Phase 1/2a
165435,Discontinued in Phase 1/2
125442,Phase 1b
2870,Phase 0
38303,Discontinued in Phase 1
157759,Phase 2
87535,Discontinued in Phase 2/3
135399,Phase 0
98495,Phase 1b
189613,Phase 1b/2a
30325,Discontinued in Phase 1
19644,Phase 1/2
164677,Phase 1
179710,Discontinued in Phase 1
192110,Phase 1/2
145277,Phase 1b/2a
123493,Phase 1b
136313,Discontinued in Phase 2
183233,Approved (orphan drug)
87754,Patented
169001,Discontinued in Phase 2
187557,Clinical trial
110522,Discontinued in Phase 2/3
111382,Discontinued in Phase 2b
16601,Phase 1
47648,Phase 0
58646,Discontinued in Phase 3
135963,Phase 1/2
118059,Discontinued in Preregistration
31196,Phase 1/2a
155716,Approved
153172,Investigative
174991,Phase 2
115193,Clinical trial
33772,Phase 1b/2a
47105,Approved (orphan drug)
180009,Phase 1
31089,Discontinued in Phase 2/3
5536,IND submitted
64032,Phase 2
29136,Phase 1b/2a
128535,Phase 1/2
86701,Phase 2
52755,Phase 0
47236,Approved
128129,Discontinued in Phase 4
189546,Clinical trial
23913,Phase 1b
104678,Patented
113856,Phase 1
189181,Phase 1/2
186876,Phase 2a
73899,BLA submitted
183194,Phase 2a
97056,Phase 2
171705,Discontinued in Phase 2
24693,Discontinued in Phase 4
37195,Discontinued in Phase 1
2260,Discontinued in Phase 1/2
115559,Phase 1/2a
181706,Phase 2a
13912,Phase 0
114575,Clinical trial
166436,Patented
157840,Phase 1/2
167768,Phase 2
187553,Phase 4
181600,Phase 1b/2a
7713,Patented
96728,Patented
5344,Preregistration
126432,Phase 1b/2a
159213,Phase 0
102127,Phase 1b
120953,Phase 1
79655,Approved
118158,Discontinued in Preregistration
145344,Investigative
52275,Phase 1/2a
82005,Clinical trial
159435,Phase 0
119592,Discontinued in Phase 2b
159433,Approved
18729,Phase 1
49179,Phase 1/2a
138107,Phase 1/2a
57179,Phase 2/3
33377,Phase 2a
89087,Clinical trial
91369,BLA submitted
87404,BLA submitted
79395,Phase 0
81871,Phase 1/2
149181,Phase 1b
26876,IND submitted
172586,Discontinued in Phase 2
21459,Phase 0
36968,Phase 1b/2a
91749,BLA submitted
169966,Investigative
78633,Phase 0
170740,Phase 1/2
144995,Phase 2b
173152,Discontinued in Phase 2b
110110,Investigative
189983,Phase 0
94903,Phase 1b/2a
77879,Investigative
4174,Preregistration
14169,Phase 1/2
139134,BLA submitted
1442,Approved (orphan drug)
53854,Patented
190359,Patented
1835,Phase 2a
105220,Phase 1b/2a
72835,Investigative
10396,Discontinued in Phase 2b
11695,Phase 1/2
65158,Approved
58233,Discontinued in Phase 3
128247,Phase 1/2
152252,Phase 1
75442,IND submitted
183323,Approved (orphan drug)
50987,Phase 0
188359,Preclinical
82515,Phase 1
77025,Discontinued in Phase 1/2
113397,Discontinued in Phase 4
84998,Phase 1/2
12396,Phase 1/2a
128511,Investigative
14739,Phase 1
2767,Phase 1
174834,Discontinued in Phase 4
116542,Discontinued in Phase 2b
161114,Discontinued in Phase 4
30418,Phase 0
127426,Phase 1
59241,Discontinued in Phase 3
54978,Discontinued in Phase 3
127106,Investigative
81849,Phase 2
126573,Phase 0
40061,Patented
81795,Approved
74712,Phase 1/2a
88764,Phase 1/2
15523,Phase 0
55909,Phase 1b/2a
192033,Phase 2/3
192097,Discontinued in Phase 2/3
129003,Phase 1/2
102373,Investigative
86139,Discontinued in Phase 2/3
22029,Discontinued in Phase 2
183551,Discontinued in Phase 4
113221,Phase 2/3
10737,Discontinued in Phase 2b
24052,Phase 0
26392,Phase 1b
142116,Investigative
178541,Phase 2a
45326,Phase 1/2a
112610,Phase 1/2
154862,Phase 1b/2a
83268,Phase 1/2
67597,Phase 1/2a
7868,Clinical trial
119864,Approved
148815,Investigative
157730,Phase 2a
87136,Phase 2
102116,Patented
171081,Phase 2/3
102950,Approved (orphan drug)
93852,Phase 2a
22655,Phase 1b
85785,Discontinued in Preregistration
54787,Phase 1/2
188207,Phase 1/2
50920,Phase 0
76503,Phase 1/2a
150988,Phase 1b/2a
109784,Discontinued in Preregistration
26075,Discontinued in Phase 4
115356,Phase 2/3
150847,Phase 0
94259,Phase 1b
91260,Patented
72789,Investigative
115326,Phase 1b
191454,Discontinued in Phase 1
91161,Discontinued in Phase 1
1566,IND submitted
109945,Discontinued in Phase 4
190254,Phase 1/2a
146296,Investigative
49446,Phase 1b/2a
63240,Patented
183230,Phase 1b/2a
101246,Phase 1/2a
73932,Discontinued in Preregistration
140524,Patented
17483,Phase 1/2a
66302,IND submitted
93349,Phase 1b
53957,Discontinued in Phase 4
146134,Phase 1b/2a
82580,Discontinued in Phase 1/2
41898,Phase 0
107690,Phase 1
21495,Discontinued in Phase 3
167543,Phase 4
164503,Investigative
118522,Discontinued in Preregistration
10551,Phase 1/2
189370,Phase 1/2a
124811,Phase 1/2
60488,Clinical trial
42707,Phase 2
92189,Phase 1b
79272,Patented
131050,Phase 2a
135455,Phase 0
63381,Patented
56799,Phase 1b/2a
172014,Phase 0
183239,Phase 2a
77655,Phase 1
126783,IND submitted
178669,Discontinued in Phase 1
170214,Phase 1/2
178300,Phase 2
131161,Investigative
139625,Phase 1/2a
134010,Discontinued in Phase 4
60526,Phase 0
141172,Discontinued in Phase 2b
17791,Phase 1/2
113618,Patented
104101,Phase 1/2
21321,Phase 2
28613,Phase 1/2a
126591,Phase 1/2
157942,Registered
27318,Patented
110064,Phase 1
72244,Discontinued in Phase 1
34902,Phase 2a
132488,Discontinued in Phase 4
52385,Discontinued in Phase 2/3
27473,Discontinued in Preregistration
72275,Phase 0
148843,Phase 1/2
168398,Phase 0
136204,Phase 1/2a
113789,Patented
123539,Approved
81173,Clinical trial
63050,Phase 1/2a
115306,Phase 1/2
174659,Phase 1/2a
117204,Discontinued in Phase 1
188940,Approved
80528,Approved (orphan drug)
59216,Phase 1
94937,Patented
42545,Discontinued in Phase 2b
122726,Phase 0
131058,Phase 2a
191728,Phase 1/2
83089,Phase 1
98253,Phase 1b
189234,Clinical trial
114854,Phase 1/2a
38353,Phase 2/3
49319,Phase 1b
135085,Phase 0
77192,Investigative
191537,BLA submitted
81715,Approved
55373,Discontinued in Preregistration
64971,Discontinued in Phase 2b
2326,Phase 1
179351,Phase 1/2a
80325,Phase 2a
105542,Discontinued in Phase 2b
138771,Approved (orphan drug)
101259,Phase 1b/2a
50128,Phase 1b
98617,Phase 1b
46740,IND submitted
180805,Phase 2a
94223,Phase 2
188349,Phase 1/2
149814,Phase 2/3
116141,Phase 1/2
191444,Investigative
155020,Discontinued in Phase 2b
136209,Phase 1
43295,Phase 0
143494,Phase 2b
21330,Phase 1
142117,Discontinued in Preregistration
78934,Phase 1b
91258,Discontinued in Preregistration
38442,Discontinued in Phase 2
170640,Phase 2/3
1465,Discontinued in Phase 4
167610,Discontinued in Preregistration
153789,Registered
3685,Investigative
21521,Phase 1b/2a
125754,Phase 1b
165832,Phase 1b/2a
165282,Phase 1/2
138266,Investigative
140308,Discontinued in Phase 2
132446,Phase 1/2
114132,Phase 1b
111992,Discontinued in Phase 2
66830,Phase 3
22237,Phase 2
176870,Phase 0
37100,Discontinued in Preregistration
166600,Phase 1/2a
78845,Phase 3
137817,Discontinued in Phase 3
69754,Phase 3
11120,Patented
14403,Phase 3
190465,Preclinical
16544,Phase 1/2
37979,Phase 1/2
152822,Discontinued in Phase 3
28497,Phase 1b
134641,Phase 0
160415,Phase 1/2
48105,Phase 0
23040,IND submitted
176377,Phase 2b
37734,Phase 1b
32199,Phase 2
111460,Phase 1/2
133893,Phase 1b
133344,Phase 1
56373,Discontinued in Phase 2b
74101,Phase 1/2a
164771,Phase 1/2
8945,Phase 2/3
9964,Discontinued in Preregistration
80816,Phase 2
68897,Phase 1b
91556,Discontinued in Phase 2
188218,Phase 2b
168527,Discontinued in Phase 1/2
170141,Phase 0
51738,Phase 0
171292,Phase 1b
90013,Discontinued in Preregistration
176205,Phase 1b/2a
98198,Phase 1/2a
120563,Discontinued in Phase 1/2
76322,IND submitted
97980,Phase 2
39101,Discontinued in Preregistration
92867,Phase 1
125907,Phase 1/2
1906,Discontinued in Phase 1
55596,Phase 2/3
77150,Phase 0
114130,Phase 2
42632,Phase 1/2
168124,Phase 2/3
171672,Phase 1/2
135594,Phase 0
8358,Phase 2
90866,Phase 1b
170984,IND submitted
16097,Phase 0
47324,Discontinued in Phase 3
149466,Discontinued in Preregistration
79965,Clinical trial
183897,Discontinued in Phase 2
178839,Phase 1
151742,Discontinued in Phase 2/3
23350,Phase 1
150691,Phase 1
174434,Discontinued in Phase 4
162327,Phase 1b
139374,Clinical trial
30517,Phase 1b
29215,Phase 0
152801,Patented
51016,Phase 1b
62206,Phase 2
88574,Phase 1
124774,Phase 1
152333,Phase 2a
55578,IND submitted
79558,BLA submitted
59791,Phase 1
78647,Phase 3
59458,Discontinued in Phase 3
33248,Phase 1/2a
25902,Phase 0
70153,Phase 1
51530,Phase 0
183384,Phase 2a
171905,Investigative
72717,Investigative
31771,Investigative
165661,Discontinued in Phase 4
136370,Phase 1b
100502,Phase 1/2a
37706,Phase 1/2
30583,Phase 1
92454,Discontinued in Phase 3
136190,Phase 1/2
66532,Discontinued in Phase 1
182957,Discontinued in Phase 2
88739,Discontinued in Phase 4
31951,Phase 1/2
130161,Discontinued in Preregistration
51599,Phase 0
145954,Phase 0
163429,Discontinued in Phase 3
172240,Investigative
7327,IND submitted
109594,Preregistration
186198,Phase 0
639,Phase 2b
167016,Discontinued in Phase 1/2
171348,Phase 1b
101460,Phase 0
146843,Phase 2a
74662,Phase 1/2
149467,Phase 1/2
52906,Discontinued in Preregistration
102773,Phase 1
75682,Phase 2/3
129371,Discontinued in Preregistration
112521,Phase 0
161891,Investigative
125913,Phase 1/2
7265,Phase 2/3
102256,Patented
177843,Discontinued in Phase 2
53211,Discontinued in Phase 2b
74365,IND submitted
81231,Approved
64388,Patented
123788,Phase 1/2
145460,Phase 2/3
146392,Phase 1/2
142064,Investigative
28633,Phase 1b/2a
81376,Discontinued in Phase 3
158484,Phase 1/2
142763,Discontinued in Preregistration
89612,Phase 1
120258,Discontinued in Phase 3
49323,Discontinued in Phase 2/3
185092,Phase 1
158750,IND submitted
98848,Phase 2
17546,Phase 1b/2a
100633,Phase 3
42955,Phase 0
141198,Discontinued in Preregistration
102647,IND submitted
122643,Phase 1/2
95582,Investigative
73818,Approved
104178,Discontinued in Phase 4
95448,Phase 1
169296,Phase 0
51604,Phase 1/2a
96751,Phase 1/2
131340,Discontinued in Preregistration
49479,Phase 0
86151,Phase 1
72813,Phase 2
50159,Phase 0
2030,Discontinued in Phase 1
2302,Phase 0
100112,Investigative
166574,Investigative
187259,Patented
180021,Discontinued in Phase 1
146615,Discontinued in Phase 2
108754,BLA submitted
5315,Phase 1/2
171661,Patented
63938,Phase 0
178932,Phase 2a
10312,Phase 0
142591,Phase 1/2a
87440,Discontinued in Phase 3
66480,Phase 1
11810,IND submitted
125741,IND submitted
39121,Phase 1b
183756,IND submitted
140888,Phase 1b/2a
10190,IND submitted
191337,Phase 1
69443,Phase 1
62191,Phase 1b/2a
159333,Phase 1b
90786,BLA submitted
80530,Phase 1b/2a
163630,Discontinued in Phase 3
123636,Phase 1b
46765,Discontinued in Phase 2
116338,Discontinued in Phase 2/3
114493,Investigative
53266,IND submitted
183949,Phase 1/2
103490,Phase 1/2
42539,Phase 2
85761,Discontinued in Preregistration
65619,Preregistration
69722,Phase 1b/2a
61763,Discontinued in Phase 4
119336,Investigative
21294,Phase 1
94416,Phase 1/2a
39133,Phase 1/2
156818,Phase 1b/2a
27732,Phase 0
169462,Phase 1
170660,Discontinued in Preregistration
15065,Phase 1
159936,Phase 2b
158608,Phase 1
91475,Phase 1b
36109,Discontinued in Phase 1
110929,Discontinued in Phase 4
11553,Discontinued in Phase 2/3
181477,Phase 1/2a
60527,Phase 2/3
138043,Discontinued in Phase 2
62013,Discontinued in Phase 2b
35196,Phase 2b
173819,Phase 1
78423,BLA submitted
68800,Phase 1
57180,Phase 1/2a
135847,Phase 1b
64291,Approved (orphan drug)
156498,Phase 1b
179279,Phase 1b
96036,Phase 0
39959,Phase 0
167400,Discontinued in Phase 1/2
88274,Phase 0
173994,Discontinued in Preregistration
129805,Investigative
101379,Discontinued in Phase 3
28172,Phase 2a
26160,Phase 2
39186,Patented
110053,Phase 1
22482,Discontinued in Phase 2b
133582,BLA submitted
104695,Phase 1/2
13116,Phase 1b/2a
13080,IND submitted
88717,Patented
15361,Phase 2b
142865,Phase 1/2a
165442,Discontinued in Phase 4
23765,Phase 1b
173599,Phase 2/3
171425,Phase 2a
43479,Phase 2/3
105061,Phase 1b/2a
167264,Phase 1/2a
4969,IND submitted
42903,Phase 1b
189615,IND submitted
94856,Discontinued in Phase 1
35192,Phase 1b/2a
108309,Phase 1b/2a
186446,Clinical trial
132980,Discontinued in Phase 1/2
29663,Phase 2
136593,Discontinued in Phase 2
86982,Discontinued in Phase 3
11532,Phase 1
76583,Discontinued in Phase 1/2
2406,Phase 1b/2a
15403,Phase 1
77557,Patented
132167,Discontinued in Phase 2/3
106706,Phase 0
12584,Phase 1/2
61462,Phase 2a
146905,IND submitted
184367,Discontinued in Phase 4
79206,Patented
79182,Phase 1b
1591,Phase 0
156805,Phase 1b
184737,Discontinued in Phase 4
20937,Investigative
109159,Patented
60693,Phase 0
180985,Phase 1b
151141,Discontinued in Phase 2/3
91413,Investigative
23025,Phase 1b
76367,Phase 1/2
76193,Discontinued in Phase 1/2
49937,Discontinued in Phase 2/3
70871,Phase 1b/2a
19459,Patented
171456,Discontinued in Phase 3
12799,Phase 1/2
184238,BLA submitted
31395,Phase 1
51165,Phase 0
141475,Patented
172026,Discontinued in Phase 2/3
61043,Phase 2/3
63545,Clinical trial
56116,Phase 1b/2a
166725,Phase 0
19655,Phase 1
144168,Phase 1/2
110124,Phase 1
110671,Phase 1
151505,Phase 2
298,Phase 2b
146894,Phase 1/2
47784,Discontinued in Preregistration
186121,Phase 0
184435,Phase 0
124945,Phase 1b
425,Phase 1/2a
46434,Patented
108317,Phase 1b/2a
182150,Phase 1b/2a
160862,Phase 0
24574,Investigative
107916,Discontinued in Preregistration
162090,Phase 1/2a
145369,Phase 0
74199,Investigative
108971,Discontinued in Preregistration
173120,Discontinued in Phase 2/3
169703,Phase 3
189887,Phase 2/3
41841,Phase 0
114997,Phase 1b/2a
65999,Phase 2a
107077,Phase 1b
86635,Discontinued in Phase 2
70983,Discontinued in Phase 3
121290,Patented
46379,Phase 1/2a
175755,Discontinued in Phase 4
134942,Phase 0
142496,IND submitted
117898,Phase 1
132066,Discontinued in Phase 4
8484,Approved
126731,Discontinued in Preregistration
142142,Investigative
165139,Phase 2
143349,Phase 2
61782,Phase 1b
101251,Patented
164131,BLA submitted
163377,Discontinued in Preregistration
120746,Phase 0
54750,Phase 1b/2a
128763,Investigative
126404,Phase 1
12554,Phase 1b/2a
184115,Discontinued in Phase 4
58979,Phase 1
113088,Phase 2/3
169920,Patented
98189,Phase 1/2
186767,Phase 1b/2a
190622,Phase 1b
46830,Discontinued in Phase 1/2
60644,Phase 1
58978,Investigative
84670,Phase 0
146919,Phase 1b
133238,Discontinued in Phase 1
168168,Discontinued in Phase 2/3
16190,Phase 1
173568,Phase 1/2a
18249,Discontinued in Phase 3
77573,Discontinued in Phase 2
121873,Approved
41565,Phase 1
112348,Phase 1
77437,Phase 1/2a
4725,Investigative
8495,Phase 1/2
121377,Phase 1b/2a
157995,Registered
52055,Discontinued in Phase 2b
63126,Phase 1
183269,Phase 2a
175323,Discontinued in Phase 3
113720,Discontinued in Phase 3
49782,Phase 1b/2a
80017,Phase 2a
72836,Phase 1/2
189302,Discontinued in Phase 3
48361,Phase 1b
85902,Discontinued in Preregistration
61925,Discontinued in Phase 4
111351,Patented
45719,Phase 2/3
102089,Phase 1/2a
86513,Discontinued in Phase 1/2
122916,Phase 1b
94730,Patented
181570,Phase 1b/2a
67482,Discontinued in Preregistration
46642,Clinical trial
159442,Phase 1b/2a
11700,Phase 2a
150611,Phase 1
14802,Phase 1
74209,Phase 1/2
125701,IND submitted
75739,Patented
22981,Phase 1b/2a
153336,Phase 0
125702,Phase 1b
117706,Discontinued in Phase 1
6695,Discontinued in Phase 2
45062,Phase 1/2a
110918,Phase 1b
66062,Phase 0
66325,Discontinued in Phase 2/3
167032,Discontinued in Phase 1/2
82758,Phase 0
169243,Discontinued in Phase 1
47174,Approved
56151,Phase 1/2a
39111,Patented
78263,Discontinued in Phase 2b
147944,Patented
47315,Phase 1
97139,Phase 1
147588,Phase 1/2a
41914,Phase 1b/2a
13623,Phase 0
124360,Phase 0
174474,Phase 1/2
61134,Investigative
37546,Phase 1
73561,Phase 1b/2a
69642,Phase 1
160230,Phase 1b/2a
68055,Phase 0
148379,Phase 1b/2a
3434,Discontinued in Preregistration
55529,Phase 2
116397,Phase 2
190914,Phase 1
36811,Phase 1
122852,Phase 1b/2a
21992,Discontinued in Phase 2
155612,Phase 2
51867,Phase 1/2a
78715,Phase 0
140149,Phase 1b
25526,Investigative
112230,Discontinued in Phase 3
99448,Phase 1b/2a
130843,Patented
150635,Phase 2
156149,Phase 1/2a
163782,Phase 1/2
7328,Phase 2a
49293,Phase 1b/2a
45378,Phase 2/3
161203,Phase 1
65699,Phase 1b
101157,Phase 1b
120447,Approved (orphan drug)
54152,Discontinued in Phase 2/3
130826,Phase 1/2a
146299,Clinical trial
4209,Investigative
53495,Phase 1/2
190239,IND submitted
153311,Phase 1/2
166613,Discontinued in Phase 4
148806,Investigative
178053,Patented
97100,Phase 1b/2a
180773,Phase 2a
44249,Phase 2/3
146925,Phase 1/2a
100352,Discontinued in Phase 1/2
82978,Phase 1/2
66446,IND submitted
88619,Patented
166421,Discontinued in Phase 4
160069,Phase 1b/2a
132633,Discontinued in Phase 2b
35239,Phase 2a
181956,Phase 2a
109669,Discontinued in Preregistration
63297,Discontinued in Phase 3
123816,Phase 1
15366,Phase 1
94110,Phase 1/2
162210,Phase 1/2
150171,Investigative
21375,Phase 2
138419,Approved (orphan drug)
33407,Discontinued in Phase 2
99363,Phase 1b/2a
147345,Phase 2b
66700,Patented
80794,Discontinued in Phase 1/2
145349,Phase 1
117255,Discontinued in Phase 2b
94117,Investigative
38257,Phase 0
21315,Phase 2
154872,Phase 3
102921,Approved (orphan drug)
122791,Phase 1/2
161917,Phase 0
115296,Phase 2
45642,Phase 2/3
185323,Discontinued in Phase 3
89275,Discontinued in Phase 3
39890,Phase 1/2a
105577,Phase 1b/2a
72250,Patented
144878,Phase 2b
78228,Investigative
14547,Phase 1
5653,IND submitted
133819,Phase 1/2
168513,Discontinued in Phase 1/2
60336,Phase 1
48662,Phase 2
9470,Phase 2
122143,Patented
12338,Phase 1
10318,Discontinued in Phase 2b
163907,Phase 1
39660,IND submitted
165682,Phase 1b/2a
55617,Phase 2
163179,Patented
89490,Phase 2/3
17076,Phase 0
147773,Phase 1b/2a
160220,Phase 1
64179,Phase 2a
81910,Discontinued in Phase 1
14843,Phase 1b/2a
178125,Phase 1
161687,Discontinued in Preregistration
80215,Approved
113151,Discontinued in Phase 1/2
33137,Phase 2a
133822,Phase 1b
140464,Phase 1/2
1515,Discontinued in Phase 2b
79472,Phase 2
119081,Phase 1b/2a
170303,Discontinued in Preregistration
18830,Discontinued in Phase 2/3
163846,Discontinued in Preregistration
45450,Phase 2/3
63585,Approved (orphan drug)
25141,Phase 2/3
51312,Phase 2/3
191295,Discontinued in Preregistration
90962,Phase 1b/2a
106015,Phase 1b
132022,Discontinued in Preregistration
76376,Discontinued in Phase 1/2
26738,Phase 1/2a
171149,Phase 0
67222,Discontinued in Preregistration
3694,Approved (orphan drug)
57105,Phase 1b/2a
76727,Patented
69135,Discontinued in Phase 1/2
105880,Phase 1b/2a
66432,Phase 1
187990,Discontinued in Preregistration
146100,Phase 1b
129406,Phase 1
175819,Patented
83058,Discontinued in Phase 4
188624,Phase 1/2
146406,Phase 1b/2a
149170,Phase 1
78621,Phase 1b
99039,Phase 1/2a
190535,Phase 1/2
191804,Patented
168026,Phase 1/2
9399,Patented
47627,Phase 0
89440,Discontinued in Preregistration
153578,Phase 1
130785,Phase 2
87035,Phase 1/2
138995,Phase 1b
143075,Discontinued in Phase 4
59717,Discontinued in Phase 3
40077,Discontinued in Phase 4
74407,Investigative
125374,Phase 1b
136701,Patented
165286,Discontinued in Preregistration
157007,Registered
2048,Investigative
98007,Phase 1
89145,Phase 2/3
83129,Phase 1
148796,Phase 1b
67294,Clinical trial
142509,Phase 1/2a
119643,Approved
174524,Phase 1/2a
178083,Investigative
183232,Approved (orphan drug)
105193,Phase 0
186062,Patented
105125,Phase 1/2
122488,Phase 2
68877,Phase 1b
142586,Phase 1/2a
99409,Phase 1
32821,Phase 1b/2a
28570,Discontinued in Preregistration
176361,Phase 1/2
187660,Phase 0
126135,Phase 1b/2a
23537,Phase 0
71632,Discontinued in Phase 1
109942,Discontinued in Phase 4
6814,IND submitted
164254,Patented
69991,Phase 1b/2a
164628,Phase 0
5330,Phase 2/3
75823,Phase 0
88675,Patented
98353,Phase 0
89379,Phase 1/2a
37889,Phase 1/2
39941,Phase 1b/2a
25991,Phase 2/3
105637,Phase 1b/2a
21944,Phase 2
185983,Phase 2/3
182822,Phase 2a
175586,Phase 0
18703,Discontinued in Preregistration
138372,Discontinued in Phase 2
136845,Discontinued in Phase 2
48314,Discontinued in Phase 3
61904,Discontinued in Phase 4
154213,Phase 1/2a
150714,Phase 2
141667,Patented
157252,Phase 2
129901,Discontinued in Phase 4
84524,Phase 1b/2a
135466,Phase 0
73112,Phase 1
86774,Phase 1/2
68709,Discontinued in Preregistration
15674,Investigative
44048,Phase 2/3
107233,Phase 1b/2a
96764,Phase 1b/2a
112202,Phase 1/2
137124,Investigative
102764,IND submitted
48260,Discontinued in Preregistration
128970,Phase 1/2
8893,Phase 2/3
187439,Patented
158258,Phase 1b/2a
154457,Discontinued in Preregistration
77680,Phase 2
18690,Phase 1
46970,BLA submitted
78924,Phase 0
50487,Phase 1/2a
42046,Phase 1
85419,Discontinued in Preregistration
109825,Preclinical
177964,IND submitted
104808,Discontinued in Phase 2b
109832,Discontinued in Phase 2/3
23977,Phase 2
133075,Discontinued in Phase 4
86357,Discontinued in Preregistration
77664,Patented
85765,Discontinued in Phase 3
67452,Discontinued in Preregistration
48603,Phase 1/2a
122764,Phase 1/2
88961,Phase 1/2a
81567,Approved
143577,Phase 1b/2a
174739,Patented
106658,Phase 1
180181,Phase 1
761,Patented
177819,Phase 1b/2a
42414,Investigative
123649,Phase 1/2
23633,Discontinued in Phase 4
171670,Phase 0
91601,Preregistration
139609,Investigative
6213,Phase 1b/2a
62064,Investigative
71437,Discontinued in Preregistration
35979,Phase 1/2
183190,Phase 1b/2a
57745,Investigative
87624,Discontinued in Phase 3
179050,Phase 1/2a
42137,Discontinued in Phase 1
10372,IND submitted
55031,Phase 1b/2a
33810,Patented
9124,Discontinued in Phase 1
108758,Investigative
190299,Phase 1/2
12704,Phase 1/2
150511,Clinical trial
56177,Phase 2
91762,Discontinued in Phase 2b
102697,Approved (orphan drug)
47480,Phase 1
12207,Phase 1
121922,Phase 2
122340,Patented
110042,Phase 1
99530,Phase 1
136953,Patented
140583,Phase 1b/2a
163040,Discontinued in Phase 2/3
22094,BLA submitted
178250,Phase 2
135582,Phase 0
71542,Discontinued in Phase 1
82904,IND submitted
45952,Phase 2/3
96237,Phase 1b
182382,Phase 1
84365,Phase 1
187684,Patented
55374,IND submitted
45810,Phase 2/3
179374,Phase 2a
131811,Phase 1b/2a
175426,Phase 2b
158972,Approved
45932,Phase 1/2a
126023,Phase 1b
32224,Phase 0
84812,Phase 1/2a
48062,Phase 0
121003,Phase 1b
60441,Phase 0
34502,Phase 1b/2a
64516,Phase 0
53610,Discontinued in Phase 2b
58421,Phase 1b/2a
154766,Phase 1b/2a
163186,Patented
169757,Patented
12316,Investigative
138309,Approved (orphan drug)
142659,Phase 2a
99816,Phase 0
63739,Phase 2
131804,Discontinued in Phase 1/2
53999,Phase 1b/2a
114472,Phase 1b
127894,Phase 1/2
68223,Discontinued in Phase 3
8853,Phase 1/2
119660,Discontinued in Preregistration
80632,Phase 2a
131261,Discontinued in Phase 2b
107156,Phase 1/2a
20789,Investigative
27775,Phase 2
11634,Phase 1
81654,Approved
158193,Phase 0
144963,Phase 1b/2a
119204,Phase 1b/2a
141704,Investigative
113428,Phase 1b
111358,Discontinued in Phase 2b
175849,Discontinued in Phase 2
126010,Phase 1b/2a
52478,Patented
86786,Discontinued in Phase 2b
72651,Phase 2
30772,Phase 0
30405,Phase 1
10545,Phase 1b
42095,Phase 1/2a
56184,Phase 1b
128935,Discontinued in Preregistration
106700,Discontinued in Preregistration
18706,Discontinued in Phase 3
134955,Phase 0
33992,Patented
123718,Phase 1
169273,BLA submitted
191924,Phase 2a
88235,Phase 2a
133413,Discontinued in Phase 1
43617,Phase 2/3
134272,Patented
24526,Phase 1/2
177832,Phase 1/2
26638,Phase 1b
153431,Phase 1/2a
61086,Phase 0
139862,Phase 1b
137886,Phase 1/2a
45076,Phase 1/2a
28098,Discontinued in Phase 4
56983,Phase 1/2a
134552,Patented
116308,Phase 2
3156,Discontinued in Phase 2b
53015,Phase 0
154005,Phase 2/3
150808,Phase 0
101097,Phase 1b
26647,Phase 1
116876,Discontinued in Preregistration
120769,Phase 4
120206,Approved (orphan drug)
181390,Phase 1/2a
77487,Discontinued in Preregistration
155471,Phase 2
30302,Discontinued in Preregistration
74815,Discontinued in Phase 4
113748,Phase 1b
145893,Phase 0
80804,Phase 2a
32491,Phase 1/2
68146,Discontinued in Phase 3
71708,Phase 1/2
26283,Phase 2
128245,Discontinued in Phase 4
31321,Investigative
122807,Discontinued in Preregistration
183075,Phase 2b
54803,Investigative
51285,Phase 1b
66910,Patented
151451,Phase 1
145835,Discontinued in Phase 2/3
41497,Discontinued in Phase 1
26073,Phase 1
69350,Discontinued in Phase 2/3
184452,Phase 1/2
9330,Discontinued in Phase 2b
34427,Phase 1/2a
141006,Discontinued in Preregistration
49134,IND submitted
64441,Discontinued in Phase 2/3
67483,Discontinued in Phase 2/3
21631,Investigative
65541,Preclinical
81057,Clinical trial
42471,Investigative
65049,Phase 1b
141611,Discontinued in Phase 1
70877,Phase 1/2a
82930,Investigative
145178,Phase 1/2
155140,Patented
128310,Discontinued in Phase 2/3
92025,Investigative
76934,Patented
11633,Phase 1/2a
31110,Discontinued in Phase 4
82467,Patented
181300,Phase 1b/2a
134479,Phase 1/2a
118714,BLA submitted
127824,Discontinued in Phase 2b
190130,Approved (orphan drug)
122121,Investigative
26510,Phase 1/2a
63441,Patented
43336,Phase 2/3
39049,Phase 2
1370,Phase 0
27651,Phase 2/3
55487,Phase 1/2
104355,BLA submitted
130322,Phase 1/2
11595,Phase 1/2a
68250,Phase 1
39508,Phase 1
149564,Phase 2b
144373,Phase 3
23665,Phase 1/2a
86103,Discontinued in Phase 1/2
162483,Investigative
138168,Phase 1b
56178,Phase 2
157984,Clinical trial
43830,Phase 1/2a
171853,Phase 1b
128302,Phase 0
125645,Phase 1b/2a
123143,Approved
58385,Phase 1b/2a
22539,Investigative
128570,Phase 1/2
46569,Investigative
74758,Phase 1/2a
24064,Discontinued in Phase 4
158795,Phase 2
115868,Phase 1/2
120523,Phase 0
91587,Phase 1b
35080,Phase 1/2
109711,Discontinued in Phase 2/3
72185,Phase 0
175402,Discontinued in Phase 3
133132,Discontinued in Phase 4
118297,Phase 1b/2a
10020,Phase 0
173895,Phase 1/2a
52624,Phase 1/2a
166245,Phase 1b/2a
167620,Patented
33904,Patented
163108,Discontinued in Phase 2
65594,Phase 1
52170,Phase 1b
53508,Phase 1/2a
111591,Patented
170875,Phase 0
44375,Phase 2/3
125062,Phase 2
8279,Phase 2
72913,Phase 2/3
175316,Phase 0
20887,Phase 1/2a
170403,Phase 1/2
89034,IND submitted
118945,Discontinued in Phase 2
141643,Patented
190050,Phase 1b
30792,Phase 1
141352,Phase 2/3
23996,Patented
179834,Phase 1/2a
37635,Phase 2
133299,Approved
84628,Phase 1/2
20222,Phase 0
128905,IND submitted
159271,Phase 2
47554,Patented
127092,Discontinued in Phase 3
176087,Phase 1/2
169287,Phase 2b
77141,Investigative
96797,Phase 1/2a
46002,Phase 2/3
20395,Phase 0
176414,Phase 0
1974,Discontinued in Phase 1
156449,Discontinued in Preregistration
68790,Phase 0
32932,Phase 1/2
122508,Phase 1
109822,Discontinued in Phase 1/2
132512,Phase 2
177801,Phase 1b
64913,Clinical trial
49016,Phase 0
127061,Patented
158826,Clinical trial
17856,Phase 2b
123443,Phase 0
104120,Phase 2
95309,Patented
119967,Approved (orphan drug)
33143,Discontinued in Phase 2
41773,Phase 1
147333,Investigative
177,Phase 2b
155293,Discontinued in Preregistration
136169,Phase 1b
101745,Investigative
75835,Phase 0
151914,Phase 2a
27849,Phase 0
105695,Phase 1
65000,Preclinical
120047,Approved (orphan drug)
71736,Phase 0
87036,Phase 1b
157261,Patented
160413,Phase 3
69380,Phase 1b/2a
856,Discontinued in Phase 4
57156,Clinical trial
88966,Patented
139823,Phase 1/2a
128344,Phase 1b/2a
157807,Patented
48012,Phase 3
55834,Phase 2
46753,Approved
172537,Discontinued in Phase 2b
171135,Phase 0
147009,Discontinued in Preregistration
163700,Discontinued in Phase 2
94605,Phase 1b
106111,Phase 1b/2a
78204,Phase 1
124571,Phase 1
189795,Phase 1b/2a
96280,Discontinued in Phase 1/2
140155,Discontinued in Phase 2
187316,Clinical trial
31669,Phase 1/2
45036,Phase 1/2a
76641,Phase 0
50781,Phase 1
94500,Phase 1/2
49793,Phase 2
103510,BLA submitted
109359,Discontinued in Phase 2/3
59953,Phase 1b/2a
105462,Phase 1/2a
129392,Phase 0
88007,Patented
62621,Patented
146961,Phase 1b
182751,Phase 2a
183729,Phase 2a
141079,Phase 1/2
142267,Patented
88057,Discontinued in Phase 2
36565,Discontinued in Phase 1
57210,Phase 1/2
132700,Discontinued in Phase 1/2
132752,Phase 0
136086,Phase 1b
174025,Phase 1b/2a
6416,Discontinued in Phase 2
187744,Patented
155589,Phase 2/3
155861,Phase 1
121898,Approved
156043,Phase 1b
129850,Phase 0
1100,Clinical trial
67161,IND submitted
62128,Discontinued in Phase 4
79127,Phase 1b
19393,Discontinued in Preregistration
36564,Phase 2
141842,Discontinued in Phase 2b
80527,Discontinued in Phase 2
49235,Discontinued in Preregistration
146551,Discontinued in Phase 2
187885,Patented
68661,Phase 1
167025,Phase 4
127635,Phase 1/2
163863,Phase 0
82002,Clinical trial
54142,Phase 1b
31331,Investigative
188005,Patented
124373,Phase 1
104024,Patented
60047,Phase 1
38591,Phase 1b/2a
66441,Phase 2
50994,Discontinued in Phase 2
36936,Phase 1
18048,Phase 2a
63301,Patented
158613,Phase 2
174284,Phase 1/2
104092,Phase 0
74280,Phase 1/2a
156099,Discontinued in Phase 2b
159533,Phase 2b
47477,Phase 1/2
165448,Phase 0
25026,Discontinued in Phase 4
37029,Phase 2
135389,Phase 0
10348,Preclinical
18663,Phase 1/2
146881,Investigative
74788,Discontinued in Phase 4
51965,Phase 1b
120704,Clinical trial
63719,Discontinued in Phase 2/3
81361,Discontinued in Phase 1
164443,Investigative
139581,Phase 1/2a
69007,Discontinued in Phase 3
123185,Phase 1
167706,Discontinued in Phase 2/3
165529,Phase 0
162256,Discontinued in Phase 2/3
182133,Phase 1
105025,Approved (orphan drug)
86768,Discontinued in Phase 1/2
97162,Phase 1/2a
88181,Phase 1/2
148405,Clinical trial
145113,Phase 0
131442,Phase 1b/2a
142792,Phase 1/2a
9936,Phase 1
42514,Phase 2a
70868,Discontinued in Preregistration
127816,Phase 0
106608,Discontinued in Phase 2
28492,Phase 1/2
133512,Phase 1/2
129407,Discontinued in Preregistration
184270,Discontinued in Phase 4
16585,Discontinued in Phase 1
172930,Phase 0
58118,Phase 0
116075,Clinical trial
165056,Phase 1/2a
75415,Phase 1/2a
179998,Discontinued in Preregistration
73227,Discontinued in Preregistration
35205,Phase 1b
6122,Phase 2a
30513,Discontinued in Preregistration
66635,Discontinued in Phase 2
173955,Discontinued in Preregistration
43903,Phase 2/3
124102,Discontinued in Preregistration
53866,Phase 1b/2a
27071,Phase 1b
49554,Patented
167114,Discontinued in Phase 2
85550,Discontinued in Phase 2b
98901,Phase 1/2a
86295,Phase 0
26558,Phase 1/2a
179090,Discontinued in Phase 1/2
82622,Phase 0
34933,Phase 1b
63505,Phase 1b
13507,Phase 0
170903,Phase 1
57316,Approved (orphan drug)
156254,Discontinued in Preregistration
103010,Investigative
3753,Discontinued in Phase 3
178000,Investigative
188559,Phase 1/2
50710,Patented
89317,Phase 1/2a
290,Phase 1
83026,Phase 0
100219,Discontinued in Phase 1/2
1636,Patented
107884,Discontinued in Phase 4
184628,Discontinued in Phase 4
103078,Approved (orphan drug)
45590,Phase 1/2a
30044,IND submitted
97803,Phase 1/2a
141259,Patented
98482,Phase 1/2a
6112,IND submitted
79080,Phase 2a
33935,Phase 2
107994,Discontinued in Phase 2b
119634,Discontinued in Phase 4
40991,Investigative
45121,Phase 2/3
107730,Discontinued in Phase 2/3
179219,Discontinued in Phase 1/2
22894,Phase 1/2
129104,Phase 0
188639,Phase 2/3
114510,Investigative
161130,Discontinued in Phase 4
48820,Phase 1
74963,Phase 1/2
109776,Approved
17270,Phase 0
141059,Discontinued in Phase 1
143870,Investigative
51926,Phase 2
177332,Phase 2/3
59393,Phase 1b/2a
128760,Discontinued in Phase 2b
146136,Phase 2b
58262,Discontinued in Phase 3
148535,Phase 1b/2a
11053,IND submitted
2565,Phase 2
121765,Approved
88752,Patented
58789,Phase 0
188651,Phase 1b/2a
116389,Discontinued in Phase 1
4611,Phase 1b/2a
110611,Phase 2
169632,IND submitted
101066,Phase 1/2a
170524,Patented
191101,Phase 1/2a
168861,Discontinued in Phase 4
139632,Phase 1b
159885,Discontinued in Phase 1/2
47445,Discontinued in Phase 2b
12542,Phase 1
137097,Discontinued in Phase 2
152128,Phase 0
17595,Investigative
16627,Phase 1
46252,Phase 1/2
177116,Phase 1b
107678,IND submitted
129415,Discontinued in Preregistration
117036,Discontinued in Preregistration
64303,Phase 0
75757,Phase 0
113443,Phase 1
90349,Investigative
170513,Discontinued in Preregistration
53552,Discontinued in Phase 4
109489,Discontinued in Preregistration
182374,Phase 2a
37061,Discontinued in Phase 1/2
14615,Investigative
171760,Phase 2a
89512,Phase 1b
50276,Discontinued in Phase 2/3
24895,Phase 1/2a
187198,Patented
89732,Phase 0
43601,Phase 2/3
173621,Phase 2a
44601,Phase 2/3
26310,Phase 1
120331,Phase 0
7851,Phase 1/2
87131,Discontinued in Phase 2b
18320,Phase 1
80872,Phase 2
158470,Phase 2/3
147858,Phase 1b
137321,Discontinued in Phase 2
31723,Phase 1
20141,Patented
174767,Phase 1/2a
79779,Phase 2
180480,Phase 1/2
8473,Discontinued in Phase 2
182364,Phase 3
186724,Patented
89493,Phase 1/2a
4162,Phase 2a
92861,Phase 2b
31675,Discontinued in Phase 1/2
134023,Phase 1/2a
12385,Phase 2b
114888,Discontinued in Phase 2b
165748,Phase 1b
64352,Phase 1/2
106383,Patented
108333,Phase 2
85436,Discontinued in Phase 2b
143184,Phase 1b/2a
125028,Phase 1b
101393,Discontinued in Preregistration
109074,Discontinued in Phase 3
25629,Phase 1
188742,Phase 2/3
11720,IND submitted
59706,Investigative
71764,Patented
163900,Discontinued in Preregistration
95407,Patented
145660,Phase 1
49032,Phase 3
2944,Discontinued in Phase 2b
182553,Phase 2a
51788,Phase 2/3
115001,Phase 2
27293,Phase 1/2a
31103,Phase 2
22853,Discontinued in Phase 4
47290,Patented
20553,IND submitted
81434,Phase 1b/2a
163598,Patented
51849,Discontinued in Phase 3
62237,Phase 1/2a
13559,Investigative
48734,Patented
107142,Phase 1/2a
46109,Phase 1/2a
10089,Discontinued in Phase 2/3
37869,Phase 1/2
38157,Phase 0
139152,BLA submitted
95699,Phase 2/3
87185,Phase 1/2
60400,Phase 1/2a
101029,Discontinued in Preregistration
12862,IND submitted
71345,Phase 0
169583,IND submitted
120148,IND submitted
5162,Phase 1/2
7463,Phase 2/3
134927,Phase 0
116396,Discontinued in Preregistration
557,Phase 1/2a
56176,Phase 2
122430,Phase 0
148957,Phase 0
128369,Discontinued in Phase 2b
142949,Phase 1b/2a
9920,Discontinued in Phase 2/3
126523,Discontinued in Preregistration
32452,Phase 2
115996,Phase 1b/2a
63661,Approved (orphan drug)
52115,Discontinued in Phase 2b
34763,Phase 1b
111711,Patented
122854,Patented
133516,Phase 1/2
39525,Phase 1/2a
157678,Phase 2a
102454,Phase 1/2a
85775,Discontinued in Phase 2b
190301,Phase 1/2
36299,Patented
154053,Discontinued in Phase 2
80512,Patented
125235,Phase 1b/2a
105452,Phase 1/2
20234,Phase 1
55798,IND submitted
68174,Clinical trial
7190,Discontinued in Phase 2
17911,Phase 1/2a
62095,Discontinued in Phase 3
60268,Phase 1b
19289,Investigative
161128,Discontinued in Preregistration
113751,Phase 1b/2a
35015,Phase 1/2a
63924,Phase 1
121101,Phase 2a
190024,Phase 1/2a
166301,Discontinued in Phase 4
127912,Phase 1b/2a
73734,Approved
24981,Investigative
95263,Phase 1b/2a
107080,Phase 1/2a
116558,Discontinued in Phase 2/3
179141,Discontinued in Phase 1/2
150451,Discontinued in Phase 2
6525,Investigative
118384,Phase 1b/2a
33448,Phase 1b/2a
178642,Discontinued in Phase 2/3
42701,Phase 1
165847,Patented
14838,Phase 1/2
156055,Phase 1b/2a
69506,Phase 1b/2a
159647,Investigative
141507,Discontinued in Phase 2/3
169011,Phase 1b/2a
10783,Discontinued in Preregistration
47275,Patented
104576,Phase 0
31031,Investigative
178754,Phase 1/2a
185889,Phase 0
46792,Approved
64529,Phase 1b/2a
111654,Phase 0
124638,Discontinued in Phase 4
154469,Discontinued in Preregistration
82751,Phase 1/2a
151992,Phase 2a
34100,Phase 0
181793,Discontinued in Phase 2b
26165,Investigative
178590,Discontinued in Phase 2/3
168409,Discontinued in Phase 1/2
56809,Phase 0
87378,Phase 1b/2a
150068,Phase 1
34157,Phase 0
18512,Preclinical
181903,Phase 2a
131282,Discontinued in Phase 4
2680,Phase 0
73658,Approved (orphan drug)
76149,Phase 1/2a
54858,Patented
39075,Phase 1/2a
83336,Investigative
171473,Discontinued in Phase 2b
185431,IND submitted
191919,Phase 2/3
15143,Discontinued in Phase 1
56014,Patented
78508,Discontinued in Phase 4
183928,Phase 0
174396,Phase 2
157234,Phase 1b/2a
154988,Investigative
76846,IND submitted
126200,Discontinued in Preregistration
36283,Phase 1
182996,Discontinued in Phase 2b
155798,Discontinued in Phase 3
161853,Investigative
163437,Approved (orphan drug)
49942,Phase 1b
159629,Phase 2
85293,Discontinued in Preregistration
56634,Phase 0
189524,Phase 1b
121721,Approved
153911,Phase 1
63958,Discontinued in Phase 2
152488,Patented
128586,Investigative
42491,Phase 1b/2a
130612,Phase 0
47417,Discontinued in Phase 2b
19031,Phase 0
159913,Phase 1b/2a
52043,Discontinued in Phase 2/3
163357,Phase 1b/2a
158046,Registered
171993,Phase 1
169910,IND submitted
41417,Phase 1b
111384,Phase 1/2
131368,Discontinued in Preregistration
165953,Phase 1b/2a
20539,Discontinued in Phase 4
34869,Phase 1b
69469,Phase 1b
56797,Phase 2
139559,Phase 1/2a
74575,Discontinued in Phase 1/2
12479,Phase 2b
139590,BLA submitted
72388,IND submitted
52771,Discontinued in Preregistration
40508,Phase 1
171130,IND submitted
32575,Phase 1/2
81378,Phase 1b
172273,Phase 1b
80097,Discontinued in Phase 1
47154,Approved
70599,Discontinued in Preregistration
16459,Phase 1
109402,Approved
142855,Discontinued in Phase 1/2
114389,Patented
104285,Patented
14017,Phase 2b
145276,Phase 1b/2a
41132,Discontinued in Phase 1/2
185570,Phase 2a
174117,Discontinued in Preregistration
86483,Phase 1
111463,Phase 1/2
95607,Phase 1b
34405,Phase 0
125656,BLA submitted
51339,Phase 1
110853,Discontinued in Phase 2b
83061,Discontinued in Phase 4
171522,Discontinued in Phase 2/3
119205,BLA submitted
149159,Phase 1b/2a
147076,Investigative
46554,Phase 0
60551,Phase 1
172891,Phase 1/2
83169,Phase 1
189825,Clinical trial
73371,Clinical trial
14057,Phase 1
115023,Phase 2
188728,Phase 1/2
106286,Phase 1
118321,IND submitted
30154,Discontinued in Preregistration
140075,BLA submitted
148489,Phase 0
127093,Discontinued in Phase 4
180942,Phase 1
176460,Phase 1b/2a
13035,Phase 1b/2a
91361,Phase 1b
127356,Discontinued in Phase 2b
156739,Discontinued in Phase 1/2
86844,Discontinued in Phase 1
92300,Discontinued in Phase 1
92026,Discontinued in Phase 1
185371,Discontinued in Phase 3
31688,Discontinued in Phase 2b
113518,Phase 0
176782,Phase 1/2a
184431,BLA submitted
147746,Discontinued in Phase 2/3
68801,Phase 1
28965,Phase 4
116639,Discontinued in Phase 3
143421,Phase 2
55563,Phase 1b/2a
109961,Patented
177101,Discontinued in Phase 4
117669,Discontinued in Phase 1/2
106288,Phase 0
114395,Phase 1/2
94680,Phase 1/2a
55838,Phase 1b/2a
127339,Patented
46943,Approved
37704,Phase 1b
183830,Phase 1b/2a
149872,Phase 1
116036,Phase 1/2
146658,Discontinued in Preregistration
84682,Phase 1/2a
73829,Phase 1/2a
186229,Preclinical
88406,Phase 1
191443,Phase 1/2a
79121,Phase 1b
184837,Phase 1/2
181042,Phase 1
166911,Discontinued in Phase 1
121967,Approved (orphan drug)
67867,Phase 1/2
96898,Phase 2
9142,Discontinued in Phase 2
64953,Approved (orphan drug)
154272,Patented
7618,Phase 2
60979,Discontinued in Phase 2/3
103011,IND submitted
160868,Phase 1/2
117589,Discontinued in Phase 1/2
8129,Patented
179100,Phase 1
182301,Phase 2a
179778,Phase 1/2a
126255,Phase 1b/2a
61553,Discontinued in Phase 1
177304,Phase 1b
64741,Phase 2a
5488,Preregistration
153857,Registered
100751,Phase 1/2a
129243,Discontinued in Phase 1
141631,Phase 1
132094,Discontinued in Phase 4
28151,Discontinued in Phase 2/3
92537,Patented
89044,BLA submitted
78098,Discontinued in Phase 4
21480,Phase 1b/2a
125247,Phase 1/2
180216,Phase 1b/2a
87601,Discontinued in Phase 3
91722,Phase 1b/2a
150059,Discontinued in Phase 2
26880,Phase 1b/2a
144865,Phase 1/2
123014,Phase 0
118795,Phase 1
110857,Discontinued in Phase 4
10750,Discontinued in Phase 2b
168924,Phase 2
9503,Patented
123875,Phase 1b/2a
46495,Phase 1
151965,Phase 0
56555,Phase 1/2
164138,Phase 1
21617,Discontinued in Phase 1/2
100485,Discontinued in Phase 1/2
183792,Discontinued in Phase 2
42116,Phase 1
18986,Phase 1b
112510,Phase 0
155622,Phase 2
29562,Discontinued in Phase 1
4947,Investigative
73988,Phase 1/2
28848,Phase 1b/2a
137520,Phase 2
4228,Preregistration
58942,Phase 2/3
127739,Discontinued in Preregistration
171603,Discontinued in Phase 2
160730,Phase 1/2
4953,Phase 1b/2a
12214,Phase 1/2a
115820,Phase 2
65224,Phase 1/2
92851,Phase 1b/2a
127655,Phase 1/2a
190274,Clinical trial
134182,Phase 1/2
186943,Phase 2/3
44100,Phase 1/2a
175263,Phase 3
69261,Discontinued in Phase 1/2
172163,IND submitted
6175,IND submitted
129462,Discontinued in Phase 2b
40134,Phase 0
31884,Discontinued in Phase 1
49188,Discontinued in Phase 2/3
109071,Discontinued in Preregistration
72285,Phase 1b
54423,Discontinued in Phase 2b
172898,Discontinued in Phase 2b
33442,Approved (orphan drug)
143361,Phase 1b/2a
164945,Phase 1/2
187494,Phase 4
181286,Phase 1b
77321,Phase 1/2a
3622,Investigative
123540,Investigative
164325,Discontinued in Preregistration
31686,Phase 1b/2a
65052,Preclinical
137283,Phase 1b/2a
101920,Phase 1
164566,Discontinued in Preregistration
120111,Approved (orphan drug)
36667,Phase 0
189539,Clinical trial
173378,Phase 1
76778,Patented
78060,Phase 1
2159,Phase 1b
126222,Phase 1b
124780,Phase 1b
69855,Patented
117473,Phase 1
109714,Phase 1
164794,Patented
85838,Discontinued in Phase 2b
51440,Phase 1
158188,Phase 1/2a
184145,Phase 0
42260,Phase 2
60829,Phase 1b/2a
159190,Phase 2
57473,Phase 0
5084,Discontinued in Phase 2
165208,Phase 1/2
30607,Phase 1b
102025,Approved (orphan drug)
184537,Phase 1/2
155720,Approved
142304,Investigative
14118,Phase 0
51710,Phase 1b
65543,Phase 1b
98619,Phase 1/2a
100672,Phase 1b
33270,Phase 2/3
190677,Phase 1/2
188735,Phase 0
16435,Phase 1
25613,Phase 2a
69852,Patented
81464,Phase 1b/2a
89385,Phase 2/3
114456,Discontinued in Phase 1
5961,Phase 1b/2a
105167,Discontinued in Phase 3
85369,Discontinued in Phase 3
61777,Discontinued in Phase 4
187679,Patented
85888,Discontinued in Phase 3
96830,Phase 1/2a
117663,Discontinued in Phase 1
41945,Phase 1
113014,Patented
108720,Discontinued in Phase 2/3
89763,Phase 1b/2a
51624,Phase 1b
167147,Phase 4
48342,Discontinued in Phase 2
165643,Phase 1b/2a
136872,Investigative
8024,Phase 2
102036,IND submitted
103062,Approved (orphan drug)
124960,Discontinued in Preregistration
102524,Phase 1b
142197,Patented
2532,Phase 1b/2a
87652,Phase 1/2
173567,Phase 1
145926,Discontinued in Phase 2
180747,Discontinued in Phase 4
1682,Phase 1
169645,Phase 1
3000,Discontinued in Phase 2b
170868,Discontinued in Phase 1
28117,Phase 1/2
128685,Phase 1/2
125004,Phase 1
166122,Phase 1b/2a
45776,Phase 2/3
117298,Discontinued in Phase 2/3
182582,Phase 1
94417,Phase 1b
104000,Phase 2
59812,Phase 1/2a
26972,Phase 1b
20871,Phase 1
154230,Patented
29827,Phase 1b
11358,Phase 2a
92841,Phase 1
170388,Phase 2/3
100549,IND submitted
9295,Phase 1/2a
75034,Phase 2a
64162,Phase 1/2
86932,Investigative
22372,Phase 1/2
177130,Phase 1/2a
83960,Discontinued in Phase 3
27106,Phase 1b/2a
77312,Discontinued in Phase 1/2
29506,Phase 1b/2a
108789,Phase 1b
153792,Phase 1
10268,IND submitted
24038,Phase 1
16725,Phase 1/2a
76119,Phase 1/2
106182,Phase 1b
66015,Preclinical
63200,Patented
39874,Phase 2
122070,Discontinued in Phase 2/3
113998,Phase 0
37021,Phase 1
5798,Phase 2a
177895,Investigative
87979,BLA submitted
133212,Phase 1/2
146308,Phase 1/2
74745,Phase 2
162075,Phase 1/2a
79495,Phase 1/2a
126570,IND submitted
56243,Phase 1b/2a
72395,Phase 1/2
6870,Phase 1b/2a
49650,Phase 1b/2a
93314,Phase 2
107591,Phase 0
185929,Preclinical
122325,Phase 1/2
2695,Phase 1
90577,Investigative
132193,IND submitted
137122,Discontinued in Phase 2b
192108,Phase 1b/2a
64188,Phase 1/2a
61503,IND submitted
90325,Discontinued in Phase 1
29703,Discontinued in Phase 4
172368,Discontinued in Phase 2b
182429,Phase 1/2
131041,Investigative
146448,Phase 2b
31560,Discontinued in Phase 4
105680,Phase 1b
3915,Phase 1
187466,Clinical trial
26557,Phase 1
22093,BLA submitted
11691,Investigative
175442,Phase 1/2a
35138,Phase 2
149728,IND submitted
55825,Phase 1
70790,Discontinued in Phase 2b
138505,Discontinued in Phase 2
41878,Phase 1
101264,Phase 2/3
191979,Phase 2/3
110725,Phase 1b
189549,Phase 2/3
54128,Phase 1/2a
104464,Patented
43685,Phase 1/2a
173781,Phase 1
109438,Discontinued in Preregistration
55458,IND submitted
145291,Phase 0
165110,Phase 2
42812,Phase 2/3
166793,Phase 2
109564,Discontinued in Preregistration
170706,Patented
186055,Phase 0
85479,Discontinued in Preregistration
22414,Phase 1/2
161248,Discontinued in Preregistration
92277,Phase 2b
124081,Phase 1
88536,Discontinued in Phase 4
116149,Discontinued in Phase 2
54326,Discontinued in Phase 2
76205,Investigative
30921,Patented
46755,Approved
84433,Phase 1/2
130105,Patented
72715,Phase 2/3
26354,Phase 1b/2a
144027,Phase 0
13049,Phase 1
2974,Discontinued in Phase 2b
13948,Investigative
46805,Discontinued in Phase 2
15423,Phase 1
153325,Investigative
1986,Discontinued in Phase 1
135706,Phase 1/2
148517,Discontinued in Phase 1
50510,Phase 0
77514,Discontinued in Preregistration
52057,IND submitted
38709,Phase 1
147721,Discontinued in Phase 2
113389,Clinical trial
18398,Phase 3
18900,IND submitted
184049,Phase 0
26898,IND submitted
144558,Phase 1/2a
174008,Discontinued in Phase 2b
121056,Phase 2b
37393,Phase 1b/2a
106996,Phase 1b
61570,Phase 1/2
143631,Phase 1/2
90616,Clinical trial
179899,Phase 1/2a
117171,Phase 1b
44578,Phase 2/3
92036,Discontinued in Phase 2
79394,Discontinued in Phase 1/2
144952,Discontinued in Phase 2
124436,Phase 1b/2a
185023,Phase 1
109571,Phase 1
152415,IND submitted
96782,Phase 1b
141116,Patented
127029,Phase 1/2
107680,Discontinued in Phase 3
153379,IND submitted
30157,Phase 1b
113935,Discontinued in Preregistration
98861,Phase 1/2
72762,Investigative
141152,Investigative
55748,Phase 0
107037,Phase 1b/2a
151483,Phase 0
79100,Phase 0
187966,Discontinued in Preregistration
123744,Phase 1/2
80812,Clinical trial
108415,Phase 0
22179,Discontinued in Phase 1/2
130179,Phase 1b/2a
145419,Discontinued in Phase 2
49313,Phase 1b
105743,Phase 1b
144162,Phase 1/2
185476,IND submitted
2550,Phase 1b/2a
44904,Phase 2/3
28686,Phase 1/2a
89346,Phase 1/2
24521,Discontinued in Phase 4
2292,Discontinued in Preregistration
163775,Phase 1/2
178176,Discontinued in Phase 1
9535,Phase 2
5481,Investigative
176467,Phase 1b/2a
1758,Discontinued in Phase 2/3
11469,Phase 1b
12547,Phase 0
114862,BLA submitted
61480,Phase 1/2
190802,Phase 4
185473,Preclinical
37350,Phase 2
161919,Phase 2
108255,Discontinued in Phase 1/2
41345,Phase 1b
48997,IND submitted
112072,Phase 1
2490,Discontinued in Preregistration
55668,Phase 1b/2a
55823,Investigative
38510,IND submitted
18633,IND submitted
14030,Phase 1
181789,Phase 1/2a
51718,IND submitted
46177,Phase 2/3
179923,Phase 1/2a
35937,Phase 0
132371,Phase 1b/2a
178012,Phase 1/2a
13351,Phase 0
127120,Phase 1b/2a
132111,Discontinued in Phase 2/3
115049,Phase 1/2
54672,Phase 1/2a
126621,IND submitted
138681,Discontinued in Phase 2
167068,Discontinued in Phase 1/2
162439,Discontinued in Preregistration
129823,Patented
143933,Phase 2
126312,Phase 1b/2a
23430,Phase 2a
29222,Phase 0
103871,Phase 1b
102043,Phase 1b
94804,Patented
84014,Phase 0
120195,Discontinued in Phase 1/2
91341,Discontinued in Phase 2
18720,Discontinued in Phase 2/3
8704,Phase 2
175034,Phase 1/2
37515,Phase 2
8170,Investigative
65858,Preclinical
143389,Patented
86627,Patented
178074,Patented
191239,Discontinued in Phase 1
118581,Discontinued in Preregistration
158126,Phase 2b
174350,Discontinued in Phase 3
172885,Discontinued in Phase 3
33250,Approved (orphan drug)
31543,Phase 0
192061,Patented
51063,Investigative
146168,Phase 1
52331,Investigative
80446,Phase 1b/2a
42251,Discontinued in Phase 1
74323,Discontinued in Phase 2b
91104,BLA submitted
171549,Phase 2
34583,Phase 1b/2a
156003,Phase 1b/2a
13011,Phase 1
184430,BLA submitted
16873,Discontinued in Phase 1
29741,Investigative
157217,Phase 1b/2a
186071,Patented
51038,IND submitted
101145,Discontinued in Phase 1/2
14517,Phase 1/2a
156711,IND submitted
29234,Phase 1b
125497,BLA submitted
165124,Phase 0
156652,Phase 1/2
82976,Phase 2/3
164008,Phase 1/2
142085,Discontinued in Phase 2b
8463,Discontinued in Phase 3
59808,Approved (orphan drug)
135148,Phase 0
173048,Discontinued in Phase 2
92533,Phase 1/2a
39899,Phase 2
1627,Patented
142202,Discontinued in Phase 2b
532,Phase 1
182402,Phase 2a
15029,Phase 1/2
13155,Phase 3
13976,Phase 1
156198,Phase 1b/2a
60140,Phase 1
10285,Phase 1b/2a
50952,Discontinued in Phase 3
139123,Approved (orphan drug)
167997,Investigative
31613,Phase 2
165321,Discontinued in Phase 4
13805,Phase 1
110948,Phase 2
139776,Phase 1/2
185961,Phase 4
75952,Phase 1/2a
90958,BLA submitted
162115,Phase 1/2a
50028,Discontinued in Preregistration
153054,Phase 1/2a
23113,Phase 1
77707,Discontinued in Phase 2b
186140,Phase 2a
185383,Discontinued in Phase 3
166460,Phase 0
182569,Phase 1b/2a
167169,Phase 4
66919,Phase 1/2
15364,Phase 3
159192,Patented
113621,Patented
159438,Discontinued in Phase 1
64190,Phase 1
57597,Discontinued in Phase 1/2
45467,Phase 1/2a
86957,Patented
143457,Phase 1b/2a
156855,IND submitted
37821,Phase 1/2a
55846,Phase 1b/2a
91689,Patented
155876,Phase 1/2
29662,Phase 0
31892,Phase 1b
30686,Phase 1/2
82258,Phase 1/2a
63670,Investigative
137080,Phase 2
1487,Approved (orphan drug)
181597,Discontinued in Phase 4
12930,Phase 0
73240,Clinical trial
121903,Phase 2
184457,Phase 1
10939,Phase 1
108064,Investigative
190702,Approved (orphan drug)
139637,BLA submitted
188607,Phase 2b
188450,Phase 2b
174857,Phase 0
189270,Phase 1/2a
162702,Discontinued in Phase 4
160119,Phase 1b
17950,Discontinued in Phase 4
398,Phase 2
60656,Clinical trial
62931,IND submitted
106922,IND submitted
3030,Discontinued in Phase 3
166424,Phase 1b/2a
150646,Phase 0
111469,Phase 1b
145922,Phase 1b/2a
89142,Discontinued in Phase 4
137201,Discontinued in Phase 3
158138,Phase 2a
168354,Phase 2
113521,Phase 0
136995,Investigative
73803,Clinical trial
123612,Phase 1/2
146125,IND submitted
158267,Phase 2/3
59180,Phase 0
97610,Phase 1/2a
80364,Clinical trial
94142,IND submitted
79365,Phase 2a
66130,Phase 2a
31114,Discontinued in Preregistration
4582,IND submitted
113457,Phase 1b/2a
15087,Phase 1
48802,Patented
189191,Preclinical
153085,Phase 1b/2a
102791,IND submitted
20747,Patented
85986,Phase 1
105048,Phase 0
50442,Phase 0
125952,Phase 1b/2a
2508,Discontinued in Preregistration
76052,IND submitted
103719,Patented
117668,Discontinued in Phase 1/2
26297,Discontinued in Phase 4
140224,Investigative
152604,Approved
2519,Phase 1b/2a
180690,Phase 1/2a
54630,Discontinued in Phase 2b
136251,Patented
61881,Phase 1b
157409,Phase 1b/2a
186304,Patented
81184,Discontinued in Phase 3
61295,Phase 1
114644,Discontinued in Phase 3
97363,Phase 1
17417,Phase 1
63916,Phase 2/3
80473,Discontinued in Phase 2
163436,Phase 0
3689,Discontinued in Phase 2b
129492,Phase 1
51551,Phase 1b/2a
98053,Phase 1b
156018,Phase 1b
175963,Phase 2
150424,Phase 1b/2a
172501,Patented
27911,Phase 1/2a
53722,Discontinued in Preregistration
91235,Clinical trial
69580,IND submitted
161696,Phase 0
74065,Phase 1/2
26764,Phase 1b
49549,Investigative
40909,Approved
56656,Phase 1b/2a
28837,Investigative
117966,Phase 3
170709,Phase 0
48863,Investigative
137850,Discontinued in Phase 3
11942,Phase 2
162799,Phase 2
50298,Patented
56332,Discontinued in Phase 2b
35505,Discontinued in Phase 2b
3796,Discontinued in Preregistration
68788,Phase 1
17667,Phase 3
177925,Investigative
67330,Phase 1b/2a
20242,Phase 1
33198,Phase 2/3
3026,IND submitted
92585,Approved (orphan drug)
170497,Phase 0
184625,Phase 0
12868,Phase 3
177659,Phase 2
147129,Investigative
182073,Phase 2a
167980,Patented
123771,Investigative
136648,Investigative
44757,Phase 1/2a
90930,Phase 1b/2a
98982,Phase 1/2
167429,Investigative
134995,Phase 0
8825,Discontinued in Phase 1
97836,Discontinued in Phase 2b
121886,Discontinued in Phase 2b
53769,Discontinued in Preregistration
128013,Phase 0
104202,BLA submitted
67077,Patented
129051,Investigative
88213,Patented
140554,BLA submitted
27842,Phase 1b
86460,Phase 0
159536,Phase 2
40162,Phase 0
131866,Phase 1
171229,Phase 1b
108855,Phase 1
30534,Discontinued in Phase 4
40495,Discontinued in Preregistration
55879,Phase 1/2a
132906,Discontinued in Phase 4
75590,Phase 0
164832,Phase 1/2
189751,Phase 2b
122935,Patented
31862,IND submitted
88775,Phase 1
155822,Phase 1b
158364,Phase 1b/2a
98899,Phase 1/2a
165080,Phase 2
106692,Phase 0
70461,Phase 1
12883,Phase 1
151496,Phase 1
73245,Discontinued in Preregistration
150240,Phase 1/2a
34044,Phase 1
66548,Discontinued in Phase 1
190441,Approved (orphan drug)
124834,Patented
179448,Discontinued in Phase 2/3
104664,Phase 0
40291,Phase 1b/2a
19284,Phase 1
145698,Phase 0
30120,Discontinued in Phase 4
147966,Phase 1b/2a
141657,Phase 1b
59072,Phase 0
28135,Phase 1
58426,Phase 0
14972,IND submitted
68993,Phase 1
6228,Investigative
138161,BLA submitted
2121,Phase 2
31920,Investigative
100524,Phase 2
190390,Approved (orphan drug)
21367,Phase 2
7037,Discontinued in Phase 2
169058,Discontinued in Phase 2
62597,Discontinued in Phase 3
142497,Discontinued in Phase 2b
86025,Phase 1b
125795,Phase 1b/2a
116700,Discontinued in Phase 4
167716,Phase 0
80895,Phase 1/2a
114927,Phase 1b
122000,Discontinued in Phase 2b
66439,Phase 1/2a
87247,Patented
105396,Phase 2a
149959,Phase 2b
5674,Phase 2/3
59324,Phase 0
111821,Phase 0
117781,Investigative
173794,BLA submitted
159958,Discontinued in Preregistration
100985,Phase 1/2a
61399,Phase 2/3
34688,Phase 1/2a
179900,Discontinued in Phase 2/3
80888,Phase 2a
33274,Approved (orphan drug)
36893,Phase 1b/2a
35631,Phase 0
178862,Phase 1/2
111389,Phase 0
37907,Discontinued in Phase 3
149235,Investigative
33237,BLA submitted
65214,Discontinued in Phase 2b
104437,Discontinued in Phase 4
52045,Discontinued in Phase 2/3
14973,IND submitted
49424,Phase 0
48805,Discontinued in Preregistration
57773,Investigative
120614,Approved (orphan drug)
95890,Investigative
52108,Discontinued in Phase 3
80374,Discontinued in Phase 1/2
177224,Phase 1/2a
21033,Phase 2/3
75810,Phase 1/2
93569,Phase 1
16896,Phase 2b
66276,Discontinued in Phase 1/2
117208,Discontinued in Phase 1/2
178845,Phase 0
173290,Investigative
70467,Phase 1/2a
119844,IND submitted
4225,Phase 2/3
72402,IND submitted
1829,Phase 2a
79116,Phase 1b
80442,Phase 1b/2a
93765,Phase 1b
184704,Phase 1/2
29842,Phase 0
74747,Phase 1
23768,Discontinued in Phase 4
36413,Phase 1
92599,Phase 1b
156637,Phase 0
103292,Patented
43294,Phase 1/2a
115005,Clinical trial
81751,Phase 1
152682,Phase 1/2a
158779,Phase 2
190650,Approved (orphan drug)
51776,Discontinued in Phase 2b
163378,Patented
183639,Phase 2a
115150,Phase 1/2a
122042,Approved (orphan drug)
142726,Phase 2a
3197,Phase 1
142264,Phase 2/3
145901,Phase 1b/2a
158823,Phase 1b
36193,Discontinued in Phase 1
87821,Phase 2a
72681,Investigative
126097,BLA submitted
6286,Phase 2/3
12489,Phase 1/2
149435,Discontinued in Phase 2
150083,Phase 1b
72369,Phase 1b
18889,IND submitted
41804,Phase 1b
54212,Phase 1b
33302,Phase 0
179178,Phase 1
151220,Phase 1/2
98288,Phase 2
67442,Discontinued in Preregistration
94746,Phase 1
53365,Phase 1
19336,IND submitted
181625,Phase 2b
58401,Discontinued in Phase 3
132942,Discontinued in Phase 1/2
102106,Discontinued in Preregistration
181937,Phase 2/3
4667,Phase 1/2
134322,Phase 1/2
117475,Discontinued in Phase 2b
113143,Phase 1b
180170,Phase 1b/2a
120445,Discontinued in Phase 2
121882,BLA submitted
187140,Phase 1b
155735,Phase 1b/2a
102841,Phase 1b
6516,Investigative
157540,Approved (orphan drug)
189455,Phase 1/2
151126,Phase 0
155115,Phase 1b
137370,Phase 1
138361,BLA submitted
132109,IND submitted
138076,Clinical trial
105295,Phase 1b
125318,IND submitted
19439,Investigative
124183,Phase 1/2
164536,Discontinued in Preregistration
168019,Phase 1b
103049,Discontinued in Preregistration
63440,Patented
114501,Phase 0
167070,Discontinued in Preregistration
138607,BLA submitted
129919,Discontinued in Preregistration
186125,Phase 2a
91253,Discontinued in Phase 1
155029,Phase 1/2
156308,Phase 1/2
118616,Phase 1b/2a
21340,Phase 0
74800,Phase 1/2a
93398,Discontinued in Phase 1
36142,Phase 1b/2a
98692,Phase 1b/2a
29801,Investigative
132476,Discontinued in Phase 1/2
68707,Phase 1/2
131899,Discontinued in Phase 4
32291,Discontinued in Phase 1
191621,Phase 1
117667,Discontinued in Phase 2/3
154316,Discontinued in Preregistration
97053,Phase 1/2a
97398,Phase 1b
113879,IND submitted
82485,Phase 1/2
164748,Phase 0
140588,Phase 1b/2a
22440,Phase 2/3
180,Phase 1
93568,Phase 1/2a
24706,Discontinued in Phase 4
180252,Phase 2a
51968,Phase 1b
166403,Phase 1b/2a
100050,Phase 1b
117391,Phase 1b
35858,Phase 2a
52408,Discontinued in Preregistration
10667,Discontinued in Phase 2b
4108,Phase 2/3
63964,Clinical trial
68255,Phase 1
126709,IND submitted
149359,Discontinued in Phase 2
123969,Investigative
41199,Discontinued in Phase 2
94843,Phase 1b/2a
29162,Phase 1b
78583,Phase 0
153722,Phase 1/2a
70138,Phase 0
191309,Phase 2a
170421,Phase 0
2433,Phase 1b/2a
186580,Phase 0
151431,Phase 2
135785,Phase 2/3
64058,Discontinued in Phase 2b
169340,Discontinued in Preregistration
181847,Discontinued in Phase 4
139690,Phase 1/2a
141325,Discontinued in Preregistration
71607,Patented
119629,Discontinued in Phase 4
61411,Patented
3848,Investigative
68786,Phase 1/2a
62777,Discontinued in Phase 3
113207,Discontinued in Phase 4
52535,Investigative
143050,Discontinued in Phase 4
17396,Phase 1/2a
48842,Phase 1b/2a
139521,Investigative
30838,Phase 0
157014,Discontinued in Phase 4
85204,Phase 2b
124849,Patented
105118,Patented
181780,Phase 1/2
77704,Phase 2
31740,Discontinued in Preregistration
175221,IND submitted
2303,Phase 1b/2a
19091,Discontinued in Phase 3
62061,Phase 1b
170002,IND submitted
69858,Patented
150510,Phase 1b
167344,Discontinued in Phase 1/2
85089,Phase 1b/2a
129832,Phase 0
58473,Investigative
126423,Phase 1b
96297,Discontinued in Phase 4
37817,Discontinued in Phase 3
103008,Application submitted
184750,Discontinued in Phase 3
89899,Clinical trial
108830,Phase 1/2a
178856,Discontinued in Phase 1/2
188210,Discontinued in Phase 3
60501,Discontinued in Phase 3
127750,Phase 1/2
100731,Patented
6958,IND submitted
44037,Phase 1/2a
140793,Phase 1b/2a
120162,Discontinued in Phase 3
18870,Discontinued in Phase 2/3
46473,Phase 1
123669,Phase 1b
90004,IND submitted
35339,Discontinued in Phase 2
106897,Phase 1b/2a
189423,Patented
187703,Phase 4
12182,Phase 1/2
33201,BLA submitted
155699,Phase 2/3
53264,Discontinued in Phase 3
21,Discontinued in Preregistration
31969,Investigative
120494,Approved (orphan drug)
53591,Phase 1b/2a
48489,Phase 3
111745,Discontinued in Phase 4
2049,Phase 1b
55720,Discontinued in Phase 2b
172694,Discontinued in Phase 2
65388,Phase 1/2a
162920,Patented
70735,Phase 1b
136698,Phase 0
2697,Discontinued in Preregistration
121394,Patented
13190,Phase 1
20139,Clinical trial
178783,Phase 1/2
37166,Discontinued in Phase 1/2
12344,Phase 1/2
162274,Phase 1
164401,BLA submitted
61068,Approved (orphan drug)
189436,IND submitted
112801,Phase 1/2
136245,Phase 1/2
23613,Phase 2
12916,Phase 1
5474,Phase 2a
55375,Discontinued in Phase 2/3
132861,Patented
86253,Investigative
20595,Phase 1b
20022,Phase 1/2
28715,Phase 0
163622,Discontinued in Phase 1/2
148717,Clinical trial
55408,Phase 0
96065,BLA submitted
78549,Discontinued in Phase 1
82582,Investigative
125088,Phase 1b
21267,Phase 1b
139355,BLA submitted
64762,Clinical trial
173272,Phase 2a
26275,Phase 0
114791,Phase 2a
107198,Phase 1/2a
16246,Phase 1/2a
94823,Discontinued in Phase 4
68444,Phase 1
48783,Discontinued in Phase 2b
41198,Discontinued in Phase 1/2
57055,Phase 1/2
163575,Discontinued in Phase 1
178097,Patented
124605,Discontinued in Phase 4
169367,Phase 2a
51985,Discontinued in Phase 3
139596,BLA submitted
16413,IND submitted
23887,Phase 1/2a
175699,Discontinued in Phase 3
178959,Discontinued in Phase 1/2
129102,Discontinued in Phase 2/3
99036,Phase 1/2a
42270,Discontinued in Phase 1
102396,Patented
127703,Discontinued in Preregistration
111502,Discontinued in Phase 2b
187749,Phase 0
105482,Phase 1
20816,Patented
154584,Phase 3
15075,Phase 3
75801,Phase 1/2
112431,Phase 1
156556,IND submitted
80815,Phase 2
8499,Phase 1/2a
49462,Discontinued in Phase 2b
90599,Phase 1b
179742,Approved
102601,Discontinued in Preregistration
179969,Phase 1
51453,Investigative
158346,Phase 1b/2a
46446,Approved
136271,Phase 1/2a
141928,Phase 2/3
54759,Phase 1b
112690,Phase 0
45837,Phase 1/2a
101854,Phase 1b
141778,Discontinued in Preregistration
183678,Phase 1/2
188041,Patented
74030,Phase 1/2a
38921,Phase 1b
167298,Discontinued in Preregistration
86374,Patented
147503,Discontinued in Phase 1
8193,Phase 1b
34839,Patented
173920,Phase 1b/2a
179303,Phase 1/2
46019,Phase 1/2a
175888,Discontinued in Phase 3
10644,Phase 0
139724,BLA submitted
168429,Phase 1b/2a
100367,Phase 0
191501,BLA submitted
35497,Phase 1
89399,Phase 2/3
53515,Phase 1/2
188301,Phase 2/3
172431,Phase 2
156362,Phase 1
126983,Discontinued in Preregistration
144054,IND submitted
160489,Phase 1/2a
41103,Investigative
178377,Phase 0
122140,Phase 1b
13025,Phase 0
76838,Phase 0
47603,Patented
101584,Phase 1
29143,Phase 0
29046,Phase 1/2a
44479,Phase 2/3
182259,Phase 2
145826,Discontinued in Phase 1
140024,Approved (orphan drug)
23699,Phase 1
142584,IND submitted
75096,Discontinued in Phase 2b
157761,Registered
143375,Phase 1b/2a
135929,IND submitted
96126,Discontinued in Phase 1/2
106614,Discontinued in Phase 4
144602,IND submitted
172638,Phase 1/2
190122,Phase 1b
14301,IND submitted
120475,Phase 0
190717,Phase 1/2
121155,Phase 2b
136607,Phase 1/2a
132068,Discontinued in Preregistration
188122,Phase 1/2a
55510,IND submitted
108223,Discontinued in Phase 1/2
139630,Investigative
73881,Discontinued in Phase 4
81607,Approved
57656,Phase 1/2a
152977,Phase 1
69084,Phase 1
158284,Phase 2/3
89710,IND submitted
49158,Discontinued in Phase 2
13170,Phase 1
152561,Patented
103331,Phase 1/2a
14514,Phase 1
26658,Phase 0
94324,IND submitted
137198,Phase 1/2a
21967,Patented
72824,Phase 1b/2a
509,Approved (orphan drug)
183111,Phase 1/2a
46065,Phase 2a
116669,Discontinued in Phase 1/2
139502,BLA submitted
190068,Phase 2/3
32322,Phase 2a
58175,Phase 2/3
762,Discontinued in Phase 4
50797,Discontinued in Phase 2b
173063,Phase 2a
61851,Discontinued in Phase 2b
117088,Discontinued in Phase 1/2
145851,Investigative
65142,Phase 2a
100932,Phase 1/2a
190932,Discontinued in Phase 1
76896,Discontinued in Phase 1/2
822,Phase 1b
73542,Approved
128376,Phase 1
23162,Phase 1b/2a
109861,Discontinued in Preregistration
97131,Phase 1/2
79831,Phase 1/2a
106228,Phase 2/3
172645,Phase 0
43267,Phase 0
34906,Phase 1b
6340,Phase 2/3
102688,Phase 1/2
63815,Phase 2
108905,Phase 3
180922,Phase 2a
56744,Phase 1
153221,Phase 1/2
128078,Investigative
103445,Discontinued in Phase 2/3
151558,Phase 2
132421,Discontinued in Phase 1/2
166535,Phase 1b
65125,Preclinical
45442,Phase 2/3
183603,Phase 1/2
54689,Phase 2
164383,Investigative
21855,Discontinued in Phase 2
160367,Phase 0
110262,Phase 1b/2a
75112,Discontinued in Phase 1
140945,Phase 2/3
49357,Phase 0
146001,Phase 1b/2a
160511,Phase 0
164350,Discontinued in Preregistration
182651,Phase 2a
8531,Phase 0
81560,Phase 1
74283,Phase 1/2
127148,Phase 0
1032,Discontinued in Phase 1/2
107344,Discontinued in Phase 4
71627,Phase 1
6659,Discontinued in Phase 2
64709,Approved (orphan drug)
102281,Phase 1/2a
47624,Patented
72783,Phase 2
67120,Phase 0
159951,Phase 1b
128907,Investigative
150813,Phase 1
166775,Clinical trial
180594,Discontinued in Phase 2b
73252,Clinical trial
36989,Phase 1
2046,Discontinued in Phase 1
85916,Discontinued in Phase 2b
31612,Phase 0
73174,IND submitted
147844,Phase 1
128468,Discontinued in Phase 2b
162882,Discontinued in Phase 2/3
14368,Phase 1
6347,Phase 2a
70073,Phase 1b
138672,BLA submitted
174987,Phase 1/2
126504,Phase 1
942,Discontinued in Phase 1/2
182361,Phase 1/2a
164523,Phase 0
105768,Phase 2a
85227,Discontinued in Preregistration
30059,Phase 1b
56736,Discontinued in Phase 2/3
1056,Discontinued in Phase 1
150756,Phase 2
175459,Discontinued in Phase 3
138659,Discontinued in Phase 2
164680,Discontinued in Preregistration
47952,Phase 1b
3505,Patented
184729,Phase 1/2
75282,Phase 1/2
119312,Phase 1b/2a
113997,Phase 1b/2a
176349,Investigative
112594,Phase 0
102143,Investigative
149521,Phase 1
131941,IND submitted
5236,Preregistration
139158,Phase 1b
66011,Phase 1b
85181,Phase 2/3
105064,Phase 1b
61632,Investigative
71149,Phase 1b/2a
122817,Phase 1b
129650,Phase 1/2
48302,IND submitted
32095,Phase 2
17688,Investigative
32976,Phase 2
120830,Approved (orphan drug)
4201,Preregistration
52605,Phase 2
162391,Phase 0
18477,Phase 1/2
69148,IND submitted
57707,Discontinued in Phase 4
9189,Discontinued in Phase 1/2
62441,Patented
186901,Phase 1
88839,Patented
46596,Phase 1/2a
114889,Discontinued in Phase 2/3
174034,Phase 1b/2a
178345,Phase 1b/2a
95232,Phase 1/2a
92029,Discontinued in Phase 2
80731,Phase 2
38496,Phase 1b
169930,IND submitted
118856,Phase 1b/2a
87899,Approved
70151,Phase 1b/2a
173357,Phase 2a
12619,Phase 1
32995,Phase 1/2
62210,Investigative
147393,Phase 1/2a
180276,Phase 2b
158301,Phase 2/3
168983,Discontinued in Phase 1/2
82857,Phase 1
86969,Phase 1/2
108230,Phase 0
4877,Discontinued in Phase 2
13101,Phase 0
186221,Patented
109688,Approved
27325,Phase 1b/2a
165731,Phase 2
90178,BLA submitted
81352,Discontinued in Phase 3
131287,IND submitted
189557,Approved (orphan drug)
8194,Phase 2
99280,Patented
32074,Phase 2
35939,Phase 1/2a
137345,Patented
120731,Phase 0
179495,Phase 0
178334,Phase 1/2a
85795,Discontinued in Phase 3
134361,Discontinued in Phase 4
163222,Patented
43985,Phase 2/3
74313,Phase 2
46741,Discontinued in Phase 1
23412,Phase 1/2
34884,Phase 2b
171426,Patented
133340,Discontinued in Phase 1
32779,Phase 1b/2a
161027,Patented
75089,Phase 1/2
152690,Phase 1/2a
70956,Phase 1b
30865,Clinical trial
152222,Discontinued in Phase 2/3
31060,Phase 0
93483,Phase 2b
65662,Phase 2a
152522,Patented
186364,Patented
118090,Discontinued in Phase 2
168610,Discontinued in Phase 3
159620,Phase 1
52564,Phase 1/2a
162523,Investigative
47898,Discontinued in Phase 2b
90582,Phase 1b/2a
169678,Discontinued in Phase 2/3
23938,Discontinued in Phase 2/3
111991,Discontinued in Phase 2
82822,Discontinued in Preregistration
88834,Phase 0
179503,Phase 2a
151153,Phase 2
40811,Phase 0
62417,Discontinued in Phase 3
128904,Discontinued in Phase 2b
52298,Phase 1b/2a
9181,Discontinued in Phase 2
108355,Phase 1/2a
3177,Phase 0
25605,Phase 2
186313,Phase 2/3
85083,Phase 1/2
21847,Discontinued in Phase 2
93342,Discontinued in Phase 3
176110,Phase 1
139074,Phase 1/2a
48122,Patented
26435,Phase 1b
3755,Investigative
170552,Phase 1/2
127207,Discontinued in Preregistration
138400,Phase 1b
9590,Discontinued in Phase 2b
5966,Discontinued in Phase 2
80559,Phase 1/2a
28086,Clinical trial
5780,Phase 2a
40606,Investigative
85964,Discontinued in Phase 2b
68153,Discontinued in Phase 2/3
49071,Phase 0
78916,Phase 2a
16637,Phase 1/2
108488,Patented
85788,Discontinued in Preregistration
70799,Phase 2/3
35987,Phase 2
153881,Phase 1b
173942,Patented
30942,Phase 1
135814,Phase 2
180709,Phase 2
164984,Investigative
133058,Discontinued in Preregistration
2268,Phase 2
191410,IND submitted
172235,Discontinued in Phase 2
166767,Phase 0
128315,Discontinued in Preregistration
95713,Phase 0
83672,Phase 2/3
161416,Phase 0
153533,Phase 1
125446,Investigative
92156,Phase 1/2a
67195,Phase 2a
188955,Patented
41517,Phase 1
51037,IND submitted
103165,Phase 1
128665,Patented
102327,Investigative
56383,Phase 2
17197,Phase 1/2a
158602,Phase 1b/2a
47391,Discontinued in Phase 2b
56040,Phase 2/3
97402,Phase 2
62281,Phase 1b
129382,Phase 0
59102,Discontinued in Phase 3
157875,Phase 1
82416,Discontinued in Preregistration
157504,Discontinued in Phase 1/2
110954,Discontinued in Phase 4
24790,Phase 1b/2a
182701,Phase 2a
173159,Discontinued in Phase 2
184671,BLA submitted
152970,Phase 1/2a
28891,Phase 4
116114,Phase 2
172889,Phase 0
82644,Phase 2
94480,IND submitted
165652,Phase 1b/2a
62796,Investigative
132520,Discontinued in Phase 2b
61208,Phase 1
14335,Phase 1/2
85272,Discontinued in Preregistration
161185,Discontinued in Phase 1/2
121919,Patented
166359,Investigative
122083,Investigative
129255,Phase 1/2
107325,Phase 1/2a
184814,BLA submitted
20969,Patented
5206,Phase 2a
123621,Phase 0
56573,Phase 1
6587,Discontinued in Phase 2
102184,Phase 1/2
16751,Phase 0
43017,Patented
86738,Discontinued in Phase 1/2
78356,Approved (orphan drug)
106520,Phase 2b
152714,Phase 1/2a
150895,Phase 1
192120,Phase 1/2
165963,Phase 1b/2a
72909,Phase 2
98500,Phase 1b/2a
169388,Discontinued in Phase 4
66713,Patented
148325,Phase 2a
89663,Phase 1b/2a
184002,Phase 0
161692,Investigative
168219,Approved (orphan drug)
38935,IND submitted
121617,Phase 0
174316,Phase 2
106200,Phase 0
172491,Discontinued in Phase 2/3
112892,Discontinued in Phase 2
190768,Clinical trial
74500,Discontinued in Phase 4
128787,Phase 1/2
39269,Discontinued in Phase 2/3
89886,Phase 1b/2a
147867,Discontinued in Preregistration
136011,Preclinical
187345,Phase 0
181965,Phase 1b/2a
34453,Phase 1/2a
157525,Phase 2
28587,Phase 1b
100399,Preclinical
64628,Discontinued in Phase 2b
76192,IND submitted
68540,Phase 1
99986,Phase 1b
57374,Phase 2/3
163743,Phase 0
67310,Phase 1b/2a
185162,BLA submitted
150122,Phase 1b/2a
175146,Discontinued in Phase 1/2
28426,Phase 1/2a
108800,Phase 1/2a
12361,Discontinued in Phase 1
174382,Phase 1
49073,Investigative
162169,Investigative
142970,Phase 2b
49038,Phase 1b/2a
86195,Phase 0
76447,Phase 0
110166,IND submitted
133756,Phase 1/2a
180316,Phase 1b/2a
104550,Patented
155732,Discontinued in Phase 2b
146427,Investigative
132495,Patented
107101,Phase 1/2a
65380,Phase 1/2
48315,Discontinued in Phase 2b
131574,Discontinued in Preregistration
47916,Phase 1b/2a
80022,Phase 1b/2a
72742,Phase 2/3
15395,Phase 1
127680,Discontinued in Phase 2b
158245,Phase 1b/2a
153358,Phase 1b
116661,Investigative
82947,Phase 2/3
178815,Phase 1/2a
159597,Discontinued in Phase 1/2
180097,Phase 1
177474,Phase 1b
147894,Phase 1b
60698,Discontinued in Phase 3
119534,Discontinued in Preregistration
47697,Phase 0
88692,Phase 1
2293,Phase 0
52782,Phase 1b
149276,Phase 1b/2a
7714,Phase 0
25920,Patented
162430,IND submitted
181817,Phase 1/2a
76637,Phase 0
165878,Investigative
81257,Clinical trial
20474,IND submitted
173073,Discontinued in Phase 2
179588,Patented
16663,Phase 1/2
56452,Phase 1b/2a
61989,Phase 1b
188597,Phase 1/2
57160,Phase 1b
45939,Phase 1/2a
158685,Approved
50538,Phase 1b
139439,BLA submitted
141596,Patented
108389,Phase 1b
176549,Discontinued in Phase 4
25240,Investigative
141717,Patented
123653,Phase 1/2
45627,Phase 1/2a
107540,Discontinued in Phase 4
77387,Phase 1/2a
190655,IND submitted
164137,Phase 1
148409,Discontinued in Phase 2/3
4804,Preregistration
108890,Phase 3
70100,Phase 1/2
11784,Phase 1
152454,IND submitted
48760,Phase 3
152540,Approved
42396,Phase 1b/2a
180201,Phase 2a
43065,Patented
87551,Discontinued in Phase 2
69602,Discontinued in Phase 2/3
182505,Phase 2a
149611,Investigative
101739,IND submitted
88890,Phase 0
79814,Discontinued in Phase 1/2
102061,Phase 1/2a
164845,Phase 1/2a
122141,Phase 0
14032,Phase 1
124857,Phase 1b
46253,Phase 1/2
159791,Investigative
60154,Investigative
2961,Discontinued in Phase 2
38427,Discontinued in Phase 4
104377,Discontinued in Phase 4
68076,IND submitted
4332,Phase 1b/2a
27121,IND submitted
187598,Phase 1/2a
48186,Phase 2
84161,Discontinued in Phase 2/3
39641,Phase 1b/2a
46031,Phase 2/3
8848,Discontinued in Preregistration
140522,BLA submitted
156868,IND submitted
51160,Discontinued in Phase 2/3
90846,Approved
186686,Clinical trial
126648,Phase 1
162246,Phase 1/2
190858,Approved (orphan drug)
182318,Phase 1/2a
123411,Phase 1b
111495,Patented
150859,Phase 1/2
149858,Phase 1/2
168919,Clinical trial
73379,Phase 2a
157022,Clinical trial
185256,Discontinued in Phase 1
187521,Phase 4
151938,Phase 1/2
96251,Discontinued in Phase 3
54063,Discontinued in Preregistration
166800,Phase 2/3
176232,Phase 1/2a
122014,Patented
17372,IND submitted
156142,Discontinued in Phase 3
111588,Phase 1/2
137807,Investigative
179733,Phase 1/2a
97290,Phase 2
151415,Phase 1
107886,Discontinued in Phase 2b
144828,Investigative
35714,Discontinued in Preregistration
158078,Discontinued in Phase 2
115046,Clinical trial
67613,IND submitted
85518,Discontinued in Preregistration
44848,Phase 2/3
32661,Phase 2
37568,Phase 1b/2a
168440,Investigative
41013,IND submitted
147973,Investigative
72272,Phase 1/2
81297,Approved
91035,Approved
23541,Phase 2a
116259,Phase 2/3
136222,Phase 1/2a
92891,Phase 1/2
66804,Patented
69840,Patented
95207,Discontinued in Phase 4
179821,Discontinued in Phase 1/2
178383,Discontinued in Phase 1
183160,Phase 1b/2a
63547,Approved (orphan drug)
122733,Phase 1/2
61677,Investigative
78979,Phase 0
19389,Investigative
187667,Phase 1b/2a
131294,Discontinued in Preregistration
81428,Phase 1b/2a
27665,Patented
43853,Phase 1/2a
120081,Phase 4
29695,Discontinued in Phase 1
54135,Phase 1b/2a
113073,Phase 1
23517,Phase 1/2a
137743,Discontinued in Phase 4
168696,Phase 2
63016,Investigative
39190,Phase 1/2a
113194,Phase 1
77115,Investigative
115203,Discontinued in Phase 2
98044,Phase 0
59979,Phase 2/3
100467,Phase 1/2a
43402,Phase 2/3
59287,Phase 1
113299,Patented
43427,Phase 1/2a
153188,Patented
101888,Phase 1/2
6509,Phase 2a
123545,Phase 1b/2a
30883,Phase 0
132973,Patented
43289,Preregistration
1256,Investigative
115982,Discontinued in Preregistration
138925,Approved (orphan drug)
128721,Phase 1/2
62826,Phase 1
35930,Phase 2a
4612,Phase 2a
183134,Phase 2a
31555,Clinical trial
186994,Patented
30041,Investigative
8125,Phase 1b
38923,Phase 2
66106,Discontinued in Phase 1
132195,Discontinued in Phase 2/3
5813,Discontinued in Phase 2
30473,Phase 2
75525,Phase 1/2a
119817,Phase 0
109502,Discontinued in Phase 2/3
107006,Discontinued in Preregistration
191713,Phase 0
4210,Preregistration
165876,Discontinued in Phase 1/2
173660,Approved
95113,Phase 1
101564,Phase 1/2
128997,IND submitted
152472,Discontinued in Phase 4
98410,Phase 2
53358,Patented
96970,Phase 1/2a
125018,Discontinued in Preregistration
5049,Investigative
186831,Phase 4
144990,Discontinued in Phase 2
137359,Investigative
77253,Phase 0
35643,Discontinued in Preregistration
9251,Discontinued in Preregistration
63761,Phase 2a
89677,Phase 1b/2a
133564,IND submitted
139104,Phase 1b
4559,Phase 1/2
140313,Investigative
149551,Phase 1/2
90385,Preregistration
117688,Discontinued in Phase 1/2
122057,IND submitted
112138,Phase 0
170813,Phase 0
90146,Discontinued in Phase 3
177202,Phase 1/2a
55422,Discontinued in Preregistration
11012,Patented
72848,Investigative
110682,Phase 1
153971,Phase 1/2
158777,IND submitted
143298,Phase 1b/2a
167148,Discontinued in Phase 1/2
161491,Patented
2520,Phase 2
177590,Phase 1b
73250,Investigative
142362,Phase 0
102457,Investigative
371,Phase 1/2a
191656,Phase 1/2
177486,Phase 2
98061,Phase 1/2a
143090,Phase 2b
149376,Phase 1b
93914,Discontinued in Phase 3
190940,Investigative
84185,Discontinued in Preregistration
118568,Discontinued in Phase 1/2
116109,BLA submitted
191943,Phase 2/3
141819,Discontinued in Phase 2b
16099,Phase 0
16372,Phase 1
82619,Discontinued in Preregistration
144255,Discontinued in Phase 2
95162,Patented
189351,Phase 1/2
140868,Phase 1b/2a
48925,Discontinued in Phase 3
58061,Phase 0
86655,Phase 1b
102844,Patented
129998,Phase 1/2
137477,Phase 1/2
154557,Phase 2
68556,Discontinued in Phase 4
54472,Phase 3
137273,Discontinued in Phase 2/3
148534,Phase 1/2a
36784,Discontinued in Preregistration
69752,Discontinued in Phase 2
83023,Phase 1/2a
168369,Discontinued in Phase 1
187945,Patented
164464,Phase 0
41371,Discontinued in Preregistration
132005,IND submitted
10193,Discontinued in Phase 2/3
121102,Phase 1b
61505,Discontinued in Phase 1
106398,Patented
168896,Investigative
44440,Phase 2/3
20154,Clinical trial
72234,Discontinued in Phase 4
63347,Phase 0
8245,Phase 2
175015,Discontinued in Phase 1/2
85625,Discontinued in Phase 2b
136351,Investigative
41964,Phase 1
29003,Phase 0
13861,Phase 1
172700,Discontinued in Phase 2/3
78699,Phase 0
119862,Approved (orphan drug)
85984,Discontinued in Phase 2b
99548,Phase 1/2a
177880,Investigative
120350,Approved
71410,Phase 1b/2a
155912,Phase 1b
86875,Discontinued in Phase 2
145626,Phase 1b/2a
50596,Phase 3
24739,Discontinued in Phase 2b
145628,Phase 1b/2a
153879,Phase 0
64008,Patented
134575,Phase 1/2a
189915,Phase 1/2
65131,Preclinical
61285,Phase 1
38441,Phase 1b/2a
135613,Phase 0
173976,Discontinued in Preregistration
114411,Patented
148289,Phase 1b
145442,Phase 1b
12215,Investigative
168482,Clinical trial
96619,Discontinued in Phase 2b
131175,Phase 1/2a
121370,Patented
58667,Phase 1b/2a
64336,Phase 2
129304,Discontinued in Phase 2b
150103,IND submitted
120495,Approved (orphan drug)
111073,Discontinued in Phase 4
116617,Phase 2
139357,Phase 1b
10440,Discontinued in Phase 2/3
159076,Approved
148258,Phase 1/2
135422,Phase 0
189013,Phase 1/2
182993,Discontinued in Phase 2b
86762,Patented
38633,Phase 1
188953,Phase 1/2
112352,Discontinued in Phase 2
102870,Investigative
130293,Phase 1/2
103187,Phase 1/2
38819,Discontinued in Phase 2b
138901,Discontinued in Phase 2
142981,Patented
140089,Discontinued in Phase 2
124716,Investigative
103694,Phase 2a
15313,Phase 0
45342,Phase 1/2a
92740,Discontinued in Phase 3
48104,Discontinued in Phase 2b
3772,Approved
7355,Phase 2a
64902,Phase 1/2
101129,Phase 2/3
42236,Phase 1
13891,Phase 0
127204,Phase 0
35194,Phase 1b
94763,Discontinued in Phase 4
15181,Phase 1/2a
13073,Phase 1
7439,Phase 1/2
142248,Discontinued in Phase 2/3
78255,Discontinued in Phase 3
32386,Phase 1/2
167694,Phase 2
40307,Patented
19248,Phase 1
111096,Phase 1/2
80157,Phase 2a
123308,Approved
19360,IND submitted
53671,Phase 1b
130709,Phase 1b
19846,Phase 1
36943,Phase 1b/2a
63167,Phase 0
39516,Phase 1b/2a
166286,Patented
15277,Phase 1/2a
76423,Phase 1b
182790,Phase 1/2a
47730,Discontinued in Phase 2
156931,Phase 1b/2a
24090,Phase 1
12003,Discontinued in Phase 2/3
22017,Discontinued in Phase 3
73384,Phase 2
137048,Investigative
127185,Phase 0
167850,Phase 0
166237,Discontinued in Phase 1/2
16443,Investigative
160163,Investigative
71970,Phase 0
84974,Phase 1b/2a
119309,Patented
48475,Phase 1/2a
144858,Phase 1/2a
19518,Phase 0
118478,Discontinued in Preregistration
70612,Phase 0
124082,Phase 1/2
59822,Discontinued in Phase 3
38248,Phase 1b
171163,Phase 1/2a
31847,Discontinued in Phase 2b
33106,Phase 0
80363,Phase 1/2a
143485,Patented
26930,Phase 1b/2a
87668,Discontinued in Phase 1/2
75065,Patented
188129,Phase 1/2
82053,Discontinued in Phase 2/3
66506,Preclinical
112715,Discontinued in Phase 3
86006,Phase 1
133528,IND submitted
27612,Phase 1b/2a
79019,Patented
91486,Discontinued in Preregistration
159762,Phase 1b/2a
149100,Phase 2b
144587,Phase 1/2a
67648,Phase 1b
146398,IND submitted
148224,Phase 1b/2a
128206,IND submitted
97917,Phase 1/2a
73759,Phase 1b
84286,Phase 1b/2a
157418,Phase 2a
7356,Phase 1b/2a
34792,Phase 1/2
4779,Investigative
107731,Discontinued in Phase 1
59992,Phase 0
102532,Application submitted
73024,Investigative
61240,Phase 1
62841,Patented
186347,Phase 1b/2a
125896,BLA submitted
101323,Phase 3
150660,Phase 1/2
124216,Phase 1/2
110273,Phase 1b/2a
120288,Clinical trial
10383,Discontinued in Phase 3
34816,Phase 1
71165,Phase 1b/2a
139334,Phase 1b
8105,Patented
20965,Phase 1
139922,BLA submitted
23308,Discontinued in Phase 2/3
88280,Phase 1/2
179999,Phase 1/2a
53436,Phase 0
72484,Investigative
116440,Discontinued in Phase 3
60048,Phase 0
81319,Discontinued in Phase 1
51891,Phase 1b/2a
95488,Phase 2
9875,Phase 1/2
152018,Phase 1/2
63372,Phase 1b/2a
104982,Phase 1b/2a
132666,Discontinued in Phase 4
179916,Discontinued in Phase 2/3
163924,Phase 0
109718,Discontinued in Preregistration
34285,Phase 1
45540,Phase 1/2a
162753,Phase 1/2a
8405,Approved
1723,Phase 2/3
87330,Phase 1/2
426,Phase 1/2a
59925,Phase 1b/2a
71381,Phase 0
116157,Phase 2
18195,Phase 1/2a
157340,Phase 2a
140723,Phase 1b/2a
10914,Phase 0
63338,Discontinued in Phase 3
70874,IND submitted
90227,Discontinued in Phase 2
68162,Phase 2b
151279,Phase 2
97550,Phase 1b
25324,Phase 1b
178834,Patented
35751,Phase 0
98370,Phase 1b
148818,Phase 0
85493,Discontinued in Phase 2b
57868,Phase 0
18093,Phase 2a
35207,Phase 1/2a
130028,Phase 1/2
10466,Discontinued in Phase 2/3
157310,IND submitted
107959,Discontinued in Phase 2b
93029,Investigative
99733,Phase 1
153335,Phase 1/2
21586,Discontinued in Phase 2
104655,Investigative
126295,Phase 1b/2a
182577,Phase 1/2a
47145,Discontinued in Phase 1/2
86795,Phase 1/2
100512,Phase 1/2
108867,Discontinued in Preregistration
155968,Discontinued in Preregistration
89186,Discontinued in Phase 4
123582,Discontinued in Phase 4
120872,Approved
15129,Phase 1
165613,Phase 1b/2a
34809,Discontinued in Preregistration
174769,Discontinued in Phase 2
180665,Phase 1b/2a
20775,Phase 1/2a
6527,Phase 2a
27004,Phase 1b/2a
107744,Discontinued in Phase 3
58341,Phase 0
184331,Discontinued in Phase 4
72568,IND submitted
69011,Phase 1
172552,Phase 0
11301,Discontinued in Phase 3
160469,Phase 1/2
97971,Phase 1/2a
63305,Discontinued in Preregistration
151518,Phase 2/3
190826,Phase 1/2a
61494,Phase 2
130139,Patented
128510,Investigative
22791,Discontinued in Phase 2/3
168250,Phase 2
147706,Phase 1/2a
104163,Investigative
163037,Discontinued in Phase 2/3
158958,Phase 0
181059,Phase 2
2612,Phase 1b
172329,Phase 1
133624,Phase 1/2a
5520,Phase 1b/2a
89909,Patented
5409,Investigative
66484,Discontinued in Phase 1/2
110381,Phase 3
75070,Discontinued in Phase 1
5369,Phase 1/2
169483,Phase 1
14405,Phase 0
120435,Discontinued in Phase 1/2
119999,Approved (orphan drug)
83174,Discontinued in Phase 4
113888,Discontinued in Phase 3
23409,Phase 1
91754,Patented
62142,Investigative
42143,Discontinued in Phase 1
160292,Phase 2a
57883,Phase 1b/2a
15093,Phase 1/2a
176428,Phase 1
100979,Phase 2/3
32841,Phase 3
141458,Discontinued in Phase 2b
189966,Phase 1b
14614,Phase 1/2a
63993,Clinical trial
134498,Phase 1/2
23836,Phase 2
33206,Phase 0
42202,Phase 0
22134,Investigative
174248,IND submitted
86694,Discontinued in Phase 1
77605,Discontinued in Preregistration
187231,Phase 1
42164,Phase 0
95589,Phase 2a
16235,Phase 1/2a
44644,Phase 1/2a
4307,Phase 1/2
132818,Phase 1
63602,Discontinued in Phase 2b
57970,Investigative
53707,Phase 0
188677,Phase 1b/2a
40034,Phase 1
187802,Patented
52700,Phase 1/2a
75014,Clinical trial
53078,IND submitted
169204,Clinical trial
169590,IND submitted
24622,Phase 2/3
9864,Phase 0
164083,Investigative
95324,Discontinued in Phase 1
77213,Phase 1
72716,Phase 1b/2a
178610,Phase 0
187031,Patented
157206,Investigative
61386,Patented
35343,Discontinued in Phase 4
2984,IND submitted
110768,Phase 1
58518,Investigative
41383,IND submitted
77964,Clinical trial
31434,Discontinued in Phase 3
180937,Phase 2/3
99298,Phase 1/2
145917,Discontinued in Preregistration
144266,Phase 3
136839,Patented
166016,Discontinued in Phase 1/2
155593,Phase 2
11684,IND submitted
187054,Patented
128784,Discontinued in Phase 3
54069,Phase 1b/2a
173285,Discontinued in Phase 2
184296,Phase 1/2
95021,Patented
182832,Phase 1
76958,Investigative
1882,Discontinued in Phase 1
163492,Discontinued in Phase 2
123339,Phase 1b
143711,Phase 1b/2a
136434,Discontinued in Phase 2/3
148402,Investigative
8397,Approved (orphan drug)
188985,Approved (orphan drug)
186416,Clinical trial
174419,Phase 1/2
189343,Phase 1/2
55380,Discontinued in Phase 2b
185548,Patented
29276,Phase 2
12449,Phase 0
65710,Approved (orphan drug)
38767,Discontinued in Phase 2
35278,Phase 1/2a
117652,Investigative
84743,Phase 1/2
5400,Investigative
22836,Phase 2
11238,BLA submitted
5626,IND submitted
20460,Phase 1
99808,Phase 1
59313,Investigative
59656,Phase 0
145236,Phase 1b/2a
134900,Phase 0
2810,Phase 1/2a
166367,Patented
172138,Phase 2a
27737,Phase 1b
166182,Phase 1b/2a
28659,Phase 1b
54833,Discontinued in Phase 2/3
190247,Phase 1/2
44685,Phase 1/2a
65496,Approved
143488,Phase 1/2a
182411,Phase 1/2a
168604,Discontinued in Phase 2
31499,Phase 1b
60003,Discontinued in Phase 4
191081,Phase 1/2
99010,Phase 1/2
32582,Phase 1/2
145953,Phase 2/3
164039,Phase 1
40113,Phase 0
8141,Phase 1/2
79338,Discontinued in Phase 1/2
18202,Phase 2
106024,Discontinued in Preregistration
144509,Discontinued in Phase 1/2
114203,Phase 1/2
86013,Phase 1b
65689,Discontinued in Phase 4
149516,Phase 2/3
123338,Phase 1b
78693,Phase 0
188259,Phase 1/2
151523,Phase 0
123593,Phase 0
43405,Phase 1/2a
73670,Approved (orphan drug)
64809,Phase 1/2a
178689,Phase 0
176031,IND submitted
58418,Investigative
12857,Phase 1
141857,Phase 2/3
138463,Approved (orphan drug)
103409,Phase 2
174432,Discontinued in Phase 4
143990,Investigative
163227,Patented
19319,Patented
148461,Discontinued in Phase 2
129644,Phase 0
84709,Phase 1b/2a
73071,Phase 0
137210,Phase 1b
5294,Phase 2a
47069,Approved
68784,Phase 1/2
117067,Discontinued in Phase 2/3
183515,Phase 1b/2a
142823,Phase 1b/2a
180954,Phase 2a
10315,IND submitted
59263,Phase 1
28360,Phase 1b
134863,Phase 0
17393,Phase 1
121134,Phase 2a
72917,Phase 1
94400,Phase 1/2a
21017,Phase 2
19223,Patented
36461,Discontinued in Phase 4
124932,Phase 1/2
4079,Phase 2/3
79077,Phase 1b
11104,Investigative
124477,Phase 1
36509,Investigative
182194,Discontinued in Phase 2b
96229,Patented
151930,Phase 1
5158,IND submitted
186603,Patented
6067,IND submitted
107191,Phase 2b
36537,Phase 2a
35193,Discontinued in Preregistration
12289,Phase 2b
64133,Phase 2a
160650,Phase 0
126890,IND submitted
63194,IND submitted
37111,Phase 1
145455,Phase 1b/2a
145310,Phase 1
115330,Discontinued in Phase 2
18262,Phase 2a
12153,IND submitted
71930,Phase 1/2
25406,Discontinued in Phase 4
47545,Phase 1
36440,Patented
35280,Investigative
122790,Discontinued in Phase 4
29101,Discontinued in Phase 2/3
153800,Phase 3
42310,Investigative
43018,Phase 0
103220,Phase 1/2
36221,Discontinued in Phase 1
135907,Phase 1/2
2839,Discontinued in Phase 3
99957,Phase 1b
24032,Phase 1
100291,Phase 0
161052,Discontinued in Phase 3
17386,Phase 1/2
185384,Discontinued in Phase 1
133055,Investigative
39466,Phase 1b/2a
79750,Phase 2
157816,Discontinued in Phase 1/2
63280,Patented
135782,Phase 3
181499,Phase 1b/2a
191512,Approved (orphan drug)
6518,Phase 2a
134370,Patented
168972,Investigative
83571,IND submitted
30420,Discontinued in Phase 4
148483,Clinical trial
13460,Phase 1/2a
81349,Discontinued in Phase 1
19049,Phase 2
140651,Phase 2a
136393,Patented
139275,Discontinued in Phase 2
75969,Phase 1/2a
86020,Phase 0
51077,Phase 1b/2a
188503,Phase 2b
78071,Phase 1/2
72036,Investigative
134012,Phase 1
134509,Phase 1b
108857,Phase 1/2a
27745,Phase 1b/2a
47880,Phase 2/3
191946,Discontinued in Phase 2b
158706,Phase 1b/2a
64429,Phase 1/2a
168242,Phase 1b/2a
161410,Phase 1/2
103774,Phase 1/2a
104435,BLA submitted
148478,Discontinued in Phase 1
153162,Discontinued in Phase 4
75199,Phase 0
99321,Phase 1
151485,Phase 0
88941,Phase 1/2a
66428,Discontinued in Phase 2b
71846,Phase 1b/2a
155308,Phase 1b
35986,Phase 2
84168,Phase 1
99259,Phase 1/2a
112013,Discontinued in Phase 3
154854,Phase 1b/2a
134952,Phase 0
93799,Phase 2b
75166,Discontinued in Phase 2b
169053,Discontinued in Phase 1
47160,IND submitted
158238,Phase 0
85090,Phase 0
139764,Phase 1b
99262,Discontinued in Phase 2/3
6365,Phase 2a
11661,Discontinued in Phase 2b
16117,Phase 0
98270,Phase 2
57404,Phase 1/2a
37751,Phase 1/2a
60371,Phase 2/3
4448,Phase 2a
184174,Discontinued in Phase 4
69142,Phase 3
166623,Phase 1/2
98064,Phase 2
111318,Phase 0
4752,Investigative
22408,Phase 1/2
136298,Phase 1
156849,Phase 2
116416,Discontinued in Preregistration
96274,Discontinued in Phase 1/2
177854,Discontinued in Preregistration
78871,Phase 2a
72532,IND submitted
184210,Discontinued in Phase 4
63229,Phase 0
38525,Phase 1/2a
42101,Investigative
157581,Phase 1b/2a
140252,BLA submitted
118197,Approved
25276,Phase 0
50122,Phase 1b/2a
94965,Phase 1b
38816,Phase 1b/2a
104522,Clinical trial
94957,Phase 1
12062,IND submitted
191264,Investigative
163614,Phase 2b
86771,Discontinued in Phase 2b
174867,Phase 1
132205,Discontinued in Phase 4
161326,Discontinued in Phase 1/2
106280,Phase 1/2a
58704,Phase 0
159273,Phase 1/2
187834,Discontinued in Preregistration
167699,Patented
1609,Phase 2
117953,Phase 2/3
9956,IND submitted
116754,Discontinued in Phase 3
86029,Phase 1b
110096,IND submitted
75663,Phase 1/2a
158886,Investigative
2766,Phase 1b/2a
188839,Patented
6884,Discontinued in Phase 2
103370,Phase 0
37946,Phase 1/2
79122,Phase 0
68865,Discontinued in Phase 1/2
26424,Investigative
140386,Phase 1b
139792,Clinical trial
7140,Phase 1b/2a
10803,Preclinical
71921,Phase 0
121182,Phase 2
155642,Phase 2
57117,Phase 1/2a
149883,Phase 1b
165561,Discontinued in Phase 2/3
124046,Phase 0
188936,Phase 1/2
170688,Phase 0
950,Clinical trial
116934,Discontinued in Phase 3
189679,Phase 2/3
12313,Investigative
169875,Phase 1/2a
62970,Phase 1/2a
110551,Phase 1b/2a
104136,Phase 1/2
91334,Discontinued in Preregistration
102019,Investigative
31142,Discontinued in Preregistration
41176,Discontinued in Phase 1/2
86484,Phase 0
175713,Discontinued in Phase 2
346,Discontinued in Phase 2/3
50423,Discontinued in Phase 2b
37284,Phase 2
117556,Discontinued in Preregistration
44047,Phase 2/3
149600,Phase 1
175701,Discontinued in Phase 3
69209,Phase 1
47131,Approved
46759,Discontinued in Phase 2/3
64422,Approved
58019,Phase 2/3
45674,Phase 2/3
183852,Discontinued in Phase 2
32798,Phase 1
121963,Phase 2b
5788,IND submitted
155152,Phase 1/2
2235,Approved
63274,Patented
29511,Clinical trial
23391,Phase 2
20883,Patented
70360,Phase 1
47925,Phase 1
75243,Phase 1/2
123340,Phase 1b
162005,Phase 2a
109761,Phase 3
162542,IND submitted
149145,Phase 1b
95938,Phase 1b
89231,Discontinued in Phase 4
42836,Phase 1b
138739,BLA submitted
17091,Phase 3
42104,Phase 1b/2a
73180,Investigative
111360,Phase 1/2
49194,Phase 1b
15436,Phase 1b/2a
145900,Phase 1b/2a
26581,Phase 1
15221,Phase 1/2
38655,Phase 1
82654,Phase 1
91565,Investigative
36315,Phase 1/2a
56557,Discontinued in Preregistration
170848,Phase 1/2a
185421,IND submitted
134477,Phase 1/2
68384,Phase 2b
187916,Discontinued in Phase 4
135347,Phase 0
56934,Phase 1b/2a
111145,Discontinued in Phase 4
71030,Discontinued in Phase 1/2
107672,Phase 0
104605,Patented
166241,Discontinued in Phase 4
66415,Phase 1b/2a
161991,Patented
50922,Phase 0
41312,BLA submitted
150471,Phase 1b
36607,Phase 0
162611,Phase 1
188215,Patented
81072,Phase 1
53300,Phase 0
7128,Investigative
191045,Phase 1/2
56954,IND submitted
47368,Investigative
26244,Phase 1b
76687,Discontinued in Phase 1/2
175761,IND submitted
15942,Phase 1
12393,Phase 1/2
48610,Phase 0
180704,Phase 2a
37298,Phase 1b/2a
19944,Phase 1
88540,Phase 1/2
160933,Phase 1/2
154332,Investigative
66769,Phase 0
107050,Phase 0
85460,Discontinued in Phase 2b
24,Patented
36962,Discontinued in Phase 3
63327,Phase 0
108010,Discontinued in Phase 4
160308,Phase 0
58465,Discontinued in Phase 1/2
110337,Phase 1b/2a
13180,Investigative
49343,Phase 0
66087,Preregistration
141214,Investigative
59230,Investigative
158653,Phase 1b
139147,Investigative
136721,Phase 1/2
169067,Investigative
79184,Patented
134259,Patented
138375,Approved (orphan drug)
3868,Discontinued in Phase 1
77949,Phase 1/2
113294,Clinical trial
51966,Phase 1b
138518,BLA submitted
65211,Phase 1
62902,Patented
144480,Discontinued in Phase 2/3
4565,Phase 2a
157050,Investigative
132313,IND submitted
95222,Patented
185342,Approved
142396,Patented
26072,Discontinued in Phase 4
83422,Phase 0
59096,Phase 0
180013,Discontinued in Phase 1
21936,Discontinued in Phase 1/2
151325,Phase 0
59612,Approved (orphan drug)
101052,Phase 1b
158844,BLA submitted
1475,Phase 0
165578,Discontinued in Phase 2/3
140116,Phase 1b
96765,Phase 1b
84914,Phase 1b/2a
174845,Phase 1/2
159715,Phase 1b/2a
104264,Patented
141981,Patented
112694,Phase 1/2
131674,Discontinued in Phase 4
107734,Discontinued in Phase 2b
89685,Phase 1b/2a
176942,Phase 0
178038,Phase 2a
174563,Phase 0
118507,Discontinued in Preregistration
16216,Phase 0
151820,Phase 1/2
75780,IND submitted
60233,Phase 1b/2a
149541,Phase 2/3
131662,Phase 1/2
177235,Phase 1/2a
50617,Discontinued in Phase 2/3
106025,Phase 1/2
6032,Phase 2/3
180241,Phase 1
2296,Discontinued in Phase 1/2
104885,Patented
84673,Phase 1/2
13417,Discontinued in Phase 1
97950,Phase 1b
60264,Clinical trial
184023,BLA submitted
19415,Discontinued in Phase 2
102138,Approved (orphan drug)
142830,Discontinued in Preregistration
89361,Phase 1/2
98755,Phase 1/2a
104040,Phase 2
60052,Phase 0
25948,Phase 1b
16532,Phase 1/2a
14849,Phase 0
105331,Phase 1b
30002,Discontinued in Preregistration
16958,Phase 1
150711,Phase 2
154285,Phase 1b/2a
120799,Approved (orphan drug)
63122,Patented
89475,Phase 2/3
87046,Phase 2
28624,Phase 2
26699,Phase 1b
13877,Phase 1/2
12089,Phase 1
51524,Discontinued in Preregistration
27916,Phase 1b
103023,Phase 1/2a
56079,Phase 1
190257,Preclinical
40245,Discontinued in Preregistration
57164,Phase 0
67004,Phase 1/2
83112,Discontinued in Preregistration
102913,Phase 1
165400,Phase 1b/2a
76138,Phase 1b/2a
55780,Discontinued in Phase 3
137954,Discontinued in Phase 2
27002,Phase 1b
181818,Phase 1/2a
23060,Phase 2a
20890,Phase 1/2
170754,Phase 1
66843,Patented
69498,Phase 1
75537,Phase 0
86816,Discontinued in Phase 2b
121766,Phase 2
147704,Phase 1b
119291,Phase 1b/2a
137471,Investigative
140339,Phase 2
4733,Discontinued in Phase 2
128242,IND submitted
166093,Phase 1b/2a
141258,Phase 0
63827,Phase 1b/2a
31537,Phase 1b
60474,Discontinued in Phase 3
143919,Phase 1/2
142999,Discontinued in Phase 1/2
5214,Phase 1b/2a
81648,Approved
67934,Phase 1b
46672,Approved
157880,Clinical trial
180273,Phase 2a
166184,Phase 1b/2a
186582,Phase 0
11631,Phase 1b
98021,Phase 1/2
121461,Approved
54781,Phase 2
161760,IND submitted
164868,Phase 0
132744,Discontinued in Phase 3
169105,Investigative
92373,Phase 2
160382,Phase 2a
4983,Investigative
101947,Phase 0
86236,Phase 0
90092,Clinical trial
144943,Phase 1/2
121237,Phase 1b/2a
124782,Patented
165642,Phase 1b/2a
142259,Discontinued in Phase 1
147866,Patented
155517,Patented
80544,Discontinued in Phase 3
40630,Phase 1
180789,Phase 1/2a
113964,Phase 1b
86838,Patented
1920,Investigative
105977,Phase 2a
8641,Clinical trial
190221,Phase 1/2
171952,IND submitted
154191,Patented
72861,IND submitted
172907,Discontinued in Phase 2
65316,Phase 1b/2a
178446,Phase 1/2
149742,Investigative
175852,Discontinued in Phase 1/2
128578,Phase 1
87474,Discontinued in Phase 1
97897,Phase 2/3
60406,Investigative
65969,BLA submitted
47909,IND submitted
23753,Discontinued in Phase 2/3
53334,IND submitted
6707,Phase 2/3
5511,Phase 1b/2a
39240,Phase 1/2a
121864,Phase 0
40362,Phase 0
130344,Phase 1/2
15425,Phase 0
77541,Discontinued in Preregistration
71776,Discontinued in Phase 1
117361,Investigative
27962,Phase 2
117122,Discontinued in Phase 2b
148558,Investigative
142256,Investigative
163183,Patented
107953,Discontinued in Phase 2/3
123042,Phase 1b
174169,Phase 1/2
110797,Phase 1b
91014,BLA submitted
94714,Phase 1/2a
38493,Investigative
14468,Phase 1
84508,Phase 1/2
76493,Patented
32630,Phase 1
159038,Approved
70078,Phase 2a
186718,Patented
144056,Phase 1/2
162063,Investigative
11253,IND submitted
26905,Phase 1b/2a
115176,Phase 1/2a
96866,Phase 1b
162019,Phase 2
90960,Approved
46966,Approved
33436,Phase 1b/2a
92368,Discontinued in Phase 1
155356,Phase 1
72582,Investigative
88704,Discontinued in Phase 4
109367,Phase 2
173241,Discontinued in Phase 2
50055,Phase 1b/2a
173436,Phase 1/2
81307,Discontinued in Phase 1
12561,Phase 0
146944,IND submitted
14646,Phase 1/2
29673,Discontinued in Preregistration
102934,Approved
33744,Phase 1b
164185,Phase 1/2a
126589,Discontinued in Phase 4
185006,BLA submitted
174039,Phase 2a
61071,Phase 2/3
104433,Phase 0
21882,Approved (orphan drug)
141413,Discontinued in Phase 2b
148539,Discontinued in Phase 2
3629,Investigative
92402,Discontinued in Phase 1
94556,Discontinued in Phase 1
34734,Phase 2a
178891,Phase 1
88792,Phase 1/2
9582,IND submitted
142964,Phase 2/3
28990,Phase 2
29881,Investigative
48897,Phase 3
68012,Phase 1/2a
133425,Approved
45600,Phase 2/3
170394,Phase 0
46132,Phase 1/2a
45413,Phase 1/2a
179936,Phase 1
34947,Phase 1b/2a
11525,Phase 1/2a
6638,Phase 1/2
170564,IND submitted
88973,Patented
169773,Phase 1b
10974,Phase 2a
108854,Phase 1
171239,Phase 1
154072,Phase 1/2a
52444,Phase 1b
22053,Discontinued in Phase 3
122113,IND submitted
57599,Phase 2/3
48682,Discontinued in Phase 2
61483,Discontinued in Phase 1/2
166124,Phase 1b/2a
71054,Discontinued in Phase 1/2
115618,Phase 1b/2a
67728,Phase 0
25469,Phase 2
70040,Phase 0
157613,Patented
160061,Phase 2
16378,Phase 1
69529,Discontinued in Phase 3
15857,Phase 1
93943,Phase 1b/2a
73278,BLA submitted
9877,Phase 0
188959,Approved (orphan drug)
140284,Phase 1/2
25995,Phase 1/2a
171959,Discontinued in Phase 2b
172853,Phase 2a
29951,Investigative
177835,Phase 1b/2a
13384,Phase 1
121365,Phase 1b/2a
22252,Investigative
97348,Phase 2
70542,Phase 1b
170708,Phase 0
107814,Discontinued in Phase 2/3
15527,Discontinued in Phase 1
130839,Phase 1b/2a
6232,Phase 2a
78931,Patented
98608,Phase 2
16947,Phase 1
29288,Phase 0
75563,Phase 0
186592,Phase 1b
163742,BLA submitted
85763,Discontinued in Phase 2b
126053,Phase 1
125584,Phase 1/2
133269,Approved
100797,Phase 1/2a
191678,Phase 0
114061,Phase 1
115562,Discontinued in Preregistration
63426,Phase 1
7667,Discontinued in Phase 3
51661,Discontinued in Preregistration
153769,Phase 2/3
156762,Clinical trial
175345,Phase 2b
126763,Patented
15399,Phase 0
106029,Phase 2
189210,Phase 2/3
126058,IND submitted
12260,Phase 1
94962,Phase 1
166149,Phase 1b
74026,Discontinued in Phase 3
45513,Phase 2/3
107861,Clinical trial
109884,Phase 2
183173,Approved (orphan drug)
66650,Discontinued in Preregistration
74826,Phase 2/3
135941,Preclinical
18444,Phase 3
24371,Phase 1
7158,Phase 1b/2a
188883,Phase 1/2
91414,BLA submitted
66254,IND submitted
1355,Approved
184406,BLA submitted
95563,Phase 1b
111002,Discontinued in Phase 4
13811,Phase 0
40700,Phase 1/2a
50724,Phase 1
108599,Discontinued in Phase 2/3
84372,Phase 1b/2a
123993,Phase 1
71388,Discontinued in Preregistration
103956,Phase 1/2
20651,Phase 1b/2a
172241,Investigative
93328,Phase 2b
119745,Phase 2
103574,BLA submitted
142089,Phase 1b
101475,Discontinued in Phase 3
2210,Discontinued in Phase 2b
30298,Phase 0
111419,Phase 1/2
54084,Discontinued in Phase 2/3
69966,Patented
84948,Phase 1/2
184783,Phase 0
113236,Clinical trial
89570,Phase 1
140115,Investigative
180382,Phase 1
151428,Phase 1b/2a
132545,Discontinued in Preregistration
42150,Phase 1b
23588,Phase 1
132802,Discontinued in Phase 1/2
84615,Phase 0
123890,Phase 0
1349,Approved
156103,Discontinued in Phase 3
60990,Phase 1/2
76003,Phase 1/2
107939,IND submitted
144470,Phase 3
77852,Phase 0
152026,Phase 1b/2a
5221,IND submitted
107095,Phase 1/2a
99893,Phase 1b
85953,Discontinued in Preregistration
117200,Discontinued in Phase 3
102895,Application submitted
154089,Investigative
32809,Phase 2
65750,Phase 1
146255,Discontinued in Phase 1
183635,Phase 1b/2a
96519,Discontinued in Phase 1/2
177222,Phase 2
41408,Phase 2
167257,Discontinued in Phase 1
5255,Discontinued in Phase 2
182143,Discontinued in Phase 2b
185941,Phase 1
35565,Discontinued in Phase 3
71520,Phase 0
137238,Phase 1b
125250,Phase 1b/2a
159711,Phase 1b
45619,Phase 1/2a
63254,Patented
9988,Phase 1
163282,Phase 1b/2a
22949,Phase 2a
26206,Phase 1b/2a
20943,Phase 0
25964,Discontinued in Phase 4
32870,Phase 1b/2a
19897,Discontinued in Phase 2b
4751,Discontinued in Phase 2
67826,Phase 1b
50979,Phase 1/2
186284,Phase 2b
186404,Phase 2b
112996,Phase 1b
37640,Discontinued in Preregistration
186137,Phase 1b/2a
142776,Phase 1b/2a
82128,Clinical trial
107506,Phase 1/2a
172714,Discontinued in Phase 2b
87965,Discontinued in Phase 2
77954,Registered
161545,Phase 2a
137816,Phase 1/2a
48329,Discontinued in Preregistration
75745,Phase 0
68664,Phase 2b
98968,Patented
179598,Phase 0
61237,Phase 1
108489,Discontinued in Phase 2/3
88228,Phase 0
12115,Phase 1/2
15179,Phase 1/2a
49867,Discontinued in Phase 2/3
42541,Phase 1
27913,Discontinued in Phase 1
164096,Phase 1/2a
125972,Phase 1b/2a
97635,Phase 1/2a
119228,Phase 2b
143987,Phase 0
92032,Phase 1b
48306,Discontinued in Phase 2b
58228,Phase 0
58957,Phase 0
5578,Preregistration
189880,Phase 2b
84022,Phase 1/2
148048,Phase 2b
94689,Phase 1b
156629,Phase 1b/2a
145069,Discontinued in Phase 2
180980,Phase 1/2
176347,Phase 1b
95372,Phase 1/2a
150534,Phase 0
188317,Clinical trial
140331,Discontinued in Phase 2
132687,Discontinued in Phase 4
31348,Phase 0
155162,Phase 1b
149341,Clinical trial
23740,Discontinued in Phase 2b
161759,Phase 2
55856,Discontinued in Phase 2b
183348,Phase 1/2
33053,Phase 1b/2a
6850,IND submitted
6088,Phase 2/3
60074,Discontinued in Phase 3
110264,Phase 1b/2a
42704,Phase 1/2
43895,Phase 2/3
74940,Phase 1/2a
67982,Phase 2a
112713,Phase 0
58477,Phase 1b/2a
117338,Discontinued in Phase 2/3
43544,Phase 2/3
41639,Phase 1/2a
170636,Phase 1/2
121112,Phase 2a
31775,Phase 1
173336,Phase 1
186958,Patented
142022,Patented
21354,Phase 2a
100842,Phase 1/2a
71897,Phase 0
21266,Phase 1b
126517,Discontinued in Phase 4
83163,Patented
132731,Phase 1b/2a
131547,Phase 1/2
184058,BLA submitted
173103,Phase 2
79727,Phase 1b
44027,Phase 1/2a
66179,Phase 0
144884,Phase 2b
144628,Phase 0
32457,Phase 1/2
55102,IND submitted
114511,Phase 0
29366,Phase 1b
7428,Phase 1b/2a
187302,Phase 0
145966,Discontinued in Phase 2
151773,Phase 1
144104,Phase 1/2
13684,Phase 1
173355,Phase 2
166891,Phase 2
147175,Discontinued in Phase 2
9784,Phase 1/2
18588,Discontinued in Phase 2/3
26453,Phase 1b
169733,Phase 1b/2a
43424,Phase 2/3
46985,Approved
69481,Discontinued in Phase 3
145973,Phase 1
133470,Phase 1
149111,Discontinued in Phase 2/3
77512,Patented
135443,Phase 0
143155,Investigative
13921,Phase 2b
112331,Discontinued in Phase 3
120406,Approved (orphan drug)
76492,Patented
90919,Investigative
34760,Phase 1b/2a
109647,Discontinued in Preregistration
47716,Discontinued in Preregistration
145453,Phase 1/2a
30965,Phase 1
103482,Phase 1/2
180961,Phase 1/2a
35018,Phase 2
53473,Discontinued in Phase 2/3
9104,Discontinued in Phase 2/3
99098,Patented
22760,Phase 0
156453,Phase 1
144849,Phase 2b
76650,Discontinued in Preregistration
181591,Phase 1
20705,Phase 1b/2a
127417,Discontinued in Phase 4
170014,Investigative
175536,Discontinued in Phase 4
49056,Discontinued in Phase 2b
21939,Discontinued in Phase 3
173230,Phase 2a
109033,Discontinued in Phase 2
95123,Discontinued in Phase 4
159558,Phase 1/2
134100,Phase 1/2a
169077,Discontinued in Phase 2
63115,Phase 1b
52834,Phase 0
145067,Discontinued in Phase 2/3
38873,Phase 2
100993,Phase 3
175072,Phase 2
67906,Phase 1/2a
91888,Phase 1/2
186358,Patented
151034,Phase 2
12874,Phase 1/2
104409,Phase 1/2a
30662,Discontinued in Preregistration
112684,Phase 1
53085,Investigative
180404,Phase 2a
175239,Discontinued in Phase 4
108629,Discontinued in Phase 1
156354,Phase 1b/2a
169626,Phase 3
41451,Phase 1b/2a
52097,Phase 1b/2a
68819,Phase 1
122750,Phase 0
172699,Discontinued in Phase 2/3
22956,Phase 1b
34744,Phase 1/2
155267,Phase 2a
63644,Discontinued in Phase 2/3
147857,Phase 2a
147881,Phase 2b
19294,Discontinued in Phase 3
29758,Phase 0
95083,Phase 1b/2a
97690,Phase 1b
11818,Discontinued in Preregistration
46092,Phase 1/2a
25034,Phase 1/2a
144043,Phase 0
101869,Phase 2
69318,Phase 1
25182,Phase 1/2a
95032,Patented
113599,Discontinued in Preregistration
47192,Phase 4
182933,Phase 1
67777,Phase 1
180520,Phase 1b/2a
123024,Phase 1
40131,Investigative
183752,IND submitted
51498,IND submitted
11293,Patented
6064,Phase 4
16531,Phase 1
9776,Preclinical
169111,Clinical trial
104426,Patented
73976,Discontinued in Phase 4
24399,Phase 1b
49564,Phase 1/2a
113803,Phase 1
907,Phase 0
163088,Patented
13554,Phase 1
97490,Phase 1b/2a
8080,Phase 0
156662,Phase 1b/2a
125588,Discontinued in Phase 3
85127,Phase 1/2a
69487,Phase 1b
180348,Discontinued in Phase 4
106666,Phase 1/2a
177716,Phase 1b
118531,Phase 2/3
169559,Discontinued in Phase 2/3
88986,BLA submitted
157270,Discontinued in Phase 1/2
161487,Discontinued in Preregistration
165128,Phase 0
176717,Discontinued in Phase 4
119374,Phase 2b
108655,BLA submitted
179735,Phase 1
98501,Phase 1b
163020,Discontinued in Preregistration
73443,Clinical trial
172509,Phase 1/2
33829,Discontinued in Preregistration
118365,Discontinued in Phase 1/2
55136,Phase 0
175615,Phase 2b
138529,Approved (orphan drug)
90875,BLA submitted
171058,Phase 1/2a
161684,Patented
121494,Phase 1b/2a
38474,Phase 2
30687,Phase 1b/2a
149918,Phase 1b
176642,Phase 0
186830,Phase 2a
59347,Phase 1
40678,Phase 2/3
158654,Phase 1b/2a
26079,Phase 1/2a
164121,Phase 1/2
74396,IND submitted
127664,Phase 0
141822,Discontinued in Preregistration
42673,Discontinued in Phase 2/3
49772,Phase 1
93096,Phase 1/2
87011,Discontinued in Phase 2b
168417,Phase 0
141776,Investigative
72942,IND submitted
80450,Phase 2
105505,Phase 1
81713,Phase 1
15442,Phase 0
37597,Phase 0
90641,Discontinued in Phase 2b
152404,Patented
175397,Phase 0
4120,Preregistration
28248,Discontinued in Phase 4
168627,Discontinued in Phase 1/2
149984,Phase 2/3
49610,IND submitted
156519,Phase 1b
29395,Phase 1b/2a
74023,IND submitted
29461,Phase 1b/2a
87242,Phase 1
90946,Phase 1b
88818,Phase 1
38885,IND submitted
89608,Phase 1
49252,Discontinued in Phase 3
164754,Phase 1/2
54246,Patented
61671,Discontinued in Phase 2b
111783,Patented
66682,Patented
66219,Investigative
89437,Phase 1/2a
154773,Phase 2
24904,Phase 1
149321,Phase 2/3
18309,Phase 2a
113845,Phase 1
154345,Patented
74420,Discontinued in Phase 4
167968,Patented
146173,Phase 1b/2a
23630,Discontinued in Phase 4
187536,Phase 2a
47792,Phase 0
122049,Approved
91046,Clinical trial
99008,Phase 1/2a
91548,Phase 2/3
140388,Phase 1/2a
131233,Discontinued in Phase 3
11137,Investigative
2901,Investigative
48626,Phase 1b/2a
191469,Patented
171241,Phase 0
2645,Phase 1b/2a
16649,Phase 1
1947,Approved
156625,Patented
138062,Phase 1/2a
158894,Clinical trial
191812,Phase 1
66166,Discontinued in Phase 1
2948,Phase 1b
31481,Investigative
152322,Approved (orphan drug)
94300,Discontinued in Phase 3
108189,Phase 1b/2a
86924,Phase 1/2
79359,Phase 2
141686,Patented
145792,Clinical trial
25260,IND submitted
17793,Phase 1/2
73196,Investigative
26863,Phase 1/2
89739,Phase 0
96669,Investigative
104903,Phase 1b/2a
191888,Phase 2a
46938,Phase 1/2a
180758,Discontinued in Phase 2
99995,Phase 1
182575,Phase 2b
54890,Phase 1b/2a
62914,Discontinued in Phase 4
132892,Phase 0
18594,Discontinued in Phase 4
184199,Discontinued in Phase 4
88438,Discontinued in Phase 4
188960,Approved (orphan drug)
61164,Phase 1b
61626,Discontinued in Phase 2b
96068,Phase 0
162647,Phase 2
141521,Phase 2/3
113563,Phase 1
668,Phase 1/2a
143839,Discontinued in Phase 1/2
12459,Phase 1b/2a
129056,Phase 0
135485,Phase 0
47894,IND submitted
85480,Discontinued in Phase 3
88735,Phase 1
8839,Approved
95188,Patented
111361,Discontinued in Phase 4
175678,Phase 1
56511,IND submitted
106677,Discontinued in Phase 2b
132276,Phase 0
183231,IND submitted
113324,Phase 1b/2a
150035,Phase 1b
78158,Approved (orphan drug)
15513,Phase 1
58395,Phase 1
54562,Discontinued in Phase 2b
67854,Phase 1
165558,Phase 0
101363,Phase 1b/2a
86662,Investigative
77187,Phase 0
43648,Phase 2/3
185454,Phase 1/2a
52853,Phase 2
100129,Phase 1
89977,Phase 0
189350,Approved (orphan drug)
10635,Discontinued in Phase 2/3
20408,Phase 1
6129,Investigative
100200,Discontinued in Phase 1/2
70297,Phase 1
125958,IND submitted
131839,Phase 1b/2a
166011,Phase 2
41193,Discontinued in Phase 1/2
12516,Phase 1
183973,Phase 1/2
134582,Phase 1/2
142653,Phase 1b/2a
60714,Investigative
135876,Phase 1b/2a
155482,Phase 2
185402,Approved
171105,Patented
125039,Phase 1/2
105893,Phase 2a
81390,Phase 1b
138535,BLA submitted
62917,Discontinued in Phase 3
45005,Phase 1/2a
35257,Discontinued in Phase 3
135867,IND submitted
6121,IND submitted
167217,Phase 4
94441,Phase 1b
190830,Phase 1b
139788,BLA submitted
182841,Phase 1
60416,Phase 0
63493,Phase 1b/2a
178869,Phase 0
71628,Phase 0
163258,Phase 1/2
4650,Investigative
72852,Investigative
139801,Phase 1/2a
173701,Phase 2a
54621,Phase 2
10233,Phase 1b/2a
115803,Clinical trial
108242,Phase 1b
122601,Phase 1/2
54809,Discontinued in Phase 2/3
87831,Discontinued in Phase 3
174691,Discontinued in Phase 1/2
163413,Phase 1/2
13089,Phase 1/2
91598,BLA submitted
77678,Phase 1/2
96449,Discontinued in Phase 1/2
117325,Clinical trial
122130,Discontinued in Phase 4
189602,Phase 1b
158438,Phase 1
53423,Phase 0
167310,Discontinued in Preregistration
41484,Phase 1b/2a
26148,Discontinued in Preregistration
154186,Phase 1/2a
140593,Phase 1b/2a
169068,Phase 1b/2a
80010,Discontinued in Phase 1/2
106360,Phase 0
22687,Investigative
11134,Discontinued in Phase 2/3
179186,Discontinued in Phase 3
26577,BLA submitted
86506,Phase 2
89833,Discontinued in Preregistration
64723,Clinical trial
43111,Phase 1b/2a
161304,Investigative
37853,Phase 0
56183,Phase 1b
18076,Phase 3
149928,Phase 1/2a
272,Phase 1/2a
140372,Investigative
12555,Phase 1b/2a
90711,Phase 2a
82502,Phase 1
78133,Approved (orphan drug)
5292,Investigative
105917,Phase 2/3
94685,Patented
7922,Clinical trial
181099,Phase 1b/2a
108259,Investigative
86804,Phase 1/2
114208,Phase 1/2a
151259,Phase 1/2
79358,Phase 2
36898,Phase 1b/2a
113771,Phase 1/2
14513,Phase 1
188986,Approved (orphan drug)
128894,Phase 1/2
137352,Phase 2
140997,Patented
29115,Phase 1/2a
33549,BLA submitted
70272,Phase 0
123247,Phase 2
125676,BLA submitted
38081,Phase 1b
122502,Phase 1/2
131171,Phase 0
75953,Phase 0
55911,Phase 1b
105736,Investigative
146853,Discontinued in Preregistration
91437,Phase 1b
143450,Phase 2b
172964,Discontinued in Phase 2
86551,Phase 2
171006,Phase 1
28798,Phase 1/2a
48882,Phase 0
105601,Phase 1b/2a
15886,Phase 0
171954,Patented
114469,Phase 2
40397,Phase 2
14693,Phase 1
119001,Phase 1b/2a
115949,Clinical trial
108907,Phase 4
63358,Discontinued in Phase 3
122361,Discontinued in Phase 4
135760,Preclinical
127451,Discontinued in Preregistration
64780,Discontinued in Phase 2b
74249,Phase 2
168660,Discontinued in Phase 1/2
73144,Phase 1
133606,Phase 1
169249,Discontinued in Phase 1/2
43039,Patented
144041,Phase 1/2
103183,IND submitted
54044,Phase 1/2
138687,Phase 1b
20035,IND submitted
100411,Phase 1
158629,Phase 1b
135925,Phase 2/3
3491,Investigative
7083,Investigative
11298,Discontinued in Phase 4
99169,Phase 1
152234,Phase 2
54589,Phase 1
162693,Phase 1/2a
121065,Phase 0
122515,Phase 1b
129519,Investigative
183499,Phase 1b
149827,Discontinued in Phase 2
139967,BLA submitted
36611,Discontinued in Phase 2
92023,Phase 1b
141697,Phase 0
173596,BLA submitted
106789,Discontinued in Phase 2b
32187,Phase 1/2a
145115,Phase 1
12174,Phase 1/2
116246,Phase 1/2
75384,Investigative
164990,Phase 2
114162,Phase 1
171547,Phase 1/2
26382,Phase 2
110098,IND submitted
134864,Phase 0
151994,Phase 2a
179077,Phase 0
100621,Investigative
39196,Phase 1b
112929,Phase 0
119563,Approved
74641,Phase 1/2
181481,Phase 1
166485,Phase 1
61796,Discontinued in Phase 4
94156,Phase 1/2a
177207,Phase 1b
139043,BLA submitted
25565,Discontinued in Phase 2/3
89793,Investigative
62562,Patented
68203,Phase 3
19936,Phase 1
161061,Phase 1/2a
139433,Investigative
188292,IND submitted
174725,Phase 0
132785,Discontinued in Phase 1/2
129186,Phase 1/2
93885,Phase 2
40870,IND submitted
43350,Phase 1/2a
36583,Phase 1b/2a
190587,Phase 1/2
7095,Phase 1b/2a
10031,Phase 1/2
70840,Phase 1/2a
30445,Discontinued in Phase 1
95456,Phase 2a
84601,Phase 0
74306,Discontinued in Phase 3
103684,Phase 2a
80429,Phase 2a
157879,Discontinued in Phase 4
37560,Phase 2
87341,Phase 1/2a
188979,Phase 1/2
188729,Phase 1b/2a
29488,Phase 1/2a
4795,Preregistration
82304,Discontinued in Preregistration
28586,Phase 1b
78849,Phase 2a
152402,Investigative
57516,Phase 1/2a
153751,Investigative
130939,Patented
66775,Phase 1b/2a
41168,Discontinued in Phase 4
186091,Phase 0
104118,Discontinued in Phase 4
6739,Phase 4
33366,Phase 2/3
104498,Discontinued in Phase 4
165431,Discontinued in Phase 4
169671,Discontinued in Phase 2/3
93562,Phase 2b
10893,Phase 1
32705,Patented
4790,Phase 2a
84873,Phase 1/2
98704,Discontinued in Phase 2b
59952,Phase 1/2a
159475,Phase 0
186851,Patented
86592,Discontinued in Phase 4
134310,Phase 1/2a
135068,Phase 0
107479,Phase 0
68501,Discontinued in Phase 4
21269,Phase 2
12217,Investigative
5985,Investigative
119637,Discontinued in Phase 2b
186642,Phase 0
133924,Phase 1/2
140353,Phase 1/2a
165686,Patented
91108,Phase 0
74795,Phase 1/2
188449,Phase 0
107201,Phase 1/2
97621,Investigative
36016,Phase 1b
103348,Phase 1b
126153,Phase 1
14781,IND submitted
147364,Phase 1/2a
180160,Phase 2/3
60916,Phase 0
190029,Phase 1b/2a
190192,Phase 2b
145050,Phase 1b
136592,Investigative
163949,Phase 1
84646,Phase 0
167085,Phase 4
57647,Discontinued in Phase 2/3
176701,Phase 2b
19778,Phase 0
52119,Phase 1/2a
32010,Phase 2
92204,Phase 1b/2a
58067,Discontinued in Phase 2/3
127296,Phase 1
104346,Patented
81844,Approved
54323,Phase 1/2a
145943,Discontinued in Phase 1
105411,Phase 2b
63578,Discontinued in Phase 2
61168,Phase 1
171113,Phase 1
47707,Investigative
128457,IND submitted
61996,Discontinued in Phase 2b
159848,Phase 1
190639,Phase 1/2
139826,Approved (orphan drug)
182959,Phase 2
21411,Phase 2
99726,Patented
146833,Phase 2
39861,Patented
48477,Phase 1b/2a
74956,Discontinued in Phase 2b
11785,Phase 1/2
142716,Phase 2b
88720,Phase 1
145761,Discontinued in Preregistration
85439,Discontinued in Phase 2b
149357,Discontinued in Phase 2
112572,Discontinued in Phase 3
34801,Discontinued in Phase 3
150725,Phase 0
170846,Phase 1/2
190418,Phase 1/2
90689,Preclinical
60631,Phase 1
44510,Phase 1/2a
106006,Phase 1b/2a
97178,Phase 2
85188,Phase 2b
171654,Discontinued in Phase 2b
106873,Discontinued in Phase 2b
181493,Discontinued in Phase 2b
118780,Phase 2a
46941,Phase 2
120645,Discontinued in Phase 4
181219,Phase 1b/2a
155554,Phase 2a
107872,Phase 1
92242,Registered
18238,Phase 2
98003,Phase 1/2a
181973,Phase 2a
122857,Phase 1/2
145179,Investigative
51392,Phase 1/2
83004,Phase 2
51586,Phase 2
2212,Preclinical
39811,Patented
78559,Phase 3
2097,Phase 2
115057,Discontinued in Phase 2
22954,Discontinued in Phase 4
77933,Phase 1/2
15646,IND submitted
140341,Phase 1b
79802,Phase 1b/2a
61045,Phase 1b/2a
126972,Phase 1
150048,Phase 2/3
78560,Phase 1b
148246,Investigative
39043,Investigative
10409,Discontinued in Phase 2b
42569,Discontinued in Phase 2b
10139,Discontinued in Phase 2b
148536,Phase 1b/2a
3818,Investigative
29895,Phase 1
8512,Phase 1
155693,Phase 2
33037,Phase 1/2
130310,Phase 1/2
61256,Phase 1
187245,Phase 2b
66707,Phase 0
57025,Phase 2
108426,Phase 1/2a
125281,IND submitted
69225,Discontinued in Phase 1/2
48644,Discontinued in Phase 2/3
32101,Phase 2/3
62720,Patented
1101,Clinical trial
92226,Phase 2b
153088,IND submitted
178098,Phase 1/2
79730,Discontinued in Phase 1/2
28315,Phase 1/2a
67699,Phase 1
10109,Phase 1/2
31319,Phase 1b
11674,Discontinued in Preregistration
42844,Investigative
53073,Discontinued in Phase 4
66437,Discontinued in Phase 2/3
131834,Phase 1b/2a
181357,Discontinued in Phase 2
127840,Phase 1b/2a
105780,Phase 0
57761,Phase 1/2a
125775,Phase 1b/2a
85328,Discontinued in Phase 2b
116181,Clinical trial
32385,Phase 2a
57746,Investigative
138193,Phase 1/2a
150577,Phase 1/2
134858,Phase 0
92978,Discontinued in Phase 3
139254,Approved (orphan drug)
162284,Phase 1b/2a
86545,Discontinued in Phase 2
146095,Phase 1b/2a
34641,Phase 1
86224,Investigative
149031,Phase 1/2a
190582,Phase 2b
103303,Phase 1/2a
119041,Phase 2a
115542,Approved (orphan drug)
64842,Phase 1
73649,Phase 1/2a
21433,Phase 1b/2a
169275,Phase 1
10584,Phase 1b/2a
143780,Phase 2/3
108275,Investigative
96533,Discontinued in Phase 1/2
138987,Phase 1/2a
55722,Phase 1b
151362,Phase 0
78616,Phase 0
59173,Investigative
183116,Phase 1b/2a
18169,Phase 2
114407,IND submitted
154264,Phase 1/2a
135316,Phase 0
156808,Phase 1/2
70679,Phase 2
45405,Phase 1/2a
16549,Phase 1
101710,Phase 1b
141901,Discontinued in Preregistration
35427,Phase 1/2
25423,Phase 1b/2a
41645,Investigative
22676,Phase 1/2
77830,Investigative
139125,Investigative
111803,Phase 1/2
192111,Phase 1/2
51820,Phase 3
72340,Phase 1b/2a
151009,Phase 1
49624,Phase 1/2
104133,Phase 0
189633,Preclinical
121081,Phase 1b
112440,Discontinued in Phase 3
177173,Discontinued in Phase 4
117237,Phase 2
19141,Phase 0
155284,Discontinued in Preregistration
184903,Phase 0
140097,BLA submitted
144097,Phase 1/2
93055,Investigative
109629,Phase 3
67297,Discontinued in Phase 1
88214,Patented
176295,Phase 2/3
182455,Phase 2a
14801,Phase 1
159155,Phase 1
137200,Phase 1/2a
188101,Discontinued in Phase 2/3
1328,Discontinued in Phase 2
166297,Discontinued in Phase 1/2
175811,Discontinued in Phase 3
87832,Phase 0
124868,Phase 1
101278,Phase 3
122432,Phase 1/2
157501,Registered
109966,Phase 1b
67679,IND submitted
717,Phase 2
162538,IND submitted
98302,Phase 1b/2a
52645,Phase 1b
57636,Phase 1b
178731,Phase 1/2
77791,Discontinued in Phase 2/3
90498,Discontinued in Preregistration
28507,Phase 1/2a
125790,Phase 1b/2a
101623,Phase 2a
10797,Discontinued in Phase 3
49309,Phase 1b/2a
120369,Phase 4
188239,Clinical trial
119104,IND submitted
14875,Phase 1
25111,Phase 1
27542,Phase 0
64310,Phase 1
59851,Phase 1
80118,BLA submitted
179496,Phase 0
69513,Discontinued in Phase 1/2
663,Approved (orphan drug)
94095,Investigative
136234,Phase 1/2a
5701,Phase 2a
32869,Phase 1/2
75337,Phase 1/2a
54829,Discontinued in Preregistration
141231,Discontinued in Phase 4
141571,Patented
43372,Phase 1/2a
111830,Phase 1b
33716,Phase 1/2a
77908,Phase 1b
12019,Phase 1/2
37873,Phase 0
26257,Discontinued in Phase 4
170897,Phase 0
110290,Phase 1/2a
61526,Phase 1
3900,Phase 0
63989,Phase 2a
50694,Discontinued in Phase 3
169028,Discontinued in Phase 3
140874,Phase 3
123766,Phase 0
130,Phase 2
163161,Phase 1/2a
23548,Phase 1b
164495,Phase 1/2
63826,IND submitted
22905,Phase 0
48405,Patented
24538,Phase 2
126025,Phase 1b/2a
151550,Phase 2
143606,Investigative
108816,Phase 1/2a
137366,Phase 1/2a
183599,Phase 2a
22749,Phase 1/2a
178384,Discontinued in Phase 1
43452,Phase 1/2a
161595,Phase 1/2a
32449,Phase 1/2
39884,Phase 0
69957,Patented
1748,Phase 2
29897,Discontinued in Phase 2b
167108,Phase 1/2a
29883,Discontinued in Preregistration
9493,Patented
132156,Discontinued in Phase 2b
99916,Phase 1
161954,Investigative
39576,Discontinued in Preregistration
152967,Investigative
66165,Discontinued in Phase 4
3740,Discontinued in Preregistration
142882,Discontinued in Preregistration
73265,Discontinued in Phase 3
81878,Phase 1/2
190801,Patented
76711,Phase 1/2a
135371,Phase 0
170591,Phase 1b/2a
6672,Phase 1b/2a
21917,Phase 1b/2a
59252,Phase 1/2a
26722,Phase 1b
24340,Phase 1/2a
62558,Discontinued in Phase 3
125493,Phase 1/2
183665,Phase 1b/2a
90181,Phase 1b
49312,Phase 1b
103817,Discontinued in Phase 2b
85081,Phase 0
35432,Phase 0
58353,Discontinued in Phase 1/2
187519,Preclinical
92594,Approved (orphan drug)
182486,Phase 1b
121452,Phase 1
76771,Phase 0
16802,Phase 3
145594,Investigative
69081,Discontinued in Phase 1/2
103544,Phase 1/2a
154888,Phase 3
189970,Phase 4
120057,Phase 0
58030,Discontinued in Phase 3
150177,Discontinued in Phase 2
157415,Discontinued in Phase 1/2
18036,Discontinued in Phase 2/3
46480,Phase 1/2
70137,Phase 1b
67217,Discontinued in Phase 1
24419,Discontinued in Phase 2/3
39100,Phase 1/2a
66749,Phase 0
97219,Phase 1/2a
96358,Discontinued in Phase 3
94341,Phase 2b
72426,Phase 2
68507,Phase 1
50503,Phase 1/2
125332,Phase 1b/2a
139291,Phase 1b
109813,Phase 1
35108,Phase 1
161393,Investigative
77398,Phase 2/3
131202,Phase 2/3
75919,Investigative
165170,Phase 2
75878,Phase 1b/2a
119811,Discontinued in Phase 1/2
135017,Phase 0
120965,Phase 1/2a
125533,Phase 1
18623,Phase 1b
188372,Phase 2b
189950,Phase 1/2
12784,Phase 1
162720,Phase 1b
122216,Phase 1b
185818,Patented
155304,Phase 1/2a
178668,Discontinued in Phase 2/3
162598,Discontinued in Phase 4
134957,Phase 0
32211,Phase 3
19548,IND submitted
12905,Phase 1
146003,Discontinued in Phase 2
58244,Phase 1/2a
63781,Approved (orphan drug)
185193,Discontinued in Phase 4
155429,Phase 1
11730,Phase 1
172600,Phase 2a
140594,Phase 3
103157,Investigative
132265,IND submitted
20673,Phase 1b/2a
124411,Phase 1
99727,Patented
22111,Discontinued in Phase 4
138497,BLA submitted
189405,Phase 1b/2a
134332,Discontinued in Phase 4
166983,Discontinued in Phase 1
71007,Discontinued in Phase 3
45479,Phase 2/3
131276,Phase 1/2
160269,Discontinued in Phase 1/2
81621,Phase 1
134561,Phase 1/2
44336,Phase 2/3
65384,Phase 2
34331,Phase 1/2a
132778,Discontinued in Preregistration
84029,Discontinued in Preregistration
88058,Phase 2/3
82303,Phase 0
167777,Discontinued in Phase 2
35877,Phase 2a
63960,Phase 1/2a
74835,Phase 0
3206,Phase 0
43922,Phase 2/3
81126,Phase 1b
128831,Discontinued in Preregistration
27155,Phase 1b/2a
120238,Approved (orphan drug)
159118,Phase 2
24660,Phase 2/3
10249,Investigative
74142,Phase 1/2a
5406,Investigative
24317,Phase 2
191208,Phase 1/2
259,Phase 1
22910,Phase 2
73053,Phase 2a
21435,Phase 2
76675,Patented
67417,Discontinued in Phase 1
123435,Phase 1/2
134961,Phase 0
107017,Phase 1/2a
36559,Discontinued in Preregistration
160281,Discontinued in Phase 1/2
21643,Discontinued in Phase 2
108560,Investigative
91350,Clinical trial
84517,Phase 1/2a
180580,Phase 1/2
184576,Phase 0
21584,Investigative
148408,Phase 1/2a
125309,Discontinued in Phase 4
160122,Phase 1b/2a
142854,Discontinued in Preregistration
30186,Phase 2
161647,Discontinued in Preregistration
29994,Discontinued in Phase 3
67146,Phase 0
134402,Discontinued in Phase 4
63106,Phase 1
85660,Discontinued in Phase 2b
118035,Phase 2
181870,Phase 1b/2a
34626,Phase 0
181384,Phase 1
102730,Investigative
189767,Phase 1/2
110111,Discontinued in Phase 2/3
153155,Phase 1b/2a
139635,BLA submitted
176129,Phase 0
96283,Discontinued in Phase 1/2
134517,Phase 1
22455,Investigative
157459,Phase 1
75232,Phase 2
135474,Phase 0
61016,Phase 1/2a
90198,Clinical trial
130292,Phase 2b
160731,Phase 0
29957,Discontinued in Phase 2b
83987,Discontinued in Phase 2/3
170272,Patented
141551,IND submitted
183093,Discontinued in Phase 2b
66019,Discontinued in Phase 2
155680,Approved
90194,IND submitted
73805,Phase 1/2a
159124,Investigative
138915,BLA submitted
53214,IND submitted
4290,Investigative
174030,Phase 2a
45694,Phase 1/2a
36631,Phase 1
112065,Phase 0
64670,Discontinued in Phase 2b
41430,Phase 2
74014,Phase 1b
147089,Phase 1/2
24515,Phase 1/2a
97721,Phase 1/2a
47411,Discontinued in Preregistration
151658,Phase 1/2
143025,Phase 1b/2a
125476,BLA submitted
138958,BLA submitted
93331,Phase 2b
102066,Approved
16904,Phase 1/2
80612,Approved (orphan drug)
143860,Discontinued in Phase 3
144596,Discontinued in Phase 2/3
66049,Discontinued in Phase 3
74134,Phase 1/2a
44359,Phase 2/3
73800,Phase 2/3
54982,IND submitted
75889,Phase 1/2a
48199,Phase 0
152243,Phase 0
144254,Phase 3
65096,Phase 2
63551,Approved
38129,Phase 0
1271,Patented
117015,Discontinued in Phase 2b
59547,Phase 2/3
121671,Phase 2
170004,Discontinued in Preregistration
120448,Clinical trial
108421,Phase 1b
112968,Discontinued in Phase 3
68193,Discontinued in Phase 1/2
24472,Discontinued in Preregistration
73344,Phase 2/3
165288,Phase 0
156539,Preclinical
79573,Clinical trial
7530,Investigative
134035,Patented
8796,Discontinued in Preregistration
39651,Discontinued in Preregistration
117841,Phase 2b
180754,Phase 2a
186559,Preclinical
104084,Patented
72157,Discontinued in Preregistration
18175,Discontinued in Preregistration
85588,Discontinued in Phase 2b
35815,Discontinued in Phase 2b
86595,Phase 1b
177869,Phase 1b/2a
55100,Discontinued in Phase 3
19136,Phase 1
144693,Patented
83856,Discontinued in Phase 2
115370,Phase 1/2a
164881,BLA submitted
66110,Phase 2a
153991,Phase 1/2a
63241,Patented
174266,Phase 0
33872,Investigative
1489,Discontinued in Phase 2/3
116636,Discontinued in Preregistration
128284,Phase 0
39511,Investigative
63710,Phase 0
123650,Phase 0
41555,Phase 1
154576,Phase 3
12543,Phase 1
58796,Phase 1
5305,Phase 2/3
136591,Phase 1/2
6252,Investigative
105675,Phase 1
143493,Phase 2
19254,Discontinued in Phase 3
173952,Discontinued in Preregistration
126403,Phase 1b
187960,Phase 1b
113517,Phase 1b/2a
182480,Phase 1/2
154740,Phase 2/3
165541,Discontinued in Phase 4
112207,Discontinued in Phase 2
57127,Phase 1b/2a
168876,Discontinued in Phase 3
27698,Phase 1b/2a
110591,Phase 1/2
186432,Phase 0
155866,Phase 1b
11155,Phase 1/2a
140466,Phase 2a
161314,Investigative
42341,Phase 1/2a
185364,Discontinued in Phase 1
103992,Phase 0
139526,BLA submitted
169650,Discontinued in Phase 2/3
41056,Discontinued in Phase 1/2
116553,Phase 1
148107,Phase 1b/2a
23726,Phase 2a
85384,Discontinued in Phase 3
59911,Phase 2/3
121948,Approved (orphan drug)
11597,Phase 1/2
181063,Phase 3
154851,Phase 1b/2a
83783,Discontinued in Phase 4
41458,Discontinued in Preregistration
160190,Phase 1b/2a
134539,Patented
190951,Discontinued in Phase 1
105828,Discontinued in Phase 4
147887,Phase 2b
128589,Phase 0
180720,Phase 1b/2a
24525,Phase 1/2a
56852,Phase 3
175188,Discontinued in Phase 3
81919,Clinical trial
177705,Phase 1b
26750,Phase 1/2a
86897,Patented
167727,Phase 1b/2a
118078,Phase 1/2a
45991,Phase 2/3
75114,Phase 1/2
2510,Phase 1b/2a
93728,Discontinued in Phase 3
52977,Phase 4
91030,Discontinued in Preregistration
160483,Phase 1
147171,Phase 1b/2a
25345,Phase 1b/2a
136789,Discontinued in Phase 2
43877,Phase 1/2a
126172,Phase 1b/2a
123892,Patented
50807,Phase 1b/2a
19882,Phase 1
72555,Investigative
26195,Discontinued in Phase 2/3
78233,Phase 1/2
153931,IND submitted
41004,Investigative
27585,Phase 1b
32040,Phase 1/2a
82063,Phase 1b/2a
87672,Phase 0
53293,IND submitted
176763,Phase 1/2
139617,Clinical trial
24178,Phase 2/3
50258,Phase 1b/2a
43777,Phase 2/3
132017,Discontinued in Phase 2b
77827,Discontinued in Phase 2/3
147443,Phase 1b/2a
130203,Phase 1b/2a
136674,Discontinued in Phase 2b
79592,Discontinued in Phase 3
15912,Discontinued in Phase 1
106336,Phase 0
134443,Phase 1/2
98664,Phase 2
160465,Phase 1
191607,Phase 1/2
144218,Phase 3
33408,Phase 1b
14436,Phase 1
133762,Phase 1/2
118578,Discontinued in Phase 2/3
147370,Discontinued in Phase 2
33211,Clinical trial
136878,Phase 1/2a
121144,Phase 2b
21473,Discontinued in Phase 4
11668,Phase 1b
134033,Phase 1b
64404,Discontinued in Phase 2/3
145189,IND submitted
51910,Discontinued in Phase 2b
15424,Phase 1
22048,Patented
103162,Approved (orphan drug)
80935,Phase 1
134888,Phase 0
158015,Patented
42986,Phase 0
68029,Phase 1/2
106754,IND submitted
99526,Phase 1
135829,Preclinical
159289,Phase 1b/2a
7727,Patented
135124,Phase 0
176825,Discontinued in Phase 4
127184,Phase 0
126578,Phase 1/2
122674,IND submitted
169030,Phase 1b/2a
137837,Phase 2
28649,Phase 1/2a
167301,Phase 4
127787,Discontinued in Preregistration
78718,Phase 2a
186683,Phase 4
120530,Discontinued in Phase 3
172579,Discontinued in Phase 2b
101567,Investigative
150935,Phase 1
4918,Phase 2a
61547,Discontinued in Phase 1
102254,Investigative
23042,Phase 1/2
53719,Phase 1
175035,IND submitted
35666,Discontinued in Phase 3
28641,Phase 0
151936,Phase 1
46054,Phase 1/2a
179164,Discontinued in Phase 1
69064,Phase 1
156156,Discontinued in Phase 3
106680,Phase 1/2a
75803,Discontinued in Phase 1/2
190032,Approved
120481,Phase 4
88209,BLA submitted
135846,Phase 1/2
2405,Phase 1b
81631,Phase 1
25438,Phase 1
171482,Discontinued in Phase 2/3
13770,Phase 1
38048,Phase 1/2a
29069,Phase 1b/2a
58859,Phase 2/3
152959,Phase 2
112847,Discontinued in Phase 3
118939,Phase 2b
42400,Phase 1
80997,Phase 2a
25536,Investigative
184719,BLA submitted
53070,Phase 1/2a
125488,Discontinued in Phase 3
34875,Phase 1b/2a
126986,Phase 1/2
85502,Discontinued in Phase 2b
51809,Phase 1b/2a
121553,Discontinued in Phase 1
46463,Phase 2b
25985,Phase 1b
14992,Phase 1
71782,Patented
71907,Phase 1b
170942,IND submitted
185752,Phase 1b
114079,Discontinued in Preregistration
59080,Approved (orphan drug)
34311,Phase 1b/2a
111196,Phase 1/2
94514,Phase 1/2
96536,Phase 1
63822,Investigative
57460,Phase 1/2a
41186,IND submitted
78170,Discontinued in Phase 4
1751,Phase 1b/2a
79838,BLA submitted
182969,Phase 1b/2a
44215,Phase 2/3
71250,Discontinued in Phase 1/2
93887,Investigative
98218,Phase 1b/2a
142615,Discontinued in Phase 1/2
181694,Discontinued in Phase 2b
30326,Phase 1/2a
83678,Phase 1/2a
113766,IND submitted
103944,Patented
55283,Phase 1/2a
46475,Phase 1
167361,Phase 4
116104,Phase 1/2
25928,Phase 1/2
167309,Investigative
91071,Investigative
188844,Clinical trial
92619,Phase 1b/2a
74410,Discontinued in Phase 4
20912,Phase 1/2a
130673,Phase 1b
92216,Phase 2/3
44579,Phase 1/2a
91252,Discontinued in Phase 2/3
154164,Patented
140791,Phase 2a
76764,IND submitted
73471,Phase 1b
77893,Phase 1b
85934,Discontinued in Phase 2b
142413,Discontinued in Phase 2/3
96846,Phase 1b/2a
168937,Discontinued in Phase 4
20620,Phase 1/2
38150,Patented
27587,Phase 1b/2a
64125,Phase 1/2a
55678,Patented
35285,Phase 2a
105277,Phase 2a
185171,Investigative
128249,Patented
42331,Phase 1
166519,Phase 1/2
10360,Discontinued in Phase 2b
86894,Phase 1/2
28519,Discontinued in Preregistration
84408,Phase 0
148902,Phase 1b/2a
48379,Phase 1/2a
165787,Patented
71494,Phase 0
40580,Phase 1
134686,Phase 0
49401,Discontinued in Phase 3
105877,Discontinued in Preregistration
51013,Phase 1b
93073,Phase 1/2
98000,Phase 1/2a
168731,Clinical trial
152462,Patented
167444,Phase 1/2a
58602,Investigative
141861,Patented
87962,Phase 1/2a
169903,Patented
68949,Phase 1b
62835,Phase 1/2a
153704,Registered
65021,Phase 2b
150215,Discontinued in Phase 2/3
37842,Phase 1b
77856,Phase 1b
99734,Phase 1
18752,Phase 2
27224,Phase 1b/2a
165915,Phase 1
111476,Phase 2
142858,Discontinued in Phase 4
146747,Phase 2/3
134547,Phase 1/2
11388,Phase 1
103676,Phase 1
184284,Phase 1/2
142486,Discontinued in Phase 2b
75377,Phase 1/2a
131229,Discontinued in Preregistration
68511,Discontinued in Preregistration
26690,Phase 1/2a
52789,Discontinued in Preregistration
148162,Phase 1b/2a
54096,Discontinued in Phase 4
101302,Phase 1b
149711,Phase 2/3
64350,Patented
71997,Phase 1b
91178,BLA submitted
1976,Investigative
129724,Phase 0
95961,Discontinued in Phase 3
156834,Phase 1/2
36290,Patented
184808,Discontinued in Phase 4
43673,Phase 2/3
99088,Phase 1
65663,Discontinued in Phase 4
55227,Phase 2
54322,Phase 0
26100,Discontinued in Preregistration
79251,Discontinued in Phase 4
81809,Phase 2
73967,Discontinued in Preregistration
68900,Discontinued in Phase 2/3
65702,Preclinical
119122,Phase 1/2a
46788,Discontinued in Phase 1/2
66245,Discontinued in Phase 2/3
127837,Patented
35135,Phase 1/2a
171581,Discontinued in Phase 2b
36552,Phase 2a
70919,IND submitted
145454,Phase 1b/2a
73200,Patented
121193,Phase 2
127735,Patented
127915,Patented
94389,Phase 1b
173035,Discontinued in Phase 2/3
42357,Investigative
54653,Discontinued in Preregistration
174897,IND submitted
12277,Phase 0
45714,Phase 2/3
129584,Discontinued in Phase 3
34132,Phase 1
169620,Phase 0
76341,Phase 1/2
185280,Discontinued in Phase 1
155703,Phase 2
139180,Phase 1b
170427,Discontinued in Phase 1
188776,Phase 1/2a
169338,Phase 0
146394,Discontinued in Phase 2
185935,Phase 0
185021,Phase 1
155986,Discontinued in Phase 3
7535,Phase 2a
87516,Phase 1b/2a
77732,Phase 0
43339,Phase 1/2a
160554,Phase 2/3
188325,Phase 1/2
12240,Phase 0
18531,Phase 2a
84117,Discontinued in Phase 1/2
30226,Investigative
80821,Phase 2a
182362,Phase 1/2a
40882,Discontinued in Phase 4
172626,Patented
140627,Preregistration
172174,Phase 0
187301,Patented
149315,Phase 1b/2a
120264,Approved
90912,BLA submitted
177285,Phase 2
141811,Patented
73322,Approved (orphan drug)
73475,Phase 2a
85676,Discontinued in Phase 2b
54010,Phase 1b/2a
127221,Phase 0
167784,Phase 2
2338,Phase 1
134532,Phase 1/2a
172766,Phase 2
102842,Investigative
191784,IND submitted
43845,Phase 1/2a
98311,Phase 1/2a
66381,Phase 1b
41869,Phase 1
26911,BLA submitted
135659,Phase 2/3
144339,Discontinued in Phase 2
190968,Discontinued in Phase 1
31396,Investigative
75343,Preclinical
27036,Phase 1
42847,Phase 1b
18016,Phase 1/2a
16506,Phase 1
182304,Phase 2a
169401,Patented
38363,Phase 0
156368,Phase 1b
150075,Phase 2b
175967,Phase 0
181605,Phase 2a
28425,Patented
1588,Phase 1/2
128216,Discontinued in Phase 3
6123,Phase 1b/2a
50820,Discontinued in Phase 2/3
182597,Discontinued in Phase 4
7759,Phase 1
162563,Patented
34820,Phase 1
185302,Approved
114757,Phase 1/2a
156957,Phase 1b/2a
94596,Phase 1/2a
11368,Discontinued in Preregistration
143334,Discontinued in Preregistration
94668,Phase 1/2a
337,Phase 1/2a
167356,Discontinued in Phase 1/2
63721,Approved (orphan drug)
8394,Phase 1/2a
3661,Discontinued in Phase 2b
47153,Approved
52568,Phase 4
149324,Phase 2b
25877,Discontinued in Phase 4
31054,Discontinued in Preregistration
88008,Phase 1/2a
141457,Phase 0
23394,Phase 1b/2a
33460,Phase 1b/2a
17291,Phase 1/2a
131965,Patented
187261,Phase 1
73964,BLA submitted
95967,Discontinued in Preregistration
150503,Phase 1b
189839,Patented
187544,Phase 2b
65638,Discontinued in Phase 1
32567,Phase 1
6421,Phase 2/3
42328,IND submitted
27058,Phase 1
147868,Phase 1/2
174050,Phase 1
129142,IND submitted
78601,Patented
83040,Phase 1/2a
38148,Phase 1b
13992,Discontinued in Phase 1
181738,Phase 2/3
162287,Phase 4
124675,Phase 1
119013,Discontinued in Phase 2/3
95578,Patented
190436,Phase 1/2a
20519,Phase 1/2
53683,Phase 1/2a
152307,Phase 2/3
191774,Phase 0
108155,Phase 1b
115018,Phase 1b/2a
71683,Phase 0
7626,Phase 2
92176,Phase 1/2
20285,IND submitted
26300,Phase 1/2
134544,Phase 1
8735,Phase 1/2a
16827,Investigative
76538,Phase 1
104375,BLA submitted
176333,Phase 1b
112323,Phase 1
62337,Phase 2/3
111081,Discontinued in Phase 3
56408,Discontinued in Phase 4
17988,Phase 1/2a
123559,Phase 1b
86043,Phase 1b/2a
85097,Phase 1/2a
93186,Discontinued in Phase 3
115753,Phase 1b/2a
124990,Phase 1b
2396,Phase 1b
151679,Phase 2
126978,Discontinued in Phase 2b
31199,Phase 1b
18156,Phase 2
20972,Phase 1/2a
8076,IND submitted
72048,Discontinued in Preregistration
84157,Phase 0
126157,BLA submitted
92158,Phase 2b
116163,Phase 1/2a
152662,Phase 1/2a
175290,Phase 3
183423,Phase 1/2
39080,Phase 1
82791,Phase 1/2a
53984,Phase 1/2a
121893,Phase 1b/2a
155193,Investigative
95688,Investigative
127415,Discontinued in Preregistration
159786,Phase 1b/2a
171097,Phase 1/2
11244,Discontinued in Phase 1/2
104438,Discontinued in Preregistration
173515,Discontinued in Phase 4
18809,IND submitted
187682,Patented
170821,Phase 0
171111,Phase 1
7211,Phase 2a
29344,Phase 1b
103825,Patented
104287,IND submitted
133242,Discontinued in Phase 1
94322,Phase 1/2a
34350,Discontinued in Phase 2/3
190334,Phase 4
188098,Phase 4
154123,Phase 1/2a
84102,Discontinued in Phase 4
5124,Phase 1b/2a
47446,Phase 2
124030,Phase 0
29645,Phase 1
35832,Phase 0
83322,Discontinued in Phase 4
119223,Registered
67334,Clinical trial
124056,Investigative
13112,Phase 1/2
172683,Phase 2
83903,Phase 2
89572,Phase 1
106845,Discontinued in Phase 2b
97064,Patented
44030,Phase 1/2a
73487,Phase 2a
42420,Phase 1
111442,Discontinued in Phase 3
133608,Phase 1/2a
26411,Phase 1/2
50069,Discontinued in Preregistration
99446,Phase 1/2a
150158,Phase 2a
178133,Phase 1
89594,Phase 1
133464,Phase 1/2
182964,Phase 3
79335,Phase 1b
103114,Discontinued in Preregistration
83197,Phase 1/2a
176737,Phase 2b
146911,Phase 2
2841,Phase 0
154813,Phase 2
96019,Discontinued in Phase 4
122788,Patented
155561,Phase 2
7495,Phase 4
98167,Phase 1/2a
9603,IND submitted
130796,Clinical trial
47911,Investigative
7509,Phase 1b/2a
59305,Discontinued in Phase 1/2
60243,Phase 1
105557,Phase 1b/2a
177440,Phase 1b
1333,Approved
4613,Phase 1/2
119011,Discontinued in Phase 3
11506,Phase 1b
85949,Discontinued in Phase 2b
143547,Phase 2a
119848,Approved
189021,Phase 0
105403,Phase 2a
171857,Discontinued in Phase 2
22521,Phase 1
123290,Phase 1/2
50715,Phase 0
96497,Phase 0
51993,Phase 2
59034,Investigative
188716,Phase 2/3
189429,Phase 1/2
168005,Phase 1b/2a
57400,Approved (orphan drug)
62942,Patented
151287,Phase 0
37804,Phase 1b
160666,Phase 3
82170,Clinical trial
96642,Phase 1b
62981,Patented
177221,Phase 1b
32561,Phase 1/2
185282,Approved
127270,IND submitted
181397,Discontinued in Phase 4
117798,Phase 0
127419,Phase 1/2
80820,Patented
36871,Phase 1
175125,Phase 2
151095,Phase 1
43597,Phase 1/2a
71112,Phase 1b
42462,Investigative
83865,Phase 1
72536,Phase 1b/2a
8188,Phase 2
183156,Discontinued in Preregistration
158529,Phase 1
98086,Phase 1/2a
50686,Discontinued in Phase 2b
19001,Discontinued in Phase 2/3
182855,Phase 2a
153475,Discontinued in Preregistration
105117,Investigative
139999,Phase 1/2a
36885,Phase 2
107076,Phase 3
184182,Phase 0
24030,Phase 2/3
3851,Phase 1
74141,IND submitted
38370,Discontinued in Preregistration
30399,Discontinued in Phase 2b
10283,Preclinical
45676,Phase 1/2a
7419,Phase 1b/2a
46334,IND submitted
36906,Phase 1
15794,Phase 1
89407,Phase 1/2a
56425,Phase 0
176276,Discontinued in Phase 4
174678,Phase 1
84939,Phase 1b/2a
94211,Phase 2b
112893,Phase 0
147593,Patented
34333,Discontinued in Phase 2/3
113268,Phase 2a
65201,Phase 2/3
134000,Phase 1/2
34800,Patented
31861,Patented
15145,Discontinued in Phase 1
109972,Phase 1b
43783,Phase 2/3
78432,Discontinued in Phase 1
20893,Phase 2b
28558,Phase 1/2a
28764,Investigative
144103,Investigative
21746,BLA submitted
94553,Patented
181285,Phase 1b
101800,Phase 1
135753,Phase 1/2
61336,Phase 1
8829,Discontinued in Phase 2
4888,IND submitted
162687,Phase 2
74840,Phase 2/3
105775,Phase 1b/2a
146271,Investigative
47805,Discontinued in Phase 2b
58397,Phase 0
66264,Phase 2b
4218,Investigative
103416,Phase 2
125471,Phase 1b/2a
13977,Phase 1
70207,Phase 2/3
56606,Phase 1b
80770,Discontinued in Phase 4
170064,Patented
159330,BLA submitted
121910,Approved (orphan drug)
30042,Phase 1
99464,Phase 2
75327,Phase 1/2a
91531,Discontinued in Phase 2
10679,IND submitted
47600,Phase 1b
143932,Investigative
15737,Phase 1
187216,Discontinued in Preregistration
79830,Phase 1b/2a
24955,Phase 2/3
93684,Discontinued in Phase 1
108656,Phase 1b/2a
140964,Investigative
10600,IND submitted
146501,Patented
185835,Phase 2b
9957,Discontinued in Phase 2b
181895,Discontinued in Phase 2b
22059,Phase 3
85367,Discontinued in Phase 2b
9969,IND submitted
72940,Phase 2
70465,Phase 1
8623,Clinical trial
180074,Phase 1b
168464,Discontinued in Phase 1
85376,Discontinued in Phase 2b
75615,Phase 0
126753,Phase 0
61806,Discontinued in Phase 2b
175466,Phase 1/2
8680,Investigative
141866,Discontinued in Phase 2b
156347,Phase 1/2
166910,Discontinued in Phase 2
105479,Phase 1/2a
80712,Discontinued in Phase 3
91256,BLA submitted
141578,Discontinued in Phase 2b
140192,Phase 1b
94159,Phase 2b
131802,Phase 1/2
181897,Discontinued in Phase 4
42425,Phase 0
74357,Phase 1/2a
118350,IND submitted
60537,Discontinued in Phase 1/2
4800,Phase 1b/2a
174615,Phase 3
188042,Phase 0
32714,Phase 1
184819,Phase 0
93275,Phase 2b
129203,Phase 1/2a
113233,Phase 2a
143476,Discontinued in Phase 3
75994,Phase 2/3
67369,Discontinued in Phase 1
20255,Phase 1b/2a
104331,Phase 1b
3812,Discontinued in Phase 4
6526,IND submitted
9418,Phase 2
155003,Phase 1/2a
105741,Phase 1b
115745,Phase 1b
9426,IND submitted
50675,Phase 1/2a
39552,Discontinued in Phase 4
138511,Phase 1b
179661,Discontinued in Phase 1/2
70373,Phase 1b/2a
175704,Phase 1
14126,Phase 1
25813,Discontinued in Phase 4
70436,Phase 0
67354,Discontinued in Phase 1
149730,Phase 1b
13666,Phase 1/2
52023,Discontinued in Preregistration
191637,IND submitted
98345,Phase 2/3
110494,Phase 3
45098,Phase 2/3
171617,IND submitted
39986,Patented
13820,IND submitted
99567,Phase 1b/2a
104283,Investigative
48498,Phase 1b
160048,Phase 1b
123641,Patented
118741,BLA submitted
120419,Discontinued in Phase 1/2
103145,Approved (orphan drug)
96563,Discontinued in Phase 2/3
78075,Discontinued in Phase 3
98492,Patented
19249,IND submitted
23995,Phase 1
51044,Phase 1b/2a
176439,Phase 1/2
44739,Phase 1/2a
110672,Phase 1
11151,Discontinued in Phase 4
189460,Approved
81481,Phase 1/2a
181263,Phase 3
47439,Phase 1
166794,Phase 2
95202,Phase 1
57905,Discontinued in Phase 1/2
180302,Phase 2a
76736,Phase 1b/2a
150827,Phase 1b/2a
165499,Phase 1b
25497,Phase 1b/2a
190317,IND submitted
70882,Investigative
161699,Phase 2
67991,Phase 1
158716,IND submitted
121037,Phase 1b
82023,Clinical trial
143653,Patented
282,Phase 1/2a
84181,Phase 2
55560,Phase 3
142652,Phase 2/3
354,Phase 2
59602,Phase 0
183566,Discontinued in Phase 4
5651,Discontinued in Phase 2
104430,Phase 1/2a
119590,Discontinued in Preregistration
157823,Phase 1
81029,Clinical trial
187126,Discontinued in Preregistration
168382,Discontinued in Phase 3
168111,Clinical trial
33304,Phase 1b/2a
75009,Patented
116904,Discontinued in Phase 1
135944,Phase 1/2
56658,Phase 1b/2a
81407,Clinical trial
147221,Phase 1
81720,Phase 1
137045,Phase 1/2a
124995,Phase 1b
111131,Phase 1/2
39450,Phase 1/2a
148548,Phase 1b/2a
57539,Discontinued in Phase 4
57459,Phase 2/3
182618,Phase 1/2a
24861,Investigative
23986,Phase 1b/2a
22421,Phase 2a
287,Phase 2b
48213,Discontinued in Phase 2b
88599,Discontinued in Phase 4
145438,Investigative
97380,Phase 1b/2a
65571,Discontinued in Phase 2/3
43581,Phase 1/2a
152549,Patented
128351,Discontinued in Preregistration
154823,Phase 1b/2a
86364,Patented
78760,Phase 0
152933,Discontinued in Phase 3
174183,Phase 3
52947,Phase 0
38654,Phase 2
185169,Discontinued in Phase 4
139443,BLA submitted
168295,Phase 2
28725,Phase 1/2a
115924,Phase 1/2a
110248,Phase 1b
117368,Discontinued in Phase 1/2
89953,Clinical trial
114809,Phase 1
115426,Phase 2
155730,Phase 2
141513,Phase 1b
32965,Phase 1/2a
106771,Phase 2b
22515,Phase 1
165819,Investigative
68372,Phase 1
148541,Phase 2/3
93234,Discontinued in Phase 3
137393,Phase 1/2
49066,IND submitted
63628,Patented
158560,Phase 1
107063,IND submitted
153765,Phase 1/2a
114690,Investigative
92511,Phase 4
52882,Patented
95743,Phase 2/3
51977,Discontinued in Phase 2/3
17340,Phase 1b/2a
183782,IND submitted
112770,Discontinued in Phase 3
114014,Phase 1/2a
115338,Phase 2
98107,Investigative
117875,Investigative
129612,Discontinued in Phase 3
128222,IND submitted
25056,Phase 2
81537,Approved
80204,Patented
184804,Phase 0
81359,Clinical trial
29742,Phase 1
7666,Phase 1b/2a
48687,Phase 1
82357,Phase 1
38528,Phase 2/3
135960,Phase 1b
171813,Discontinued in Phase 2
91906,Phase 0
190656,Approved
3426,Phase 1/2
67093,Patented
37596,Phase 1
187012,Phase 1b
37091,Discontinued in Phase 1/2
93420,Discontinued in Phase 3
161971,Patented
7623,Discontinued in Phase 3
178608,Phase 1/2a
94422,Phase 1/2
189,Phase 2
186761,Patented
170496,Patented
131089,Phase 1/2
112891,Discontinued in Phase 2
156435,Phase 1/2a
189874,Discontinued in Phase 3
861,Phase 1/2
175970,Discontinued in Phase 3
182627,Phase 1/2a
104561,Patented
147359,Patented
1564,Discontinued in Phase 2b
138757,BLA submitted
181642,Phase 1
174458,Discontinued in Phase 3
73770,Approved
153736,Approved
148727,Phase 1/2
30968,Discontinued in Phase 2b
45773,Phase 1/2a
126625,Discontinued in Phase 4
52806,IND submitted
99091,Phase 1b/2a
89420,Phase 1/2a
47928,Phase 0
146924,Phase 1b
171741,Phase 1
127117,Patented
149642,Phase 2b
174645,Discontinued in Phase 4
73721,Phase 1/2a
2891,Discontinued in Phase 2
143366,Investigative
182060,Phase 2
162825,Phase 1/2
148545,Phase 0
73432,Phase 2
156710,Clinical trial
53345,Discontinued in Phase 4
67567,IND submitted
32863,Phase 1b/2a
76106,Phase 1/2a
39912,Phase 0
124246,Phase 1
96329,Patented
59267,Phase 2/3
19341,Phase 1/2a
43958,Phase 1/2a
190087,Phase 0
177657,Phase 2
25875,Discontinued in Phase 2/3
69212,Discontinued in Phase 2
48311,Phase 1/2a
116042,Phase 1/2a
21047,Phase 2
110159,Discontinued in Phase 2/3
26884,Phase 1b
165860,Discontinued in Phase 4
159382,Approved
2947,Discontinued in Phase 2
63583,Clinical trial
191715,Phase 1/2
161858,Phase 1b
79138,Phase 1b
174854,Discontinued in Phase 2
46488,Clinical trial
63273,Phase 1b/2a
68091,Phase 0
65708,Discontinued in Phase 2b
131401,Discontinued in Phase 2b
13158,Phase 0
168658,Phase 2
98656,Discontinued in Phase 2
169595,Phase 1
85572,Discontinued in Preregistration
80755,Phase 1/2a
155330,Investigative
79110,Phase 1b
135780,Phase 1b/2a
181078,Phase 1/2a
174334,Patented
123427,Phase 1b
17500,Investigative
75915,Phase 1/2a
51191,Phase 0
94255,Phase 2
115632,Phase 2
17388,Phase 1/2a
39835,IND submitted
147107,Phase 2b
114069,Phase 1b/2a
13563,Investigative
57015,Phase 1/2a
117639,Discontinued in Phase 4
17227,Phase 1
60002,Investigative
11588,Investigative
32377,Phase 1/2a
19996,Phase 2
116452,Investigative
47788,Phase 1/2
18027,Discontinued in Phase 4
150855,Phase 1
36430,Patented
184718,BLA submitted
57948,Phase 0
39749,Phase 2
18972,Phase 2
63209,Phase 0
99852,Phase 1
187322,Patented
67389,Discontinued in Phase 1
145188,Investigative
41282,BLA submitted
72124,Patented
44068,Phase 1/2a
95811,Phase 2a
25667,Discontinued in Preregistration
154836,Phase 2/3
95080,Patented
185898,Phase 0
46782,IND submitted
59751,Discontinued in Phase 4
150554,Discontinued in Phase 2/3
27280,Phase 1/2a
83975,Patented
6541,Phase 4
128319,Phase 1/2
67373,Discontinued in Phase 2/3
68941,Discontinued in Phase 4
45943,Phase 2/3
120398,Approved (orphan drug)
155688,Phase 2/3
175647,Discontinued in Phase 4
164985,Discontinued in Preregistration
92353,Phase 2b
34775,Phase 1/2a
159596,Phase 1
18229,Phase 1
119747,Phase 1
59249,Discontinued in Phase 1/2
66833,Phase 0
173423,IND submitted
90179,Phase 2a
57612,Phase 0
176781,Phase 1/2
48955,Investigative
72758,Investigative
18299,Discontinued in Preregistration
98702,Phase 1/2a
138089,Approved (orphan drug)
63318,Discontinued in Phase 3
117502,Discontinued in Phase 2b
172276,Discontinued in Phase 2
67048,Phase 1b/2a
163057,Discontinued in Phase 2
179131,Phase 0
120138,Phase 0
49380,Phase 1b
113320,Phase 1
18793,Discontinued in Phase 2/3
65631,BLA submitted
157901,Phase 1
130381,Discontinued in Phase 2b
171780,Discontinued in Phase 2b
180123,Phase 1/2a
178576,Phase 1/2
7660,Phase 2
27103,Phase 1b/2a
139099,Discontinued in Phase 2
151186,Phase 1b/2a
75880,IND submitted
40565,Phase 1/2
83770,Phase 0
50393,Phase 3
148561,Clinical trial
92922,Discontinued in Phase 3
62684,Discontinued in Phase 4
159471,Discontinued in Phase 3
11066,Approved (orphan drug)
685,Approved (orphan drug)
37837,Discontinued in Phase 3
169090,Clinical trial
183757,Approved (orphan drug)
159451,Investigative
5656,Phase 2a
111938,Phase 1/2
72046,Discontinued in Phase 1
27552,Discontinued in Phase 3
191406,Phase 1/2
86093,Discontinued in Phase 2
165410,Discontinued in Phase 1
106914,Discontinued in Phase 3
153265,Investigative
113928,Phase 1
37109,Phase 1
164988,Phase 0
162557,Patented
98868,Phase 1/2a
128066,Phase 1/2
98895,Phase 1/2
64118,Approved
57862,Discontinued in Phase 3
31011,Patented
158208,Phase 0
43377,Phase 2/3
157635,IND submitted
162946,Phase 1/2
70640,Phase 1b/2a
42473,Phase 1b
81536,Investigative
63064,Discontinued in Phase 4
131555,Phase 1b/2a
155929,Phase 1b/2a
40293,Investigative
154824,Phase 3
172651,Phase 1b
39710,IND submitted
101782,Phase 1b
26773,Phase 1
24487,Phase 1/2
173034,Discontinued in Phase 2/3
67825,Approved (orphan drug)
36807,Phase 2a
35171,Phase 1b
46112,Phase 2/3
55339,Phase 0
46129,Phase 2/3
15020,Phase 0
133437,Approved
102049,Phase 0
50560,Discontinued in Phase 3
93638,Phase 1
17784,Investigative
159544,Phase 1
174305,Phase 1/2
9322,IND submitted
166809,Patented
132427,Phase 1b/2a
63514,Phase 1b
70630,Phase 1b
64533,Clinical trial
30395,Phase 1
38209,Phase 2a
29904,Discontinued in Phase 3
117775,Discontinued in Phase 2b
20910,Phase 2b
10118,Phase 1
9507,Discontinued in Phase 1
63146,Phase 1
88924,Patented
155000,Discontinued in Phase 2b
85541,Discontinued in Phase 2b
73214,Investigative
60732,Approved (orphan drug)
98247,Investigative
104850,Discontinued in Phase 2b
69291,Phase 1b
68513,IND submitted
11542,Phase 1b
41924,Phase 1/2a
32960,Phase 1/2
92676,Phase 1b/2a
112248,Discontinued in Phase 3
12263,Discontinued in Phase 1
134245,Patented
74536,Phase 1/2a
19081,Phase 1/2
191913,Phase 2/3
183192,Discontinued in Phase 2
43782,Phase 1/2a
75287,IND submitted
121730,BLA submitted
103028,Phase 1/2a
172040,Discontinued in Phase 2
103858,Discontinued in Phase 4
26133,Phase 1b
190658,IND submitted
97478,Phase 0
173881,Approved
44946,Phase 2/3
13472,Phase 1/2
111197,Phase 0
96794,Phase 1/2a
171931,Phase 0
165143,Phase 1/2
39703,Phase 2/3
158412,Phase 1b/2a
72158,Phase 1/2
150712,Phase 2
96777,Phase 2/3
184016,Discontinued in Phase 4
35547,Phase 1/2
55516,Discontinued in Phase 2b
135516,Phase 0
11214,Phase 1b
107496,Phase 3
190939,Phase 1/2
118198,Phase 1/2a
52310,Phase 1b/2a
188194,Clinical trial
71041,Phase 1b/2a
61360,Phase 1
102185,Phase 1
40320,Discontinued in Preregistration
105449,Phase 1
40214,Phase 0
60624,Phase 1/2a
56901,Phase 0
163637,Phase 1/2a
55437,Phase 2
106909,Phase 1b
152523,IND submitted
135608,Phase 0
105272,Phase 1
156182,Discontinued in Phase 3
26060,Discontinued in Phase 2/3
159884,Phase 1
14181,Phase 1
71406,IND submitted
65761,BLA submitted
3084,Discontinued in Phase 2b
158601,Phase 1b/2a
131934,Discontinued in Phase 1/2
94861,Phase 1
69265,Discontinued in Phase 3
13096,Phase 1
70692,Discontinued in Phase 3
169165,Discontinued in Phase 4
40436,Patented
19923,Phase 2a
11703,Phase 1b
39465,Phase 1/2a
83576,Discontinued in Preregistration
53320,Phase 2
66519,Phase 1b
86274,Investigative
181562,Phase 1/2a
107338,Phase 1/2a
8282,Patented
173958,Discontinued in Preregistration
69328,IND submitted
154874,Phase 2
78524,Discontinued in Preregistration
74176,Discontinued in Phase 4
16024,Phase 0
143413,Patented
165368,Discontinued in Preregistration
44460,Phase 1/2a
23061,Phase 1b/2a
156408,Phase 1b
175416,Discontinued in Phase 1/2
29636,Phase 1
177691,Phase 1b
67986,Phase 2a
156880,Discontinued in Phase 1/2
12417,Phase 1/2
10213,Phase 1/2
63424,Discontinued in Phase 4
101823,Investigative
175870,Phase 1/2
5697,Investigative
104603,Investigative
99003,Patented
151659,Phase 1/2
11883,Phase 1b
86572,Investigative
94722,Phase 1
184204,Phase 0
3403,Patented
100363,IND submitted
22173,Discontinued in Preregistration
159559,Phase 1/2
138379,Phase 1b
173202,Discontinued in Phase 2/3
172060,Discontinued in Phase 2b
140630,Registered
130711,Phase 1b/2a
183677,IND submitted
36177,Phase 1b/2a
144694,Patented
81487,Phase 1/2a
143226,Phase 1b/2a
35887,Phase 0
31160,Investigative
51742,Discontinued in Phase 2
50404,Phase 1b
57306,Phase 0
101434,Phase 1b
11659,Phase 1/2
28830,Phase 1/2a
64378,Phase 1/2a
126500,Phase 0
141212,Patented
170931,Discontinued in Phase 1
159304,Discontinued in Preregistration
92188,Phase 1b/2a
103500,Phase 1b
144876,Investigative
93904,Phase 2a
187718,Phase 1/2a
180490,Phase 1/2a
86089,Patented
96790,Phase 1b/2a
184453,Phase 1/2
111771,Phase 1/2
41868,Phase 1
181779,Phase 1/2
119603,Approved
110696,Phase 1/2
25931,Phase 1/2a
136847,Discontinued in Phase 4
94810,Phase 1/2a
5749,Phase 4
11437,Phase 2/3
183135,IND submitted
376,Phase 2
106910,Phase 0
158711,Phase 1b/2a
459,Phase 1/2a
130176,Phase 1/2
140871,Phase 2a
169196,Phase 0
153871,Phase 2/3
181051,Phase 2a
127268,Phase 0
128458,IND submitted
93479,Phase 1b
127375,Patented
146601,Phase 1b/2a
17425,Phase 0
186525,Phase 2b
176588,Phase 1b
36374,Phase 1
41839,Discontinued in Phase 1
183655,Phase 1b/2a
191905,Patented
133430,Approved
47679,Phase 1b/2a
122495,Phase 0
47019,Discontinued in Phase 1/2
129826,IND submitted
111571,Phase 2
45165,Phase 1/2a
9758,Phase 1/2
87407,Phase 2a
190641,Phase 2/3
139416,BLA submitted
1936,Investigative
169179,Patented
114987,Phase 1/2a
189856,Phase 2b
127870,Phase 0
34078,Discontinued in Phase 2/3
177917,Discontinued in Phase 4
130486,Phase 0
68151,Discontinued in Phase 3
190377,Phase 1/2
139239,BLA submitted
30566,Phase 1/2
134311,Phase 1/2a
35163,Phase 1b/2a
88169,Phase 1/2a
190460,Phase 1b
30321,Patented
169843,Discontinued in Phase 2b
169378,Patented
114781,Phase 2a
127413,IND submitted
10994,Discontinued in Phase 4
117491,Phase 1b
60232,Phase 1/2a
3784,Discontinued in Phase 4
124348,Phase 1/2
32328,Phase 0
72757,IND submitted
11152,Discontinued in Preregistration
65393,Phase 1
64666,Discontinued in Phase 2b
167756,Phase 2
186176,Clinical trial
69836,Phase 1
188001,Patented
59121,Phase 1b/2a
29365,Investigative
77268,Phase 2/3
178833,Patented
169942,Investigative
136320,Investigative
83127,Phase 1/2a
150337,IND submitted
96279,Phase 1b/2a
93577,Discontinued in Phase 2b
32283,Phase 2
14065,Phase 0
121287,Phase 1/2a
29982,Phase 1
116212,Discontinued in Phase 2
64206,IND submitted
173774,Phase 2a
129535,Patented
159126,BLA submitted
191287,IND submitted
63354,Phase 0
43746,Phase 2/3
179695,Phase 1b
89884,Phase 1b/2a
36531,Phase 1
187925,Discontinued in Phase 2
12847,Phase 1
19783,Investigative
121349,Phase 1b/2a
189802,Phase 2b
47009,Approved
139807,Investigative
28458,Phase 1/2a
138341,Clinical trial
79626,Phase 2a
9798,Discontinued in Phase 2b
177466,Phase 1/2a
66280,Phase 2b
132729,Discontinued in Phase 1/2
142070,Patented
100628,Phase 1/2a
78129,Discontinued in Phase 3
76726,Patented
111117,Discontinued in Phase 2b
25772,Patented
115168,Phase 1/2a
63114,IND submitted
150649,Phase 1
45746,Phase 2/3
116593,Phase 1
191487,Patented
26096,Phase 1b
121527,Discontinued in Preregistration
39758,Phase 1/2
1850,Phase 1/2a
46450,Phase 0
156386,Phase 1/2
162780,Phase 1b
17010,Phase 1
72411,IND submitted
132720,Patented
117845,Phase 1b
131659,Phase 1/2
2772,Phase 2
33096,Phase 2a
113584,Phase 1/2
113431,Phase 2a
162528,Patented
76903,Phase 1/2a
191846,Phase 2a
56765,Phase 0
88033,Approved
40878,Investigative
54206,Phase 1b/2a
45587,Phase 1/2a
92793,Phase 2
115794,Approved (orphan drug)
33655,BLA submitted
161350,Phase 1/2
117550,Phase 1/2
126307,Phase 1/2
11538,Phase 2a
25006,Phase 1/2a
122228,Phase 1
97867,Phase 1
114078,Discontinued in Preregistration
96379,Discontinued in Phase 1/2
71761,Discontinued in Preregistration
46868,Discontinued in Phase 2
109626,Phase 1
27740,Phase 0
60453,Discontinued in Phase 1/2
175919,Discontinued in Phase 2b
42601,Discontinued in Phase 2/3
129276,Phase 1
166862,Phase 1b
62524,Discontinued in Phase 4
45221,Phase 1/2a
83241,Phase 1b/2a
183250,Phase 2
154829,Phase 2
142958,Investigative
71391,Patented
50529,Phase 3
91810,Approved (orphan drug)
181256,Phase 2a
151695,Phase 1
177894,Phase 1/2
90221,Phase 1b
36608,Phase 1b/2a
182140,Phase 1/2a
17730,Phase 0
45274,Phase 2/3
162756,Phase 1b
191973,Phase 2/3
136606,Phase 1
8589,Phase 1
45048,Phase 2/3
62888,Phase 0
40521,Phase 1b
30135,Phase 1
165602,Phase 1b/2a
103591,Phase 1/2
61961,Discontinued in Phase 4
36604,Discontinued in Preregistration
113891,Phase 1/2
28817,Phase 4
118419,Discontinued in Preregistration
109173,Patented
139785,Investigative
10788,IND submitted
1898,Discontinued in Phase 1
104443,Investigative
115302,Phase 1/2a
18646,Phase 0
169342,Phase 2/3
148166,Discontinued in Phase 1
146250,Phase 1b/2a
151901,Discontinued in Phase 2/3
87114,Discontinued in Phase 1
156189,Discontinued in Preregistration
178295,Phase 1b/2a
166145,Phase 1b/2a
169505,Phase 1
9759,Discontinued in Phase 3
41206,Approved
191543,Phase 2a
64896,Phase 0
45303,Phase 2/3
123314,Phase 1b/2a
27033,IND submitted
165085,Phase 1/2a
35088,Patented
17212,Investigative
24023,Phase 1b/2a
3085,Phase 1
90336,Discontinued in Phase 2b
148120,Phase 2
184956,Phase 1/2
13573,Phase 1
45914,Phase 2a
35345,Discontinued in Phase 3
2999,Investigative
53035,Investigative
42026,Phase 0
177463,Phase 1b
4359,Phase 1b/2a
99151,Phase 1
85994,Phase 1
168677,Phase 2
93429,Phase 1b
75895,Patented
128275,Patented
85372,Discontinued in Phase 3
135588,Phase 0
186912,Phase 0
35300,Phase 1
152039,Phase 2
146257,Investigative
107664,Phase 3
33956,Phase 1/2
180012,Discontinued in Phase 2
42671,Discontinued in Phase 1
58540,Phase 0
73178,Phase 1b/2a
56147,Phase 1/2
75478,Patented
146270,Phase 1/2
185902,Phase 1b
125616,BLA submitted
142046,Patented
179838,Discontinued in Phase 4
107165,Discontinued in Phase 2b
97439,Phase 1/2
48418,Discontinued in Preregistration
142097,Phase 2/3
22079,Discontinued in Phase 2
17355,Phase 1b/2a
165324,IND submitted
46245,Phase 1/2
15141,Phase 1
147223,Phase 2
24459,Phase 0
158033,Phase 1b/2a
109404,Discontinued in Phase 1/2
86231,Phase 1
170556,Phase 2/3
177497,Phase 2
108422,Phase 0
35350,Discontinued in Phase 1/2
118188,Discontinued in Preregistration
170446,Phase 1/2
35694,Discontinued in Preregistration
6881,Phase 1/2
116899,Discontinued in Phase 4
126617,Discontinued in Phase 4
83224,Phase 2
115415,Discontinued in Preregistration
10513,Discontinued in Phase 2b
1717,Patented
11295,Patented
13519,Phase 1
128515,Discontinued in Phase 4
75753,Phase 0
71461,Phase 1
56830,Patented
112884,Discontinued in Phase 3
105040,Phase 1/2
16237,Phase 1/2a
106568,Patented
58695,Phase 1b/2a
93966,Discontinued in Phase 3
8253,Discontinued in Phase 3
72199,Phase 1
140959,Phase 1/2
96572,Phase 1b/2a
41063,Approved
168078,Patented
49172,Phase 2/3
53390,Phase 1b/2a
91966,Discontinued in Phase 2
41145,IND submitted
161043,Discontinued in Phase 4
140787,Preregistration
24789,Discontinued in Phase 2/3
85140,Phase 0
10533,Patented
54355,Discontinued in Phase 2/3
92080,Discontinued in Phase 1
143306,Phase 2b
27146,Phase 1
65960,Phase 1/2a
52105,Phase 2
183605,Phase 1b/2a
98287,Phase 1
142976,Phase 1b/2a
109382,Discontinued in Phase 1/2
158087,Discontinued in Phase 4
103812,Phase 0
58400,Phase 0
140626,Phase 2a
97679,Phase 1/2a
51749,Discontinued in Phase 2b
29236,Phase 1b
87367,Discontinued in Phase 2
143562,Phase 1b/2a
91925,Phase 1/2a
3837,Discontinued in Phase 3
141382,Investigative
165798,Investigative
154495,Approved (orphan drug)
100295,Discontinued in Phase 1/2
18938,Phase 1/2
172989,Discontinued in Phase 2
57860,Phase 1b
127528,Phase 0
35381,Phase 0
51449,Phase 2
133891,Phase 1/2a
77762,Phase 1/2a
68746,Phase 1b
187589,Patented
144146,Phase 1/2
160863,Phase 1
180785,Phase 1b
56270,Discontinued in Phase 3
3483,BLA submitted
35678,Phase 1/2
185769,Phase 0
24454,Investigative
57087,Discontinued in Phase 2/3
42565,Phase 1
80356,Phase 2a
44092,Phase 1/2a
181690,Phase 1/2a
27668,Patented
37744,Phase 1b
44597,Phase 1/2a
97091,Phase 1/2
188902,Phase 1/2a
74834,Phase 1/2
162615,Phase 2
113313,Clinical trial
64104,Phase 1/2
95057,Patented
59262,Discontinued in Phase 3
138393,Phase 1/2a
62725,Discontinued in Preregistration
172910,Discontinued in Phase 2/3
170246,Phase 0
87213,Discontinued in Phase 2/3
114161,Phase 1/2
20461,Discontinued in Preregistration
24020,Phase 2
139781,Discontinued in Phase 2
47426,Phase 1/2
91214,Discontinued in Phase 2/3
74764,IND submitted
150374,Phase 2/3
23426,Phase 0
113846,Phase 1b
26822,Phase 1/2a
77128,IND submitted
163841,Phase 1/2
57208,Phase 1/2a
66617,Phase 1b/2a
169336,Patented
29874,Discontinued in Phase 3
136495,Phase 1/2a
94202,Discontinued in Phase 2b
72796,Phase 2/3
160235,Investigative
67367,Discontinued in Phase 1
6551,Discontinued in Phase 2
20133,Patented
83983,Phase 0
178115,Phase 2a
142856,Phase 1b/2a
133158,Phase 1/2a
40584,Phase 0
68143,Phase 0
14731,Phase 1
31372,Phase 0
191453,Phase 2a
186594,Phase 4
191670,Phase 1
72372,Phase 1b
66659,Investigative
122007,Phase 1b/2a
99226,Phase 2
30106,Investigative
134103,Phase 1b
153679,IND submitted
85025,Phase 0
88229,Phase 1b/2a
53608,Discontinued in Phase 2b
184592,Discontinued in Phase 3
144175,IND submitted
64148,Discontinued in Phase 2
112457,Discontinued in Phase 3
119667,Discontinued in Phase 2b
91995,Phase 1/2a
147241,Phase 0
182557,Discontinued in Phase 2
91449,Preregistration
66693,Patented
168158,Approved
82768,Discontinued in Phase 4
11294,Discontinued in Phase 1/2
132345,Discontinued in Phase 4
158794,IND submitted
14342,Phase 0
9984,Preclinical
153643,Phase 1b
133279,Discontinued in Preregistration
114213,Phase 1b/2a
104043,Investigative
70224,Phase 0
146059,Phase 2b
51364,Discontinued in Phase 2/3
89533,Discontinued in Preregistration
43863,Phase 2/3
92250,Phase 2/3
23461,Phase 1
26347,Phase 1
5054,Phase 1/2
35390,Discontinued in Phase 1/2
145542,Phase 0
109021,Discontinued in Preregistration
105813,Phase 1b
138214,Phase 1/2a
186644,Phase 2b
84953,Phase 1/2
132422,Phase 1b/2a
12107,Phase 1
125912,Phase 1b/2a
44386,Phase 2/3
53443,Investigative
4905,Investigative
41970,Phase 1
166409,Phase 1b
163166,Phase 2
183066,Phase 1b/2a
160101,Discontinued in Phase 1/2
187578,Phase 0
9397,Clinical trial
48304,Discontinued in Phase 2/3
145126,Investigative
36401,Discontinued in Phase 4
140228,BLA submitted
10341,IND submitted
9272,Discontinued in Phase 2
142724,Phase 2/3
175229,Phase 1/2
117710,Phase 1/2
37437,Phase 2a
97537,Investigative
170364,Discontinued in Phase 1
104900,Phase 1/2
51858,Phase 2
88046,Phase 1
126205,Phase 1b/2a
33619,Clinical trial
149002,Phase 1/2a
17540,Phase 1
7384,Phase 2/3
119918,Approved (orphan drug)
176317,Investigative
157093,Patented
40829,Phase 0
130358,Phase 1/2
137547,Discontinued in Phase 4
31305,Phase 1
154430,Discontinued in Preregistration
166185,Phase 1b/2a
67413,Discontinued in Phase 2/3
27511,BLA submitted
86328,Discontinued in Phase 4
176341,Clinical trial
118465,Discontinued in Preregistration
50448,Phase 1/2a
12134,Phase 1/2
75124,Discontinued in Phase 2b
3654,Discontinued in Phase 2b
30979,Phase 1/2
99998,Phase 2
95192,Discontinued in Phase 1
169189,Phase 2
147130,Phase 1/2a
82096,Clinical trial
21826,Discontinued in Phase 2
9186,Discontinued in Preregistration
103166,IND submitted
191984,Phase 2a
186655,Phase 0
35436,Discontinued in Phase 2b
81526,Investigative
113304,Phase 1b/2a
171521,Discontinued in Phase 2
109193,Patented
67912,Discontinued in Preregistration
61781,Discontinued in Phase 4
1847,Phase 2a
120450,Discontinued in Phase 3
184950,Phase 0
5404,Phase 2a
17738,Phase 1b/2a
26121,Discontinued in Phase 2/3
123395,Phase 0
146315,Discontinued in Phase 2/3
101521,Patented
138829,Phase 1b
89749,Phase 1b/2a
95056,Patented
152803,Discontinued in Phase 3
127819,Discontinued in Preregistration
88780,Patented
129021,Phase 0
188334,Phase 1/2
25930,Phase 1/2
168384,Phase 1b/2a
104335,BLA submitted
122504,Phase 0
37397,Discontinued in Phase 3
92804,Phase 1/2a
22270,Phase 2b
114973,Discontinued in Phase 2
184946,BLA submitted
181084,Phase 1
101740,Phase 1
59570,Discontinued in Phase 3
157874,Phase 1/2
178513,Discontinued in Phase 1
453,Phase 2
186720,Phase 1b
103234,Investigative
33873,Discontinued in Preregistration
147058,Discontinued in Phase 2
28978,Investigative
43636,Phase 1/2a
80941,Phase 2a
9082,Discontinued in Preregistration
183977,Phase 0
6562,IND submitted
12873,Phase 1/2
9614,Discontinued in Phase 1/2
88858,Investigative
71849,Phase 0
157251,Phase 1
139472,Discontinued in Phase 2
11669,Phase 1/2a
80242,Phase 2a
187412,Patented
47091,Approved
101165,Phase 1/2a
121638,Phase 2
9103,Discontinued in Phase 2
97270,Phase 1b
117544,Discontinued in Phase 1
3988,Phase 0
179260,Phase 0
35904,Phase 1
91636,BLA submitted
95170,Phase 1/2a
57724,Phase 0
67199,Phase 1/2
163177,Patented
102984,Patented
97503,Phase 1
162943,Patented
186010,Phase 0
58498,Phase 1/2
60465,Phase 1b/2a
177213,Phase 1/2a
81400,Discontinued in Phase 3
156770,Clinical trial
42659,Phase 2
102930,Phase 1/2a
25764,Discontinued in Phase 2/3
3180,IND submitted
100065,Phase 1b
98594,Phase 1/2a
46000,Phase 2/3
176236,Patented
161746,Discontinued in Phase 1/2
95104,Patented
172516,Phase 2a
3670,Discontinued in Preregistration
189306,IND submitted
179125,Phase 1
106966,Phase 0
56251,Phase 1/2a
64215,Approved (orphan drug)
58431,Discontinued in Phase 2/3
188873,Phase 2/3
23722,Phase 0
149200,Phase 1/2
17819,Phase 1b/2a
28288,IND submitted
147092,Phase 1b/2a
25165,Phase 0
36778,Phase 1b/2a
49848,Phase 3
4924,IND submitted
169989,Investigative
104801,Patented
109322,Patented
84449,Phase 1b/2a
112010,Phase 1/2
161902,Investigative
141898,Discontinued in Preregistration
171635,Phase 2a
89922,Phase 1b/2a
48676,Phase 0
63614,Phase 2
152093,Phase 1
39027,Discontinued in Phase 4
37985,Phase 2/3
62169,Phase 1/2
52035,Phase 1/2a
7709,Phase 0
99032,Phase 1b
69583,Discontinued in Phase 3
2419,Phase 0
182251,Phase 2a
44498,Phase 2/3
107351,Phase 1b
100255,Phase 1b/2a
128191,Discontinued in Preregistration
46998,Discontinued in Phase 1/2
147745,Phase 1/2a
189756,Phase 2/3
2470,Phase 1
43608,Phase 2/3
165377,Discontinued in Phase 1
76973,Discontinued in Phase 1/2
185066,BLA submitted
107988,Discontinued in Preregistration
62751,IND submitted
40998,Approved
120257,Phase 4
107659,Phase 1/2a
168113,Approved (orphan drug)
4313,Phase 2a
97734,Phase 1b
114385,Phase 1
59155,Phase 2/3
126582,Discontinued in Phase 2/3
151188,Phase 1b/2a
77529,Discontinued in Preregistration
113358,Phase 1
163364,Phase 0
57362,Phase 0
163971,Phase 1/2
150006,Phase 1/2a
47927,Phase 0
158624,Phase 2/3
183191,Discontinued in Phase 4
63985,Discontinued in Phase 2/3
36289,Patented
99830,Phase 1
134189,Patented
140320,Clinical trial
47504,Phase 1/2
162217,Phase 0
73120,Phase 1
90690,Patented
140246,Investigative
46552,Phase 1
78270,Clinical trial
64758,Phase 1/2a
185349,Discontinued in Phase 4
41402,Phase 1/2a
32129,Phase 1b/2a
956,Discontinued in Phase 2
32483,Phase 1
148571,Phase 1/2
37333,Phase 1b/2a
5834,Phase 2a
189916,Phase 1/2a
19500,IND submitted
14195,Phase 0
162823,Phase 1/2
74482,Discontinued in Phase 3
22210,BLA submitted
129201,Phase 0
176865,Phase 1/2
138507,Approved (orphan drug)
127938,Investigative
109335,Discontinued in Preregistration
158132,Discontinued in Phase 4
5522,Phase 1/2
110163,Phase 1
112736,Discontinued in Phase 2
16703,Phase 2b
114077,Patented
72830,Investigative
118622,Discontinued in Preregistration
181128,Phase 1/2a
154662,Phase 1b/2a
49017,Phase 0
150221,Phase 2b
35838,Phase 1/2
97844,Discontinued in Phase 2
73472,Investigative
62319,Phase 1
66238,IND submitted
71828,Phase 1b/2a
22431,Investigative
104607,Investigative
11378,Investigative
160985,Phase 1b/2a
109133,Discontinued in Phase 2
191389,Phase 1/2a
135398,Phase 0
59834,Investigative
190339,Phase 1/2
116823,Discontinued in Phase 1
86696,Discontinued in Phase 2b
102758,Investigative
136347,Phase 1/2a
189694,Approved
92889,Phase 2b
53818,Phase 1b
100571,Phase 1/2a
112640,Discontinued in Phase 2
41124,Discontinued in Phase 4
102443,Discontinued in Preregistration
180107,Phase 1/2a
143162,Phase 2b
89519,Phase 0
116312,Phase 1b
35446,Discontinued in Phase 2b
188904,Phase 4
100539,Phase 2
154912,Phase 3
161956,Phase 0
29986,Patented
12837,Phase 1
120006,Approved (orphan drug)
146857,Phase 1/2a
105169,Phase 1b
16085,Phase 1/2
68489,Discontinued in Preregistration
82084,Phase 1b/2a
110718,Phase 0
2193,Discontinued in Phase 2
86007,Phase 1b/2a
188583,Phase 1/2
13358,Phase 1
102466,IND submitted
103966,Patented
96837,Investigative
116148,Discontinued in Phase 2
151221,Discontinued in Phase 2/3
2648,Phase 1b
14730,Phase 1
18122,Phase 3
41683,Investigative
26217,Phase 1/2a
31615,Clinical trial
122970,Phase 1
6304,Phase 2a
101726,Phase 1/2a
178873,Discontinued in Phase 3
77422,Phase 1/2
108005,Clinical trial
189993,Phase 1/2
168140,Approved
185401,Discontinued in Phase 4
38548,Phase 2
137447,Phase 1/2a
13267,Phase 1
156604,Approved (orphan drug)
69764,Discontinued in Phase 2/3
172004,Phase 1/2
71735,Phase 0
30992,Discontinued in Preregistration
141008,Investigative
46056,Phase 2/3
141058,Discontinued in Preregistration
150559,Phase 1/2a
61415,Patented
17579,Phase 1/2a
35922,Phase 0
69165,Phase 1b
137622,Phase 1
40196,Phase 1b
155673,Phase 2
171380,Phase 2
88310,Discontinued in Phase 2
31254,Discontinued in Phase 3
186289,Preclinical
82815,Patented
63837,Phase 2a
81891,Discontinued in Phase 1/2
30871,Investigative
51642,Phase 1b
72125,Phase 0
51899,Phase 1/2a
191503,IND submitted
157991,Phase 0
4084,Preregistration
39391,Phase 1b/2a
165899,Investigative
21974,Approved (orphan drug)
104406,Patented
105534,Phase 1/2
57654,Phase 2/3
119729,Discontinued in Phase 4
68673,IND submitted
90352,Approved (orphan drug)
28277,Phase 2a
185314,Approved
157246,Discontinued in Phase 2
88785,Phase 1/2
116910,Phase 1/2
46831,Clinical trial
81658,Approved
23093,Phase 0
76472,Phase 1/2a
85079,Phase 1b/2a
13904,Phase 0
140953,Phase 0
137539,Investigative
69308,Phase 1b/2a
87251,Approved
9510,Discontinued in Phase 1
152566,Phase 1/2a
137385,Discontinued in Phase 2/3
60592,Approved (orphan drug)
40559,Phase 1
38361,Patented
132902,Phase 1
157937,Phase 0
148509,Phase 1b/2a
121753,Discontinued in Phase 2b
157032,Registered
71556,Phase 0
101051,Phase 1/2
120500,IND submitted
93858,Discontinued in Phase 3
151548,Phase 1b/2a
143300,Phase 2/3
67078,Patented
36506,Patented
87450,BLA submitted
109516,Phase 1
7108,Phase 4
6155,Discontinued in Phase 2
151424,Discontinued in Phase 2/3
129749,Discontinued in Phase 4
70328,Phase 1
45961,Phase 2/3
119554,Discontinued in Phase 4
103929,Phase 1/2a
109599,Discontinued in Preregistration
174361,Patented
48937,Investigative
189177,Phase 0
134708,Phase 0
51784,Discontinued in Phase 3
40676,Discontinued in Preregistration
44551,Phase 2/3
69340,Phase 3
53753,Discontinued in Phase 3
136951,Patented
23640,Investigative
158149,Phase 1/2
106160,Phase 1/2a
61912,Discontinued in Phase 4
6923,Phase 2a
22177,BLA submitted
95139,Patented
92474,Discontinued in Phase 3
22660,Phase 1b
86246,Phase 0
60011,Phase 1b/2a
73073,Phase 1/2a
97073,Phase 1/2a
143080,Phase 1/2a
41454,Phase 1
188455,Phase 1/2
159211,Clinical trial
159129,Phase 1b
176431,Phase 1b/2a
36494,Investigative
136910,Discontinued in Phase 2/3
157100,Discontinued in Phase 1
94019,Discontinued in Phase 3
177947,Discontinued in Phase 4
128318,Phase 1/2
13588,Phase 1
11899,Phase 1/2a
62333,Phase 1b
156150,Discontinued in Preregistration
22337,Phase 2a
151211,Phase 1
173751,Phase 1
154368,Investigative
139359,Phase 1/2
111974,Phase 1/2
97794,Phase 2
17944,Discontinued in Phase 2/3
72131,Phase 1
116415,Discontinued in Phase 2b
142487,Phase 1/2a
60067,Phase 1b/2a
11930,Patented
25449,Phase 1/2
115779,Phase 2
170250,Phase 1
38389,Phase 0
43416,Phase 2/3
2457,Phase 2
6371,Discontinued in Phase 2
103809,Phase 1
19787,Phase 2a
130213,Patented
8098,Investigative
1085,Clinical trial
29991,Patented
100566,Patented
66411,Patented
134116,Phase 1b
78791,Phase 1b
20574,Phase 1
47379,Phase 1/2a
173458,Investigative
81492,Phase 1/2
75555,Investigative
152781,Patented
174949,Phase 1
148000,Phase 1
39136,Patented
127873,Patented
121821,Approved
52067,Phase 1/2
96011,Phase 1/2a
46775,Approved
153184,Phase 0
123870,Investigative
91734,Approved (orphan drug)
132112,Discontinued in Phase 1/2
135615,Phase 0
160133,Phase 2
64900,Phase 2a
76047,Phase 1/2a
28694,Investigative
115852,Phase 1/2
163260,Patented
162339,Phase 0
189711,Preclinical
128079,Investigative
129197,Discontinued in Phase 2b
191742,Phase 1
132206,Discontinued in Phase 4
43911,Phase 2/3
43198,Discontinued in Phase 3
78325,Clinical trial
95606,Phase 1b
59595,Phase 1
12119,Phase 1/2a
158228,Phase 1/2
141390,Discontinued in Preregistration
78579,Patented
23282,Phase 2a
161526,Discontinued in Phase 1/2
182315,Phase 1b/2a
184558,Discontinued in Phase 4
7518,Phase 1b/2a
161441,IND submitted
155640,Approved
29756,Phase 1/2
168065,Patented
41719,Discontinued in Phase 1
110565,Discontinued in Phase 2b
6423,Investigative
164622,Phase 1/2
117704,Discontinued in Phase 1
190261,Phase 1/2
96456,Discontinued in Phase 3
146194,Phase 1/2a
12165,IND submitted
54773,Discontinued in Phase 4
74061,Discontinued in Preregistration
99344,Phase 1/2a
19947,Phase 0
50933,Discontinued in Phase 2/3
107995,Discontinued in Phase 2b
47767,Phase 1/2a
22959,Phase 1
191014,IND submitted
189730,Phase 2/3
108019,Discontinued in Phase 1
84687,Phase 1/2a
156751,IND submitted
94022,Discontinued in Phase 1
56194,Discontinued in Phase 2b
117825,Phase 2b
70014,Patented
186634,Patented
109572,Preregistration
80840,Clinical trial
3797,Investigative
175851,Phase 1/2
124888,Phase 0
165090,Phase 1
133304,Approved
96072,Phase 1/2
23980,Phase 1b/2a
76600,Phase 1/2a
58586,Investigative
50261,Phase 1b/2a
112818,Discontinued in Phase 3
147296,Phase 2b
37772,Phase 1b
161119,Discontinued in Preregistration
69919,Phase 1
53825,IND submitted
167330,Discontinued in Phase 2
28090,Phase 2
118331,Phase 1
115728,Discontinued in Phase 2
127080,Phase 1
45534,Phase 1/2a
2959,Phase 1/2
181687,Phase 2/3
9583,Discontinued in Phase 2/3
151205,Phase 0
162694,Discontinued in Phase 4
127345,Discontinued in Phase 4
42849,Phase 1/2
48460,Phase 1b/2a
12605,Phase 1/2
157528,Phase 1
148492,Phase 1/2
94102,Phase 1b/2a
108163,Discontinued in Phase 1/2
61835,Discontinued in Phase 4
77951,Preregistration
54632,Discontinued in Phase 2b
147467,Phase 2a
103494,BLA submitted
57338,Discontinued in Phase 3
155835,Phase 1b/2a
153682,Phase 1b/2a
172925,Discontinued in Phase 2b
151419,Phase 1
161094,Discontinued in Phase 4
63770,Phase 1/2a
89505,Phase 2/3
75699,Discontinued in Phase 1/2
118979,BLA submitted
10034,IND submitted
145497,Discontinued in Phase 2
123643,Phase 2
98820,Phase 2
146066,Phase 1b
114495,Discontinued in Phase 1
27791,Phase 2/3
871,Phase 1/2a
116740,Discontinued in Phase 4
95821,Phase 1
49238,Phase 1b/2a
187268,Phase 1/2a
125050,IND submitted
162137,Phase 0
59558,Phase 2/3
153390,Phase 1b/2a
79671,Phase 1b
86331,Phase 1/2
111532,Phase 1
59731,Phase 1b/2a
168110,Discontinued in Phase 2/3
120471,Investigative
150491,Phase 2/3
67641,IND submitted
44860,Phase 1/2a
65335,Phase 1b
58749,Phase 1b/2a
190759,IND submitted
82636,Phase 1
76377,Phase 0
97893,Phase 1/2a
2771,Phase 1b/2a
68136,Clinical trial
72493,Investigative
96829,Phase 1/2a
137562,Phase 1/2a
15623,Discontinued in Phase 1
1433,Approved
111870,Phase 0
82709,Phase 0
8200,Investigative
24546,Discontinued in Preregistration
67711,Phase 2
27843,Phase 1
166982,Discontinued in Phase 2
20727,Discontinued in Phase 4
121257,Phase 1b/2a
2029,Phase 1/2a
64840,Approved
119007,Phase 1/2a
157749,Discontinued in Phase 4
180138,Phase 2/3
117388,Discontinued in Phase 1/2
171202,Phase 1/2
96543,Phase 1/2a
90799,BLA submitted
107633,Phase 1/2a
135227,Phase 0
179018,Phase 1/2
157715,Phase 1/2a
188935,Phase 1/2
133536,IND submitted
166979,Phase 4
111193,Discontinued in Phase 4
160957,Phase 1
188528,Phase 2b
135843,Preclinical
132268,Discontinued in Phase 2b
185418,Preclinical
125087,Phase 1b
166102,Phase 1b/2a
168252,Discontinued in Phase 1
84630,Phase 0
30436,Investigative
181268,Phase 1/2a
125448,Discontinued in Phase 3
150913,Phase 2
57065,Phase 1
181960,Phase 2
184858,Discontinued in Phase 4
167702,Discontinued in Preregistration
174758,Discontinued in Phase 4
25192,Phase 1/2
67209,Discontinued in Phase 1
88055,Approved
121136,Phase 1b
174312,Phase 1/2
62912,Phase 1b/2a
171904,Investigative
182874,Phase 2a
83346,Investigative
132392,Discontinued in Phase 1/2
85494,Discontinued in Preregistration
136937,Discontinued in Phase 2/3
113773,Phase 0
105471,Discontinued in Preregistration
38617,Discontinued in Phase 2
176162,Discontinued in Phase 2b
70424,Phase 1
24527,Investigative
129174,Discontinued in Phase 2/3
127222,Phase 0
116466,Discontinued in Phase 1
87968,Approved
35542,Phase 0
179457,Patented
110937,Discontinued in Phase 3
188856,Approved (orphan drug)
158374,Phase 1b
42828,Phase 1b
89224,Phase 1/2
80727,Phase 1/2a
96594,Phase 1b/2a
105858,Phase 1/2
3393,Phase 1/2
18542,Discontinued in Phase 2/3
167042,Discontinued in Phase 2
67788,IND submitted
99650,Phase 1/2a
47482,Patented
130023,Phase 2/3
13522,Phase 0
147519,Investigative
16587,Phase 1b/2a
21921,Investigative
1132,Discontinued in Phase 1
179938,Phase 1/2a
94279,Discontinued in Phase 2b
110164,Phase 1/2a
148511,Phase 2b
33006,Phase 1/2a
8154,Phase 2
157466,IND submitted
4549,Phase 2/3
34184,Phase 0
67478,Approved (orphan drug)
106877,Phase 1/2a
113551,Discontinued in Preregistration
38243,Phase 0
159107,Investigative
173061,Phase 2
105381,Phase 1b
92236,Patented
16760,Phase 1
30983,Phase 2
115004,Clinical trial
104652,Phase 0
124489,IND submitted
49594,IND submitted
149571,Phase 1b
93515,Phase 1/2
53669,Phase 2
1319,Approved
131076,IND submitted
156708,Approved (orphan drug)
173592,Approved
125535,Phase 1b/2a
187507,Investigative
180649,Phase 1b/2a
60321,Investigative
83338,Phase 0
93647,Phase 1
3781,Discontinued in Phase 3
4309,Preregistration
5893,Phase 4
52003,Phase 1/2a
84259,Phase 1/2a
69781,Discontinued in Phase 3
178938,Patented
55449,Phase 0
52036,Phase 1b
8481,Phase 1b
40512,Phase 0
3207,Patented
76871,Phase 0
81834,Approved
26965,IND submitted
46812,Phase 1/2a
141859,Patented
121156,Phase 2a
73349,Phase 1/2a
7702,Patented
151107,Phase 1b/2a
47852,Discontinued in Preregistration
172480,Discontinued in Phase 2b
96342,Phase 1b/2a
104960,Phase 1/2
179252,Phase 1/2
13439,Phase 2b
117165,Clinical trial
135238,Phase 0
10353,Investigative
133689,Discontinued in Phase 4
184257,Discontinued in Phase 4
55989,Discontinued in Phase 2b
167250,Discontinued in Preregistration
178132,Phase 1
52222,Phase 1
99388,Phase 1
102310,Investigative
93747,Phase 2b
152023,Discontinued in Phase 2/3
6016,Phase 2a
130218,Phase 1/2a
124727,Approved
183189,Phase 2a
52461,Discontinued in Phase 3
28553,Discontinued in Preregistration
98520,Patented
38690,Phase 1/2a
188981,Patented
63024,Discontinued in Phase 4
123209,Approved
49467,Phase 1/2a
84443,Phase 1/2
80593,Phase 1
30152,Discontinued in Preregistration
143137,Phase 1b/2a
87064,Phase 1/2a
152299,Phase 2/3
170499,Phase 0
101993,Phase 0
175155,Phase 3
40871,Discontinued in Phase 4
16299,Phase 1b/2a
125662,Phase 1b
120021,Discontinued in Phase 4
112746,Discontinued in Phase 3
169035,Clinical trial
137364,Phase 1/2
27348,Discontinued in Preregistration
107679,Discontinued in Preregistration
105705,Phase 2/3
87314,Phase 1/2
59870,Phase 1/2
106939,Phase 2b
102724,Investigative
152115,Phase 2
161014,Discontinued in Phase 3
130030,Phase 3
145798,Phase 0
148817,Phase 2b
67087,Phase 1/2
179920,Phase 1/2
180605,Phase 2a
72834,Investigative
119551,Discontinued in Preregistration
35179,Discontinued in Phase 2
27833,Phase 1b
107983,Discontinued in Phase 1
47072,Approved
48399,Phase 1/2a
115381,Phase 1/2a
166045,Phase 1b/2a
180670,Phase 1b/2a
133411,Approved
145729,Phase 1/2
71554,Phase 1b/2a
109220,Discontinued in Phase 2
67830,Discontinued in Phase 1
27827,Phase 2/3
14278,Phase 1
191397,IND submitted
17860,Phase 3
78738,Phase 0
152684,Approved
13182,Phase 1/2
121685,Phase 1b/2a
4213,IND submitted
4550,Phase 1/2
41118,Approved
79236,Phase 2/3
138024,Investigative
84513,Phase 1/2
161680,Investigative
65217,Discontinued in Phase 4
116854,Discontinued in Phase 3
102822,Approved
73958,Phase 2/3
2734,Phase 0
152603,Discontinued in Phase 3
140562,BLA submitted
40479,Phase 2
145734,Investigative
45336,Phase 2/3
93238,Discontinued in Phase 3
141482,Discontinued in Phase 2b
139199,Clinical trial
38729,Phase 2
101365,Patented
73806,Approved
149192,Patented
75419,Phase 1/2a
54911,Discontinued in Phase 2b
120380,Discontinued in Phase 1/2
57430,Phase 2/3
20013,Phase 2a
32236,Phase 2a
35434,Discontinued in Preregistration
50051,Discontinued in Preregistration
60158,Discontinued in Phase 3
135624,Phase 0
15289,Investigative
50712,Phase 1/2
176098,Phase 2
165418,Discontinued in Phase 2/3
146947,Phase 1
54503,Discontinued in Phase 2b
48744,Phase 0
191234,Patented
143276,Phase 2/3
153186,Investigative
112544,Discontinued in Phase 2
86743,Phase 1b/2a
146282,Phase 2b
190025,Approved (orphan drug)
89435,Phase 1/2a
93059,Phase 1b/2a
78646,Discontinued in Phase 4
114925,Phase 1b/2a
133705,Phase 1
156706,Phase 2
28963,Phase 4
117332,Investigative
151382,Discontinued in Phase 2/3
121700,Approved (orphan drug)
51505,Phase 0
175866,Phase 1
155037,Phase 1
86697,Discontinued in Phase 4
33406,Approved (orphan drug)
43101,IND submitted
130440,Phase 1
96729,Phase 0
80188,Phase 2a
181505,Phase 2a
50172,Phase 0
138486,Investigative
153488,Discontinued in Preregistration
138098,Clinical trial
70671,Phase 1
123686,Phase 1/2
114776,Phase 2a
95632,Phase 2a
37185,Phase 2
91832,Clinical trial
165083,Phase 1
90948,Discontinued in Phase 2/3
1645,Patented
167311,Discontinued in Phase 2
7839,Phase 1/2a
185647,Patented
80857,Phase 2a
148339,Phase 1/2a
112816,Phase 1
185291,Discontinued in Phase 3
131410,Phase 1/2
124067,Approved
85490,Discontinued in Phase 2b
173663,Phase 1b/2a
178414,Discontinued in Phase 1/2
9947,Phase 1b
61469,Patented
161182,Phase 0
51046,Patented
775,Discontinued in Phase 1
46347,Phase 1b/2a
109297,IND submitted
85650,Discontinued in Preregistration
156797,Phase 2
161349,Investigative
187701,Phase 4
76309,Investigative
114808,BLA submitted
37684,Discontinued in Phase 2b
59605,Discontinued in Phase 3
143144,Phase 1b/2a
31806,Phase 2
58639,Phase 1b/2a
145068,Discontinued in Phase 2
177445,Phase 1b
88957,Phase 1
163529,Discontinued in Phase 2/3
166972,Discontinued in Phase 1/2
183527,IND submitted
152610,Phase 1/2a
190036,Phase 2b
128930,Phase 1/2
183494,Phase 2a
163896,Phase 1/2
124475,Phase 0
96144,BLA submitted
66111,Phase 2a
40985,Approved
163943,Phase 1
167463,Discontinued in Phase 1
21464,BLA submitted
156138,Discontinued in Phase 2b
161122,Phase 0
26468,Phase 1/2a
113181,Phase 1b
128767,Discontinued in Preregistration
183314,Phase 2a
174628,Phase 1/2
143289,Phase 1b/2a
85822,Discontinued in Phase 3
161711,Investigative
7203,Phase 1b/2a
57762,Investigative
123303,Phase 1/2
110308,Phase 2b
110052,Phase 1
105033,Phase 1b/2a
142529,IND submitted
139214,Phase 1b
100381,Approved
103603,Phase 2a
86835,Phase 1b
75176,Phase 2
94107,Phase 2b
8220,Discontinued in Phase 4
164052,Phase 1/2
2414,Phase 1b
175983,Discontinued in Phase 1/2
89549,Phase 1b/2a
105628,Phase 1b/2a
132226,Phase 1b/2a
38487,Phase 0
186434,Phase 2b
120160,Clinical trial
134689,Phase 0
155987,Discontinued in Phase 4
17904,Phase 2/3
72182,Phase 1/2
107527,Phase 2b
28985,Phase 2
122858,Phase 0
76460,Phase 1/2
7538,Phase 1/2
82652,Discontinued in Phase 4
141020,Patented
42416,Phase 1b
137565,Discontinued in Phase 3
184646,BLA submitted
118456,Phase 1/2a
101111,Phase 1/2a
107057,Phase 1b
1586,BLA submitted
17385,Phase 1/2
59686,Phase 0
31298,Discontinued in Phase 2b
67471,Discontinued in Phase 1
55254,IND submitted
139693,Discontinued in Phase 2
112215,Phase 1
70880,IND submitted
60438,Discontinued in Phase 3
118052,Approved
106688,Phase 1b
70477,Investigative
121063,Phase 1
144659,Phase 0
154250,Phase 0
71338,Phase 1b/2a
19589,Phase 0
51699,Phase 1b
58068,Phase 1
114949,Phase 1/2
127763,Phase 1/2a
30045,Phase 1
93159,Investigative
111540,Phase 1/2
119224,Phase 2
171692,Discontinued in Phase 2/3
177389,Phase 1/2a
97028,Phase 2
173697,Phase 1b/2a
162868,Investigative
127784,Discontinued in Phase 3
31291,Investigative
147667,Phase 1/2a
73623,Clinical trial
60520,Phase 1b
168787,Discontinued in Phase 1
55905,Phase 2
80859,Approved
95613,Phase 2/3
117777,Phase 2
155122,Patented
142150,Investigative
161913,Investigative
129725,Patented
141687,Discontinued in Phase 4
100597,Phase 1b
2513,Phase 1b
34229,Phase 1/2a
107713,Discontinued in Phase 1
89066,IND submitted
165470,Phase 0
89631,Phase 0
109140,Phase 0
40085,IND submitted
22341,Investigative
56857,Phase 2
161300,Patented
155078,Phase 1b/2a
40223,Phase 2
42339,Phase 1b/2a
28469,IND submitted
106694,Phase 1/2a
72901,IND submitted
141137,Phase 2/3
115416,Approved (orphan drug)
58883,Discontinued in Phase 4
79892,Phase 2
132263,Discontinued in Phase 4
55130,Patented
90513,Clinical trial
104979,Patented
89651,Phase 1b/2a
192084,Phase 2
163054,Discontinued in Phase 1
66024,Phase 1b/2a
177115,Phase 2a
83495,Phase 1
133714,Phase 1/2a
82521,Discontinued in Preregistration
40084,Phase 0
24283,Phase 1b
75226,Phase 1/2
120146,Discontinued in Phase 3
9746,Discontinued in Phase 1/2
77361,Phase 1/2a
67997,Approved (orphan drug)
20873,Phase 1/2
75037,Patented
171439,Discontinued in Phase 2/3
3676,Discontinued in Phase 3
1641,Discontinued in Phase 2
173695,Approved
62388,Phase 0
110610,Phase 1
55195,Phase 1/2
164679,Discontinued in Preregistration
77238,Phase 1
529,Phase 2b
90800,BLA submitted
47228,Phase 1/2
130910,Discontinued in Phase 4
146288,Phase 2b
154062,Patented
132542,Discontinued in Phase 4
54070,Phase 1b/2a
114370,Phase 2
190520,Approved (orphan drug)
162932,Patented
179031,Discontinued in Phase 2/3
72223,Phase 0
180288,Phase 2/3
14047,Phase 1/2
124401,Phase 1b
191716,Phase 1/2
183845,Phase 1b/2a
182468,Phase 1/2a
28445,Phase 0
164644,Phase 0
77087,Phase 1/2a
35478,Phase 1/2
137012,Investigative
173289,Discontinued in Phase 2/3
97821,Phase 0
58908,Phase 1
72085,Discontinued in Preregistration
179809,Phase 1
67891,Phase 0
121322,Patented
115253,Phase 2
141187,Patented
172180,Phase 2a
120802,Discontinued in Phase 3
169130,Clinical trial
64196,Phase 1
147328,Phase 1/2
128333,Discontinued in Phase 2b
175329,IND submitted
150586,Phase 1b/2a
139220,Clinical trial
182653,Phase 2a
100039,Phase 2/3
51866,Patented
77001,Phase 0
97393,Phase 2/3
128442,Investigative
79103,Phase 2a
51162,Discontinued in Phase 2b
86839,Phase 1/2a
55003,Phase 1/2a
1501,Phase 0
63156,Investigative
63946,Phase 0
17725,Phase 1b/2a
44752,Phase 2/3
172607,Discontinued in Phase 2b
147853,Phase 2b
185878,Patented
65690,Discontinued in Phase 1
111380,Phase 2
85235,Discontinued in Phase 2b
79884,Approved (orphan drug)
187704,Phase 4
183533,Approved (orphan drug)
19425,Patented
99875,Investigative
136090,Phase 3
157829,IND submitted
46619,Patented
60762,Phase 2/3
96277,Discontinued in Phase 1/2
76333,Phase 1/2a
70922,Phase 1/2a
88403,Discontinued in Phase 4
103969,Phase 1/2a
16128,Phase 2b
51645,Discontinued in Phase 3
3989,Phase 1
113314,Phase 1b
26038,Discontinued in Phase 4
67740,Discontinued in Phase 1
182924,Phase 2a
15440,Phase 0
170733,Phase 1
10820,Phase 1
153821,Approved
125070,Phase 1
111643,Phase 2
170368,Phase 1b
142447,Phase 1/2a
58133,Phase 1b/2a
46397,Discontinued in Phase 3
63171,IND submitted
117228,Discontinued in Phase 1/2
20952,Patented
149176,Phase 1b/2a
2914,IND submitted
91902,Patented
81424,Discontinued in Phase 3
142388,Phase 1/2a
105084,Phase 1b
61122,Investigative
21930,Discontinued in Phase 2b
62540,Patented
100262,Phase 1
103928,Phase 1/2a
79120,Phase 3
168395,Discontinued in Phase 2
40091,Phase 1b/2a
8251,Investigative
43745,Phase 2/3
155441,Phase 1
71694,Discontinued in Phase 3
33785,Phase 2a
34457,Phase 0
180285,Phase 1b
144906,Investigative
129167,Phase 1/2a
104638,Phase 0
165397,Phase 1
9834,IND submitted
30667,Phase 1b
84933,Phase 1/2
75586,Phase 1/2a
99507,Phase 1
12976,Phase 1
39537,Phase 0
53123,Phase 1/2a
128363,Discontinued in Preregistration
27408,Discontinued in Preregistration
32151,Phase 2a
152302,Phase 2a
64958,Patented
166993,Discontinued in Phase 1
17524,Phase 1
92875,Discontinued in Phase 2b
88469,Phase 1
101671,Phase 2a
126730,IND submitted
152490,Phase 2/3
18073,Discontinued in Phase 3
137105,Discontinued in Phase 2/3
30065,Phase 1
186035,Phase 2a
57300,Phase 1b
35641,Phase 0
118159,Discontinued in Preregistration
147935,Phase 2a
180990,Phase 1/2a
113908,Phase 0
23174,Discontinued in Phase 2/3
69990,Phase 2
129163,Discontinued in Preregistration
47580,Patented
61424,Phase 2a
8291,Phase 2
49428,Phase 1/2a
59892,Approved (orphan drug)
126880,Phase 0
150087,Phase 2/3
114124,Phase 0
179413,Phase 1/2a
69510,Investigative
96087,Phase 1/2a
11407,Phase 1/2
184153,Phase 1/2
65951,Discontinued in Phase 2
63951,Phase 2a
190614,Phase 2/3
153100,Phase 0
82720,Phase 1b/2a
158604,Phase 2b
100227,Discontinued in Phase 3
70636,Discontinued in Preregistration
63065,Discontinued in Preregistration
115651,Phase 1/2a
163127,Phase 1
68791,Discontinued in Phase 4
103128,IND submitted
88678,Phase 1
47998,Phase 0
113894,Phase 1/2a
34464,Phase 1b/2a
24251,Phase 1b
190711,Phase 0
22277,Phase 1b/2a
159106,Approved
46891,Discontinued in Phase 2
185714,Phase 2b
37808,Phase 1/2a
72020,Phase 1/2
39241,Phase 1b/2a
22136,Discontinued in Phase 2
108692,Investigative
107911,Discontinued in Phase 1
79847,Investigative
191133,Discontinued in Phase 4
41067,Discontinued in Phase 1/2
48514,Phase 1b
135794,Phase 1b/2a
97560,Phase 2
137992,Phase 1b
36028,Discontinued in Phase 1
21438,Phase 2a
53398,Phase 1b/2a
111983,Discontinued in Phase 3
108664,Patented
93296,Phase 1b/2a
95988,Phase 1
69207,Discontinued in Phase 1/2
66395,Patented
145814,Phase 2b
95517,Phase 1
67730,Phase 2a
159264,Phase 0
49666,Discontinued in Phase 2b
79360,Phase 2
177084,Phase 1b/2a
34366,Phase 1b/2a
10490,Discontinued in Phase 2b
102236,Phase 0
45764,Phase 1/2a
41892,Investigative
87287,Phase 1
33497,Phase 2a
142137,Phase 1b
166441,Phase 0
28026,Phase 2
115405,Phase 2
62334,Investigative
170354,IND submitted
39429,Phase 2
13867,Phase 1
34584,Phase 1b/2a
153112,Phase 1b/2a
30769,Phase 1/2
19807,Discontinued in Phase 2b
72832,Phase 2
126407,Phase 1/2
30013,Phase 0
60967,Phase 1
51433,Discontinued in Phase 2/3
20826,Phase 1/2a
178984,Phase 2a
97237,Phase 1/2
71208,Phase 1b
2754,Phase 2
156333,Discontinued in Phase 2b
26716,Phase 1b
75168,Discontinued in Phase 1
126532,Discontinued in Phase 2b
141805,Discontinued in Preregistration
2238,Discontinued in Phase 2
69493,Discontinued in Phase 3
60994,Investigative
91478,Phase 1b
187611,Phase 4
165456,Discontinued in Preregistration
83949,Phase 2
75295,Discontinued in Phase 2/3
114273,Discontinued in Preregistration
169324,Phase 0
185828,Phase 1/2a
167407,Discontinued in Phase 2
45110,Phase 1/2a
35799,Discontinued in Phase 1/2
103536,Phase 1/2a
89178,Phase 1/2a
54989,Investigative
125192,Phase 1b/2a
10684,IND submitted
67,Phase 2b
88559,Phase 1
166379,Investigative
76884,Discontinued in Preregistration
46652,Approved
51606,Discontinued in Phase 2
46144,Phase 2/3
110237,IND submitted
111324,Phase 1/2
78982,Phase 2a
49806,Phase 1b
41783,Phase 1
111957,Phase 0
164509,Phase 2/3
115546,Phase 1/2a
156289,Phase 1b/2a
173162,Discontinued in Phase 2/3
15720,Discontinued in Phase 1
71011,Discontinued in Phase 3
153939,Phase 2/3
72343,Phase 1b/2a
174917,Discontinued in Phase 3
92528,Phase 1b/2a
178827,Phase 2a
5312,Phase 2a
114104,Discontinued in Phase 3
180783,Phase 1
186850,Phase 0
5189,Phase 1/2
67665,IND submitted
45142,Phase 1/2a
77090,Patented
87160,Discontinued in Phase 2/3
68141,Approved (orphan drug)
135224,Phase 0
28748,Phase 4
128170,IND submitted
130801,Phase 1b
160326,Phase 0
113137,Phase 1
103796,Phase 1/2
131641,IND submitted
40784,Phase 2b
126011,Phase 1b
108715,Phase 1
21401,Phase 1b/2a
1127,Discontinued in Phase 2
129845,Discontinued in Phase 3
108848,Phase 2b
127602,Phase 1/2
143102,Investigative
73935,Clinical trial
121576,Phase 2
180766,Phase 1b/2a
105154,Phase 1b
46835,Phase 4
18933,IND submitted
63391,IND submitted
65205,Phase 1b
7353,Investigative
172068,Discontinued in Phase 2/3
14095,Phase 1
137391,Phase 1/2a
43466,Phase 2/3
44393,Phase 2/3
69890,Phase 1
150839,Phase 2
38844,Discontinued in Phase 2b
156217,Phase 1/2
120565,Discontinued in Phase 4
177696,Approved
164286,Phase 1/2
113022,Phase 1/2
107973,Discontinued in Phase 2
34469,Discontinued in Phase 2/3
141959,IND submitted
182288,Phase 2/3
56225,Phase 0
90295,Phase 1b
191336,Investigative
38149,Phase 0
54484,Phase 1b/2a
100726,Investigative
24437,Phase 2/3
40096,Phase 1b
169587,Discontinued in Phase 2/3
20489,Phase 0
64110,Discontinued in Phase 2
97382,Phase 1b
105288,Phase 1b
47658,Phase 0
125944,Phase 1/2
93582,Phase 1b/2a
2459,Phase 1b
25214,Phase 2/3
26630,Phase 1/2a
139713,Phase 1/2a
168269,Phase 1b/2a
83418,Phase 1/2a
39406,Patented
107258,Discontinued in Preregistration
123336,Phase 1/2
6494,Phase 1/2
130051,Phase 1/2
118015,Phase 1b/2a
156185,Phase 1b/2a
162746,Investigative
62586,Phase 1
88418,Phase 1
39640,Phase 1/2a
95623,Phase 1
169938,IND submitted
141479,IND submitted
60049,Phase 0
134925,Phase 0
69301,Discontinued in Phase 3
152277,Phase 2
16065,Phase 1/2
32340,Phase 2a
38223,Phase 2a
113793,Discontinued in Preregistration
83559,Phase 1
181449,Phase 1b/2a
68705,Phase 1
173911,Clinical trial
64057,Phase 2a
100713,Phase 1/2
19495,Patented
59845,Investigative
29043,Phase 1/2a
7027,Phase 4
60281,Phase 1/2a
7627,Discontinued in Phase 3
192000,Discontinued in Phase 1/2
108781,Phase 3
91672,BLA submitted
123938,Phase 0
55993,Phase 0
44976,Phase 2/3
116629,Discontinued in Phase 1/2
176862,Discontinued in Phase 2
100661,Phase 1/2
73940,Clinical trial
49798,IND submitted
2546,Phase 1b/2a
24325,Phase 1b
114600,Investigative
79494,Phase 1b/2a
88159,Phase 0
106642,Discontinued in Phase 4
156248,Phase 1/2a
91224,BLA submitted
178595,Discontinued in Phase 1/2
6223,Phase 2a
149254,Phase 1b/2a
73506,Approved
48194,Patented
41997,Phase 1b/2a
165764,Phase 1b/2a
27415,Phase 2
135433,Phase 0
136311,Phase 1/2
117023,Discontinued in Phase 1
103402,Phase 0
97020,Phase 1/2a
63466,Phase 1
141188,Patented
181233,Phase 1
148434,Phase 1b/2a
168745,Phase 1b/2a
66663,Phase 0
100944,Phase 2
124861,Discontinued in Preregistration
185251,Discontinued in Phase 3
40895,Phase 1/2a
19683,Discontinued in Preregistration
130208,Phase 1b/2a
149721,Phase 1b/2a
118175,Discontinued in Preregistration
23355,Phase 2
66866,Phase 0
60897,Phase 1/2a
63366,Phase 1
145302,Discontinued in Phase 2
98730,Phase 1/2a
73572,Phase 2/3
86538,Patented
159506,Phase 1
76398,Phase 1b/2a
46494,Phase 1
125313,Phase 1
143222,Investigative
103616,Phase 1/2a
78210,Investigative
111410,Discontinued in Phase 4
169453,Phase 2
12962,Phase 3
139328,BLA submitted
139638,Clinical trial
101512,Phase 1b/2a
41486,Phase 1/2a
181091,Phase 1
16007,Discontinued in Phase 1
63048,Phase 0
174330,IND submitted
167060,Phase 1/2a
95533,Phase 2
29399,IND submitted
15048,Discontinued in Phase 1
183393,Phase 1/2
125870,Phase 1b/2a
139136,Phase 1b
104854,Phase 2a
63783,Phase 1/2a
82189,Phase 1b/2a
12331,Phase 1
125519,Phase 1b
122452,Discontinued in Preregistration
110974,Discontinued in Phase 2b
96402,Phase 2b
97795,Phase 1b
26715,BLA submitted
261,Phase 1/2a
138643,Phase 1b
74968,Phase 1/2a
8008,IND submitted
175339,Discontinued in Phase 1/2
32270,Discontinued in Phase 1
67708,Phase 0
98857,Phase 0
131756,Phase 2
141429,Patented
134482,Patented
67026,Phase 1b
106424,Phase 1
14120,Phase 1/2
22462,Phase 1
68135,Phase 1
102637,Phase 1
68620,Phase 2b
103874,Phase 1b/2a
149657,Discontinued in Phase 2/3
58887,Phase 2/3
103420,Phase 1
81796,IND submitted
56070,Discontinued in Preregistration
15579,Investigative
120093,Discontinued in Phase 2
39657,Investigative
189824,Approved
34394,Phase 1b/2a
85252,Discontinued in Phase 3
87550,Approved
33217,Phase 1b/2a
50054,Phase 1b/2a
94797,Phase 1b
156667,Phase 1b/2a
110058,Phase 1
161495,Phase 1/2a
77023,Phase 1/2a
21869,Phase 1b/2a
82625,Phase 1
70587,Phase 1b/2a
80599,Phase 1
44955,Phase 1/2a
152679,Discontinued in Phase 3
68619,Phase 1/2
13732,Phase 3
192052,Clinical trial
98561,Phase 1/2a
188306,Phase 4
151070,Phase 2
142807,Discontinued in Phase 1/2
87783,Discontinued in Phase 1/2
164675,Phase 1/2
72297,Phase 1b
14567,Discontinued in Phase 1
97182,Phase 1b/2a
9932,Preclinical
49455,Phase 1b
92681,Phase 1b
71095,Discontinued in Phase 3
177455,Phase 1/2a
156750,Discontinued in Phase 1/2
54030,IND submitted
110845,Phase 1b
84135,Phase 1b/2a
19833,Phase 2a
100422,Phase 1
178450,Phase 1
188969,Phase 0
99016,Phase 2
127294,Phase 0
68811,Phase 1
31062,Phase 1
54639,Discontinued in Phase 2b
56272,Discontinued in Phase 3
27700,Phase 2/3
52078,Phase 0
76732,Phase 1/2
153053,Phase 1
57002,Phase 1b/2a
37131,Phase 1
181651,Phase 2a
62497,Discontinued in Phase 3
163474,Phase 1b
134781,Phase 0
104474,Phase 1b/2a
142204,Discontinued in Phase 2b
131219,Phase 1b/2a
30925,Clinical trial
43537,Phase 2/3
109439,Phase 1
105207,Phase 1b/2a
186538,Patented
26421,Phase 0
110572,Phase 1/2
185959,Preclinical
172225,Phase 0
141490,Discontinued in Phase 4
165962,Phase 1b/2a
117425,Clinical trial
182823,Phase 2a
189860,Phase 2/3
89969,Phase 1
51371,Phase 1/2a
165775,Phase 1
88723,Phase 0
63044,Discontinued in Phase 4
71350,Phase 0
8431,Phase 1b
183466,Discontinued in Preregistration
33505,Phase 1b/2a
61809,Phase 1b
110932,Phase 1/2
78449,IND submitted
5555,Phase 2a
43729,Phase 2/3
46009,Phase 2/3
42429,Phase 0
109113,Discontinued in Phase 2
104990,Discontinued in Preregistration
101833,Phase 2
47318,Phase 1/2
12537,Phase 1/2
86240,IND submitted
187097,Phase 1b/2a
65863,Discontinued in Phase 2
9676,Phase 1b
42105,Discontinued in Phase 1
10572,Patented
35880,Investigative
169579,Phase 2
20557,Phase 1/2
60398,Phase 2/3
78274,IND submitted
138154,Approved (orphan drug)
50827,Phase 1/2a
104415,BLA submitted
117021,Investigative
177724,Phase 1b
109981,Patented
48722,Discontinued in Phase 3
17701,Phase 1
165084,Phase 1
81432,Phase 1b
48032,Discontinued in Phase 2/3
100527,Phase 1/2
48719,Phase 1/2a
113917,Phase 1
114689,Phase 2
39176,Discontinued in Preregistration
104243,Investigative
137240,Phase 2
32760,Phase 2a
79639,Phase 2
185161,Phase 1/2
171937,Phase 1b
126141,IND submitted
148458,Phase 1b/2a
125134,Phase 1/2a
134962,Phase 0
189784,Phase 1b
18387,Discontinued in Phase 3
47556,Phase 1/2a
174496,Patented
43143,Phase 1b/2a
171869,IND submitted
12696,Investigative
57838,Phase 0
127586,Phase 1/2
147084,Phase 2/3
91124,Clinical trial
191926,Clinical trial
117974,Discontinued in Phase 2
116550,Phase 1/2
163074,Phase 1/2
176582,Phase 0
71746,Phase 0
187694,Phase 2b
43168,Discontinued in Phase 1/2
23236,Phase 1b/2a
106556,Phase 0
52494,Phase 1
125123,Approved
138212,Phase 1b
111774,Phase 0
61470,Phase 2a
166396,Discontinued in Phase 1/2
160417,Phase 1/2a
101091,Phase 0
25136,Phase 2
53853,Phase 0
163601,Discontinued in Phase 1/2
44756,Phase 1/2a
43055,Patented
33049,Phase 1/2a
118278,Discontinued in Phase 1/2
14061,Phase 0
41304,Phase 1
132828,Discontinued in Phase 3
162642,Investigative
117190,Phase 1/2
53621,IND submitted
176804,Phase 1b
125425,Phase 1b/2a
114849,Patented
4268,Phase 2a
117273,Phase 1
134549,Phase 1/2a
101626,Phase 1b
4968,Investigative
130147,Patented
93414,IND submitted
119484,Phase 2/3
56973,Phase 0
59887,Discontinued in Phase 2/3
14932,Phase 1
54581,Investigative
25648,Phase 2
154846,Phase 1b/2a
55423,IND submitted
102415,Discontinued in Preregistration
164428,Phase 1/2
138625,BLA submitted
43317,Phase 1/2a
168064,Patented
57066,Phase 1b/2a
141494,Patented
169849,Discontinued in Preregistration
30924,Discontinued in Phase 3
1039,Approved
21736,Discontinued in Phase 3
133396,Discontinued in Phase 1
62706,Phase 1
6114,Phase 1b/2a
173996,Discontinued in Phase 1/2
178340,Phase 2
87637,Phase 2a
35152,Phase 1/2
24548,Phase 2/3
173540,Phase 1b/2a
45473,Phase 2/3
26384,Phase 1
188510,Phase 1b
191583,Phase 2a
51851,Discontinued in Phase 2b
145659,Phase 0
187691,Phase 0
10028,Investigative
33588,Phase 1b
58961,Discontinued in Phase 3
183477,Discontinued in Phase 2
150636,Phase 2
93436,Phase 2a
44236,Phase 1/2a
120411,Phase 0
70622,Patented
32435,Phase 1/2
102483,IND submitted
178222,Phase 2/3
124991,Approved
52970,Patented
188062,Phase 2b
185712,Phase 0
191578,Phase 2a
136289,Phase 1/2a
74210,Discontinued in Phase 3
37072,Phase 0
162099,Phase 2
15445,Phase 0
82925,Phase 1/2a
103643,Phase 2a
66597,Discontinued in Phase 2/3
142210,Discontinued in Phase 4
50244,Phase 1/2a
78534,Discontinued in Preregistration
112571,Discontinued in Phase 3
146058,Phase 2b
99143,Discontinued in Phase 2/3
70544,Discontinued in Phase 4
151974,Phase 1
27374,Discontinued in Preregistration
100318,Discontinued in Phase 2/3
148607,Patented
115710,Approved (orphan drug)
87211,Phase 0
82682,Discontinued in Phase 2/3
32429,Phase 1b/2a
93348,Phase 1b/2a
43963,Phase 1/2a
122415,Phase 1b
115453,Phase 1
39665,Phase 1/2a
30424,Discontinued in Preregistration
164069,Phase 1
127861,IND submitted
8163,Patented
76372,Phase 1b/2a
170677,Phase 1/2
69800,Investigative
21601,BLA submitted
99956,Phase 1
178277,Investigative
65070,Phase 2
132895,Discontinued in Phase 2/3
69774,Phase 2
128590,Phase 0
184760,Discontinued in Phase 4
45955,Phase 1/2a
17733,Phase 1
6546,Phase 1b/2a
57804,Phase 1b
155610,Approved
142700,Phase 2/3
108467,Discontinued in Phase 2/3
166304,Phase 1b/2a
93948,Phase 1/2a
99985,Phase 1b
61661,Discontinued in Phase 4
130295,Phase 1/2
60201,Discontinued in Phase 1/2
81591,Phase 1
167266,Phase 4
182613,Phase 3
104644,Phase 0
62381,Patented
77831,Investigative
162153,Investigative
179124,Phase 1b
131373,Discontinued in Phase 2b
111167,Phase 1/2
114295,Discontinued in Preregistration
188315,IND submitted
43189,Investigative
146109,Phase 2/3
53602,Phase 1b/2a
2878,Phase 1b
64564,Phase 2
133030,Discontinued in Preregistration
99400,Phase 1/2
140458,Phase 1
180004,Discontinued in Phase 2
52030,Phase 1b/2a
104744,Phase 1/2a
91209,Phase 1b
177721,Phase 2a
48742,Phase 0
42221,Phase 0
14121,Phase 1/2
176049,Discontinued in Phase 4
37686,Phase 1/2
37007,Discontinued in Phase 3
103861,Phase 1/2
156912,Phase 1/2
126510,Discontinued in Phase 2b
187484,Phase 2b
124148,Phase 1/2
78809,Phase 0
157425,Phase 1b/2a
14754,Phase 0
88660,Phase 0
65839,BLA submitted
191509,Discontinued in Phase 1
128864,Discontinued in Phase 3
101785,Phase 2
160258,Discontinued in Preregistration
32815,Phase 2/3
104150,Phase 1/2a
144205,Phase 3
149706,Phase 1b/2a
78636,Phase 3
51923,Investigative
1887,Approved
111879,Patented
462,Discontinued in Phase 1/2
93085,Phase 1b/2a
148705,Phase 2
74530,Discontinued in Phase 3
44139,Phase 1/2a
141140,Patented
82219,Clinical trial
6915,Phase 1b/2a
154227,Patented
164301,Phase 1/2
113897,Phase 1
138928,Phase 1b
171461,Phase 0
74469,Phase 1/2a
137260,BLA submitted
114095,IND submitted
24949,Phase 1b
67099,Patented
18659,Discontinued in Preregistration
49790,Phase 1b
95758,Patented
118518,Discontinued in Phase 3
181734,Phase 1
72077,Phase 0
95007,Patented
69033,Phase 2a
162475,Discontinued in Preregistration
138433,Phase 1b
7842,Phase 2
5147,Discontinued in Phase 2
103057,Phase 0
28941,Phase 1/2a
105787,Phase 2/3
112149,Phase 0
31000,Phase 0
59970,Discontinued in Phase 3
34292,Phase 1b/2a
97135,Phase 1/2a
189262,Phase 2/3
68638,Phase 2a
53745,Discontinued in Phase 2/3
154532,Phase 2/3
91451,Investigative
176674,Phase 1/2a
177690,Phase 1b/2a
151907,Phase 2/3
44861,Phase 1/2a
70610,Discontinued in Preregistration
120619,Phase 0
60221,Discontinued in Phase 3
89669,Phase 1b/2a
146653,Phase 1/2a
113534,Phase 1/2a
36422,Discontinued in Phase 3
138980,BLA submitted
185854,Patented
108709,Discontinued in Phase 2/3
163626,Discontinued in Phase 1/2
28801,Phase 1b
116322,Discontinued in Phase 2b
17831,Discontinued in Phase 1
151538,Phase 1
108090,Phase 2
83016,Phase 0
131152,Patented
172216,Phase 0
27314,Phase 1
70238,Phase 2/3
147466,Investigative
145864,Phase 2b
32486,Phase 1b/2a
54449,Discontinued in Preregistration
59119,Phase 1
17331,Phase 1
92762,Phase 1/2a
178701,Phase 1/2a
186891,Phase 4
69197,Phase 2b
182077,Phase 1/2a
19658,Approved
180923,Phase 2a
94561,Phase 1
9100,Phase 1
29105,Phase 4
120710,Approved (orphan drug)
54670,Phase 0
99337,Phase 1
77379,Phase 1/2a
165482,IND submitted
169894,Investigative
115402,Phase 1/2a
113333,Phase 1b/2a
114779,Discontinued in Preregistration
69283,Discontinued in Phase 3
76608,IND submitted
90134,Clinical trial
303,Phase 1
108880,Discontinued in Preregistration
163276,Clinical trial
187498,Patented
41548,Discontinued in Phase 1
78774,Phase 2/3
132047,Patented
61306,Phase 1
11527,Phase 2/3
3625,Approved
170030,IND submitted
154737,Phase 3
121591,Discontinued in Phase 1
113611,Phase 1
32753,Discontinued in Phase 1
73019,Investigative
162506,Investigative
4294,IND submitted
13239,Phase 0
68733,IND submitted
2504,Phase 1b
59308,Phase 1/2a
12505,Investigative
42550,Phase 0
19578,Phase 0
160072,Phase 1b
32502,Phase 1/2a
131957,IND submitted
31021,Investigative
166247,Patented
152838,Discontinued in Phase 3
44665,Phase 2/3
11315,Phase 2
88661,Patented
97418,Phase 1/2a
149305,Phase 1/2a
172754,Discontinued in Phase 2
14777,Phase 1
49589,Phase 2
172092,Phase 1/2
72470,IND submitted
66370,Phase 0
27267,Phase 1/2a
60475,Discontinued in Phase 2/3
6680,Phase 2a
102260,IND submitted
116622,Discontinued in Phase 2b
136108,Phase 2
178562,Discontinued in Phase 3
169143,Investigative
86193,Investigative
114358,Phase 0
74269,IND submitted
180613,Phase 3
99792,Phase 1
49510,Phase 1b/2a
40826,Phase 1/2
179360,Phase 1
129278,Phase 1/2
82889,Phase 2/3
179476,Discontinued in Phase 1
159955,Phase 1b/2a
111901,Phase 1/2
172746,Discontinued in Phase 2b
68271,Phase 0
184417,Phase 1/2
26128,Investigative
77890,Investigative
139173,BLA submitted
182854,Phase 2a
23297,Discontinued in Phase 4
30005,Phase 1
8318,Phase 0
34472,Phase 1
125836,BLA submitted
120688,Clinical trial
62603,Phase 1b
37670,Discontinued in Preregistration
115354,Phase 1b/2a
181576,Phase 2b
24024,Phase 1b
55959,Investigative
103678,Phase 1/2
74689,Phase 1/2
92580,Phase 1b
27019,IND submitted
76459,Phase 1/2
36605,Discontinued in Preregistration
34108,Phase 1b/2a
132485,Discontinued in Phase 4
24836,Phase 2a
146854,Phase 1/2
7067,Phase 2/3
49973,Phase 1b/2a
136588,BLA submitted
137511,Investigative
38620,Discontinued in Preregistration
130097,Phase 2a
187399,Preclinical
85725,Discontinued in Preregistration
132102,Discontinued in Phase 1/2
85257,Discontinued in Preregistration
57874,Investigative
163509,Phase 1b/2a
184564,Phase 0
88302,Discontinued in Phase 1
106533,Approved
145105,Phase 1/2
157839,Registered
47563,Phase 1b
129570,Discontinued in Phase 2b
185669,Patented
180020,Discontinued in Phase 2
69795,Phase 1/2a
58982,Discontinued in Phase 3
135381,Phase 0
188261,Phase 1b/2a
140043,Phase 1/2a
124702,Patented
5983,Phase 4
151373,Phase 1
136960,Phase 2
7762,Phase 1/2a
60456,Phase 1/2a
102972,Phase 1/2a
177918,Discontinued in Phase 2b
88644,Phase 1
141040,Phase 2/3
48754,Patented
32138,Patented
99868,Phase 1
36519,Phase 2
117409,Discontinued in Phase 1/2
184784,Discontinued in Phase 4
151911,Phase 2a
131257,IND submitted
106021,Phase 2/3
168504,Discontinued in Phase 1/2
25917,Phase 2/3
134435,Phase 1/2
59929,Investigative
9513,Phase 0
59947,Discontinued in Phase 4
29731,Investigative
36920,Discontinued in Preregistration
159780,Phase 2b
142029,Patented
70503,Phase 1/2a
100544,Phase 2/3
80085,Approved (orphan drug)
159793,Phase 1b/2a
92573,Phase 2a
63398,Discontinued in Phase 3
57102,IND submitted
65340,Approved
162806,Phase 1/2
164642,BLA submitted
116685,Clinical trial
124583,Phase 0
122591,Phase 1
21969,Approved (orphan drug)
60422,Investigative
176983,Phase 2
109353,Phase 4
160173,Discontinued in Phase 1/2
68204,Phase 2b
76672,Investigative
112983,Phase 2a
141510,Discontinued in Preregistration
190135,IND submitted
51781,Discontinued in Phase 3
77546,Phase 1
123720,Phase 0
163576,Discontinued in Phase 2
132704,Phase 1/2
41350,IND submitted
83741,Phase 0
56652,Phase 2
190681,IND submitted
130210,Patented
18898,Phase 1b
168864,Clinical trial
22636,Phase 1/2
67500,Phase 1b/2a
110175,Phase 1
76990,Phase 1/2a
186185,Phase 2a
123655,Phase 1/2
45783,Phase 2/3
148435,Phase 1b/2a
168593,Phase 1b/2a
50779,Phase 1/2a
103459,Phase 1b
16706,Phase 3
63360,Patented
148386,Investigative
102120,IND submitted
88272,Phase 1/2
57360,Phase 0
156893,IND submitted
28723,Phase 1/2a
78248,Approved (orphan drug)
112342,Phase 0
43211,Phase 0
57635,Phase 1
153248,Phase 1
44276,Phase 1/2a
99144,Patented
39985,IND submitted
75685,Investigative
178149,Phase 2/3
152019,Phase 1/2
18067,Phase 1
88300,Phase 1
85537,Discontinued in Phase 3
149316,Phase 1b/2a
146552,Phase 2/3
161908,Phase 1b
102314,Phase 1/2a
46925,Approved
62292,Phase 1b
169160,Patented
187191,Phase 4
84545,Phase 0
21561,Patented
58676,Phase 0
190700,Phase 1b
113345,Phase 1/2
179123,Phase 1b
47760,Discontinued in Phase 2/3
30532,Phase 0
50490,Discontinued in Phase 3
172344,Phase 1/2
147761,Phase 2/3
146777,Phase 1/2
117873,Phase 2b
110873,Phase 1
107470,Phase 0
47208,Discontinued in Phase 1/2
111088,Patented
106797,Phase 1b
32130,Phase 2a
111624,Phase 1/2
24995,Patented
130423,Phase 0
66528,Phase 1
18170,Phase 2a
26024,Phase 2
33289,Phase 1b/2a
187700,Phase 2a
148576,Phase 1/2
161527,Discontinued in Preregistration
65030,Phase 1b/2a
154899,Phase 1b/2a
41418,Phase 1b/2a
159392,Phase 1/2
114921,Clinical trial
164409,Discontinued in Preregistration
151093,Phase 1
161502,Investigative
182338,Phase 2/3
117411,Phase 1b
183302,IND submitted
26218,Phase 1/2a
66827,Patented
165166,Discontinued in Preregistration
140414,Phase 2
118043,Discontinued in Preregistration
103356,Phase 1b
140117,Phase 1b
90444,BLA submitted
167490,Discontinued in Preregistration
148737,Investigative
133043,Phase 1b/2a
125648,Discontinued in Phase 4
74934,Phase 1b/2a
129333,Phase 1/2
86830,Discontinued in Phase 2
27507,BLA submitted
132202,Phase 1
172080,Patented
130470,Phase 0
31959,Phase 1
74854,Phase 2/3
99710,Patented
179349,Discontinued in Phase 1/2
102418,Approved (orphan drug)
91390,Clinical trial
136368,IND submitted
150234,Phase 1b
68046,Discontinued in Phase 1
62900,Patented
188587,Phase 2/3
163089,Discontinued in Phase 2/3
23611,Phase 0
44701,Phase 1/2a
31090,Phase 0
157953,Phase 1
24545,Discontinued in Phase 4
6749,Discontinued in Phase 2
168196,Phase 2
134448,Phase 1/2
13218,Phase 0
152736,Approved
19592,Phase 1
132293,IND submitted
7221,Phase 1b/2a
124251,Phase 1/2
73888,Phase 2/3
39963,Phase 0
142715,Discontinued in Phase 4
27607,Phase 1b/2a
139483,BLA submitted
76978,Phase 1
175306,Patented
43106,Phase 1b
101559,Investigative
154934,Phase 1b/2a
24238,Phase 1
31357,Phase 1b
171323,Phase 1
7730,Phase 1/2a
147768,Phase 1b/2a
120860,Discontinued in Phase 2
170140,Phase 0
53042,Discontinued in Preregistration
65651,Preclinical
167481,Phase 4
85233,Discontinued in Preregistration
163042,Discontinued in Phase 3
59786,Phase 1/2
158099,Registered
39803,Phase 2/3
189347,Preclinical
62475,Phase 1/2
174587,Phase 0
121943,Discontinued in Phase 2b
49519,Phase 1/2a
187011,Phase 4
124152,Phase 1/2
156557,Discontinued in Phase 2
177606,Phase 1b
24724,Phase 2
132932,Phase 2
102234,Approved
51047,Phase 1/2
2252,Phase 1b
152491,Phase 1b/2a
19982,Approved (orphan drug)
105848,Phase 1b
109131,Discontinued in Preregistration
160276,Phase 1b
165527,Phase 1
37504,Discontinued in Preregistration
121219,Phase 0
159012,Phase 1b/2a
170606,IND submitted
25218,Phase 1/2a
165039,Discontinued in Preregistration
44332,Phase 1/2a
12114,Phase 2a
57704,Phase 1
96430,Phase 2b
83599,Phase 0
46520,Phase 1/2
95681,Discontinued in Preregistration
44841,Phase 2/3
142230,Discontinued in Preregistration
93778,IND submitted
51572,Discontinued in Phase 2b
16171,Phase 1
43197,Discontinued in Phase 3
61290,Patented
153440,Phase 1
179780,Discontinued in Phase 2b
31448,Discontinued in Phase 2b
93363,Investigative
28852,Phase 1b/2a
36483,Discontinued in Phase 1/2
28059,Discontinued in Preregistration
43846,Phase 1/2a
12951,Phase 0
87752,Phase 2a
10637,Phase 0
121799,Phase 1b/2a
157920,Discontinued in Phase 1/2
15244,Phase 1b/2a
129907,Discontinued in Preregistration
3106,Phase 2a
132686,Discontinued in Preregistration
137225,Phase 1/2
19300,IND submitted
133178,Discontinued in Phase 3
151852,Phase 1
102671,Application submitted
97798,Phase 1b/2a
173985,Discontinued in Preregistration
8762,Phase 1b/2a
183285,IND submitted
37637,Discontinued in Phase 3
105816,Phase 1/2
29196,Investigative
131622,IND submitted
36994,Discontinued in Preregistration
95727,Phase 1/2
107053,Discontinued in Phase 2b
157017,Phase 1
101921,Phase 2a
177816,Phase 1/2
107684,Discontinued in Phase 1/2
3289,Phase 0
145443,Phase 1/2a
45809,Phase 2/3
143001,Phase 1b/2a
175996,Discontinued in Phase 3
120443,Phase 0
177547,Phase 1b/2a
28765,Investigative
126104,Phase 1
117125,Clinical trial
107921,IND submitted
2079,Phase 2
55171,Discontinued in Phase 2/3
2801,Patented
13203,Phase 1
16736,Phase 1/2
21310,Phase 1
116429,Discontinued in Phase 1/2
110495,Phase 3
111840,Phase 1/2
165385,Discontinued in Phase 2/3
190095,Phase 2/3
31233,Discontinued in Preregistration
101116,Investigative
165053,Phase 1/2
118937,Phase 2
91959,Phase 1/2a
49310,Phase 1b/2a
60556,Phase 0
177431,Phase 2
47934,Discontinued in Phase 2
137192,Phase 2
150542,Phase 1b
139270,Phase 1/2a
114873,Phase 2/3
190662,Phase 2b
104758,Phase 2
94679,Discontinued in Phase 4
14257,Phase 0
61009,Phase 1/2a
140234,BLA submitted
152174,Phase 1
92380,Phase 1/2
66770,Phase 0
87975,Phase 0
37465,Discontinued in Phase 1
113098,Phase 1/2
113008,Discontinued in Phase 1
5552,Discontinued in Phase 2
188371,Phase 0
66717,Patented
185939,Patented
62697,Discontinued in Phase 3
60647,Discontinued in Phase 4
143179,Investigative
55568,Phase 1b
152980,Discontinued in Phase 2b
10203,IND submitted
55645,Discontinued in Preregistration
58113,Phase 1b/2a
113558,Phase 1/2a
177014,Phase 0
46010,Phase 2/3
61563,IND submitted
56406,Discontinued in Phase 4
106698,IND submitted
28540,Phase 1b
184861,Phase 1/2
190575,Phase 1b/2a
69570,Phase 1
129228,Discontinued in Phase 2b
175881,Phase 2
51953,Discontinued in Phase 2b
52679,Phase 1/2
124131,Phase 1b
40202,Discontinued in Phase 4
14271,Phase 1
185981,Patented
40425,Phase 1/2a
75145,Phase 1/2
36975,Phase 1b
101286,Phase 0
179060,Discontinued in Phase 1
118737,Phase 1
177253,Phase 1b
152788,Approved
95144,Discontinued in Phase 1
113535,Phase 1b/2a
125963,Phase 1b
32573,Phase 2/3
109258,Phase 1/2a
100877,Phase 1/2a
97097,Phase 1/2
183768,Phase 1/2
162883,Patented
167204,Phase 1/2a
42234,Investigative
118135,Clinical trial
167738,Discontinued in Phase 2/3
31853,Phase 2
13752,Investigative
77342,Phase 1
26799,BLA submitted
33738,Phase 2/3
183983,Discontinued in Phase 4
33451,Clinical trial
110386,Phase 3
67295,Phase 1b
154535,Phase 1b/2a
45866,Phase 2a
129283,Patented
28663,Discontinued in Phase 2/3
72480,Phase 2
176771,Phase 1b
114142,Phase 0
25823,Investigative
103172,Investigative
69199,Phase 1b
95115,Patented
38306,Phase 0
169927,Patented
40145,Discontinued in Preregistration
92650,Discontinued in Phase 2
146080,Phase 1/2
163645,Patented
59633,Discontinued in Phase 3
44615,Phase 2/3
54937,Phase 2
32533,Phase 1/2
118398,Phase 1/2a
161779,Phase 2
5652,Investigative
186739,Preclinical
135450,Phase 0
58200,Phase 0
167455,Discontinued in Phase 2
788,Discontinued in Phase 3
62062,Phase 1b
192069,Discontinued in Phase 2b
149793,Phase 0
111475,Phase 2
167471,Phase 4
12800,Phase 1/2
11175,Discontinued in Phase 3
136060,Phase 1b/2a
15324,Phase 1b/2a
146195,Phase 1b/2a
154916,Phase 2/3
68374,Phase 1/2
176219,Investigative
165475,Discontinued in Phase 4
166188,Phase 1b
142600,Phase 1/2a
157381,Phase 1
86321,Phase 1/2
155303,Phase 1b
175068,Phase 1/2
128359,Discontinued in Preregistration
180666,Phase 1b/2a
122675,Discontinued in Preregistration
126540,Phase 1
100871,Phase 1/2
154942,Phase 1b/2a
88013,Discontinued in Phase 1/2
127326,Investigative
183971,Discontinued in Phase 4
150658,Phase 1/2
34252,Phase 0
50319,Phase 1
179251,Phase 1/2
169034,Discontinued in Phase 1
160403,Phase 0
29140,Phase 1b/2a
135893,Phase 1/2
97895,Phase 1
53831,Phase 0
88359,Phase 1/2a
137862,Discontinued in Phase 2/3
79021,Phase 3
49150,Phase 0
70490,Phase 0
6943,Phase 2/3
7034,Phase 1/2
136967,Investigative
135112,Phase 0
120109,Discontinued in Phase 2
34386,Phase 1
119513,Discontinued in Preregistration
146511,Discontinued in Phase 2
109064,Discontinued in Phase 3
130332,Investigative
10636,Phase 1b/2a
38013,Discontinued in Phase 2b
236,Discontinued in Phase 2/3
156596,Discontinued in Phase 2
154078,Phase 1/2a
82772,Phase 2
63010,Phase 1/2a
140859,Phase 3
134970,Phase 0
65719,Phase 1b/2a
2594,Phase 1b
86643,Patented
95287,Phase 1b/2a
170633,Phase 1b/2a
110013,Phase 1
136238,Discontinued in Phase 2/3
186677,Phase 1b/2a
65159,Phase 1
78494,Discontinued in Phase 2
152612,Approved
97333,Phase 1/2a
31185,Phase 1
78818,Phase 2/3
61219,Phase 1
107308,Phase 0
36050,Phase 1
81398,Phase 1b/2a
129222,Phase 1/2
27983,Phase 2/3
90940,Phase 2/3
134193,Discontinued in Phase 4
58406,Investigative
124637,Phase 1
59574,Phase 0
94477,Phase 1/2
144992,Phase 2/3
126313,Phase 1/2
66167,Phase 1/2a
127686,Investigative
30849,Discontinued in Phase 2b
184577,Phase 0
40796,Phase 1
68634,IND submitted
132624,Phase 2
38346,Phase 1b
84077,Phase 1b/2a
8234,IND submitted
83674,Phase 1/2
99277,Phase 2
137913,Phase 1/2a
166928,Phase 1/2a
190101,Preclinical
44083,Phase 1/2a
185638,Patented
129705,Phase 0
142632,Phase 1b/2a
47356,Discontinued in Phase 1
172757,Discontinued in Phase 2b
78769,Phase 1b
104871,Discontinued in Preregistration
129385,Patented
90537,Preregistration
4600,IND submitted
187675,Phase 0
118358,Phase 2b
119302,Phase 2a
92709,Phase 1/2
172102,Discontinued in Phase 2b
27508,BLA submitted
138241,Discontinued in Phase 2
110705,Phase 1
25918,Phase 2/3
13734,Phase 0
28106,Phase 1b/2a
183914,Phase 2a
9556,IND submitted
25848,Phase 1/2a
112143,Phase 1
164835,Discontinued in Preregistration
35234,Phase 2
151479,Phase 2
124015,Phase 1
10432,IND submitted
50999,Phase 1
61679,Discontinued in Phase 4
68401,Approved (orphan drug)
173547,Phase 1
13452,Phase 1/2a
76231,Investigative
95076,Phase 1/2a
4086,Investigative
127651,Discontinued in Preregistration
157896,Discontinued in Phase 2
98582,Phase 1b/2a
181632,Phase 1
46246,Investigative
170457,Phase 0
50269,Phase 2
186570,Phase 1b
109753,Discontinued in Preregistration
25404,Phase 1/2a
110189,IND submitted
181344,Discontinued in Phase 2b
39185,IND submitted
25152,Phase 1/2
46982,Phase 4
56012,Discontinued in Preregistration
181899,Phase 1b/2a
185526,Phase 2a
7021,IND submitted
57713,Phase 1b/2a
138768,Discontinued in Phase 2
92717,Investigative
55509,Discontinued in Preregistration
106442,Approved (orphan drug)
91283,Phase 1b
42951,Phase 1b
115189,Phase 1/2a
80312,Phase 2
149831,Phase 2b
135075,Phase 0
144474,Discontinued in Phase 1/2
7180,Phase 4
140978,Discontinued in Phase 2b
119114,Phase 1
149647,Phase 2b
188393,IND submitted
106923,IND submitted
161383,Investigative
189120,Discontinued in Phase 3
104091,Phase 1b
5372,Discontinued in Phase 2
42049,Phase 1
79660,Approved (orphan drug)
86258,Discontinued in Phase 4
32335,Phase 1/2a
106774,Discontinued in Phase 3
116189,Phase 1/2a
6051,Phase 1b/2a
70545,Patented
110404,Phase 3
147770,Phase 2b
73434,Approved
106903,Phase 1b
151957,Phase 2
37002,Phase 2a
183125,Phase 2b
22903,Phase 1b/2a
154889,Phase 3
165243,Phase 0
153193,Phase 1
181262,Phase 1/2a
47148,Phase 1/2
148695,Discontinued in Phase 2
172740,Discontinued in Phase 2/3
160375,Phase 1
7599,Phase 1b
10015,Investigative
180726,Phase 2b
34535,Phase 1/2a
88883,Phase 0
127781,Patented
69405,Discontinued in Phase 1/2
94473,Phase 2b
158428,Phase 1b/2a
176657,Discontinued in Phase 4
130712,Clinical trial
33309,BLA submitted
170691,Phase 1
99794,Patented
67397,Discontinued in Phase 1
15568,Phase 1
4627,IND submitted
107757,Discontinued in Phase 2
69724,IND submitted
100082,Patented
56976,Phase 1/2a
182071,Phase 2a
23504,Phase 2a
134938,Phase 0
80578,Phase 2a
184502,BLA submitted
70878,Phase 1/2
125833,Phase 1/2
173307,Phase 1/2
190723,Patented
93365,Phase 2
17264,Phase 0
60999,Phase 1
5731,Phase 4
181547,Discontinued in Phase 4
8043,Patented
87191,Phase 1/2
186472,Phase 1b
70118,Investigative
148799,Discontinued in Phase 2/3
68614,Phase 1b
57441,Phase 1b/2a
101377,Patented
17234,Phase 1
158230,Phase 1/2a
124653,Phase 1
75771,Phase 0
44681,Phase 2/3
73280,Investigative
93236,Phase 2
115311,Approved (orphan drug)
87170,Phase 1/2
35949,Phase 2b
91931,Investigative
19694,Approved (orphan drug)
18901,Discontinued in Preregistration
133280,Discontinued in Phase 1
3773,Discontinued in Phase 2b
125667,Phase 1/2a
51067,Phase 1
102471,Discontinued in Preregistration
114745,Discontinued in Phase 1
44870,Phase 1/2a
65355,Phase 1b/2a
10257,Preclinical
99436,Phase 1/2a
65015,Discontinued in Phase 2
95003,Discontinued in Phase 4
45998,Phase 1/2a
150156,Phase 1b
164011,BLA submitted
181342,Phase 1
117529,Discontinued in Phase 1/2
87270,Patented
35715,Discontinued in Phase 3
635,Phase 1/2a
55849,Discontinued in Preregistration
157069,Phase 1
134333,Discontinued in Phase 4
153022,Discontinued in Phase 2b
60352,Phase 1b
13479,Phase 1
129012,Discontinued in Phase 2b
867,Phase 1/2
146724,Phase 1b
55598,Phase 2
11841,Discontinued in Phase 2b
139582,Discontinued in Phase 2
84107,Phase 2
5168,Phase 2a
90303,Discontinued in Phase 1
62596,Investigative
108585,Discontinued in Phase 1
44381,Phase 1/2a
13005,Phase 0
152483,Phase 0
121669,Approved
115315,Phase 1/2a
143841,Phase 1b/2a
50384,Phase 1
5118,Investigative
9591,Phase 0
101730,Phase 2b
30800,Investigative
158392,Phase 2/3
167548,Discontinued in Phase 1/2
39455,Phase 1
19680,Phase 1/2
27074,IND submitted
69745,Discontinued in Phase 3
163273,Discontinued in Preregistration
78602,Discontinued in Phase 4
77928,Discontinued in Phase 1
55661,IND submitted
41179,Discontinued in Phase 4
170115,Phase 1/2
84082,Phase 1b/2a
11963,Phase 1
185176,Investigative
150875,Phase 2
26308,Phase 2
129948,Discontinued in Phase 3
90496,BLA submitted
48403,Phase 0
187841,Discontinued in Phase 2
56208,Phase 2
67091,Patented
120885,Investigative
165009,Discontinued in Preregistration
142180,Discontinued in Phase 2b
20390,Phase 1/2
35521,Phase 0
38471,Phase 1b
7921,Patented
117837,Phase 1/2a
40208,Phase 1
183734,Phase 2a
189098,IND submitted
189490,Phase 2b
90433,Phase 0
152888,Phase 1b/2a
107394,Phase 1/2a
85350,Discontinued in Preregistration
163343,Investigative
45893,Phase 1/2a
158771,Phase 0
129332,Discontinued in Phase 3
142148,Patented
112146,Discontinued in Phase 3
178538,Discontinued in Phase 2/3
164574,Phase 1/2
107950,Discontinued in Phase 2b
94871,Discontinued in Phase 4
78671,Phase 0
146023,Investigative
150790,Phase 2
12415,Phase 1/2
100054,Phase 2
142301,Discontinued in Phase 2b
108067,Investigative
67719,Discontinued in Phase 4
137464,Phase 2
69704,Phase 1b/2a
174855,Phase 2
152786,Phase 1/2a
125909,Discontinued in Phase 4
182029,Phase 1/2
16510,IND submitted
54992,Discontinued in Preregistration
155189,Phase 1b
153399,Phase 1b/2a
107982,Discontinued in Phase 2/3
99302,Patented
33028,Phase 1/2a
132584,Phase 0
168,Approved (orphan drug)
81812,Phase 2
155345,Phase 1
44258,Phase 2/3
33030,Phase 3
70323,Phase 1b/2a
21072,Phase 1/2a
127140,Discontinued in Phase 2b
112118,Phase 1/2
127398,Investigative
36282,Discontinued in Phase 3
76645,Phase 1/2a
155477,Patented
125030,Phase 1b/2a
161888,Phase 1b
65246,Phase 2a
88588,Phase 1
17330,Phase 1
132674,Phase 1b/2a
145982,Discontinued in Phase 1
76904,Phase 2/3
76425,Phase 1/2a
36768,Discontinued in Phase 2b
62377,Discontinued in Phase 3
63765,Clinical trial
96323,Discontinued in Phase 1/2
39488,Phase 0
40646,Phase 1b
89113,BLA submitted
156895,Discontinued in Phase 1/2
105797,Phase 1/2a
60121,Phase 1b/2a
14112,Phase 2b
14484,Phase 0
19048,Phase 1/2
169818,Patented
132863,Phase 1/2
35327,Phase 1/2
186936,Phase 2a
3865,Phase 1b
188551,Clinical trial
167365,Discontinued in Phase 1
40548,Phase 2
97215,Phase 1/2
151592,Phase 2
63477,Discontinued in Phase 2b
14798,Phase 1
105591,Phase 1
36738,Discontinued in Phase 2b
177827,Phase 1b/2a
157024,IND submitted
106404,Phase 1
87972,Discontinued in Phase 2/3
28776,Phase 1b/2a
55755,Investigative
166658,Patented
12613,Phase 1
110840,Phase 1
55470,Patented
75705,Phase 0
171711,Phase 1/2
102956,Patented
94498,Phase 2b
87382,Discontinued in Phase 1
84641,Phase 0
169744,IND submitted
131818,IND submitted
92243,Phase 2b
72378,Phase 1b
83167,Phase 1/2
118680,Discontinued in Preregistration
19780,Phase 2
3036,Phase 2a
22038,Phase 0
36930,Phase 2
50663,Discontinued in Preregistration
147263,Phase 2b
37914,Phase 1b
77972,Discontinued in Phase 2/3
19037,Phase 1/2
125624,Phase 1/2
60877,Phase 1b/2a
97533,Phase 2/3
137182,Phase 1b
132897,Discontinued in Phase 1/2
140068,Approved (orphan drug)
51163,Discontinued in Phase 2b
31375,Clinical trial
153565,IND submitted
174331,Phase 1/2
156777,IND submitted
161413,Investigative
178291,Phase 2/3
55919,Discontinued in Phase 2b
142733,Phase 1b/2a
16605,IND submitted
168246,Approved (orphan drug)
59068,Phase 0
161605,Phase 2a
110254,Investigative
121931,Phase 1b/2a
29184,Phase 1/2a
161861,IND submitted
184670,BLA submitted
56081,Discontinued in Preregistration
144334,Phase 1/2a
91380,Phase 1b/2a
115746,Phase 1b
74809,Phase 1/2
158760,IND submitted
113635,Phase 1
11052,Discontinued in Preregistration
113054,Phase 1
65785,Discontinued in Phase 2
185747,Phase 1b/2a
161023,Patented
153041,Phase 1b/2a
111227,Phase 1/2
178534,Phase 0
25603,Discontinued in Phase 2/3
164906,Phase 1/2a
137088,Phase 1/2a
177007,Phase 2/3
59427,Phase 1
3432,IND submitted
100949,Phase 2/3
8992,IND submitted
104405,Patented
173585,Phase 1
80922,Phase 1b/2a
34253,Phase 0
175954,Patented
111717,Discontinued in Phase 2b
45007,Phase 2/3
164593,Investigative
46536,Discontinued in Preregistration
107497,Phase 1b
85238,Discontinued in Phase 2b
81347,Clinical trial
67070,Patented
120509,Discontinued in Phase 2
10035,Discontinued in Phase 2b
16376,Phase 1
2727,Phase 2
86939,Phase 1/2
147381,Phase 1b/2a
134790,Phase 0
128778,Discontinued in Phase 2b
141749,Discontinued in Phase 2b
98094,Phase 0
69019,Phase 1b
40191,Phase 1b/2a
29565,Approved
180394,Discontinued in Phase 2b
25969,Phase 1/2
99819,Phase 1
113371,Phase 1b
1378,Phase 1/2
66821,Patented
104736,Phase 1b
145141,Phase 1/2a
173170,IND submitted
82510,Discontinued in Phase 4
63933,Approved (orphan drug)
101226,Patented
170489,Phase 1/2
36192,Phase 1
70796,Phase 2
112135,Discontinued in Phase 2
175327,Phase 1
74604,Investigative
81869,Phase 1b/2a
148312,Phase 1
101439,Discontinued in Phase 3
71136,Phase 1b
68775,Discontinued in Preregistration
137768,Investigative
45510,Phase 1/2a
38017,Phase 2
46325,Phase 1/2
99378,Phase 1/2a
137369,Discontinued in Phase 3
15454,IND submitted
178440,Discontinued in Phase 1/2
103986,Patented
113229,Phase 1b/2a
102751,Discontinued in Preregistration
163836,Phase 1/2
159682,Discontinued in Preregistration
61519,Discontinued in Phase 1/2
11484,Phase 2a
73277,Discontinued in Phase 4
158815,Phase 1
191906,Phase 2a
87505,Discontinued in Phase 2
23356,Phase 2a
76262,Phase 1/2a
186736,Discontinued in Preregistration
56295,Phase 1/2a
45079,Phase 2/3
144112,Phase 1/2
119718,Approved
33225,BLA submitted
27422,Patented
14705,Phase 1
94702,Phase 1/2a
139037,Investigative
25728,Phase 2
33153,BLA submitted
167587,Discontinued in Phase 2
14965,Phase 0
187588,Patented
217,Phase 1/2a
94851,Patented
45403,Phase 1/2a
114891,Approved (orphan drug)
138312,Phase 1b
60186,Discontinued in Phase 3
190946,Investigative
142270,Investigative
98472,Phase 1b/2a
1799,Phase 0
111119,Phase 1/2
31077,Phase 1b/2a
143834,Phase 2b
143390,Investigative
35539,Discontinued in Phase 1/2
11048,Discontinued in Phase 4
10691,Investigative
156031,Phase 1b
165491,IND submitted
152474,Discontinued in Phase 3
56032,Phase 1/2a
22335,Investigative
146215,Phase 2b
7476,Investigative
185826,Phase 2a
143257,Phase 1b/2a
5926,Phase 2a
42792,Phase 1/2
171915,Discontinued in Phase 2
142047,Discontinued in Preregistration
104277,Discontinued in Phase 4
116498,Discontinued in Phase 2/3
169792,Phase 0
26266,Investigative
179120,Patented
155017,Discontinued in Phase 4
66645,Discontinued in Phase 3
3370,Phase 1/2a
137779,Investigative
15741,IND submitted
173108,Discontinued in Phase 2b
188600,Discontinued in Phase 3
47377,Phase 0
73673,Phase 1/2a
33102,Phase 2
92959,Phase 1b
61448,Phase 2a
187016,Clinical trial
115603,Discontinued in Phase 2
182936,Phase 1b
12522,Phase 1/2
109644,Approved
47714,Phase 0
118097,Phase 2b
46234,IND submitted
70266,Phase 1
97614,Phase 1/2a
177426,Phase 1b/2a
17463,Phase 0
70695,Phase 2
75666,Phase 1/2a
101789,Phase 2a
12172,Phase 1
127796,Phase 0
94767,Patented
52098,Phase 1b/2a
157089,IND submitted
129516,Discontinued in Phase 2b
136012,Preclinical
13173,Phase 1/2a
42581,Phase 1
126492,Discontinued in Phase 2b
125710,Phase 1b/2a
30367,Phase 1b
9760,Phase 0
7875,Phase 1/2
79278,Phase 2a
161973,Investigative
183041,Phase 1/2
46730,Phase 4
63393,Phase 1b/2a
191307,IND submitted
16123,Phase 1
166713,Phase 1/2
141101,Discontinued in Phase 2b
19184,Discontinued in Phase 1/2
181804,Phase 2a
70505,Discontinued in Phase 4
17581,Phase 1/2a
67024,Phase 1/2
30097,Phase 1b
55204,Phase 0
161336,Phase 0
84732,Phase 1/2a
163340,IND submitted
125319,Phase 1b
144418,Phase 1/2a
83740,Discontinued in Phase 1/2
58134,Phase 1/2
156164,Discontinued in Phase 2b
129495,Discontinued in Phase 1
134485,Phase 1/2
25281,Phase 1b/2a
90133,Clinical trial
112635,Phase 1
14823,Phase 0
44142,Phase 1/2a
99027,Phase 1b
36911,Discontinued in Phase 1/2
96801,Phase 1/2a
146639,Phase 2b
4366,IND submitted
143550,Discontinued in Preregistration
177736,Phase 2
3357,Discontinued in Phase 3
140781,Phase 2a
1544,Phase 1/2a
144530,Clinical trial
4421,Phase 2a
105347,Phase 2a
171346,Discontinued in Phase 2b
120474,Phase 0
164128,Phase 1/2
161127,Discontinued in Phase 1/2
37813,Phase 0
118317,Discontinued in Phase 2/3
141049,Phase 0
21127,Phase 2
57345,Discontinued in Phase 1/2
138494,Clinical trial
13638,Phase 0
15480,Investigative
27597,Phase 1b/2a
45984,Phase 2/3
4163,Phase 1/2
188668,Phase 1/2a
64626,Phase 1b/2a
183266,Discontinued in Phase 4
68534,Discontinued in Phase 4
179340,Phase 0
45881,Phase 2/3
96727,Phase 1/2a
148533,Investigative
139665,Phase 1b
87945,Approved
117441,Investigative
81653,Phase 1
186544,Patented
41110,Discontinued in Phase 1/2
51101,Discontinued in Phase 3
78304,Investigative
176455,Phase 1b/2a
36490,Patented
101471,Phase 1b
153341,Phase 1
86736,Phase 1b
122437,Phase 1b
21077,Phase 2
160771,Phase 1
101628,Phase 1b
135562,Phase 0
122962,Phase 1/2
39273,Phase 2
149617,Phase 1/2a
104689,Phase 1/2
8148,Phase 0
9483,Phase 2
122116,Phase 0
175698,Discontinued in Phase 4
58471,Phase 1b/2a
50349,Phase 0
81979,Phase 1b/2a
128981,Discontinued in Phase 2b
96863,Phase 1/2
157916,Registered
3318,Patented
79753,Phase 1
15853,Phase 1/2a
116827,Discontinued in Phase 2/3
155280,Discontinued in Phase 1/2
145748,Discontinued in Phase 1
49925,Phase 1b
84830,Phase 0
183369,Phase 2a
36763,Phase 1b/2a
77637,Phase 1/2a
94949,Patented
22245,Phase 2/3
98230,Phase 1/2a
168052,Patented
94320,Phase 2a
132489,Discontinued in Preregistration
60564,Approved (orphan drug)
96045,Phase 1b
88614,Phase 1
113184,Phase 2a
63601,Phase 2a
57034,Patented
101672,Phase 1/2
154891,Phase 1b/2a
19760,Phase 0
131734,Discontinued in Preregistration
3150,Patented
10460,Phase 1/2
26982,Phase 1b/2a
125445,Phase 1b/2a
12382,IND submitted
54929,Phase 0
74424,Phase 1/2a
131057,Phase 2a
154491,IND submitted
84175,Discontinued in Phase 2
167420,Phase 1/2a
61966,Discontinued in Phase 4
153253,Phase 2
28660,Phase 1b
22699,Phase 2/3
20386,Phase 1/2
132131,Patented
186308,Phase 1/2a
160995,Patented
145988,Phase 1b
138035,BLA submitted
30330,Discontinued in Phase 4
160958,Phase 1/2a
47536,Investigative
167427,Discontinued in Phase 1
60851,Phase 1b/2a
77681,Phase 2
184622,BLA submitted
43153,Discontinued in Phase 1
89892,Investigative
32023,Phase 1b/2a
168046,Patented
134504,Phase 1/2
25566,Discontinued in Phase 2/3
76668,Phase 1/2
70797,Discontinued in Phase 2b
64493,Phase 0
23629,Discontinued in Phase 2b
22473,Discontinued in Phase 4
117859,IND submitted
81766,IND submitted
187356,Phase 2a
135191,Phase 0
104494,Phase 1b/2a
67878,Phase 2a
101806,Phase 1b
3187,Phase 1b
47122,Discontinued in Phase 1/2
76851,Phase 1/2a
74648,Phase 1/2a
103702,Phase 1/2
180494,Discontinued in Phase 2b
31225,Clinical trial
87807,Approved
26999,BLA submitted
91643,Approved
76804,Patented
94992,Phase 1/2a
20838,Phase 0
24791,Phase 2
139095,Phase 1/2a
29640,Discontinued in Phase 4
114426,Phase 1
150226,Phase 2
99239,Phase 1
34711,Phase 2a
1484,Phase 1/2a
53171,Investigative
36795,Phase 2
40941,Approved
90874,BLA submitted
69342,Phase 2/3
158981,IND submitted
186001,Phase 0
93606,Discontinued in Phase 1
20572,IND submitted
172295,Discontinued in Phase 2b
110202,IND submitted
71499,Patented
44719,Phase 2/3
70987,Discontinued in Phase 3
112539,Phase 1
13990,Phase 1
108238,Phase 0
96095,Discontinued in Phase 1/2
24081,Phase 1/2a
91735,Approved (orphan drug)
149839,Phase 1b/2a
92821,Investigative
185586,Phase 2a
59746,Discontinued in Phase 3
101609,Phase 2a
47940,Phase 1/2a
140559,Phase 0
25747,Phase 1/2
141441,Phase 1b
22876,Phase 1b/2a
35450,Discontinued in Phase 1/2
185142,Phase 0
56527,Phase 1b/2a
120433,Phase 4
182828,Phase 1/2a
130351,Phase 2/3
125538,IND submitted
93605,Phase 1b/2a
14446,Phase 0
7633,Discontinued in Phase 3
87272,Phase 1/2a
88777,Phase 1
163726,Discontinued in Preregistration
177493,Phase 1b
110961,Discontinued in Phase 3
82268,Phase 1/2
19340,IND submitted
173850,Phase 1b/2a
10433,Discontinued in Phase 3
106952,Discontinued in Phase 4
5483,Phase 2a
93036,Phase 1b/2a
174018,Discontinued in Preregistration
177016,Phase 1
68259,Discontinued in Phase 4
10815,Discontinued in Phase 2b
49251,Phase 1b
152465,Phase 1b/2a
97578,Phase 1b
88593,Phase 1
20792,Phase 1/2a
117931,Investigative
164788,Phase 1/2
125037,Phase 1
12978,Phase 1
116354,Discontinued in Phase 3
186290,Phase 2a
163541,Patented
112831,Discontinued in Phase 2
187465,Phase 0
61131,Phase 1b/2a
56608,Phase 1/2
70726,Phase 0
145451,Phase 1/2
120970,Phase 1b
153542,IND submitted
9326,Phase 1
108498,Phase 1
91844,Clinical trial
123542,Phase 0
135407,Phase 0
57743,Phase 1b/2a
160399,Phase 1/2a
170090,Patented
52842,Phase 1b/2a
124979,Phase 0
9283,Phase 2/3
71660,Phase 1/2
5925,Phase 1b/2a
79432,Phase 2a
102384,Phase 1b
117531,Phase 1b
164823,Phase 0
10266,Discontinued in Phase 3
45229,Phase 1/2a
54134,Phase 1b/2a
180388,Phase 2/3
62082,Investigative
110793,Discontinued in Phase 3
88084,Discontinued in Phase 3
112972,Phase 1
189066,Phase 1/2
149302,Clinical trial
75719,Phase 0
176953,Phase 2b
56112,Phase 1b/2a
71224,Phase 1b
41433,Phase 1b
61041,Discontinued in Phase 1/2
89541,Phase 1b
138488,Phase 1b
130133,Phase 1/2a
47761,Discontinued in Phase 2/3
168925,Discontinued in Phase 2
91924,Phase 1
125707,Phase 1/2
78706,Phase 2a
106673,Phase 1b/2a
190133,Phase 1b/2a
1891,Approved
55488,Phase 1/2a
90064,BLA submitted
129879,Patented
6135,Investigative
124668,Phase 1/2
181444,Discontinued in Phase 2b
143511,Phase 1/2
128695,Discontinued in Preregistration
150846,Phase 0
54780,Phase 2/3
7708,Patented
9707,Phase 1/2a
89292,Discontinued in Phase 4
143280,Phase 1b/2a
154712,Phase 2b
60043,Phase 1
33564,Phase 1b
99867,Phase 0
15619,Phase 0
86048,Phase 1
19666,Phase 1
164725,Phase 1/2a
71762,Phase 1/2
139816,BLA submitted
83656,Patented
132214,Discontinued in Phase 1/2
33043,Phase 0
170967,Phase 0
73944,BLA submitted
61795,Discontinued in Phase 4
86856,Phase 1b
35394,Discontinued in Phase 4
75834,Phase 1
44231,Phase 2/3
177403,Phase 1b
34081,Phase 1
121837,Phase 1b/2a
76264,Phase 1/2a
119226,Phase 1b/2a
90959,Approved
122279,IND submitted
180095,Phase 1/2a
69948,Patented
5198,Phase 1/2
187473,Patented
30525,Phase 1
71596,Discontinued in Phase 1
116472,Investigative
6107,Phase 1/2
157095,Phase 1
110012,Phase 1
185652,Phase 0
105829,Phase 2
28254,Discontinued in Phase 4
7832,Phase 1
157049,Investigative
127016,Phase 0
2003,Approved
143021,Phase 1b/2a
30557,Discontinued in Phase 2b
162291,Phase 1b/2a
54116,Phase 0
168901,Discontinued in Phase 1
19752,Phase 1/2
122879,Approved
158687,Phase 1b
38833,Phase 1/2
43555,Phase 1/2a
127203,Phase 1/2
8001,Phase 2
2837,Phase 1b
106332,Phase 0
7768,Patented
173691,Phase 1/2a
92148,Phase 2/3
39689,Phase 0
116877,Phase 2
57687,Phase 1b/2a
11824,Discontinued in Phase 2/3
152922,Investigative
180563,Phase 3
15002,Investigative
166897,Phase 2b
69229,Discontinued in Phase 3
45249,Phase 2/3
152057,Phase 1/2
168515,Discontinued in Phase 3
120913,Investigative
41250,Approved
184335,BLA submitted
81899,Discontinued in Phase 1
77994,Investigative
9471,Discontinued in Phase 1
59557,Discontinued in Phase 1/2
179722,Phase 1b
161135,Discontinued in Phase 1/2
178189,Phase 2a
124745,Phase 1/2
165132,Phase 1/2
8046,Phase 0
44927,Phase 2/3
114704,Discontinued in Phase 3
42784,Phase 1/2
81552,Phase 2
155840,Phase 2
130872,Phase 1b
5220,Investigative
63279,Discontinued in Phase 4
176754,Discontinued in Phase 2
184619,Discontinued in Phase 4
149914,Phase 1b/2a
43635,Phase 1/2a
121774,Discontinued in Preregistration
108725,Investigative
21303,Phase 1/2
146248,Phase 2
137559,Phase 1/2a
86080,Clinical trial
89146,Phase 1b
65637,Discontinued in Phase 4
160171,Phase 1b/2a
14943,Phase 1
91085,Discontinued in Phase 1
35444,Discontinued in Preregistration
154767,Phase 1b/2a
133420,Discontinued in Phase 1
121359,Phase 1/2a
125557,BLA submitted
88036,Discontinued in Phase 1/2
27862,Phase 1/2
174726,Discontinued in Phase 4
21579,Phase 1b/2a
53967,Phase 0
46097,Phase 2/3
109749,Phase 4
135798,Phase 1/2
115441,Phase 1/2a
129538,IND submitted
46280,Patented
14070,Phase 1/2
184192,Phase 1
30799,Phase 1/2
136821,Phase 1/2a
180037,Discontinued in Phase 1
9090,Discontinued in Phase 2
173178,Discontinued in Phase 3
159357,Phase 1b/2a
3482,Approved
69976,Phase 1b
107989,Discontinued in Phase 2/3
188676,Phase 1/2
186864,Phase 4
48392,Phase 1b/2a
139829,Investigative
174795,Discontinued in Phase 1/2
189261,Phase 1/2
168594,Approved
130273,Discontinued in Phase 2/3
42918,Phase 1/2
33828,Investigative
51885,Discontinued in Phase 2b
178727,Phase 1/2a
95945,Discontinued in Preregistration
155388,Phase 1/2a
166063,Phase 1b/2a
172289,IND submitted
101299,Discontinued in Preregistration
132424,Phase 1/2
99299,Phase 0
10586,Phase 1
50198,Phase 1b
165275,Phase 1/2
125149,Discontinued in Phase 4
103762,Phase 0
1771,Patented
156183,Phase 1/2a
29376,Phase 1b/2a
117155,Discontinued in Phase 2b
93628,Discontinued in Phase 3
73129,Phase 0
163269,Clinical trial
106129,Discontinued in Preregistration
117838,Phase 1
126897,Phase 0
160883,Clinical trial
130993,Investigative
112325,Discontinued in Phase 3
54370,IND submitted
182085,Phase 1b
120585,Phase 0
5818,Phase 2a
149252,Phase 2b
134357,Patented
127561,Discontinued in Phase 4
30627,Phase 1b/2a
44436,Phase 1/2a
147202,Phase 0
47587,Phase 0
5138,Discontinued in Phase 2
58036,Phase 0
171352,Discontinued in Phase 2
105092,Phase 1/2a
107835,Discontinued in Phase 3
163648,Discontinued in Phase 1/2
27701,Phase 2
168500,Discontinued in Phase 4
187746,Phase 2a
5937,Investigative
22828,Discontinued in Phase 2/3
190479,Phase 2b
140779,Phase 3
146082,Discontinued in Phase 2
85578,Discontinued in Preregistration
110039,Phase 1
13323,Phase 1b/2a
8003,Patented
128273,Discontinued in Preregistration
116019,Phase 1b
15863,Investigative
52345,Phase 1
130386,Patented
40986,Approved
148772,Discontinued in Phase 2
26329,Phase 1/2a
45733,Phase 1/2a
7130,Phase 2a
115413,Discontinued in Phase 2
98939,Phase 1/2
61350,Patented
125031,Phase 1/2
134676,Phase 0
172245,Phase 1
80259,Phase 1b
120283,Phase 0
65862,Phase 1b/2a
121643,Approved (orphan drug)
183754,Phase 1b
110423,Phase 3
1006,Discontinued in Phase 1
55284,Phase 1/2a
113248,Phase 1b/2a
54765,Discontinued in Phase 2/3
99089,Phase 1/2a
24642,Phase 1b/2a
92548,Phase 1/2
61585,Phase 1/2a
47010,Phase 1
51904,Discontinued in Phase 3
181133,Phase 1
146712,Phase 0
72690,IND submitted
37186,Phase 1
60567,Phase 2/3
188356,Phase 1/2a
185152,Phase 1
148685,Patented
44897,Phase 2/3
127764,Phase 1
145053,Phase 1/2a
171901,Discontinued in Phase 2/3
98882,Phase 1b
143310,Discontinued in Preregistration
163654,Discontinued in Phase 2
191743,Phase 1
188448,IND submitted
111385,Discontinued in Phase 4
83111,Phase 1
60125,Investigative
127788,Discontinued in Phase 2b
166108,Phase 1b
35031,Patented
191942,Phase 2a
42372,Phase 1
24727,Phase 1b
131607,Discontinued in Phase 2/3
10204,Discontinued in Phase 2b
122851,Phase 2
188513,Patented
120381,Discontinued in Phase 2
157368,Clinical trial
105876,Phase 1/2a
71521,Phase 0
26054,Investigative
82899,Discontinued in Phase 1/2
25628,Discontinued in Phase 4
126967,Discontinued in Preregistration
80663,Approved
43679,Phase 2/3
359,Phase 1/2a
97582,Phase 1/2a
137883,Discontinued in Phase 4
109421,Discontinued in Preregistration
183403,Phase 4
30083,Phase 2
174681,IND submitted
49670,Phase 1/2a
16515,Phase 3
16196,Phase 1
12022,Discontinued in Phase 2/3
109894,Discontinued in Preregistration
126004,Phase 1/2
187478,Phase 1b
127247,Discontinued in Preregistration
60256,Approved (orphan drug)
179901,Discontinued in Phase 1/2
108114,Phase 2
51081,Phase 1b
14617,Investigative
130329,Discontinued in Preregistration
165688,Phase 1b
63215,Phase 1b
40166,Phase 1b/2a
180989,Phase 1/2a
69282,Phase 1
174680,IND submitted
167409,Phase 4
2764,Discontinued in Phase 1/2
168162,Discontinued in Phase 1
32607,Phase 1/2a
143463,Phase 1/2
72108,Discontinued in Phase 4
154111,Discontinued in Phase 4
50580,Phase 0
135968,Phase 2
40103,Phase 2/3
82116,Discontinued in Phase 2/3
73190,IND submitted
91289,Phase 1b
30158,Discontinued in Phase 2b
101240,Phase 1/2a
32846,Phase 2/3
70203,Phase 1
31921,Phase 2a
165680,Discontinued in Phase 4
7072,Phase 4
13368,Investigative
142963,Investigative
146223,Phase 1/2a
151613,Phase 1
159095,Phase 1b
181258,Discontinued in Phase 2
37420,Discontinued in Phase 1
58683,Discontinued in Phase 2/3
185056,Phase 1
131068,Phase 1/2a
93929,Phase 2b
119723,Approved
28820,Phase 4
100728,Phase 1/2
145272,Phase 1b/2a
162154,Investigative
160159,Phase 1b/2a
25453,Investigative
31660,Phase 0
66531,Phase 0
160444,Phase 1/2a
127514,Phase 1/2
113080,Phase 1
57361,Phase 0
6925,Phase 2/3
21501,Discontinued in Phase 1/2
8404,Phase 1b
126563,Discontinued in Preregistration
32241,Phase 2
167131,Discontinued in Phase 2
121190,Phase 1b
99250,Patented
116683,Discontinued in Phase 1
159336,Discontinued in Phase 1
135414,Phase 0
132610,Discontinued in Preregistration
157841,Phase 1b/2a
72843,Investigative
2476,Discontinued in Phase 1/2
150682,Phase 0
51662,Patented
158634,Phase 1/2
92443,Phase 4
175544,IND submitted
163948,Phase 1/2
78674,Phase 2a
30116,Phase 1/2
105323,Phase 1b
41751,Phase 1b
24197,Discontinued in Phase 2/3
93775,Phase 1/2
170509,Phase 1/2
185872,Phase 1b
10673,Preclinical
172389,Phase 2
23874,Phase 2a
67454,Clinical trial
173429,Discontinued in Phase 2b
83190,Phase 0
95151,Patented
166503,Phase 1
48365,Phase 2
104614,Phase 0
30982,Phase 0
107792,Discontinued in Phase 2/3
161056,Phase 1
119712,Discontinued in Phase 2b
16754,Phase 1
20369,Phase 1b/2a
47732,Phase 1
28908,Investigative
3062,Phase 1/2a
2025,Phase 1b
118051,BLA submitted
132804,Patented
967,Clinical trial
80349,Discontinued in Phase 1
50986,Phase 0
7061,Phase 1/2
118087,Discontinued in Preregistration
159046,Phase 1b/2a
45490,Phase 2/3
14235,Investigative
168939,Discontinued in Phase 1
81967,Clinical trial
17145,Phase 1
58226,Discontinued in Phase 3
90186,Phase 1b
109145,Phase 1/2a
118012,Phase 1
58070,Investigative
107651,Discontinued in Preregistration
96184,Phase 1
59190,Investigative
9073,Approved
2042,Discontinued in Phase 1
133588,IND submitted
25072,Discontinued in Phase 2b
104948,Phase 0
191446,IND submitted
47301,Phase 1/2
154835,Phase 1b/2a
11085,Discontinued in Phase 3
86112,Phase 1/2
93557,Phase 1b
145717,Phase 1/2a
143354,Phase 2b
181026,Phase 2b
11865,Phase 1b
154764,Phase 2/3
16536,Investigative
94465,Discontinued in Phase 1
7970,Phase 0
139020,BLA submitted
47885,Phase 1b
185328,Discontinued in Phase 1
131011,Phase 0
77043,Phase 1/2
2509,Phase 0
78140,Approved (orphan drug)
187040,Phase 2a
65275,Discontinued in Phase 2
94948,Patented
172176,Phase 1/2
165180,Phase 1
1126,Clinical trial
159365,Approved
30252,Phase 1
113760,Phase 1
11014,Discontinued in Phase 3
19009,Phase 0
125718,IND submitted
4902,Investigative
134714,Phase 0
139378,Phase 1b
33864,Phase 1b
104228,Phase 1/2a
121601,Discontinued in Phase 2b
156502,Discontinued in Phase 2b
183898,Phase 4
40317,Discontinued in Phase 2
164853,Phase 0
165622,Phase 1b/2a
19135,Discontinued in Phase 3
128715,Phase 1/2
124117,Phase 1/2
44876,Phase 1/2a
138850,Phase 1b
4382,Discontinued in Phase 2
141867,Discontinued in Phase 2b
69413,Phase 2b
142103,IND submitted
132459,Discontinued in Phase 4
89164,Phase 1/2
159328,Patented
3931,Phase 1/2a
161227,Discontinued in Phase 1/2
145020,Discontinued in Preregistration
153611,Phase 2a
19660,Phase 2a
88670,Phase 1
110867,Phase 1/2
7559,Discontinued in Phase 2
152161,Phase 0
116230,Phase 1
5980,Phase 2a
81339,Approved
56486,Phase 0
72677,Investigative
112973,Phase 1
191892,Discontinued in Phase 2
77878,Investigative
180156,Phase 2a
171832,Discontinued in Phase 2b
129185,Patented
97444,Discontinued in Phase 2b
111434,Discontinued in Phase 4
118821,Phase 2/3
27330,Discontinued in Preregistration
94671,Patented
79422,Discontinued in Phase 1/2
115966,Phase 1/2a
50824,Discontinued in Phase 2b
81925,Clinical trial
96991,Phase 1/2
70391,Phase 1b/2a
51755,Phase 1b/2a
190694,Phase 1b
16064,Phase 1/2
128772,Phase 1
40115,Phase 1/2
122918,Phase 1b/2a
151561,Phase 0
99415,Discontinued in Phase 2/3
42895,Patented
43379,Phase 1/2a
140763,Phase 1b/2a
156110,Phase 1/2a
38754,Phase 2
188596,Approved (orphan drug)
37032,Phase 2a
176977,Phase 2b
49820,Phase 1b/2a
176010,Discontinued in Phase 1/2
59138,Phase 2/3
50032,Phase 1/2
3997,Phase 1b
110881,Discontinued in Phase 4
189492,Phase 2b
36253,Discontinued in Phase 3
145554,Phase 1b
109689,Discontinued in Phase 2/3
2966,Phase 2a
161501,IND submitted
19960,Phase 2
10150,Phase 0
51490,Phase 1b
174595,Discontinued in Phase 4
28419,Phase 1/2a
126468,Phase 2b
99741,Phase 1
131539,IND submitted
29995,Clinical trial
7549,Phase 4
154163,Discontinued in Phase 3
30285,Phase 1
71714,Phase 1/2
82126,Phase 1b/2a
190470,Phase 1/2
56875,Discontinued in Phase 2b
49997,Phase 2
50332,Phase 1b
115440,Phase 2/3
98974,Phase 1b/2a
35141,Phase 2a
7799,Phase 1
50114,Patented
130150,Phase 1/2
156288,IND submitted
98297,Phase 0
155324,Phase 1
134501,Discontinued in Phase 4
161477,Phase 0
130716,Phase 2
69606,Phase 1
92381,Phase 1
176778,Discontinued in Phase 2
87236,Discontinued in Phase 2/3
120487,Investigative
65742,Discontinued in Phase 1
120316,Discontinued in Phase 1/2
82775,Phase 1/2
59400,Phase 1b
87757,Approved
86497,Investigative
94275,Phase 2
97231,Phase 1/2a
510,Phase 1
183272,IND submitted
105469,Phase 1/2a
144057,Phase 1/2
51472,Phase 1
54234,IND submitted
117189,Discontinued in Phase 1/2
126361,Investigative
10960,Phase 0
100662,Phase 1/2a
6098,Phase 1/2
118133,Discontinued in Phase 1/2
4921,Preregistration
173149,Phase 0
99405,Phase 1
155484,Phase 2a
128050,Phase 0
105854,Phase 2/3
68874,Phase 2/3
129827,IND submitted
158178,Phase 0
89107,Investigative
49832,Phase 0
19390,Discontinued in Phase 2
71703,Phase 1b
43268,Phase 1b
158967,Phase 1/2
90820,Clinical trial
136451,Phase 1/2
165484,Discontinued in Phase 2/3
21962,Discontinued in Phase 2
54021,Phase 0
74068,Discontinued in Phase 4
37818,Phase 1/2a
137584,Phase 2
88439,Phase 1
126707,Discontinued in Preregistration
20521,Phase 1b/2a
168079,Investigative
181776,Phase 2b
129308,Phase 0
19951,Discontinued in Phase 2b
132404,Discontinued in Phase 4
185420,Discontinued in Phase 3
127939,Discontinued in Preregistration
190657,Clinical trial
32547,Phase 3
45216,Phase 2/3
154082,Discontinued in Phase 3
100461,Patented
164623,Investigative
115182,Discontinued in Phase 2
141260,Patented
22520,Discontinued in Phase 4
682,Discontinued in Phase 1/2
128113,IND submitted
132722,Discontinued in Preregistration
91502,Discontinued in Phase 1
15392,Phase 1/2
108976,Phase 0
152631,Discontinued in Phase 3
145744,Phase 1b/2a
116780,Discontinued in Phase 3
163229,Phase 1b
2170,Discontinued in Phase 2b
55072,Phase 1/2a
47965,Discontinued in Phase 2/3
3312,Phase 1/2a
43286,Phase 1/2a
97274,Phase 1/2a
165606,Patented
93590,Phase 1/2
21001,Phase 1b
103575,Phase 1/2a
93834,Phase 2
141012,Investigative
147579,Phase 2b
49175,Phase 1b/2a
13569,Phase 1/2
103443,Phase 1b
129500,Phase 0
162507,IND submitted
61202,Phase 1
2849,Discontinued in Phase 2
95164,Patented
4849,Preregistration
11239,Phase 1b
33013,Phase 2a
19368,IND submitted
147975,Phase 1b
82132,Clinical trial
71575,Phase 0
70916,Phase 1b/2a
166764,Phase 1b/2a
142198,Investigative
61750,Discontinued in Phase 4
40511,Patented
62669,Phase 0
147720,Discontinued in Phase 2
93769,Phase 2b
33213,BLA submitted
46036,Phase 1/2a
145775,Phase 2b
47323,Patented
154661,Phase 1b/2a
145622,Phase 1
53099,Phase 1/2a
122017,Phase 2
126586,IND submitted
25083,Investigative
77480,Phase 1
65034,BLA submitted
105941,Phase 1/2
181695,Discontinued in Phase 2b
117037,Phase 2
152073,Phase 2
173970,Discontinued in Preregistration
79380,Approved (orphan drug)
186606,Phase 2a
174692,Discontinued in Phase 2
38650,Phase 1/2a
158352,Phase 2/3
138278,Phase 1b
125185,Phase 1b/2a
106229,Phase 2a
92299,Discontinued in Phase 1
92853,Discontinued in Phase 1
118756,IND submitted
122531,Phase 1/2
1286,Patented
86735,Phase 1/2
15195,Investigative
45903,Phase 2a
180559,Phase 2
124871,Phase 0
167810,Discontinued in Phase 3
51231,Discontinued in Phase 2b
182705,Phase 2a
69834,Patented
38347,Phase 2/3
100980,Discontinued in Phase 1/2
192031,Patented
74057,Phase 2
124998,Phase 1/2
183437,IND submitted
80702,Phase 2
149148,Phase 1/2a
44559,Phase 2/3
20045,Phase 0
42751,Discontinued in Phase 1
47308,Patented
76368,Phase 1/2
31566,Phase 2
10408,Phase 1/2
17980,Discontinued in Preregistration
5216,Phase 1/2
116675,Discontinued in Phase 2b
133249,Discontinued in Phase 1
18140,Phase 2a
170249,IND submitted
145741,Phase 2
85693,Discontinued in Phase 3
102347,Phase 1/2
73206,Patented
144505,Phase 3
39538,Phase 0
140943,Discontinued in Phase 3
143229,Phase 2
64746,Discontinued in Phase 2/3
156106,Investigative
185281,Discontinued in Phase 4
60648,Approved (orphan drug)
100650,Discontinued in Phase 1/2
185794,Patented
190494,Approved (orphan drug)
64198,Patented
110100,IND submitted
62654,Discontinued in Phase 4
116159,Clinical trial
128524,Phase 1b/2a
231,Discontinued in Phase 1/2
84777,Phase 1/2a
126346,Investigative
63185,Discontinued in Preregistration
182669,Phase 1b/2a
25332,Discontinued in Phase 4
178014,Phase 1/2
145925,Discontinued in Phase 2
113019,Phase 1b/2a
12749,Phase 1
105690,Phase 1/2
130788,Phase 2
154914,Phase 2
172126,Discontinued in Phase 2b
64187,Phase 1b/2a
58278,Investigative
100786,Investigative
79514,Phase 2a
40624,Phase 2
168669,Phase 1b/2a
56883,Discontinued in Phase 2b
144033,Phase 1/2
65065,Discontinued in Phase 2/3
50405,Phase 2
189637,Phase 1/2
80560,Clinical trial
61953,Phase 1b
50901,IND submitted
106668,IND submitted
66777,Patented
15291,Investigative
172795,Patented
121126,Phase 2/3
135164,Phase 0
85931,Discontinued in Phase 2b
93191,Discontinued in Phase 1
102754,Approved (orphan drug)
35282,Phase 2
159134,IND submitted
135258,Phase 0
107596,Discontinued in Phase 4
145382,Phase 2/3
86125,Phase 1b/2a
34941,Phase 1b
127818,Phase 1/2
34665,Phase 1/2a
31229,Phase 1b
115630,Phase 1/2a
60356,Phase 0
78962,Phase 1b
124209,Discontinued in Phase 4
2221,Phase 1/2
134129,Phase 1/2a
74238,Phase 1/2a
111205,Phase 1/2a
149529,Phase 2b
292,Phase 1
94959,Patented
11888,Phase 2
32538,Phase 0
134074,Phase 1b
132561,Discontinued in Phase 1/2
43591,Phase 2/3
172279,Discontinued in Phase 2/3
26090,Phase 0
162840,BLA submitted
92408,Patented
29056,Phase 2
97282,Phase 0
151644,Phase 0
55862,Discontinued in Phase 3
44220,Phase 1/2a
151626,Phase 1b/2a
57490,Phase 1/2
121829,Discontinued in Phase 2b
177276,Phase 1b
109914,Phase 4
180589,Phase 1/2a
12790,Phase 1/2a
62101,Discontinued in Phase 4
126576,Phase 1
6251,Phase 1/2
50808,Phase 1b
116301,Phase 2/3
187740,Phase 1b
158828,IND submitted
173228,Phase 2
171313,Phase 1b
90273,Investigative
185072,Discontinued in Phase 4
12097,Phase 1/2a
158010,Clinical trial
110878,Discontinued in Phase 2b
155066,Investigative
53616,Phase 1/2
129931,Patented
127974,Investigative
68557,IND submitted
24302,Phase 1/2
23573,Phase 1b/2a
182954,Phase 2a
59689,Discontinued in Phase 3
75270,Phase 1b/2a
183018,Phase 1/2a
84665,Phase 0
14990,Phase 1
117588,Discontinued in Phase 1/2
139354,BLA submitted
21305,Phase 1b
161395,Phase 1/2a
119936,Clinical trial
8488,Patented
56164,Phase 1/2
141228,Investigative
78548,Discontinued in Preregistration
89365,Discontinued in Phase 3
110885,Phase 0
173867,Phase 1b/2a
136037,Phase 2/3
108153,Discontinued in Phase 1/2
84354,IND submitted
152147,Phase 1b/2a
108596,Discontinued in Phase 1
37026,Phase 1
93772,Phase 1/2
137697,Phase 2
70817,Phase 1b/2a
168544,Phase 2
86011,Phase 1b/2a
3259,Discontinued in Phase 3
29594,Discontinued in Phase 2b
133712,Patented
20991,Phase 0
123445,Phase 2
21514,BLA submitted
166961,Investigative
75439,Discontinued in Phase 1/2
159750,Phase 1b/2a
131130,Phase 1b
186697,Investigative
180024,Phase 1
105807,Discontinued in Phase 4
115170,Phase 2
12315,Investigative
72509,Phase 1b/2a
44445,Phase 1/2a
184149,Discontinued in Phase 4
146280,Investigative
135042,Phase 0
80761,Phase 1
116788,Discontinued in Phase 1/2
172147,Phase 1b
164410,Discontinued in Preregistration
107763,Discontinued in Phase 3
103081,Phase 1
189902,Approved
97938,Phase 1b/2a
22419,Investigative
50577,Phase 1
101773,Phase 2
109239,Phase 1/2
62355,Phase 0
122797,Phase 1/2
153889,Approved
126435,Phase 1b/2a
74399,Discontinued in Phase 1/2
91181,Phase 1/2
102150,Approved
120430,Approved (orphan drug)
166744,Phase 2/3
156589,Phase 1b/2a
181125,Phase 2b
97142,Phase 0
107256,IND submitted
143805,Phase 2
132771,Discontinued in Phase 4
144831,Phase 1b/2a
177921,Phase 1
175595,Discontinued in Phase 2/3
47000,Approved
172526,Discontinued in Phase 2
107367,Phase 0
66980,Phase 0
119324,Discontinued in Phase 1
66183,Phase 1/2a
147416,Phase 1
29012,Phase 1/2a
43513,Phase 2/3
35,Phase 2
137649,Discontinued in Phase 3
102413,Phase 0
152441,Investigative
85668,Discontinued in Preregistration
188567,Preclinical
190019,Phase 1/2
81663,Phase 1
32068,Phase 2a
115420,Phase 1/2a
117612,Investigative
184396,Phase 0
84495,Phase 0
82375,Phase 0
167604,Discontinued in Phase 1/2
6571,IND submitted
172078,IND submitted
117722,Discontinued in Phase 2b
165157,Phase 1
7006,Phase 2/3
110074,Phase 1
66346,Preclinical
13136,Phase 0
7752,Patented
183882,Discontinued in Phase 2
142459,Phase 1b
84748,Phase 1/2
113878,Phase 0
187096,Discontinued in Preregistration
124306,Patented
146640,Phase 1b/2a
153174,Patented
123782,Phase 0
4302,Investigative
123025,Phase 1
51848,Phase 1
157708,Registered
5101,Preregistration
186508,Patented
73941,Discontinued in Phase 4
64819,Discontinued in Phase 2b
111598,Discontinued in Phase 2b
87141,Phase 1b
139747,BLA submitted
140988,Investigative
178443,Patented
138943,Phase 1/2a
39042,Discontinued in Phase 2
80089,Phase 1
80459,Phase 1
180014,Discontinued in Preregistration
114220,Phase 0
117377,Phase 2
52698,Patented
130394,Patented
64275,Approved (orphan drug)
56529,Discontinued in Preregistration
186438,Phase 0
81284,Phase 1b/2a
95376,Phase 1
123851,Phase 1/2
142720,Phase 1/2a
31816,Investigative
158151,Phase 1b
31873,Phase 1
114820,BLA submitted
99718,Phase 1/2a
18461,Phase 2a
188848,Phase 1b
35265,Discontinued in Preregistration
43380,Phase 1/2a
113855,IND submitted
127577,Discontinued in Phase 2b
110657,Phase 1
138990,Approved (orphan drug)
98168,Phase 1/2a
86807,Patented
74765,IND submitted
53947,Discontinued in Phase 2/3
1528,Phase 1/2
91943,IND submitted
109038,Phase 1b
85922,Discontinued in Phase 2b
60285,Discontinued in Phase 1/2
179268,Discontinued in Phase 1
89433,Phase 1/2a
63077,Discontinued in Phase 3
96965,Phase 1b
147733,Phase 1b/2a
161704,Patented
118181,Phase 1b/2a
94599,Patented
25632,Phase 1/2
46216,Phase 2/3
120346,Phase 0
150824,Discontinued in Phase 2/3
6310,IND submitted
185763,Patented
42842,Investigative
123769,Phase 1b
143584,Phase 1/2a
32123,Discontinued in Phase 1
121209,Phase 2a
21357,Phase 1b/2a
110909,Phase 0
63851,Approved (orphan drug)
157507,Phase 1/2a
166341,Discontinued in Phase 4
107689,Phase 1/2a
37940,Phase 1b
141763,Patented
123045,Investigative
178223,Phase 2a
184082,BLA submitted
135563,Phase 0
119765,Discontinued in Phase 4
176545,Phase 2b
75420,Phase 1b
177860,Discontinued in Phase 2/3
129081,Phase 1/2
81994,Discontinued in Phase 1
134188,Patented
76154,Patented
99551,Discontinued in Phase 2/3
73067,Phase 2a
57339,Discontinued in Phase 2/3
143707,Investigative
45521,Phase 2/3
106712,Phase 2b
51929,Investigative
150570,Phase 1
89565,Phase 1b/2a
17489,Phase 1
173255,IND submitted
45723,Phase 1/2a
147061,IND submitted
138651,BLA submitted
3016,Discontinued in Phase 3
30683,Phase 2
27729,Phase 1b
107827,Discontinued in Phase 2
97651,Phase 1/2
108271,Discontinued in Phase 1/2
94682,Patented
28930,Phase 0
171179,Phase 1b/2a
133041,IND submitted
127163,Discontinued in Preregistration
123313,Phase 2
2382,Discontinued in Preregistration
173046,Patented
94192,Phase 1/2a
24343,Investigative
168420,Discontinued in Phase 3
97430,Phase 2
174675,Discontinued in Phase 3
168711,Discontinued in Phase 1
151678,Phase 2
53244,Phase 1/2a
3680,Approved (orphan drug)
167062,Phase 4
93295,Discontinued in Phase 1
81238,Discontinued in Phase 3
151611,Phase 1
43607,Phase 2/3
150018,Phase 1b/2a
35466,Discontinued in Phase 3
158302,Phase 1
150236,Phase 2a
25044,Phase 1/2
147180,Phase 0
149452,Phase 2b
155165,Investigative
159487,Phase 1b/2a
105314,Phase 1
36252,Phase 0
142523,Discontinued in Phase 2/3
14638,Phase 0
185308,Discontinued in Phase 1
74733,IND submitted
87512,Discontinued in Phase 2/3
59796,Phase 0
185871,Phase 4
120493,Discontinued in Phase 2
124566,Phase 1b
8392,Phase 1/2
25355,Phase 1b/2a
110324,Discontinued in Phase 2/3
43371,Phase 1/2a
26207,Phase 1b
138796,Phase 1b
75676,IND submitted
180646,Discontinued in Phase 2b
10589,Discontinued in Phase 3
98078,Phase 1b/2a
105574,Phase 1b/2a
155314,Phase 1/2a
140880,Registered
17640,Discontinued in Phase 1
50769,Phase 2
131856,Phase 0
89796,Phase 1b/2a
28407,Phase 1/2a
117454,Discontinued in Phase 3
66762,Patented
149664,Investigative
94530,Phase 1
35688,Phase 1/2
11981,Phase 1
17620,Phase 1
101488,Phase 1b/2a
128561,Discontinued in Phase 4
62921,Patented
103262,Investigative
90462,Phase 0
106587,Discontinued in Phase 3
178692,Discontinued in Phase 3
139164,Discontinued in Phase 2
78074,IND submitted
87453,Phase 2a
66100,Approved (orphan drug)
111395,Phase 1/2
105006,Approved (orphan drug)
183545,Phase 1b/2a
78457,Phase 1
165945,Phase 1b/2a
152544,Approved
112163,Discontinued in Phase 3
164259,Discontinued in Preregistration
19424,Phase 0
123811,Patented
28474,Phase 2b
174085,Phase 1/2
150789,Phase 2
37142,Discontinued in Phase 3
123044,Approved
59783,Phase 2/3
161817,Phase 0
155935,Phase 1/2
105918,Phase 1/2a
47185,Discontinued in Phase 2
113392,Phase 2/3
107166,Discontinued in Phase 3
28674,Phase 4
97817,Investigative
32303,Phase 1b/2a
46770,Phase 1/2a
58178,Discontinued in Phase 3
105223,Phase 1b/2a
89542,Phase 1b
77940,Discontinued in Phase 3
10868,Phase 0
126692,Phase 0
14896,Phase 1
115990,Phase 1/2a
98041,Investigative
92724,Phase 1b/2a
32860,Phase 1/2a
173283,Discontinued in Phase 2
118749,Phase 1/2a
44011,Phase 1/2a
138944,Discontinued in Phase 2
35477,Phase 1/2
128299,Discontinued in Phase 4
161411,Patented
133867,Patented
28835,Investigative
56134,Discontinued in Phase 4
129088,Discontinued in Phase 2b
11213,BLA submitted
176551,Phase 2
28771,Phase 2
185331,Discontinued in Phase 3
126872,Phase 0
77593,Phase 1/2
16776,Discontinued in Phase 1
113703,Phase 1b/2a
45848,Phase 2/3
137635,Phase 1/2a
7573,Phase 2/3
105811,Phase 2/3
39620,Discontinued in Preregistration
83045,Phase 0
182816,Phase 1b/2a
138093,Phase 1b
53965,Phase 2
100440,Discontinued in Phase 2
163062,Patented
86105,Phase 1/2
135962,Phase 1b/2a
64459,Approved (orphan drug)
23632,IND submitted
106679,Phase 1b
4563,Investigative
99904,Phase 1
179075,Phase 1/2a
146927,Discontinued in Phase 2/3
96444,Phase 2b
85481,Discontinued in Phase 2b
35847,Phase 0
46513,Phase 1
182734,Phase 1
113396,Phase 1
96740,Phase 1/2a
26588,Phase 1/2a
126002,Phase 1b
101509,Patented
5569,Preregistration
52352,Phase 1/2a
64978,Phase 1/2
150931,Phase 1
73079,IND submitted
156020,Discontinued in Preregistration
135296,Phase 0
122249,Phase 1b
87030,Phase 1b
182632,Phase 1
34096,Phase 1/2a
107905,Discontinued in Phase 2b
89055,BLA submitted
175120,Discontinued in Phase 2
181216,Phase 1b/2a
141626,Discontinued in Phase 2b
161839,Phase 2
2576,Phase 1b
81042,BLA submitted
132705,IND submitted
183822,Discontinued in Phase 2
157413,IND submitted
124368,Phase 1b
50016,Discontinued in Phase 4
186921,Phase 4
186880,Phase 0
144891,Phase 1b
26552,Phase 1/2a
94216,Phase 2a
41359,Discontinued in Preregistration
174549,Discontinued in Preregistration
85147,Phase 1/2a
84058,Discontinued in Preregistration
124974,Phase 0
136447,Patented
88034,Discontinued in Phase 2
110593,Discontinued in Preregistration
118886,BLA submitted
150468,Phase 1b
168602,Discontinued in Phase 2
13602,Phase 0
128433,Phase 1/2
150516,Phase 2/3
89124,BLA submitted
42214,IND submitted
137246,Discontinued in Phase 2/3
102456,IND submitted
43423,Phase 2/3
121838,Discontinued in Phase 1
144555,Phase 2
19414,Investigative
105094,Phase 1/2
9917,IND submitted
120341,Discontinued in Phase 4
100253,Phase 0
67960,Clinical trial
164766,Phase 1/2
38900,Phase 1/2a
157127,Investigative
118973,BLA submitted
164660,Phase 2/3
95055,Patented
61624,Discontinued in Phase 4
136438,Phase 1
90168,BLA submitted
152248,Phase 0
12935,Discontinued in Phase 1
104964,Phase 1b
117072,Investigative
153237,Phase 1b
100725,Discontinued in Phase 1/2
62396,Investigative
61523,Discontinued in Phase 1
120996,Phase 1b
141170,Discontinued in Phase 2b
133134,Discontinued in Preregistration
186129,Phase 0
182921,Phase 2a
124622,Discontinued in Preregistration
148118,Phase 1
140013,Clinical trial
101500,Phase 1b/2a
161967,Discontinued in Preregistration
27322,IND submitted
5334,Investigative
132820,Phase 2
49754,Phase 0
95851,Discontinued in Phase 3
49592,Discontinued in Phase 3
15032,Phase 1
71750,Phase 1/2
150883,Phase 0
89334,Phase 1/2a
152598,Phase 1/2a
52058,IND submitted
102989,Investigative
72807,Investigative
38264,Phase 0
115569,Phase 2
180641,Phase 1
14922,Phase 1
128482,Phase 0
46889,Discontinued in Phase 2
89430,Phase 2/3
13142,Phase 0
137204,BLA submitted
30320,Investigative
20909,Phase 0
57922,Phase 0
32105,Phase 1
13642,Phase 1/2
40467,Discontinued in Phase 2
8419,Phase 1
21344,Patented
30502,Phase 0
149969,Discontinued in Phase 2/3
144361,Phase 3
116874,Discontinued in Phase 3
50651,Phase 1/2a
162502,Discontinued in Preregistration
12812,Phase 0
130722,Phase 2
128279,Discontinued in Preregistration
89381,Discontinued in Phase 3
108735,Discontinued in Phase 2b
166402,Phase 1b/2a
77920,IND submitted
70539,Phase 1/2
54197,Discontinued in Phase 2/3
109136,Phase 0
107505,Phase 1b
5441,Phase 1/2
100515,Discontinued in Phase 1/2
166874,Phase 2a
173773,Phase 1b
148544,Phase 2b
187986,Phase 0
57221,Phase 0
37454,Phase 1
5603,Phase 1/2
16248,Investigative
22769,Discontinued in Phase 4
83596,Phase 0
150743,Discontinued in Phase 2/3
170350,Phase 0
168278,Phase 1b/2a
135914,Preclinical
73237,Approved (orphan drug)
108706,Discontinued in Phase 1
110349,Phase 1b/2a
170914,Phase 1b
96620,Phase 1/2
34571,Discontinued in Phase 2/3
19093,Phase 2
37608,Discontinued in Phase 2b
41225,Phase 1/2a
18406,Phase 1
26745,BLA submitted
189734,Phase 1/2a
68561,Phase 2a
137868,Phase 1/2
23296,Discontinued in Phase 2b
104047,IND submitted
117568,Discontinued in Phase 1/2
121543,Phase 2
179792,Phase 1
45592,Phase 2/3
190304,Phase 1b
63258,Discontinued in Phase 3
176838,Discontinued in Phase 2
102900,Patented
65997,Discontinued in Phase 3
179470,Phase 0
183900,IND submitted
69320,Discontinued in Phase 2
7088,Phase 1/2
126007,Phase 1/2
145662,Phase 1b/2a
96236,Phase 1b
148660,IND submitted
138734,BLA submitted
104165,Patented
88287,Discontinued in Phase 2
80772,Phase 2a
38125,Patented
98043,Phase 1/2a
173354,Phase 2
89513,Phase 1
186351,Phase 4
26342,Discontinued in Phase 2/3
78810,Patented
131326,Phase 1/2
179472,Discontinued in Phase 3
124047,Phase 1
83028,Phase 0
78909,Patented
87308,Phase 0
77895,Phase 1b
18800,Phase 0
83530,Phase 1
121635,BLA submitted
185736,Phase 2a
134392,Phase 1/2a
95289,Phase 1b
115266,Discontinued in Phase 2
88995,IND submitted
92192,Phase 2b
160978,Phase 1/2
2185,Discontinued in Phase 2
159911,Investigative
123449,Phase 1
112975,Phase 2a
149651,Phase 2a
16857,Phase 1
19935,Discontinued in Preregistration
157736,Phase 1/2
71507,Phase 0
72448,Investigative
120335,Clinical trial
140207,BLA submitted
64339,Phase 1b/2a
109268,Discontinued in Phase 1/2
179903,Phase 1/2
8655,Phase 1b/2a
161437,Phase 0
156994,Approved (orphan drug)
147576,Phase 1b/2a
114149,Patented
161327,Discontinued in Preregistration
137678,Phase 1
800,Discontinued in Phase 3
90554,Clinical trial
93530,Phase 1b/2a
132224,Discontinued in Phase 1/2
32548,Phase 1b/2a
147951,Phase 1b/2a
114114,Phase 1
185612,Patented
176555,Phase 1b
164387,Phase 0
142795,Investigative
80920,Approved (orphan drug)
61412,Phase 2a
59671,Phase 2/3
121117,Phase 1b
46255,Phase 1/2
54506,IND submitted
69174,Phase 1
2481,Discontinued in Preregistration
37361,Discontinued in Phase 1/2
66260,Discontinued in Phase 1/2
62791,IND submitted
12428,Phase 0
157610,Discontinued in Phase 2
32541,Phase 1/2
3590,Approved
172487,Discontinued in Phase 2
136954,Discontinued in Phase 2b
7972,Phase 1b
65100,Phase 0
173707,Clinical trial
13592,Phase 1
104184,Patented
50072,Discontinued in Phase 2/3
131967,Phase 1/2
102334,Approved (orphan drug)
129994,Discontinued in Preregistration
38809,Phase 1
180269,Phase 1b/2a
169803,Phase 1/2a
45263,Phase 2/3
128329,IND submitted
85325,Discontinued in Phase 2b
94081,Phase 2b
66724,Patented
186079,Preclinical
1439,Phase 1/2a
44186,Phase 2/3
158580,Phase 1
157151,Discontinued in Phase 4
95918,Phase 2a
189092,Phase 1/2
15234,Phase 0
132690,Discontinued in Phase 1/2
190218,Phase 2b
88326,Phase 1/2
35186,Phase 2
1307,Approved
188617,Patented
115847,Phase 1/2
40989,Discontinued in Phase 2
42452,Investigative
69224,Discontinued in Phase 2/3
161214,Discontinued in Phase 4
99421,Patented
865,Phase 1/2
135284,Phase 0
15743,Phase 2b
172152,Discontinued in Phase 2/3
42683,Phase 2
52554,Patented
949,Clinical trial
144950,Discontinued in Phase 2/3
7307,Discontinued in Phase 2
188476,Phase 2b
128536,Phase 0
74646,Phase 1/2
43677,Phase 1/2a
86910,Phase 1b
67583,Phase 1/2a
123930,Phase 1/2
119030,Phase 1b/2a
20191,Clinical trial
104613,Patented
74178,Discontinued in Phase 3
9908,Phase 1b
158562,Phase 2/3
190117,Phase 1/2
2931,Phase 1
103830,Phase 1/2a
8266,Phase 1
184582,Discontinued in Phase 3
114874,Phase 1/2a
94342,Phase 2b
20509,Phase 1
100320,Discontinued in Phase 2
151566,Phase 0
174105,Discontinued in Phase 4
64412,Phase 2
52607,Phase 0
189505,Approved (orphan drug)
75205,Patented
71969,Phase 1
72114,Phase 0
9262,IND submitted
97012,Phase 2
182057,Discontinued in Phase 2
85254,Discontinued in Preregistration
60950,Discontinued in Phase 3
178748,Discontinued in Phase 1
82937,Phase 1
69407,Phase 1
152388,Phase 1b/2a
90649,Phase 1/2
36675,Phase 2
97900,Discontinued in Phase 2
76044,Phase 1/2
92073,Discontinued in Phase 2
23983,Phase 2
142598,Phase 3
91457,IND submitted
191545,Discontinued in Phase 1
47296,Phase 0
101372,IND submitted
5114,Phase 2a
62536,Investigative
183472,Approved (orphan drug)
126882,Phase 1/2
153329,Phase 1/2
143425,Phase 1b/2a
21609,BLA submitted
96333,Phase 1/2a
80318,Discontinued in Phase 1/2
173144,Phase 2
157697,Discontinued in Phase 4
181347,Discontinued in Phase 4
4090,Phase 2/3
101839,Phase 2a
84759,Phase 1b/2a
144233,Discontinued in Phase 1/2
77334,Phase 1b/2a
95792,Phase 1/2a
4543,Preregistration
100774,IND submitted
20661,Phase 2
116986,Discontinued in Phase 1
60473,Discontinued in Phase 3
92100,Discontinued in Phase 1/2
7113,Phase 1b/2a
106574,Patented
148612,Phase 1/2a
33721,Phase 1b/2a
88510,Phase 1
134447,Phase 1
124142,Phase 1
103586,Phase 1/2
58289,Discontinued in Phase 3
165994,Phase 1
8381,Approved (orphan drug)
70654,Discontinued in Preregistration
49417,Discontinued in Preregistration
60109,Discontinued in Phase 3
184176,Phase 1/2
27679,IND submitted
165281,Phase 1/2
139313,Phase 1b
162660,Phase 1b
35885,Phase 1/2a
139645,Phase 1/2
979,Phase 1
64327,Discontinued in Phase 2b
176303,Investigative
44869,Phase 1/2a
92504,Phase 0
18638,Discontinued in Phase 2/3
13994,Phase 1b/2a
31735,Clinical trial
149457,Phase 1b
93891,Phase 1b/2a
143856,Phase 1b/2a
137061,Discontinued in Phase 3
101366,Discontinued in Phase 2b
164022,Phase 1/2
144279,Discontinued in Phase 2
151289,Phase 1
134703,Phase 0
155728,Phase 1b
130754,Clinical trial
75057,Discontinued in Phase 2/3
13189,Phase 1
187210,Phase 0
66972,Patented
141903,Discontinued in Preregistration
20195,Clinical trial
37193,Phase 1b/2a
125013,Investigative
91575,Phase 0
30781,Investigative
154639,Phase 1b/2a
144837,Investigative
46715,Approved
60620,Approved (orphan drug)
177958,Preclinical
133219,Phase 1/2
108261,Phase 2
159517,Phase 3
156610,Phase 1b/2a
159670,Discontinued in Preregistration
166135,Phase 1
70755,Discontinued in Phase 2b
114764,Discontinued in Phase 3
9809,Discontinued in Phase 3
98824,Discontinued in Phase 2
8514,Approved
172347,Phase 2
74539,Phase 1/2
141527,IND submitted
123727,Patented
117187,Discontinued in Phase 2/3
131691,Discontinued in Phase 2/3
70677,Phase 0
12810,Phase 1
118922,Approved
14295,Phase 0
168783,Phase 1b/2a
190151,Patented
121981,Discontinued in Phase 2b
186578,Phase 1/2a
36420,Patented
88471,Phase 0
124851,Phase 1
144624,Discontinued in Preregistration
51186,Patented
167325,Phase 4
14087,Discontinued in Phase 1
64633,Approved (orphan drug)
56546,IND submitted
179462,Phase 1b
153300,Phase 2
61340,Phase 1
71269,Phase 1b/2a
97483,Phase 1/2
58252,Phase 1b
104686,Phase 2
77275,Phase 1/2a
101461,Patented
175886,Phase 0
127591,Patented
105359,Phase 1b
109900,Discontinued in Preregistration
188905,Preclinical
62401,Patented
82453,Phase 2
86974,Phase 1/2a
182840,Phase 1/2a
178099,Phase 1
188030,Phase 0
149912,Phase 1
166327,Patented
11312,Patented
101428,Phase 1b/2a
132515,Discontinued in Phase 4
76792,Discontinued in Phase 1/2
52601,IND submitted
143125,Patented
143112,Phase 1b/2a
186765,Phase 2b
165047,Phase 0
26092,Phase 2
108363,Phase 1/2a
164654,Investigative
94340,Phase 1
185079,BLA submitted
151293,Phase 1
58755,Phase 1
24966,Phase 1/2
20745,Discontinued in Preregistration
126642,IND submitted
171009,Phase 0
9743,IND submitted
85197,Phase 2/3
137219,Investigative
28103,Phase 2a
16935,Phase 0
139968,Clinical trial
52249,Discontinued in Phase 2/3
84996,Phase 0
50908,Phase 1b/2a
79972,Clinical trial
36352,Discontinued in Phase 4
114388,Phase 0
6414,Investigative
6929,Discontinued in Phase 2
108461,Investigative
117339,Discontinued in Phase 3
2151,Phase 1b
101645,Phase 2a
121507,Phase 2b
133616,Phase 1/2
85712,Discontinued in Phase 2b
9411,Approved
9309,IND submitted
166345,Phase 1b/2a
172993,Discontinued in Phase 2/3
46967,Approved
9554,Approved
125559,Phase 1b
32831,Patented
106226,Phase 1b
36713,Phase 1b/2a
152749,Patented
105961,Discontinued in Preregistration
184256,Discontinued in Phase 4
93258,IND submitted
48949,Phase 0
58989,Discontinued in Phase 3
173934,Patented
358,Phase 1
134122,Discontinued in Phase 4
75068,Discontinued in Phase 2b
166563,Phase 1b
47370,Phase 0
50117,Discontinued in Phase 2b
41052,Approved
122192,Phase 1b/2a
111299,Phase 1/2
53663,Phase 1b/2a
115333,Phase 1b/2a
11913,Discontinued in Phase 2/3
25052,Phase 1
82295,IND submitted
92047,Discontinued in Phase 2
167984,Patented
34233,Phase 1
121532,Phase 1b/2a
114603,Investigative
116333,Phase 1
155470,Approved
75298,Phase 1b/2a
187223,Phase 4
106004,Phase 1/2
32319,Phase 2a
145503,Phase 0
109117,Phase 1/2a
7008,Investigative
187187,Phase 1b/2a
112829,Discontinued in Phase 3
25735,Patented
36581,Discontinued in Phase 2
11251,Discontinued in Phase 3
109528,Preregistration
140733,Phase 1b/2a
178947,Phase 0
29761,Investigative
91626,Phase 1b
142281,Phase 1b
109949,Phase 1
154179,Investigative
122527,Phase 1/2
175960,Discontinued in Phase 1/2
68659,Discontinued in Phase 4
76686,IND submitted
177425,Phase 1b
139998,Phase 1/2a
59617,Phase 1b/2a
1009,Clinical trial
160791,Phase 3
79527,Phase 2
100182,Phase 1
18867,IND submitted
86868,Patented
123371,Phase 1b
123972,Phase 1b
36376,Phase 1/2a
70801,Phase 0
121364,Phase 1/2a
38261,Phase 1b
59660,Phase 0
39505,Phase 1
29299,Phase 2/3
34620,Phase 1/2a
111725,Phase 0
157065,Phase 1/2a
30743,Phase 2
43284,Phase 1b
82217,Phase 1b/2a
172975,Phase 1/2
33268,Phase 1b/2a
4934,Phase 2a
137863,Investigative
115521,Approved (orphan drug)
52323,Phase 1/2a
62916,Investigative
169504,Phase 1
85973,Discontinued in Phase 2b
56550,Phase 2
36828,Discontinued in Phase 2b
169926,IND submitted
131831,Discontinued in Phase 2/3
99638,Phase 1/2
11002,Phase 0
33696,Phase 1b
154173,Patented
178794,Phase 0
95850,Phase 1b
173395,Phase 1/2
55238,IND submitted
152805,Patented
136229,Discontinued in Phase 2
129483,Investigative
30076,Patented
188847,Phase 2/3
113573,Patented
58711,Discontinued in Phase 2/3
131859,Discontinued in Phase 2/3
188867,Phase 2b
118914,Phase 1b/2a
4323,Phase 1b/2a
68947,Phase 1b
27482,Discontinued in Phase 3
33865,Patented
161136,Phase 1/2a
101024,Phase 2a
54009,Phase 2
119027,Phase 1
155132,Phase 1b/2a
9990,IND submitted
142124,Patented
137294,Phase 1b
139042,BLA submitted
13210,Phase 1
118760,Phase 2
157515,Discontinued in Phase 4
189279,Clinical trial
101933,Phase 2a
172946,Discontinued in Phase 2
22887,Phase 1/2a
108603,Discontinued in Phase 2/3
32513,Phase 1b/2a
174860,Phase 0
76998,IND submitted
142355,Discontinued in Phase 1
50627,Discontinued in Phase 2b
84328,Phase 1/2a
96917,Phase 2/3
75120,Phase 2
69548,Discontinued in Phase 2/3
36447,Investigative
85482,Discontinued in Preregistration
158102,Discontinued in Phase 1/2
102167,Application submitted
109602,Discontinued in Phase 1/2
112173,Phase 0
154130,Discontinued in Phase 2b
139618,BLA submitted
161554,Investigative
120649,Phase 0
47888,Phase 1b
99676,Patented
86488,Phase 1b/2a
146917,Phase 2b
71178,Discontinued in Phase 1
173424,Patented
190427,Phase 2b
155465,Approved (orphan drug)
154178,Phase 0
60426,Phase 2/3
107549,Phase 1/2a
60947,Phase 2/3
191304,Investigative
61107,Phase 1
58384,Phase 1/2a
92745,Discontinued in Phase 3
104974,Phase 1/2
140510,Phase 0
171035,Phase 1/2
102265,Discontinued in Preregistration
171289,Phase 1/2a
141327,Discontinued in Phase 4
161274,Discontinued in Phase 4
131930,Discontinued in Preregistration
61228,Phase 1
135034,Phase 0
73438,Phase 2a
160767,Phase 0
29720,Investigative
37860,Phase 1b
45104,Phase 2/3
149936,Phase 1/2
86907,Discontinued in Phase 3
162408,Phase 1
13129,Discontinued in Phase 1
136835,Phase 1b/2a
58741,Phase 1/2a
157503,Phase 1b/2a
28279,Phase 1/2a
179590,Phase 1/2
180737,Phase 2/3
58009,Discontinued in Phase 3
32512,Phase 1/2
161459,Phase 2
104364,Patented
134642,Phase 0
78164,IND submitted
108048,IND submitted
155112,Investigative
135456,Phase 0
106982,Phase 1b
185615,Phase 2a
65166,Phase 1b/2a
147753,Investigative
36208,Phase 1
85473,Discontinued in Preregistration
10564,Phase 1/2
182291,Phase 1
101147,Phase 1/2a
76502,Phase 1b/2a
49890,Patented
174493,Phase 1/2
98792,Phase 2
118327,Phase 1b/2a
67072,Patented
67071,Patented
32673,Phase 3
48696,Phase 2/3
135429,Phase 0
101688,Phase 1b
33734,Phase 0
143774,Investigative
166173,Phase 1b/2a
156745,Phase 2
9810,Phase 1/2
83423,Investigative
27670,IND submitted
105666,Phase 1/2a
165348,IND submitted
8988,IND submitted
67089,Phase 1b
153204,Discontinued in Phase 4
146680,Phase 1b/2a
54583,Phase 1/2
55065,Phase 0
72983,Investigative
70027,Phase 2a
37117,Phase 0
130044,Phase 2
74219,Phase 1/2
36588,Discontinued in Phase 2b
7247,Phase 2/3
92937,Phase 2b
73997,Discontinued in Phase 4
61195,Phase 1
136191,Phase 2/3
117484,Discontinued in Phase 1
25794,Phase 0
116271,Phase 1b/2a
164718,Phase 0
115111,Phase 2
105520,Phase 1/2a
128523,Discontinued in Phase 1
22013,Phase 1b/2a
113176,Phase 2a
23551,Phase 1
145531,Phase 1/2a
68528,Phase 2a
28402,Phase 1b
76786,Phase 0
118879,Phase 2/3
976,Discontinued in Phase 2b
131105,Phase 1/2
147436,Phase 0
41453,Phase 1/2
96447,Phase 1
138110,Approved (orphan drug)
143695,Discontinued in Phase 1/2
77495,Phase 1
53629,Investigative
82717,Phase 1/2
14762,Phase 1b/2a
124636,Patented
142147,Patented
180911,Phase 1/2a
187636,Discontinued in Preregistration
75482,Phase 1/2a
76479,Discontinued in Phase 1/2
541,Phase 2
123789,Phase 1/2
66922,Phase 1b/2a
64688,Approved
55818,Phase 0
98126,Phase 1b
146316,Discontinued in Phase 2
42931,Patented
33415,Clinical trial
93707,Discontinued in Phase 2b
50666,Phase 1b/2a
142048,Phase 2/3
163612,Phase 1b/2a
182175,Phase 2b
165357,IND submitted
9938,IND submitted
113595,Investigative
18315,Phase 1/2a
68961,Phase 2a
184818,Phase 0
76879,Phase 1/2a
151154,Phase 2
48175,Phase 1/2a
119826,Discontinued in Phase 3
159216,Phase 1b/2a
169416,Approved (orphan drug)
177441,Phase 1b
32419,Phase 1/2a
86885,Phase 1/2
17922,Discontinued in Phase 3
34783,Phase 2/3
22238,Phase 0
87508,Approved
150477,Phase 2/3
176441,Discontinued in Phase 4
11009,Phase 1/2
68690,IND submitted
139512,Phase 1/2
127169,Patented
121253,Phase 1b/2a
117025,Clinical trial
41764,Phase 1
158848,Phase 1/2
147938,Phase 1b
23926,Discontinued in Phase 4
61239,Patented
43820,Phase 1/2a
80305,Discontinued in Phase 2
176863,Phase 2
17164,Phase 1b/2a
163303,Phase 1b/2a
145754,Phase 1b
41872,IND submitted
160384,Phase 1
155340,Phase 0
23518,Discontinued in Phase 2b
89985,Phase 2/3
34524,Phase 0
181392,Phase 1
50519,Investigative
13945,Investigative
65922,Phase 2a
13483,Phase 1
143922,Phase 1b
123393,Phase 1/2
6748,Phase 4
118033,Phase 0
169222,Discontinued in Phase 4
27527,Phase 1/2a
121453,Approved (orphan drug)
70192,Phase 0
162751,Phase 2
70786,Phase 1b
15400,Phase 0
60633,Phase 1b/2a
26807,Phase 1b
178335,Phase 1b/2a
77306,Phase 0
948,Discontinued in Phase 1
57766,Phase 2/3
42445,Phase 0
150558,Phase 1/2
138054,Clinical trial
145703,Phase 2b
18994,Phase 2
8899,Discontinued in Preregistration
181664,Phase 3
67587,Phase 1
151331,Phase 1
130250,Phase 1/2
68248,Clinical trial
136941,Phase 2
44422,Phase 1/2a
103465,Phase 1b/2a
156069,Phase 1b
70072,Phase 1b
61688,Discontinued in Phase 4
33807,Discontinued in Preregistration
49583,Phase 1b/2a
59132,Phase 1
137020,Investigative
150562,Phase 0
138554,Phase 1b
84458,Phase 1/2
187552,Phase 1b
191859,Phase 2/3
134396,Phase 1b
145892,Phase 2b
112197,Phase 0
33474,Phase 2/3
5425,Preregistration
113163,Phase 1
26363,Phase 1
4282,Preregistration
2281,Phase 1
39464,Phase 0
13713,Phase 0
55251,Discontinued in Phase 2b
77615,Phase 1/2
105624,Phase 1
3430,Patented
123656,Phase 1/2
136817,Discontinued in Phase 2
164247,Phase 1/2
120002,Discontinued in Phase 3
166531,Phase 1b
65707,Discontinued in Phase 2
155694,Phase 2a
186555,Phase 2b
69574,Phase 3
74615,Patented
30790,Phase 0
174300,Phase 1
44852,Phase 1/2a
43300,Phase 1b
129070,IND submitted
29134,Phase 2
185756,Clinical trial
100829,Phase 2/3
111188,Phase 2
104366,Patented
105989,Phase 1
35451,Phase 0
64390,Phase 1/2
136644,BLA submitted
147431,Phase 1b
93216,Discontinued in Phase 1
154770,Phase 2
85957,Discontinued in Phase 3
134916,Phase 0
170145,Phase 1
156601,Phase 1
57942,Investigative
147231,Phase 1b
68878,IND submitted
28903,Investigative
54997,Phase 0
119727,Discontinued in Phase 2b
168225,Discontinued in Phase 1
142130,Discontinued in Phase 3
87536,Phase 1/2
82747,Phase 1
138367,Phase 1b
140042,Phase 1/2a
104814,Discontinued in Phase 2b
190241,Clinical trial
161537,Phase 0
147591,Phase 2/3
172346,Phase 2
77358,Phase 0
134614,Phase 1
97493,Phase 1b
23802,Phase 1b
125755,Phase 1b/2a
14978,Phase 3
51963,Phase 1b/2a
96387,Discontinued in Phase 3
69596,Phase 1b/2a
122903,Discontinued in Phase 4
51481,Phase 3
127189,Patented
174407,Discontinued in Phase 4
13824,Phase 2b
33130,IND submitted
25372,Discontinued in Phase 4
65109,Discontinued in Phase 2
14277,Phase 1
179113,Phase 2a
80841,Approved (orphan drug)
89002,BLA submitted
62332,Phase 1b
73993,Phase 1b/2a
188712,Phase 2b
151928,Phase 0
23230,Phase 1/2a
170414,Phase 0
183985,Phase 1/2
188628,Approved
184703,Discontinued in Phase 4
2949,Phase 1b
5364,Investigative
140469,Phase 2a
23428,Phase 2
65559,Discontinued in Phase 4
107124,Discontinued in Phase 1/2
15789,Phase 0
187858,Discontinued in Preregistration
20130,Clinical trial
16489,Discontinued in Phase 1
188952,Phase 1b
61513,Discontinued in Phase 1/2
2902,Discontinued in Phase 2b
28707,Phase 1b/2a
108351,Phase 0
16370,Phase 1
18484,Phase 2a
150279,Phase 1/2a
157821,Patented
4932,Investigative
46197,Phase 1/2a
150378,Phase 0
32366,Phase 1b/2a
113305,Phase 1b/2a
5447,Phase 2a
55428,Phase 2
132130,Discontinued in Phase 1/2
95759,Phase 1
150925,Phase 0
176894,Phase 0
54769,Phase 0
149401,IND submitted
58890,Phase 1/2
155807,Phase 2
61375,Phase 1
80553,Clinical trial
160567,Phase 3
75257,Phase 1/2
127713,Phase 1/2
68773,Phase 1/2
92773,Phase 1b/2a
81273,Approved
53088,IND submitted
50164,Discontinued in Preregistration
159164,Phase 1b/2a
122757,Discontinued in Phase 4
57358,Discontinued in Phase 3
43244,Phase 1/2
61670,Discontinued in Phase 4
64054,IND submitted
69757,Phase 1b
189783,Phase 2/3
146149,Phase 0
176310,Phase 1b/2a
124517,Phase 0
41178,Investigative
28356,Phase 1b
76303,Phase 0
160677,Phase 0
137498,Discontinued in Phase 2/3
174181,Phase 2
54830,IND submitted
70020,Phase 1/2a
88436,Phase 0
181606,Phase 2a
93922,Phase 1/2a
133781,Phase 1b
135527,Phase 0
41626,Investigative
135477,Phase 0
32321,Phase 2/3
38323,Phase 3
87300,Discontinued in Phase 1/2
162488,IND submitted
8527,Discontinued in Phase 2b
93737,Discontinued in Phase 1
165151,BLA submitted
127576,Discontinued in Phase 2b
848,Discontinued in Phase 3
140600,Registered
188855,Approved (orphan drug)
149987,Phase 2b
25077,Phase 1/2
9839,IND submitted
187383,Patented
13934,Phase 1
150779,Phase 1/2
181443,Discontinued in Phase 2b
58066,Discontinued in Phase 3
74374,Phase 1/2a
67135,Patented
14812,Investigative
14101,Phase 0
19462,IND submitted
144923,Phase 2b
79130,Discontinued in Phase 4
10156,Phase 0
71427,Patented
108638,Phase 1
26512,Phase 1b
1736,Phase 0
143473,Phase 1b/2a
118929,Discontinued in Preregistration
133748,Phase 1/2
145685,Phase 1/2
4336,Preregistration
78913,Phase 0
8114,Phase 0
133949,Phase 1b
151071,Phase 2
168798,Discontinued in Phase 1/2
66674,Patented
19391,IND submitted
108711,Phase 1b/2a
84668,Phase 1/2
58444,Clinical trial
177032,Phase 1b
13987,Phase 0
978,Investigative
103131,Phase 1/2
98788,Discontinued in Phase 2b
44707,Phase 1/2a
45841,Phase 2/3
22885,Phase 1
58865,Investigative
79832,Clinical trial
153154,Phase 1b/2a
58801,Discontinued in Phase 1/2
100118,Approved
137692,Investigative
148605,Phase 2/3
159437,Phase 1b
61067,Discontinued in Phase 4
15569,Phase 1
58557,Investigative
151215,Phase 1
178944,Phase 1
96196,Phase 0
127594,IND submitted
127902,Investigative
138885,Phase 1b
31263,Discontinued in Preregistration
46915,Clinical trial
172950,Discontinued in Phase 2/3
55978,Phase 1b/2a
170181,Patented
22543,Phase 1b/2a
38922,Phase 2/3
183692,Investigative
68272,Discontinued in Preregistration
102614,Approved (orphan drug)
105908,Phase 1/2a
176314,Phase 0
39066,Phase 1b/2a
186480,Phase 1b
50564,Phase 2
113967,Phase 2
136978,Phase 1
37035,Phase 2
119853,Discontinued in Phase 2
45169,Phase 2/3
22422,IND submitted
187690,Phase 0
145791,Phase 1b
102830,IND submitted
113376,Phase 1b/2a
45691,Phase 1/2a
91344,Discontinued in Phase 2b
14566,Phase 1
178028,Patented
11978,Phase 2
33793,Phase 1b
2491,Phase 0
75881,Discontinued in Phase 1/2
186078,Phase 0
152072,Phase 2
16121,Phase 1
113216,Discontinued in Phase 3
26975,IND submitted
114719,Phase 2
3617,Approved (orphan drug)
30955,Clinical trial
157021,Discontinued in Phase 4
131086,Phase 1b
123387,Phase 1
140584,Phase 3
140413,Phase 1/2
184782,Phase 0
33192,Phase 1b
167020,Discontinued in Phase 1/2
93334,Phase 1/2a
5166,Investigative
119984,Clinical trial
84533,Phase 1/2
43821,Phase 1/2a
56849,Discontinued in Phase 2b
57177,Discontinued in Phase 1/2
91765,Patented
96082,Discontinued in Phase 3
148448,Discontinued in Phase 2/3
43827,Phase 1/2a
118902,Discontinued in Phase 2
21169,Phase 0
42599,Discontinued in Phase 1
77650,Discontinued in Preregistration
164386,Discontinued in Preregistration
95939,Discontinued in Phase 3
149792,Phase 2b
160343,Phase 1/2
95992,Phase 1/2
145355,Phase 1b/2a
43257,Preregistration
6536,Phase 2a
82052,Clinical trial
172113,Discontinued in Phase 2/3
147717,Phase 1b/2a
156941,Phase 1b/2a
84598,Phase 1/2
171025,IND submitted
154113,Patented
133854,Phase 1/2a
137915,Phase 1/2a
148768,Phase 1/2a
42914,Phase 1b
8858,IND submitted
96435,Discontinued in Phase 1
83311,Phase 2
155633,Phase 2
158859,Phase 1b/2a
54065,Phase 4
30491,Investigative
114337,Phase 1
23263,Discontinued in Phase 4
50095,Phase 1/2
127829,Discontinued in Phase 2b
16208,Phase 0
27285,Phase 2
2013,Phase 1b
173471,Discontinued in Phase 2b
124135,Discontinued in Preregistration
162845,IND submitted
178652,Patented
53189,Phase 1b
4722,Investigative
135690,Preclinical
79900,Discontinued in Phase 3
176038,Discontinued in Phase 1/2
90660,Discontinued in Phase 2/3
143761,Phase 1b/2a
89644,Patented
26704,Phase 1b
33173,Phase 2a
95566,Phase 2a
129280,Phase 1b/2a
41195,Approved
49591,Phase 1b
149250,Phase 1b/2a
149613,Phase 1b
2591,Phase 1b/2a
39690,Phase 1/2a
88605,Patented
103475,Phase 1b
131933,Discontinued in Phase 2b
93727,Investigative
74713,Phase 2
113437,Phase 1b/2a
43500,Phase 1/2a
84960,Phase 0
77671,Phase 1
12719,Phase 0
58439,Phase 2/3
123351,Discontinued in Phase 4
45344,Phase 2/3
106491,Discontinued in Phase 2b
125587,Phase 1/2
145838,Patented
49060,Phase 1
99800,Phase 1
111871,Phase 1
162396,Investigative
130988,Patented
61305,Patented
10716,Phase 0
66226,Phase 0
86342,IND submitted
185194,Approved
129072,Discontinued in Phase 3
69269,Phase 2b
157390,Phase 1b/2a
15549,IND submitted
14518,Phase 1/2a
78312,Phase 1
125997,BLA submitted
82471,Phase 1/2
162059,Phase 2
30028,Phase 0
64263,Phase 1b/2a
78456,Discontinued in Phase 1/2
8857,Discontinued in Phase 2/3
77154,IND submitted
149689,Investigative
148959,Discontinued in Preregistration
96136,Phase 1/2
187421,Patented
27310,Patented
78062,Discontinued in Phase 3
92103,Phase 1/2a
44832,Phase 2/3
183123,Phase 2a
109953,Patented
97367,Phase 1/2
180882,Phase 1
15308,Phase 0
138601,BLA submitted
64856,Discontinued in Phase 2b
66284,Discontinued in Phase 3
148785,Phase 1b/2a
56188,Discontinued in Phase 3
18324,Phase 2a
100558,Phase 3
38217,Phase 2b
129069,IND submitted
63775,Approved (orphan drug)
109060,Phase 0
89687,Phase 1
168120,Approved (orphan drug)
50208,Discontinued in Phase 2/3
129762,Phase 1/2
50074,Discontinued in Phase 2b
128058,Discontinued in Phase 2b
185923,Phase 2/3
68951,Phase 1b
15146,Phase 1b/2a
178155,Phase 1b/2a
54894,Phase 1b/2a
179827,Phase 1/2a
129387,Discontinued in Phase 1
67727,Phase 1b
174789,IND submitted
118800,Discontinued in Phase 1/2
134600,Phase 1
130648,Phase 1
54039,Phase 1/2
12026,IND submitted
20518,Discontinued in Preregistration
74626,Discontinued in Phase 3
71884,Discontinued in Phase 1
22374,IND submitted
109628,Phase 4
27684,Phase 2
51324,Phase 1/2
122701,Phase 1b
98821,Phase 2/3
45682,Phase 2/3
129657,Phase 1/2
26212,Phase 1b
115246,Discontinued in Phase 2
143358,Discontinued in Preregistration
144126,Investigative
110280,Phase 1/2a
178270,Phase 2
148742,Phase 1
54088,Discontinued in Phase 2b
145119,Phase 1b/2a
119721,Discontinued in Preregistration
34306,Patented
189913,Phase 2/3
118590,Phase 2b
189659,Preclinical
124121,Phase 0
29998,Phase 0
136497,Phase 1/2
160646,Phase 0
170904,Phase 0
126068,Discontinued in Phase 3
127190,Phase 1/2
174906,Phase 1/2
154402,Discontinued in Preregistration
51468,Phase 1/2a
21654,Phase 1b/2a
125335,Phase 1b/2a
88068,Phase 1b/2a
118611,IND submitted
36665,Discontinued in Preregistration
188444,Discontinued in Phase 3
163285,Investigative
172854,Phase 0
98403,Phase 1/2
83541,Phase 0
60382,Discontinued in Phase 3
66858,Phase 1b
128779,Patented
107929,Discontinued in Phase 1
50119,Discontinued in Preregistration
68594,Phase 2a
84311,Phase 1/2
87519,BLA submitted
157616,Phase 2
145872,Phase 1/2a
16741,Phase 1
37422,Phase 2a
20274,Phase 1b/2a
40302,Discontinued in Phase 4
52704,Phase 3
167096,Phase 1/2a
183652,Approved (orphan drug)
158982,Phase 2
100424,Phase 1b
191664,IND submitted
105689,Phase 1/2
19895,Phase 2a
113444,Discontinued in Phase 3
37968,Phase 1/2a
10081,IND submitted
5741,Discontinued in Phase 2
72390,Phase 2
57495,Phase 1
100838,Phase 1b
160594,Phase 3
77167,Investigative
49743,Discontinued in Phase 2b
61598,Discontinued in Phase 4
185531,Patented
76996,Phase 1b/2a
151586,Phase 1b
5638,Phase 2/3
181716,Phase 1b/2a
73857,Patented
80475,Phase 1/2a
188267,Patented
102353,Phase 1
136801,Phase 2
153318,Phase 0
164651,Phase 1/2
166008,Phase 1b
169525,Phase 1
40641,Phase 1b/2a
145486,Phase 0
102489,Discontinued in Preregistration
59527,Discontinued in Phase 4
123992,Discontinued in Phase 4
171467,Phase 2a
41210,Discontinued in Phase 2
17918,Phase 1/2a
131823,Patented
105590,Phase 1b/2a
68654,Discontinued in Preregistration
188775,Preclinical
70342,Phase 1b/2a
157355,Phase 1
45149,Phase 1/2a
19820,Approved (orphan drug)
185691,Phase 4
66373,Discontinued in Phase 2/3
102675,IND submitted
153048,Patented
179526,Discontinued in Phase 2/3
169566,Discontinued in Phase 2/3
102149,Investigative
171843,Phase 2
87305,Discontinued in Phase 2/3
172064,Discontinued in Phase 2
151792,Phase 2
3506,Patented
119413,Phase 2
57333,Phase 0
149063,Discontinued in Phase 1
24541,Phase 1b/2a
56504,Phase 1
14107,Phase 1
172704,Discontinued in Phase 2b
30619,Phase 1/2
78267,Investigative
122963,Phase 1/2
53282,IND submitted
60141,Phase 1/2a
158039,Discontinued in Phase 1/2
117194,Discontinued in Phase 3
22116,Discontinued in Phase 2
68389,Phase 1
181319,Phase 1b/2a
159309,Phase 2
65572,Preclinical
100304,Preclinical
188549,IND submitted
104863,Phase 1/2a
127266,Discontinued in Phase 2/3
83901,Phase 1
177857,Patented
68315,Phase 1
159523,Phase 1
97311,Phase 1
67249,Discontinued in Phase 1
174814,Phase 1
18980,Discontinued in Phase 2/3
35518,Phase 1/2
88478,Phase 0
119258,Phase 2b
132651,Phase 1b/2a
170114,Investigative
95298,Phase 1
144258,Discontinued in Phase 1/2
119820,Discontinued in Phase 1/2
85567,Discontinued in Phase 3
184103,Discontinued in Phase 4
12939,Phase 1b/2a
133478,Phase 1/2
96947,Phase 1/2
69063,Discontinued in Phase 1/2
15831,Phase 0
154379,Discontinued in Preregistration
25702,Discontinued in Phase 4
49947,Discontinued in Phase 2b
154246,Discontinued in Preregistration
21281,Phase 1
27620,Phase 1b
81736,Investigative
712,Phase 1/2
53198,IND submitted
150736,Phase 1
129985,Patented
161233,Phase 1/2
58950,Investigative
143347,Investigative
137454,Phase 1
171129,Phase 0
62004,Discontinued in Phase 2b
123506,Approved
66086,Phase 2
60652,Phase 1/2a
19866,Phase 0
74785,Phase 1/2
140998,Investigative
7747,Patented
27943,Clinical trial
12053,Phase 0
166888,Phase 2a
124994,Phase 0
38616,Phase 1b/2a
29521,Phase 2
68882,Discontinued in Phase 2/3
59330,Investigative
105973,Phase 1b
177612,Phase 1b
29237,Phase 1b
97221,Phase 1/2a
106704,Discontinued in Phase 2
112887,Phase 1
177561,Phase 1b
53170,Discontinued in Phase 2
159976,Phase 1b
18201,Phase 1/2
13763,Phase 1
31991,Discontinued in Phase 4
169463,Phase 1
159370,Discontinued in Phase 1
3484,Approved
61094,Investigative
180626,Phase 2b
47013,IND submitted
125650,Phase 1b/2a
150788,Phase 1b/2a
25889,Discontinued in Preregistration
77273,Patented
29325,Phase 1b/2a
142574,Discontinued in Phase 2b
34857,Discontinued in Preregistration
177242,Phase 1b
73813,Phase 1b/2a
55836,Phase 2/3
149274,Investigative
19620,Phase 0
90256,Phase 2/3
139744,BLA submitted
168186,Discontinued in Phase 2/3
60413,Phase 0
112214,Phase 1/2
72427,Phase 2/3
66761,Phase 0
59566,Investigative
123102,Phase 1
171597,Discontinued in Phase 2b
173306,Phase 1/2
169760,Discontinued in Phase 2/3
98523,Phase 1b
53512,Phase 1
174876,Discontinued in Phase 1/2
29340,Discontinued in Phase 2b
92578,Discontinued in Phase 2b
80181,Discontinued in Phase 1
92984,Phase 1b/2a
71206,Discontinued in Phase 1
4226,Phase 1/2
125602,Phase 1b
44495,Phase 2/3
32412,Phase 0
80071,Investigative
107469,Phase 1b
186824,Phase 2b
67020,Phase 0
79035,Phase 0
68043,Discontinued in Phase 4
103283,Discontinued in Preregistration
48557,Phase 3
22668,Discontinued in Phase 4
339,Phase 2
72588,Phase 2
14122,Phase 1/2
125638,IND submitted
156958,Discontinued in Phase 1/2
99647,Phase 1
18025,Phase 2a
56386,Phase 1b/2a
95225,Patented
41284,Phase 1
5918,Phase 1/2
44950,Phase 1/2a
55767,Phase 1b/2a
15777,Phase 1/2
14060,Phase 0
134037,Phase 1/2a
60759,Discontinued in Phase 4
165081,Phase 0
67661,Phase 1b
82662,Phase 1b/2a
12510,Phase 1/2
174670,Phase 2b
182421,Phase 2a
148369,Phase 1/2a
43422,Phase 1/2a
124528,Phase 1b
172027,Discontinued in Phase 2/3
40880,Discontinued in Phase 2/3
108440,Phase 1b
69060,Investigative
185982,Phase 0
191055,Phase 1
188425,Phase 2b
141871,Phase 1
181034,Phase 1
84700,Phase 0
145912,Phase 1/2a
126702,Phase 1/2
21474,Investigative
95762,Phase 1b
111010,Discontinued in Phase 3
114943,Phase 2
169195,Phase 3
19904,Phase 0
54170,Phase 2
190933,Discontinued in Phase 1
119393,IND submitted
118867,Phase 2a
23125,Phase 1b/2a
155389,Phase 1
39872,Phase 2
152355,Discontinued in Phase 4
73149,Phase 1b/2a
149042,Phase 1b/2a
131386,Phase 1b/2a
133313,Approved
168963,Discontinued in Phase 2
37895,Phase 1
184456,Phase 1
102687,Phase 1/2a
52817,IND submitted
189612,Phase 1/2
24698,Phase 1
181103,Phase 2a
99892,Phase 1
73020,Phase 2
107085,Phase 1b
23771,Phase 2/3
127544,Phase 0
105839,Phase 1/2a
112158,Discontinued in Phase 3
3451,Discontinued in Phase 2
168953,Investigative
37222,Phase 0
55772,Phase 1b/2a
153250,Phase 1
2230,Discontinued in Phase 2
67423,Discontinued in Phase 2/3
144765,Phase 0
51416,Phase 2/3
176174,Discontinued in Phase 1/2
48673,Phase 1
33327,Phase 1
47434,Phase 1/2
63809,Phase 0
40116,Phase 1b/2a
12129,IND submitted
169039,Discontinued in Phase 2
156624,Discontinued in Phase 4
146184,Phase 1/2a
174672,Discontinued in Phase 4
174422,Discontinued in Phase 2
120191,Approved (orphan drug)
85534,Discontinued in Phase 3
12982,Phase 1/2a
28581,Phase 1/2a
179831,Phase 1
18844,Phase 0
61135,Phase 1
59394,Phase 1/2
99775,Phase 1
53578,Discontinued in Phase 2
188634,Phase 2b
150765,Phase 0
118917,BLA submitted
17600,Phase 1/2
14706,Phase 1
38676,Discontinued in Preregistration
25691,Phase 2
17743,Phase 1
11790,Phase 2a
410,Approved (orphan drug)
83662,Phase 1
22732,Discontinued in Phase 4
139137,Phase 1b
33334,Approved (orphan drug)
138642,Phase 1b
86088,BLA submitted
179932,Discontinued in Phase 2/3
129336,Discontinued in Phase 2b
91127,Approved (orphan drug)
77456,IND submitted
112186,Phase 0
13679,Phase 0
59893,Discontinued in Phase 1/2
21370,Phase 2a
21809,Phase 1/2a
139444,Phase 1b
93825,Phase 2b
167406,Discontinued in Preregistration
152089,Phase 1
130158,Investigative
82518,Phase 1/2a
88796,Phase 1
108377,Phase 1b
50790,Discontinued in Phase 2
129414,Investigative
111069,Discontinued in Phase 2b
89645,Phase 1b/2a
8030,IND submitted
122735,Phase 0
50648,Phase 0
172741,Discontinued in Phase 2/3
58350,Investigative
161903,Investigative
177124,Phase 1
22553,Patented
14031,Phase 1
24488,Phase 1/2a
121153,Phase 0
176028,Phase 1/2
15915,Phase 1b/2a
123120,Discontinued in Phase 4
35142,Phase 2a
6240,Phase 1b/2a
4797,Investigative
95760,Phase 1b
112254,Discontinued in Phase 3
190699,Preclinical
105832,Phase 2/3
155222,Phase 1b/2a
131835,Phase 1b/2a
186991,Phase 1
121465,Phase 0
27083,Phase 1b
60317,Phase 1b/2a
4530,Phase 1b/2a
165477,Phase 1b
89978,Phase 0
54316,Phase 1/2
117848,Phase 0
134404,Phase 1
154458,Discontinued in Phase 2b
26203,Phase 2
97232,Patented
63955,Clinical trial
157731,Phase 1
155434,IND submitted
170667,Phase 0
82753,Discontinued in Preregistration
132040,Discontinued in Preregistration
51900,Phase 1b
79068,Phase 0
137872,Phase 1/2a
29472,Phase 1b/2a
169668,Phase 3
95597,Phase 1/2a
68917,Discontinued in Phase 3
32214,Phase 2a
131903,IND submitted
74343,Investigative
46534,Phase 0
176745,Phase 1/2
131269,IND submitted
2059,Approved
141881,Phase 2/3
19268,Phase 1
61527,IND submitted
27550,Discontinued in Phase 3
167279,Phase 4
26478,Phase 0
123150,Phase 1/2
33354,Phase 2/3
121614,Phase 2
2873,Investigative
84425,Phase 1/2a
140486,Phase 2a
179511,Phase 1/2
186814,Patented
158379,Phase 1/2
20117,Investigative
32696,Phase 1b/2a
33605,Phase 2a
159746,Phase 1b/2a
109535,Discontinued in Phase 2/3
122449,Phase 1b
65353,Discontinued in Phase 2
142712,Phase 1b/2a
127310,Phase 1/2
182926,Phase 2b
75183,Discontinued in Phase 2/3
37675,Discontinued in Phase 1
17573,Phase 0
28864,Phase 1/2a
79006,Phase 1b
166256,Discontinued in Phase 1/2
63877,Approved
36716,Discontinued in Phase 1/2
105159,Phase 1b
4534,Preregistration
96314,Phase 1b/2a
81493,Phase 1/2a
1653,Discontinued in Phase 1/2
134743,Phase 0
70645,Phase 0
66433,Patented
43020,IND submitted
37025,Discontinued in Preregistration
77797,Discontinued in Phase 4
133994,Phase 1/2
96861,Phase 2/3
56432,Phase 1/2a
66952,Patented
171563,Discontinued in Phase 2
56940,Discontinued in Phase 2/3
166998,Discontinued in Preregistration
18480,Phase 1/2
149779,Phase 1/2
98032,Discontinued in Phase 2b
183090,Phase 1/2a
47897,Discontinued in Phase 2/3
73728,Phase 2/3
93666,Phase 2b
132218,Discontinued in Phase 4
12192,Phase 1/2
156851,Preregistration
7099,Phase 4
145029,Discontinued in Phase 2
120277,Discontinued in Phase 4
112592,Discontinued in Phase 2
148754,Phase 2a
129042,Phase 1/2
173200,Discontinued in Phase 2
106022,Phase 2/3
134529,Discontinued in Phase 4
130509,Patented
71104,Phase 1b
100619,Phase 2/3
38627,Discontinued in Phase 4
185261,Discontinued in Phase 4
116473,Phase 1
15067,Phase 1
122054,Phase 1
470,Phase 1/2a
103017,Investigative
54599,Investigative
53617,Discontinued in Phase 3
113162,Phase 1b/2a
65906,Phase 1
20823,Investigative
190878,Phase 1/2a
106407,Patented
84742,Phase 1/2a
67754,Phase 1b
19275,Patented
101967,Phase 1
187642,Phase 1b
81084,Phase 1b
26084,Discontinued in Phase 2/3
125611,Phase 1b
124323,Phase 1
152625,Patented
113477,Phase 2a
134657,Phase 0
119382,Discontinued in Phase 1
35914,Phase 2a
37439,Phase 1
140023,Discontinued in Phase 2
129906,Phase 1/2
35777,Phase 1/2
41568,IND submitted
167932,Patented
92591,Phase 2a
178175,Phase 1b/2a
131067,Phase 1/2
180639,Phase 1/2a
128311,Patented
188066,Phase 2b
152949,Phase 1
71174,Discontinued in Phase 1/2
33478,Approved (orphan drug)
103244,Phase 0
10620,Discontinued in Phase 2b
187741,Phase 1
74650,Discontinued in Phase 4
132977,IND submitted
21900,Approved (orphan drug)
121075,Phase 1/2a
18161,Discontinued in Preregistration
79776,Clinical trial
91621,Approved (orphan drug)
7322,Phase 1/2
92805,Phase 1b
23421,Phase 1b/2a
31360,Phase 0
77531,Phase 1
82377,Discontinued in Phase 1/2
78554,Phase 2/3
26801,Phase 1b
105080,Phase 1/2
45502,Phase 1/2a
29532,Phase 2/3
154568,Phase 3
161663,Investigative
154910,Phase 1b/2a
101948,Discontinued in Phase 2/3
131047,Phase 2a
53441,Phase 1b/2a
73474,Phase 2a
75058,Phase 1/2
8878,Approved
159040,Approved
181378,Phase 1/2a
66048,Approved (orphan drug)
14604,Phase 1/2a
134747,Phase 0
81928,Clinical trial
126811,Discontinued in Preregistration
151985,Phase 2/3
139898,BLA submitted
93125,Phase 1/2
129221,Patented
86731,Phase 2
172808,Phase 2
142166,Patented
187872,Discontinued in Phase 4
160342,Phase 3
84349,Discontinued in Phase 2
20601,Phase 1b/2a
54668,Phase 1
120879,Clinical trial
19716,Phase 1/2
80487,Phase 1
118231,Discontinued in Phase 4
11749,Phase 1/2
76609,Discontinued in Phase 1/2
70187,Phase 1
97634,Phase 1b
26202,Investigative
175754,Discontinued in Phase 3
73184,Phase 1
163711,Discontinued in Phase 2/3
180826,Phase 2b
2199,Phase 1b
25582,Discontinued in Preregistration
12267,Phase 1b/2a
25210,Phase 2
61489,Discontinued in Phase 1/2
176575,Phase 2
160099,Phase 1b/2a
188150,Phase 4
157997,Phase 1b/2a
90467,Discontinued in Phase 2
166010,Phase 2
135215,Phase 0
181922,Phase 2a
56128,Discontinued in Phase 2b
140782,Preregistration
151511,Phase 2/3
40310,IND submitted
121887,Phase 2b
83132,Phase 0
137514,Discontinued in Phase 2b
16939,Phase 1
110288,Phase 1/2a
124804,Phase 1/2
167144,Phase 1/2a
154917,Phase 2
2090,Phase 2b
12707,Phase 1
150863,Discontinued in Phase 2/3
76130,Discontinued in Preregistration
156391,Phase 1/2a
179942,Discontinued in Phase 4
140842,Preregistration
13053,IND submitted
177201,Approved (orphan drug)
104779,Phase 1/2a
49919,Phase 1b/2a
120862,Approved (orphan drug)
94,Phase 1
102837,Approved (orphan drug)
134336,Phase 1/2
96625,Phase 1b
68710,Discontinued in Phase 4
23690,Phase 1b/2a
21895,Phase 1/2
63622,Clinical trial
46211,Phase 1/2a
24241,Investigative
17147,Phase 1b/2a
95726,Phase 1/2a
74837,Phase 1/2
185105,Phase 1
172237,Discontinued in Phase 2/3
122769,Patented
18226,Discontinued in Phase 3
58673,Phase 1b/2a
180179,Phase 1/2
73722,Approved
178741,Phase 0
183698,BLA submitted
146685,Phase 1b
171201,Phase 1/2
186843,Patented
184336,Phase 1
98850,Phase 1
121035,Phase 2a
98290,Phase 1
183889,Phase 1b
96732,Phase 2
117376,Discontinued in Preregistration
33791,Discontinued in Phase 2
55041,Phase 0
48138,Discontinued in Phase 2
104190,Phase 1/2a
94573,Phase 1
136723,Phase 1b/2a
102233,Investigative
98783,Phase 1/2a
83082,Phase 1
87331,Phase 0
34929,Discontinued in Preregistration
150061,Discontinued in Phase 2
241,Discontinued in Phase 1
68482,Phase 1/2a
94619,Discontinued in Phase 4
108543,Patented
151225,Phase 1b/2a
153609,Phase 1/2a
96025,Phase 1/2
95964,Phase 2/3
108919,Phase 3
110906,Discontinued in Phase 4
168930,Phase 0
160928,Patented
104820,Discontinued in Phase 2b
141700,Discontinued in Phase 2b
180396,Discontinued in Phase 2b
171067,IND submitted
58071,Discontinued in Phase 4
82145,Clinical trial
42782,Phase 0
154845,Phase 2
172695,Discontinued in Phase 2
132843,Phase 1b/2a
21745,Approved (orphan drug)
62705,Discontinued in Preregistration
80851,Phase 1
42677,Phase 1
134099,Phase 1/2
10192,Preclinical
91403,Phase 1b
96869,Phase 0
97017,Phase 1/2a
26507,Phase 1b
20189,Patented
38697,Phase 2/3
117259,Discontinued in Phase 3
176653,Phase 2b
89217,Discontinued in Phase 4
64037,Phase 0
65194,Phase 2a
39900,Phase 1/2a
39276,Discontinued in Preregistration
111762,Phase 1
149345,Discontinued in Phase 2/3
65054,Approved
59487,Phase 1
68195,Phase 1b
53637,Phase 1
54470,Discontinued in Preregistration
131279,Phase 1b/2a
43800,Phase 2/3
141318,Discontinued in Preregistration
48017,Phase 1b/2a
89199,Phase 1/2a
106950,Discontinued in Preregistration
87050,Phase 1/2
121994,Phase 2
34948,Phase 2/3
15471,Phase 1
171673,Phase 1/2
19918,Phase 1
108000,Discontinued in Phase 2/3
161261,Phase 0
155639,Phase 2/3
81530,Phase 1
179228,Phase 1b
65642,Phase 2/3
55541,Phase 0
81496,Phase 1/2a
186494,Phase 2b
530,Phase 2
23958,Phase 1
9338,Discontinued in Phase 1
45974,Phase 1/2a
92104,Phase 1b/2a
70420,Phase 1b/2a
98826,Phase 1b
42028,Phase 2
14946,Phase 0
119529,Patented
75254,Phase 1/2
81358,Discontinued in Phase 3
99282,Phase 0
117086,Discontinued in Phase 1
126132,Phase 1b/2a
115961,Discontinued in Preregistration
140387,Investigative
3112,Discontinued in Phase 2b
117218,Discontinued in Phase 2/3
96980,Patented
62165,Investigative
42702,Phase 0
171475,Phase 1b
145556,Phase 2a
131740,Patented
179371,Discontinued in Phase 1
64520,Phase 2a
71547,Phase 1b
133825,Patented
173484,Phase 0
18804,Discontinued in Phase 2/3
132166,Phase 1/2
46332,Phase 1/2
27172,Phase 1b
136462,Discontinued in Phase 2/3
54397,Phase 1
189859,Phase 1/2
64617,Approved (orphan drug)
33959,Patented
54325,Phase 1b/2a
136896,BLA submitted
69277,Discontinued in Phase 3
124192,IND submitted
41094,Discontinued in Phase 1/2
142898,Phase 2b
183306,IND submitted
126451,Phase 0
141905,Phase 2/3
31195,Clinical trial
107721,Discontinued in Phase 2
76505,Discontinued in Phase 1/2
116383,Discontinued in Phase 1
146345,Patented
154975,Investigative
86415,IND submitted
187517,Phase 1b/2a
118602,BLA submitted
73130,Phase 2
63671,Phase 1
183148,Phase 4
12324,Phase 1
44345,Phase 2/3
3139,Investigative
148620,Investigative
2581,Phase 0
93639,Phase 2b
14136,Investigative
140515,Phase 1
145120,Phase 1b/2a
189567,Phase 0
173498,Discontinued in Phase 2/3
63642,Phase 0
125494,Phase 1b
30261,Patented
126543,Discontinued in Phase 1
170102,IND submitted
114112,Phase 1/2a
110467,Phase 1b/2a
164716,Discontinued in Preregistration
67384,Clinical trial
30363,Discontinued in Preregistration
183959,Discontinued in Phase 4
58305,Investigative
92708,Phase 2a
148298,Phase 1/2
83092,Phase 2/3
59529,Discontinued in Phase 1/2
33504,Phase 1b
40304,Phase 2
6151,Phase 2/3
127559,Discontinued in Preregistration
107125,Discontinued in Phase 2b
109874,Discontinued in Preregistration
142262,Patented
3316,Phase 2a
47631,Patented
89628,Phase 0
44515,Phase 1/2a
16555,Phase 1
132826,IND submitted
129527,Phase 1/2a
88413,Phase 1
146019,Phase 2b
182844,Discontinued in Phase 2b
161142,Phase 0
173517,Phase 1/2
161363,Investigative
141337,Phase 0
19632,Phase 0
31174,Discontinued in Preregistration
138239,Phase 1/2a
54075,Phase 1/2a
184036,Phase 0
122640,Phase 1
49214,Patented
76316,Phase 1/2a
3101,Discontinued in Phase 2
172505,Discontinued in Phase 2b
119602,Discontinued in Phase 2b
190132,Phase 1/2
107319,Phase 1/2a
4955,Phase 1/2
169857,Phase 1/2a
24221,Discontinued in Phase 2b
81438,Phase 1b
82878,Phase 1/2a
161748,Phase 1b
106130,Phase 1/2
184964,Discontinued in Phase 4
133171,Investigative
147788,Patented
150500,Phase 2b
96511,Phase 0
161096,Phase 1/2a
190617,Phase 1/2
70651,Phase 2
132341,IND submitted
135396,Phase 0
104081,Phase 1/2
161209,Discontinued in Preregistration
136792,Phase 2
123280,Phase 2
186260,Phase 2a
38111,Discontinued in Phase 4
96473,Phase 1/2a
40026,Discontinued in Preregistration
25533,Phase 1
6706,IND submitted
4979,Phase 2a
41102,Discontinued in Phase 4
23184,Phase 1/2a
76002,Phase 1/2a
183549,Phase 2a
76613,Phase 1/2
12117,Phase 1b
125429,Discontinued in Phase 4
150142,IND submitted
74044,Discontinued in Preregistration
83471,Phase 1/2
86140,IND submitted
112503,Phase 1
58513,Discontinued in Phase 3
181919,Phase 1b/2a
182345,Discontinued in Phase 2b
140135,Approved (orphan drug)
89803,Phase 1b/2a
49110,Phase 1b
105439,Phase 1/2
73563,Clinical trial
90594,Approved (orphan drug)
19323,Patented
121493,Approved
148944,Phase 2b
90025,Approved (orphan drug)
17660,IND submitted
100674,Phase 2
14117,Phase 0
180349,Phase 1b/2a
50794,Patented
141301,Discontinued in Preregistration
102047,Patented
53887,Phase 1/2a
133259,Discontinued in Phase 1
122642,Discontinued in Preregistration
28593,Discontinued in Phase 2/3
153064,Discontinued in Phase 3
154931,Phase 1b/2a
161013,Phase 0
66878,Phase 1/2
144578,Phase 1/2
78609,Phase 2/3
139390,Phase 1b
186075,Phase 2b
29238,Phase 1b
148804,Phase 1/2
60481,Discontinued in Phase 1/2
183033,Phase 1
189914,Phase 1b
95053,Phase 1
84248,Discontinued in Phase 2/3
149599,Phase 1
72707,Phase 1b/2a
28225,Phase 1
96899,Phase 1b
39725,Phase 1/2a
164335,Phase 1/2a
186163,Phase 2/3
157376,Discontinued in Phase 2
28863,Phase 1/2a
14343,Phase 0
150999,Phase 2
61026,Discontinued in Phase 3
182716,Phase 1b/2a
76616,Phase 1/2
188770,Phase 1b
23868,Phase 1
3765,Approved
167470,Phase 4
177050,Phase 1
111253,Phase 1/2a
144362,Phase 3
141368,Investigative
119190,Discontinued in Preregistration
59351,Phase 2/3
109497,Phase 3
143164,Discontinued in Phase 3
94678,Phase 1/2a
184132,Phase 1
38180,Phase 0
56186,Phase 1b/2a
170481,Phase 1
5958,Investigative
168198,Discontinued in Phase 1
6111,Investigative
79294,Phase 2a
40406,Investigative
174607,Discontinued in Phase 1/2
131020,IND submitted
15193,Investigative
52231,Phase 1b/2a
152398,Discontinued in Preregistration
158500,Phase 1b/2a
121512,Approved
170387,Discontinued in Preregistration
63554,Phase 1/2
67317,Discontinued in Phase 1
117959,Investigative
102175,IND submitted
33307,Clinical trial
84391,Phase 0
150031,Phase 2
148171,Clinical trial
19689,Phase 2a
170699,Phase 1/2
77033,Phase 1/2a
55194,Patented
15694,Phase 0
131207,Phase 1/2a
147158,Phase 1b
144348,Discontinued in Phase 2/3
172436,Discontinued in Phase 2b
49381,Phase 1b
39056,Investigative
182838,Phase 2/3
184942,Discontinued in Phase 4
168444,Clinical trial
147240,Phase 2/3
45420,Phase 1/2a
186803,Phase 4
182634,Phase 1
138285,Discontinued in Phase 2
144892,Investigative
174107,Discontinued in Phase 3
66249,Phase 1b/2a
6666,Investigative
174503,Discontinued in Phase 2
21472,Discontinued in Phase 1/2
8672,Phase 1b/2a
159860,Phase 1
106244,Phase 1/2
152953,Investigative
29090,Phase 1b
89476,Phase 1b/2a
96505,Discontinued in Phase 1/2
146092,Phase 2
71009,Phase 1b/2a
35918,Investigative
94190,Phase 2a
132272,Patented
89416,Phase 1b/2a
82917,Phase 2
177181,Phase 2b
75194,Discontinued in Phase 2b
18500,Phase 1/2
102031,Investigative
120916,Phase 2a
188269,Phase 2b
159421,Discontinued in Phase 1
88630,Phase 1
146764,Investigative
81467,Clinical trial
73159,Discontinued in Preregistration
154554,Phase 2
126341,IND submitted
145284,Phase 1b
27156,Phase 1b
42867,Patented
107276,Phase 1b
177842,Phase 1b/2a
5440,Phase 2a
64839,Approved (orphan drug)
76033,Phase 1b
57258,Investigative
29253,Phase 4
180335,Phase 1b
83713,Investigative
11353,Phase 1/2
182079,Phase 1/2
94131,Phase 1b
27445,Phase 0
27793,Phase 2
10942,Phase 0
50509,Phase 1
22236,Phase 1
162011,Patented
115110,Clinical trial
155226,Phase 2a
83963,Phase 1/2
156075,Phase 1/2
154067,Discontinued in Phase 3
159194,Clinical trial
57057,Phase 1b/2a
177416,Phase 1b
24612,Phase 2
30110,Investigative
69087,Phase 2a
77430,Discontinued in Preregistration
51232,Discontinued in Phase 2b
8139,Patented
23458,Phase 1b/2a
137470,Discontinued in Phase 2/3
117767,Discontinued in Phase 2/3
90647,BLA submitted
180075,Phase 1/2a
48087,Phase 1b/2a
21405,Phase 1b/2a
124567,Phase 2
101210,Phase 1/2a
85378,Discontinued in Phase 3
55935,Investigative
143657,Phase 1/2a
45820,Phase 1/2a
152498,Discontinued in Phase 4
14808,Investigative
185984,Phase 2b
74616,Phase 1/2a
123730,IND submitted
180894,Discontinued in Phase 2b
13038,Phase 1
1004,Phase 2/3
640,Phase 2
25125,Phase 0
140886,Phase 2a
103934,Phase 1b/2a
145415,Phase 1b/2a
81594,Approved
12562,Phase 0
165306,Phase 1/2
61151,Discontinued in Phase 4
28927,Phase 0
143599,Discontinued in Phase 1/2
50161,Investigative
60360,Phase 0
131195,Phase 1/2
156402,Discontinued in Phase 3
17535,Phase 1
182438,Phase 2/3
4500,Investigative
109180,Phase 0
146618,Patented
180048,Phase 1
26973,Phase 1b
29578,Clinical trial
89447,Discontinued in Preregistration
123331,Patented
146454,Phase 1b
83690,Phase 1/2a
13223,Discontinued in Phase 1
65191,Discontinued in Phase 4
117886,Phase 1
57246,Discontinued in Phase 3
143386,Discontinued in Preregistration
24427,Phase 2
21209,Phase 0
17449,Discontinued in Phase 1
97928,Discontinued in Phase 2
107388,Phase 1/2a
175684,Patented
54378,Patented
8898,IND submitted
74862,Phase 1/2
135596,Phase 0
91496,Discontinued in Phase 2b
147819,Phase 1b
147351,Phase 1b
77668,Phase 1/2
34255,Patented
72511,Investigative
16183,Phase 1/2
126103,Phase 1b
171835,Discontinued in Phase 3
177150,Discontinued in Phase 3
26534,Phase 1/2a
39011,Patented
41072,Discontinued in Phase 1/2
35750,Discontinued in Phase 1/2
5055,Investigative
190881,Preclinical
163003,Patented
99214,Phase 0
41747,Phase 1b
118002,IND submitted
42680,Phase 1/2
178288,Phase 2b
188746,Phase 1/2a
101556,Phase 1/2a
180507,Discontinued in Phase 2
21690,Patented
61053,Phase 1b/2a
174468,Discontinued in Phase 4
77785,Discontinued in Phase 4
171612,Discontinued in Phase 2b
83846,Phase 2/3
87239,Phase 0
153831,Phase 1/2a
57993,Phase 1b/2a
92231,Discontinued in Phase 1
95843,Phase 1
15641,Phase 1
76356,Phase 1/2
13455,Phase 1
5230,IND submitted
88114,Phase 1b/2a
33909,Patented
78278,Discontinued in Preregistration
68436,Investigative
40064,Phase 0
170918,Phase 0
6382,IND submitted
18518,Discontinued in Phase 2b
121975,Phase 2
73195,Phase 1b
171471,Discontinued in Phase 2b
12283,Phase 1
149244,Investigative
76253,Phase 1/2a
110277,Discontinued in Preregistration
107925,Discontinued in Phase 3
11936,IND submitted
146842,Investigative
38450,Phase 1/2a
48464,Discontinued in Preregistration
60606,Discontinued in Phase 3
121251,Phase 1/2a
165825,Phase 1b/2a
43480,Phase 2/3
14578,Phase 0
25106,Patented
57380,Clinical trial
16437,Phase 1/2a
21306,Phase 1b
149455,Investigative
153859,Phase 1b
123141,Phase 1b
16078,Phase 0
26753,Phase 1b
76375,Discontinued in Phase 1/2
58097,Phase 1/2a
89118,IND submitted
17521,Phase 0
27141,IND submitted
130904,Investigative
66697,Phase 0
133726,Patented
117401,Investigative
84435,Phase 0
142549,Phase 1
31728,Discontinued in Phase 3
119161,IND submitted
54847,Investigative
181087,Phase 2/3
159736,Phase 1b
10033,Phase 0
63256,Investigative
27038,Phase 1b
144824,Patented
62809,Phase 0
150733,Phase 1
188222,Phase 2/3
52596,Phase 1
2289,Phase 1b/2a
27016,Phase 1b
38120,Discontinued in Phase 2
115165,Phase 1b/2a
93388,IND submitted
156377,Discontinued in Phase 3
69894,Patented
69423,Discontinued in Phase 1/2
73825,Phase 1b/2a
142162,Discontinued in Phase 4
169493,Phase 3
121185,Phase 1/2a
10493,Phase 1b
114013,Phase 1
174706,Phase 1/2
7301,Phase 2a
97755,Phase 1
46268,BLA submitted
60078,Phase 0
39478,Phase 2/3
89898,Phase 2/3
34180,Discontinued in Phase 2/3
138592,Discontinued in Phase 2
97751,Phase 1/2a
32895,Phase 0
37030,Discontinued in Phase 1
116804,Discontinued in Phase 1
96235,Phase 1/2a
144970,Investigative
3489,Approved
71779,Discontinued in Preregistration
117040,Discontinued in Phase 4
111242,Discontinued in Phase 4
148833,Phase 1b
125268,Discontinued in Phase 4
17601,Phase 1/2
64452,Discontinued in Phase 2
157141,IND submitted
81431,Clinical trial
165375,Phase 1
25921,Phase 1/2a
37617,Phase 2a
6405,Investigative
3473,Patented
105366,Phase 1b
156982,Phase 1
40762,Phase 0
8079,Phase 1
14860,Phase 1b/2a
75611,Phase 1/2a
57126,Phase 1/2
111794,Discontinued in Phase 4
34910,Phase 2
52924,Discontinued in Phase 3
179375,Discontinued in Phase 1/2
84852,Phase 1/2a
55644,Discontinued in Phase 3
35050,Phase 1b
137989,Clinical trial
46199,Phase 2/3
6642,Investigative
22663,Phase 1
116413,Phase 1
132504,Discontinued in Phase 1/2
4782,Phase 1b/2a
10622,Discontinued in Phase 2/3
87896,Discontinued in Phase 2
77005,Phase 0
73467,Clinical trial
169797,Patented
191274,Discontinued in Phase 1
60301,Phase 0
145645,Phase 1/2
73000,IND submitted
190412,Phase 4
179069,Phase 1/2
109787,Approved
37403,Phase 1b/2a
158288,Phase 1
88060,Approved
53622,IND submitted
59916,Phase 1
117819,Phase 1
149353,Phase 1/2a
131986,IND submitted
107838,Discontinued in Phase 2/3
66301,Phase 1b
39785,Discontinued in Preregistration
85492,Discontinued in Phase 3
182037,Phase 2/3
5859,Investigative
87069,Discontinued in Phase 1
148873,Clinical trial
38771,Phase 1b
11544,Phase 1
131829,IND submitted
146209,Phase 2
14200,Phase 0
29169,Discontinued in Phase 2/3
164821,BLA submitted
46398,Phase 1/2a
60758,Investigative
173301,Discontinued in Phase 2
130355,Investigative
183353,Approved (orphan drug)
144643,Phase 0
76521,Phase 1/2a
141961,Phase 0
16058,Investigative
124952,Discontinued in Preregistration
167154,Discontinued in Preregistration
120690,Discontinued in Phase 3
96724,Discontinued in Phase 2
127019,Discontinued in Preregistration
96190,Discontinued in Phase 1/2
112179,Phase 1
172098,Phase 0
165649,Phase 1b
91394,BLA submitted
158496,Phase 1b/2a
62026,Phase 1/2a
52949,Investigative
56539,Phase 1/2a
107263,Phase 1/2a
61590,Discontinued in Phase 3
62335,IND submitted
24455,Discontinued in Phase 2/3
89964,Investigative
140432,Phase 2a
120842,Phase 0
92357,Phase 2
72607,Phase 2/3
69863,Phase 1
99628,Phase 1
38862,Phase 0
40226,Discontinued in Preregistration
47193,Phase 2a
71979,Phase 1b
125158,IND submitted
149171,Phase 1
134192,Discontinued in Phase 4
24631,Discontinued in Preregistration
80504,Clinical trial
99756,Patented
132764,Phase 2
128043,Investigative
34446,Phase 0
187202,Patented
19451,Investigative
22087,Discontinued in Phase 2
44079,Phase 2/3
171982,Discontinued in Phase 2
187676,Clinical trial
179501,Discontinued in Phase 1
27272,Phase 2
138169,Phase 1b
110854,Discontinued in Phase 2b
15162,Phase 1
45671,Phase 2/3
101113,Phase 3
154034,Investigative
134868,Phase 0
111885,Phase 0
110436,Phase 1b/2a
109111,Discontinued in Preregistration
163398,Patented
141234,Phase 0
185563,Phase 2
71475,Phase 1b
44961,Phase 2/3
77891,Investigative
72811,IND submitted
154765,Phase 2
134262,Discontinued in Phase 4
34776,Patented
22814,Phase 1/2a
61124,Approved (orphan drug)
30382,Phase 0
190027,Phase 1/2
96183,Phase 1/2a
46951,Discontinued in Phase 1
107899,Discontinued in Phase 2
87386,Patented
139779,Phase 1/2a
56321,Phase 2
79353,Discontinued in Phase 2
74322,Discontinued in Phase 3
148577,Discontinued in Phase 2
21205,Phase 1
22104,Discontinued in Phase 3
91285,Phase 1b
1999,Approved
140395,Phase 1/2
155285,Phase 1
57121,Discontinued in Phase 1/2
155971,Phase 1/2
79583,Phase 2
152917,Investigative
190745,Phase 2/3
169810,Phase 1/2
19084,IND submitted
143158,Phase 2b
105684,Phase 2a
63345,Discontinued in Preregistration
183641,Discontinued in Phase 4
179183,Phase 0
105514,Patented
73598,Approved (orphan drug)
31182,Phase 1
78513,Clinical trial
41184,Approved
20116,Phase 1
180145,Discontinued in Phase 2b
169272,Phase 0
138251,BLA submitted
52198,Phase 2
73984,Phase 1b
139689,Phase 1/2
107223,Phase 1
138572,Approved (orphan drug)
32615,Phase 2/3
35028,Phase 2b
171171,Phase 0
40167,Discontinued in Phase 2
31295,Phase 1
91758,Approved
187050,Phase 1b
61367,Phase 1
106089,Phase 1/2
47748,Phase 1b
107034,IND submitted
75397,Phase 1/2a
186286,Discontinued in Preregistration
191125,IND submitted
7810,Phase 1/2
47239,Approved
91236,Clinical trial
155804,Phase 1/2a
181021,Phase 2a
120997,Phase 1
183245,Phase 1b/2a
58746,Phase 2/3
121031,Phase 1/2a
153832,Discontinued in Preregistration
183687,Discontinued in Phase 2
120696,Approved
53983,Phase 1/2a
64101,Approved (orphan drug)
16268,Phase 0
68658,Phase 1b
146957,Discontinued in Phase 1
144408,Discontinued in Phase 2/3
36589,Discontinued in Preregistration
7580,Phase 2a
70667,Phase 0
83744,Phase 0
59501,Discontinued in Phase 1/2
82509,Phase 1
69427,Discontinued in Phase 3
6831,Investigative
140092,Investigative
5850,Investigative
114752,Phase 1b
47518,Patented
27013,Phase 1b
29326,Phase 1
167804,Discontinued in Phase 3
68249,Approved (orphan drug)
14901,Phase 1/2a
42667,Phase 2
23500,Phase 0
80266,Discontinued in Phase 3
78496,Discontinued in Phase 1/2
133458,Approved
144572,Phase 1/2a
48836,Phase 1b
101978,Phase 1/2a
110951,Phase 1/2
155311,Phase 2a
33033,Phase 2a
150349,Phase 2b
90569,Discontinued in Phase 1
59696,Approved (orphan drug)
27420,Investigative
31314,Discontinued in Phase 3
8411,Phase 1
48081,Phase 3
118224,Phase 1/2a
91752,Discontinued in Preregistration
140058,BLA submitted
9644,Clinical trial
125296,BLA submitted
172340,Phase 1/2
167576,Phase 1/2a
157273,Phase 1/2a
184060,Phase 1
65552,Discontinued in Phase 2b
36112,Phase 2/3
38272,Phase 2a
146623,Phase 1/2a
167296,Discontinued in Phase 1/2
93075,Phase 1
137811,Phase 1/2a
114184,Phase 1/2
114755,Discontinued in Phase 1
30397,Phase 1b
27379,Phase 1
76744,Phase 1
99403,Patented
109672,Phase 4
135950,Phase 3
74197,Phase 1/2a
72224,Phase 1b/2a
106139,Phase 1/2a
127366,Phase 0
179568,Phase 1
114056,Discontinued in Phase 3
28651,Phase 1/2a
86828,Discontinued in Phase 1/2
15573,Phase 1/2a
39991,Phase 1b/2a
98707,Phase 1
64166,Phase 0
128229,Phase 0
109683,Phase 3
52294,Discontinued in Preregistration
181742,Phase 1
12802,Phase 1/2
79340,Discontinued in Phase 3
45337,Phase 2/3
97661,Phase 1b
134162,Phase 1/2
85963,Discontinued in Phase 2b
26149,Discontinued in Phase 4
170128,Phase 0
162982,Phase 1/2
95501,Phase 2/3
117389,Discontinued in Phase 1/2
43931,Phase 1/2a
17255,Discontinued in Phase 1
82497,Phase 0
131284,Discontinued in Preregistration
14139,Investigative
183400,Phase 1b/2a
124193,Discontinued in Preregistration
30697,Phase 1b
8190,Patented
58428,Phase 0
153878,Phase 1/2
53162,Phase 0
95586,Phase 1b
87501,Patented
148222,Phase 1/2a
49061,Discontinued in Phase 3
105786,Discontinued in Phase 4
167328,Discontinued in Phase 1/2
112506,Discontinued in Phase 3
64457,Clinical trial
32868,Phase 2a
84288,Phase 1/2a
141943,Phase 1/2
14574,Phase 1
170676,Phase 1/2
62258,Phase 1
14857,Discontinued in Phase 1
67595,IND submitted
33676,Phase 1b/2a
172805,Phase 0
181905,Phase 2a
150186,Phase 1b/2a
3126,Discontinued in Phase 2b
14786,Phase 3
88943,Phase 1
76841,Phase 1/2
102048,Phase 1/2
79891,Phase 2
186980,Phase 2a
21987,Approved (orphan drug)
48275,Investigative
92376,Phase 2
112641,Phase 0
104969,Phase 1/2
112088,Discontinued in Phase 2
48981,Discontinued in Preregistration
144067,Patented
49797,Discontinued in Preregistration
154383,Investigative
46090,Phase 2a
89014,BLA submitted
68666,Discontinued in Phase 4
22224,Discontinued in Phase 2/3
177516,Phase 2
113264,Discontinued in Phase 4
47200,Discontinued in Phase 2/3
25836,Phase 1b/2a
13743,Phase 1
176167,Phase 1b/2a
190764,Phase 2b
124899,Phase 1/2
137476,Phase 1/2
94264,Phase 2b
130407,Discontinued in Phase 1
163499,Discontinued in Phase 2b
70049,Phase 0
124997,Phase 1b/2a
180492,Phase 1
184454,BLA submitted
127638,Phase 1/2
84716,Phase 0
67194,IND submitted
112077,Phase 0
62273,Phase 1b
4771,IND submitted
24464,Phase 2
82952,Phase 1b/2a
172656,Discontinued in Phase 2/3
111984,Discontinued in Phase 3
93598,Discontinued in Phase 3
41203,Phase 1/2a
59694,Investigative
152140,Phase 1/2
164369,Phase 1
28784,Phase 0
109452,Phase 4
166965,Phase 4
145832,Phase 1b
188947,Phase 1/2
131594,Discontinued in Preregistration
53927,Discontinued in Preregistration
52559,Investigative
147917,Phase 2/3
147108,Phase 1b/2a
148640,Phase 1b
161875,Phase 1/2a
21750,Phase 1/2
181046,Discontinued in Phase 2b
152002,Phase 0
23153,Phase 1/2
164448,Phase 0
93890,Discontinued in Phase 2b
67075,Phase 0
16599,Phase 0
52779,Phase 1b/2a
177926,Discontinued in Phase 3
127349,Patented
133276,Approved
23027,Phase 2
101960,Discontinued in Phase 2/3
40872,Patented
154344,Patented
102557,Approved (orphan drug)
107288,Discontinued in Preregistration
58545,Phase 1/2a
65226,Phase 2/3
169630,Phase 1
104981,Phase 1b/2a
124391,Discontinued in Preregistration
16747,Phase 1
55995,Phase 1/2a
10922,Phase 0
124105,Phase 2
25644,Phase 1
17482,Phase 1/2
105823,Patented
83034,Phase 2/3
98560,Phase 1/2a
60689,Phase 1b/2a
50685,Discontinued in Phase 2b
186711,Phase 4
73036,Patented
128936,Discontinued in Phase 3
29977,Phase 1b
130373,Phase 1/2
33162,Phase 2/3
133423,Approved
126453,Phase 2b
20265,IND submitted
80309,Approved (orphan drug)
60347,Phase 1b/2a
131682,Discontinued in Phase 1/2
76273,Phase 0
67408,Approved (orphan drug)
45596,Phase 1/2a
104320,Phase 2
184759,Phase 0
14296,Phase 0
124768,Patented
56182,Phase 1b/2a
142433,Phase 3
73121,Phase 1
87654,Phase 1b/2a
145513,Phase 2b
87327,Phase 0
93262,Phase 2
32783,Phase 2/3
16893,IND submitted
79896,Patented
108526,Discontinued in Phase 2/3
130760,Clinical trial
77254,Phase 0
152175,Phase 1
44672,Phase 2/3
38385,IND submitted
89003,BLA submitted
162871,Patented
169704,Phase 0
70750,Patented
133892,Phase 1b
33503,Discontinued in Phase 2
48339,Phase 1/2a
103458,Phase 1/2
94536,Phase 1/2a
72580,Phase 2/3
8593,Phase 1/2
145164,Phase 1b
191079,Discontinued in Preregistration
146556,Phase 0
95184,Phase 1/2a
156997,Investigative
132146,Phase 1
180225,Phase 2b
141949,Discontinued in Preregistration
157954,Phase 2
93604,Discontinued in Phase 2b
99130,Phase 1/2a
100741,Investigative
167927,Phase 0
184955,Discontinued in Phase 3
81581,Phase 1
191102,Investigative
3527,Phase 1/2a
157471,Phase 1
10722,Phase 0
101481,Phase 1b/2a
55708,Phase 1b/2a
27967,IND submitted
17271,Phase 0
84976,Phase 0
184880,Discontinued in Phase 4
114290,Patented
3933,Discontinued in Phase 1
120982,Phase 1b
91854,Phase 1b
94003,Phase 2b
181526,Phase 2b
176320,Patented
162074,Investigative
156767,Phase 0
85125,Phase 0
134353,Phase 1/2a
14124,Phase 1/2a
141572,Patented
12017,Phase 1
26505,BLA submitted
77971,Approved (orphan drug)
49320,Discontinued in Phase 3
110054,Phase 1
116175,Phase 2/3
85935,Discontinued in Preregistration
107784,Discontinued in Phase 2/3
9254,Discontinued in Phase 1
66535,Phase 1b
22590,Patented
185768,Phase 1/2a
12666,Phase 1
48264,Phase 1/2
155854,Phase 1/2
83198,Phase 1
52242,Phase 1b/2a
169670,Phase 2
148228,Discontinued in Phase 2
133561,IND submitted
5190,Investigative
105258,Phase 1
190066,Clinical trial
169288,Phase 0
84809,Phase 1b/2a
58482,Phase 0
75137,Discontinued in Phase 4
58930,Phase 0
88298,Phase 1b/2a
182399,Phase 1b/2a
96373,Discontinued in Phase 3
117214,Discontinued in Phase 3
82977,Phase 1/2
184361,Phase 0
79609,Approved (orphan drug)
162669,Phase 1/2a
12506,Investigative
112070,Phase 1/2
159756,Phase 2b
55545,Phase 0
17207,Investigative
163855,Phase 1/2a
42264,Phase 1b
165045,Discontinued in Preregistration
185077,Phase 1/2
87465,Phase 0
77470,Patented
167140,Discontinued in Phase 1/2
4351,Phase 2a
51646,Discontinued in Phase 3
87042,Discontinued in Phase 4
95543,Discontinued in Phase 3
54618,Phase 1b/2a
141990,Discontinued in Preregistration
134152,Phase 1
175842,IND submitted
146982,Investigative
57069,Phase 1b/2a
48558,Phase 1b/2a
191352,Phase 1/2
117809,Phase 2b
117508,Discontinued in Phase 1/2
92261,Phase 1/2a
58599,Discontinued in Phase 2/3
89998,Discontinued in Phase 2b
109692,Phase 1
64137,Discontinued in Phase 2/3
37126,Phase 1
114106,Phase 2
31377,Phase 2
54909,Discontinued in Phase 3
14688,Phase 2b
158405,Discontinued in Preregistration
116687,Discontinued in Phase 2/3
56343,Investigative
24795,Phase 0
123808,Phase 2
25668,Discontinued in Phase 4
42519,Phase 1/2a
53238,Discontinued in Phase 2
7025,Phase 1/2
41847,Phase 1/2a
180256,Phase 2a
171677,Phase 2a
93556,Phase 1b
105964,Phase 1b/2a
1598,Approved
57331,Phase 1
68734,Discontinued in Preregistration
119651,Discontinued in Preregistration
36746,Discontinued in Phase 2
154049,Discontinued in Phase 3
19603,Discontinued in Preregistration
118255,Approved
71478,Discontinued in Phase 3
45811,Phase 1/2a
166516,Phase 1/2a
186281,Patented
162768,Phase 1b
13442,Phase 3
28429,Phase 0
110118,IND submitted
99705,Patented
100793,Phase 1/2a
149431,Phase 1/2a
138465,Investigative
188392,Discontinued in Phase 3
120048,Clinical trial
103009,Phase 1/2a
84746,Phase 0
47636,Phase 0
74898,Phase 1/2a
1707,Discontinued in Phase 1/2
29160,Phase 1b
176217,Patented
160093,Phase 1b/2a
166469,Phase 1
90969,Clinical trial
150880,Phase 2
96362,Phase 1b/2a
87816,Phase 1
38806,Investigative
67928,Discontinued in Phase 2
67176,IND submitted
78896,Phase 1b
83828,Phase 0
30797,Discontinued in Phase 2b
2197,Phase 1/2
134284,Phase 1b
183927,BLA submitted
80481,Phase 1
129110,Phase 1/2
23390,Investigative
160822,Phase 1/2
69973,Phase 1
142499,Phase 3
94195,Investigative
170610,Phase 0
106470,Approved
33,Discontinued in Phase 1/2
83726,Discontinued in Phase 2/3
54674,Discontinued in Preregistration
51136,Phase 1/2a
173533,Patented
146364,Phase 1b/2a
29935,Clinical trial
46455,Phase 0
19755,Discontinued in Preregistration
176016,Phase 2
150178,Discontinued in Phase 2
135108,Phase 0
122691,Discontinued in Phase 4
126911,Discontinued in Preregistration
79226,Phase 1b
132966,Discontinued in Preregistration
36826,Phase 1
97862,Phase 1/2a
143504,Phase 1b/2a
63903,Phase 1b/2a
11979,Investigative
40209,Phase 0
126330,Phase 1b/2a
160064,Phase 1
151995,Phase 2a
76565,Phase 1/2a
159653,Phase 2
56722,Phase 2
130060,Phase 2a
122384,Approved
3556,Discontinued in Phase 2b
122901,Patented
112861,Phase 1/2
156437,Discontinued in Phase 2b
10859,Phase 1
87195,Phase 1
49619,Phase 1/2
65277,Phase 1b/2a
129683,IND submitted
37766,Phase 1/2
174015,Discontinued in Preregistration
176366,Phase 0
141125,Discontinued in Phase 2b
43131,Phase 0
32296,Phase 1b/2a
90723,BLA submitted
146324,Phase 1
143317,Patented
23503,Phase 2
66157,Phase 1b
105996,Discontinued in Phase 4
41388,Phase 1
140563,Phase 1
183017,Phase 1/2a
123468,Phase 1/2
142562,IND submitted
45265,Phase 2/3
134319,Discontinued in Phase 4
89523,Phase 1b
155638,Phase 2/3
86442,Phase 0
105255,Phase 1b
189202,IND submitted
40364,Phase 0
167944,Investigative
125968,Discontinued in Phase 3
109394,Discontinued in Preregistration
180820,Phase 1b/2a
133607,Phase 1
189132,Phase 2/3
85767,Discontinued in Preregistration
188415,Phase 1/2
8824,Discontinued in Phase 1
45892,Phase 1/2a
140855,Registered
127198,IND submitted
94141,Phase 1
77739,Discontinued in Preregistration
142303,Phase 1
144872,Discontinued in Phase 2/3
155334,Phase 1
107644,Phase 0
40039,Phase 0
153038,Phase 1
156292,Phase 1/2a
57891,Phase 1
50671,Phase 1b/2a
112213,Phase 1/2
157235,Patented
95084,Discontinued in Phase 1
80505,Approved (orphan drug)
146328,Phase 1b/2a
11779,Phase 2/3
162592,Phase 1b
78529,Clinical trial
60470,Phase 0
84730,Phase 0
9380,Discontinued in Phase 1
81818,Approved
34566,Phase 1b/2a
159052,Phase 1/2
187060,Phase 0
19322,Phase 2a
110673,Discontinued in Phase 3
177360,Phase 1b/2a
1368,Discontinued in Phase 4
10698,Discontinued in Phase 2b
73052,Phase 1/2a
48467,Phase 1/2a
36113,Phase 2/3
27228,Patented
117294,Discontinued in Phase 3
64098,Phase 0
41153,IND submitted
86785,Discontinued in Phase 2
50842,Patented
158443,Phase 2/3
191386,BLA submitted
138354,Investigative
104707,Phase 1/2
93012,Phase 1/2a
134921,Phase 0
106121,Phase 1b
78850,Phase 2a
136536,Investigative
50641,Discontinued in Preregistration
138949,Investigative
88336,Approved
76913,Phase 1/2
79028,Phase 1b
173972,Discontinued in Preregistration
95270,Patented
90975,Approved (orphan drug)
78019,Clinical trial
68564,Phase 1/2
51486,Phase 1b/2a
163483,Phase 1/2a
11535,Discontinued in Phase 2/3
108458,Phase 1b/2a
106455,Discontinued in Phase 3
86179,Discontinued in Phase 2/3
132849,Discontinued in Phase 4
149024,Discontinued in Phase 1
133406,Discontinued in Phase 1/2
111109,Phase 1b
17063,Discontinued in Phase 1
162353,Preclinical
131795,Patented
142083,Discontinued in Phase 2b
151322,Phase 0
91659,Approved (orphan drug)
188113,Phase 2b
20967,Registered
188501,Phase 0
174466,Phase 1/2
68685,Phase 1/2
109855,Discontinued in Phase 1/2
9577,Discontinued in Phase 2b
179734,Phase 1/2
68973,Discontinued in Phase 1/2
85985,Discontinued in Phase 2b
140102,BLA submitted
1949,Phase 1b
158499,Phase 1b/2a
96809,Investigative
177092,Phase 1b
43588,Phase 1/2a
13148,IND submitted
70863,Phase 1/2a
1774,Phase 2a
156002,IND submitted
127358,Investigative
163092,Discontinued in Phase 2/3
124588,IND submitted
81687,Approved
22573,Phase 1
129549,Phase 1/2
170098,IND submitted
105488,Phase 1b
22077,Patented
121434,Approved (orphan drug)
146452,Investigative
188346,Phase 2b
132247,Phase 1/2
139975,Phase 1/2
40384,Phase 1
21730,Discontinued in Phase 2
9038,Discontinued in Phase 2
86870,Phase 1/2
86173,Investigative
44528,Phase 2/3
190863,IND submitted
123735,Phase 1b
167725,Phase 2
78442,Approved
7325,Discontinued in Phase 2
133995,Phase 1/2
164358,Phase 0
21234,Phase 0
96896,Patented
42294,Phase 1b/2a
305,Phase 1/2a
135787,Preclinical
127643,Discontinued in Preregistration
189260,Clinical trial
106633,Phase 1/2
130567,Phase 0
13084,IND submitted
144698,Discontinued in Phase 4
27102,Phase 1
86657,Patented
17931,Phase 1/2a
165323,Phase 1b/2a
140056,Clinical trial
169764,Patented
87993,Phase 0
155518,Phase 2/3
28054,Phase 2
164614,Phase 0
98946,Phase 1b/2a
15452,IND submitted
119812,IND submitted
80849,Phase 2a
113832,Phase 1
119326,Phase 1/2a
118820,Phase 1b/2a
72306,Discontinued in Phase 3
84797,Phase 1/2a
132937,Discontinued in Preregistration
187379,Patented
72174,Discontinued in Preregistration
162980,Patented
136670,Phase 0
172381,Discontinued in Phase 3
55303,Phase 1b
67263,Discontinued in Phase 2/3
139038,Phase 1b
24651,Phase 2a
40754,Phase 2
105756,Phase 2
33003,Phase 1/2
160561,Phase 1/2a
185567,Phase 1b/2a
33400,Phase 1b/2a
76891,Phase 1b
127827,Investigative
30265,Clinical trial
138243,Approved (orphan drug)
189089,Approved (orphan drug)
172919,IND submitted
82826,Discontinued in Phase 4
74560,Discontinued in Phase 4
183337,Approved (orphan drug)
15209,Phase 1
107210,Phase 0
189331,Clinical trial
62926,Phase 1
40193,Investigative
168234,Discontinued in Phase 1
176386,Phase 1/2a
36877,Phase 0
186470,Phase 2a
132273,Patented
159956,Phase 1
35823,Discontinued in Phase 4
191752,Phase 1/2
1441,Phase 0
147642,Discontinued in Phase 2
2477,Phase 1b
29320,Discontinued in Preregistration
79476,Patented
35772,Phase 0
127316,Discontinued in Phase 3
16612,Phase 3
70052,Discontinued in Preregistration
74089,Phase 2
88928,Investigative
103086,Discontinued in Preregistration
191244,Phase 1/2
46726,Clinical trial
147863,Discontinued in Phase 2/3
184640,Discontinued in Phase 4
145230,Phase 0
82383,Phase 2
24106,Phase 1
76081,Phase 1/2
155338,Phase 1/2
132433,Discontinued in Preregistration
71640,Discontinued in Phase 4
54444,Phase 1b/2a
175868,IND submitted
151643,Phase 0
169379,Phase 0
80555,Discontinued in Phase 2
805,Discontinued in Phase 1
74543,Discontinued in Phase 1/2
60540,Phase 1/2a
188025,Investigative
154336,Patented
149386,Phase 0
3639,Approved
178265,Phase 1b/2a
127305,IND submitted
120423,Investigative
189811,Phase 1/2
139577,Phase 1b
54678,Phase 1b/2a
162937,Patented
136933,Phase 1/2a
106045,Discontinued in Preregistration
142273,Phase 0
189096,Approved
147054,Phase 1b/2a
184758,Phase 0
53168,Phase 1/2a
85647,Discontinued in Preregistration
129976,Phase 0
169349,Phase 2/3
1420,Discontinued in Phase 4
66556,Discontinued in Phase 3
68584,Phase 1
179732,Phase 1/2a
19684,Phase 1
91949,Phase 1/2a
125265,Phase 1b/2a
98845,Phase 1/2a
41853,IND submitted
26122,Phase 1b/2a
150507,Phase 1b
72515,IND submitted
102918,Discontinued in Preregistration
168010,Phase 1/2
9392,Phase 2
14512,Phase 1
58539,Phase 2/3
12219,Investigative
85517,Discontinued in Phase 2b
105887,Phase 1/2a
50931,Phase 1/2
162084,Patented
168899,Discontinued in Phase 4
83033,Phase 2
64810,Investigative
78852,Phase 1b
108023,Phase 1/2
191372,Investigative
18255,Phase 2a
42789,Phase 1
80094,Discontinued in Phase 1/2
44556,Phase 1/2a
96332,Phase 2b
23642,Discontinued in Phase 2/3
1423,Phase 1/2
149114,Patented
135087,Phase 0
33532,Phase 1b/2a
3707,Discontinued in Phase 4
114479,Phase 2
177240,Phase 1b
48390,Phase 2
120210,Discontinued in Phase 3
174861,Discontinued in Phase 4
26052,Phase 1b/2a
97295,Investigative
98337,Phase 1b
13531,Phase 1
11046,Phase 0
1870,Discontinued in Phase 1
38891,Phase 1b/2a
179149,Phase 1b
116454,Discontinued in Phase 3
141741,Patented
22980,Phase 1
4889,Phase 2a
92496,Phase 1
43324,Phase 1/2a
4637,Phase 2a
164489,Phase 1
38144,Phase 0
117435,Discontinued in Phase 2b
157547,Patented
45705,Phase 2/3
75589,Phase 0
171609,Discontinued in Phase 2/3
121644,Approved (orphan drug)
132142,Phase 1b/2a
93000,Discontinued in Phase 3
112604,Discontinued in Phase 2
104698,Phase 2
83844,Discontinued in Phase 4
95885,Phase 2
76122,Phase 1/2
98509,Phase 1/2a
18339,Phase 1/2
175288,Phase 2
169597,IND submitted
70470,Phase 1
153230,Patented
41923,Phase 1/2a
18422,Phase 2
141182,Patented
7946,Patented
128409,Phase 0
75160,Phase 2a
105360,Phase 1b
179334,Phase 1
62631,IND submitted
79337,Phase 2a
187400,Phase 2/3
39855,Phase 1
111449,Phase 1
101713,Phase 2
175139,IND submitted
145031,Phase 2/3
21573,Investigative
143048,Phase 1b/2a
121310,Patented
67313,Discontinued in Phase 2/3
91052,BLA submitted
75315,Investigative
9891,IND submitted
22952,Discontinued in Phase 2/3
43354,Phase 2/3
62033,Discontinued in Phase 4
158305,Phase 1
75725,Discontinued in Phase 1/2
37646,Discontinued in Phase 2
157448,Registered
161923,Investigative
88289,Discontinued in Phase 1/2
68299,Phase 1
14950,Phase 1
34376,Phase 1/2a
21554,Investigative
39109,Phase 1
134204,Phase 1/2
38860,IND submitted
76579,Phase 1b
26663,Phase 1b
111068,Phase 2
114553,Investigative
94863,Patented
40417,Discontinued in Phase 2
88357,Phase 1/2
52569,Phase 4
7519,Phase 2/3
121424,Phase 1b/2a
101715,Investigative
26545,Phase 1
102772,Phase 1/2
84867,Phase 1/2a
34491,Phase 0
149058,Phase 1b/2a
929,Clinical trial
124404,Phase 1/2
151647,Phase 0
186612,Phase 0
105049,Phase 1/2
56036,Phase 3
30554,IND submitted
120635,Phase 0
111670,Discontinued in Phase 2b
65108,Phase 1b/2a
89464,Phase 1/2
96633,Phase 1/2a
185853,Patented
140140,BLA submitted
183826,Discontinued in Preregistration
134030,Phase 1/2a
45511,Phase 2/3
120275,Discontinued in Phase 1/2
117805,Phase 1/2a
186665,Phase 2a
178316,Discontinued in Phase 1
191761,Phase 0
10640,Discontinued in Preregistration
15387,Investigative
175211,Phase 0
102750,Discontinued in Preregistration
109324,Phase 0
59223,Phase 2/3
145672,Investigative
144392,Discontinued in Phase 1/2
177661,Phase 1b
137022,Discontinued in Phase 2/3
151982,Discontinued in Phase 2/3
88331,Approved
78942,Patented
34846,Phase 1b
148730,Phase 1b/2a
158296,Phase 1b/2a
37933,Phase 0
135742,Phase 1/2
177067,Phase 2/3
53743,Discontinued in Phase 2/3
53258,Phase 1b
1161,Patented
44670,Phase 1/2a
119802,Phase 0
174174,Discontinued in Phase 1/2
186852,Phase 0
8701,Phase 1/2a
188573,Phase 1b/2a
155887,Phase 1/2
60828,Phase 1b
163607,Discontinued in Phase 2/3
124803,Discontinued in Phase 4
148598,Phase 2a
4505,Phase 1/2
172307,Phase 2a
82743,Phase 2
7420,Phase 2/3
120262,Approved (orphan drug)
173407,Phase 1b
50940,Phase 2/3
37954,Phase 1b
11337,Discontinued in Phase 2b
150473,Phase 1b
134729,Phase 0
76237,Phase 1/2
116521,Investigative
75336,Discontinued in Phase 2
162441,Patented
55501,Phase 1b
133655,Phase 1b
27193,Phase 1b
161432,Investigative
95948,Phase 1b/2a
10277,Discontinued in Phase 3
174840,Phase 1
49870,Discontinued in Phase 2b
44749,Phase 1/2a
142699,Investigative
7260,Investigative
160170,Phase 1b/2a
30142,Phase 0
175174,Discontinued in Phase 1/2
91407,BLA submitted
128689,IND submitted
95555,Phase 2
90141,Phase 2a
123077,Approved
73270,Clinical trial
96624,Phase 1b/2a
50445,Phase 0
34050,Approved
186595,Phase 0
177750,Phase 2
167841,Phase 0
149015,Phase 1
41862,Phase 2a
23357,Phase 1b/2a
19815,Phase 2a
134760,Phase 0
165468,Discontinued in Phase 1/2
24031,Phase 2/3
157046,Approved (orphan drug)
27765,Phase 2/3
131320,Patented
180625,Phase 2b
6044,Phase 1/2
167837,Discontinued in Phase 3
62688,Phase 1
121167,Phase 2a
35256,Investigative
145022,Phase 1/2
139208,Discontinued in Phase 1/2
82215,Clinical trial
150444,Investigative
50883,Phase 1b
93488,Phase 2a
61383,Patented
140799,Phase 3
52054,Discontinued in Phase 3
136986,Phase 1b
37530,Phase 2
5141,Phase 2a
110007,Phase 1
82401,Phase 1b/2a
254,Phase 2b
164337,Phase 1/2
156853,Phase 1b/2a
35833,Discontinued in Phase 4
175412,Phase 1/2
20689,Phase 1b/2a
115580,Phase 1/2a
19358,Phase 2/3
63592,Phase 1/2
71686,Discontinued in Phase 1
121613,Approved
129488,Phase 0
108882,Phase 1
149489,Phase 1b
13093,Phase 1
22943,Phase 1
36881,Discontinued in Phase 1/2
84494,Phase 1b/2a
52080,Phase 1/2a
167889,Patented
165726,Patented
10521,Phase 0
57759,Discontinued in Phase 2/3
162970,Phase 1/2
128293,IND submitted
188368,Approved
114369,Discontinued in Preregistration
130755,Phase 2
76091,Phase 0
169089,Discontinued in Phase 4
49082,Phase 0
137842,Phase 1/2a
58018,Phase 2/3
188572,Phase 1/2
61027,Phase 1
140186,BLA submitted
107976,Discontinued in Phase 2/3
173116,Discontinued in Phase 2
171262,Phase 0
56810,Phase 1b
170038,Investigative
25041,Phase 1/2
38305,Phase 0
148092,Phase 1b
90775,Phase 0
51031,Phase 1/2a
135254,Phase 0
132733,IND submitted
45897,Phase 2/3
182098,Discontinued in Phase 4
182541,Phase 1
23448,Discontinued in Phase 4
38740,Phase 1/2a
186189,Phase 0
102584,Investigative
30191,Investigative
179084,Discontinued in Phase 2/3
126455,IND submitted
179747,Phase 0
134445,Discontinued in Phase 4
135377,Phase 0
30731,Investigative
23803,Discontinued in Phase 2/3
113167,Phase 1b/2a
51612,Phase 1/2a
166834,Phase 1b/2a
94079,Phase 1b
82490,Phase 1/2a
127705,Discontinued in Phase 4
172156,Investigative
28114,Phase 1/2a
44251,Phase 1/2a
163414,Phase 1b
109988,Phase 1b
15735,Phase 0
97889,Phase 1b
120244,IND submitted
59139,Phase 2/3
168717,Discontinued in Phase 1/2
22187,Phase 1b/2a
80673,Approved (orphan drug)
46084,Phase 1/2a
30803,Phase 2
43547,Phase 1/2a
147245,Phase 1/2
164195,Phase 1/2
54403,Discontinued in Preregistration
158326,Phase 1b/2a
177111,Phase 1/2
36321,Discontinued in Phase 3
129164,Phase 0
9449,Clinical trial
84642,Phase 1/2a
118926,Discontinued in Phase 2/3
102038,Approved
184310,BLA submitted
183817,Approved (orphan drug)
17196,Phase 1/2a
40750,Phase 1/2a
168156,Approved (orphan drug)
152380,Discontinued in Preregistration
96578,Phase 1
124520,Discontinued in Phase 4
95082,Phase 1
124701,Phase 1/2
180157,Discontinued in Phase 2
167454,Discontinued in Preregistration
85638,Discontinued in Preregistration
50581,Phase 0
157809,Phase 1
112817,Discontinued in Phase 3
64556,Discontinued in Phase 2/3
38083,Discontinued in Phase 1/2
38293,Phase 2a
59474,Phase 2/3
79009,Discontinued in Phase 4
77764,Phase 2/3
127372,Phase 1b/2a
20487,Phase 1b/2a
157005,Phase 2
97577,Phase 1b
187241,Phase 0
87202,Patented
139644,Phase 1/2
104289,Phase 1/2a
15679,Phase 1/2
2451,Phase 1b/2a
106047,Phase 1/2
60297,Phase 1b/2a
166560,Phase 1/2a
110138,Phase 2
63975,Phase 1
145465,Phase 1
105815,Phase 1/2
53749,Phase 0
118093,Phase 2
106937,Phase 1b
30174,Discontinued in Phase 3
68465,Discontinued in Phase 2b
103990,Phase 1/2a
125566,Investigative
92938,Phase 2b
181313,Phase 3
102382,IND submitted
20694,Phase 0
85464,Discontinued in Preregistration
114380,Phase 1
4479,Investigative
134623,Patented
70945,Phase 1b/2a
55,Discontinued in Phase 1/2
90495,BLA submitted
186539,Patented
10106,IND submitted
67126,Phase 0
101930,Phase 1/2a
126000,Discontinued in Preregistration
81019,Phase 1
131377,Patented
51397,Phase 0
18836,Discontinued in Phase 2/3
38117,Discontinued in Phase 4
24565,Investigative
10703,Phase 1
184608,Phase 1/2
30728,Discontinued in Phase 2b
67821,Discontinued in Phase 1
40169,Discontinued in Phase 2/3
40052,Discontinued in Phase 4
49028,Phase 1/2a
153342,Phase 0
20583,Phase 0
49372,Phase 3
113820,Phase 1b
98696,Phase 1b/2a
147,Phase 1
2226,Discontinued in Phase 3
160882,Discontinued in Preregistration
160094,Phase 1b/2a
84460,Phase 0
46581,Phase 1/2
36524,Phase 1/2
82933,IND submitted
128623,Discontinued in Preregistration
154582,Phase 1b/2a
125400,Discontinued in Preregistration
173740,Phase 2a
83334,Discontinued in Phase 1/2
104079,Phase 1/2a
48430,Phase 1b
35429,Discontinued in Phase 1/2
61977,Discontinued in Phase 2b
190982,Investigative
74944,Clinical trial
157499,Phase 2
65331,Phase 2/3
168447,Discontinued in Phase 1/2
137690,Phase 1/2a
90952,BLA submitted
62823,Phase 1b
21805,Investigative
109492,Discontinued in Phase 1/2
183876,IND submitted
111412,Phase 1/2
58101,Discontinued in Phase 1/2
142110,Discontinued in Preregistration
41708,Phase 0
147423,Phase 2b
34481,Phase 1b/2a
43912,Phase 2/3
184688,Discontinued in Phase 4
33790,Approved (orphan drug)
145558,Clinical trial
173156,Discontinued in Phase 2
89238,Phase 1/2a
106538,Phase 2a
63595,Phase 1
48257,Investigative
171013,Phase 1/2
161666,Discontinued in Phase 1/2
21024,Phase 2/3
184559,Discontinued in Phase 4
83687,IND submitted
46823,BLA submitted
155587,Patented
12973,Phase 1/2a
80679,Phase 1b
171659,IND submitted
115167,Phase 2/3
161025,Phase 1/2a
81105,Approved
103550,BLA submitted
121741,Phase 1b/2a
92387,Phase 2b
125781,Investigative
69075,Phase 1b
77604,IND submitted
7102,IND submitted
190546,Approved (orphan drug)
96795,Phase 1/2
84893,Phase 1/2
119509,Phase 0
64164,Investigative
71158,Discontinued in Phase 1/2
138229,BLA submitted
145384,IND submitted
80942,Phase 2a
182397,Discontinued in Phase 4
51080,Phase 1b
33439,Clinical trial
141754,Discontinued in Phase 4
169442,Phase 1
190910,IND submitted
168691,Clinical trial
146269,Phase 1/2
181166,Phase 1b/2a
94260,Phase 1/2a
110638,Discontinued in Phase 2b
143970,Phase 1/2
3470,Phase 2a
160062,Phase 1b/2a
55852,Discontinued in Phase 2b
122215,Phase 0
67066,Phase 1/2
77516,Phase 1
79564,Discontinued in Phase 3
49248,Phase 1b
1650,Discontinued in Phase 2
118642,Phase 1
73354,Phase 2a
53491,Phase 0
98994,Phase 1b
126318,IND submitted
140775,Registered
39509,Phase 0
26590,Phase 1b
85269,Discontinued in Preregistration
136360,Phase 1/2a
135024,Phase 0
133261,Phase 1/2
136017,Phase 3
12664,Phase 0
72792,Phase 2
110822,Phase 1b
38519,Discontinued in Phase 2/3
44884,Phase 1/2a
157335,IND submitted
153695,Phase 1/2a
169329,Patented
149938,Phase 1/2a
27251,Phase 1/2a
25635,Phase 1/2a
60407,Phase 1
15117,Phase 0
171465,Phase 2
75738,Patented
137054,Phase 1
134285,Phase 1b
19676,Approved
15563,Phase 1/2a
154489,Approved (orphan drug)
23720,Phase 1
110348,Discontinued in Phase 2/3
26697,BLA submitted
48086,Phase 1b/2a
47299,Investigative
94641,Phase 1b
162899,Phase 1
91712,BLA submitted
48440,Discontinued in Phase 2/3
157410,Approved (orphan drug)
4588,Preregistration
71566,Phase 0
18427,Discontinued in Phase 2/3
166652,Patented
95740,Phase 1b
2942,IND submitted
39498,Phase 2
175137,Phase 1
95157,Phase 1b
189317,Phase 1/2
189597,Phase 1/2
83523,Discontinued in Phase 2/3
66632,Discontinued in Phase 2
27457,Phase 1
165683,Phase 1b/2a
184240,Phase 0
47081,Phase 1/2
74314,Discontinued in Phase 4
74234,Discontinued in Phase 4
156543,Investigative
68377,Preclinical
151045,Phase 0
40735,IND submitted
155299,Discontinued in Preregistration
7232,Phase 1/2
12354,Phase 0
97494,Phase 1b
44429,Phase 1/2a
124896,Phase 1b
23540,Phase 2
100022,Phase 2
132862,Discontinued in Phase 4
179561,Patented
170695,Phase 0
107148,Discontinued in Phase 4
53343,Phase 1/2a
175574,Phase 1/2
16418,Phase 3
149612,Phase 2a
113006,Phase 1
82251,Phase 2/3
48527,Phase 0
66129,Phase 2a
129975,Phase 1/2
172442,Discontinued in Phase 2
150052,Phase 1/2
20940,Phase 1
107482,IND submitted
142662,IND submitted
176912,Phase 1b
97126,Phase 1b/2a
69089,Phase 2b
466,Phase 1
144248,Discontinued in Phase 1/2
121463,Patented
182951,Phase 2a
46174,Phase 1/2a
57136,Phase 0
81099,Approved
137686,Phase 1b
152644,Approved
67946,Phase 2a
41972,Discontinued in Phase 1
72705,Phase 2
97892,Discontinued in Phase 2b
187512,Phase 0
173777,Discontinued in Phase 1
149410,Phase 1b/2a
12208,Phase 1
168960,Discontinued in Phase 1/2
130243,Patented
41025,Discontinued in Phase 4
177476,Approved
79803,Phase 1/2a
26476,Phase 1b
66354,Phase 0
46459,Phase 1b/2a
166308,Phase 1b
169265,BLA submitted
61429,Patented
87066,Phase 1b
185353,Discontinued in Phase 4
107665,Phase 1b
178281,Phase 2/3
178906,Phase 2a
83123,Phase 1/2
142121,Phase 2/3
29387,Phase 1b/2a
140587,Preregistration
138013,BLA submitted
64243,Patented
172988,Discontinued in Phase 2
32314,Phase 1/2a
140928,Discontinued in Phase 2b
174086,IND submitted
188780,Phase 1/2
14924,Phase 0
91815,Phase 1b
136642,Phase 0
33469,Phase 1b/2a
112923,Phase 1
73701,Patented
47814,Phase 1b/2a
131079,Phase 1/2a
75901,Phase 0
174891,Discontinued in Phase 3
102845,Phase 1/2a
12261,Phase 1
124390,IND submitted
76323,Discontinued in Phase 1/2
125467,Phase 1/2
132182,IND submitted
57147,Discontinued in Phase 4
179525,Discontinued in Phase 2/3
176845,Phase 2b
59839,Phase 2/3
184185,Discontinued in Phase 4
52935,Phase 1/2a
53140,Phase 1/2
192056,Phase 2a
118858,Discontinued in Phase 1/2
117755,Discontinued in Phase 2b
14586,Phase 1
86382,Investigative
150032,Phase 2b
104972,Phase 1/2
122822,Phase 1
21741,Phase 1b/2a
141347,Discontinued in Phase 1
94608,Phase 1/2a
35586,Discontinued in Phase 3
45726,Phase 1/2a
172396,Discontinued in Phase 2b
44618,Phase 2/3
174214,Discontinued in Phase 3
108534,BLA submitted
151507,Phase 2
134892,Phase 0
190341,Phase 1b/2a
70590,Phase 0
187705,Phase 0
85929,Discontinued in Preregistration
46933,Discontinued in Phase 2
82881,Phase 0
89972,Phase 0
126162,Phase 1b
154790,Phase 1b/2a
130622,Investigative
29001,Phase 0
124416,Phase 1/2
82794,Phase 0
69358,Phase 3
168310,Approved (orphan drug)
93785,Discontinued in Phase 2b
147635,Phase 1/2
60917,Phase 0
133952,Phase 1/2
103056,Phase 1/2a
136548,Phase 2
127751,Discontinued in Preregistration
54517,IND submitted
44636,Phase 1/2a
158421,Phase 1
46070,Phase 1/2a
44093,Phase 1/2a
91984,Discontinued in Phase 2
139098,Discontinued in Phase 2
89683,Phase 1b/2a
124830,Phase 1b
143472,Phase 1b/2a
55326,Phase 2
107606,Phase 1
184393,Phase 1/2
119296,Phase 1/2a
182100,Phase 1b/2a
138382,BLA submitted
154335,Patented
160656,Phase 3
172129,Discontinued in Phase 3
178409,Discontinued in Phase 1
120640,Clinical trial
182764,Phase 3
167697,Phase 1/2a
53514,Phase 1
138315,BLA submitted
119792,Clinical trial
79037,Phase 2a
50502,Patented
16800,Phase 2b
89140,Discontinued in Phase 3
86388,Phase 2
96645,Phase 0
29740,Phase 0
132152,Discontinued in Preregistration
68106,Phase 1
8203,Discontinued in Phase 4
46506,Approved (orphan drug)
88874,Patented
66084,Phase 2a
11801,Phase 1
125065,Patented
89360,Phase 1/2a
167023,Discontinued in Phase 2
60981,Phase 1/2a
115465,Phase 1/2a
41714,Phase 1/2a
53128,Discontinued in Phase 3
102439,Patented
150426,Phase 2b
127650,Investigative
178095,Patented
44732,Phase 1/2a
77491,Patented
105681,Discontinued in Phase 4
46043,Phase 1/2a
23013,Discontinued in Phase 2/3
71177,Phase 1b/2a
21030,Phase 1b/2a
20666,Phase 1/2a
179872,Phase 1/2
20364,Discontinued in Phase 2b
56941,Discontinued in Phase 2/3
190173,Phase 2/3
18301,Phase 2a
128980,Discontinued in Phase 2b
191464,IND submitted
30881,Investigative
191486,Patented
116771,Phase 1b
133131,Discontinued in Phase 4
56415,Phase 0
26595,BLA submitted
30537,Phase 1b/2a
140899,Phase 3
89720,Phase 1/2
113663,IND submitted
162761,Phase 1/2a
103287,Application submitted
79389,Phase 1
46074,Phase 2a
179879,Phase 1
157876,Phase 2
14502,Phase 1
41215,Discontinued in Phase 1/2
53087,Phase 1/2
89387,Discontinued in Preregistration
155646,Approved
125426,Investigative
156013,Discontinued in Phase 4
92273,Phase 2
184251,BLA submitted
78005,Phase 1
27859,Discontinued in Phase 1
99433,Patented
109608,Discontinued in Preregistration
89975,Phase 0
79864,Phase 2
149390,Phase 1/2
146766,Phase 1b
57715,Phase 1b/2a
190897,Phase 1/2
48888,Phase 1
81256,Discontinued in Phase 3
119046,IND submitted
187,Discontinued in Phase 1/2
57859,Phase 1
538,Discontinued in Phase 1
79523,Phase 1/2a
63021,Patented
18661,Discontinued in Phase 2/3
70459,IND submitted
92292,Phase 2
167182,Phase 4
142093,Discontinued in Preregistration
79342,Discontinued in Phase 4
185385,Discontinued in Phase 4
56037,Phase 3
105685,Phase 2/3
53112,Phase 4
74360,Phase 1/2a
177520,Approved
39408,Phase 1/2
189373,Preclinical
47057,Discontinued in Phase 2/3
184743,BLA submitted
21174,Patented
93458,Phase 2b
31620,Discontinued in Phase 4
190756,Phase 1/2
172143,Discontinued in Phase 2b
149681,Phase 2b
34176,Phase 1b/2a
30780,Discontinued in Phase 4
35957,Phase 1/2
144150,Investigative
160809,Phase 3
130908,IND submitted
54266,Discontinued in Preregistration
147066,Phase 1b/2a
37883,Phase 0
45377,Phase 2/3
9191,Phase 1/2
77886,Discontinued in Phase 2
168695,Phase 2
141092,Patented
47067,Phase 2a
175837,Discontinued in Phase 3
22540,Phase 2
149635,IND submitted
64975,Approved (orphan drug)
142713,Phase 1b/2a
73526,Approved (orphan drug)
141277,Discontinued in Preregistration
181575,Phase 2b
79150,Phase 0
115123,Phase 1b/2a
65439,Phase 1b
26002,Phase 1/2
34207,Phase 1b/2a
11944,Discontinued in Preregistration
130664,Phase 1b/2a
7167,Phase 1b/2a
186037,Investigative
48129,Phase 0
104502,BLA submitted
154799,Phase 1b/2a
57386,Discontinued in Phase 3
31642,Phase 0
33517,Phase 1b/2a
177422,Phase 1/2a
520,Approved (orphan drug)
15371,Phase 1/2a
79907,Approved
